Citrus Sinensis ID: 007490
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 601 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M0X5 | 675 | Cysteine-rich receptor-li | yes | no | 0.975 | 0.868 | 0.487 | 1e-174 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.928 | 0.834 | 0.511 | 1e-169 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.940 | 0.835 | 0.461 | 1e-158 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.863 | 0.827 | 0.478 | 1e-151 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.938 | 0.836 | 0.445 | 1e-150 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.936 | 0.854 | 0.467 | 1e-149 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.938 | 0.679 | 0.423 | 1e-142 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.903 | 0.823 | 0.445 | 1e-142 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.926 | 0.836 | 0.439 | 1e-140 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.946 | 0.882 | 0.455 | 1e-138 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 612 bits (1577), Expect = e-174, Method: Compositional matrix adjust.
Identities = 329/675 (48%), Positives = 422/675 (62%), Gaps = 89/675 (13%)
Query: 6 LLMVFLFLCFVSNFLGFTTAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRS 65
L VFLF+ T +DP YL H CPNTTT++RNS++ +NL LSSL +S +
Sbjct: 11 LFSVFLFMILK------TVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSL---SSPN 61
Query: 66 NGFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTIL 125
++ F NA AG+ + S+RVYG+F CRGD+ + C+DCV FA QRCP EK I
Sbjct: 62 AAYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIW 121
Query: 126 FDECLLRYSNQSFFSNSDMSSQLSMWNLQNVTEPD--KFNVFLGNLMNQVITQAVNNPKR 183
+DEC++RYSNQS + + + N QN+TE +FN L L+ V +A + ++
Sbjct: 122 YDECMVRYSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRK 181
Query: 184 FEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLR 243
F K N++ FQT+YSLVQCTPDL+++DCE CLR + LPRCC GGRV+ PSC+ R
Sbjct: 182 FATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFR 241
Query: 244 YESYPFYNESAIAVPPS-------PPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFI 296
YE YPFYNE+ A P + PP ++ +GK G + + I+ +A V + VL +
Sbjct: 242 YELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGK-GKNLTVIVTAIAVPVSVCVLLL 300
Query: 297 AGLCFL-RRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGE 355
+C+L RR K +A E ++ IT+ E+LQF F IE ATNKFS NKLG GGFGE
Sbjct: 301 GAMCWLLARRRNNKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGE 360
Query: 356 VYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415
VYKG L G+ +A+KRLS+ S QGA+EFKNEV +VAKLQHRNL +LLG+CL+G+EKILVY
Sbjct: 361 VYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVY 420
Query: 416 EFVPNKSLDYFLY-----------------------------DSQLRIIHRDLKASNILL 446
EFVPNKSLDYFL+ DS+L IIHRDLKASNILL
Sbjct: 421 EFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILL 480
Query: 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLAL 506
D M+PKISDFG+ARIFGVDQTQ NT RIVGTYGYMSPEYA+HG++SVKSDVYSFGVL L
Sbjct: 481 DADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVL 540
Query: 507 ETITGKKNSSFYQTDGAEDLLSY------------------------------------- 529
E ITGKKNSSFY+ DG DL++Y
Sbjct: 541 ELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLC 600
Query: 530 --EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKS-TSKSM 586
ED ++RPSM I++ +NS +VTL +P++ + + + P SD S TSKS+
Sbjct: 601 VQEDSSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSASDHSATSKSL 660
Query: 587 PWSVDEASITEVYPR 601
P SVD++SIT VYPR
Sbjct: 661 PLSVDDSSITIVYPR 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 596 bits (1537), Expect = e-169, Method: Compositional matrix adjust.
Identities = 336/657 (51%), Positives = 421/657 (64%), Gaps = 99/657 (15%)
Query: 24 TAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYS 83
+A DP Y+ H C NT +T NST+ +NL L+SL +SR+ +S F NAT GQ
Sbjct: 33 SAQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASL---SSRNASYSTGFQNATVGQAP-- 87
Query: 84 DRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSD 143
DRV GLF CRGD+ + C+ CV+FA + RCP +K T+ +DEC+LRYSNQ+ S
Sbjct: 88 DRVTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLI 147
Query: 144 MSSQLSMWNLQNVT--EPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTVYSLV 201
+ + + N +NVT + D + + +NQ T A+N+ K+F RK N++A Q+ Y LV
Sbjct: 148 TTGGVILVNTRNVTSNQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLV 207
Query: 202 QCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPPSP 261
QCTPDL+ +DC CL+ + Q+P + R G R++ PSC RYE Y FY ESA+ PP P
Sbjct: 208 QCTPDLTRQDCSRCLQLVINQIP---TDRIGARIINPSCTSRYEIYAFYTESAVPPPPPP 264
Query: 262 ---------PPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNA 312
PP S GK G S +IAIV PI+V +LFIAG CFL RRA K Y
Sbjct: 265 PSISTPPVSAPPRS-----GKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSY-Y 318
Query: 313 VLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRL 372
A +DITT +SLQ D++TI+ AT+ F NK+G+GGFGEVYKG L G E+AVKRL
Sbjct: 319 TPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRL 378
Query: 373 SRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY---- 428
S+SSGQG EFKNEVVLVAKLQHRNLVRLLGFCL+G+E++LVYE+VPNKSLDYFL+
Sbjct: 379 SKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAK 438
Query: 429 -------------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463
DS+L IIHRDLKASNILLD MNPKI+DFG+ARIF
Sbjct: 439 KGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIF 498
Query: 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA 523
G+DQT+ NTSRIVGTYGYMSPEYAMHGQ+S+KSDVYSFGVL LE I+GKKNSSFYQTDGA
Sbjct: 499 GLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGA 558
Query: 524 EDLLSY---------------------------------------EDPADRPSMATIVLA 544
DL+SY EDPA+RP+++TIVL
Sbjct: 559 HDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLM 618
Query: 545 LNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASITEVYPR 601
L S++VTL VPRQP LF SR + + + +TSKS+ SVD+ASIT+++PR
Sbjct: 619 LTSNTVTLPVPRQPGLFFQSRIGKDPLDTD------TTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 303/657 (46%), Positives = 408/657 (62%), Gaps = 92/657 (14%)
Query: 24 TAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYS 83
+A +P YL H CPN TT++ NST+ +NL LSS ASR+ +S F N AGQ
Sbjct: 33 SAQNPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSF---ASRNASYSTGFQNIRAGQTP-- 87
Query: 84 DRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSD 143
DRV GLF CRGDL C +CV F+ RCP ++ ++EC+LRYS+++F S
Sbjct: 88 DRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVT 147
Query: 144 MSSQLSMWNLQNVT----EPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTVYS 199
+L M N N++ + D+F + + MNQ +A N+ ++F KT ++ QT+Y
Sbjct: 148 YEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYG 207
Query: 200 LVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPP 259
LVQCTPDL+ +DC CL ++ ++ R G R +PSCN RYE Y FYNE+AI P
Sbjct: 208 LVQCTPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPS 265
Query: 260 SPP------PPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAV 313
PP PP + + GKSG +S+ ++ + + V+ + + G CFL +R +K ++
Sbjct: 266 PPPLFPGSTPPLTSPSIPGKSG-NSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTA 324
Query: 314 LEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLS 373
+D+ T +SLQ D++TI+ ATN F+ NK+GRGGFGEVYKG +G+E+AVKRLS
Sbjct: 325 SASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLS 384
Query: 374 RSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY----- 428
++S QG EFK EVV+VAKLQHRNLVRLLGF L+G+E+ILVYE++PNKSLD L+
Sbjct: 385 KNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQ 444
Query: 429 ------------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464
DS+L IIHRDLKASNILLD +NPKI+DFG+ARIFG
Sbjct: 445 TQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFG 504
Query: 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
+DQTQ NTSRIVGTYGYM+PEYAMHGQFS+KSDVYSFGVL LE I+G+KNSSF ++DGA+
Sbjct: 505 LDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQ 564
Query: 525 DLLSY---------------------------------------EDPADRPSMATIVLAL 545
DLL++ EDPA RP+++T+ + L
Sbjct: 565 DLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMML 624
Query: 546 NSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKS-TSKSMPWSVDEASITEVYPR 601
S++VTL VPRQP FI +S P ++ SD+S T+KS P S+D+ IT++YPR
Sbjct: 625 TSNTVTLPVPRQPGFFI-----QSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 536 bits (1382), Expect = e-151, Method: Compositional matrix adjust.
Identities = 296/618 (47%), Positives = 383/618 (61%), Gaps = 99/618 (16%)
Query: 30 YLAHFCPNTTTFTRNSTFQSNLNLFLSSLPT-NASRSNGFSGCFYNATAGQPSYSDRVYG 88
Y+ H CPNTTT++RNS + +NL LSSL NAS S GF +A AGQ DRV G
Sbjct: 26 YIKHICPNTTTYSRNSPYLTNLRTLLSSLSAPNASYSTGFQ----SARAGQAP--DRVTG 79
Query: 89 LFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSN------- 141
LF CRGD+ C++CV F+ + +CP E+++ +DEC+LRYS+Q+ S
Sbjct: 80 LFLCRGDVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAW 139
Query: 142 SDMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTVYSLV 201
M+ +S+ + + ++F F+ + MNQ +A ++P++F K ++A QT+Y LV
Sbjct: 140 IRMNGNISI----DQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLV 195
Query: 202 QCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPPSP 261
QCTPDL+ +DC CL ++ +P + GGR LY SCN RYE + FYNE+ + +P
Sbjct: 196 QCTPDLTRQDCFSCLESSIKLMPLY---KTGGRTLYSSCNSRYELFAFYNETTVRTQQAP 252
Query: 262 PPPASVTR-------LQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAVL 314
PP + L GKS S+ ++AIV I+V A+L IAG CF +R NA
Sbjct: 253 PPLPPSSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNA-- 310
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSR 374
D D T ESLQ D++ I ATNKFS +NK+G+GGFGEVYKG +G E+AVKRLS+
Sbjct: 311 -PAFDGDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSK 369
Query: 375 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD----- 429
SSGQG EFKNEVV+VAKLQHRNLVRLLGF + G E+ILVYE++PNKSLDYFL+D
Sbjct: 370 SSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQN 429
Query: 430 ------------------------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
S+L IIHRDLKASNILLD MNPK++DFGLARIFG+
Sbjct: 430 QLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGM 489
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
DQTQ NTSRIVGT+GYM+PEYA+HGQFSVKSDVYSFGVL LE I+GKKN+SFY+TDGA D
Sbjct: 490 DQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHD 549
Query: 526 LLSY---------------------------------------EDPADRPSMATIVLALN 546
L+++ EDPA+RP ++TI + L
Sbjct: 550 LVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLT 609
Query: 547 SHSVTLSVPRQPALFIGS 564
S++VTL VP QP + S
Sbjct: 610 SNTVTLPVPLQPGFPVQS 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1373), Expect = e-150, Method: Compositional matrix adjust.
Identities = 297/666 (44%), Positives = 403/666 (60%), Gaps = 102/666 (15%)
Query: 24 TAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPT-NASRSNGFSGCFYNATAGQPSY 82
+A DP YL H+CPNTTT++ NST+ +NL LSSL + NAS S GF NATAG+
Sbjct: 23 SAQDPFYLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNASYSTGFQ----NATAGKAP- 77
Query: 83 SDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNS 142
DRV GLF CRGD+ C++CV F+ CP + +++C+LRYS+++ S +
Sbjct: 78 -DRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTA 136
Query: 143 DMSSQLSMWNLQNVTEP-----DKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTV 197
+ + + N P D F F+ + M++ +A N+ ++ T +A+Q +
Sbjct: 137 ITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNL 196
Query: 198 YSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAV 257
Y L+QCTPDL+ DC CL+ ++ + R G R+ +PSC RYE YPFYNESAI
Sbjct: 197 YGLLQCTPDLTRADCLSCLQSSINGMAL---SRIGARLYWPSCTARYELYPFYNESAIET 253
Query: 258 PPS--------------PPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLR 303
PP PP S + L GKSG +S+ ++ V + V+ + + G CFL
Sbjct: 254 PPLPPPPPPPPPRESLVSTPPISSSSLPGKSG-NSTVLVVAVVVLAVLLFIALVGYCFLA 312
Query: 304 RRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH 363
++ +K ++ +D+ T +SLQ D++TI+ ATN F+ NK+GRGGFGEVYKG +
Sbjct: 313 KKKKKTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSN 372
Query: 364 GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423
G+E+AVKRLS++S QG EFK EVV+VAKLQHRNLVRLLGF L+G+E+ILVYE++PNKSL
Sbjct: 373 GKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSL 432
Query: 424 DYFLY-----------------------------DSQLRIIHRDLKASNILLDVQMNPKI 454
D L+ DS+L IIHRDLKASNILLD +NPKI
Sbjct: 433 DCLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKI 492
Query: 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKN 514
+DFG+ARIFG+DQTQ NTSRIVGTYGYM+PEYAMHGQFS+KSDVYSFGVL LE I+G+KN
Sbjct: 493 ADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKN 552
Query: 515 SSFYQTDGAEDLLSY---------------------------------------EDPADR 535
SSF ++DGA+DLL++ EDPA R
Sbjct: 553 SSFGESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKR 612
Query: 536 PSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASI 595
P+++T+ + L S++VTL VPRQP FI R + + +T+KS P S+D+ SI
Sbjct: 613 PAISTVFMMLTSNTVTLPVPRQPGFFIQCRAVKD----PLDSDQSTTTKSFPASIDDESI 668
Query: 596 TEVYPR 601
T++YPR
Sbjct: 669 TDLYPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 528 bits (1360), Expect = e-149, Method: Compositional matrix adjust.
Identities = 305/653 (46%), Positives = 410/653 (62%), Gaps = 90/653 (13%)
Query: 24 TAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYS 83
+A DP +LA++CPN TT++ NST+ +NL + L + +SR+ +S F NAT GQ
Sbjct: 22 SAQDPRFLAYYCPNATTYSSNSTYLTNLK---TLLSSLSSRNASYSTGFQNATVGQAL-- 76
Query: 84 DRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSD 143
DRV GLF CRGD+ C++CVTFA N RCP ++ ++EC+LRYS+++ S +
Sbjct: 77 DRVTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAI 136
Query: 144 MSSQLSMWNLQNVTEP-----DKF-NVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTV 197
+ + N P ++F N+ L N MNQ+ +A +NP++F KT +A QT
Sbjct: 137 TNEGEFILRNPNHISPIQNQINQFTNLVLSN-MNQIAIEAADNPRKFSTIKTELTALQTF 195
Query: 198 YSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAV 257
Y LVQCTPDLS ++C CL ++ ++P R G R +PSCN RYE Y FYNE+AI
Sbjct: 196 YGLVQCTPDLSRQNCMNCLTSSINRMP---FSRIGARQFWPSCNSRYELYDFYNETAIGT 252
Query: 258 PPSPPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAVLEQN 317
PP P PP + L KSG S+ ++A+V PI+V ++FIAG CF +RA+K Y +
Sbjct: 253 PPPPLPPLASPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALD 312
Query: 318 ADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG 377
D D TT+ESLQ D++ I+ ATN FS +NK+GRGGFG+VYKG +G E+AVKRLS++S
Sbjct: 313 ED-DKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSE 371
Query: 378 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY--------- 428
QG EFKNEVV+VA L+H+NLVR+LGF +E +E+ILVYE+V NKSLD FL+
Sbjct: 372 QGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLY 431
Query: 429 --------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468
DS+L IIHRDLKASNILLD MNPKI+DFG+ARIFG+DQT
Sbjct: 432 WTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQT 491
Query: 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLS 528
Q NTSRIVGTYGYMSPEYAM GQFS+KSDVYSFGVL LE I+G+KN+SF +TD A+DL++
Sbjct: 492 QQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVT 551
Query: 529 Y---------------------------------------EDPADRPSMATIVLALNSHS 549
+ EDP RP+M+TI + L S++
Sbjct: 552 HAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNT 611
Query: 550 VTLSVPRQPALFIGSRTERSFPEREFECSDKSTS-KSMPWSVDEASITEVYPR 601
+ L P+QP F+ SR P SD+ST+ KS+ S+D+ S++++ PR
Sbjct: 612 MALPAPQQPGFFVRSR-----PGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 304/718 (42%), Positives = 399/718 (55%), Gaps = 154/718 (21%)
Query: 20 LGFTTAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQ 79
L T+A DP Y+ H CP+ TF R+ST+ +NL LS+L +S S +S F NATAG+
Sbjct: 131 LVVTSALDPTYVYHVCPSWATFPRSSTYMTNLITLLSTL---SSPSASYSTGFQNATAGK 187
Query: 80 PSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFF 139
+ DRV GLF CRGD+ C+ CV+FA + RCP+EK T+ +D+C LRYSN++
Sbjct: 188 --HPDRVTGLFNCRGDVSPEVCRRCVSFAVNETSTRCPIEKEVTLYYDQCTLRYSNRNIL 245
Query: 140 SNSDMSSQLSMWNLQNVT--EPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTV 197
S S+ + + + N QN+T E +F + MNQ A N+ KRF+ R N++ ++
Sbjct: 246 STSNTNGGIILANSQNMTSNEQARFKDLVLTTMNQATIAAANSSKRFDARSANFTTLHSL 305
Query: 198 YSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAV 257
Y+LVQCT DL+ +DC CL+ + QLP + + GG+ + PSC+ R+E FYN+SA+
Sbjct: 306 YTLVQCTHDLTRQDCLSCLQQIINQLP---TEKIGGQFIVPSCSSRFELCLFYNQSAVT- 361
Query: 258 PPSPPPPAS--------------------------------------------------V 267
+P P + V
Sbjct: 362 --TPQPQQNSAPPPPPTSIPSPRPGLNSRFPLITCLSAVSFEKFKDLLKPGFICILIKIV 419
Query: 268 TRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAV-------------- 313
+ GK G SS IIA+V I + +LF+A +R +K A+
Sbjct: 420 SENTGKGGNSSVIIIAVVVSITALLLLFVAVFSVRTKRRKKMIGAIPLLNVKRKDTEVTE 479
Query: 314 -LEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRL 372
L +N D+ ITT SLQFDFK I ATN F NKLG+GGFGEVYKG P G ++AVKRL
Sbjct: 480 PLAENGDS-ITTAGSLQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRL 538
Query: 373 SRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY---- 428
S++SGQG +EF+NEVV+VAKLQHRNLVRLLG+CLEG+EKILVYEFV NKSLDYFL+
Sbjct: 539 SKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTM 598
Query: 429 -------------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463
DS+L IIHRDLKA NILLD MNPK++DFG+ARIF
Sbjct: 599 KRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIF 658
Query: 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA 523
G+DQT+ NT R+VGTYGYM+PEYAM+GQFS+KSDVYSFGVL E I+G KNSS YQ D +
Sbjct: 659 GMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDS 718
Query: 524 -EDLLSY---------------------------------------EDPADRPSMATIVL 543
+L++Y ED DRP+M+ IV
Sbjct: 719 VSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQ 778
Query: 544 ALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASITEVYPR 601
L + S+ L+VP+QP F R E + S + S+D+ASIT V PR
Sbjct: 779 MLTTSSIVLAVPKQPGFFFRGRHE------QVGEVGSSVDRLALCSIDDASITSVAPR 830
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-142, Method: Compositional matrix adjust.
Identities = 296/664 (44%), Positives = 400/664 (60%), Gaps = 121/664 (18%)
Query: 27 DPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYSDRV 86
DP Y+ H C N +RNS + SNL L+SL +N + FS ++ T GQ S D V
Sbjct: 28 DPTYVGHVCTNR--ISRNSIYFSNLQTLLTSLSSNNAY---FSLGSHSLTKGQNS--DMV 80
Query: 87 YGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSDMSS 146
+GL+ C+GDL +C++CV FA K+ RCP K I +DEC+L YS+++ F ++ ++
Sbjct: 81 FGLYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTT 140
Query: 147 QLSMWNLQNVT--EPDKFNVFLGNLMNQVITQAVNN-PKRFEIRKTNYSAFQTVYSLVQC 203
+ WN Q VT + D+FN + +LM + +A N+ K+F ++K+++S+ Q++Y+ VQC
Sbjct: 141 TIITWNTQKVTADQSDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQC 200
Query: 204 TPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNES---------- 253
PDL+S DC +CL+ ++ +L + GGR L PSCN RYE YPFY E+
Sbjct: 201 IPDLTSEDCVMCLQQSIKEL---YFNKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPV 257
Query: 254 ------AIAVPPSPPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCF-LRRRA 306
++ P PP GK S+ IIAIV P+ + ++ +A F +RA
Sbjct: 258 SAPPLPLVSTPSFPP---------GKGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRA 308
Query: 307 EKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQE 366
+K Y+ E +DITT SLQFDFK IE AT+KFS NKLG+GGFG+VYKG LP+G +
Sbjct: 309 KKTYDTPEE----DDITTAGSLQFDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQ 364
Query: 367 IAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF 426
+AVKRLS++SGQG +EFKNEVV+VAKLQHRNLV+LLGFCLE +EKILVYEFV NKSLDYF
Sbjct: 365 VAVKRLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYF 424
Query: 427 LYDSQLR-----------------------------IIHRDLKASNILLDVQMNPKISDF 457
L+DS+++ IIHRDLKA NILLD MNPK++DF
Sbjct: 425 LFDSRMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADF 484
Query: 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517
G+ARIF +DQT+ +T R+VGTYGYMSPEYAM+GQFS+KSDVYSFGVL LE I+G+KNSS
Sbjct: 485 GMARIFEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSL 544
Query: 518 YQTDGA-EDLLSY---------------------------------------EDPADRPS 537
YQ D + +L++Y ED +RP+
Sbjct: 545 YQMDASFGNLVTYTWRLWSDGSPLDLVDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPT 604
Query: 538 MATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASITE 597
M+ IV L + S+ L+VP+ P F S E++ P S KS S+D ASIT
Sbjct: 605 MSAIVQMLTTSSIALAVPQPPGFFFRSNHEQAGP---------SMDKSSLCSIDAASITI 655
Query: 598 VYPR 601
+ PR
Sbjct: 656 LAPR 659
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 498 bits (1281), Expect = e-140, Method: Compositional matrix adjust.
Identities = 293/666 (43%), Positives = 390/666 (58%), Gaps = 109/666 (16%)
Query: 24 TAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYS 83
+A +P YL H C TTT++ NST+ +NL + L + +SR+ +S F NATAGQ
Sbjct: 22 SAQNPFYLYHNCSITTTYSSNSTYSTNLK---TLLSSLSSRNASYSTGFQNATAGQAP-- 76
Query: 84 DRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSD 143
D V GLF CRG++ C+ C+ + RCP E+ +++C+LRYSN++ S +
Sbjct: 77 DMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLN 136
Query: 144 MSSQLSMWNLQN--VTEPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTVYSLV 201
+ M N +N + D+F + N MN +A + KRF + K + +A Q++Y +V
Sbjct: 137 TDGGVFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMV 196
Query: 202 QCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVP-PS 260
QCTPDL+ +DC CL+ ++ Q+ + GGR PSC RY++Y FYNE + P S
Sbjct: 197 QCTPDLTEQDCLDCLQQSINQV---TYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQDS 253
Query: 261 PPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAV------- 313
P P GK G SS +IA+V PI V+ +LF+A R + +K A+
Sbjct: 254 SPRP-------GKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKR 306
Query: 314 ---------LEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHG 364
E +DITT SLQFDFK I AT+ F NKLG+GGFGEVYKG P G
Sbjct: 307 KETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSG 366
Query: 365 QEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLD 424
++AVKRLS++SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEG+EKILVYEFVPNKSLD
Sbjct: 367 VQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLD 426
Query: 425 YFLY-----------------------------DSQLRIIHRDLKASNILLDVQMNPKIS 455
YFL+ DS+L IIHRDLKA NILLD MNPK++
Sbjct: 427 YFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 486
Query: 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNS 515
DFG+ARIFG+DQT+ NT R+VGTYGYM+PEYAM+G+FS+KSDVYSFGVL LE ++G KNS
Sbjct: 487 DFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNS 546
Query: 516 SFYQTDGA-EDLLSY---------------------------------------EDPADR 535
S Q DG+ +L++Y ED DR
Sbjct: 547 SLDQMDGSISNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDANDR 606
Query: 536 PSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASI 595
P+M+ IV L + S+ L+VPR P F+ S+ E++ E C TS +S+DEASI
Sbjct: 607 PTMSAIVQMLTTSSIALAVPRPPGFFLRSKQEQA----ERACPSMDTSDL--FSIDEASI 660
Query: 596 TEVYPR 601
T V PR
Sbjct: 661 TSVAPR 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 493 bits (1268), Expect = e-138, Method: Compositional matrix adjust.
Identities = 304/668 (45%), Positives = 392/668 (58%), Gaps = 99/668 (14%)
Query: 7 LMVFLFLCFVSNFLGFTTAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSN 66
L+ F+FL S+ +A + YL H C TTTF+ NST+ +NL LSSL + + S
Sbjct: 4 LISFIFLFLFSSITA--SAQNTFYLYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSY 61
Query: 67 GFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILF 126
F ATAGQ DRV GLF CR D+ S C+ CVTFA RCP +K +
Sbjct: 62 STG--FQTATAGQAP--DRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYY 117
Query: 127 DECLLRYSNQSFFSNSDMSSQLSMWNLQN--VTEPDKFNVFLGNLMNQVITQAVNNPKRF 184
++CLLRYSN++ + + + M + +N + D+F + MN +A + K++
Sbjct: 118 EQCLLRYSNRNIVATLNTDGGMFMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARSFKKW 177
Query: 185 EIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRY 244
+RK + +A Q++Y +V+CTPDL +DC CL+ + Q+ + GGR+L PSC RY
Sbjct: 178 AVRKIDLNASQSLYGMVRCTPDLREQDCLDCLKIGINQVTY---DKIGGRILLPSCASRY 234
Query: 245 ESYPFYNESAIAVP-PSPPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLR 303
++Y FYNES + P S P P GK G SS IIA+V PI V+ +L +A +R
Sbjct: 235 DNYAFYNESNVGTPQDSSPRP-------GKGGNSSVIIIAVVVPITVLFLLLVAVFS-VR 286
Query: 304 RRAEKKYNAVLEQNAD-NDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP 362
+ ++ N D NDITT SLQFDFK IE ATN F NKLG+GGFGEVYKG L
Sbjct: 287 AKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLS 346
Query: 363 HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS 422
G ++AVKRLS++SGQG +EF+NEVV+VAKLQHRNLV+LLG+CLEG+EKILVYEFVPNKS
Sbjct: 347 SGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKS 406
Query: 423 LDYFLY-----------------------------DSQLRIIHRDLKASNILLDVQMNPK 453
LD+FL+ DS+L IIHRDLKA NILLD MNPK
Sbjct: 407 LDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPK 466
Query: 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKK 513
I+DFG+ARIFG+DQT+ T R+VGTYGYMSPEYAM+GQFS+KSDVYSFGVL LE I+G K
Sbjct: 467 IADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMK 526
Query: 514 NSSFYQTD-GAEDLLSY---------------------------------------EDPA 533
NSS YQ D +L++Y ED
Sbjct: 527 NSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAE 586
Query: 534 DRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEA 593
DRP+M++IV L + + L+ PR P F S+ E++ P S S SVDEA
Sbjct: 587 DRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQEQAGP---------SIDSSTHCSVDEA 637
Query: 594 SITEVYPR 601
SIT V PR
Sbjct: 638 SITRVTPR 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 601 | ||||||
| 359474717 | 663 | PREDICTED: cysteine-rich receptor-like p | 0.950 | 0.861 | 0.558 | 0.0 | |
| 255555035 | 671 | ATP binding protein, putative [Ricinus c | 0.968 | 0.867 | 0.555 | 0.0 | |
| 255555031 | 674 | ATP binding protein, putative [Ricinus c | 0.945 | 0.842 | 0.561 | 0.0 | |
| 224113935 | 674 | predicted protein [Populus trichocarpa] | 0.956 | 0.853 | 0.558 | 0.0 | |
| 359474715 | 684 | PREDICTED: cysteine-rich receptor-like p | 0.973 | 0.855 | 0.528 | 0.0 | |
| 351721533 | 667 | cysteine-rich protein precursor [Glycine | 0.938 | 0.845 | 0.533 | 0.0 | |
| 356575777 | 671 | PREDICTED: cysteine-rich receptor-like p | 0.978 | 0.876 | 0.505 | 0.0 | |
| 356575779 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.978 | 0.882 | 0.508 | 1e-180 | |
| 255555033 | 579 | ATP binding protein, putative [Ricinus c | 0.816 | 0.848 | 0.613 | 1e-180 | |
| 356575785 | 675 | PREDICTED: cysteine-rich receptor-like p | 0.978 | 0.871 | 0.502 | 1e-179 |
| >gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/653 (55%), Positives = 445/653 (68%), Gaps = 82/653 (12%)
Query: 24 TAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYS 83
T + P YL H CPNTTTF NS++++NLN LSSL +NA+R GF YN TAG+ +
Sbjct: 18 TESAPGYLYHICPNTTTFNPNSSYETNLNFALSSLSSNATRDTGF----YNVTAGR-TPP 72
Query: 84 DRVYGLFRCRGDLGSTACQDCV-TFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNS 142
D YGLF CRGD+ S CQDCV T + V QRC K+ I +DEC+LRYSN+SFFS
Sbjct: 73 DVAYGLFLCRGDVTSQVCQDCVATAVNETVRQRCRGFKQAIIWYDECMLRYSNESFFSQV 132
Query: 143 DMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQAVNNP--KRFEIRKTNYSAFQTVYSL 200
S ++SMWN QN+TEPD+FN LG+ ++ + TQAVN+ K+F ++ N++ FQ VYSL
Sbjct: 133 SESPRVSMWNTQNITEPDQFNQVLGDTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSL 192
Query: 201 VQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPPS 260
VQCTPDLS C+ CL G + LP CC G+QG RVL+PSCN+RYE YPFY +S A P
Sbjct: 193 VQCTPDLSPDQCDRCLIGTIAILPDCCGGKQGARVLFPSCNVRYELYPFY-QSVAAPPSP 251
Query: 261 PPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLF-IAGLCFLRRRAEKKYNAVLEQNAD 319
PP S +GK G+SS TI+ IV P V V+F I CF+RR A+K+Y+ + +N +
Sbjct: 252 PPARPSEPSTEGKGGISSKTIVIIVVPTFVSVVIFSILCYCFIRRCAKKRYDTLEAENVE 311
Query: 320 NDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQG 379
+ITT +SLQFD TI+ ATN FS NK+G GGFG VYKG L GQEIA+KRLS+SSGQG
Sbjct: 312 FNITTEQSLQFDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQG 371
Query: 380 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY----------- 428
A EFKNEVVLVAKLQHRNLVRLLGFCLEG+EKILVYE+VPNKSLDYFL+
Sbjct: 372 AVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQPTKRGQL 431
Query: 429 ---------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467
DS+LR+IHRDLKASN+LLD MNPKISDFG+ARIFGVDQ
Sbjct: 432 DWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQ 491
Query: 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL 527
TQGNT+R+VGTYGYMSPEYAMHG+FSVKSDVYSFGVL LE I+GK+++ F+++D AEDLL
Sbjct: 492 TQGNTNRVVGTYGYMSPEYAMHGRFSVKSDVYSFGVLVLEIISGKRSNCFHESDQAEDLL 551
Query: 528 SY---------------------------------------EDPADRPSMATIVLALNSH 548
SY EDP DRPSMA++VL L+S+
Sbjct: 552 SYAWKLWRNDTPLEFMGPTTRNSFSKNEVIRCIHMGLLCVQEDPDDRPSMASVVLMLSSY 611
Query: 549 SVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASITEVYPR 601
SVTL +P+QPA F + FP E SD+S SKSM WSV+EASIT++YPR
Sbjct: 612 SVTLPLPQQPASFSRTGALSDFPIMALE-SDQSASKSMTWSVNEASITDLYPR 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1765), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/672 (55%), Positives = 446/672 (66%), Gaps = 90/672 (13%)
Query: 11 LFLCFVSNFLGFTTAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSG 70
+ L F+ A P Y HFC NTTTFT NST+Q+NLN LSSL NA+ S GF
Sbjct: 9 IILLFLLRLAIIVKAESPEYRYHFCSNTTTFTPNSTYQTNLNQVLSSLSNNANNSIGF-- 66
Query: 71 CFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECL 130
+N +GQ D VYG F CRGD+ + CQDCVTFAT+++ +RCP+EK + +D+CL
Sbjct: 67 --FNIPSGQQP--DDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDQCL 122
Query: 131 LRYSNQSFFSNSDMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQA---VNNPKRFEIR 187
LRY NQSF S D + + + N Q++++PD+F+ L M + T A + K+F
Sbjct: 123 LRYENQSFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGEKKFAAT 182
Query: 188 KTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESY 247
N++AFQ +YSLVQCTPDLS+ C CLRGA+ LP CC G++G VLYPSCN+RYE Y
Sbjct: 183 DDNFTAFQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCNVRYEVY 242
Query: 248 PFYNESAIAVPPSPPP--------PASVTR--LQGKSGLSSSTIIAIVAPIVVIAVLFIA 297
PF+N +A+ PP P S TR +G+SG+S+ I+AIVAP+ + VLF
Sbjct: 243 PFFNATAVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIAIVLFSL 302
Query: 298 GLCFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVY 357
C+LRRR KKY+AV E N+ITT+ESLQ D T+E ATNKFS+DNKLG GGFGEVY
Sbjct: 303 AYCYLRRRPRKKYDAVQEDG--NEITTVESLQIDLNTVEAATNKFSADNKLGEGGFGEVY 360
Query: 358 KGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417
KG+LP+GQEIAVK+LSRSSGQGAQEFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYEF
Sbjct: 361 KGILPNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEF 420
Query: 418 VPNKSLDYFLY-----------------------------DSQLRIIHRDLKASNILLDV 448
V NKSLDYFL+ DSQLRI+HRDLK SNILLD
Sbjct: 421 VSNKSLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVSNILLDR 480
Query: 449 QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508
MNPKISDFG ARIFGVDQ+QGNT RIVGTYGYMSPEYAMHGQFSVKSD+YSFGVL LE
Sbjct: 481 NMNPKISDFGTARIFGVDQSQGNTKRIVGTYGYMSPEYAMHGQFSVKSDMYSFGVLILEI 540
Query: 509 ITGKKNSSFYQTDGAEDLLSY--------------------------------------- 529
I GKKNSSFY+ DGA DL+SY
Sbjct: 541 ICGKKNSSFYEIDGAGDLVSYVWKHWRDGTPMEVMDPVIKDSYSRNEVLRCIQIGLLCVQ 600
Query: 530 EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWS 589
EDPADR +MAT+VL LNS SVTL VP+QPA I SR++ + P + E DKST KSM S
Sbjct: 601 EDPADRLTMATVVLMLNSFSVTLPVPQQPAFLIHSRSQPTMPMKGLEL-DKSTPKSMQLS 659
Query: 590 VDEASITEVYPR 601
VD+ IT++YPR
Sbjct: 660 VDQEPITQIYPR 671
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555031|ref|XP_002518553.1| ATP binding protein, putative [Ricinus communis] gi|223542398|gb|EEF43940.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/655 (56%), Positives = 447/655 (68%), Gaps = 87/655 (13%)
Query: 27 DPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYSDRV 86
+P YL H C NTTTF NST+Q+NLN SL NA+ S GF YN ++GQ D +
Sbjct: 27 EPVYLYHVCSNTTTFAPNSTYQTNLNQLFPSLSNNANNSIGF----YNRSSGQDP--DDI 80
Query: 87 YGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSDMSS 146
YGLF CRGD+ + CQDCVTFA++++ +RCP+EK + +DECLL Y+N+S +S
Sbjct: 81 YGLFLCRGDVSTDVCQDCVTFASQDIVKRCPIEKVAIVWYDECLLHYANRSLYSIMAQEP 140
Query: 147 QLSMWNLQNVTEPDKFNVFLGNLMNQVITQAVN---NPKRFEIRKTNYSAFQTVYSLVQC 203
+ + N+QN+ + D+FN L M ++ T+A + K+F ++ N++AF+ +YSLVQC
Sbjct: 141 GVFLLNVQNIADQDRFNNLLATTMGKLATEAASAASGEKKFAVKIDNFTAFEKLYSLVQC 200
Query: 204 TPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAI-------A 256
TPDLS+ DC CL+ A+ LP CC G++GGRVLYPSCN+RYE YPF+N +A+ +
Sbjct: 201 TPDLSNLDCGRCLQAAISNLPTCCDGKRGGRVLYPSCNIRYEVYPFFNVTALEPPPPSPS 260
Query: 257 VPPSPPPPASVTR--LQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAVL 314
PPP +S TR +GKSGLS+ TI+AIVAP+ V V F G C+LRRRA KKY+A
Sbjct: 261 PVVPPPPTSSGTRPETKGKSGLSTVTIVAIVAPVAVAIVFFFLGCCYLRRRARKKYDAGQ 320
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSR 374
E +A N+ITT+ESLQ D TIE AT+KFS+ NKLG GGFG+VYKG LP+GQEIAVK+LSR
Sbjct: 321 EDDAGNEITTVESLQIDLNTIEAATDKFSAANKLGEGGFGKVYKGTLPNGQEIAVKKLSR 380
Query: 375 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY------ 428
SS QGAQEFKNEVVL+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+
Sbjct: 381 SSVQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDAKKQG 440
Query: 429 -----------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
DSQL+IIHRDLK SNILLD MNPKISDFG+ARIFGV
Sbjct: 441 QLDWQTRYKIVGGIARGIIYLHEDSQLKIIHRDLKVSNILLDKDMNPKISDFGMARIFGV 500
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
DQTQGNT+RIVGTYGYMSPEYAMHG FSVKSD+YSFGVL LE I GKKNSSFY+ GA D
Sbjct: 501 DQTQGNTNRIVGTYGYMSPEYAMHGHFSVKSDIYSFGVLVLEIICGKKNSSFYEIHGASD 560
Query: 526 LLSY---------------------------------------EDPADRPSMATIVLALN 546
L+SY ED DRP+MATI+L LN
Sbjct: 561 LVSYVWTHWKDGTPMEVVDPVLKDSYSRNEVLRCIQIGLLCVQEDATDRPTMATIMLMLN 620
Query: 547 SHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEASITEVYPR 601
S SVTL VPRQPA F+ S +E + P + SDKST+KSM W +E SIT+VYPR
Sbjct: 621 SFSVTLPVPRQPAFFLHSSSEPTMPMEGLQ-SDKSTTKSMQWYGNEESITQVYPR 674
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113935|ref|XP_002316618.1| predicted protein [Populus trichocarpa] gi|222859683|gb|EEE97230.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 670 bits (1729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/661 (55%), Positives = 454/661 (68%), Gaps = 86/661 (13%)
Query: 22 FTTAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPS 81
T A DP +L +CPNTTTFTRNST+Q+NLNL LSSL +NA+R+N +G FYN +AGQ
Sbjct: 19 ITQAQDPTFLYPYCPNTTTFTRNSTYQANLNLLLSSLSSNATRNN-ING-FYNVSAGQDP 76
Query: 82 YSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSN 141
D VYG+F CRGD+ ++ C++CV FA K+V +RCP+EK I FDEC LRYSN++ FS
Sbjct: 77 --DAVYGMFLCRGDVSNSVCRNCVNFAAKDVLERCPIEKVAMIWFDECELRYSNRNIFST 134
Query: 142 SDMSSQLSMWNLQNVT-EPDKFNVFLGNLMNQVITQAVNNP---KRFEIRKTNYSAFQTV 197
D L M + NVT +PD+FN + +N + +A + P K+F +++ NY+ Q +
Sbjct: 135 VDQDFTLFMMSPNNVTVQPDRFNQLVETTINDIAARAASAPSGAKKFAVQQVNYTGIQKL 194
Query: 198 YSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAV 257
Y+LVQCTPDLS+ DC CL+GA+ +L CC+ +QGGRVL+ SCN RYE Y FYN +A A
Sbjct: 195 YTLVQCTPDLSTPDCSRCLQGAISKLGNCCNRKQGGRVLFASCNFRYELYEFYNATAAAE 254
Query: 258 PPSPPPPASVTRL--------QGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKK 309
PPPP +++ +GK G+S+ IIAI+ P+ V VLF G CFL RRA+
Sbjct: 255 AAPPPPPVALSPPPTSGPETRKGKGGVSTVLIIAILIPVTVSLVLFCLGFCFLSRRAKSN 314
Query: 310 YNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAV 369
N+ E + N+IT +ESLQFD +I+ ATN FS+DNKLG GGFGEVYKG LP+GQ IAV
Sbjct: 315 KNSAQENDVGNEITNVESLQFDLSSIQDATNHFSADNKLGEGGFGEVYKGTLPNGQAIAV 374
Query: 370 KRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY- 428
KRLS+ SGQGA EFKNEV+LVAKLQHRNLVRLLGFCLEG+EKILVYEFVPNKSLDYF++
Sbjct: 375 KRLSKGSGQGAAEFKNEVILVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFVFD 434
Query: 429 ----------------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460
DS+LR+IHRDLKASNILLD MN K+SDFG+A
Sbjct: 435 PEKQGLLDWSKRYKIIGGIARGILYLHEDSRLRVIHRDLKASNILLDGDMNAKVSDFGMA 494
Query: 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT 520
RIFGVDQTQG T+RIVGTYGYMSPEYAMHGQFSVKSD YSFGVL LE I+GKKNSSFYQT
Sbjct: 495 RIFGVDQTQGCTNRIVGTYGYMSPEYAMHGQFSVKSDAYSFGVLILEIISGKKNSSFYQT 554
Query: 521 DGAEDLLSY---------------------------------------EDPADRPSMATI 541
GA DL SY EDPA RP+MAT+
Sbjct: 555 GGAADLASYAWKHWRDGTPLEVMDPTLADTYSRNEVMRCIHIGLLCVQEDPASRPTMATV 614
Query: 542 VLALNSHSVTLSVPRQPALFIGSRTER-SFPEREFECSDKSTSKSMPWSVDEASITEVYP 600
VL LNS+S+TL +P++PA F+ SRT++ S P +EF +DKS S S+P+S DE SITEVYP
Sbjct: 615 VLLLNSYSITLPLPQEPAFFLHSRTDQGSIPSKEF-FADKSKSNSVPYSGDEGSITEVYP 673
Query: 601 R 601
R
Sbjct: 674 R 674
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474715|ref|XP_003631522.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/683 (52%), Positives = 442/683 (64%), Gaps = 98/683 (14%)
Query: 10 FLFLCFVSNFLG-FTTAADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGF 68
LFLC + + A P+Y+ H C NTTT NST+Q+NLN LSSL +NA+R+NGF
Sbjct: 9 LLFLCALGLAISCLAIQAAPDYIHHVCSNTTTIQPNSTYQTNLNSLLSSLSSNATRANGF 68
Query: 69 SGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDE 128
YNATAGQ D YGLF CRGD+ C+DCV A+ + Q+C K+ I +D+
Sbjct: 69 ----YNATAGQSP--DVAYGLFLCRGDVAIDDCRDCVANASAEILQQCSGVKKAIIWYDQ 122
Query: 129 CLLRYSNQSFFSNSDMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQAVNNP--KRFEI 186
C+L YSN+S FS + + L ++NLQNVT+P FN + + MN T A N+ K+F
Sbjct: 123 CMLHYSNRSIFSRVEENPMLQLYNLQNVTDPGPFNQLVVDTMNATATLAANDESGKKFAT 182
Query: 187 RKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYES 246
++ N++ QT+YSLVQCTPDLS DC CL GA+G L CCSG+QG R L PSCN RYE
Sbjct: 183 KEENFTGSQTLYSLVQCTPDLSIADCSKCLEGAIGALSLCCSGKQGARTLTPSCNARYEL 242
Query: 247 YPFYN-ESAIAVPPSPPPPASVTRL------------------QGKSGLSSSTIIAIVAP 287
YPFY E+ P P P S T L +GK G+SS TI+ IV P
Sbjct: 243 YPFYQLEAGPLAPALAPAPTSATVLLPPPPAPSSKSSATEPSTEGKGGISSKTIVIIVVP 302
Query: 288 IVVIAVLF-IAGLCFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDN 346
V V+F I CF+RR A+K+Y+ + +N + +ITT +SLQFD TI+ ATN FS N
Sbjct: 303 TFVSVVIFSILCYCFIRRCAKKRYDTLEAENVEFNITTEQSLQFDLATIQAATNNFSDHN 362
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
K+G GGFG VYKG L GQEIA+KRLS+SSGQGA EFKNEVVLVAKLQHRNLVRLLGFCL
Sbjct: 363 KIGEGGFGAVYKGTLSSGQEIAIKRLSKSSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCL 422
Query: 407 EGDEKILVYEFVPNKSLDYFLY-----------------------------DSQLRIIHR 437
EG+EKILVYE+VPNKSLDYFL+ DS+LR+IHR
Sbjct: 423 EGEEKILVYEYVPNKSLDYFLFDPDKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHR 482
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DLKASN+LLD MNPKISDFG+ARIFGVDQTQGNT+R+VGTYGYMSPEYAMHG+FSVKSD
Sbjct: 483 DLKASNVLLDGDMNPKISDFGMARIFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVKSD 542
Query: 498 VYSFGVLALETITGKKNSSFYQTDGAEDLLSY---------------------------- 529
VYSFGVL LE I+GK+++ F+++D AEDLLSY
Sbjct: 543 VYSFGVLVLEIISGKRSNCFHESDQAEDLLSYAWKLWRNDTPLEFMGPTTRNSFSKNEVI 602
Query: 530 -----------EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECS 578
EDP DRPSMA++VL L+S+SVTL +P+QPA F + FP E S
Sbjct: 603 RCIHMGLLCVQEDPDDRPSMASVVLMLSSYSVTLPLPQQPASFSRTGALSDFPIMALE-S 661
Query: 579 DKSTSKSMPWSVDEASITEVYPR 601
D+S SKSM WSV+EASIT++YPR
Sbjct: 662 DQSASKSMTWSVNEASITDLYPR 684
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/656 (53%), Positives = 424/656 (64%), Gaps = 92/656 (14%)
Query: 25 AADPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAG-QPSYS 83
++ P YL H C T T NS +Q NL L+SL +NA+ + F N T G S S
Sbjct: 25 SSTPVYLYHNCSGGNT-TANSAYQLNLRTLLTSLSSNATTTE-----FSNNTVGLGTSPS 78
Query: 84 DRVYGLFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSD 143
DRVYGLF CRGD+ S CQ CV AT + +C + K+ I +DEC +RYSN+SFFS D
Sbjct: 79 DRVYGLFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVIWYDECTVRYSNRSFFSTVD 138
Query: 144 MSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQAVN---NPKRFEIRKTNYSAFQTVYSL 200
++ + N N++ D F L +N+ +A N K++ + + N S FQ++Y L
Sbjct: 139 TRPRVGLLNTANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYCL 198
Query: 201 VQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPPS 260
QCTPDLS +C CL G +G LP CC G+QGGRVLYPSCN+RYE YPFY +A S
Sbjct: 199 AQCTPDLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCNVRYELYPFYRVTASPPSSS 258
Query: 261 PPPPASVTRLQ-----GKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYN-AVL 314
P PP + G SG+S+ TI+AIV PI V ++FI G+CFL RRA KK +V
Sbjct: 259 PSPPTLLPPPTSPISPGSSGISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSVK 318
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSR 374
E DI T++SLQFDF TIE ATNKFS+DNKLG GGFGEVYKG L GQ +AVKRLS+
Sbjct: 319 EGKTAYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFGEVYKGTLSSGQVVAVKRLSK 378
Query: 375 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY------ 428
SSGQG +EFKNEVV+VAKLQHRNLVRLLGFCL+G+EKILVYE+VPNKSLDY L+
Sbjct: 379 SSGQGGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYEYVPNKSLDYILFDPEKQR 438
Query: 429 -----------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
DS+LRIIHRDLKASNILLD MNPKISDFG+ARIFGV
Sbjct: 439 ELDWGRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLDGDMNPKISDFGMARIFGV 498
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
DQTQGNTSRIVGTYGYM+PEYAMHG+FSVKSDVYSFGVL +E ++GKKNSSFYQTDGAED
Sbjct: 499 DQTQGNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLLMEILSGKKNSSFYQTDGAED 558
Query: 526 LLSY---------------------------------------EDPADRPSMATIVLALN 546
LLSY EDPADRP+MATIVL L+
Sbjct: 559 LLSYAWQLWKDGTPLELMDPILRESYNQNEVIRSIHIGLLCVQEDPADRPTMATIVLMLD 618
Query: 547 SHSVTLSVPRQPALFIGSRTERSFP-EREFECSDKSTSKSMPWSVDEASITEVYPR 601
S++VTL P QPA F+ S T+ + P E F+ +S+P SV++ SI+E+ PR
Sbjct: 619 SNTVTLPTPTQPAFFVHSGTDPNMPKELPFD-------QSIPMSVNDMSISEMDPR 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/677 (50%), Positives = 432/677 (63%), Gaps = 89/677 (13%)
Query: 3 AFKLLMVFLFLCFVSNFLGFTTAAD---PNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLP 59
+FKL+ +F+ + NFL F T P +LA CP+ T T NSTFQ N+ SSL
Sbjct: 6 SFKLIFLFVLV----NFLSFATPKAQQVPTFLAQDCPSNGT-TANSTFQINIRTLFSSLS 60
Query: 60 TNASRSNGFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQ--RCP 117
+NA+ +N FYN+T + SD VYGLF CRGD+ C CV AT+ ++ +C
Sbjct: 61 SNATANN----VFYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQCS 116
Query: 118 VEKRTTILFDECLLRYSNQSFFSNSDMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQA 177
+ K+ I +DEC++RYSN+SFFS D + + N N++ F + + MN+ +A
Sbjct: 117 LSKQAVIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEA 176
Query: 178 VNNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLY 237
K++ ++ N S FQT+Y LVQCTPDLS++ C CL A+G LP CC G+QGGR+L
Sbjct: 177 AIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILN 236
Query: 238 PSCNLRYESYPFYNESAIAVPPSPPPPASVTR-----LQGKSGLSSSTIIAIVAPIVVIA 292
PSCN+RY+ YPFY + A P S PP S G S +S TI+AIV PI V
Sbjct: 237 PSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGNIISYGGSEISPGTIVAIVVPITVAV 296
Query: 293 VLFIAGLCFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGG 352
+LFI G+ L +RA KK N+ + + +I+ +ESL+FDF TIE AT+KFS NKLG GG
Sbjct: 297 LLFIVGIWLLSKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGG 356
Query: 353 FGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412
FGEVYKG+LP GQE+AVKRLS++SGQG EFKNEV +VAKLQH+NLVRLLGFCLEG+EKI
Sbjct: 357 FGEVYKGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKI 416
Query: 413 LVYEFVPNKSLDYFLY-----------------------------DSQLRIIHRDLKASN 443
LVYEFV NKSLDY L+ DS+L+IIHRDLKASN
Sbjct: 417 LVYEFVANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASN 476
Query: 444 ILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGV 503
+LLD MNPKISDFG+ARIFGVDQTQ NT+RIVGTYGYMSPEYAMHG++S KSDVYSFGV
Sbjct: 477 VLLDGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGV 536
Query: 504 LALETITGKKNSSFYQTDGAEDLLSY---------------------------------- 529
L LE I+GK+NSSFY+TD AEDLLSY
Sbjct: 537 LILEIISGKRNSSFYETDVAEDLLSYAWKLWKDEAPLELMDQSLRESYTRNEVIRCIHIG 596
Query: 530 -----EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSK 584
EDP DRP+MA++VL L+S+SVTL VP QPA +I SRTE + P+ D+ST+
Sbjct: 597 LLCVQEDPIDRPTMASVVLMLDSYSVTLQVPNQPAFYINSRTEPNMPKG--LKIDQSTTN 654
Query: 585 SMPWSVDEASITEVYPR 601
S SV++ S++EV PR
Sbjct: 655 STSKSVNDMSVSEVDPR 671
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575779|ref|XP_003556014.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1647), Expect = e-180, Method: Compositional matrix adjust.
Identities = 342/672 (50%), Positives = 432/672 (64%), Gaps = 84/672 (12%)
Query: 3 AFKLLMVFLFLCFVSNFLGFTTAAD---PNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLP 59
+FKL+ +F+ + NFL F T P +LA CP+ T T NSTFQ N+ SSL
Sbjct: 6 SFKLIFLFVLV----NFLSFATPKAQQVPTFLAQDCPSNGT-TANSTFQINIRTLFSSLS 60
Query: 60 TNASRSNGFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQ--RCP 117
+NA+ +N FYN+T + SD VYGLF CRGD+ C CV AT+ ++ +C
Sbjct: 61 SNATANN----VFYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQCS 116
Query: 118 VEKRTTILFDECLLRYSNQSFFSNSDMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQA 177
+ K+ I +DEC++RYSN+SFFS D + + N N++ F + + MN+ +A
Sbjct: 117 LSKQAVIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEA 176
Query: 178 VNNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLY 237
K++ ++ N S FQT+Y LVQCTPDLS++ C CL A+G LP CC G+QGGR+L
Sbjct: 177 AIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILN 236
Query: 238 PSCNLRYESYPFYNESAIAVPPSPPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIA 297
PSCN+RY+ YPFY + A P S PP S G S +S TI+AIV PI V +LFI
Sbjct: 237 PSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGGGSEISPGTIVAIVVPITVAVLLFIV 296
Query: 298 GLCFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVY 357
G+ L +RA KK N+ + + +I+ +ESL+FDF TIE AT+KFS NKLG GGFGEVY
Sbjct: 297 GIWLLSKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVY 356
Query: 358 KGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417
KG+LP GQE+AVKRLS++SGQG EFKNEV +VAKLQH+NLVRLLGFCLEG+EKILVYEF
Sbjct: 357 KGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEF 416
Query: 418 VPNKSLDYFLY-----------------------------DSQLRIIHRDLKASNILLDV 448
V NKSLDY L+ DS+L+IIHRDLKASN+LLD
Sbjct: 417 VANKSLDYILFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDG 476
Query: 449 QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508
MNPKISDFG+ARIFGVDQTQ NT+RIVGTYGYMSPEYAMHG++S KSDVYSFGVL LE
Sbjct: 477 DMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEI 536
Query: 509 ITGKKNSSFYQTDGAEDLLSY--------------------------------------- 529
I+GK+NSSFY+TD AEDLLSY
Sbjct: 537 ISGKRNSSFYETDVAEDLLSYAWKLWKDEAPLELMDQSLRESYTRNEVIRCIHIGLLCVQ 596
Query: 530 EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWS 589
EDP DRP+MA++VL L+S+SVTL VP QPA +I SRTE + P+ D+ST+ S S
Sbjct: 597 EDPIDRPTMASVVLMLDSYSVTLQVPNQPAFYINSRTEPNMPKG--LKIDQSTTNSTSKS 654
Query: 590 VDEASITEVYPR 601
V++ S++EV PR
Sbjct: 655 VNDMSVSEVDPR 666
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555033|ref|XP_002518554.1| ATP binding protein, putative [Ricinus communis] gi|223542399|gb|EEF43941.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1645), Expect = e-180, Method: Compositional matrix adjust.
Identities = 334/544 (61%), Positives = 395/544 (72%), Gaps = 53/544 (9%)
Query: 31 LAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYSDRVYGLF 90
L + C NTT FT NST+Q+NLN LSSL NA+ S GF +N +GQ D VYG F
Sbjct: 30 LYYVCSNTTAFTPNSTYQTNLNKLLSSLSNNANNSIGF----FNIPSGQQP--DDVYGSF 83
Query: 91 RCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSDMSSQLSM 150
CRGD+ + CQDCVTFAT+++ +RCP+EK + +DECLLRY NQSF S D + L M
Sbjct: 84 LCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDECLLRYENQSFISTMDQTPGLYM 143
Query: 151 WNLQNVTEPD--KFNVFLGNLMNQVITQA---VNNPKRFEIRKTNYSAFQTVYSLVQCTP 205
WN QN++ D +FN L + MN + T+A + K+F +++ ++++FQ +YSLVQCTP
Sbjct: 144 WNTQNISTSDQVRFNALLASTMNNLATEASTAASGEKKFAVKEDSFTSFQKLYSLVQCTP 203
Query: 206 DLSSRDCEVCLRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPPSPPPPA 265
DLS+ DC CL+ A+ LP CC G+QGGRVLYPSCN+RYE Y F+N +A+ PP P P
Sbjct: 204 DLSTSDCGQCLQTAISNLPSCCGGKQGGRVLYPSCNIRYEVYLFFNATALEPPPPAPSPV 263
Query: 266 SVT-----------RLQGKSGLSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAVL 314
+++GK G+S+ TIIAIVAPI V VLF G C+LRRR KKY AV
Sbjct: 264 VPLPPPPTGLGAKPQIEGKRGISTVTIIAIVAPIAVATVLFSLGCCYLRRR--KKYEAVQ 321
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSR 374
E +A N+ITT ESLQ D TIEVATNKFS+DNKLG GGFGEVYKG LP+GQEIAVK+LSR
Sbjct: 322 EDDARNEITTAESLQIDLNTIEVATNKFSADNKLGEGGFGEVYKGTLPNGQEIAVKKLSR 381
Query: 375 SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY------ 428
SSGQGA+EFKNEV L+AKLQHRNLVRLLGFCLEG EKILVYEFVPNKSLDYFL+
Sbjct: 382 SSGQGAEEFKNEVALLAKLQHRNLVRLLGFCLEGAEKILVYEFVPNKSLDYFLFDPEKQA 441
Query: 429 -----------------------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
DS+LRIIHRDLKASNILLD MN KISDFG+ARIFGV
Sbjct: 442 QLDWSRRYKIIGGIARGIVYLHEDSRLRIIHRDLKASNILLDRNMNSKISDFGMARIFGV 501
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD+YSFG+L LE I+GKKNSSFYQ DG +D
Sbjct: 502 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDMYSFGILVLEIISGKKNSSFYQIDGVDD 561
Query: 526 LLSY 529
L+SY
Sbjct: 562 LVSY 565
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575785|ref|XP_003556017.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 5 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 342/681 (50%), Positives = 432/681 (63%), Gaps = 93/681 (13%)
Query: 3 AFKLLMVFLFLCFVSNFLGFTTAAD---PNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLP 59
+FKL+ +F+ + NFL F T P +LA CP+ T T NSTFQ N+ SSL
Sbjct: 6 SFKLIFLFVLV----NFLSFATPKAQQVPTFLAQDCPSNGT-TANSTFQINIRTLFSSLS 60
Query: 60 TNASRSNGFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFATKNVTQ--RCP 117
+NA+ +N FYN+T + SD VYGLF CRGD+ C CV AT+ ++ +C
Sbjct: 61 SNATANN----VFYNSTVAGANPSDTVYGLFMCRGDVPFQLCGQCVINATQKLSSDLQCS 116
Query: 118 VEKRTTILFDECLLRYSNQSFFSNSDMSSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQA 177
+ K+ I +DEC++RYSN+SFFS D + + N N++ F + + MN+ +A
Sbjct: 117 LSKQAVIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANISNQANFMRLMFDTMNETADEA 176
Query: 178 VNNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLPRCCSGRQGGRVLY 237
K++ ++ N S FQT+Y LVQCTPDLS++ C CL A+G LP CC G+QGGR+L
Sbjct: 177 AIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCLSDAIGLLPWCCEGKQGGRILN 236
Query: 238 PSCNLRYESYPFYNESAIAVPPSPPPPASVTRLQGKSGLSSSTIIAIVAPIVVIAVLFIA 297
PSCN+RY+ YPFY + A P S PP S G S +S TI+AIV PI V +LFI
Sbjct: 237 PSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGGGSEISPGTIVAIVVPITVAVLLFIV 296
Query: 298 GLCFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVY 357
G+ L +RA KK N+ + + +I+ +ESL+FDF TIE AT+KFS NKLG GGFGEVY
Sbjct: 297 GIWLLSKRAAKKRNSAQDPKTETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVY 356
Query: 358 KGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417
KG+LP GQE+AVKRLS++SGQG EFKNEV +VAKLQH+NLVRLLGFCLEG+EKILVYEF
Sbjct: 357 KGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEF 416
Query: 418 VPNKSLDYFLY--------------------------------------DSQLRIIHRDL 439
V NKSLDY L+ DS+L+IIHRDL
Sbjct: 417 VANKSLDYILFGRFIFSEFFNPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDL 476
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
KASN+LLD MNPKISDFG+ARIFGVDQTQ NT+RIVGTYGYMSPEYAMHG++S KSDVY
Sbjct: 477 KASNVLLDGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVY 536
Query: 500 SFGVLALETITGKKNSSFYQTDGAEDLLSY------------------------------ 529
SFGVL LE I+GK+NSSFY+TD AEDLLSY
Sbjct: 537 SFGVLILEIISGKRNSSFYETDVAEDLLSYAWKLWKDEAPLELMDQSLRESYTRNEVIRC 596
Query: 530 ---------EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDK 580
EDP DRP+MA++VL L+S+SVTL VP QPA +I SRTE + P+ D+
Sbjct: 597 IHIGLLCVQEDPIDRPTMASVVLMLDSYSVTLQVPNQPAFYINSRTEPNMPKG--LKIDQ 654
Query: 581 STSKSMPWSVDEASITEVYPR 601
ST+ S SV++ S++EV PR
Sbjct: 655 STTNSTSKSVNDMSVSEVDPR 675
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M0X5 | CRK25_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4874 | 0.9750 | 0.8681 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00001153001 | SubName- Full=Chromosome chr2 scaffold_113, whole genome shotgun sequence; (663 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 601 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-23 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 7e-46
Identities = 81/258 (31%), Positives = 110/258 (42%), Gaps = 61/258 (23%)
Query: 345 DNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNL 398
KLG G FGEVYKG L E+AVK L + + +EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRI 434
V+LLG C E + +V E++ L +L Y
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNF 123
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
IHRDL A N L+ + KISDFGL+R D + +M+PE G+F+
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGKFTS 182
Query: 495 KSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY------------------------ 529
KSDV+SFGVL E T G++ Y E++L Y
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQC 239
Query: 530 --EDPADRPSMATIVLAL 545
EDP DRP+ + +V L
Sbjct: 240 WAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-46
Identities = 83/260 (31%), Positives = 115/260 (44%), Gaps = 64/260 (24%)
Query: 345 DNKLGRGGFGEVYKGVL-----PHGQEIAVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNL 398
KLG G FGEVYKG L E+AVK L +S Q +EF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDSQLR 433
V+LLG C E + ++V E++P L +L Y
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
IHRDL A N L+ + KISDFGL+R ++ D + ++ +M+PE G+F
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKF 181
Query: 493 SVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY---------------------- 529
+ KSDV+SFGVL E T G+ Y ++L Y
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGE---EPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLML 238
Query: 530 ----EDPADRPSMATIVLAL 545
EDP DRP+ + +V L
Sbjct: 239 QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 72/226 (31%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 348 LGRGGFGEVYKGVLPH-GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
LG GGFG VY G+++A+K + + S +E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 406 LEGDEKILVYEFVPNKSLDYFLYD--------------SQL----------RIIHRDLKA 441
+ + LV E+ SL L + Q+ IIHRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 442 SNILLD-VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVY 499
NILLD K++DFGL+++ D++ T IVGT YM+PE + G +S KSD++
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 500 SFGVLALETITGKKNSSFYQTDGAEDLLSY---EDPADRPSMATIV 542
S GV+ Y+ +DL+ +DP RPS I+
Sbjct: 179 SLGVI------------LYELPELKDLIRKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 6e-43
Identities = 84/259 (32%), Positives = 113/259 (43%), Gaps = 66/259 (25%)
Query: 347 KLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLVR 400
KLG G FGEVYKG L ++AVK L + + +EF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIH 436
LLG C +G+ +V E++P L FL Y +H
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 437 RDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGY-----MSPEYAMHG 490
RDL A N L+ + KISDFGL+R I+ D + G M+PE G
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMAPESLKDG 179
Query: 491 QFSVKSDVYSFGVLALETIT-------GKKNSSFYQ--TDG----------AE--DLLSY 529
+F+ KSDV+SFGVL E T G N + DG E +L+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ 239
Query: 530 ---EDPADRPSMATIVLAL 545
DP DRP+ + +V L
Sbjct: 240 CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 59/192 (30%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNLVRLLG 403
KLG G FG+VY G+ +A+K + + + +E E+ ++ KL+H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 404 FCLEGDEKILVYEFVPNKSLDYFLYDS-----------------------QLRIIHRDLK 440
+ D+ LV E+ L L I+HRDLK
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLK 124
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYS 500
NILLD + K++DFGLAR + VGT YM+PE + + D++S
Sbjct: 125 PENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181
Query: 501 FGVLALETITGK 512
GV+ E +TGK
Sbjct: 182 LGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 66/193 (34%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLG 403
KLG G FG VYK G+ +AVK L + S + Q + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 404 FCLEGDEKILVYEFVPNKSLDYFL-------------YDSQL----------RIIHRDLK 440
+ D LV E+ L +L Q+ IIHRDLK
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLK 125
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE-YAMHGQFSVKSDVY 499
NILLD KI+DFGLA+ + + + VGT YM+PE + K DV+
Sbjct: 126 PENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 500 SFGVLALETITGK 512
S GV+ E +TGK
Sbjct: 184 SLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 82/264 (31%), Positives = 114/264 (43%), Gaps = 67/264 (25%)
Query: 346 NKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVR 400
KLG G FGEVYKG L E+AVK L + + + +F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------Y 428
LLG C E + LV E++ L +L Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGYMSPEYA 487
+ + +HRDL A N L+ + KISDFGL+R ++ D + T + +M+PE
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESL 179
Query: 488 MHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQ--TDGA---------EDLLSY 529
G F+ KSDV+SFGVL E T G N + G ++L Y
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL--Y 237
Query: 530 E--------DPADRPSMATIVLAL 545
E DP DRP+ + +V L
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 28/195 (14%)
Query: 346 NKLGRGGFGEVYKGVLPH-GQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
LGRG FG VY + G+ +AVK LS S + + + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 403 GFCLEGDEK-ILVY-EFVPNKSLDYFL-------------YDSQL----------RIIHR 437
G + ++ + ++ E+V SL L Y Q+ I+HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
D+K +NIL+D K++DFG A+ G +T T + GT +M+PE ++ +D
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185
Query: 498 VYSFGVLALETITGK 512
++S G +E TGK
Sbjct: 186 IWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 33/203 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG G FGEV+ G ++AVK L + + F E ++ KL+H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRH 60
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDS 430
LV+L C E + +V E++ SL FL Y
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ---TQGNTSRIVGTYGYMSPEYA 487
IHRDL A NIL+ + KI+DFGLAR+ D+ +G I T +PE A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 488 MHGQFSVKSDVYSFGVLALETIT 510
+G+F++KSDV+SFG+L E +T
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-31
Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 27/194 (13%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
F+ + KLG G FGEV++G+ + +A+K L Q+F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR-------------------------IIH 436
C G+ ++ E + SL FL + + IH
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
RDL A NIL+ + K++DFGLAR+ D + +I Y + +PE A HG FS KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 497 DVYSFGVLALETIT 510
DV+SFG+L E T
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 32/193 (16%)
Query: 347 KLGRGGFGEVYKG-VLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
K+G+GGFGEVYK G+E+A+K + S + ++ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 406 LEGDEKILVYEFVPNKSLD--------------------------YFLYDSQLRIIHRDL 439
L+ DE +V EF SL +L+ IIHRD+
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS--NGIIHRDI 124
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
KA+NILL K+ DFGL+ + +VGT +M+PE + K+D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 500 SFGVLALETITGK 512
S G+ A+E GK
Sbjct: 182 SLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 32/225 (14%)
Query: 348 LGRGGFGEVYKGV-LPHGQ----EIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLVRL 401
LG G FG VYKGV +P G+ +A+K L + A +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHR 437
LG CL + L+ + +P L ++ Y + R++HR
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DL A N+L+ + KI+DFGLA++ VD+ + + +M+ E +H ++ KSD
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193
Query: 498 VYSFGVLALETIT-GKKNSSFYQTDGAEDLLSYEDPADRPSMATI 541
V+S+GV E +T G K DLL + +P + TI
Sbjct: 194 VWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 66/188 (35%), Positives = 94/188 (50%), Gaps = 38/188 (20%)
Query: 348 LGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407
+G+G FG+V G GQ++AVK L S AQ F E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 408 GDEKILVYEFVPNKSL-DY----------------FLYD---------SQLRIIHRDLKA 441
G+ +V E++ SL DY F D + +HRDL A
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAA 130
Query: 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYAMHGQFSVKSDVY 499
N+L+ + K+SDFGLA+ + +QG S G + +PE +FS KSDV+
Sbjct: 131 RNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKKFSTKSDVW 183
Query: 500 SFGVLALE 507
SFG+L E
Sbjct: 184 SFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+ +GRG FG VYKG+ L G +A+K++S + + E+ L+ L+H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 403 GFCLEGDEKILVYEFVPNKSL----------------DYF-------LYDSQLRIIHRDL 439
G D ++ E+ N SL Y Y + +IHRD+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
KA+NIL K++DFG+A + +VGT +M+PE S SD++
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIW 183
Query: 500 SFGVLALETITGK 512
S G +E +TG
Sbjct: 184 SLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 36/206 (17%)
Query: 346 NKLGRGGFGEVYKGVLP-----HGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLV 399
+LG G FG+V G+++AVK L+ S + + +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 400 RLLGFCLEGDEKI--LVYEFVPNKSLDYFL--------------YDSQL----------R 433
+ G C + + L+ E++P+ SL +L + SQ+ R
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT--QGNTSRIVGTYGYMSPEYAMHGQ 491
IHRDL A NIL++ + KISDFGLA++ D+ + Y +PE +
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSK 188
Query: 492 FSVKSDVYSFGVLALETIT-GKKNSS 516
FS SDV+SFGV E T G + S
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 65/192 (33%), Positives = 93/192 (48%), Gaps = 32/192 (16%)
Query: 346 NKLGRGGFGEVYKGV--LPHGQEI--AVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG G FG V KGV + G+E+ AVK L + G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFLYD-------------SQL----------RIIHR 437
L+G C G+ +LV E P L +L Q+ +HR
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYAMHGQFSVK 495
DL A N+LL + KISDFG++R G + G + + +PE +G+FS K
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 496 SDVYSFGVLALE 507
SDV+S+GV E
Sbjct: 179 SDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 34/195 (17%)
Query: 347 KLGRGGFGEVYKGVL-PHGQEIAVKRL---SRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
LG+G G VYK P G+ A+K++ + ++ E+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65
Query: 403 G-FCLEGDEKILVYEFVPNKSLDYFLYD------------------------SQLRIIHR 437
G F EG+ I V E++ SL L ++ IIHR
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
D+K SN+L++ + KI+DFG++++ ++ T + VGT YMSPE +S +D
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQGESYSYAAD 182
Query: 498 VYSFGVLALETITGK 512
++S G+ LE GK
Sbjct: 183 IWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 47/212 (22%)
Query: 348 LGRGGFGEVYKGVLPHGQE------IAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNLVR 400
LG G FG+V+ G H + +AVK L ++ A++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------- 427
G C EGD I+V+E++ + L+ FL
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 428 ----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGYM 482
Y + +HRDL N L+ + KI DFG++R ++ D + ++ +M
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR-WM 191
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETIT-GKK 513
PE M+ +F+ +SDV+SFGV+ E T GK+
Sbjct: 192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 46/110 (41%), Positives = 63/110 (57%), Gaps = 7/110 (6%)
Query: 32 AHFCPNTTT---FTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYSDRVYG 88
H C + T+ T NSTF+SNLN LSSL +NA+ S+G F T+G D VYG
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKG--FAAGTSGAAP--DTVYG 56
Query: 89 LFRCRGDLGSTACQDCVTFATKNVTQRCPVEKRTTILFDECLLRYSNQSF 138
L +CRGDL ++ C+ C+ A + + CP +K I +D C LRY + F
Sbjct: 57 LAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 52/209 (24%)
Query: 348 LGRGGFGEVYKGVL------PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVR 400
LG G FG+VYKG L +A+K L + + QEF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------- 427
LLG C + +++E++ + L FL
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 428 ------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD--QTQGNTSRIVGT 478
Y S +HRDL A N L+ + KISDFGL+R I+ D + Q + V
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV-- 190
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALE 507
+M PE ++G+F+ +SD++SFGV+ E
Sbjct: 191 -RWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 33/192 (17%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
KLG G FGEV++G+ + +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 407 EGDEKILVYEFVPNKSLDYFLYDSQLRI-------------------------IHRDLKA 441
+ +V E + SL +L R IHRDL A
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA 131
Query: 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAMHGQFSVKSDV 498
N+L+ K++DFGLAR+ D +R G + +PE A++ +FS+KSDV
Sbjct: 132 RNVLVGENNICKVADFGLARVIKEDIY---EAR-EGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 499 YSFGVLALETIT 510
+SFG+L E +T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 38/201 (18%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEI-AVKR--LSRSSGQGAQEFKNEVVLVAKLQHRNLVRL- 401
++G+G FG+VY ++ +K LS S + ++ NEV ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 402 ------------LGFCLEGD--EKILVYE-----FVPNKSLDYFLYDSQL---------- 432
+ + GD +KI + F + LD+F+ QL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV---QLCLALKYLHSR 122
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
+I+HRD+K NI L K+ DFG++++ T +VGT Y+SPE + +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPY 180
Query: 493 SVKSDVYSFGVLALETITGKK 513
+ KSD++S G + E T K
Sbjct: 181 NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 45/207 (21%)
Query: 348 LGRGGFGEVYKG----VLPHG---QEIAVKRLSR-SSGQGAQEFKNEVVLVAKLQHRNLV 399
LG G FGEVY+G +L G +AVK L + ++ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------------YD 429
+LLG CL + + ++ E + L +L Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 430 SQLRIIHRDLKASNILLDVQMNP-----KISDFGLAR-IFGVDQTQGNTSRIVGTYGYMS 483
Q+ IHRDL A N L+ + KI DFGLAR I+ D + ++ +M+
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WMA 181
Query: 484 PEYAMHGQFSVKSDVYSFGVLALETIT 510
PE + G+F+ +SDV+SFGVL E +T
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 37/199 (18%)
Query: 345 DNKLGRGGFGEVYKGVL--PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNLV 399
+ +G G FGEV +G L P +EI A+K L + SS + +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRII 435
RL G + +++ E++ N SLD FL Y S++ +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIF----GVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
HRDL A NIL++ + K+SDFGL+R T+G I T +PE + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAYRK 184
Query: 492 FSVKSDVYSFGVLALETIT 510
F+ SDV+SFG++ E ++
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 64/195 (32%), Positives = 94/195 (48%), Gaps = 33/195 (16%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLS----RSSGQGA-QEFKNEVVLVAKLQHRNLVRL 401
LG G FG VY+G+ L G AVK +S +GQ A ++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 402 LGFCLEGDEKILVYEFVPNKSL-------DYF------LYDSQL----------RIIHRD 438
LG E D + E VP SL F LY Q+ +HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSD 497
+K +NIL+D K++DFG+A+ G+ +M+PE G + + +D
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 498 VYSFGVLALETITGK 512
++S G LE TGK
Sbjct: 185 IWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 28/198 (14%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
+ + K+G G GEVYK G+E+A+K++ R Q + NE++++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFLY-------DSQL-----------------R 433
+V L GDE +V E++ SL + + Q+
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
+IHRD+K+ NILL + K++DFG A ++++ N+ +VGT +M+PE +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 494 VKSDVYSFGVLALETITG 511
K D++S G++ +E G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 74/225 (32%), Positives = 117/225 (52%), Gaps = 32/225 (14%)
Query: 348 LGRGGFGEVYKGV-LPHGQEI----AVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRL 401
LG G FG VYKG+ +P G+ + A+K L+ ++G A EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFLYD------SQL------------------RIIHR 437
LG CL + LV + +P+ L ++++ SQL R++HR
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DL A N+L+ + KI+DFGLAR+ D+ + N +M+ E + +F+ +SD
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193
Query: 498 VYSFGVLALETIT-GKKNSSFYQTDGAEDLLSYEDPADRPSMATI 541
V+S+GV E +T G K T DLL + +P + TI
Sbjct: 194 VWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI 238
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 34/203 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
EV KLG G FGEV+ G ++A+K L + S + F E L+ +LQH
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQH 60
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------------------YD 429
LVRL + + E I ++ E++ N SL FL +
Sbjct: 61 PRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYA 487
+ IHRDL+A+NIL+ + KI+DFGLAR+ ++ T+R + + +PE
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAI 175
Query: 488 MHGQFSVKSDVYSFGVLALETIT 510
+G F++KSDV+SFG+L E +T
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-23
Identities = 41/94 (43%), Positives = 55/94 (58%), Gaps = 2/94 (2%)
Query: 157 TEPDKFNVFLGNLMNQVITQAV-NNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVC 215
T F L L++ + + A ++ K F T+ +A TVY L QC DLS+ DC C
Sbjct: 14 TANSTFESNLNALLSSLSSNAASSSGKGFAAG-TSGAAPDTVYGLAQCRGDLSASDCRSC 72
Query: 216 LRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPF 249
L A+ +L RCC ++GGR+ Y SC LRYESYPF
Sbjct: 73 LATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 64/204 (31%), Positives = 90/204 (44%), Gaps = 40/204 (19%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSR---SSGQGAQEFKNEVVLVAKLQH-RNLVRLL 402
KLG G FGEVY + +A+K L++ S + + F E+ ++A L H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL--------------------------YDSQLRIIH 436
F + LV E+V SL+ L Y IIH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 437 RDLKASNILLDVQMN-PKISDFGLARIFGVDQT----QGNTSRIVGTYGYMSPEYAMH-- 489
RD+K NILLD K+ DFGLA++ + S VGT GYM+PE +
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 490 -GQFSVKSDVYSFGVLALETITGK 512
S SD++S G+ E +TG
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 8e-23
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 348 LGRGGFGEVYKGVLPH-GQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LG+G FG+V G+ A+K L + + + E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 404 FCLEGDEKI-LVYEFVPNKSLDYFLYDS-----------------------QLRIIHRDL 439
+ + +EK+ LV E+ P L L L II+RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
K NILLD + K++DFGLA+ + ++ NT GT Y++PE + + D +
Sbjct: 120 KPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 500 SFGVLALETITGKKNSSFYQTDGAE 524
S GVL E +TGK FY D E
Sbjct: 178 SLGVLLYEMLTGK--PPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 64/196 (32%), Positives = 77/196 (39%), Gaps = 34/196 (17%)
Query: 347 KLGRGGFGEVYKG--VLPHGQEI--AVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLVRL 401
KLG G FG V +G G+ I AVK L +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 402 LGFCLEGDEKILVYEFVPNKSL---------DYFL----------------YDSQLRIIH 436
G L ++V E P SL +FL Y R IH
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGV--DQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
RDL A NILL KI DFGL R D V + + +PE FS
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSH 179
Query: 495 KSDVYSFGVLALETIT 510
SDV+ FGV E T
Sbjct: 180 ASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 31/193 (16%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404
K+G+G FG+VYKGVL E+AVK R + ++F E ++ + H N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 405 CLEGDEKILVYEFVPNKSLDYFLYDSQLRI------------------------IHRDLK 440
C++ +V E VP SL FL + R+ IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 441 ASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
A N L+ KISDFG++R G+ +I + +PE +G+++ +SDV
Sbjct: 121 ARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTSESDV 178
Query: 499 YSFGVLALETITG 511
+S+G+L ET +
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 74/272 (27%), Positives = 108/272 (39%), Gaps = 66/272 (24%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHG------QEIAVKRL-SRSSGQGAQEFKNEVV 388
EV + + LG G FGEVY+G+ ++AVK L S Q +F E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
+++K H+N+VRL+G E + ++ E + L FL
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 428 ---------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLAR-IFGVDQTQGNTSR 474
Y + IHRD+ A N LL KI+DFG+AR I+ + R
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-GR 180
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETI-------TGKKNSSFYQ--TDGAED 525
+ +M PE + G F+ K+DV+SFGVL E G+ N + T G
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240
Query: 526 LLSYE---------------DPADRPSMATIV 542
P DRP+ ATI+
Sbjct: 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 61/194 (31%), Positives = 88/194 (45%), Gaps = 32/194 (16%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
++G G FG V+ G +++A+K + R ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 407 EGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKAS 442
E LV+EF+ + L +L Y +IHRDL A
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 443 NILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAMHGQFSVKSDVY 499
N L+ K+SDFG+ R DQ +T GT + SPE ++S KSDV+
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 500 SFGVLALETITGKK 513
SFGVL E + K
Sbjct: 186 SFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 58/199 (29%), Positives = 85/199 (42%), Gaps = 39/199 (19%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+G+G FG V K G+ + K + + + Q+ +EV ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 403 G---------------FCLEGDEKILVYEFVPNKS-----------------LDY--FLY 428
+C GD L+ + + L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
D ++HRDLK +NI LD N K+ DFGLA+I G D + T VGT YMSPE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183
Query: 489 HGQFSVKSDVYSFGVLALE 507
H + KSD++S G L E
Sbjct: 184 HMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
F KLG G +G VYK + GQ +A+K + + QE E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 401 LLGFCLEGDEKILVYEF-----------VPNKSLD-----YFLYDS--------QLRIIH 436
G + + +V E+ + NK+L LY + + IH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
RD+KA NILL+ + K++DFG++ T + ++GT +M+PE ++ K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 497 DVYSFGVLALETITGK 512
D++S G+ A+E GK
Sbjct: 181 DIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 41/206 (19%)
Query: 348 LGRGGFGEV----YKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
LG+G FG V Y + + G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 403 GFCLEGDEK--ILVYEFVPNKSL-DYF-------------LYDSQL----------RIIH 436
G C + LV E++P SL DY LY SQ+ R +H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQ-----TQGNTSRIVGTYGYMSPEYAMHGQ 491
RDL NIL++ + KI DFGL ++ D+ + S I + +PE +
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPESLTESK 187
Query: 492 FSVKSDVYSFGVLALETIT-GKKNSS 516
FSV SDV+SFGV+ E T K+ S
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 62/193 (32%), Positives = 85/193 (44%), Gaps = 32/193 (16%)
Query: 348 LGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407
LG G FG V+ G ++A+K + R +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 408 GDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASN 443
+V E++ N L +L Y IHRDL A N
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130
Query: 444 ILLDVQMNPKISDFGLARIFGVDQ---TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYS 500
L+ K+SDFGLAR DQ +QG + + PE + +FS KSDV+S
Sbjct: 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSKSDVWS 186
Query: 501 FGVLALETITGKK 513
FGVL E + K
Sbjct: 187 FGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 9e-22
Identities = 62/191 (32%), Positives = 93/191 (48%), Gaps = 31/191 (16%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
KLG G FGEV+ G + ++AVK L + Q F E L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 407 EGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKA 441
+ + ++ E++ SL FL Y + IHRDL+A
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA 131
Query: 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYAMHGQFSVKSDVY 499
+N+L+ + KI+DFGLAR+ ++ T+R + + +PE G F++KSDV+
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 500 SFGVLALETIT 510
SFG+L E +T
Sbjct: 189 SFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 34/203 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ KLG G FGEV+ G ++AVK L + + F E ++ KL+H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDSQLR--------------------- 433
LV+L + + +E I +V E++ SL FL D + R
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 434 ----IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYA 487
IHRDL+++NIL+ + KI+DFGLAR+ + T+R + + +PE A
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAA 175
Query: 488 MHGQFSVKSDVYSFGVLALETIT 510
++G+F++KSDV+SFG+L E +T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 65/189 (34%), Positives = 89/189 (47%), Gaps = 34/189 (17%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
+G G FG V +G GQ++AVK + AQ F E ++ KL H+NLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 407 EGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKA 441
I V E + +L FL Y +++HRDL A
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128
Query: 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSF 501
NIL+ K+SDFGLAR V + S++ + +PE H +FS KSDV+S+
Sbjct: 129 RNILVSEDGVAKVSDFGLAR---VGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSY 183
Query: 502 GVLALETIT 510
GVL E +
Sbjct: 184 GVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ 394
E+ + +KLG G +GEVY+GV + +AVK L + +EF E ++ +++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 60
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD---------------SQL------- 432
H NLV+LLG C ++ EF+ +L +L + +Q+
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 433 ---RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
IHRDL A N L+ K++DFGL+R T + + +PE +
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 179
Query: 490 GQFSVKSDVYSFGVLALETIT 510
+FS+KSDV++FGVL E T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 65/242 (26%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVL 389
DFK ++ +G G F V +E A+K L + Q +E K + V
Sbjct: 2 DFKFGKI----------IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVK 49
Query: 390 VAKL------QHRNLVRLLGFCLEGDEKI-LVYEFVPN----------KSLDY---FLYD 429
+ K H +++L + + +E + V E+ PN SLD Y
Sbjct: 50 IEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYA 108
Query: 430 SQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ------------ 467
+++ IIHRDLK NILLD M+ KI+DFG A++ +
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 468 -TQGNTSRI-----VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK---KNSSFY 518
+Q +R VGT Y+SPE SD+++ G + + +TGK + S+ Y
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228
Query: 519 QT 520
T
Sbjct: 229 LT 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 49/224 (21%)
Query: 347 KLGRGGFGEVY----KGVLPHGQE--IAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG G FG+V+ +LP + +AVK L +S Q+F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------- 427
G C EG ++V+E++ + L+ FL
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 428 -----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGY 481
Y + L +HRDL N L+ + KI DFG++R I+ D + R + +
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLPIRW 190
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE 524
M PE ++ +F+ +SD++SFGV+ E T GK+ +YQ E
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ--PWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 32/196 (16%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKR-----LSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LG+G FG VY + G+E+AVK+ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 402 LGFCLEGDEKILVY-EFVPNKSLDYFL-------------YDSQL----------RIIHR 437
G CL DE + ++ E++P S+ L Y Q+ I+HR
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 438 DLKASNILLDVQMNPKISDFGLA-RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
D+K +NIL D N K+ DFG + R+ + + + GT +MSPE + K+
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA 188
Query: 497 DVYSFGVLALETITGK 512
DV+S G +E +T K
Sbjct: 189 DVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 29/197 (14%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
K++ K+G+G G VY + + GQE+A+K+++ + NE++++ + +H N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLD------------------------YFLYDSQLRII 435
L L GDE +V E++ SL FL+ +Q +I
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ--VI 137
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K+ NILL + + K++DFG +Q++ +T +VGT +M+PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 496 SDVYSFGVLALETITGK 512
D++S G++A+E + G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 58/196 (29%), Positives = 85/196 (43%), Gaps = 34/196 (17%)
Query: 348 LGRGGFGEVYKGVLPHGQ-EIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
LG+G +G VY Q IA+K + + Q E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 407 EGDEKILVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLK 440
E + E VP SL L Y +I+HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 441 ASNILLDVQMNP-KISDFGLA-RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ--FSVKS 496
N+L++ KISDFG + R+ G++ T GT YM+PE G + +
Sbjct: 136 GDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 497 DVYSFGVLALETITGK 512
D++S G +E TGK
Sbjct: 193 DIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 38/209 (18%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEIAVKRLSRSSG---QGAQEFKNEVVLV 390
E+ + + +G G FGEV++G+L P +E+AV + G + Q+F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD--------------------- 429
+ H N++RL G + +++ E++ N +LD +L D
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 430 ---SQLRIIHRDLKASNILLDVQMNPKISDFGLARIF-----GVDQTQGNTSRIVGTYGY 481
S + +HRDL A NIL++ + K+SDFGL+R+ G T G I T
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT--- 177
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+PE + +F+ SDV+SFG++ E ++
Sbjct: 178 -APEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 34/203 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ D KLG+G FGEV+ G ++A+K L + + F E ++ KL+H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRH 60
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------------------YD 429
LV L + + +E I +V EF+ SL FL Y
Sbjct: 61 DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYA 487
++ IHRDL+A+NIL+ + KI+DFGLAR+ + T+R + + +PE A
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAA 175
Query: 488 MHGQFSVKSDVYSFGVLALETIT 510
++G+F++KSDV+SFG+L E +T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 34/198 (17%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEF----KNEVVLVAKLQHRNLVR 400
++G G +G+VYK G+ +A+K++ + F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 401 LLGFCLEGDEK--ILVYEFVPN------KSLDYFLYDSQLR-----------------II 435
L + +V+E++ + S + +SQ++ I+
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSV 494
HRD+K SNIL++ K++DFGLAR + + T+R++ T Y PE + ++
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGP 181
Query: 495 KSDVYSFGVLALETITGK 512
+ D++S G + E GK
Sbjct: 182 EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 348 LGRGGFGEVYKGV-LPHGQEI----AVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LG G FG VYKG+ +P G+ + A+K L +S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 402 LGFCLEGDEKILVYEFVPNKSL-DY-----------------------FLYDSQLRIIHR 437
LG CL + LV + +P L DY Y ++R++HR
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DL A N+L+ + KI+DFGLAR+ +D+T+ + +M+ E +H +F+ +SD
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSD 193
Query: 498 VYSFGVLALETIT-GKKNSSFYQTDGAEDLLSYEDPADRPSMATI 541
V+S+GV E +T G K DLL + +P + TI
Sbjct: 194 VWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI 238
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 34/203 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 60
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL---YDSQLRI----------------- 434
LV+L + + +E I +V E++ SL FL LR+
Sbjct: 61 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 435 -----IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYA 487
+HRDL+A+NIL+ + K++DFGLAR+ + T+R + + +PE A
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAA 175
Query: 488 MHGQFSVKSDVYSFGVLALETIT 510
++G+F++KSDV+SFG+L E T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS---RSSGQGAQEFKNEVVLVAKLQ 394
F + K+G+G F VYK + L G+ +A+K++ + Q+ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 395 HRNLVRLLGFCLEGDEKILVYEF-------------------VPNKSL-DYFL------- 427
H N+++ L +E +E +V E +P +++ YF+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 428 YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
+ RI+HRD+K +N+ + K+ D GL R F T ++ +VGT YMSPE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE-R 177
Query: 488 MHGQ-FSVKSDVYSFGVLALETITGKKNSSFYQ 519
+H ++ KSD++S G L E + S FY
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 30/199 (15%)
Query: 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKR--LSRSSGQGAQEFKNEVVLVAKLQHRNL 398
F NK+G+G FG V+K V + A+K+ LS+ + + +E +E ++AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDSQLR 433
+R L+ + +V E+ N L L + +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE ++
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYN 179
Query: 494 VKSDVYSFGVLALETITGK 512
KSDV++ GV+ E TGK
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 5e-20
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 53/210 (25%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN---------EVVLVA 391
+ KLG G +G VYK G+ +A+K++ + + E+ L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53
Query: 392 KLQHRNLVRLLGFCLEGDEKILVYEFVPN---KSLD------------YFLYDSQL---- 432
+L+H N+V+LL + LV+E+ K LD +Y QL
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMY--QLLRGL 111
Query: 433 ------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486
RI+HRDLK NIL++ K++DFGLAR FG+ T +V T Y +PE
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEI 169
Query: 487 AMHGQF---SVKSDVYSFG-VLALETITGK 512
+ + +V D++S G + A E ITGK
Sbjct: 170 LLGSKHYSTAV--DIWSVGCIFA-EMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLS-RSSGQGAQE-----FKNEVVLVAKLQHRNLV 399
LG+G +G VY G+ GQ IAVK++ +S A E + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL-------------YDSQL----------RIIH 436
+ LG CL+ + + EFVP S+ L Y Q+ ++H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV----GTYGYMSPEYAMHGQF 492
RD+K +N++L K+ DFG AR G S ++ GT +M+PE +
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 493 SVKSDVYSFGVLALETITGK 512
KSD++S G E TGK
Sbjct: 186 GRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 84/290 (28%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYK----GVLPHGQE---IAVKRLSR-SSGQGAQEFKNEV 387
E N +G+G FG V++ G+LP + +AVK L +S +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREA 59
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------- 427
L+A+ H N+V+LLG C G L++E++ L+ FL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 428 -------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR- 461
Y S+ + +HRDL N L+ M KI+DFGL+R
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKN 514
I+ D + + + + +M PE + +++ +SDV+++GV+ E + G +
Sbjct: 180 IYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 515 SS--FYQTDGAEDLLSYED-----------------PADRPSMATIVLAL 545
+Y DG ++LS D P+DRPS A+I L
Sbjct: 239 EEVIYYVRDG--NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 66/275 (24%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGV---LPHGQ---EIAVKRLS-RSSGQGAQEFKNEVV 388
E+ K + +LG+G FG VY+G+ + G+ +A+K ++ +S + EF NE
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEF----------------------VPNKSLDYF 426
++ + ++VRLLG G ++V E + +L F
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 427 L-----------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSR 474
+ Y + + +HRDL A N ++ + KI DFG+ R I+ D +
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQTDGAEDLL 527
++ +M+PE G F+ KSDV+SFGV+ E T G N + L
Sbjct: 182 LLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240
Query: 528 SYE-----------------DPADRPSMATIVLAL 545
+P RP+ IV +L
Sbjct: 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 33/202 (16%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRL---SRSSGQGAQEFKNEVVLVAKLQHR 396
++ K+G G +G VYKG GQ +A+K++ S G + + E+ L+ +LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 397 NLVRLLGFCLEGDEKILVYEFV------------PNKSLDYFLYDSQL------------ 432
N+V L ++ L++EF+ + +D L S L
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 433 -RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
R++HRDLK N+L+D + K++DFGLAR FG+ + T +V T Y +PE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 492 -FSVKSDVYSFGVLALETITGK 512
+S D++S G + E T K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 31/200 (15%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEI----AVKRLSRSSGQGA-QEFKNEVVLVAKLQ 394
+F LG G FG VYKG+ +P G+++ A+K L ++ A +E +E ++A +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSL-DYFL-----------------------YDS 430
+ ++ RLLG CL + L+ + +P L DY Y
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
+ R++HRDL A N+L+ + KI+DFGLA++ G D+ + + +M+ E +H
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 491 QFSVKSDVYSFGVLALETIT 510
++ +SDV+S+GV E +T
Sbjct: 187 IYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 46/205 (22%)
Query: 348 LGRGGFGEVYKGVLPHGQE------IAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVR 400
LGRG FGEV+ +E + VK L ++ + Q EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------Y 428
LLG C E + ++ E+ L FL +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG---YMSPE 485
S R +HRDL A N L+ Q K+S L++ D ++ +++PE
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLRWLAPE 188
Query: 486 YAMHGQFSVKSDVYSFGVLALETIT 510
FS KSDV+SFGVL E T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 52/213 (24%)
Query: 347 KLGRGGFGEVYKG--VLP---HGQEIAVKRLSR-SSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG FG++YKG LP H Q +A+K L ++ Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------- 427
LLG + +++E++ L FL
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 428 -------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD--QTQGNTSRIVG 477
Y S +H+DL A NIL+ Q++ KISD GL+R I+ D + Q + +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI- 190
Query: 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+M PE M+G+FS SD++SFGV+ E +
Sbjct: 191 --RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 34/203 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG G FGEV+ ++AVK + S + F E ++ LQH
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------------------YD 429
LV+L + E I ++ EF+ SL FL +
Sbjct: 61 DKLVKLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYA 487
Q IHRDL+A+NIL+ + KI+DFGLAR+ + T+R + + +PE
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAI 175
Query: 488 MHGQFSVKSDVYSFGVLALETIT 510
G F++KSDV+SFG+L +E +T
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 32/195 (16%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKRL---SRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
K+G G +G VYK G+ +A+K++ + G + + E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 403 GFCLEGDEKILVYEF-----------VPNKSLDYFL---YDSQL----------RIIHRD 438
++ LV+EF P LD L Y QL R++HRD
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSD 497
LK N+L+D + K++DFGLAR FGV + T +V T Y +PE + Q+S D
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSRQYSTPVD 182
Query: 498 VYSFGVLALETITGK 512
++S G + E + +
Sbjct: 183 IWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 4e-19
Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 29/197 (14%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
K++ K+G+G G V+ + + GQE+A+K+++ + NE++++ +L++ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLD------------------------YFLYDSQLRII 435
L L GDE +V E++ SL FL+ +Q +I
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ--VI 137
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K+ N+LL + + K++DFG +Q++ +T +VGT +M+PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 496 SDVYSFGVLALETITGK 512
D++S G++A+E + G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 49/223 (21%)
Query: 347 KLGRGGFGEVY----KGVLPHGQEI--AVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG G FG+V+ + P +I AVK L +S ++F E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------- 427
G C+EGD I+V+E++ + L+ FL
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 428 ---YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD--QTQGNTSRIVGTYGY 481
Y + +HRDL N L+ + KI DFG++R ++ D + G+T + +
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI---RW 188
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
M PE M+ +F+ +SDV+S GV+ E T K +YQ E
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ-PWYQLSNNE 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN---EVVLVAKLQHRNLVRL 401
+LG G G V K + P G+ +AVK + + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGF 64
Query: 402 LGFCLEGDEKILVYEFVPNKSLD--------------------------YFLYDSQLRII 435
G + + E++ SLD +L+ + +II
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKII 123
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K SNIL++ + K+ DFG++ V+ + T VGT YM+PE +SVK
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPERIQGNDYSVK 179
Query: 496 SDVYSFGVLALETITGKKNSSFYQT--DGAEDLLSY---EDPADRPS 537
SD++S G+ +E TG+ DG +LL Y E P PS
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 37/202 (18%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE---------FKNEVVLVAKLQHRN 397
+G G FG VY G+ G+ +AVK++ S + + E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRI 434
+V+ LG L+ D + E+VP S+ L Y I
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG--NTSR--IVGTYGYMSPEYAMHG 490
IHRD+K +NIL+D + KISDFG+++ + N +R + G+ +M+PE
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187
Query: 491 QFSVKSDVYSFGVLALETITGK 512
++ K+D++S G L +E +TGK
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 69/265 (26%)
Query: 348 LGRGGFGEVYKGVL--PHG--QEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LG G FG V +G L G ++AVK +L + +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 402 LGFCLEGDEK------ILVYEFVPNKSLDYFLYDSQL----------------------- 432
+G C E +++ F+ + L FL S+L
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 433 ------RIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD-QTQGNTSRIVGTYGYMSP 484
IHRDL A N +L M ++DFGL++ I+ D QG +++ +++
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWIAI 184
Query: 485 EYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQ--------------TDGA 523
E ++ KSDV++FGV E T G +N Y D
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDEL 244
Query: 524 EDLLSY---EDPADRPSMATIVLAL 545
DL+ DP DRP+ + L
Sbjct: 245 YDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 46/207 (22%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRL---SRSSGQGAQE-------FKNEVVLVAKLQHR 396
+G+G +G VY + + G+ +AVK++ + +G+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 397 NLVRLLGFCLEGDEKILVY-EFVPNKSL-----DYFLYDSQL------------------ 432
N+V+ LGF +E + ++ E+VP S+ Y ++ QL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLAR----IFGVDQTQGNTSRIVGTYGYMSPE--Y 486
I+HRDLKA N+L+D KISDFG+++ I+ DQ N S + G+ +M+PE +
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMS-MQGSVFWMAPEVIH 183
Query: 487 AMHGQFSVKSDVYSFGVLALETITGKK 513
+ +S K D++S G + LE G++
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 30/192 (15%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLS-RSSGQGAQEFKNEVVLVAKLQH---RNLVRLL 402
+GRG +G VY+G +P G+ +A+K ++ + + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLK 440
G L+G ++ E+ S+ + Y ++ +IHRD+K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIK 128
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-FSVKSDVY 499
A+NIL+ N K+ DFG+A + +Q S VGT +M+PE G+ + K+D++
Sbjct: 129 AANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIW 186
Query: 500 SFGVLALETITG 511
S G+ E TG
Sbjct: 187 SLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 54/225 (24%)
Query: 335 IEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLS-RSSGQGAQEFKNEV 387
I ++T +F + LG FG+VYKG L Q +A+K L ++ G +EFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------- 427
++ ++LQH N+V LLG + +++ + + L FL
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 428 -------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD- 466
+ S ++H+DL N+L+ ++N KISD GL R ++ D
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 467 -QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+ GN+ + +MSPE M+G+FS+ SD++S+GV+ E +
Sbjct: 180 YKLMGNSLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 32/202 (15%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQE-IAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLV 399
F+ ++G+G FGEVYKG+ +E +A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 400 RLLGFCLEGDEKILVYEFVPN-------------------------KSLDYFLYDSQLRI 434
R G L+G + ++ E++ K LDY + R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
IHRD+KA+N+LL Q + K++DFG+A Q + NT VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDF 180
Query: 495 KSDVYSFGVLALETITGKKNSS 516
K+D++S G+ A+E G+ +S
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 29/197 (14%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
K++ K+G+G G VY + + GQE+A+K+++ + NE++++ + ++ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDY------------------------FLYDSQLRII 435
L L GDE +V E++ SL FL+ +Q +I
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ--VI 137
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K+ NILL + + K++DFG +Q++ +T +VGT +M+PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 496 SDVYSFGVLALETITGK 512
D++S G++A+E + G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN--EVVLVAKLQHRNLVRLLG 403
K+G G +G VYK G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 404 FCLEGDEKILVYEF---------------VPNKSLDYFLYDSQL----------RIIHRD 438
+ LV+EF +P + +LY QL I+HRD
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY--QLLQGLAFCHSHGILHRD 123
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE--YAMHGQFSVKS 496
LK N+L++ + K++DFGLAR FG + V T Y +PE +S
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD-KGYSTPV 180
Query: 497 DVYSFGVLALETITGK 512
D++S G + E ++ +
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
NK+G G FG+VY V L G+ +AVK R+ + + +E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL-------------YDSQL----------RIIHRDL 439
G + ++ + E+ +L+ L Y QL I+HRD+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQT----QGNTSRIVGTYGYMSPEYAMHGQFSVK 495
K +NI LD K+ DFG A + T + + + GT YM+PE G+
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTPAYMAPEVITGGKGKGH 183
Query: 496 ---SDVYSFGVLALETITGKKNSSFYQT 520
+D++S G + LE TGK+ S
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 29/197 (14%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
K++ K+G+G G VY + + GQE+A+++++ + NE++++ + ++ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLD------------------------YFLYDSQLRII 435
L L GDE +V E++ SL FL+ +Q +I
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ--VI 138
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K+ NILL + + K++DFG +Q++ S +VGT +M+PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 496 SDVYSFGVLALETITGK 512
D++S G++A+E I G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 56/242 (23%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLVRLLG 403
+G G VY + LP+ +++A+KR+ Q + E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 404 FCLEGDEKILVYEF-------------VPN----------------KSLDYFLYDSQLRI 434
+ GDE LV + P K L+Y + Q
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 435 IHRDLKASNILLDVQMNPKISDFGL-ARIF-GVDQTQGNTSRIVGTYGYMSPEYAMHGQ- 491
IHRD+KA NILL + KI+DFG+ A + G D+T+ VGT +M+PE M
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182
Query: 492 -FSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPSMATIVLALNSHSV 550
+ K+D++SFG+ A+E TG S Y P M ++L L +
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYSKY-----------------PPMKVLMLTLQNDPP 225
Query: 551 TL 552
+L
Sbjct: 226 SL 227
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 51/219 (23%)
Query: 347 KLGRGGFGEVY----KGVLPHGQE--IAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG G FG+V+ + P + +AVK L + ++F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------------- 427
G C +GD I+V+E++ + L+ FL
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 428 ------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD--QTQGNTSRIVGT 478
Y + +HRDL N L+ + KI DFG++R ++ D + G+T +
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-- 189
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517
+M PE M+ +F+ +SDV+SFGV+ E T K F
Sbjct: 190 -RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 8e-18
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 40/198 (20%)
Query: 348 LGRGGFGEVYKGVL--PHGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKLQHRNLVRLL 402
+G G FGEV G L P +EI V + +G + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL--YDSQLRII----------------------HRD 438
G + ++V E++ N SLD FL +D Q +I HRD
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 131
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG------YMSPEYAMHGQF 492
L A NIL++ + K+SDFGL+R+ D T+R G + +PE + +F
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAIAYRKF 186
Query: 493 SVKSDVYSFGVLALETIT 510
+ SDV+S+G++ E ++
Sbjct: 187 TSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 70/241 (29%), Positives = 109/241 (45%), Gaps = 37/241 (15%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEI----AVKRL-SRSSGQGAQEFKN 385
K E+ K LG G FG V+KG+ +P G I A+K + RS Q QE +
Sbjct: 4 LKETELRKLKL-----LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD 58
Query: 386 EVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL-DY------------------- 425
++ + L H +VRLLG C G LV + P SL D+
Sbjct: 59 HMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117
Query: 426 ----FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
Y + R++HR+L A NILL +I+DFG+A + D + S +
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSYEDPADRPSMAT 540
M+ E + G+++ +SDV+S+GV E ++ G + + + DLL + +P + T
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICT 237
Query: 541 I 541
I
Sbjct: 238 I 238
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 349 GRGGFGEVYKGVLPHGQEI-AVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRL--- 401
G+G FG+V +++ A+K +++ + NE ++ +L H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 402 ----------LGFCLEGD---------------EKILVYEFVPNKSLDYFLYDSQLRIIH 436
+ L GD K + E V +L+Y S+ IIH
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIV--LALEYL--HSK-GIIH 123
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
RD+K NILLD Q + I+DF +A T+ GT GYM+PE +SV
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 497 DVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPSMAT 540
D +S GV A E + GK+ + + + + ++ AD AT
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT 224
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 64/253 (25%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLS-RSSGQGAQEFKNEVVLVAKLQHRN 397
F+ +G+G FGEVYK + Q +A+K + + ++ + E+ +++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 398 LVRLLGFCLEG------------------------DEK---ILVYEFVPNKSLDYFLYDS 430
+ + G L+G DE ++ E + L+Y L++
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL--LGLEY-LHEE 117
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
IHRD+KA+NILL + + K++DFG++ ++ NT VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 491 QFSVKSDVYSFGVLALETITGK----------------KN-------SSFYQTDGAEDLL 527
+ K+D++S G+ A+E G+ KN + F + +D +
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKF--SKPFKDFV 231
Query: 528 SY---EDPADRPS 537
S +DP +RPS
Sbjct: 232 SLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 30/201 (14%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
+LG G FG V+ G ++A+K + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 407 EGDEKILVYEFVPNKSLDYFLYDSQLRI------------------------IHRDLKAS 442
+ +V EF+ N L +L Q ++ IHRDL A
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129
Query: 443 NILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFG 502
N L+ K+SDFG+ R + +D ++S + PE ++S KSDV+SFG
Sbjct: 130 NCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188
Query: 503 VLALETIT-GK---KNSSFYQ 519
VL E T GK + S Y+
Sbjct: 189 VLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 62/194 (31%), Positives = 89/194 (45%), Gaps = 33/194 (17%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
+LG G FG V G ++A+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 407 EGDEKILVYEFVPNKSLDYFLYDSQLRI------------------------IHRDLKAS 442
+ +V E++ N L +L + R IHRDL A
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAAR 129
Query: 443 NILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAMHGQFSVKSDVY 499
N L+D Q K+SDFGL+R D+ + VG+ + PE ++ +FS KSDV+
Sbjct: 130 NCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 500 SFGVLALETIT-GK 512
+FGVL E + GK
Sbjct: 186 AFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 37/200 (18%)
Query: 347 KLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGA--QEFKNEVVLVAKLQHRNLVRL 401
+LG G FG V KG+ + +AVK L + A E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRD 438
+G C E + +LV E L+ FL Y + +HRD
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVD----QTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
L A N+LL Q KISDFGL++ G D + + + V Y +PE + +FS
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APECMNYYKFSS 177
Query: 495 KSDVYSFGVLALETIT-GKK 513
KSDV+SFGVL E + G+K
Sbjct: 178 KSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 32/195 (16%)
Query: 348 LGRGGFGEVYKGVL--PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+G G FGEV +G L P +EI A+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRD 438
G + +++ EF+ N +LD FL Y S++ +HRD
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRD 131
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG---TYGYMSPEYAMHGQFSVK 495
L A NIL++ + K+SDFGL+R D + + +G + +PE + +F+
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA 191
Query: 496 SDVYSFGVLALETIT 510
SDV+S+G++ E ++
Sbjct: 192 SDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 335 IEVATNKFSSDNKLGRGGFGEVYKGV--LPHGQEI--AVKRLSR-SSGQGAQEFKNEVVL 389
E+ + +G G FG+VY+GV P ++I AVK +S ++F E +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------YDSQL--- 432
+ + H ++V+L+G E + +V E P L +L Y QL
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 433 -------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
R +HRD+ A N+L+ K+ DFGL+R D++ S+ +M+PE
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPE 178
Query: 486 YAMHGQFSVKSDVYSFGVLALETIT-GKK 513
+F+ SDV+ FGV E + G K
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 40/199 (20%)
Query: 348 LGRGGFGE--VYK----GVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LG+G FGE +Y+ L +E+ + RLS + A NE+V+++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQHPNIIAY 64
Query: 402 LGFCLEGDEKILVYE--------------------FVPNKSLDYFL-------YDSQLRI 434
+ D+ L+ E F L Y Y + I
Sbjct: 65 YNHFM--DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
+HRD+K NI L K+ DFG+++I G + + T +VGT YMSPE +++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNF 180
Query: 495 KSDVYSFGVLALETITGKK 513
KSD+++ G + E +T K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 58/190 (30%), Positives = 88/190 (46%), Gaps = 30/190 (15%)
Query: 348 LGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFCL 406
LG+G FGEV+KG L +AVK Q + +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 407 EGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKAS 442
+ +V E VP FL Y IHRDL A
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122
Query: 443 NILLDVQMNPKISDFGLARIF--GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYS 500
N L+ KISDFG++R G+ + G + + +PE +G++S +SDV+S
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVWS 179
Query: 501 FGVLALETIT 510
+G+L ET +
Sbjct: 180 YGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 68/201 (33%), Positives = 90/201 (44%), Gaps = 45/201 (22%)
Query: 348 LGRGGFGEV----YKGVLPH----GQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNL 398
LG G FG+V Y P G+ +AVK L R GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 399 VRLLGFCLEGDEKI--LVYEFVPNKSL-DYF-----------LYDSQL----------RI 434
V+ G C E K L+ E+VP SL DY L+ Q+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG-----YMSPEYAMH 489
IHRDL A N+LLD KI DFGLA+ +G+ V G + + E
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 490 GQFSVKSDVYSFGVLALETIT 510
+FS SDV+SFGV E +T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 348 LGRGGFGEVY--KGVLPHG----QEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
+GRG FG V+ + ++I V+++++ AQ NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFLYDS-------------------------QLRIIH 436
LE ++V E+ P +L ++ I+H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 437 RDLKASNILLDV-QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
RDLK NILLD +M KI DFG+++I ++ +VGT Y+SPE ++ K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 496 SDVYSFGVLALETITGKK 513
SD+++ G + E + K+
Sbjct: 182 SDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 38/244 (15%)
Query: 347 KLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFK-NEVVLVAKLQHRNLVRLLGF 404
KLG G + VYKG EI A+K + + +G E+ L+ +L+H N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 405 CLEGDEKILVYEFVPN---KSLD--------------YFLYDSQL----------RIIHR 437
++ +LV+E++ K +D F Y QL R++HR
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY--QLLKGIAFCHENRVLHR 124
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-SRIVGTYGYMSPEYAMHGQ-FSVK 495
DLK N+L++ + K++DFGLAR FG+ NT S V T Y +P+ + + +S
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 496 SDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPSMATIVLALNSHSVTLSVP 555
D++S G + E ITG+ F T+ + LL P+ +T + P
Sbjct: 182 IDIWSVGCIMAEMITGR--PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239
Query: 556 RQPA 559
R P
Sbjct: 240 RYPP 243
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 40/199 (20%)
Query: 348 LGRGGFGEVYKGVL--PHGQEI--AVKRLSR-SSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+G+G FG VY G L GQ+I AVK L+R + + ++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 403 GFCLEGD-EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHR 437
G CL + ++V ++ + L F+ Y + + +HR
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 438 DLKASNILLDVQMNPKISDFGLAR------IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
DL A N +LD K++DFGLAR + V G + +M+ E +
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWMALESLQTQK 178
Query: 492 FSVKSDVYSFGVLALETIT 510
F+ KSDV+SFGVL E +T
Sbjct: 179 FTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 59/196 (30%), Positives = 85/196 (43%), Gaps = 36/196 (18%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LG+GGFGEV V G+ A K+L + +G Q NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 404 FCLEGDEKI-LVYEFVPNKSLDYFLYD-------------------------SQLRIIHR 437
+ E + + LV + L Y +Y+ Q RI++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQFSVKS 496
DLK N+LLD N +ISD GLA V+ G + GT GYM+PE +
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 497 DVYSFGVLALETITGK 512
D ++ G E I G+
Sbjct: 176 DWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 27/165 (16%)
Query: 347 KLGRGGFGEVYK-GVLPHGQEIAVKR--LSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
++G G G V+K G+ +A+K+ L R G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 404 FCLEGDEKILVYEFVPN------KSLDYFLYDSQ-----------------LRIIHRDLK 440
G +LV E++P+ + + L ++Q I+HRDLK
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
+N+L+ KI+DFGLAR+F ++ + + + V T Y +PE
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 33/198 (16%)
Query: 347 KLGRGGFGEVYKGV--LPHGQ-EIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRLL 402
+LG G FG V KGV + Q ++A+K L + + + E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRD 438
G C E + +LV E L+ FL Y +HRD
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY--GYMSPEYAMHGQFSVKS 496
L A N+LL Q KISDFGL++ G D + +R G + + +PE +FS +S
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 497 DVYSFGVLALETIT-GKK 513
DV+S+G+ E + G+K
Sbjct: 180 DVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 37/89 (41%), Positives = 54/89 (60%), Gaps = 9/89 (10%)
Query: 426 FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLA--RIFGVDQTQGNTSRIVGTYGYMS 483
+LY+ RI+HRD+K SNIL++ + K+ DFG++ I + T VGT YMS
Sbjct: 118 YLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT------FVGTSTYMS 170
Query: 484 PEYAMHGQFSVKSDVYSFGVLALETITGK 512
PE G+++VKSDV+S G+ +E GK
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 71/300 (23%), Positives = 109/300 (36%), Gaps = 92/300 (30%)
Query: 336 EVATNKFSSDNKLGRGGFGEVY---------------KGVLPHGQE--IAVKRLSRSSGQ 378
E + KLG G FGEV+ +AVK L +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 379 GA-QEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------- 427
A ++F EV ++++L N+ RLLG C ++ E++ N L+ FL
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 428 ------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463
Y L +HRDL N L+ KI+DFG++R
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-- 178
Query: 464 GVDQTQGNTSRIVGT----YGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKN---- 514
+ + R+ G +M+ E + G+F+ KSDV++FGV E +T ++
Sbjct: 179 --NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 515 ----------SSFYQTDGAEDLLS---------YE--------DPADRPSMATIVLALNS 547
F++ DG + L YE D DRP+ I L L
Sbjct: 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 32/202 (15%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQE-IAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLV 399
F+ ++G+G FGEV+KG+ Q+ +A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 400 RLLGFCLEGDEKILVYEFVPN-------------------------KSLDYFLYDSQLRI 434
+ G L+G + ++ E++ K LDY + +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
IHRD+KA+N+LL Q + K++DFG+A Q + NT VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDS 180
Query: 495 KSDVYSFGVLALETITGKKNSS 516
K+D++S G+ A+E G+ +S
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS---RSSGQGAQEFKNEVVLVAKLQHRN 397
F + K+GRG F EVY+ L + +A+K++ + Q+ E+ L+ +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 398 LVRLLGFCLEGDEKILVYEF-------------------VPNKSL-DYFL-------YDS 430
+++ L +E +E +V E +P +++ YF+ +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
R++HRD+K +N+ + K+ D GL R F T ++ +VGT YMSPE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 181
Query: 491 QFSVKSDVYSFGVLALE 507
++ KSD++S G L E
Sbjct: 182 GYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 57/229 (24%)
Query: 336 EVATNKFSSDNKLGRGGFGEV----------YKGVLPHGQE-----IAVKRLSRSSGQGA 380
E + KLG G FGEV + G + +AVK L + A
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 381 Q-EFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------ 427
+ +F E+ ++++L++ N++RLLG C+ D ++ E++ N L+ FL
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 428 -----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IF 463
Y + L +HRDL N L+ KI+DFG++R ++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 464 GVD--QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
D + QG R V +M+ E + G+F+ SDV++FGV E T
Sbjct: 181 SGDYYRIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 46/212 (21%)
Query: 342 FSSDN-----KLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQ 394
F++++ ++GRG FG V K + P G +AVKR+ + + Q ++ +V +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 395 H-RNLVRLLGFCL-EGDEKI----------LVYEFVPN-------------------KSL 423
+V+ G EGD I Y++V K+L
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 424 DYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMS 483
+Y +L+IIHRD+K SNILLD N K+ DFG I G +R G YM+
Sbjct: 121 NYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMA 175
Query: 484 PEYAMHGQ---FSVKSDVYSFGVLALETITGK 512
PE + V+SDV+S G+ E TGK
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 60/229 (26%)
Query: 347 KLGRGGFGEVY----KGVLPHGQE-------------IAVKRLSRSSGQGAQ-EFKNEVV 388
KLG G FGEV+ +G+ + +AVK L + + A+ +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
++++L+ N++RLL C+ D ++ E++ N L+ FL
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 428 -------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474
Y S L +HRDL N L+ KI+DFG++R + G+ R
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGDYYR 187
Query: 475 IVG----TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519
I G +MS E + G+F+ SDV++FGV E +T K + Q
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 45/202 (22%)
Query: 348 LGRGGFGEV----YKGVLPHG----QEIAVKRLS-RSSGQGAQEFKNEVVLVAKLQHRNL 398
LG G FG+V Y P G +++AVK L S G + K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 399 VRLLGFCLE-GDEKI-LVYEFVPNKSLDYFL--------------YDSQL---------- 432
V+ G C E G I L+ EF+P+ SL +L Y Q+
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ----TQGNTSRIVGTYGYMSPEYAM 488
+ +HRDL A N+L++ + KI DFGL + D+ + + V Y +PE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---APECLI 185
Query: 489 HGQFSVKSDVYSFGVLALETIT 510
+F + SDV+SFGV E +T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 34/201 (16%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRL---SRSSGQGAQEFKNEVVLVAKLQHRN 397
F K+G G +G VYK G+ +A+K++ + + G + + E+ L+ +L H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------------YDSQL---------- 432
+V+LL ++ LV+EF+ ++ L F+ Y QL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
R++HRDLK N+L++ + K++DFGLAR FGV + T +V T Y +PE + ++
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGCKY 177
Query: 493 -SVKSDVYSFGVLALETITGK 512
S D++S G + E +T +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 59/186 (31%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 348 LGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407
+G+G FG+V G G ++AVK + + AQ F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 408 GDEKI-LVYEFVPNKSL-DYFL------------------------YDSQLRIIHRDLKA 441
+ +V E++ SL DY Y +HRDL A
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSF 501
N+L+ K+SDFGL + TQ +T ++ + +PE +FS KSDV+SF
Sbjct: 131 RNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSDVWSF 185
Query: 502 GVLALE 507
G+L E
Sbjct: 186 GILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 68/260 (26%)
Query: 348 LGRGGFGEVYKGVLPHGQEI---AVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
LG G FG V +G L I AVK +++ + ++F +E V + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 403 GFCLEGDEK--------------------ILVYE-------FVPNKSLDYFLYD------ 429
G CL+ E L+Y ++P + L F+ D
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 430 --SQLRIIHRDLKASNILLDVQMNPKISDFGLA-RIFGVD-QTQGNTSRIVGTYGYMSPE 485
S IHRDL A N +L+ MN ++DFGL+ +I+ D QG +++ +++ E
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWIAIE 184
Query: 486 YAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQ--------------TDGAE 524
++ KSDV+SFGV E T G +NS Y DG
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLY 244
Query: 525 DLLS---YEDPADRPSMATI 541
L+S +P DRPS T+
Sbjct: 245 SLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 34/196 (17%)
Query: 347 KLGRGGFGEVYK-GVLPHGQEIAVKR--LSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
KLG+G +G VYK L Q A+K L S + ++ NE+ ++A + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 404 FCLEGDEKILVYEFVPNKSLDYFLYDSQ---------------------------LRIIH 436
L+G++ +V E+ P L + + +I+H
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH 126
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
RDLK++NILL KI D G++++ + +GT YM+PE +S KS
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSYKS 182
Query: 497 DVYSFGVLALETITGK 512
D++S G L E T
Sbjct: 183 DIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 40/194 (20%)
Query: 348 LGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL-G 403
LG G FG+VYK H G A K + S + ++F E+ ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQ--HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 404 FCLEGDEKILVYEFVPNKSLDYF-------LYDSQLR-----------------IIHRDL 439
+ E IL+ EF +LD L + Q+R +IHRDL
Sbjct: 71 YFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 440 KASNILLDVQMNPKISDFGL-ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS----- 493
KA NILL + + K++DFG+ A+ Q + +GT +M+PE F
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 494 VKSDVYSFGVLALE 507
K+D++S G+ +E
Sbjct: 187 YKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 52/214 (24%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKR-LSRSSGQG----AQEFKNEVVLVAKLQHRNLVR 400
KLG G FGEVYK + G+ +A+K+ L + G A E+ ++ KL+H N+V
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKLKHPNVVP 71
Query: 401 LLGFCLE-----GDEKILVYEFVP-----------NKS---------------LDYFLYD 429
L+ +E ++ VY P N S L+ Y
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYL 131
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN----------TSRIVGTY 479
+ I+HRD+KA+NIL+D Q KI+DFGLAR + T+ +V T
Sbjct: 132 HENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV-TR 190
Query: 480 GYMSPEYAMHG-QFSVKSDVYSFGVLALETITGK 512
Y PE + +++ D++ G + E T +
Sbjct: 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404
++G G +G+VYK E+ A+K + G + + E+ ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 405 CLEGDEKILVYE------------------------FVPNKSLDYFLYDSQLRIIHRDLK 440
L D+ +V E +V ++L Y + IHRD+K
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128
Query: 441 ASNILLDVQMNPKISDFGL-ARIFGVDQTQGNTSRIVGTYGYMSPEYA---MHGQFSVKS 496
+NILL + K++DFG+ A++ T +GT +M+PE A G + K
Sbjct: 129 GANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185
Query: 497 DVYSFGVLALE 507
D+++ G+ A+E
Sbjct: 186 DIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 54/220 (24%)
Query: 345 DNKLGRGGFGEVYKGV------LPHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRN 397
LG G FG+V K +AVK L ++ ++ +E L+ ++ H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------------ 427
+++L G C + +L+ E+ SL FL
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 428 -----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470
Y ++++++HRDL A N+L+ KISDFGL+R + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
S+ +M+ E ++ +SDV+SFGVL E +T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 39/201 (19%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLS----RSSGQGA--QEFKNEVVLVAKLQHRNLVR 400
LG G F Y+ + G +AVK+++ SS Q + + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL-------------YDSQL----------RIIHR 437
+LG E L E++ S+ + L Y QL +IIHR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 438 DLKASNILLD-VQMNPKISDFGLA-----RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
D+K +N+L+D +I+DFG A + G + QG +++GT +M+PE Q
Sbjct: 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPEVLRGEQ 184
Query: 492 FSVKSDVYSFGVLALETITGK 512
+ DV+S G + +E T K
Sbjct: 185 YGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 347 KLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404
++GRG FGEV+ G L +AVK + +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 405 CLEGDEKILVYEFVPNKSLDYFLYDSQLRI------------------------IHRDLK 440
C + +V E V FL R+ IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 441 ASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
A N L+ + KISDFG++R GV + G +I + +PE +G++S +SDV
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYSSESDV 179
Query: 499 YSFGVLALETIT 510
+SFG+L E +
Sbjct: 180 WSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 43/215 (20%)
Query: 338 ATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QH 395
T F +G G +G+VYK GQ +A+K + +E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 396 RNLVRLLGFCL------EGDEKILVYEF--------------VPNKSLD-----YFLYDS 430
N+ G + D+ LV E K L Y L ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 431 --------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
+ ++IHRD+K NILL K+ DFG++ +D T G + +GT +M
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWM 180
Query: 483 SPE-----YAMHGQFSVKSDVYSFGVLALETITGK 512
+PE + +SDV+S G+ A+E GK
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS---RSSGQGAQEFKNEVVLVAKLQHRN 397
F + K+GRG F EVY+ L G +A+K++ + + E+ L+ +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 398 LVRLLGFCLEGDEKILVYEF-------------------VPNKSL-DYFL-------YDS 430
+++ +E +E +V E +P K++ YF+ +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
R++HRD+K +N+ + K+ D GL R F T ++ +VGT YMSPE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 181
Query: 491 QFSVKSDVYSFGVLALETITGKKNSSFY 518
++ KSD++S G L E S FY
Sbjct: 182 GYNFKSDIWSLGCLLYE--MAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 51/251 (20%)
Query: 336 EVATNKFSSDNKLGRGGFGEVY----KGVLPHGQE--IAVKRLSRSSGQGAQ-EFKNEVV 388
EVA K + +LG+G FG VY KGV+ E +A+K ++ ++ + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
++ + ++VRLLG +G +++ E + L +L
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 428 ------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSR 474
Y + + +HRDL A N ++ KI DFG+ R I+ D +
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY----- 529
++ +MSPE G F+ SDV+SFGV+ E T + YQ E +L +
Sbjct: 182 LLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFVMEGG 238
Query: 530 --EDPADRPSM 538
+ P + P M
Sbjct: 239 LLDKPDNCPDM 249
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 41/201 (20%)
Query: 348 LGRGGFGEVY---KGVLPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQHRNLVRL 401
+ +G +G V+ K G A+K + ++ + E ++++ Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 402 LGFCLEGDEKI-LVYEFVPN-------KSLDYF------LYDSQ----------LRIIHR 437
+ +G + + LV E++P +++ +Y ++ IIHR
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGN-------TSRIVGTYGYMSPEYAMHG 490
DLK NIL+D + K++DFGL++ G+ + Q N RIVGT Y++PE +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 491 QFSVKSDVYSFGVLALETITG 511
S D +S G + E + G
Sbjct: 177 GHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 33/203 (16%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQE-IAVK--RLSRSSGQGAQEFKNEVVLVAKLQHR 396
+++ K+G G +G VYK E IA+K RL + E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 397 NLVRLLGFCLEGDEKI-LVYEFV-----------PNKSLDYFLYDSQL------------ 432
N+VRL + ++++ LV+E++ P+ + + L + L
Sbjct: 62 NIVRLQD-VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 433 -RIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
R++HRDLK N+L+D + N K++DFGLAR FG+ + T +V T Y +PE +
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILLGS 178
Query: 491 -QFSVKSDVYSFGVLALETITGK 512
+S D++S G + E + K
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 341 KFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR 396
+ K+G G G V + G+++AVK++ Q + NEVV++ QH
Sbjct: 20 YLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQL----------------------RI 434
N+V + L GDE +V EF+ +L + +++ +
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR---IVGTYGYMSPEYAMHGQ 491
IHRD+K+ +ILL K+SDFG Q R +VGT +M+PE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 492 FSVKSDVYSFGVLALETITGK 512
+ + D++S G++ +E + G+
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 89/291 (30%)
Query: 336 EVATNKFSSDNKLGRGGFGEV----YKGVLPHGQEI--AVKRLSRSSGQGAQEFKNEVVL 389
E+ ++ + LG G FG+V G+ + AVK L + + ++ + L
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSD---L 62
Query: 390 VAKL-------QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------- 427
V+++ +H+N++ LLG C + +V E+ + +L FL
Sbjct: 63 VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122
Query: 428 ------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-I 462
+ + + IHRDL A N+L+ KI+DFGLAR I
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 463 FGVDQTQGNTS-RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
+D + T+ R+ +M+PE ++ +SDV+SFGVL E T S Y
Sbjct: 183 HHIDYYRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--LGGSPYPGI 238
Query: 522 GAEDLLSY--------------------------EDPADRPSMATIVLALN 546
E+L E P+ RP+ +V L+
Sbjct: 239 PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 38/196 (19%)
Query: 348 LGRGGFGEVYKGVL--PHGQE--IAVKRLSRSSGQGAQE--FKNEVVLVAKLQHRNLVRL 401
LG G FGE+ +G L P +E +A+ L R+ Q F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHR 437
G G+ ++V E++ N +LD FL Y S++ +H+
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131
Query: 438 DLKASNILLDVQMNPKISDFGLA---RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
L A +L++ + KIS F + + T S ++ + +PE + FS
Sbjct: 132 GLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQYHHFSS 187
Query: 495 KSDVYSFGVLALETIT 510
SDV+SFG++ E ++
Sbjct: 188 ASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 28/193 (14%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 403
N++G G G VYK + P G+ A+K + + + + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 404 FCLEGDEKILVYEFVPNKSLD-------YFLYD------------SQLRIIHRDLKASNI 444
E ++ EF+ SL+ FL D + I+HRD+K SN+
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199
Query: 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA----MHGQFS-VKSDVY 499
L++ N KI+DFG++RI + QT + VGT YMSPE HG + D++
Sbjct: 200 LINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIW 257
Query: 500 SFGVLALETITGK 512
S GV LE G+
Sbjct: 258 SLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 52/199 (26%), Positives = 77/199 (38%), Gaps = 35/199 (17%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRN 397
K ++LG G G V K L + I A+K ++ Q + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 398 LVRLLG-FCLEGDEKI-LVYEFVPNKSLDYFL---------------------------Y 428
+V+ G F E I + E+ SLD Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
+IIHRD+K SNILL + K+ DFG++ GT YM+PE
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQ 176
Query: 489 HGQFSVKSDVYSFGVLALE 507
+S+ SDV+S G+ LE
Sbjct: 177 GKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 67/260 (25%)
Query: 341 KFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRL--SRSSGQGAQEFKNEVVLVAKLQ 394
K+ K+G G FG K +L G++ +K + S+ S + +E + EV +++ ++
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 395 HRNLVR-------------LLGFCLEGD--EKILVYE---FVPNKSLDYFLYDSQL---- 432
H N+V+ ++ +C GD +KI F ++ LD+F+ Q+
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV---QICLAL 114
Query: 433 ------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486
+I+HRD+K+ NI L K+ DFG+AR+ ++ T +GT Y+SPE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEI 172
Query: 487 AMHGQFSVKSDVYSFGVLALETITGK--------KN-------------SSFYQTDGAED 525
+ ++ KSD+++ G + E T K KN SS Y D +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD-LRN 231
Query: 526 LLSY---EDPADRPSMATIV 542
L+S +P DRPS+ +I+
Sbjct: 232 LVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 46/222 (20%)
Query: 328 LQFDFKTIEVATNKFSSDNKLGRGGFGEVYKG-VLPHGQEIAVKRLSRSSGQGAQEFKN- 385
L D + N + ++G G G+VYK G +AVK++ R+ +E K
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRI 60
Query: 386 ----EVVL---------------VAKLQHRNLVRLLGFCLEGDEKILVYEFVPN------ 420
+VVL + + L+ CL+ + +P
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILGKM 119
Query: 421 -----KSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLA-RIFGVDQTQGNTSR 474
K+L Y L + +IHRD+K SNILLD N K+ DFG++ R+ VD ++ T R
Sbjct: 120 TVAIVKALHY-LKEKH-GVIHRDVKPSNILLDASGNVKLCDFGISGRL--VD-SKAKT-R 173
Query: 475 IVGTYGYMSPEY----AMHGQFSVKSDVYSFGVLALETITGK 512
G YM+PE + ++ +++DV+S G+ +E TG+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 42/194 (21%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA--QEFKNEVVLVAKLQ---HRNLV 399
++G G +G VYK L G+ +A+K++ + E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 400 RLLGFCL--EGDEKI---LVYEFV-----------------PNKSLDY---------FLY 428
RLL C D ++ LV+E V P D FL+
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
RI+HRDLK NIL+ KI+DFGLARI+ + TS +V T Y +PE +
Sbjct: 125 SH--RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TS-VVVTLWYRAPEVLL 179
Query: 489 HGQFSVKSDVYSFG 502
++ D++S G
Sbjct: 180 QSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 44/197 (22%)
Query: 347 KLGRGGFGEVYK------GVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG G FG+VYK G L A K + S + +++ E+ ++A H +V+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALA-----AAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 401 LLG-FCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRII 435
LLG F +G I++ EF P ++D + Y ++II
Sbjct: 74 LLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-----HG 490
HRDLKA N+LL + + K++DFG++ V Q S +GT +M+PE M
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDT 190
Query: 491 QFSVKSDVYSFGVLALE 507
+ K+D++S G+ +E
Sbjct: 191 PYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 341 KFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKN-----EVVLVAKLQ 394
++ KLG G + VYK G+ +A+K++ + A++ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVP--------NKSLDY-----------------FLYD 429
H N++ LL LV+EF+ +KS+ +L+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
+ I+HRDLK +N+L+ K++DFGLAR FG + T ++V T Y +PE
Sbjct: 121 NW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYRAPELLF- 175
Query: 490 G--QFSVKSDVYSFGVLALETITGK 512
G + V D++S G + E +
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 32/198 (16%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQE-IAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLV 399
F+ K+G+G FGEV+KG+ Q+ +A+K + + ++ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 400 RLLGFCLEGDEKILVYEFVPN-------------------------KSLDYFLYDSQLRI 434
+ G L+ + ++ E++ K LDY + +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
IHRD+KA+N+LL K++DFG+A + TQ + VGT +M+PE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 495 KSDVYSFGVLALETITGK 512
K+D++S G+ A+E G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 313 VLEQNADNDITTLESLQFDFKTI-EVATNKFSSDNKLGRGGFGEVYKGV---LPHGQ--- 365
V+E N+ ++ Q + E N S LG G FG+V + L
Sbjct: 7 VIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVM 66
Query: 366 EIAVKRLSRSSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423
++AVK L ++ +E +E+ +++ L H N+V LLG C G +++ E+ L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 424 DYFL---------------YDSQL----------RIIHRDLKASNILLDVQMNPKISDFG 458
FL + Q+ IHRDL A N+LL KI DFG
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186
Query: 459 LARIFGVDQ---TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
LAR D +GN V +M+PE + ++ +SDV+S+G+L E +
Sbjct: 187 LARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 25/189 (13%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
K+G G G V H G+++AVK++ Q + NEVV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 406 LEGDEKILVYEFVPNKSLDYFLYDSQLR----------------------IIHRDLKASN 443
L GDE +V EF+ +L + +++ +IHRD+K+ +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 444 ILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGV 503
ILL K+SDFG V + +VGT +M+PE + + D++S G+
Sbjct: 149 ILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 504 LALETITGK 512
+ +E I G+
Sbjct: 207 MVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 53/195 (27%), Positives = 80/195 (41%), Gaps = 36/195 (18%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRSS--GQGAQE-FKNEVVLVAKLQHRNLVRLLG 403
LG GGFG V V + A+K + + G QE +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 404 FCLEGDEKILVY---EFVPNKSL-DY----------------------FLYDSQLRIIHR 437
+ D+K +Y E+ L F Y II+R
Sbjct: 59 YRTFKDKK-YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DLK N+LLD K+ DFG A+ Q T GT Y++PE ++ + D
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 498 VYSFGVLALETITGK 512
+S G+L E +TG+
Sbjct: 175 YWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 71/272 (26%), Positives = 110/272 (40%), Gaps = 81/272 (29%)
Query: 348 LGRGGFGEVYKGVLPHG---QEIAVKRLSRSSGQG-AQEFKNEVVLVAKL-QHRNLVRLL 402
+G G FG+V K + + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL----------------------------------- 427
G C L E+ P+ +L FL
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 428 ----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG--- 480
Y SQ + IHRDL A NIL+ KI+DFGL+R G + T G
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLP 186
Query: 481 --YMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------- 520
+M+ E + ++ SDV+S+GVL E ++ G + Y+
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246
Query: 521 ---DGAEDLLSY---EDPADRPSMATIVLALN 546
D DL+ E P +RPS A I+++LN
Sbjct: 247 NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-14
Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 35/184 (19%)
Query: 364 GQEIAVKRLSRSSGQGAQE---FKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL-VYEFVP 419
G E+A+K L + + + F+ E L A+L H N+V LL + V+E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 420 NKSL-DYFLYDSQLR----------------------IIHRDLKASNILL---DVQMNPK 453
++L + D L I+HRDLK NI++ V+ + K
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 454 ISDFGLARIF-GVD----QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508
+ DFG+ + GV T T+ ++GT Y +PE + SD+Y++G++ LE
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182
Query: 509 ITGK 512
+TG+
Sbjct: 183 LTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 44/207 (21%)
Query: 340 NKFSSDNKLGRGGFGEVYKG-VLPHGQEIAVKRLSRSSGQGAQEFKN----EVVLVAKLQ 394
NK+ +G G +G V K G+ +A+K+ S + ++ K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLR 58
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF-------------LYDSQL--------- 432
H N+V L LV+E+V L+ Y QL
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 433 -RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI---VGTYGYMSPE--- 485
IIHRD+K NIL+ K+ DFG AR S + V T Y +PE
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARAL----RARPASPLTDYVATRWYRAPELLV 174
Query: 486 -YAMHGQFSVKSDVYSFGVLALETITG 511
+G V DV++ G + E + G
Sbjct: 175 GDTNYG-KPV--DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 66/226 (29%)
Query: 347 KLGRGGFGEVYKGVLPHGQE-----------------IAVKRLSRSSGQGAQ-EFKNEVV 388
KLG G FGEV+ + + Q+ +AVK L + + A+ +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
++++L+ N++RLLG C++ D ++ E++ N L+ FL
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGV 465
Y S L +HRDL N L+ + KI+DFG++R ++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 466 D--QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETI 509
D + QG R V +M+ E + G+F+ SDV++FGV E +
Sbjct: 192 DYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 25/189 (13%)
Query: 347 KLGRGGFGEV-YKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
K+G G G V V G+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 406 LEGDEKILVYEFVPNKSLDYFLYDSQLR----------------------IIHRDLKASN 443
L GDE +V EF+ +L + +++ +IHRD+K+ +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 444 ILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGV 503
ILL K+SDFG V + +VGT +M+PE + + D++S G+
Sbjct: 147 ILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 504 LALETITGK 512
+ +E + G+
Sbjct: 205 MVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 36/196 (18%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN---EVVLVAKLQHRN 397
F+ ++G G FG VY E+ A+K++S S Q +++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 398 LVRLLGFCLEGDEKILVYEF-----------------------VPNKSLDYFLYDSQLRI 434
+ G L LV E+ + + +L Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE--YAM-HGQ 491
IHRD+KA NILL K++DFG A + + VGT +M+PE AM GQ
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDEGQ 190
Query: 492 FSVKSDVYSFGVLALE 507
+ K DV+S G+ +E
Sbjct: 191 YDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 44/209 (21%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFK---NE 386
DF+ + ++G+GG+G+V+ EI A+KR+ +S E + E
Sbjct: 2 DFQILT----------QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTE 51
Query: 387 VVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS--------------- 430
++ + LV+LL + + DE + L E+VP L +
Sbjct: 52 RDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM 110
Query: 431 --------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
+L IHRDLK N L+D + K++DFGL++ T N+ +VG+ YM
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYM 165
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETITG 511
+PE + D +S G + E + G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSGQGAQEFKNEVV 388
F T+ TN++ +G G FG V GQ +A+K++ + S+ A+ E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKI-LVYEF-------------VPNKSLDYFLYDSQLR- 433
L+ L+H N++ L + E I V E + + + YFLY LR
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI-LRG 120
Query: 434 --------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
++HRDLK SNIL++ + KI DFGLARI Q T V T Y +PE
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVSTRYYRAPE 175
Query: 486 YAMHGQ-FSVKSDVYSFGVLALETITGK 512
+ Q + V+ D++S G + E + GK
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/196 (33%), Positives = 91/196 (46%), Gaps = 36/196 (18%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLL- 402
LG+GGFGEV V G+ A K+L + +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 403 ------GFCL------EGDEKILVYEFVPNKSLD---YFLYDSQL----------RIIHR 437
CL GD K +Y + N D Y ++L RI++R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQFSVKS 496
DLK NILLD + + +ISD GLA V +G T R VGT GYM+PE + +++
Sbjct: 127 DLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 497 DVYSFGVLALETITGK 512
D + G L E I G+
Sbjct: 183 DWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRL-----SRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LGRG FGEVY G+E+AVK++ S+ + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 402 LGFCLEGDE--KILVY-EFVPNKSLDYFL-------------YDSQL----------RII 435
G CL E K+ ++ E++P S+ L Y Q+ I+
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 436 HRDLKASNILLDVQMNPKISDFGLA-RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
HRD+K +NIL D N K+ DFG + RI + + + GT +MSPE +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGR 188
Query: 495 KSDVYSFGVLALETITGKKNSSFYQTDGA 523
K+DV+S +E +T K + Y+ A
Sbjct: 189 KADVWSVACTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 51/189 (26%), Positives = 90/189 (47%), Gaps = 25/189 (13%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
K+G G G V H G+++AVK + Q + NEVV++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 406 LEGDEKILVYEFVPNKSLDYFLYDSQLR----------------------IIHRDLKASN 443
L G+E ++ EF+ +L + ++L +IHRD+K+ +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 444 ILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGV 503
ILL + K+SDFG D + + +VGT +M+PE + + D++S G+
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGI 205
Query: 504 LALETITGK 512
+ +E + G+
Sbjct: 206 MVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 64/226 (28%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSR--SSGQGAQEFKNEVV 388
KT+ +++ + + +G G +G+V G+++A+K+LSR S A+ E+
Sbjct: 7 NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR 66
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF---------------------- 426
L+ + H N++ LL F P SL+ F
Sbjct: 67 LLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK 114
Query: 427 LYDSQLR-----------------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469
L D ++ IIHRDLK SNI ++ KI DFGLAR T
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTD 169
Query: 470 GNTSRIVGTYGYMSPEYA---MHGQFSVKSDVYSFGVLALETITGK 512
+ V T Y +PE MH +V D++S G + E +TGK
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 63/195 (32%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLL- 402
LG+GGFGEV V G+ A K+L + +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 403 ------GFCL------EGDEKILVYEFVPN--KSLDYFLYDSQL----------RIIHRD 438
CL GD K +Y Y +++ RI++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQFSVKSD 497
LK NILLD + +ISD GLA V+ +G T R VGT GYM+PE + +++ D
Sbjct: 128 LKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 498 VYSFGVLALETITGK 512
+ G L E I GK
Sbjct: 184 WWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 50/212 (23%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEV----YKGVLPHGQEIAVKRLSRS----SGQGAQE 382
DF+ I+ LG G FG V +K G+ A+K LS++ Q +
Sbjct: 2 DFEFIKT----------LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEH 47
Query: 383 FKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------YD 429
NE ++ ++H LV L G + LV E+VP L L Y
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 430 SQ----------LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY 479
+Q L I++RDLK N+LLD KI+DFG A+ +G T + GT
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGRTYTLCGTP 162
Query: 480 GYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
Y++PE + + D ++ G+L E + G
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 68/202 (33%), Positives = 94/202 (46%), Gaps = 36/202 (17%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLL- 402
LG+GGFGEV V G+ A K+L + +G NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 403 ------GFCL------EGDEKILVYE-----FVPNKSLDYF------LYD-SQLRIIHRD 438
CL GD K +Y F +++ Y L D Q RI++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQT-QGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
LK NILLD + +ISD GLA QT +G VGT GYM+PE + +++ D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERYTFSPD 183
Query: 498 VYSFGVLALETITGKKNSSFYQ 519
++ G L E I G+ S F Q
Sbjct: 184 WWALGCLLYEMIAGQ--SPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 44/181 (24%)
Query: 347 KLGRGGFGEVYKGVL---PHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQHRNLVR 400
+GRG +G VYK G+E A+K+ Q Q E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 401 LLGFCLE-GDEKI-LVYEF-------------------VPN---KSLDY-------FLYD 429
L+ LE D+ + L++++ +P KSL + +L+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 430 SQLRIIHRDLKASNILL----DVQMNPKISDFGLARIFGVD-QTQGNTSRIVGTYGYMSP 484
+ ++HRDLK +NIL+ + KI D GLAR+F + + +V T Y +P
Sbjct: 127 NW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184
Query: 485 E 485
E
Sbjct: 185 E 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-13
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 58/210 (27%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN---------EVVLVAKLQHRN 397
+G G +G V V G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 398 LVRLL---------GFCLEGDEKILVYEFVP---------NKSLD-----YFLYDSQ-LR 433
++ LL F ++ +V E + + L YFLY Q LR
Sbjct: 61 IIGLLDILRPPSPEDF----NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY--QILR 114
Query: 434 ---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-TQGNTSRIVGTYGYMS 483
+IHRDLK SNIL++ + KI DFGLAR D+ +G + V T Y +
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 484 PEYAMHGQ-FSVKSDVYSFGVLALETITGK 512
PE + ++ D++S G + E +T K
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 36/196 (18%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN---EVVLVAKLQHRN 397
F +++G G FG VY H E+ AVK++S S Q +++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 398 LVRLLGFCLEGDEKILVYEF-----------------------VPNKSLDYFLYDSQLRI 434
+ G L+ LV E+ + + +L Y +
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM---HGQ 491
IHRD+KA NILL K++DFG A + N+ VGT +M+PE + GQ
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVILAMDEGQ 196
Query: 492 FSVKSDVYSFGVLALE 507
+ K DV+S G+ +E
Sbjct: 197 YDGKVDVWSLGITCIE 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 49/262 (18%)
Query: 284 IVAPIVVIAVLFIAGLCFLRRRAEKKYNAVLE-QNADNDITTLESLQFDFK-----TIEV 337
+ A +V+ V F G F+R R LE + +N+ T E FD K TI
Sbjct: 636 LGAFLVLALVAF--GFVFIRGRN------NLELKRVENEDGTWELQFFDSKVSKSITIND 687
Query: 338 ATNKFSSDNKLGRGGFGEVYKG-VLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR 396
+ +N + RG G YKG + +G + VK ++ + + E + + KLQH
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHP 743
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD--------------SQLRIIH------ 436
N+V+L+G C L++E++ K+L L + LR +H
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 437 ---RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
+L I++D + P + L + D +S Y++PE +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDIT 856
Query: 494 VKSDVYSFGVLALETITGKKNS 515
KSD+Y FG++ +E +TGK +
Sbjct: 857 EKSDIYGFGLILIELLTGKSPA 878
|
Length = 968 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 62/197 (31%), Positives = 85/197 (43%), Gaps = 42/197 (21%)
Query: 347 KLGRGGFGEVY-----KGV----LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
+LG+G FG VY K V L +EI V L+ + A + E L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHPA 63
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------------------------YDS 430
+V+ LE D ++ E+ + LD L Y
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
Q RI+HRDLKA NI L + KI DFG++R+ T GT YMSPE H
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKHQ 180
Query: 491 QFSVKSDVYSFGVLALE 507
+ KSD++S G + E
Sbjct: 181 GYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 6e-13
Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 39/201 (19%)
Query: 348 LGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 406
+G G +G+VYKG ++A ++ +G +E K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 407 E------GDEKILVYEFVPNKSLDYFLYDS-------------------------QLRII 435
+ D+ LV EF S+ + ++ Q ++I
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-----HG 490
HRD+K N+LL K+ DFG++ +D+T G + +GT +M+PE
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191
Query: 491 QFSVKSDVYSFGVLALETITG 511
+ KSD++S G+ A+E G
Sbjct: 192 TYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 35/196 (17%)
Query: 348 LGRGGFGEVYKGVLPH---GQEIAVKRLS--RSSGQGAQEFKNEVVLVAKLQHRNLVR-- 400
+G+G +GEV ++ H G++ +K+L+ +S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 401 ------------LLGFCLEGDE----KILVYEFVP-NKSLDYFL-------YDSQLRIIH 436
++GFC GD K + +P N+ +++F+ Y + I+H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
RDLK N+ L K+ D G+AR+ ++ S ++GT YMSPE + ++ KS
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183
Query: 497 DVYSFGVLALETITGK 512
DV++ G E T K
Sbjct: 184 DVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQG-AQEFKNEVVLVAKLQHRNLV 399
+ + + +G G +G V P G ++A+K++S Q Q E+ ++ + +H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 400 RLLGFCLEGD-----EKILVYEFVP-------------NKSLDYFLYDSQLR-------- 433
+L + +V E + N + YFLY LR
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI-LRGLKYIHSA 125
Query: 434 -IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI---VGTYGYMSPEYAMH 489
++HRDLK SN+LL+ + KI DFGLARI D +T + V T Y +PE ++
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 490 GQFSVKS-DVYSFGVLALETITGK 512
+ K+ D++S G + E ++ +
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 32/154 (20%)
Query: 341 KFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLS-RSSGQGAQEFK-NEVVLVAKLQHRN 397
K+ K+G G +G V+K EI A+KR+ +G E+ L+ +L+H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 398 LVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS---------------QL--------- 432
+VRL L D+K+ LV+E+ YF DS QL
Sbjct: 61 IVRLYD-VLHSDKKLTLVFEYCDQDLKKYF--DSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 433 -RIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
++HRDLK N+L++ K++DFGLAR FG+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 42/196 (21%)
Query: 347 KLGRGGFGEVYK------GVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG G FG+VYK GVL A K + S + +++ E+ ++A H N+V+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 401 LLG-------------FCLEGDEKILVYEF-----------VPNKSLDYFLYDSQLRIIH 436
LL FC G ++ E V ++L+ Y + +IIH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-----HGQ 491
RDLKA NIL + + K++DFG++ +T +GT +M+PE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 492 FSVKSDVYSFGVLALE 507
+ K+DV+S G+ +E
Sbjct: 185 YDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 42/216 (19%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGV---LPHGQ---EIAVKRLSRSSGQGAQ-EFKNEVV 388
EV+ K + +LG+G FG VY+G + G+ +AVK ++ S+ + EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
++ ++VRLLG +G ++V E + + L +L
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 428 ------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSR 474
Y + + +HRDL A N ++ KI DFG+ R I+ D +
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
++ M+PE G F+ SD++SFGV+ E +
Sbjct: 182 LLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 42/198 (21%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKN--EVVLVAKLQ---HRNLVR 400
++G G +G VYK PH G +A+K + + + EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 401 LLGFC--LEGDEKI---LVYEFVPNKSLDY--------------------------FLYD 429
L+ C D + LV+E V Y FL+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
+ I+HRDLK NIL+ K++DFGLARI+ Q + +V T Y +PE +
Sbjct: 127 N--CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVLLQ 181
Query: 490 GQFSVKSDVYSFGVLALE 507
++ D++S G + E
Sbjct: 182 STYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRL-----SRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LG+G FG VY + G+E+A K++ S + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 402 LGFCLEGDEKILV--YEFVPNKSLDYFL-------------YDSQL----------RIIH 436
G + EK L E++P S+ L Y Q+ I+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQFSVK 495
RD+K +NIL D N K+ DFG ++ G R + GT +MSPE + K
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189
Query: 496 SDVYSFGVLALETITGKKNSSFYQTDGA 523
+DV+S G +E +T K + Y+ A
Sbjct: 190 ADVWSLGCTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 36/196 (18%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN---EVVLVAKLQHRN 397
FS ++G G FG VY E+ A+K++S S Q +++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 398 LVRLLGFCLEGDEKILVYEF-----------------------VPNKSLDYFLYDSQLRI 434
++ G L LV E+ V + +L Y +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM---HGQ 491
IHRD+KA NILL K+ DFG A I + VGT +M+PE + GQ
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQ 190
Query: 492 FSVKSDVYSFGVLALE 507
+ K DV+S G+ +E
Sbjct: 191 YDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 39/199 (19%)
Query: 348 LGRGGFGEVY------KGVLPHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVR 400
LG+GGFGEV G L +++ KRL + G +GA K ++AK+ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFLYD---------------------------SQLR 433
L + LV + L Y +Y+ Q R
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
II+RDLK N+LLD N +ISD GLA + Q T GT G+M+PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 494 VKSDVYSFGVLALETITGK 512
D ++ GV E I +
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 52/221 (23%)
Query: 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHG-----QEIAVKRLSRSSGQGAQE-----FK 384
I ++ ++ + + L G FG ++ G+L +E+ VK + A E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLL 56
Query: 385 NEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS-LDYFLYDSQL----------- 432
E L+ L H+N++ +L C+E E V N L FL +L
Sbjct: 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 433 --------------------RIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD-QTQG 470
+IH+D+ A N ++D ++ KI+D L+R +F +D G
Sbjct: 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 471 -NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
N +R V +M+ E ++ ++S SDV+SFGVL E +T
Sbjct: 177 DNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 67/226 (29%), Positives = 94/226 (41%), Gaps = 58/226 (25%)
Query: 332 FKTIEVATNKFSSDNK------LGRGGFGEV---YKGVLPHGQEIAVKRLSRSSGQGAQE 382
F ++EV + F+ + +G G G V Y V GQ +A+K+LSR
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRP------- 52
Query: 383 FKN---------EVVLVAKLQHRNLVRLLGFCLEGDEKI-------LVYEF-------VP 419
F+N E+VL+ + H+N++ LL + + LV E V
Sbjct: 53 FQNVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVI 111
Query: 420 NKSLD-----YFLYDS-----QLR---IIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466
LD Y LY L IIHRDLK SNI++ KI DFGLAR G
Sbjct: 112 QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
Query: 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
T +V Y Y +PE + + D++S G + E I G
Sbjct: 172 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 44/192 (22%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRL--SRSSGQGAQEFKNEVVLVAKL-QHRNLVRL 401
KLG+G +G V+K + + +A+K++ + + AQ E++ + +L H N+V+L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 402 LG-FCLEGDEKI-LVYEF-------VPNKSL------DYFLYDSQL----------RIIH 436
L E D+ I LV+E+ V ++ Y +Y QL +IH
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY--QLLKALKYIHSGNVIH 130
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI-----VGTYGYMSPEYAMHGQ 491
RDLK SNILL+ K++DFGLAR + + + N V T Y +PE
Sbjct: 131 RDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVLTDYVATRWYRAPE------ 182
Query: 492 FSVKSDVYSFGV 503
+ S Y+ GV
Sbjct: 183 ILLGSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 52/254 (20%)
Query: 347 KLGRGGFGEVYKG--VLPHGQEIAVKRLSRSSGQGAQEFKN--EVVLVAKLQ---HRNLV 399
++G G +G+V+K + G+ +A+KR+ +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 400 RLLGFCL----EGDEKI-LVYEFV----------------PNKSLDYFLYDSQL------ 432
RL C + + K+ LV+E V P +++ ++ QL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF--QLLRGLDF 125
Query: 433 ----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
R++HRDLK NIL+ K++DFGLARI+ Q + +V T Y +PE +
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLL 182
Query: 489 HGQFSVKSDVYSFGVLALETITGKK----NSSFYQTDGAEDLLSYEDPADRPSMATIVLA 544
++ D++S G + E K +S Q D++ D P + L
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR--DVALP 240
Query: 545 LNSHSVTLSVPRQP 558
+ S QP
Sbjct: 241 RQAFH---SKSAQP 251
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 36/196 (18%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN---EVVLVAKLQHRN 397
F+ ++G G FG VY E+ A+K++S S Q +++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 398 LVRLLGFCLEGDEKILVYEF-----------------------VPNKSLDYFLYDSQLRI 434
+ G L LV E+ + + +L Y +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM---HGQ 491
IHRD+KA NILL K++DFG A I + VGT +M+PE + GQ
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 492 FSVKSDVYSFGVLALE 507
+ K DV+S G+ +E
Sbjct: 201 YDGKVDVWSLGITCIE 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 341 KFSSDNKLGRGGFGEVYKGVLPHGQEIAVKR---LSRSSGQGAQEFKNEVVLVAKLQHRN 397
++ K+G G FG++Y E V + L++ + + K EV+L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 398 LVRLLGFCLEGDEKILVYE------------------FVPNKSLDYFLYDS-------QL 432
+V E +V E F ++ L +F+ S
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 433 RIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
+I+HRD+K+ NI L M K+ DFG+AR T VGT Y+SPE +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSPEICQNRP 178
Query: 492 FSVKSDVYSFGVLALETITGK 512
++ K+D++S G + E T K
Sbjct: 179 YNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 60/251 (23%), Positives = 111/251 (44%), Gaps = 46/251 (18%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFK----NEVVLV 390
+ +KF ++G G +G+VYK G+ +A+K++ + + + F E+ ++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 391 AKLQHRNLVRLLGFCLEGDEKI----------LVYEFVP------------------NKS 422
+L HRN+V L + + + LV+E++ KS
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 423 -----LDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
L+ Y + +HRD+K SNILL+ + K++DFGLAR++ ++++ T++++
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 478 TYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGK----KNSSFYQTDGAEDLLSYEDP 532
T Y PE + ++ DV+S G + E T K N Q + L P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 533 ADRPSMATIVL 543
A P + +
Sbjct: 240 AVWPDVIKLPY 250
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 32/197 (16%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRL-----SRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
LG+G FG VY G+E+AVK++ S + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 402 LGFCLEGDEKIL--VYEFVPNKS-----------------------LDYFLYDSQLRIIH 436
G + E+ L E +P S L+ Y I+H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQFSVK 495
RD+K +NIL D N K+ DFG ++ G + + GT +MSPE + K
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK 189
Query: 496 SDVYSFGVLALETITGK 512
+D++S G +E +T K
Sbjct: 190 ADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 348 LGRGGFGEVY----KGVLPHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQHRNLV 399
LG G +G+V+ G G+ A+K L +++ + A+ + E ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 400 RLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS-----------------------QLRII 435
L + + D K+ L+ ++V L LY QL II
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII 127
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ--FS 493
+RD+K NILLD + + ++DFGL++ F ++ + S GT YM+PE G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHD 186
Query: 494 VKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
D +S GVL E +TG +S + DG ++
Sbjct: 187 KAVDWWSLGVLTFELLTG---ASPFTVDGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 52/228 (22%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQH 395
F+ LG+G FG V + L Q++AVK L S +EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 396 RNLVRLLGFCLEGDEK------ILVYEFVPNKSLDYFL---------------------- 427
N+++L+G L K +++ F+ + L FL
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 428 -------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD-QTQGNTSRIVGT 478
Y S IHRDL A N +L+ M ++DFGL++ I+ D QG S++
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--P 178
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQ 519
+++ E ++ SDV++FGV E +T G +NS Y
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 33/194 (17%)
Query: 348 LGRGGFGEVY--KGVLPH--GQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRL 401
LG+G FG+V+ + + GQ A+K L +++ + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 402 -LGFCLEGDEKILVYEFVPNKSL-------------DYFLYDSQLR----------IIHR 437
F EG + L+ +F+ L D Y ++L II+R
Sbjct: 64 HYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 122
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DLK NILLD + + K++DFGL++ +D + S GT YM+PE + +D
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSAD 180
Query: 498 VYSFGVLALETITG 511
+SFGVL E +TG
Sbjct: 181 WWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 59/208 (28%)
Query: 347 KLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN--------EVVLVAKLQ-HR 396
+LG G FG VY E+ A+K++ ++F + EV + KL H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY---------DSQLRII------------ 435
N+V+L E DE V+E++ +L Y L +S +R I
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 436 -----HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-----IVGTYGYMSPE 485
HRDLK N+L+ KI+DFGLAR + SR V T Y +PE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIR------SRPPYTDYVSTRWYRAPE 168
Query: 486 YAMHGQF-SVKSDVYSFGVLALETITGK 512
+ S D+++ G + E T +
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/195 (31%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLL- 402
LG+GGFGEV V G+ A KRL + +G NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 403 ------GFCL------EGDEKILVYE-----FVPNKSLDY-------FLYDSQLRIIHRD 438
CL GD K +Y F ++L Y + ++RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQFSVKSD 497
LK NILLD + +ISD GLA V +G + R VGT GYM+PE + ++++ D
Sbjct: 128 LKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183
Query: 498 VYSFGVLALETITGK 512
+ G L E I G+
Sbjct: 184 YWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 51/231 (22%)
Query: 319 DNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSG 377
D D++ L F+ +EV +G G +G+VYKG + GQ A+K + +
Sbjct: 5 DIDLSALRDPAGIFELVEV----------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED 54
Query: 378 QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE------GDEKILVYEFVPNKSL------- 423
+ +E K E+ ++ K HRN+ G ++ D+ LV EF S+
Sbjct: 55 E-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 424 -------DYFLYDSQ--LR---------IIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
D+ Y + LR +IHRD+K N+LL K+ DFG++ +
Sbjct: 114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QL 171
Query: 466 DQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITG 511
D+T G + +GT +M+PE + +SD++S G+ A+E G
Sbjct: 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 43/198 (21%)
Query: 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRL---SRSSGQGAQ 381
+ +F F +K+ K+G+G FGEV+K ++I A+K++ + G
Sbjct: 1 DQYEFPFCDE---VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT 57
Query: 382 EFKNEVVLVAKLQHRNLVRLLGFC----LEGDEK----ILVYEF--------VPNKSLDY 425
+ E+ ++ L+H N+V L+ C + LV+EF + NK++ +
Sbjct: 58 ALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF 116
Query: 426 FL---------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV---DQ 467
L Y + +I+HRD+KA+NIL+ K++DFGLAR F + +
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 468 TQGNTSRIVGTYGYMSPE 485
T+R+V T Y PE
Sbjct: 177 PNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 36/196 (18%)
Query: 348 LGRGGFGEV------YKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVV------LVAKLQH 395
LG+GGFGEV G + +++ KRL + SG+ + E++ + L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 396 -----RNLVRLLGFCLEGDEKILVYEFVPNKSLDY---FLYDSQ----------LRIIHR 437
+L ++ GD K +Y V + L+ Y +Q + I++R
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-SRIVGTYGYMSPEYAMHGQFSVKS 496
D+K N+LLD Q N ++SD GLA V+ G T ++ GT GYM+PE +S
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 497 DVYSFGVLALETITGK 512
D ++ G E + G+
Sbjct: 176 DWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 57/215 (26%)
Query: 345 DNKLGRGGFGEVYKGVLPHG---QEIAVKRLSR-SSGQGAQEFKNEVVLVAKL-QHRNLV 399
++ +G G FG+V + ++ A+K L +S ++F E+ ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------------- 427
LLG C + E+ P +L FL
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 428 -------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480
Y S+ + IHRDL A N+L+ + KI+DFGL+R G + T G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKKTMG 178
Query: 481 -----YMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+M+ E + ++ KSDV+SFGVL E ++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 70/248 (28%), Positives = 109/248 (43%), Gaps = 58/248 (23%)
Query: 348 LGRGGFGEVYKGVLPH---GQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVR-- 400
+G G FG ++ H Q+ A+K RL +SS ++ + E VL+AK++H N+V
Sbjct: 8 VGEGSFGRAL--LVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 401 -----------LLGFCLEGD--EKILVYE---FVPNKSLDYFL-------YDSQLRIIHR 437
++ +C GD +KI + F + L +F+ + + R++HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
D+K+ NI L K+ DFG AR+ T VGT Y+ PE + ++ KSD
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSD 182
Query: 498 VYSFGVLALETITGK--------KNSSFYQTDGAEDLL----SYE-----------DPAD 534
++S G + E T K KN G+ L SYE +P
Sbjct: 183 IWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRS 242
Query: 535 RPSMATIV 542
RPS TI+
Sbjct: 243 RPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 41/213 (19%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSGQGAQEFKNEVVL 389
KT+ +++S ++G G +G V + G+++A+K+LSR S A+ E+ L
Sbjct: 8 KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67
Query: 390 VAKLQHRNLVRLLG-------------------FCLEGDEKILVYEFVPNKSLDYFLYDS 430
+ +QH N++ LL + +KI+ + +K + Y +Y
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK-VQYLVYQM 126
Query: 431 --QLR------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
L+ IIHRDLK N+ ++ KI DFGLAR + T V T Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYR 181
Query: 483 SPEYA---MHGQFSVKSDVYSFGVLALETITGK 512
+PE MH +V D++S G + E +TGK
Sbjct: 182 APEVILNWMHYNQTV--DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 50/217 (23%)
Query: 348 LGRGGFGEVYK-------GVLPHGQEIAVKRLS-----RSSGQGAQEFKNEVVLVAK-LQ 394
LG G FG VYK L +EI V + R + + +EV ++ + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSL-DYFL-------------------------- 427
H N+VR LE D +V + + L ++F
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 428 -YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT--SRIVGTYGYMSP 484
+ RI+HRDL +NI+L I+DFGLA+ Q Q + + +VGT Y P
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYSCP 182
Query: 485 EYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
E + + K+DV++FG + + T FY T+
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 57/212 (26%)
Query: 348 LGRGGFGEVYKGVLPHG---QEIAVKRLSR-SSGQGAQEFKNEVVLVAKL-QHRNLVRLL 402
+G G FG+V K + + A+KR+ +S ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL----------------------------------- 427
G C L E+ P+ +L FL
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 428 ----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG--- 480
Y SQ + IHRDL A NIL+ KI+DFGL+R G + T G
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLP 174
Query: 481 --YMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+M+ E + ++ SDV+S+GVL E ++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 29/188 (15%)
Query: 348 LGRGGFGEVYKG-VLPHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG-F 404
LG G G VYK L + +AVK + Q + +E+ ++ K ++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 405 CLEGDEKILVYEFVPNKSLDYF-------------------LYDSQLRIIHRDLKASNIL 445
+E I EF+ SLD + Y L+I+HRD+K SN+L
Sbjct: 69 FVENRISICT-EFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNML 127
Query: 446 LDVQMNPKISDFGLARIFGVDQTQGNTSRI-VGTYGYMSPEYAMHGQFSVKSDVYSFGVL 504
++ + K+ DFG++ Q + ++ VGT YM+PE Q+ + SDV+S G+
Sbjct: 128 VNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGIS 182
Query: 505 ALETITGK 512
+E G+
Sbjct: 183 FMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
+I+HRD+K SNIL++ + K+ DFG++ +D + N+ VGT YMSPE
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-ID-SMANS--FVGTRSYMSPERLQGTH 174
Query: 492 FSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPSMATIVLALNSHSVT 551
++V+SD++S G+ +E G+ E + + ++ +
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP--- 231
Query: 552 LSVPRQPALF 561
PR A+F
Sbjct: 232 -DSPRPMAIF 240
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 47/208 (22%)
Query: 348 LGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL---- 402
LG G G V+ V + +AVK++ + Q + E+ ++ +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 403 --GFCLEGDEKIL--------VYEFV-------------PNKSLDYFLYDSQL------- 432
G L D L V E++ + F+Y QL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY--QLLRGLKYI 130
Query: 433 ---RIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQT---QGNTSRIVGTYGYMSPE 485
++HRDLK +N+ ++ + KI DFGLARI VD +G S + T Y SP
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 486 YAMHGQFSVKS-DVYSFGVLALETITGK 512
+ K+ D+++ G + E +TGK
Sbjct: 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 51/206 (24%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR-----NLVRL 401
LGRG +G V K +P G +AVKR+ R++ +QE K +++ + R V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RAT-VNSQEQK-RLLMDLDISMRSVDCPYTVTF 65
Query: 402 LGFCL-EGDEKILVYEFVPNKSLDYF---LYD-------------------------SQL 432
G EGD I + V + SLD F +YD S+L
Sbjct: 66 YGALFREGDVWICME--VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLA--RIFGVDQTQGNTSRIVGTYGYMSPEY---A 487
+IHRD+K SN+L++ K+ DFG++ + V +T G YM+PE
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-----AGCKPYMAPERINPE 178
Query: 488 MHGQ-FSVKSDVYSFGVLALETITGK 512
++ + + VKSDV+S G+ +E TG+
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 39/206 (18%)
Query: 329 QFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEV 387
Q DF+ I+ ++G G +G+VYK + G+ A+K + G+ + E+
Sbjct: 8 QEDFELIQ----------RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI 57
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL-DYF-----LYDSQLRI------- 434
+++ +H N+V G L D+ + EF SL D + L +SQ+
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ 117
Query: 435 ----------IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSP 484
+HRD+K +NILL + K++DFG++ + T +GT +M+P
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAP 175
Query: 485 EYAM---HGQFSVKSDVYSFGVLALE 507
E A G ++ D+++ G+ A+E
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 43/202 (21%)
Query: 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLS-RSSGQGAQEFK----NEVVLVAKLQHRNLV 399
N++ G +G VY+ G+ +A+K+L +G F E+ ++ KLQH N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 400 RL----LGFCLEGDEKI-LVYEFVPN--KSL-----DYFL----------------YDSQ 431
+ +G +KI +V E+V + KSL FL +
Sbjct: 68 TVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-HG 490
I+HRDLK SN+LL+ + KI DFGLAR +G +++V T Y +PE +
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS--PLKPYTQLVVTLWYRAPELLLGAK 182
Query: 491 QFSVKSDVYSFGVLALETITGK 512
++S D++S G + E +T K
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 71/265 (26%), Positives = 108/265 (40%), Gaps = 74/265 (27%)
Query: 348 LGRGGFGEVYKGVL---------PHGQEIAVKR-LSRSSGQGAQEFKNEVVLVAKLQHRN 397
LG+G F +YKGVL GQE++V + S + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLR 433
LV+L G C+ DE I+V E+V LD FL Y +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 434 IIHRDLKASNILL---DVQMNP----KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486
++H ++ NIL+ + K+SD G+ T + V +++PE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPWIAPEC 175
Query: 487 AMHGQFSVKS--DVYSFGVLALE----------TITGKKNSSFYQT-------DGAE--- 524
+GQ S+ D +SFG LE T++ + FYQ D AE
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELAN 235
Query: 525 ---DLLSYEDPADRPSMATIVLALN 546
+Y DP RPS I+ LN
Sbjct: 236 LINQCWTY-DPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 42/203 (20%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405
+G+G +G+VYK G AVK L S +E + E ++ L H N+V+ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 406 LEGDEKI-----LVYEFVPNKS-------------------LDYFLYDSQL--------R 433
+ D+ + LV E S + Y LY + L R
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR 148
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-- 491
IIHRD+K +NILL + K+ DFG++ + + NTS VGT +M+PE Q
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQY 206
Query: 492 ---FSVKSDVYSFGVLALETITG 511
+ + DV+S G+ A+E G
Sbjct: 207 DYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 70/268 (26%), Positives = 106/268 (39%), Gaps = 58/268 (21%)
Query: 348 LGRGGFGEVYK----GVLPHGQE----IAVKRLS-RSSGQGAQEFKNEVVLVAKL-QHRN 397
LG G FG+V + G+ + +AVK L ++ + + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------------ 427
++ LLG C + ++ E+ +L FL
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 428 ---------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--GNTSRIV 476
Y R IHRDL A N+L+ KI+DFGLAR GV TS
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTSNGR 197
Query: 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPA--- 533
+M+PE ++ +SDV+SFG+L E T S Y E+L
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--LGGSPYPGIPVEELFKLLREGHRM 255
Query: 534 DRPSMATIVLALNSHSVTLSVPRQPALF 561
D+PS T L + +VP Q F
Sbjct: 256 DKPSNCTHELYMLMRECWHAVPTQRPTF 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 39/206 (18%)
Query: 329 QFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEV 387
Q D++ I+ ++G G +G+VYK L G+ AVK + G + E+
Sbjct: 8 QHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEI 57
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD----SQLRI--------- 434
+V + +H N+V G L ++ + E+ SL + S+L+I
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117
Query: 435 ----------IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSP 484
+HRD+K +NILL + K++DFG+A + T +GT +M+P
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAP 175
Query: 485 EYAM---HGQFSVKSDVYSFGVLALE 507
E A +G ++ D+++ G+ A+E
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 71/279 (25%), Positives = 114/279 (40%), Gaps = 56/279 (20%)
Query: 336 EVATNKFSSDNKLGRGGFGEVY--------KGVLPHGQEIAVKRL-SRSSGQGAQEFKNE 386
EV ++ LG G FG+V K ++AVK L S ++ + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------ 427
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGV 465
Y + + IHRDL A N+L+ KI+DFGLAR I +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
D + T+ + +M+PE ++ +SDV+SFGVL E T S Y E+
Sbjct: 194 DYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGSPYPGVPVEE 250
Query: 526 ---LLSYEDPADRPSMATIVLALNSHSVTLSVPRQPALF 561
LL D+PS T L + +VP Q F
Sbjct: 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 44/205 (21%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKR-LSRSSGQGAQEFK-NEVVLVAKLQHRN-LVRLL 402
K+G G +G+VYK G+ +A+K+ +G E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 403 GFCLEGDEK-------ILVYEF-------------------VPNKSLDYFLYD------- 429
+E E+ LV+E+ +P K++ F+Y
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 430 -SQLRIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
+ ++HRDLK N+L+D Q KI+D GL R F + + T IV T Y +PE
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAPEVL 183
Query: 488 MHG-QFSVKSDVYSFGVLALETITG 511
+ +S D++S G + E
Sbjct: 184 LGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 37/203 (18%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKN----EVVLVAK 392
K+ + +G G +G V K H GQ +A+K+ S + K E+ ++ +
Sbjct: 1 EKYENLGLVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQ 56
Query: 393 LQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF------LYDSQLR------------- 433
L+H NLV L+ LV+EFV + LD L +S++R
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 434 ----IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM- 488
IIHRD+K NIL+ K+ DFG AR + + V T Y +PE +
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPELLVG 174
Query: 489 HGQFSVKSDVYSFGVLALETITG 511
++ D+++ G L E +TG
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 70/238 (29%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRS----SGQGAQEFKN 385
DF+ I+V +GRG FGEV+ ++ A+K L +S Q +
Sbjct: 2 DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRA 50
Query: 386 EVVLVAKLQHRNLVRLLGFCLEGDEKIL--VYEFVPNKSLDYFLYDS------------- 430
E ++A +V+L + DE+ L V E++P L L
Sbjct: 51 ERDILADADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108
Query: 431 ----------QLRIIHRDLKASNILLDVQMNPKISDFGLA-------------------- 460
+L IHRD+K NIL+D + K++DFGL
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 461 -----RIFGVDQTQGNTSR--IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
+ D Q VGT Y++PE + ++ D +S GV+ E + G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 10/105 (9%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
II+RDLK N+LLD + KI+DFG+ + + G +G S GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKGQK 172
Query: 492 FSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRP 536
++ D +SFGVL E + G+ S F+ D ED L DRP
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQ--SPFHGED--EDELFDSILNDRP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 345 DNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVV--------------L 389
LG G +G+V K G+ +A+K++ ++V +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPN---KSLD--YFLYDSQLR----------- 433
+ +++H N++ L+ +EGD LV + + + K +D L +SQ++
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 434 ------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN-------------TSR 474
+HRDL +NI ++ + KI+DFGLAR +G TS+
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 475 IVGTYGYMSPEYAMHGQ---FSVKSDVYSFGVLALETITGK 512
+V T Y +PE M + F+V D++S G + E +TGK
Sbjct: 194 VV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 48/239 (20%)
Query: 348 LGRGGFGEVYKGVLP--------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
LG+G F +++KG+ H E+ +K L +S ++ F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRII 435
G C+ GDE I+V E+V SLD +L + +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 436 HRDLKASNILL-----DVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
H ++ A N+LL NP K+SD G++ V + RI ++ PE
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWVPPECI 176
Query: 488 MHGQ-FSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPSMATIVLAL 545
+ Q S+ +D +SFG E +G + D + L YED P+ LA
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG-GDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN 234
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 30/193 (15%)
Query: 347 KLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFK--NEVVLVAKLQHRNLVRLLG 403
KLG G + VYKG+ +GQ +A+K +S + +G F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 404 FCLEGDEKILVYEFVPNKSLDYF-------------LYDSQL----------RIIHRDLK 440
+ V+E++ Y L+ QL I+HRDLK
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVY 499
N+L+ K++DFGLAR + +Q +S +V T Y P+ + +S D++
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIW 188
Query: 500 SFGVLALETITGK 512
G + +E + G+
Sbjct: 189 GAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
+L II+RD+K NILLD + ++DFGL++ F D+ + S GT YM+P+ G
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGG 181
Query: 491 Q--FSVKSDVYSFGVLALE--------TITGKKNSSFYQTDGAEDLLSYEDP 532
D +S GVL E T+ G+KNS Q + + +L E P
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 36/191 (18%)
Query: 350 RGGFGEVY--KGVLPHGQEIAVKRLSRSSGQGAQEFKN----EVVLVAKLQHRNLVRLLG 403
+G FG VY K G A+K L +S + N +++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 404 FCLEGDEKILVYEFVPN-------KSLDYFLYD----------------SQLRIIHRDLK 440
D LV E++ K+L D Q IIHRD+K
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYS 500
N+L+D + K++DFGL+R ++ + VGT Y++PE + SD +S
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 501 FGVLALETITG 511
G + E + G
Sbjct: 179 LGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 49/248 (19%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKR-------LSRSSGQGAQEF 383
DF+ I+V +GRG FGEV + H + I + L R+ +E
Sbjct: 2 DFEIIKV----------IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE 51
Query: 384 KNEVV---------LVAKLQHRNLVRL-LGFCLEGDEKILVYEF---VPNKSLDYFLYD- 429
+N +V L Q N + L + + + GD L+ +F +P +++ +
Sbjct: 52 RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111
Query: 430 -------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
QL +HRD+K N+LLD+ + +++DFG D T +S VGT Y+
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYI 170
Query: 483 SPEY--AMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE---DLLSYEDPAD 534
SPE AM G++ + D +S GV E + G+ + FY E ++++E+
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHEERFQ 228
Query: 535 RPSMATIV 542
PS T V
Sbjct: 229 FPSHITDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 51/225 (22%)
Query: 336 EVATNKFSSDNKLGRGGFGEVY--------KGVLPHGQEIAVKRLS-RSSGQGAQEFKNE 386
E + +K + LG G FG+V K +AVK L ++ + + +E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------ 427
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGV 465
Y + + IHRDL A N+L+ KI+DFGLAR + +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
D + T+ + +M+PE ++ +SDV+SFGVL E T
Sbjct: 191 DYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
I++RDLK NILLD + KI+DFG+ + + G T GT Y++PE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQK 172
Query: 492 FSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
++ D +SFGVL E + G+ S F+ D E
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 41/201 (20%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEI-AVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
N++G G +G VY+ EI A+K R+ E+ L+ L+H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 403 ---------------GFCLEGDEKILVYEFVPN---------------KSLDYFLYDSQL 432
+C E D L+ +P + L Y L+++
Sbjct: 73 EVVVGKHLDSIFLVMEYC-EQDLASLLDN-MPTPFSESQVKCLMLQLLRGLQY-LHEN-- 127
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
IIHRDLK SN+LL + KI+DFGLAR +G+ T ++V T Y +PE +
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVV-TLWYRAPELLLGCTT 185
Query: 493 SVKS-DVYSFGVLALETITGK 512
+ D+++ G + E + K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 39/198 (19%)
Query: 348 LGRGGFGEVYKGVLPHGQE----IAVKRLSRS----SGQGAQEFKNEVVLVAKLQHRNLV 399
LG+GG+G+V++ G + A+K L ++ + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 400 RLLGFCLEGDEKI-LVYEFVPNKSL-------DYFLYDS----------------QLRII 435
L+ + + K+ L+ E++ L F+ D+ Q II
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII 122
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN--TSRIVGTYGYMSPEYAMHGQFS 493
+RDLK NILLD Q + K++DFGL + + T GT YM+PE M
Sbjct: 123 YRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178
Query: 494 VKSDVYSFGVLALETITG 511
D +S G L + +TG
Sbjct: 179 KAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/198 (27%), Positives = 80/198 (40%), Gaps = 41/198 (20%)
Query: 348 LGRGGFGEV----YKGVLPHGQEIAVKRL------SRSSGQGAQEFKNEVVLVAKLQHRN 397
LGRG FG+V YK G+ A+K L +R + K +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 398 LVRLLGFCLEGDEKI-LVYEFVPNKSL------DYFL----------------YDSQLRI 434
LV L C + ++ + V E+ L D F Y + +I
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARI-FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
++RDLK N+LLD + KI+DFGL + G TS GT +++PE ++
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPEVLTETSYT 179
Query: 494 VKSDVYSFGVLALETITG 511
D + GVL E + G
Sbjct: 180 RAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 44/147 (29%), Positives = 60/147 (40%), Gaps = 32/147 (21%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIA---VKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRL 401
+++G G FG+V G G A VK L S+ Q F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFLY------------DSQLRI--------------- 434
LG C+E +LV EF P L +L D R+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 435 -IHRDLKASNILLDVQMNPKISDFGLA 460
IH DL N L ++ KI D+GLA
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 410 EKILVYEFVPNKSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IF-GVDQ 467
E ++ Y F + +++ + + IHRDL A NILL KI DFGLAR I+ D
Sbjct: 173 EDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229
Query: 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+ +R+ +M+PE ++ +SDV+SFGVL E +
Sbjct: 230 VRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 346 NKLGRGGFGEVYKGVLPHGQE-IAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+KLG G + VYKG +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFLYDS--------------QL----------RIIHRD 438
LV+E++ +K L +L D QL +++HRD
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSD 497
LK N+L++ + K++DFGLAR + T+ ++ +V T Y P+ + +S + D
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDYSTQID 187
Query: 498 VYSFGVLALETITGK 512
++ G + E TG+
Sbjct: 188 MWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 10/105 (9%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
II+RDLK N++LD + KI+DFG+ + +FG S GT Y++PE +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172
Query: 492 FSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRP 536
++ D +SFGVL E + G+ S F+ D ED L D P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ--SPFHGDD--EDELFESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 64/225 (28%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSGQGAQEFKNEVVL 389
KTI ++ + + +G G +G V G +AVK+LSR S A+ E+ L
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF----------------------L 427
+ ++H N++ LL F P +SL+ F L
Sbjct: 70 LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 428 YDSQLR-----------------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470
D ++ IIHRDLK SN+ ++ KI DFGLAR T
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 172
Query: 471 NTSRIVGTYGYMSPEYA---MHGQFSVKSDVYSFGVLALETITGK 512
+ V T Y +PE MH ++ D++S G + E +TG+
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSR--SSGQGAQEFKNEVVL 389
KTI +++ ++G G +G V + G ++A+K+L R S A+ E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 390 VAKLQHRNLVRLLGFCLEGDE--------------------KILVYEFVPNKSLDYFLYD 429
+ ++H N++ LL D K++ +E + + + +Y
Sbjct: 68 LKHMKHENVIGLLD-VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 430 --SQLR------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
L+ IIHRDLK N+ ++ KI DFGLAR QT + V T Y
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWY 181
Query: 482 MSPEYA---MHGQFSVKSDVYSFGVLALETITGK 512
+PE MH ++ D++S G + E +TGK
Sbjct: 182 RAPEVILNWMH--YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 37/203 (18%)
Query: 348 LGRGGFGEVYK-GVLPHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRN--LVRL 401
+GRGGFGEVY G+ A+K L + QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 402 LGFCLEGDEKI-LVYEFVPNKSLDYFLY------DSQLR-----------------IIHR 437
+ + +K+ + + + L Y L + ++R +++R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-FSVKS 496
DLK +NILLD + +ISD GLA F + + VGT+GYM+PE G + +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSSA 177
Query: 497 DVYSFGVLALETITGKKNSSFYQ 519
D +S G + + + G +S F Q
Sbjct: 178 DWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 13/121 (10%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT-QGNTSRIVGTYGYMSPEY--A 487
QL +HRD+K N+LLD + +++DFG D T Q N + VGT Y+SPE A
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEILQA 177
Query: 488 MH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE---DLLSYEDPADRPSMATI 541
M G++ + D +S GV E + G+ + FY E ++++++ P T
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHKEHFQFPPDVTD 235
Query: 542 V 542
V
Sbjct: 236 V 236
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 42/217 (19%)
Query: 332 FKTIEVATNKFSSDNK------LGRGGFGEV---YKGVLPHGQEIAVKRLSR--SSGQGA 380
F +++VA + F+ + +G G G V + VL G +AVK+LSR + A
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 64
Query: 381 QEFKNEVVLVAKLQHRNLVRLLGFCL------EGDEKILVYEF------------VPNKS 422
+ E+VL+ + H+N++ LL E + LV E + ++
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 423 LDYFLYD--------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474
+ Y LY IIHRDLK SNI++ KI DFGLAR + T
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPY 182
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
+V Y Y +PE + + D++S G + E + G
Sbjct: 183 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 36/194 (18%)
Query: 348 LGRGGFGEVYKGVLPHGQE-IAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
+G G FG V+ + A+K ++ + Q NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 404 FCLEGDEKIL--VYEFVPNKSLDYFL-----------------------YDSQLRIIHRD 438
F E D++ L + E+VP L +L Y I++RD
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
LK NILLD + + K++DFG A+ + + T + GT Y++PE + D
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDW 181
Query: 499 YSFGVLALETITGK 512
++ G+L E + G
Sbjct: 182 WALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 57/228 (25%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVV------L 389
E++ + + LG G FG+V V+ I + ++ + K++ L
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 390 VAKLQ-------HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------- 427
V++++ H+N++ LLG C + ++ E+ +L +L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 428 ------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-I 462
Y + + IHRDL A N+L+ KI+DFGLAR +
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+D + T+ + +M+PE ++ +SDV+SFGVL E T
Sbjct: 185 HNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 34/194 (17%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFK--NEVVLVAKLQHRNLVRLLG 403
KLG G + VYKG GQ +A+K + +GA F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 404 FCLEGDEKILVYEFVPNKSLDY---------------FLYDSQL----------RIIHRD 438
LV+E++ Y FL+ QL R++HRD
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF--QLLRGLAYCHQRRVLHRD 128
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSD 497
LK N+L+ + K++DFGLAR V ++ ++ +V T Y P+ + ++S D
Sbjct: 129 LKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLD 186
Query: 498 VYSFGVLALETITG 511
++ G + E TG
Sbjct: 187 MWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ- 491
I+HRD+K N+L++ KI DFGLAR+ D+++ T +V Y Y +PE M +
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRH 181
Query: 492 FSVKSDVYSFGVLALETITGK----KNSSFYQTDGAEDLL 527
++ D++S G + E + + S Q D DLL
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 41/238 (17%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKR 371
+N DN ++ E + + F +GRG FGEV ++ H Q A+K
Sbjct: 18 NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKL 75
Query: 372 LSRSSGQGAQE---FKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL--VYEFVPNKSLDYF 426
LS+ + F E ++A +V+L D+K L V E++P L
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 427 L--YD--------------------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464
+ YD + IHRD+K N+LLD + K++DFG
Sbjct: 134 MSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193
Query: 465 VDQTQGNTSRIVGTYGYMSPEYAM----HGQFSVKSDVYSFGVLALETITGKKNSSFY 518
+ VGT Y+SPE G + + D +S GV E + G ++ FY
Sbjct: 194 AN-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 66/231 (28%)
Query: 331 DFKTIEVATNKFSSDNK------LGRGGFGEV---YKGVLPHGQEIAVKRLSR--SSGQG 379
+F ++E+ + F+ + +G G G V Y +L + +A+K+LSR +
Sbjct: 9 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66
Query: 380 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF--------LYDSQ 431
A+ E+VL+ + H+N++ LL F P KSL+ F L D+
Sbjct: 67 AKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDAN 114
Query: 432 L------------------------------RIIHRDLKASNILLDVQMNPKISDFGLAR 461
L IIHRDLK SNI++ KI DFGLAR
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
G T +V Y Y +PE + + D++S G + E I G
Sbjct: 175 TAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/193 (30%), Positives = 83/193 (43%), Gaps = 32/193 (16%)
Query: 347 KLGRGGFGEVYKGVLP-HGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
KLG G + VYKG +G+ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 404 FCLEGDEKILVYEFVPNKSLDY---------------FL--------YDSQLRIIHRDLK 440
+ LV+E+V Y FL Y Q I+HRDLK
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 441 ASNILLDVQMNPKISDFGLARIFGV-DQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDV 498
N+L+ K++DFGLAR V T N V T Y P+ + ++S D+
Sbjct: 131 PQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 499 YSFGVLALETITG 511
+ G + +E I G
Sbjct: 188 WGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 42/218 (19%)
Query: 332 FKTIEVATNKFSSDNK------LGRGGFGEV---YKGVLPHGQEIAVKRLSR--SSGQGA 380
F ++EV + F+ + +G G G V Y VL + +A+K+LSR + A
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 381 QEFKNEVVLVAKLQHRNLVRLLGF-----CLEGDEKI-LVYEF------------VPNKS 422
+ E+VL+ + H+N++ LL LE + + LV E + ++
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 423 LDYFLYD--------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474
+ Y LY IIHRDLK SNI++ KI DFGLAR G T
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPY 178
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
+V Y Y +PE + + D++S G + E + K
Sbjct: 179 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 30/194 (15%)
Query: 346 NKLGRGGFGEVYKGVLPHGQE-IAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
KLG G + V+KG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 403 GFCLEGDEKILVYEFVPNKSLDY---------------FLYD--------SQLRIIHRDL 439
LV+E++ Y FLY + +++HRDL
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-HGQFSVKSDV 498
K N+L++ + K++DFGLAR V T+ ++ +V T Y P+ + ++S + D+
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDM 188
Query: 499 YSFGVLALETITGK 512
+ G + E +G+
Sbjct: 189 WGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 42/199 (21%)
Query: 348 LGRGGFGEVYKGVL--PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
+G+G +G+V+K VL +G + AVK L + +L A H N+V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 406 LE-----GDEKILVYEFVPNKS-------------------LDYFLYDSQL--------R 433
+ GD+ LV E S + Y L+++ + +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY-----AM 488
IHRD+K +NILL + K+ DFG++ + + NTS VGT +M+PE +
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQL 202
Query: 489 HGQFSVKSDVYSFGVLALE 507
+ + DV+S G+ A+E
Sbjct: 203 DSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQF 492
II+RDLK N+LLD + + KI+DFG+ + G+ G T+ GT Y++PE + +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGI--LGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL 526
D ++ GVL E + G+ S ++ D ++L
Sbjct: 174 GPAVDWWALGVLLYEMLAGQ---SPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 37/103 (35%), Positives = 56/103 (54%), Gaps = 7/103 (6%)
Query: 410 EKILVYEFVPNKSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IF-GVDQ 467
E ++ Y F K +++ + + IHRDL A NILL KI DFGLAR I+ D
Sbjct: 179 EDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+ +R+ +M+PE ++++SDV+SFGVL E +
Sbjct: 236 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 38/200 (19%)
Query: 342 FSSDNKLGRGGFGEV----YKGVLPHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQ 394
F LG G FG V +KG G+ A+K L + + Q E ++ +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 395 HRNLVRLLGFCLEGDEKILVYEFV---------------PNKSLDY--------FLYDSQ 431
H +V ++ + + + EFV PN + F Y
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
II+RDLK N+LLD + + K++DFG A+ + T + GT Y++PE
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKG 191
Query: 492 FSVKSDVYSFGVLALETITG 511
D ++ GVL E I G
Sbjct: 192 HGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 30/80 (37%), Positives = 48/80 (60%), Gaps = 4/80 (5%)
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
+I+HRD+K SNIL++ + K+ DFG++ +D + VGT YMSPE +
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPERLQGTHY 179
Query: 493 SVKSDVYSFGVLALETITGK 512
SV+SD++S G+ +E G+
Sbjct: 180 SVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 38/208 (18%)
Query: 348 LGRGGFGEVYKGVLPHGQE---IAVKRLSRSSGQGAQEFKNEV----VLVAKLQHRNLVR 400
+G+G FG+V + H + AVK L + + +E K+ + VL+ ++H LV
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 401 LLGFCLEGDEKI-LVYEFVPNKSLDYFL-----------------------YDSQLRIIH 436
L + + +K+ V ++V L + L Y L II+
Sbjct: 61 L-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
RDLK NILLD Q + ++DFGL + G+ + TS GT Y++PE +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK-EGI-EHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 497 DVYSFGVLALETITGKKNSSFYQTDGAE 524
D + G + E + G FY D AE
Sbjct: 178 DWWCLGAVLYEMLYGL--PPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 41/205 (20%)
Query: 348 LGRGGFGEVY---KGVLPHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRN--LV 399
+GRGGFGEVY K G+ A+K L + QG NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 400 RLLGFCLEGDEKI-LVYEFVPNKSLDYFL------YDSQLR-----------------II 435
+ + +K+ + + + L Y L ++++R ++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSV 494
+RDLK +NILLD + +ISD GLA D ++ VGT+GYM+PE G +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 175
Query: 495 KSDVYSFGVLALETITGKKNSSFYQ 519
+D +S G + + + G +S F Q
Sbjct: 176 SADWFSLGCMLFKLLRG--HSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 30/80 (37%), Positives = 48/80 (60%), Gaps = 4/80 (5%)
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
+I+HRD+K SNIL++ + K+ DFG++ +D + VGT YMSPE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPERLQGTHY 179
Query: 493 SVKSDVYSFGVLALETITGK 512
SV+SD++S G+ +E G+
Sbjct: 180 SVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 60/221 (27%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQHRNLVRLL 402
+G+GG GEVY P + +A+K++ + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 403 GFCLEGDEKILVYEFVP--------------------------NKSLDYFL--------- 427
C +GD VY +P S+ FL
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 428 --YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI----------FGVDQTQGNTS-- 473
Y ++HRDLK NILL + I D+G A VD+ S
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 474 ----RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510
+IVGT YM+PE + S +D+Y+ GV+ + +T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 67/251 (26%), Positives = 100/251 (39%), Gaps = 63/251 (25%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKN---EVVLVAK 392
E N++ K+G G FGEV+ QE + G +E EV ++ +
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 393 LQHRNLVR---------------LLGFCLEGD------------EKILVYEFV--PNKSL 423
L+H+N+VR L+ FC GD KI + V + L
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 424 DYFLYDSQL-------RIIHRDLKASNILLDV----------QMN-------PKISDFGL 459
Y L R++HRDLK NI L Q N KI DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSF 517
++ G++ VGT Y SPE +H + KSD+++ G + E +GK + F
Sbjct: 189 SKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPF 243
Query: 518 YQTDGAEDLLS 528
++ + L+S
Sbjct: 244 HKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 30/194 (15%)
Query: 346 NKLGRGGFGEVYKGVLP-HGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+KLG G + V+KG +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 403 GFCLEGDEKILVYEFVPNKSLDY---------------FL--------YDSQLRIIHRDL 439
LV+E++ + Y F+ Y + +I+HRDL
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDV 498
K N+L++ + K++DFGLAR V T+ ++ +V T Y P+ + ++S D+
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDM 187
Query: 499 YSFGVLALETITGK 512
+ G + E TG+
Sbjct: 188 WGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 316 QNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSR 374
+N DN + E + + +++ + +GRG FGEV Q++ A+K LS+
Sbjct: 19 KNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSK 78
Query: 375 SS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL--VYEFVPNKSLDYFL-- 427
+ F E ++A +V+L FC D+K L V E++P L +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSN 136
Query: 428 YD--------------------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467
YD + +IHRD+K N+LLD + K++DFG +D+
Sbjct: 137 YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDE 194
Query: 468 T-QGNTSRIVGTYGYMSPEY----AMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518
T VGT Y+SPE G + + D +S GV E + G ++ FY
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 52/219 (23%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSR----------------- 374
KT+ ++ + +G G +G V Q++AVK+LSR
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67
Query: 375 ----------------SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI--LVYE 416
+ + F NEV LV L +L ++ DE + L+Y+
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENF-NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ 126
Query: 417 FVPNKSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476
+ + L Y IIHRDLK SN+ ++ +I DFGLAR Q + V
Sbjct: 127 LL--RGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYV 176
Query: 477 GTYGYMSPEYA---MHGQFSVKSDVYSFGVLALETITGK 512
T Y +PE MH +V D++S G + E + GK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 410 EKILVYEFVPNKSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IF-GVDQ 467
E ++ Y F + +++ + + IHRDL A NILL KI DFGLAR I+ D
Sbjct: 174 EDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALE 507
+ ++R+ +M+PE ++ +SDV+SFGVL E
Sbjct: 231 VRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 32/82 (39%), Positives = 49/82 (59%), Gaps = 8/82 (9%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSR-IVGTYGYMSPEYAMHG 490
II+RDLK N++LD + + KI+DFG+ + IFG G T+R GT Y++PE +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-----GKTTRTFCGTPDYIAPEIIAYQ 176
Query: 491 QFSVKSDVYSFGVLALETITGK 512
+ D ++FGVL E + G+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 32/76 (42%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQT---QGNTSRIVGTYGYMSPEYAMHGQ 491
IHRDL A NILL KI DFGLAR D +GN V +M+PE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 492 FSVKSDVYSFGVLALE 507
++ +SDV+S+G+L E
Sbjct: 293 YTFESDVWSYGILLWE 308
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQG-AQEFKNEVVLVAKLQHRNLVRLLG-F 404
K+GRG +G VYK G++ L + G G + E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 405 CLEGDEKI-LVYEFVPN--------------------------KSLDYFLYDS-----QL 432
D K+ L++++ + KSL Y + D
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 433 RIIHRDLKASNILLDVQMNP-----KISDFGLARIFGVD-QTQGNTSRIVGTYGYMSPEY 486
++HRDLK +NIL+ + P KI+D G AR+F + + +V T+ Y +PE
Sbjct: 128 WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 487 AMHGQFSVKS-DVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADR 535
+ + K+ D+++ G + E +T + Q D + D DR
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 348 LGRGGFGEVYKGVLPH-GQEIAVKRLSR--SSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404
+G+G +G V + H G+++A+K+++ A E+ L+ L+H ++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 405 CL-----EGDEKILVYEFV---------PNKSL-----DYFLYDSQLR---------IIH 436
L E + +V+E + N L +FLY LR + H
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY-QLLRALKYIHTANVFH 126
Query: 437 RDLKASNILLDVQMNPKISDFGLARI-FGVDQTQGNTSRIVGTYGYMSPEY--AMHGQFS 493
RDLK NIL + KI DFGLAR+ F T + V T Y +PE + +++
Sbjct: 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT 186
Query: 494 VKSDVYSFGVLALETITGKK----NSSFYQTDGAEDLLSYEDPADRPSMATI 541
D++S G + E +TGK + +Q D DLL PS TI
Sbjct: 187 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG------TPSPETI 232
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 30/81 (37%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
+ +I+RDLK NILLD Q + + DFGL ++ D + NT GT Y++PE +
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGH 168
Query: 491 QFSVKSDVYSFGVLALETITG 511
++ D ++ GVL E +TG
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 42/125 (33%), Positives = 61/125 (48%), Gaps = 19/125 (15%)
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFG--VDQTQGNTSRIVGTYGYMSPEYAMHG 490
+IHRD+K++NILL K+ DFG ++++ V G T GT Y++PE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPYYVAPEIWRRK 220
Query: 491 QFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------EDLLSYEDP---ADRPSMAT 540
+S K+D++S GVL E +T K+ DG + L DP + P M
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKR-----PFDGENMEEVMHKTLAGRYDPLPPSISPEMQE 275
Query: 541 IVLAL 545
IV AL
Sbjct: 276 IVTAL 280
|
Length = 496 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 14/96 (14%)
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQT---QGNTSRIVGTYGYMSPEYAMHGQ 491
IHRD+ A N+LL KI DFGLAR D +GN V +M+PE
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290
Query: 492 FSVKSDVYSFGVLALETIT-GKK-------NSSFYQ 519
++V+SDV+S+G+L E + GK NS FY+
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 37/202 (18%)
Query: 341 KFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKN----EVVLVAKL 393
K+ +K+G G +G V+K + GQ +A+K+ S K E+ ++ +L
Sbjct: 2 KYEKLSKIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQL 57
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFV-----------PN-------KSLDYFLYDS----- 430
+H NLV L+ + LV+E+ P K + + +
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-H 489
+ IHRD+K NIL+ Q K+ DFG ARI + + + V T Y +PE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 490 GQFSVKSDVYSFGVLALETITG 511
Q+ DV++ G + E +TG
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 49/221 (22%)
Query: 333 KTIEVATNKFSSD-----NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNE 386
K I+ N+ + N +G G FG VY+ + + +++A+K++ Q Q E
Sbjct: 54 KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRE 109
Query: 387 VVLVAKLQHRNLVRLLGF----CLEGDEKIL----VYEFVP-------------NKSLDY 425
++++ L H N++ L + C + +EK + V EF+P N +L
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL 169
Query: 426 FL---YDSQL----------RIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGN 471
FL Y QL I HRDLK N+L+D + K+ DFG A+ + Q +
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRS 227
Query: 472 TSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITG 511
S I + Y +PE + ++ D++S G + E I G
Sbjct: 228 VSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQG-AQEFKNEVVLVAKLQHRNLVRLLG-F 404
K+GRG +G VYK G++ L + G G + E+ L+ +L+H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 405 CLEGDEKI-LVYEFVPN--------------------------KSLDYFLYDS-----QL 432
D K+ L++++ + KSL Y + D
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 433 RIIHRDLKASNILLDVQMNP-----KISDFGLARIFGVD-QTQGNTSRIVGTYGYMSPEY 486
++HRDLK +NIL+ + P KI+D G AR+F + + +V T+ Y +PE
Sbjct: 128 WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 487 AMHGQFSVKS-DVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADR 535
+ + K+ D+++ G + E +T + Q D + D DR
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 348 LGRGGFGEVYKGVLPHGQEIAVKR-------LSRSSGQGAQEFKNEVV-----LVAKLQH 395
+GRG FGEV L + ++ + L R+ +E ++ +V + L +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 396 -----RNLVRLLGFCLEGDEKILVYEF---VPNKSLDYFLYD--------SQLRIIHRDL 439
NL ++ + + GD L+ +F +P ++L + QL +HRD+
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDI 128
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY--AMH---GQFSV 494
K NIL+D+ + +++DFG D T +S VGT Y+SPE AM G++
Sbjct: 129 KPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 495 KSDVYSFGVLALETITGKKNSSFY 518
+ D +S GV E + G+ + FY
Sbjct: 188 ECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVD--QTQGNTSRIVGTYGYMSPEYAMHGQ 491
++HRDLK N+L++ KI DFGLAR F + + G + V T Y +PE + Q
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185
Query: 492 FSVKS-DVYSFGVLALETITGK 512
K+ DV+S G + E + K
Sbjct: 186 SYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 39/197 (19%)
Query: 346 NKLGRGGFGEVYKG-VLPHGQEIAVKRLSRSSGQGAQEFKN--EVVLVAKLQ-HRNLVRL 401
K+G G F EV K G+ A+K + + + ++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 402 LGFCLEGDEKIL----------VYEF-------VPNKSLDYFLYDSQL----------RI 434
+ + L +YE +P K + ++Y QL I
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMY--QLLKSLDHMHRNGI 121
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-HGQFS 493
HRD+K NIL+ K++DFG R G+ T I T Y +PE + G +
Sbjct: 122 FHRDIKPENILIK-DDILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLTDGYYG 177
Query: 494 VKSDVYSFGVLALETIT 510
K D+++ G + E ++
Sbjct: 178 PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 53/209 (25%)
Query: 346 NKLGRGGFGEVYKGVL--PHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
++LG+G +G VYK VL P G +A+K RL + Q E+ ++ K +V
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDF 64
Query: 402 LG-FCLEGDEKILVY---EFVPNKSLDYFLYD---------------------------- 429
G F +EG VY E++ SLD LY
Sbjct: 65 YGAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY--- 486
+ IIHRD+K +N+L++ K+ DFG++ + N +G YM+PE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKS 175
Query: 487 ---AMHGQFSVKSDVYSFGVLALETITGK 512
+ ++V+SDV+S G+ LE G+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 30/80 (37%), Positives = 48/80 (60%), Gaps = 4/80 (5%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQF 492
II+RDLK N++LD + + KI+DFG+ + VD G T+R GT Y++PE + +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 493 SVKSDVYSFGVLALETITGK 512
D +++GVL E + G+
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY---- 486
+L I++RD+K NILLD + + ++DFGL++ F + + + T GT YM+PE
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 487 AMHGQFSVKSDVYSFGVLALETITG 511
HG+ D +S G+L E +TG
Sbjct: 182 GGHGK---AVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 54/200 (27%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 347 KLGRGGFGEVYKGVLPHG---QEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLL 402
++G G FG+V G + G ++ VK L S+ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFL--------------------YDSQLRI-------- 434
G C E +LV EF P L +L + L +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA--MHGQF 492
IH DL N LL + KI D+GL+ + ++ +++PE +HG
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181
Query: 493 SV-----KSDVYSFGVLALE 507
V +S+V+S GV E
Sbjct: 182 LVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 53/206 (25%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN---------EVVLVAKLQHRN 397
+GRG +G V +++A+K++ A F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-------ANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 398 LVRLLGFCLEGDEK------ILVYEFV---------PNKSL-----DYFLYDSQL----- 432
++ + + + +VYE + +++L YFLY QL
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY--QLLRGLK 122
Query: 433 -----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
++HRDLK SN+LL+ + KI DFGLAR + + V T Y +PE
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAPELL 180
Query: 488 MH-GQFSVKSDVYSFGVLALETITGK 512
++ +++ DV+S G + E + K
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 53/201 (26%), Positives = 83/201 (41%), Gaps = 31/201 (15%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN----EVVLVAKLQ 394
NKF +G G +G V K +EI A+K+ S + +E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF-------------LYDSQL--------- 432
N+V L + LV+E+V L+ Y QL
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 433 -RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
I+HRD+K N+L+ K+ DFG AR + + N + V T Y SPE +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAP 177
Query: 492 FSVKSDVYSFGVLALETITGK 512
+ D++S G + E G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 45/206 (21%), Positives = 88/206 (42%), Gaps = 42/206 (20%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRN 397
++ +G G +G V + G+++A+K++ + A+ E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 398 LVRLLG-FCLEGDEKILVY-----------------EFVPNKSLDYFLYDSQL------- 432
++ + G + VY + + + + YFLY QL
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY--QLLRGLKYI 123
Query: 433 ---RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI----VGTYGYMSPE 485
+IHRDLK SN+L++ +I DFG+AR G+ + V T Y +PE
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 486 --YAMHGQFSVKSDVYSFGVLALETI 509
++ +++ D++S G + E +
Sbjct: 182 LLLSLP-EYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN-TSRIVGTYGYMSPEYAMHGQF 492
+I+RDLK NILLD + + K++DFG+ + G T+ GT Y++PE ++
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL 526
D ++ GVL E + G+ ++ D +DL
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP---FEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 34/203 (16%)
Query: 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEV----VLVAKLQHRNLVRLL 402
+G+G FG+V G AVK L + + +E + + VL+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 403 GFCLEGDEKI-LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRD 438
+ + EK+ V ++V L + L Y L II+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
LK NILLD Q + ++DFGL + GV+ + TS GT Y++PE + D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-EGVEP-EETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 499 YSFGVLALETITGKKNSSFYQTD 521
+ G + E + G FY D
Sbjct: 180 WCLGAVLYEMLYGL--PPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 44/229 (19%)
Query: 322 ITTLESLQFDFKTIEVATNKFSSDNK-----------LGRGGFGEVYKGVLPHGQ--EIA 368
I L++LQ K +T + NK LG G FG V + +A
Sbjct: 1 IQFLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVA 60
Query: 369 VKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV------- 418
+KR +S + +E ++ + H V L G + LV EFV
Sbjct: 61 IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120
Query: 419 --------PN--------KSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462
PN + + F Y L I++RDLK N+LLD K++DFG A++
Sbjct: 121 FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
Query: 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
T + GT Y++PE ++ +D ++ G+ E + G
Sbjct: 181 -----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
II+RDLK N++LD + + KI+DFG+ + D T GT Y++PE + +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYG 179
Query: 494 VKSDVYSFGVLALETITGK 512
D ++FGVL E + G+
Sbjct: 180 KSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 60/250 (24%), Positives = 98/250 (39%), Gaps = 85/250 (34%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH--GQEIAVKRLSRSS----GQGAQEFK 384
DF++I+V +GRG FGEV + V G A+K+L +S Q A +
Sbjct: 2 DFESIKV----------IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VR 49
Query: 385 NEVVLVAKLQHRNLVRLLGFCLEGDEK--ILVYEFVPNKSLDYFL--YDS---------- 430
E ++A+ + +V+L + DE L+ E++P + L D+
Sbjct: 50 AERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI 107
Query: 431 -----------QLRIIHRDLKASNILLDVQMNPKISDFGL------------ARIFGVDQ 467
+L IHRD+K N+LLD + + K+SDFGL RI +
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI--LSH 165
Query: 468 TQGNTSR--------------------------IVGTYGYMSPEYAMHGQFSVKSDVYSF 501
+ VGT Y++PE + ++ + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 502 GVLALETITG 511
GV+ E + G
Sbjct: 226 GVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 33/147 (22%), Positives = 61/147 (41%), Gaps = 26/147 (17%)
Query: 386 EVVLVAKLQHRNLVRLLGFCLEGDEKILV--------YEFVPNKS--------------- 422
E +L+ + H +++R+ + G +V Y ++ +S
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 423 LDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
L+ Y RIIHRD+K NI ++ I D G A+ V + GT
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETN 223
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETI 509
+PE +++ K+D++S G++ E +
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 10/89 (11%)
Query: 426 FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR--IF-GVDQTQGNTSRIVGTYGYM 482
FL+D II+RDLK N+LLD + + K++DFG+ + IF G TS GT Y+
Sbjct: 111 FLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-----TTSTFCGTPDYI 163
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETITG 511
+PE + D ++ GVL E + G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 37/208 (17%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQE----FKNEVVLVAKLQ 394
F + +GRG FGEV +I A+K + +S AQE F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISN 59
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVP--------NKSLDYFLYD----------------S 430
+ +L + D LV E+ P N+ D F D
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY--AM 488
Q+ +HRD+K N+L+D + K++DFG A ++ N+ VGT Y++PE M
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTM 178
Query: 489 HG----QFSVKSDVYSFGVLALETITGK 512
+G + V+ D +S GV+A E I G+
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 28/76 (36%), Positives = 39/76 (51%)
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
+HRDL A N+L+ KI DFGLAR D + +M+PE + ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 495 KSDVYSFGVLALETIT 510
SDV+SFG+L E T
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 26/78 (33%), Positives = 45/78 (57%)
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
+++HRDLK++NI L K+ DFG ++ + + S GT Y++PE ++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 493 SVKSDVYSFGVLALETIT 510
S K+D++S GV+ E +T
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-F 492
I++RDLK NILLD + + DFGL++ D NT GT Y++PE + + +
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEKGY 174
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
+ D +S GVL E G S FY D +
Sbjct: 175 TKHVDFWSLGVLVFEMCCGW--SPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 7/109 (6%)
Query: 428 YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
Y L I++RDLK NILLD Q + ++DFGL + + G TS GT Y++PE
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 488 MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRP 536
+ D + G + E + G FY + AE Y++ ++P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGL--PPFYSRNTAE---MYDNILNKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
RIIHRD+KA NI ++ + + DFG A F VD GT +PE +
Sbjct: 202 RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPY 260
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTDG 522
D++S G++ E T S ++ DG
Sbjct: 261 GPAVDIWSAGIVLFEMATCH--DSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 28/81 (34%), Positives = 38/81 (46%), Gaps = 7/81 (8%)
Query: 433 RIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
IIH D+K N+L D + + D+GL +I G GT Y SPE
Sbjct: 129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPEKIKGHN 182
Query: 492 FSVKSDVYSFGVLALETITGK 512
+ V D ++ GVL E +TGK
Sbjct: 183 YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEV----VLVAKLQHRNLVRLL 402
+G+G FG+V G+ AVK L + +E K+ + VL+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 403 GFCLEGDEKI-LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRD 438
+ + EK+ V +FV L + L Y + I++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
LK NILLD Q + ++DFGL + G+ Q+ T+ GT Y++PE + D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-EGIAQSD-TTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 499 YSFGVLALETITGKKNSSFYQTDGAE--DLLSYEDPADRPSMAT 540
+ G + E + G FY D AE D + ++ RP +
Sbjct: 180 WCLGAVLYEMLYGL--PPFYCRDVAEMYDNILHKPLVLRPGASL 221
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
II+RDLK N+LLD + + K++D+G+ + G+ + TS GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGL-RPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 494 VKSDVYSFGVLALETITGK 512
D ++ GVL E + G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
II+RDLK N+LLD + K++D+G+ + G+ TS GT Y++PE ++
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK-EGL-GPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 494 VKSDVYSFGVLALETITGK 512
D ++ GVL E + G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 27/76 (35%), Positives = 38/76 (50%)
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSV 494
+HRDL A N+LL KI DFGLAR D + +M+PE ++
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 495 KSDVYSFGVLALETIT 510
SDV+S+G+L E +
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 6/89 (6%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-SRIVGTYGYMSPEYAMHGQF 492
+++RDLK N++LD + KI+DFGL + + G T GT Y++PE +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTD 521
D + GV+ E + G+ FY D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
II+RDLK N+LLD + + K++D+G+ + G+ + TS GT Y++PE +
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGI-RPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 494 VKSDVYSFGVLALETITGK 512
D ++ GVL E + G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 422 SLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
+LDY S+ +++RDLK N++LD + KI+DFGL + D T GT Y
Sbjct: 107 ALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
++PE + D + GV+ E + G+ FY D
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 422 SLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
+LDY +I++RDLK N++LD + KI+DFGL + D T GT Y
Sbjct: 107 ALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE--DLLSYED 531
++PE + D + GV+ E + G+ FY D + +L+ ED
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 44/211 (20%), Positives = 75/211 (35%), Gaps = 47/211 (22%)
Query: 343 SSDNKLGR----GGFGEVYKGVLPHGQEIAVKR--LSRSSGQGAQEFKNEVVLVAKLQHR 396
+G+ + K P +AVK+ L S + + + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKS-------------------------LDYFLYDSQ 431
N++ + + E +V + S L+ Y
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG--------YMS 483
IHR +KAS+ILL +S + G R+V + ++S
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 484 PEY---AMHGQFSVKSDVYSFGVLALETITG 511
PE + G ++ KSD+YS G+ A E G
Sbjct: 177 PEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR-IVGTYGYMSPEYAMHGQF 492
+++RD+K N++LD + KI+DFGL + G+ + G T + GT Y++PE +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK-EGI--SDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTD 521
D + GV+ E + G+ FY D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 68/236 (28%)
Query: 340 NKFSSDNKLGRGGFGEVY-----------------KGVLPHGQEIAVKRLSRS---SGQG 379
+ F S +GRG FGEV K + +++A R R G
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 380 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY--EFVPNKSLDYFLYDS------- 430
A K + + RNL ++ F GD L+ + + ++ +++ ++
Sbjct: 61 AWVVK---MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 431 -QLRIIHRDLKASNILLDVQMNPKISDFGL------------------------------ 459
QL IHRD+K N+LLD + + K+SDFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 460 ----ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
A + ++ Q S VGT Y++PE M ++ D +S GV+ E + G
Sbjct: 178 SKRKAETWKKNRRQLAYS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 27/122 (22%)
Query: 422 SLDYFLYDSQLRIIHRDLKASNILL---DVQMNP-------------KISDFGLARIFGV 465
+LDYF ++L ++H DLK NIL+ D ++P +I D G G
Sbjct: 243 ALDYF--HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-----GC 295
Query: 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT-DGAE 524
+ + + IV T Y SPE + + +D++S G + E TGK Y T D E
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK---LLYDTHDNLE 352
Query: 525 DL 526
L
Sbjct: 353 HL 354
|
Length = 467 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 29/89 (32%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
IIHRD+K NI LD N + DFG A GT SPE +
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 494 VKSDVYSFGVLALE------TITGKKNSS 516
K+D++S G++ E T+ GK+ S
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 61/239 (25%), Positives = 92/239 (38%), Gaps = 64/239 (26%)
Query: 364 GQEIAV--KRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421
G+E+ V K L S A F L++++ H +L + G C+ G E I+V EFV +
Sbjct: 42 GRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101
Query: 422 SLDYFLYDSQLRI------------------------IHRDLKASNILL-------DVQM 450
LD L + R+ +H ++ A NILL
Sbjct: 102 PLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161
Query: 451 NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETI 509
K+SD G++ F + RI +++PE G S +D +SFG LE
Sbjct: 162 FIKLSDPGVS--FTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215
Query: 510 ----------TGKKNSSFYQTD------GAEDL-------LSYEDPADRPSMATIVLAL 545
T + FY+ ++L L+YE P RPS TI+ L
Sbjct: 216 FDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYE-PTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVD-QTQGNTSRIVGTYGYMSPEY----AMH 489
IHRD+K N+LLD + K++DFG + + +T+ VGT Y+SPE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGD 221
Query: 490 GQFSVKSDVYSFGVLALETITGKKNSSFY 518
G + + D +S GV E + G ++ FY
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 37/116 (31%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-------------------- 470
QL IHRD+K N+LLD + + K+SDFGL G+ +
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 471 NTSR---------------IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
N+ R VGT Y++PE M ++ D +S GV+ E + G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 13/91 (14%)
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARI-------------FGVDQTQGNTSRIVGTYG 480
I+HRDLK N+L+ + K++DFGL++I D + ++ GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 481 YMSPEYAMHGQFSVKSDVYSFGVLALETITG 511
Y++PE + + D ++ G++ E + G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 33/144 (22%), Positives = 54/144 (37%), Gaps = 31/144 (21%)
Query: 347 KLGRGGFGEVYKGVL---PHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQHRNLVRLL 402
++G G FG+V + + VK L ++ Q EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFLYDSQ---------------------------LRII 435
G C+E +LV+E+ L +L Q +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 436 HRDLKASNILLDVQMNPKISDFGL 459
H DL N L + K+ D+G+
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 40/184 (21%), Positives = 79/184 (42%), Gaps = 45/184 (24%)
Query: 362 PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE---FV 418
P + + KR+ ++ + A + +NE++ + +L H N++++ E+IL E ++
Sbjct: 190 PKCERLIAKRV-KAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYM 240
Query: 419 PNKSLDY----FLYDSQL----------------------------RIIHRDLKASNILL 446
+ D+ F+YD ++IHRD+K NI L
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300
Query: 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLAL 506
+ + DFG A F ++ + VGT SPE + +D++S G++ L
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILL 359
Query: 507 ETIT 510
+ ++
Sbjct: 360 DMLS 363
|
Length = 501 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 32/126 (25%), Positives = 48/126 (38%), Gaps = 45/126 (35%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIF--------------------------- 463
+L IHRD+K NIL+D + K+SDFGL+ F
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 464 -GVDQ---TQGNTSRI--------------VGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
VD T + +I VGT Y++PE + + + D +S G +
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 506 LETITG 511
E + G
Sbjct: 239 FECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 601 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.82 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.67 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.56 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.55 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.52 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.48 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.44 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.43 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.68 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.65 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.98 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.9 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.79 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.62 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.31 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.23 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.98 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.37 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.31 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.26 | |
| PLN02236 | 344 | choline kinase | 95.98 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.51 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.42 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.04 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.55 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.4 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.66 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.5 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.43 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.36 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.0 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.97 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 92.0 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.87 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.14 Aligned_cols=179 Identities=31% Similarity=0.519 Sum_probs=160.2
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
..+|...++||.|+|++||+|+++ ++.+||||.+.+. ..+..+.+..|+++|+.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888999999999999999954 5899999999776 5666778899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccC------CCcEEeecccceecCCC
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ------MNPKISDFGLARIFGVD 466 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~------~~~kL~Dfg~a~~~~~~ 466 (601)
|||.||+|.+|+ ++|+++||||||||+||||+.. -.+||+|||+|+.+...
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999887 4589999999999999999865 45899999999988633
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT 520 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 520 (601)
......+|++.|||||++...+|+.|+|+||+|+|||++++|+.||.....
T Consensus 169 ---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 169 ---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred ---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 334567999999999999999999999999999999999999999875443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.44 Aligned_cols=203 Identities=30% Similarity=0.495 Sum_probs=178.4
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.+|...+.||+|+|+.||+++. ..|+.||+|++.+. .....+.+.+||++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999996 78999999999764 4556678899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+|+.++|..++ |+|+++|||||||..|+||+++.++||+|||+|..+..+. +..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--ccc
Confidence 999999987665 7899999999999999999999999999999999886443 335
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---cCcc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---LSYE 530 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~~~~ 530 (601)
.+.+|||.|+|||++....++..+||||+||+||-||.|++||+.....+.. ++ +...
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcC
Confidence 5679999999999999999999999999999999999999999765322221 12 2228
Q ss_pred CCCCCCCHHHHHHH
Q 007490 531 DPADRPSMATIVLA 544 (601)
Q Consensus 531 dP~~RPt~~evl~~ 544 (601)
||.+|||+.+|+..
T Consensus 256 ~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 256 NPSERPSLDEVLDH 269 (592)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999865
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=341.86 Aligned_cols=191 Identities=53% Similarity=0.884 Sum_probs=165.2
Q ss_pred cccccchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEE
Q 007490 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405 (601)
Q Consensus 326 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 405 (601)
....|++.+++.+|++|...++||+|+||.||+|.+.+|..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999989999999988765543145699999999999999999999999
Q ss_pred EeCC-eeEEEEeccCCCCccccc-------------------------ccccc---eeeccccccCcEEEccCCCcEEee
Q 007490 406 LEGD-EKILVYEFVPNKSLDYFL-------------------------YDSQL---RIIHRDLKASNILLDVQMNPKISD 456 (601)
Q Consensus 406 ~~~~-~~~lv~E~~~~gsL~~~l-------------------------~~h~~---~iiHrdlkp~NIll~~~~~~kL~D 456 (601)
.+.+ +.+||+|||++|+|.++| |+|.. .||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 599999999999997765 45653 499999999999999999999999
Q ss_pred cccceecCCCCCccccccc-cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 457 FGLARIFGVDQTQGNTSRI-VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 457 fg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999654321 1111122 7999999999999999999999999999999999999877643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=332.12 Aligned_cols=205 Identities=29% Similarity=0.434 Sum_probs=170.8
Q ss_pred hhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChh-------hHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQ-------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
...+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... .....++|+++|++|+|||||++++++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 355678889999999999999998 457999999999764211 223467999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccC---CCcEEeeccccee
Q 007490 409 DEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARI 462 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~~ 462 (601)
+..||||||++||.|.+.+ |+|++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999986654 8899999999999999999766 7799999999998
Q ss_pred cCCCCCccccccccccccccCcccccCCCC---CchhhHHhHHHHHHHHHhCCCCCCCCCCCc-cccccCc---------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQF---SVKSDVYSFGVLALETITGKKNSSFYQTDG-AEDLLSY--------- 529 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~~l~~~--------- 529 (601)
.+. .....+.+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.....+. ..+.+..
T Consensus 329 ~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 329 SGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 753 234567899999999999987643 358899999999999999999997654433 3332222
Q ss_pred -----------------cCCCCCCCHHHHHHH
Q 007490 530 -----------------EDPADRPSMATIVLA 544 (601)
Q Consensus 530 -----------------~dP~~RPt~~evl~~ 544 (601)
.||+.|||+.|+++.
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 799999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=336.07 Aligned_cols=208 Identities=36% Similarity=0.581 Sum_probs=172.4
Q ss_pred CCCCcCCcccccCcceEEeeecCCCce-eeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-eeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQE-IAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-EKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~ 415 (601)
..+...+.||.|+||+||+|.+ .|+. ||||++..... ...+.|.+|+.+|.+++|||||+++|++.+.. ...|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3344556699999999999999 4555 99999976532 22568999999999999999999999999988 799999
Q ss_pred eccCCCCccccc-------------------------ccccce-eeccccccCcEEEccCC-CcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLR-IIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~-iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++|+|..++ |+|+.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999998776 669999 99999999999999997 99999999998765332
Q ss_pred ccccccccccccccCccccc--CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc-------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAM--HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL------------------- 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~------------------- 527 (601)
.......||+.|||||++. ...|+.|+|||||||++|||+||+.||...........+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSS 277 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 2233368999999999999 569999999999999999999999999765532111111
Q ss_pred -----CccCCCCCCCHHHHHHHHhcCCC
Q 007490 528 -----SYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 528 -----~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
-..||..||++.+|+..|+....
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11799999999999999986543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=322.10 Aligned_cols=201 Identities=30% Similarity=0.417 Sum_probs=171.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-eeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-EKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E 416 (601)
.+.+..+.||+|..|+||+++++ +++-+|+|.+... +....+++.+|+++++..+||+||+++|.|..+. ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45667799999999999999965 5788999999544 4556788999999999999999999999999998 5999999
Q ss_pred ccCCCCccccc-----------------------ccc-cceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL-----------------------YDS-QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h-~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||++|+|+.++ |+| +.+||||||||+|||++..|++||+|||.+..+... ..
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 99999998766 678 499999999999999999999999999999877533 45
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC--CccccccC----------------------
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT--DGAEDLLS---------------------- 528 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~--~~~~~l~~---------------------- 528 (601)
..++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... .+..+++.
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 568999999999999999999999999999999999999999876411 11111111
Q ss_pred -----ccCCCCCCCHHHHHHH
Q 007490 529 -----YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 -----~~dP~~RPt~~evl~~ 544 (601)
.+||.+||++.|+++.
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcC
Confidence 1799999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.40 Aligned_cols=185 Identities=30% Similarity=0.425 Sum_probs=163.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||+||.++.+ +++-+|+|++++. .....+...+|..+|.+++||.||+++-.|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999954 5889999999765 2345677889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+|+||+.||.|..+| |+|++|||||||||+|||||++|+++|+|||+++..-...
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-- 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-- 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--
Confidence 999999999998776 6799999999999999999999999999999998643322
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA 523 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 523 (601)
..+..++||+.|||||++.+..|+..+|+||||+++|||++|.+||........
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 335568999999999999999999999999999999999999999987664433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.62 Aligned_cols=208 Identities=29% Similarity=0.427 Sum_probs=171.2
Q ss_pred cCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEE-EEEeCCe-eEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLG-FCLEGDE-KIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~~-~~l 413 (601)
..+|++.++||+|+||+||++. ..+|..||.|.+.-. +.+..+.+..|+.+|++|+|||||++++ .+.++++ ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3468889999999999999999 668999999998643 4556678899999999999999999999 4444444 899
Q ss_pred EEeccCCCCccccc---------------------------cccc--ce--eeccccccCcEEEccCCCcEEeeccccee
Q 007490 414 VYEFVPNKSLDYFL---------------------------YDSQ--LR--IIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------------------~~h~--~~--iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
||||+..|+|..++ +.|. .+ |+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999998766 3366 45 99999999999999999999999999999
Q ss_pred cCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc----------------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL---------------- 526 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l---------------- 526 (601)
+.... ......+|||.||+||.+.+.+|+.||||||+||++|||..-++||....-......
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence 86443 335567999999999999999999999999999999999999999976432111111
Q ss_pred --------cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 --------LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 --------~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...||..||+...++..+.+.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1127999999977777666553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=328.95 Aligned_cols=214 Identities=36% Similarity=0.553 Sum_probs=179.2
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..+++..+.+...+.||+|-||+||.|.++...+||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 3445555667778999999999999999977779999999765 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
||||||+.|+|.++| |++++++|||||.++||||+++..+||+|||+++....+.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999999888 5678899999999999999999999999999999655443
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc-----------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY----------------- 529 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~----------------- 529 (601)
... .....-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+..+.+..
T Consensus 358 Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 358 YTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred eee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 322 222344678999999999999999999999999999998 7778766554444443332
Q ss_pred ------cCCCCCCCHHHHHHHHhcC
Q 007490 530 ------EDPADRPSMATIVLALNSH 548 (601)
Q Consensus 530 ------~dP~~RPt~~evl~~L~~~ 548 (601)
.+|++|||+..+...|+..
T Consensus 437 M~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHhhCCcccCCCHHHHHHHHHHh
Confidence 7999999999998888653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=304.18 Aligned_cols=180 Identities=27% Similarity=0.385 Sum_probs=155.0
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+.|+.+.++|+|+||.||+++.+ +|+.||||++.... +...+-..+|+++|++|+|||+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999965 59999999996543 3344567899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|++..-|+.+- +.|++++|||||||+||||+.+|.+||+|||+|+.+... ....+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YT 159 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYT 159 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchhh
Confidence 99875554322 679999999999999999999999999999999988632 23345
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 521 (601)
..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|+...+-
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 5688999999999987 78999999999999999999999988765543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.11 Aligned_cols=218 Identities=34% Similarity=0.536 Sum_probs=184.3
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEE
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGF 404 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~ 404 (601)
....+....+.+..+.||+|.||+||+|+... .+.||||.++..... ...+|++|++++..|+|||||+++|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34455667778888999999999999998532 456999999876554 77899999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc-------------------------------------ccccceeeccccccCcEEEc
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL-------------------------------------YDSQLRIIHRDLKASNILLD 447 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l-------------------------------------~~h~~~iiHrdlkp~NIll~ 447 (601)
|.+++..++|+|||..|+|.+|| |+.++.+|||||..+|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 99999999999999999998887 34566799999999999999
Q ss_pred cCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc
Q 007490 448 VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL 526 (601)
Q Consensus 448 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l 526 (601)
++..|||+|||+++..-............-..+||+||.|..++|+.+||||||||+|||+++ |+.|+.....++..+.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999999987543333222222344679999999999999999999999999999998 8889988777665555
Q ss_pred cCc-----------------------cCCCCCCCHHHHHHHHhcCC
Q 007490 527 LSY-----------------------EDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 527 ~~~-----------------------~dP~~RPt~~evl~~L~~~~ 549 (601)
+.. ++|.+||+++||-..|+...
T Consensus 718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 443 79999999999999997653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.05 Aligned_cols=208 Identities=30% Similarity=0.426 Sum_probs=175.4
Q ss_pred hhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
...++|..++.||+|+|++|++|+ ...++++|||++.+. .....+.+..|-..|.+| .||.|++|+-.|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999 446899999998654 233345677899999999 899999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|+|+||+++|+|..++ |+|+.|||||||||+|||||+||++||+|||.|+.+.....
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 9999999999998776 67999999999999999999999999999999998864322
Q ss_pred c---------cc--cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC----------------
Q 007490 469 Q---------GN--TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD---------------- 521 (601)
Q Consensus 469 ~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~---------------- 521 (601)
. .. ...++||..|.+||++..+..+..+|+|+||||||+|+.|.+||....+-
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 2 11 24589999999999999999999999999999999999999999654321
Q ss_pred ---cccccc---CccCCCCCCCHHHHHHH
Q 007490 522 ---GAEDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 522 ---~~~~l~---~~~dP~~RPt~~evl~~ 544 (601)
...+++ ...||.+|+|+.+|-+.
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 112222 22799999999988765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.14 Aligned_cols=206 Identities=30% Similarity=0.460 Sum_probs=179.7
Q ss_pred hhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.....|...++||+|+.|.||.++ ..+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+++|+||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 345678888999999999999998 4568899999998877777788899999999999999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|||++|+|.+.+ ++|.+||||||||.+|||++.+|.+||+|||++..+..... ...
T Consensus 350 Eym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~ 427 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRS 427 (550)
T ss_pred eecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccc
Confidence 999999997765 78999999999999999999999999999999988765543 345
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc------------------------
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY------------------------ 529 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~------------------------ 529 (601)
..+||+.|||||++....|++|.||||||++++||+-|++||-....-....++..
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL 507 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence 67999999999999999999999999999999999999999875443222222221
Q ss_pred -cCCCCCCCHHHHHHH
Q 007490 530 -EDPADRPSMATIVLA 544 (601)
Q Consensus 530 -~dP~~RPt~~evl~~ 544 (601)
.|+.+||++.|+|+.
T Consensus 508 ~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 508 VVDVEQRASAKELLEH 523 (550)
T ss_pred hcchhcCCCHHHHhcC
Confidence 799999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.52 Aligned_cols=190 Identities=25% Similarity=0.372 Sum_probs=161.7
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
..+...++|+.++.||+|+||+||+++. .+|..+|+|++++.. ......++.|-.+|...++|+||+|+-.|++.+
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 3455678999999999999999999994 469999999998763 344567888999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC-
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV- 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~- 465 (601)
.+||||||++||++..+| ..|+.|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999987776 34999999999999999999999999999999853311
Q ss_pred ---------------------CCCc-----cc------------------cccccccccccCcccccCCCCCchhhHHhH
Q 007490 466 ---------------------DQTQ-----GN------------------TSRIVGTYGYMSPEYAMHGQFSVKSDVYSF 501 (601)
Q Consensus 466 ---------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 501 (601)
.... .. ....+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 00 123679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcc
Q 007490 502 GVLALETITGKKNSSFYQTDGA 523 (601)
Q Consensus 502 Gvvl~elltg~~p~~~~~~~~~ 523 (601)
|||+||||.|.+||........
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999987665433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=311.68 Aligned_cols=180 Identities=28% Similarity=0.434 Sum_probs=153.0
Q ss_pred hcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKI 412 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 412 (601)
..+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... .....-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34567888999999999999999 5679999999987654 44456678999999999999999999999877 6899
Q ss_pred EEEeccCCCCcccc------------------------cccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYF------------------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~------------------------l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+|||+. +|..+ -|+|.+||+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999986 22222 278999999999999999999999999999999998876554
Q ss_pred ccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.. .+..+-|.+|+|||.+.+. .|+.++|+||.||||.||+.|++.+....
T Consensus 274 ~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 274 AP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred cc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 33 3445779999999999875 69999999999999999999998876543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.35 Aligned_cols=219 Identities=28% Similarity=0.403 Sum_probs=179.7
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. .+..+.+.+|++|++.|+|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 58899999997653 4456778999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+.| +|..++ |+|+.+|+|||+||.|||++.+|.+|++|||+++.+... .....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC--ceeee
Confidence 9987 776655 779999999999999999999999999999999987542 33456
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccC----------------------ccC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLS----------------------YED 531 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~----------------------~~d 531 (601)
.+.|||.|||||...+.+|+..+|+||+|||+||+++|++||...........+. .+|
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence 7889999999999999999999999999999999999999985433222222111 179
Q ss_pred CCCCCCHHHHHHH--HhcCCCCCCCCCCCcee
Q 007490 532 PADRPSMATIVLA--LNSHSVTLSVPRQPALF 561 (601)
Q Consensus 532 P~~RPt~~evl~~--L~~~~~~~~~p~~~~~~ 561 (601)
|..|.|-.+++.. .++.......|.++++.
T Consensus 239 P~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred hhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 9999998888754 34433334445555554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.08 Aligned_cols=209 Identities=26% Similarity=0.402 Sum_probs=175.1
Q ss_pred hhhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
....++|++.+.||.|..++||+|+ .+.+..||||++..... ...+.+.+|+..|+.++||||++++..|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3456789999999999999999999 56789999999976543 336889999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 414 VYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 414 v~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||.||.+|++.+++ |+|++|.||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999987765 88999999999999999999999999999999876644332
Q ss_pred ccc-c-ccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------c-
Q 007490 469 QGN-T-SRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------E- 524 (601)
Q Consensus 469 ~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~- 524 (601)
... . ..++||+.|||||+++. ..|+.|+||||||++..||.+|..||..+..... +
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 211 1 45789999999999653 5799999999999999999999999987653210 0
Q ss_pred ------------cccCccCCCCCCCHHHHHHH
Q 007490 525 ------------DLLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ------------~l~~~~dP~~RPt~~evl~~ 544 (601)
..+...||.+|||+++++..
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00111799999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=287.84 Aligned_cols=184 Identities=30% Similarity=0.409 Sum_probs=163.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
-++|+..+.||.|+||.|.+++.+ +|..+|+|++.+.. ....+...+|..+|+.+.||.++++.+.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 457888999999999999999954 58889999997753 34556778999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||++||.|..++ |+|+++|++|||||+|||||.+|.+||+|||+|+... ..
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~r 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----GR 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----Cc
Confidence 9999999998777 6799999999999999999999999999999999764 33
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~ 527 (601)
+...+|||.|+|||++...++..++|+|||||++|||+.|.+||...+...+.+.+
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI 253 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI 253 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence 66789999999999999999999999999999999999999999877665444433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=304.10 Aligned_cols=205 Identities=26% Similarity=0.426 Sum_probs=177.7
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....|+..+.||+|+||.||+|.. ..++.||+|++.-. .....+.+++|+.+|.+++++||.++++.+..+..+|++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 345678889999999999999995 45889999999765 3445678999999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+.+|++.+++ |+|..+.+|||||+.|||+..+|.+||+|||.+..+..... ..
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--cc
Confidence 999999987665 77999999999999999999999999999999987754433 23
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc-----------------------
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY----------------------- 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~----------------------- 529 (601)
..++||+.|||||++....|+.|+||||||++.+||.+|.+|+..........++.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhh
Confidence 668999999999999988999999999999999999999999977665444333332
Q ss_pred cCCCCCCCHHHHHHH
Q 007490 530 EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ~dP~~RPt~~evl~~ 544 (601)
.||+.||++.++++.
T Consensus 249 k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKH 263 (467)
T ss_pred cCcccCcCHHHHhhh
Confidence 799999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.28 Aligned_cols=221 Identities=30% Similarity=0.468 Sum_probs=183.1
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
...+++++..+.+.+.++||+|.||+||+|+| .-.||||++... ..+..+.|++|+..+++-+|.||+-++|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 34577888889999999999999999999998 346999999765 45567899999999999999999999999998
Q ss_pred CCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 408 GDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
+.. .||+.+|+|.+|..++ |+|.++|||||||..||++.++++|||+|||++..-
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 877 9999999999998877 789999999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc-----------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY----------- 529 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~----------- 529 (601)
..-..........|...|||||+++. .+|++.+||||||+|+|||++|..||.....+.+...+..
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 32221122233457789999999964 5799999999999999999999999985444433322221
Q ss_pred ----------------cCCCCCCCHHHHHHHHhcCCCCCC
Q 007490 530 ----------------EDPADRPSMATIVLALNSHSVTLS 553 (601)
Q Consensus 530 ----------------~dP~~RPt~~evl~~L~~~~~~~~ 553 (601)
.++++||.+.+|+..|+.....+|
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 699999999999999887654433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.20 Aligned_cols=203 Identities=31% Similarity=0.468 Sum_probs=170.9
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
|++.-+....++-||.|+.|.||+|++ .++.||||+++... ..+|+.|++|+||||+.+.|+|.....++||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 344444445567899999999999998 78899999885322 4588999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||||..|.|...| |+|.+.|||||||.-||||..+..+||+|||-++.+... ..
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST 267 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence 9999999987766 789999999999999999999999999999999877533 33
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccC-----------------------
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLS----------------------- 528 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~----------------------- 528 (601)
...+.||..|||||++++.+.+.|+|||||||||||||||..||.......+..-+.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqc 347 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQC 347 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHH
Confidence 456899999999999999999999999999999999999999986544322211110
Q ss_pred -ccCCCCCCCHHHHHHHHhcC
Q 007490 529 -YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 529 -~~dP~~RPt~~evl~~L~~~ 548 (601)
...|..||++++|+..|.--
T Consensus 348 w~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 348 WNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HhcCCCCCccHHHHHHHHhhc
Confidence 16899999999999998643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.25 Aligned_cols=176 Identities=29% Similarity=0.473 Sum_probs=149.2
Q ss_pred CCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChh--hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQ--GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|...++||+|.||.||+|+ ..+|+.||||+++..... ......+||+.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 457999999999765322 23456899999999999999999999999999999999
Q ss_pred ccCCCCcc------------------------cccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLD------------------------YFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~------------------------~~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+. +|+ .+-|+|++.|+||||||.|+||+++|.+||+|||+++.+.......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-- 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-- 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc--
Confidence 9974 332 2337899999999999999999999999999999999987543322
Q ss_pred ccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
...+-|.+|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|+..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 22377899999999987 46999999999999999999998766543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.41 Aligned_cols=191 Identities=26% Similarity=0.358 Sum_probs=165.5
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 410 (601)
....++|...++||+|+||+|+++..+ +++.+|||.+++.. ....+..+.|.+++... +||.+++++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455678999999999999999999965 57889999998763 45567788899988888 59999999999999999
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+|.||||+.||++..+. |+|++||||||||.+|||||.+|++||+|||+++..- ..
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--CC
Confidence 99999999999965443 6799999999999999999999999999999998632 12
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLS 528 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~ 528 (601)
...+.+++||+.|||||++.+..|+.++|+|||||+|||||.|..||....+++..+-|.
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 235778999999999999999999999999999999999999999998776655544433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.05 Aligned_cols=208 Identities=30% Similarity=0.492 Sum_probs=167.4
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC--eeEEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD--EKILVY 415 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~ 415 (601)
..++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|...... .++|.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4457788999999999999999644 8999999987664444677899999999999999999999855444 689999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCC-CCCc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGV-DQTQ 469 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~-~~~~ 469 (601)
||+++|+|..++ |+|++||||+||||+|||++. ++.+||+|||+++.... ....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999987655 679999999999999999999 79999999999987653 1111
Q ss_pred cccccccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCCC-CCC-------------c--------ccc-
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSFY-QTD-------------G--------AED- 525 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~-~~~-------------~--------~~~- 525 (601)
.......||+.|||||++.++. ...++|||||||++.||+||++||... ... . ..+
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF 255 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 2244578999999999998643 345999999999999999999999863 100 0 000
Q ss_pred --ccCccCCCCCCCHHHHHHHHh
Q 007490 526 --LLSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 526 --l~~~~dP~~RPt~~evl~~L~ 546 (601)
.+...||.+|||+.++++..-
T Consensus 256 l~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 256 LRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHhhcCcccCcCHHHHhhChh
Confidence 111179999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.94 Aligned_cols=214 Identities=29% Similarity=0.453 Sum_probs=169.6
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 406 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 406 (601)
++...++|++.++||+|+||.||+|.+ ..++.||||++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 345678899999999999999999973 235689999987543 23446789999999999 8999999999887
Q ss_pred eCC-eeEEEEeccCCCCccccc----------------------------------------------------------
Q 007490 407 EGD-EKILVYEFVPNKSLDYFL---------------------------------------------------------- 427 (601)
Q Consensus 407 ~~~-~~~lv~E~~~~gsL~~~l---------------------------------------------------------- 427 (601)
..+ ..++||||+++|+|.+++
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 644 578999999999885332
Q ss_pred ---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 428 ---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 428 ---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
|+|+.+|+||||||+|||++.++.+||+|||+++...............++..
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 56999999999999999999999999999999986543222222223345678
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc---------------------ccccc---CccCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG---------------------AEDLL---SYEDPADR 535 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~---------------------~~~l~---~~~dP~~R 535 (601)
|+|||++.+..++.++|||||||++|||++ |..||....... ..+++ ...||.+|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999997 999986533211 00111 11799999
Q ss_pred CCHHHHHHHHhcC
Q 007490 536 PSMATIVLALNSH 548 (601)
Q Consensus 536 Pt~~evl~~L~~~ 548 (601)
||+.||+++|+..
T Consensus 322 Ps~~el~~~l~~~ 334 (338)
T cd05102 322 PTFSALVEILGDL 334 (338)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=294.11 Aligned_cols=205 Identities=29% Similarity=0.407 Sum_probs=159.8
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHH--cCCCCccceEEEEEeCC----eeEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEGD----EKIL 413 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~----~~~l 413 (601)
...++.+.||+|.||.||+|.+ +++.||||++.... .+.|++|-+|.+. ++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455678999999999999998 67999999996543 4557777776664 58999999999987666 7899
Q ss_pred EEeccCCCCccccc----------------------cc---------ccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 414 VYEFVPNKSLDYFL----------------------YD---------SQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 414 v~E~~~~gsL~~~l----------------------~~---------h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
|+||.+.|+|.++| |+ |+..|+|||||++||||.+|+++.|+|||+|..
T Consensus 286 Vt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred EeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999888 22 567899999999999999999999999999999
Q ss_pred cCCCCCccccccccccccccCcccccCCC-C-----CchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCccCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-F-----SVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRP 536 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~~dP~~RP 536 (601)
+............+||.+|||||++.+.- + -.+.||||+|.|||||++...-... ......++-....-..+|
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcCCC
Confidence 98877777777789999999999997632 2 2468999999999999998654321 111111111112445678
Q ss_pred CHHHHHHHHhcCC
Q 007490 537 SMATIVLALNSHS 549 (601)
Q Consensus 537 t~~evl~~L~~~~ 549 (601)
|+.++-+..-.+.
T Consensus 445 t~e~mq~~VV~kK 457 (534)
T KOG3653|consen 445 TLEEMQELVVRKK 457 (534)
T ss_pred CHHHHHHHHHhhc
Confidence 8888766654443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.47 Aligned_cols=205 Identities=29% Similarity=0.443 Sum_probs=172.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC----Ch-hhHHHHHHHHHHHHHcC-CCCccceEEEEEeCC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS----SG-QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 409 (601)
...++|.+.+.||+|+||.|+.|+. .++..||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999984 46899999977653 22 23456778999999998 999999999999999
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccC-CCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~~ 465 (601)
..++||||+.+|.|.+++ |+|++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999887766 6799999999999999999999 999999999998763
Q ss_pred CCCccccccccccccccCcccccCCC-CC-chhhHHhHHHHHHHHHhCCCCCCCCCCC-----------cccccc-----
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQ-FS-VKSDVYSFGVLALETITGKKNSSFYQTD-----------GAEDLL----- 527 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~p~~~~~~~-----------~~~~l~----- 527 (601)
.........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...... .....+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 1223455679999999999999877 86 8899999999999999999999764311 111111
Q ss_pred -------CccCCCCCCCHHHHHH
Q 007490 528 -------SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 -------~~~dP~~RPt~~evl~ 543 (601)
...||..|+|+.+|++
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhh
Confidence 1279999999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.82 Aligned_cols=213 Identities=29% Similarity=0.468 Sum_probs=178.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhh-HHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+.+.+...+.++||+|-||+|.++....+..||||+++...... ..+|.+|+++|.+|+||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34566678899999999999999998778999999998875544 48899999999999999999999999999999999
Q ss_pred EeccCCCCccccccc-------------------------ccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 415 YEFVPNKSLDYFLYD-------------------------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 415 ~E~~~~gsL~~~l~~-------------------------h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+|||++|+|.+++.. .+.+++||||.++|+|++.++++||+|||+++-+-.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999998844 4567999999999999999999999999999966544444
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCCCcccccc----Cc--------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT--GKKNSSFYQTDGAEDLL----SY-------------- 529 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~~~l~----~~-------------- 529 (601)
....+.+-..+|||||.+..++++.++|||+||+++||+++ ..+||.....++..+-. ..
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 44445566889999999999999999999999999999876 56787655443322111 10
Q ss_pred ------------cCCCCCCCHHHHHHHHhcC
Q 007490 530 ------------EDPADRPSMATIVLALNSH 548 (601)
Q Consensus 530 ------------~dP~~RPt~~evl~~L~~~ 548 (601)
.+-.+||+++++...|+++
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 6888999999999988765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=301.77 Aligned_cols=179 Identities=27% Similarity=0.372 Sum_probs=150.2
Q ss_pred hhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHH-HHHHHHHHHHHcC-CCCccceEEEEEeCC-eeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQ-EFKNEVVLVAKLQ-HRNLVRLLGFCLEGD-EKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~~~ 412 (601)
...++|...++||.|.||.||+|+ ...|..||||++++.-....+ .=.+|++.|++|+ |||||++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345789999999999999999999 556899999999776443322 2358999999998 999999999999888 899
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+|||||+. +|.+++ |.|++|+.|||+||+|||+.....+||+|||+|+.....
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--
Confidence 99999975 332222 679999999999999999999899999999999987533
Q ss_pred ccccccccccccccCccccc-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
...+..+.|.+|+|||++. .+-|+.+.||||+|||++|+.+-++-|+...
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 2344568899999999875 5679999999999999999999998887644
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.61 Aligned_cols=199 Identities=31% Similarity=0.420 Sum_probs=172.4
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+-|++++.||.|+-|.|-+|++ .+|+.+|||++.+.. ......+.+||.+|+.+.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578899999999999999994 579999999997652 233456889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|-|.+++ |.|..+|+||||||+|+|||..+++||+|||+|..-..+ ...
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC---ccc
Confidence 999999998776 679999999999999999999999999999999864433 234
Q ss_pred ccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc----------------------
Q 007490 473 SRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY---------------------- 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~---------------------- 529 (601)
...+|++.|.+||++.+.+|. .++||||.|||||.||+|+.||+... +..++.+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 456999999999999999986 88999999999999999999997433 3333222
Q ss_pred ---cCCCCCCCHHHHHHH
Q 007490 530 ---EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ---~dP~~RPt~~evl~~ 544 (601)
.||.+|.|+.||++.
T Consensus 246 ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKH 263 (786)
T ss_pred HhccCccccccHHHHhhC
Confidence 799999999999886
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=289.06 Aligned_cols=204 Identities=25% Similarity=0.435 Sum_probs=177.3
Q ss_pred cCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
..+|++.+.||+|.||.|-++. ...|+.||||.+.+. +.++.-.+.+||+||+.|+||||+.++.+|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4568888999999999999998 467999999999765 445566788999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||..+|.|.+|+ |.|+++++|||||.+|||+|.++++||+|||++..+... ..
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~---kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK---KF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc---cH
Confidence 9999999998877 779999999999999999999999999999999887543 33
Q ss_pred cccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc------------------C---c
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL------------------S---Y 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~------------------~---~ 529 (601)
...++|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||+......+...+ . .
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLM 288 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHh
Confidence 5678999999999999999986 8899999999999999999999875533222222 1 1
Q ss_pred cCCCCCCCHHHHHHHH
Q 007490 530 EDPADRPSMATIVLAL 545 (601)
Q Consensus 530 ~dP~~RPt~~evl~~L 545 (601)
.||++|.|+.+|....
T Consensus 289 VNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 289 VNPERRATIEDIASHW 304 (668)
T ss_pred cCcccchhHHHHhhhh
Confidence 7999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.77 Aligned_cols=212 Identities=36% Similarity=0.544 Sum_probs=173.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC--Cc----eeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH--GQ----EIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
....+.+..+.||+|.||.||.|...+ |. .||||.+.+. +.+...+|.+|..+|++++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345667788999999999999999543 43 4899999775 4566788999999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc------------------------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
..+|++|||++|+|..+| |++++++|||||..+|+||++...+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999998887 66889999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE-------------- 524 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~-------------- 524 (601)
|+.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||......+..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 995433322222222234568999999999999999999999999999998 67777654432221
Q ss_pred ------cccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 525 ------DLLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ------~l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
+++. ..+|++||++..|++.+...
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1111 17999999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.29 Aligned_cols=210 Identities=30% Similarity=0.466 Sum_probs=166.7
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC-----------------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCcc
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH-----------------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLV 399 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv 399 (601)
..++|++.++||+|+||.||++++.+ +..||+|.+.... ......+.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45678999999999999999997532 3369999987643 33456789999999999999999
Q ss_pred ceEEEEEeCCeeEEEEeccCCCCccccc------------------------------------------ccccceeecc
Q 007490 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------------------------YDSQLRIIHR 437 (601)
Q Consensus 400 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l------------------------------------------~~h~~~iiHr 437 (601)
++++++.+.+..++||||+++++|..++ ++|+.+|+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999998875432 5689999999
Q ss_pred ccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhC--CCCC
Q 007490 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG--KKNS 515 (601)
Q Consensus 438 dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg--~~p~ 515 (601)
||||+|||++.++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||+++ ..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999865433222222334557889999999988999999999999999999974 4565
Q ss_pred CCCCCCc---------------------------cccccC---ccCCCCCCCHHHHHHHHhc
Q 007490 516 SFYQTDG---------------------------AEDLLS---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 516 ~~~~~~~---------------------------~~~l~~---~~dP~~RPt~~evl~~L~~ 547 (601)
....... ..+++. ..||.+|||+.+|.+.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4322111 011111 1699999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=276.90 Aligned_cols=177 Identities=29% Similarity=0.381 Sum_probs=147.4
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh--hHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ--GAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv 414 (601)
++|+.+++|++|+||.||+|+++ +++.||+|+++..... ..-.-.+||.+|.+.+|||||.+-.+.+. -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888999999999999999964 5888999999765322 12345789999999999999999988774 3568999
Q ss_pred EeccCCCCccc------------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDY------------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~------------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||++. +|.. +-|+|.+.|+|||||++|+|++..|.+||+|||+|+.++... .
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--K 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc--c
Confidence 999975 3322 227899999999999999999999999999999999886542 2
Q ss_pred ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
..+..+-|.+|+|||.+.+. .|+...|+||+|||+.||+++++-|....
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 34556789999999999875 59999999999999999999998776543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.45 Aligned_cols=216 Identities=34% Similarity=0.470 Sum_probs=176.2
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCC--C---ceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPH--G---QEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 404 (601)
..|+..-++....++||+|+||+||+|++.. + ..||||..... ......++.+|.++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455566666777999999999999999643 2 23899998752 35667889999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccc
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
......++||||++.||+|+++| |+|++++|||||..+|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999887 779999999999999999999999999999998
Q ss_pred eecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc-C----------
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL-S---------- 528 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~-~---------- 528 (601)
+.-.. .........-...|+|||.+..+.|+.++|||||||++||+++ |..|+......+....+ .
T Consensus 310 ~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 310 RAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred cCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 75321 1111111134678999999999999999999999999999999 78888765543332222 1
Q ss_pred -------------ccCCCCCCCHHHHHHHHhcCCC
Q 007490 529 -------------YEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 529 -------------~~dP~~RPt~~evl~~L~~~~~ 550 (601)
..+|++||+|.++.+.|+....
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1799999999999999876543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=267.85 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=170.2
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .....++.+|+++-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4567999999999999999999954 57789999987642 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 414 VYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 414 v~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||.+.|.|...| |.|.++||||||||+|+|++.++.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 99999999886554 6699999999999999999999999999999997642
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc-------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY------------------- 529 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~------------------- 529 (601)
.......+||..|.+||...+..++.++|+|++|++.||++.|.+||.....+.....+..
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR 255 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence 2334567999999999999999999999999999999999999999976654433333322
Q ss_pred ---cCCCCCCCHHHHHH
Q 007490 530 ---EDPADRPSMATIVL 543 (601)
Q Consensus 530 ---~dP~~RPt~~evl~ 543 (601)
.+|.+|.+..|+++
T Consensus 256 ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMD 272 (281)
T ss_pred HhccCccccccHHHHhh
Confidence 56777777766654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=293.94 Aligned_cols=175 Identities=29% Similarity=0.372 Sum_probs=153.2
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467888999999999999999964 58899999986532 23446788999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----- 171 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----
Confidence 9999999886554 669999999999999999999999999999999865322
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 22357899999999999999999999999999999999999998643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=287.24 Aligned_cols=197 Identities=21% Similarity=0.340 Sum_probs=162.5
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhh---HHHHHHHHHHHHHcCCCCccceEEEEEe----CCeeEEEEec
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQG---AQEFKNEVVLVAKLQHRNLVRLLGFCLE----GDEKILVYEF 417 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 417 (601)
...||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997653322 4678899999999999999999999877 3467899999
Q ss_pred cCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++|+|..++ ++|+ .+++||||||+|||+++++.+||+|||+++...... .
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----F 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----c
Confidence 9999998765 4576 489999999999999999999999999998653221 2
Q ss_pred cccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc------------------------
Q 007490 474 RIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL------------------------ 527 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~------------------------ 527 (601)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 3467889999999976 68999999999999999999999999755422211111
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+|||+.|+++.|+.
T Consensus 259 l~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 259 TSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred hcCCcccCcCHHHHHHHHHH
Confidence 01799999999999999865
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=298.59 Aligned_cols=179 Identities=28% Similarity=0.380 Sum_probs=152.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||+||+++.. +++.||||++.+.. ......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999854 58899999986532 233456788999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc---
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--- 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--- 469 (601)
||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999987665 669999999999999999999999999999998754321100
Q ss_pred ------------------------------cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 470 ------------------------------GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 470 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012357999999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=298.77 Aligned_cols=213 Identities=31% Similarity=0.449 Sum_probs=169.9
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 406 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 406 (601)
++...++|++.++||+|+||.||+|++ ..+..||||+++... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 445567899999999999999999963 235689999986543 33456788999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCccccc-----------------------------------------------------------
Q 007490 407 EGDEKILVYEFVPNKSLDYFL----------------------------------------------------------- 427 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l----------------------------------------------------------- 427 (601)
..+..++||||+++|+|..++
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999998874332
Q ss_pred ---------------------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 428 ---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 428 ---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 45899999999999999999999999999999986643322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc---------------------cccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG---------------------AEDL 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~---------------------~~~l 526 (601)
........++..|+|||++.+..++.++||||||+++|||++ |..||....... ..++
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 349 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI 349 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence 111222344667999999999999999999999999999998 888875432110 0011
Q ss_pred c---CccCCCCCCCHHHHHHHHhc
Q 007490 527 L---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+ ...||.+||++.||+++|+.
T Consensus 350 i~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHccCChhHCcCHHHHHHHHHh
Confidence 1 12799999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.15 Aligned_cols=212 Identities=29% Similarity=0.501 Sum_probs=177.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
+......+.++||.|.||+|++|+++. ...||||.++... .+...+|+.|..||-+++||||++|.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 444566788999999999999999753 3469999998753 45667899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.||+|||++|+|+.+| |+.+.++|||||..+|||++.+..+|++|||+++.+.++.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999988 5567889999999999999999999999999999886554
Q ss_pred Cccccccccc--cccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc---------------
Q 007490 468 TQGNTSRIVG--TYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY--------------- 529 (601)
Q Consensus 468 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~--------------- 529 (601)
... .+..-| ..+|.|||.+...+++.++|||||||+|||.++ |++|+-.....+..+.+..
T Consensus 786 ~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred Ccc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 221 111122 578999999999999999999999999999886 8889876655544433332
Q ss_pred --------cCCCCCCCHHHHHHHHhcCC
Q 007490 530 --------EDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 530 --------~dP~~RPt~~evl~~L~~~~ 549 (601)
+|-.+||.+.+|+.+|.+..
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 78899999999999997653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.83 Aligned_cols=204 Identities=22% Similarity=0.302 Sum_probs=168.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-C-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-H-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
..|.+.+.||+|++|.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34888999999999999999843 3 678899987665555556788999999999999999999999999999999999
Q ss_pred cCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 418 VPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 418 ~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 9999986533 5699999999999999999999999999999998765433222
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------cccc---c
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDL---L 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l---~ 527 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..++ +
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 306 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPL 306 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHH
Confidence 3345679999999999999999999999999999999999999986432211 0111 1
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...||.+||++.+++.
T Consensus 307 L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 307 LSKNPALRPTTQQLLH 322 (478)
T ss_pred hccChhhCcCHHHHHh
Confidence 1279999999998864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=287.12 Aligned_cols=174 Identities=32% Similarity=0.439 Sum_probs=150.4
Q ss_pred CCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 342 FSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999995 468999999986542 22334678899999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+.+|+||||||+|||+++++.+||+|||++....... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---ee
Confidence 9999986443 5699999999999999999999999999999998753222 12
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 3347899999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.59 Aligned_cols=178 Identities=26% Similarity=0.400 Sum_probs=151.1
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.|+..+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 458899999996542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc----
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ---- 469 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---- 469 (601)
|+++|+|..++ ++|+.+|+||||||+|||++.++++||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999987654 669999999999999999999999999999997643211000
Q ss_pred -----------------------------------------cccccccccccccCcccccCCCCCchhhHHhHHHHHHHH
Q 007490 470 -----------------------------------------GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508 (601)
Q Consensus 470 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 508 (601)
.......||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 001235799999999999988999999999999999999
Q ss_pred HhCCCCCCCC
Q 007490 509 ITGKKNSSFY 518 (601)
Q Consensus 509 ltg~~p~~~~ 518 (601)
++|+.||...
T Consensus 242 ltG~~Pf~~~ 251 (381)
T cd05626 242 LVGQPPFLAP 251 (381)
T ss_pred HhCCCCCcCC
Confidence 9999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=291.13 Aligned_cols=174 Identities=26% Similarity=0.335 Sum_probs=152.3
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999964 58899999986532 234566889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|.+++ ++|+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----c
Confidence 999999987654 569999999999999999999999999999999865321 2
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2346899999999999989999999999999999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.37 Aligned_cols=208 Identities=31% Similarity=0.528 Sum_probs=169.3
Q ss_pred cCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.++|.+.+.||+|+||.||+|+..+ ++.||||.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568889999999999999998533 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc-------------------------------------ccccceeeccccccCcEEEccCCCcEE
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
++||||+++++|..++ ++|+++++||||||+||+++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999998876543 459999999999999999999999999
Q ss_pred eecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------
Q 007490 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED-------- 525 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~-------- 525 (601)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.........+
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999976533222122223345788999999999999999999999999999998 999975433221111
Q ss_pred ------------cc---CccCCCCCCCHHHHHHHHh
Q 007490 526 ------------LL---SYEDPADRPSMATIVLALN 546 (601)
Q Consensus 526 ------------l~---~~~dP~~RPt~~evl~~L~ 546 (601)
++ ...||.+||++.||++.|+
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 1179999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.86 Aligned_cols=204 Identities=27% Similarity=0.385 Sum_probs=164.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|+..++||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345777899999999999999954 68999999986543 3345678999999999999999999999999999999999
Q ss_pred ccCCCCccccc-------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 417 FVPNKSLDYFL-------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
|+++++|.... |+|+.+|+||||||+|||+++++.+||+|||+++.+.... .......|
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 230 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVG 230 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccccccc
Confidence 99999886432 6799999999999999999999999999999998764322 12234578
Q ss_pred cccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cccc--
Q 007490 478 TYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------EDLL-- 527 (601)
Q Consensus 478 t~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~l~-- 527 (601)
|..|+|||++.. ...+.++|||||||++|||++|+.||......+. .+++
T Consensus 231 t~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 310 (353)
T PLN00034 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISC 310 (353)
T ss_pred CccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHH
Confidence 999999998743 2345689999999999999999999863222111 1111
Q ss_pred -CccCCCCCCCHHHHHHH
Q 007490 528 -SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 -~~~dP~~RPt~~evl~~ 544 (601)
...||.+||++.|+++.
T Consensus 311 ~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 311 CLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 12799999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.76 Aligned_cols=204 Identities=26% Similarity=0.383 Sum_probs=174.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe-eEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE-KILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv 414 (601)
-++|..++++|+|+||.++..+.+ +++.+++|++.... ....+...+|+.++++++|||||.+.+.|++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999999854 57789999986543 3344567899999999999999999999999988 8999
Q ss_pred EeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 415 YEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 415 ~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
|+|++||+|.+.+ |+|+++|+|||||+.||+++.++.+||+|||+++.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 9999999997765 6799999999999999999999999999999999886543
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccC---------------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLS--------------------- 528 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~--------------------- 528 (601)
......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...........+.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHH
Confidence 24556799999999999999999999999999999999999999987655432221111
Q ss_pred --ccCCCCCCCHHHHHHH
Q 007490 529 --YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 --~~dP~~RPt~~evl~~ 544 (601)
..+|..||++.+++.+
T Consensus 241 ~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhhcCCccCCCHHHHhhC
Confidence 1799999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.15 Aligned_cols=214 Identities=29% Similarity=0.431 Sum_probs=170.7
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
.+....++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+++++.+ +||||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34566678999999999999999998732 24579999997543 33456788999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc----------------------------------------------------------
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL---------------------------------------------------------- 427 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l---------------------------------------------------------- 427 (601)
...+..++||||+++|+|.+++
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999998875432
Q ss_pred -----------------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 428 -----------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 428 -----------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+|+++|+||||||+|||+++++.+||+|||+++...........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 558999999999999999999999999999999865433221112
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc---------------------cccc---c
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG---------------------AEDL---L 527 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~---------------------~~~l---~ 527 (601)
....++..|||||++.+..++.++|||||||++|||++ |+.||....... ..++ +
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 22335668999999999999999999999999999997 999986533211 0011 1
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.+|+++|+.
T Consensus 352 l~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 352 WNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred cCCChhhCcCHHHHHHHHHH
Confidence 12799999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=295.15 Aligned_cols=200 Identities=27% Similarity=0.381 Sum_probs=167.9
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++.+++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 58899999987542 234456889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 999999997765 56999999999999999999999999999999976532 23
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------------ccc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------------AED 525 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------------~~~ 525 (601)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 34578999999999999999999999999999999999999986432211 001
Q ss_pred cc---CccCCCCCCCHHHHHHH
Q 007490 526 LL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~ 544 (601)
++ ...+|.+||++.++++.
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhC
Confidence 11 11689999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=278.51 Aligned_cols=183 Identities=28% Similarity=0.430 Sum_probs=152.4
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEecc--CChhhHHHHHHHHHHHHHcCCCCccceEEEEEe-----
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSR--SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----- 407 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----- 407 (601)
......|...+.||+|+||.|+.+.. .+|+.||||++.. ......++..+|+++|+.++|+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34456677789999999999999994 4689999999973 455567788999999999999999999999875
Q ss_pred CCeeEEEEeccCCCCccc-----------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 408 GDEKILVYEFVPNKSLDY-----------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~-----------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
-+..|+|+|+|+. +|.. +-|.|+.+|+||||||+|+|++.+..+||+|||+|+...
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 3458999999843 3322 227799999999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccc-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 443334445678899999999875 4679999999999999999999999887654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=289.98 Aligned_cols=176 Identities=28% Similarity=0.367 Sum_probs=153.2
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
..++|++.+.||+|+||.||+++.. ++..||+|.+... .......+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4578999999999999999999964 5888999998754 3344567899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccc-eeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQL-RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~-~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|.+++ ++|+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~ 158 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 158 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----c
Confidence 999999997665 55865 6999999999999999999999999999765322 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2345789999999999999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.60 Aligned_cols=210 Identities=27% Similarity=0.400 Sum_probs=166.0
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh--------------hhHHHHHHHHHHHHHcCCCCccc
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG--------------QGAQEFKNEVVLVAKLQHRNLVR 400 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~ 400 (601)
...-++|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44568899999999999999999994 4689999999975421 12357889999999999999999
Q ss_pred eEEEEEeC--CeeEEEEeccCCCCccc-----------------------ccccccceeeccccccCcEEEccCCCcEEe
Q 007490 401 LLGFCLEG--DEKILVYEFVPNKSLDY-----------------------FLYDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 401 l~~~~~~~--~~~~lv~E~~~~gsL~~-----------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
|+.+..+. +.+|||+|||..|.+.. +-|+|.+|||||||||+|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99998764 56899999999876532 228899999999999999999999999999
Q ss_pred ecccceecCCCCCc---cccccccccccccCcccccCCC----CCchhhHHhHHHHHHHHHhCCCCCCCCCCC-------
Q 007490 456 DFGLARIFGVDQTQ---GNTSRIVGTYGYMSPEYAMHGQ----FSVKSDVYSFGVLALETITGKKNSSFYQTD------- 521 (601)
Q Consensus 456 Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~------- 521 (601)
|||.+..+...... ......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.....-
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999876332111 1234478999999999987632 347899999999999999999998543211
Q ss_pred --------------ccccccC---ccCCCCCCCHHHHHHHH
Q 007490 522 --------------GAEDLLS---YEDPADRPSMATIVLAL 545 (601)
Q Consensus 522 --------------~~~~l~~---~~dP~~RPt~~evl~~L 545 (601)
...+++. .+||.+|.++.+|....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1112222 27999999998887664
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.40 Aligned_cols=197 Identities=25% Similarity=0.329 Sum_probs=161.0
Q ss_pred CcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+++. .+|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999987532 233456788999999999999999999999999999999999999
Q ss_pred Cccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 422 SLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 422 sL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
+|..++ ++|+.||+||||||+|||++.++.+||+|||+++..... ........||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecC
Confidence 986544 679999999999999999999999999999998753211 1123345799
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------cccc---CccCCCCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDLL---SYEDPADRP 536 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l~---~~~dP~~RP 536 (601)
+.|+|||++.+..++.++|||||||++|||++|+.||........ .+++ ...||.+||
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 999999999999999999999999999999999999864332111 0111 127999999
Q ss_pred -----CHHHHHHH
Q 007490 537 -----SMATIVLA 544 (601)
Q Consensus 537 -----t~~evl~~ 544 (601)
++.++++.
T Consensus 239 ~~~~~~~~~ll~h 251 (323)
T cd05571 239 GGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHcC
Confidence 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=283.14 Aligned_cols=208 Identities=34% Similarity=0.538 Sum_probs=168.9
Q ss_pred CCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
++|++.+.||+|+||.||+|.... ...|++|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998533 2579999986543 334567899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcE
Q 007490 413 LVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPK 453 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~k 453 (601)
++|||+++++|..++ ++|+.+++||||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 999999998875443 45999999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc-----
Q 007490 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL----- 527 (601)
Q Consensus 454 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~----- 527 (601)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999986543322222333456788999999998999999999999999999998 99898654332221111
Q ss_pred ------------------CccCCCCCCCHHHHHHHHhc
Q 007490 528 ------------------SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ------------------~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.||++.|++
T Consensus 245 ~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 245 LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11799999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=268.98 Aligned_cols=203 Identities=28% Similarity=0.380 Sum_probs=169.1
Q ss_pred hcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++.|++.+.||+|.|+.|+++. .++|+.+|+|++... ...+.+++.+|++|-+.|+||||+++++...+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 35678888999999999999998 457999999988543 344678899999999999999999999999999999999
Q ss_pred EeccCCCCccc-----------------------ccccccceeeccccccCcEEEccC---CCcEEeecccceecCCCCC
Q 007490 415 YEFVPNKSLDY-----------------------FLYDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 415 ~E~~~~gsL~~-----------------------~l~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~ 468 (601)
+|+|.|+.|.. +-|.|.++|||||+||+|+|+... .-+||+|||++..++.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--- 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--- 165 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC---
Confidence 99999998732 227799999999999999999643 3489999999998862
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc-------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY------------------- 529 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~------------------- 529 (601)
.......+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.......+.+.+..
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 2334567999999999999999999999999999999999999999977443333222221
Q ss_pred -------cCCCCCCCHHHHHH
Q 007490 530 -------EDPADRPSMATIVL 543 (601)
Q Consensus 530 -------~dP~~RPt~~evl~ 543 (601)
.||.+|.|+.|.+.
T Consensus 246 LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHhccChhhhccHHHHhC
Confidence 68999988887653
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=280.18 Aligned_cols=209 Identities=32% Similarity=0.502 Sum_probs=171.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+..++|++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4457789999999999999999998788899999986543 235678999999999999999999999999999999999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|.+++ ++|+.+++||||||+||+++.++.+||+|||++......... .
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 99999887654 569999999999999999999999999999999876432221 1
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc---
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL--- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~--- 527 (601)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......... +++
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 122345678999999988889999999999999999998 99888543221100 001
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+||++.+++++|+.
T Consensus 241 l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 241 WKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ccCCcccCcCHHHHHHHHhc
Confidence 11799999999999999964
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.22 Aligned_cols=178 Identities=27% Similarity=0.393 Sum_probs=150.7
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+|+..++||+|+||.||+|+. .+++.||+|++.+.. ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999995 458899999986532 2344678899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC-----
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT----- 468 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~----- 468 (601)
|+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999986654 56999999999999999999999999999999753311000
Q ss_pred ----------------------------------------ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHH
Q 007490 469 ----------------------------------------QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508 (601)
Q Consensus 469 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 508 (601)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0001234689999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 007490 509 ITGKKNSSFY 518 (601)
Q Consensus 509 ltg~~p~~~~ 518 (601)
++|+.||...
T Consensus 242 ltG~~Pf~~~ 251 (382)
T cd05625 242 LVGQPPFLAQ 251 (382)
T ss_pred HhCCCCCCCC
Confidence 9999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=282.92 Aligned_cols=212 Identities=29% Similarity=0.472 Sum_probs=168.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
++.+++|++.+.||+|+||.||+|.+. .+..||||++.... .....++.+|+.+++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456788999999999999999998742 24679999986432 33456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc---------------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 409 DEKILVYEFVPNKSLDYFL---------------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l---------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
...++||||+++++|..++ ++|+.+++||||||+||++++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999998876432 5689999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE---------- 524 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~---------- 524 (601)
|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999876543222111222345778999999998899999999999999999999 67787543321110
Q ss_pred ----------cc---cCccCCCCCCCHHHHHHHHhc
Q 007490 525 ----------DL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 525 ----------~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
++ +...||.+|||+.|++++|++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 01 111799999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=281.18 Aligned_cols=208 Identities=26% Similarity=0.422 Sum_probs=166.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999753 35689999987653 3334678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++++|..++ ++|+.+++||||||+|||++.++.+|++|||.+........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~- 162 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI- 162 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-
Confidence 99999999987655 56999999999999999999999999999998765322111
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc-
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL- 527 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~- 527 (601)
.......++..|+|||.+.+..++.++||||||+++||+++ |+.||........ .+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11112234678999999999999999999999999999875 9999864332110 0111
Q ss_pred --CccCCCCCCCHHHHHHHHhc
Q 007490 528 --SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 --~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+||++.+|++.|+.
T Consensus 243 ~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 243 DCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHcCCCchhCCCHHHHHHHHHh
Confidence 12799999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=278.24 Aligned_cols=210 Identities=33% Similarity=0.507 Sum_probs=171.0
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+...++|++.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34567799999999999999999998778889999986543 33567889999999999999999999999999999999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|.+++ ++|+.+|+||||||+||++++++.+||+|||+++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 999999886554 569999999999999999999999999999999876522111
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc--
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL-- 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~-- 527 (601)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||......... +++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 1111223457999999998899999999999999999999 88888543321100 000
Q ss_pred -CccCCCCCCCHHHHHHHHhc
Q 007490 528 -SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 -~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+||++.++++.|++
T Consensus 240 ~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 240 CWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HhhcCcccCCCHHHHHHHHhc
Confidence 01799999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.82 Aligned_cols=178 Identities=28% Similarity=0.402 Sum_probs=153.7
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC--CceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH--GQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...++|++.+.||+|+||.||+|++.. +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 345678999999999999999998543 368999998643 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 9999999999987665 569999999999999999999999999999999865321
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 234578999999999998889999999999999999999999986543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.75 Aligned_cols=212 Identities=25% Similarity=0.335 Sum_probs=171.2
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
.+.+...++|++.+.||+|+||+||+++. .+|+.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34456678999999999999999999984 46899999998654 3344567889999999999999999988775432
Q ss_pred --------eeEEEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEE
Q 007490 410 --------EKILVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 410 --------~~~lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
..++||||+++|+|..++ |+|+.+|+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 367999999999986543 569999999999999999999999999
Q ss_pred eecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------
Q 007490 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------- 523 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------- 523 (601)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999876543322333456799999999999999999999999999999999999999864332110
Q ss_pred ---------ccc---cCccCCCCCCCHHHHHHH
Q 007490 524 ---------EDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 ---------~~l---~~~~dP~~RPt~~evl~~ 544 (601)
.++ +...||.+||++.+++..
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 001 112799999999998764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.04 Aligned_cols=180 Identities=26% Similarity=0.385 Sum_probs=151.5
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999995 458899999986532 223456889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC----
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT---- 468 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---- 468 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999987654 56999999999999999999999999999999753311000
Q ss_pred -------------------------------------ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhC
Q 007490 469 -------------------------------------QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG 511 (601)
Q Consensus 469 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 511 (601)
........||+.|||||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 0001234799999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 007490 512 KKNSSFYQ 519 (601)
Q Consensus 512 ~~p~~~~~ 519 (601)
+.||....
T Consensus 241 ~~Pf~~~~ 248 (376)
T cd05598 241 QPPFLADT 248 (376)
T ss_pred CCCCCCCC
Confidence 99986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=280.46 Aligned_cols=210 Identities=35% Similarity=0.539 Sum_probs=175.4
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+....+|++.++||.|+||.||+|...+++.+++|.+..........+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 35567799999999999999999998789999999998776656678899999999999999999999999999999999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999887654 569999999999999999999999999999999765432211
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------c---c
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------D---L 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~---l 526 (601)
.....++..|++||.+.+..++.++||||||+++|+|++ |+.||......... + .
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 113345678999999988899999999999999999998 88888653322110 0 0
Q ss_pred cCccCCCCCCCHHHHHHHHhc
Q 007490 527 LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~L~~ 547 (601)
+...||.+|||+.++++.|++
T Consensus 240 ~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 240 CWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HcCCCchhCcCHHHHHHHHhc
Confidence 112799999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=283.80 Aligned_cols=177 Identities=26% Similarity=0.377 Sum_probs=151.3
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999965 57889999986542 2334677899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|++++++..+. ++|+.+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYT 159 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cccc
Confidence 99987654332 66999999999999999999999999999999987543221 1223
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 35689999999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=282.71 Aligned_cols=175 Identities=29% Similarity=0.433 Sum_probs=147.0
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.++||.|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999854 68899999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~ 161 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYS 161 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cccc
Confidence 985 554432 6699999999999999999999999999999997643221 1223
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3467899999998865 5689999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=288.65 Aligned_cols=197 Identities=26% Similarity=0.338 Sum_probs=161.3
Q ss_pred CcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+++. .+++.||+|++.+. .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999999754 2334467788999999999999999999999999999999999999
Q ss_pred Cccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 422 SLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 422 sL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCC
Confidence 986543 6799999999999999999999999999999987532211 122345789
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------ccc---CccCCCCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DLL---SYEDPADRP 536 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l~---~~~dP~~RP 536 (601)
+.|+|||++.+..++.++|||||||++|||++|+.||......... +++ ...||.+||
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999999999999999999999999999999998653322111 111 127999997
Q ss_pred -----CHHHHHHH
Q 007490 537 -----SMATIVLA 544 (601)
Q Consensus 537 -----t~~evl~~ 544 (601)
++.|+++.
T Consensus 239 ~~~~~~~~~il~h 251 (328)
T cd05593 239 GGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHhcC
Confidence 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=276.81 Aligned_cols=205 Identities=31% Similarity=0.451 Sum_probs=166.6
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
++|++.+.||+|+||.||++++.++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999998788899999886432 334678899999999999999999999999999999999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|.+++ ++|+.+|+||||||+||+++.++.+||+|||.++........ .....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~ 161 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGA 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCC
Confidence 99887654 569999999999999999999999999999998765322211 11222
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc-----------------------cCccC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL-----------------------LSYED 531 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l-----------------------~~~~d 531 (601)
.++..|+|||++.+..++.++||||||+++|||++ |+.||........... +...+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEK 241 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 35568999999988889999999999999999999 8888864432211100 01169
Q ss_pred CCCCCCHHHHHHHHh
Q 007490 532 PADRPSMATIVLALN 546 (601)
Q Consensus 532 P~~RPt~~evl~~L~ 546 (601)
|.+||++.++++.|.
T Consensus 242 p~~Rps~~~l~~~l~ 256 (256)
T cd05114 242 PEGRPTFAELLRAIT 256 (256)
T ss_pred cccCcCHHHHHHhhC
Confidence 999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.07 Aligned_cols=179 Identities=28% Similarity=0.405 Sum_probs=152.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999954 58899999996532 233456788999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc--
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-- 470 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-- 470 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999987654 5699999999999999999999999999999987653211100
Q ss_pred ----------------------------------ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 471 ----------------------------------NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 471 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112468999999999999999999999999999999999999986
Q ss_pred CC
Q 007490 517 FY 518 (601)
Q Consensus 517 ~~ 518 (601)
..
T Consensus 241 ~~ 242 (364)
T cd05599 241 SD 242 (364)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.22 Aligned_cols=177 Identities=28% Similarity=0.387 Sum_probs=152.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
...++|++.++||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34578999999999999999999965 5788999988654 333456789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++++|.+++ |+|+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 9999999997765 5586 47999999999999999999999999998754321
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234688999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=288.17 Aligned_cols=196 Identities=24% Similarity=0.309 Sum_probs=159.9
Q ss_pred CcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+++. .+|+.||+|++... .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998653 2234456778999999999999999999999999999999999999
Q ss_pred Cccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 422 SLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 422 sL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
+|..++ |+|+.+|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCC
Confidence 986544 6799999999999999999999999999999987532211 122345789
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------c---ccCccCCCCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------D---LLSYEDPADRP 536 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~---l~~~~dP~~RP 536 (601)
+.|+|||++.+..++.++|||||||++|||++|+.||......... + .+...||.+||
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 9999999999999999999999999999999999998654322111 1 11127999998
Q ss_pred -----CHHHHHH
Q 007490 537 -----SMATIVL 543 (601)
Q Consensus 537 -----t~~evl~ 543 (601)
++.++++
T Consensus 239 ~~~~~~~~~~l~ 250 (323)
T cd05595 239 GGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHc
Confidence 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=286.23 Aligned_cols=209 Identities=29% Similarity=0.525 Sum_probs=167.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCc----eeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQ----EIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..+|+..+.||+|+||.||+|++. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457999999999999999999853 333 48999986543 34557788999999999999999999999864 578
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+++||+++|+|.+++ |+|+.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999886544 67999999999999999999999999999999987654332
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc--------------------c
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL--------------------L 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l--------------------~ 527 (601)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||........... +
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 244 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 222222334678999999999999999999999999999998 9999865432211110 1
Q ss_pred ---CccCCCCCCCHHHHHHHHhcC
Q 007490 528 ---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~~L~~~ 548 (601)
...+|.+||++.+++..|...
T Consensus 245 ~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 245 VKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 116999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=283.46 Aligned_cols=176 Identities=30% Similarity=0.424 Sum_probs=146.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999964 688999999865432 233467789999999999999999999999999999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 160 (303)
T cd07869 84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTY 160 (303)
T ss_pred CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccC
Confidence 9975 332221 6799999999999999999999999999999997543221 122
Q ss_pred ccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 33467899999998865 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=287.97 Aligned_cols=169 Identities=27% Similarity=0.355 Sum_probs=145.9
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5789999998653 233456678899999999999999999999999999999999999998
Q ss_pred cccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 424 DYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 424 ~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcc
Confidence 6654 5699999999999999999999999999999997542221 12334578999
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 99999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=280.86 Aligned_cols=210 Identities=30% Similarity=0.484 Sum_probs=170.1
Q ss_pred cCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999742 24568999987666666678999999999999999999999999999999
Q ss_pred EEEeccCCCCccccc------------------------------------ccccceeeccccccCcEEEccCCCcEEee
Q 007490 413 LVYEFVPNKSLDYFL------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISD 456 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~D 456 (601)
+||||+++++|..++ ++|+.+++||||||+||++++++.+||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 999999999886443 45999999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc------------
Q 007490 457 FGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA------------ 523 (601)
Q Consensus 457 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~------------ 523 (601)
||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 243 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 243 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999986543222222223345778999999998899999999999999999998 8888754322110
Q ss_pred --------cccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 524 --------EDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 --------~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+++ ...||.+|||+.++++.|+..
T Consensus 244 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 244 PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0011 117999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.20 Aligned_cols=179 Identities=28% Similarity=0.383 Sum_probs=151.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.++||+|+||.||+++. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 468899999986532 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc---
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--- 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--- 469 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999987654 679999999999999999999999999999999643210000
Q ss_pred ---------c---------------------------------ccccccccccccCcccccCCCCCchhhHHhHHHHHHH
Q 007490 470 ---------G---------------------------------NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALE 507 (601)
Q Consensus 470 ---------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 507 (601)
. ......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0012468999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 007490 508 TITGKKNSSFY 518 (601)
Q Consensus 508 lltg~~p~~~~ 518 (601)
|++|+.||...
T Consensus 241 lltG~~Pf~~~ 251 (377)
T cd05629 241 CLIGWPPFCSE 251 (377)
T ss_pred hhcCCCCCCCC
Confidence 99999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.14 Aligned_cols=185 Identities=25% Similarity=0.340 Sum_probs=155.8
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
..+....++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344556678999999999999999999964 5788999998642 223345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 409 DEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
+..++||||+++|+|..++ ++|+.+|+||||||+|||+++++.+||+|||++......
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999987655 569999999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcccccCC----CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHG----QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 21 122345799999999998654 3788999999999999999999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.16 Aligned_cols=216 Identities=28% Similarity=0.405 Sum_probs=172.5
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcC-CCCccceEEE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGF 404 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 404 (601)
..++...++|++.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 345667889999999999999999999842 13469999997543 334567899999999996 9999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc---------------------------------------------------------
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL--------------------------------------------------------- 427 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l--------------------------------------------------------- 427 (601)
+.+.+..+|||||+++|+|.+++
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999998875432
Q ss_pred --------------------------------------------------------------ccccceeeccccccCcEE
Q 007490 428 --------------------------------------------------------------YDSQLRIIHRDLKASNIL 445 (601)
Q Consensus 428 --------------------------------------------------------------~~h~~~iiHrdlkp~NIl 445 (601)
++|+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 568899999999999999
Q ss_pred EccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc--
Q 007490 446 LDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG-- 522 (601)
Q Consensus 446 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~-- 522 (601)
++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999986543322222223456788999999999999999999999999999997 888875432111
Q ss_pred -------------------ccccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 523 -------------------AEDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 523 -------------------~~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
..+++ ...||.+||++.+|.++|+..
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 01111 117999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.01 Aligned_cols=208 Identities=33% Similarity=0.485 Sum_probs=167.8
Q ss_pred CCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
++|++.+.||+|+||.||+|++ .+++.|++|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999983 246789999987543 3344678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc----------------------------------------ccccceeeccccccCcEEEccCCCcE
Q 007490 414 VYEFVPNKSLDYFL----------------------------------------YDSQLRIIHRDLKASNILLDVQMNPK 453 (601)
Q Consensus 414 v~E~~~~gsL~~~l----------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~k 453 (601)
||||+++++|..++ ++|+++|+||||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999998876543 45999999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------
Q 007490 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE-------- 524 (601)
Q Consensus 454 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~-------- 524 (601)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999986543322222233445678999999988889999999999999999998 88887543221100
Q ss_pred ------------c---ccCccCCCCCCCHHHHHHHHhc
Q 007490 525 ------------D---LLSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 525 ------------~---l~~~~dP~~RPt~~evl~~L~~ 547 (601)
+ .+...||.+||++.+|.++|..
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 1112799999999999998854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=292.97 Aligned_cols=183 Identities=26% Similarity=0.339 Sum_probs=154.2
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
.+...++|++.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445678999999999999999999954 5889999998643 22334557889999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
.++||||+++|+|..++ |+|+.+|+||||||+|||++.++.+||+|||++........
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999987654 67999999999999999999999999999999987543221
Q ss_pred ccccccccccccccCcccccCC----CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHG----QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 198 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred -ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 122345799999999998653 4789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=290.70 Aligned_cols=203 Identities=28% Similarity=0.363 Sum_probs=165.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999954 68899999987542 234566889999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence 999999987654 569999999999999999999999999999999876433221 2
Q ss_pred cccccccccccCccccc------CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------
Q 007490 472 TSRIVGTYGYMSPEYAM------HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------- 522 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------- 522 (601)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 22346899999999986 4567899999999999999999999985432110
Q ss_pred cccc---cCccCCCCCCCHHHHHHH
Q 007490 523 AEDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 523 ~~~l---~~~~dP~~RPt~~evl~~ 544 (601)
..++ +. .+|.+||++.+++..
T Consensus 240 ~~~li~~ll-~~p~~R~t~~~l~~h 263 (330)
T cd05601 240 FLDLIQSLL-CGQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHc-cChhhCCCHHHHhCC
Confidence 0011 11 499999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=285.44 Aligned_cols=198 Identities=30% Similarity=0.405 Sum_probs=160.0
Q ss_pred CCcccccCcceEEeeec----CCCceeeEEEeccCC----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 345 DNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.+.||+|+||.||+++. ..++.||||++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999984 357889999986532 2334567889999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cccc
Confidence 99999886543 5699999999999999999999999999999987542221 1223
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-------------------cccc---cCccC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-------------------AEDL---LSYED 531 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-------------------~~~l---~~~~d 531 (601)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..++ +...|
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4578999999999998889999999999999999999999986533211 0111 11279
Q ss_pred CCCCC-----CHHHHHHH
Q 007490 532 PADRP-----SMATIVLA 544 (601)
Q Consensus 532 P~~RP-----t~~evl~~ 544 (601)
|.+|| ++.++++.
T Consensus 239 p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HhHcCCCCCCCHHHHhcC
Confidence 99999 78877653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=280.35 Aligned_cols=211 Identities=29% Similarity=0.470 Sum_probs=171.4
Q ss_pred cCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 346788899999999999999742 34568999987766666678999999999999999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcE
Q 007490 413 LVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPK 453 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~k 453 (601)
+||||+++++|.+++ ++|+++|+||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999998876543 45899999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc---------
Q 007490 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------- 523 (601)
Q Consensus 454 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------- 523 (601)
|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 243 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence 999999976543322222233456788999999999999999999999999999999 9998754322110
Q ss_pred -----------ccc---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 524 -----------EDL---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 524 -----------~~l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
.++ +...+|.+||++.+|+++|+...
T Consensus 244 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 244 LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 001 11179999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=272.09 Aligned_cols=201 Identities=31% Similarity=0.463 Sum_probs=160.8
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999964 68899999876543 34456789999999999999999999999999999999999999988
Q ss_pred cccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccc
Q 007490 424 DYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY 479 (601)
Q Consensus 424 ~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 479 (601)
..++ ++|+.+|+||||||+||+++.++.+||+|||++.................+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 7654 5699999999999999999999999999999987543221111111112345
Q ss_pred cccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc---CccCCCCC
Q 007490 480 GYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL---SYEDPADR 535 (601)
Q Consensus 480 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~---~~~dP~~R 535 (601)
.|+|||.+.++.++.++||||||+++|||++ |..|+........ .+++ ...+|.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQR 240 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhC
Confidence 7999999999999999999999999999998 8888754322111 0111 11799999
Q ss_pred CCHHHHHHHHh
Q 007490 536 PSMATIVLALN 546 (601)
Q Consensus 536 Pt~~evl~~L~ 546 (601)
|++.+++++|+
T Consensus 241 ps~~~~~~~l~ 251 (252)
T cd05084 241 PSFSTVHQELQ 251 (252)
T ss_pred cCHHHHHHHHh
Confidence 99999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=274.72 Aligned_cols=209 Identities=30% Similarity=0.493 Sum_probs=169.0
Q ss_pred cCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.+.||+|+||.||+|++.. ...||||.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578899999999999999998643 3579999886543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+|||+++++|..++ ++|+.+|+||||||+||++++++.++|+|||+++........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999987654 569999999999999999999999999999999876422221
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc-
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL- 527 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~- 527 (601)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||........ .+++
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLML 242 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 11222344678999999998999999999999999999998 9888754322111 1111
Q ss_pred --CccCCCCCCCHHHHHHHHhc
Q 007490 528 --SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 --~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+||++.||+++|+.
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 243 DCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred HHcCCCcccCcCHHHHHHHHHh
Confidence 11799999999999999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=277.17 Aligned_cols=209 Identities=29% Similarity=0.433 Sum_probs=166.0
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCc----eeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQ----EIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|++.+.||+|+||.||+|++. +++ ++++|.+.... .....++..|+..+++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 356888899999999999999853 344 47788875433 2334677888989999999999999998754 5578
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+++||+++++|.+++ ++|+.+++||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999987665 56999999999999999999999999999999987643332
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc---------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL--------------------- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l--------------------- 526 (601)
........++..|+|||.+.++.++.++||||||+++|||++ |+.||.........++
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHH
Confidence 222333456778999999998999999999999999999998 9988865432211111
Q ss_pred --cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 --LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...||.+|||+.|+++.|...
T Consensus 245 ~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 245 VKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred HHHcCCCcccCcCHHHHHHHHHHH
Confidence 1117999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=275.04 Aligned_cols=209 Identities=33% Similarity=0.500 Sum_probs=168.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+...+|+..++||+|++|.||+|.+. .++.|++|++... ......+.+|++++++++||||+++++++..++..+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 34456888899999999999999964 4888999998654 334567889999999999999999999999999999999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|.+++ ++|+.+++||||||+||++++++.+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999887654 569999999999999999999999999999999865432211
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------------------cc--
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--------------------LL-- 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--------------------l~-- 527 (601)
.......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.... ++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1112234568999999999999999999999999999998 888875432211100 11
Q ss_pred -CccCCCCCCCHHHHHHHHhc
Q 007490 528 -SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 -~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.+++++|+.
T Consensus 241 cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HccCCcccCCCHHHHHHHHHh
Confidence 11699999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=279.33 Aligned_cols=202 Identities=41% Similarity=0.634 Sum_probs=159.1
Q ss_pred cCCcccccCcceEEeeecC-----CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 344 SDNKLGRGGFGEVYKGVLP-----HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+.+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999975 2678999999654 334578899999999999999999999999988889999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++|+|.+++ |+|+.+++|+||+++||++++++.+||+|||++............
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999997765 668999999999999999999999999999999876322222223
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccC-----------------------
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS----------------------- 528 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~----------------------- 528 (601)
........|+|||.+....++.++||||||+++|||++ |+.|+...........+.
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~ 242 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCW 242 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHc
Confidence 33456778999999999999999999999999999999 678876543322111111
Q ss_pred ccCCCCCCCHHHHHHHH
Q 007490 529 YEDPADRPSMATIVLAL 545 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~L 545 (601)
..||.+||++.+|++.|
T Consensus 243 ~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 243 SHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SSGGGS--HHHHHHHH
T ss_pred CCChhhCcCHHHHHhcC
Confidence 17999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=290.07 Aligned_cols=170 Identities=22% Similarity=0.278 Sum_probs=144.2
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
...+|++.++||+|+||.||+++. .+++.||+|.... ..+.+|++++++|+||||+++++++..+...++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 456799999999999999999995 4588999997532 346789999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
++.+ +|..++ |+|+.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 164 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~ 241 (391)
T PHA03212 164 RYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYY 241 (391)
T ss_pred cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccc
Confidence 9864 443322 6799999999999999999999999999999997532211 12233
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 457999999999999999999999999999999999999775
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=286.49 Aligned_cols=176 Identities=27% Similarity=0.434 Sum_probs=144.3
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----eeE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-----EKI 412 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 412 (601)
+|++.++||+|+||.||+|+. .+++.||||++... .......+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578889999999999999995 46899999998643 2233456889999999999999999999886432 479
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||++ ++|..++ |+|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999996 4554433 679999999999999999999999999999999764322111
Q ss_pred -cccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 -GNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 11234578999999999865 6789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=272.84 Aligned_cols=184 Identities=26% Similarity=0.338 Sum_probs=156.3
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..-++|+++++||.|.-|+||++++.+ +..+|+|++.+.. .+...+.+.|-+||+.++||.++.|+..++.++..+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 344567888999999999999999754 5889999998753 334556788999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC--
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV-- 465 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~-- 465 (601)
++||||+||+|..+. |+|-.|||+|||||+||||.++|++.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999997654 78999999999999999999999999999998753210
Q ss_pred -------------------------------C-C--------------------CccccccccccccccCcccccCCCCC
Q 007490 466 -------------------------------D-Q--------------------TQGNTSRIVGTYGYMSPEYAMHGQFS 493 (601)
Q Consensus 466 -------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 493 (601)
. . .......++||..|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 00113357899999999999999999
Q ss_pred chhhHHhHHHHHHHHHhCCCCCCCCCC
Q 007490 494 VKSDVYSFGVLALETITGKKNSSFYQT 520 (601)
Q Consensus 494 ~~sDvwSlGvvl~elltg~~p~~~~~~ 520 (601)
.++|+|+|||++|||+.|+.||.....
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 999999999999999999999976543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-33 Score=285.46 Aligned_cols=176 Identities=28% Similarity=0.375 Sum_probs=146.9
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHH---HHcCCCCccceEEEEEeCCeeEEE
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLV---AKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999854 58999999987532 23345566776665 456899999999999999999999
Q ss_pred EeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 415 YEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 415 ~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcc
Confidence 9999999886543 679999999999999999999999999999998753221 1223
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 34578999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=292.06 Aligned_cols=205 Identities=28% Similarity=0.401 Sum_probs=168.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999964 68999999987532 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC-----
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ----- 467 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~----- 467 (601)
||+++++|..++ ++|+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999887654 5699999999999999999999999999999998654332
Q ss_pred ----------------------CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--
Q 007490 468 ----------------------TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-- 523 (601)
Q Consensus 468 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-- 523 (601)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 00112345689999999999999999999999999999999999999865432110
Q ss_pred ---------------------ccccCc--cCCCCCCC-HHHHHHH
Q 007490 524 ---------------------EDLLSY--EDPADRPS-MATIVLA 544 (601)
Q Consensus 524 ---------------------~~l~~~--~dP~~RPt-~~evl~~ 544 (601)
.+++.. .||.+||+ +.++++.
T Consensus 241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h 285 (350)
T cd05573 241 KIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH 285 (350)
T ss_pred HHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence 000000 48999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=279.37 Aligned_cols=207 Identities=31% Similarity=0.480 Sum_probs=165.9
Q ss_pred CCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34777899999999999999853 257899999975433 33467889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcE
Q 007490 413 LVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPK 453 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~k 453 (601)
+++||+++++|..++ ++|+.+|+||||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 999999888765442 55999999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc------
Q 007490 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL------ 526 (601)
Q Consensus 454 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l------ 526 (601)
|+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..||......+..+.
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999886543322222223345778999999988899999999999999999998 7778754332211111
Q ss_pred -----------------cCccCCCCCCCHHHHHHHHh
Q 007490 527 -----------------LSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 527 -----------------~~~~dP~~RPt~~evl~~L~ 546 (601)
+...+|.+||++.+|++.|+
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11179999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=282.94 Aligned_cols=171 Identities=29% Similarity=0.382 Sum_probs=142.4
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHH-HHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVV-LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||+||+++.. +|+.||||++.... ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 222334445544 56789999999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccC
Confidence 9986544 679999999999999999999999999999998753221 122334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 99999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=283.86 Aligned_cols=206 Identities=29% Similarity=0.367 Sum_probs=174.6
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChh---hHHHHHHHHHHHHHcC-CCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQ---GAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 410 (601)
......|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+++.+++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3456678899999999999999999654 999999999776443 3468899999999998 9999999999999999
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccC----CCcEEeecccceecC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQ----MNPKISDFGLARIFG 464 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~----~~~kL~Dfg~a~~~~ 464 (601)
.++|||++.||.|.+.+ ++|+.||+||||||+|+|+... +.+|++|||++....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999886544 6799999999999999999643 479999999999876
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc-----------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL----------------- 527 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~----------------- 527 (601)
. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 4 33456689999999999999999999999999999999999999999765532211111
Q ss_pred ---------CccCCCCCCCHHHHHHH
Q 007490 528 ---------SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 ---------~~~dP~~RPt~~evl~~ 544 (601)
...||.+|+|+.++++.
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11799999999999884
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=273.35 Aligned_cols=205 Identities=31% Similarity=0.460 Sum_probs=166.7
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
++|++.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999998677789999886443 234678999999999999999999999999889999999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|.+++ ++|+.+++|+||||+||+++.++.+||+|||.++........ .....
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~ 161 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGS 161 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCC
Confidence 98877654 569999999999999999999999999999999865432211 11123
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------cc---cCccC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DL---LSYED 531 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l---~~~~d 531 (601)
.++..|++||++.+..++.++||||||+++|||++ |+.||......... ++ +...+
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 45678999999988889999999999999999998 99888654321110 00 11179
Q ss_pred CCCCCCHHHHHHHHh
Q 007490 532 PADRPSMATIVLALN 546 (601)
Q Consensus 532 P~~RPt~~evl~~L~ 546 (601)
|.+||++.+|+..|+
T Consensus 242 p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 242 AEERPTFQQLLSSIE 256 (256)
T ss_pred cccCCCHHHHHHhhC
Confidence 999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=289.75 Aligned_cols=186 Identities=25% Similarity=0.329 Sum_probs=156.8
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
+..++...++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999964 5788999998642 22334567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 408 GDEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
++..++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999999999987654 66999999999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcccccCC----CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHG----QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 221 122345799999999998654 3789999999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=277.72 Aligned_cols=213 Identities=29% Similarity=0.457 Sum_probs=169.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
++..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456788999999999999999999743 24579999886543 23345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc---------------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 409 DEKILVYEFVPNKSLDYFL---------------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l---------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
+..++||||+++++|..++ ++|+++|+||||||+||++++++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999998886554 4589999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA----------- 523 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~----------- 523 (601)
|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.....++.
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999986533222111222345678999999998899999999999999999998 6777753221111
Q ss_pred ---------cccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 524 ---------EDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ---------~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+++ ...||.+|||+.++++.|++.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0111 117999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=272.89 Aligned_cols=206 Identities=28% Similarity=0.449 Sum_probs=163.6
Q ss_pred CCcCCcccccCcceEEeeecCC----CceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe-----
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE----- 410 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 410 (601)
|.+.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998542 367999998754 23345678999999999999999999998876554
Q ss_pred -eEEEEeccCCCCccccc-----------------------------ccccceeeccccccCcEEEccCCCcEEeecccc
Q 007490 411 -KILVYEFVPNKSLDYFL-----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 411 -~~lv~E~~~~gsL~~~l-----------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
.++++||+++++|..++ ++|+.+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 78999999999885443 569999999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc---------------
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------- 524 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------- 524 (601)
+...............++..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 87643322222222334678999999988899999999999999999999 88887543321111
Q ss_pred -----cc---cCccCCCCCCCHHHHHHHHhc
Q 007490 525 -----DL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 525 -----~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
++ +...||.+||++.|+++.|+.
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 111799999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=277.84 Aligned_cols=209 Identities=30% Similarity=0.463 Sum_probs=165.1
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC---------------CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccce
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH---------------GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRL 401 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l 401 (601)
..++|++.++||+|+||.||+++... ...||+|.+... .......+.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45689999999999999999987532 224899998754 33345678999999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCCccccc-----------------------------------ccccceeeccccccCcEEE
Q 007490 402 LGFCLEGDEKILVYEFVPNKSLDYFL-----------------------------------YDSQLRIIHRDLKASNILL 446 (601)
Q Consensus 402 ~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------------------------~~h~~~iiHrdlkp~NIll 446 (601)
++++...+..++||||+++++|..++ ++|+.+++||||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999998875432 4699999999999999999
Q ss_pred ccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCCCcc-
Q 007490 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT--GKKNSSFYQTDGA- 523 (601)
Q Consensus 447 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~- 523 (601)
+.++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++ +..||........
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 9999999999999976533222112222345678999999998899999999999999999998 4556643221110
Q ss_pred --------------------------ccc---cCccCCCCCCCHHHHHHHHh
Q 007490 524 --------------------------EDL---LSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 524 --------------------------~~l---~~~~dP~~RPt~~evl~~L~ 546 (601)
.++ +...||.+||++.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 011 11179999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=278.68 Aligned_cols=171 Identities=28% Similarity=0.401 Sum_probs=143.4
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 57889999986532 22334556677777654 899999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccC
Confidence 9986554 6799999999999999999999999999999997643222 22334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=275.00 Aligned_cols=208 Identities=30% Similarity=0.487 Sum_probs=168.1
Q ss_pred cCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|+..++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999632 35678999987766666778999999999999999999999999999999
Q ss_pred EEEeccCCCCccccc--------------------------------------ccccceeeccccccCcEEEccCCCcEE
Q 007490 413 LVYEFVPNKSLDYFL--------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 413 lv~E~~~~gsL~~~l--------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
++|||+++++|..++ ++|+.+|+||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 999999998875432 568999999999999999999999999
Q ss_pred eecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc-----------
Q 007490 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG----------- 522 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~----------- 522 (601)
+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC
Confidence 99999976543222112223345678999999999999999999999999999998 888874422110
Q ss_pred ---------ccccc---CccCCCCCCCHHHHHHHHh
Q 007490 523 ---------AEDLL---SYEDPADRPSMATIVLALN 546 (601)
Q Consensus 523 ---------~~~l~---~~~dP~~RPt~~evl~~L~ 546 (601)
..+++ ...||.+||++.||++.|+
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 244 ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00111 1279999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=283.69 Aligned_cols=171 Identities=27% Similarity=0.377 Sum_probs=142.6
Q ss_pred CcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHH-HHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVV-LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++. .+|+.||+|++.+.. ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999986532 223344555554 56779999999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.||+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccC
Confidence 9886544 679999999999999999999999999999998753211 112334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 99999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=284.89 Aligned_cols=176 Identities=27% Similarity=0.378 Sum_probs=148.5
Q ss_pred CCCcCCcccccCcceEEeeec----CCCceeeEEEeccC----ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRS----SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
+|++.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.+++++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999874 35789999998643 223345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999986654 66999999999999999999999999999999986533222
Q ss_pred ccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 122345789999999998765 478999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=283.33 Aligned_cols=172 Identities=27% Similarity=0.379 Sum_probs=145.7
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 4789999998653 223345677888988876 899999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||++....... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccccccc
Confidence 9986543 6699999999999999999999999999999987542221 12334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=282.73 Aligned_cols=213 Identities=30% Similarity=0.452 Sum_probs=168.1
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 406 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 406 (601)
|+...++|++.+.||+|+||.||+|+.. .++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4556678999999999999999999742 24789999986543 23345678899999999 8999999999886
Q ss_pred eC-CeeEEEEeccCCCCccccc----------------------------------------------------------
Q 007490 407 EG-DEKILVYEFVPNKSLDYFL---------------------------------------------------------- 427 (601)
Q Consensus 407 ~~-~~~~lv~E~~~~gsL~~~l---------------------------------------------------------- 427 (601)
.. ...+++|||+++++|..++
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5678999999998875432
Q ss_pred --------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccc
Q 007490 428 --------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481 (601)
Q Consensus 428 --------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 481 (601)
++|+.+|+||||||+|||++.++.+||+|||+++.+.............++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 458999999999999999999999999999999875433222222234556789
Q ss_pred cCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc-c--------------------cccc---CccCCCCCC
Q 007490 482 MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG-A--------------------EDLL---SYEDPADRP 536 (601)
Q Consensus 482 ~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~-~--------------------~~l~---~~~dP~~RP 536 (601)
+|||++.+..++.++|||||||++|||++ |+.||....... . .+++ ...+|++||
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999998 999986432211 0 0111 126999999
Q ss_pred CHHHHHHHHhc
Q 007490 537 SMATIVLALNS 547 (601)
Q Consensus 537 t~~evl~~L~~ 547 (601)
++.||+++|+.
T Consensus 322 s~~ell~~l~~ 332 (337)
T cd05054 322 TFSELVEILGD 332 (337)
T ss_pred CHHHHHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=271.77 Aligned_cols=206 Identities=25% Similarity=0.413 Sum_probs=166.5
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 345799999999999999999995 4688999999876555555678899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~ 164 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRK 164 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cccC
Confidence 99999987654 5699999999999999999999999999999998664221 1122
Q ss_pred cccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc------------------------ccc
Q 007490 474 RIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA------------------------EDL 526 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~------------------------~~l 526 (601)
...++..|+|||.+. ...++.++||||||+++|||++|+.|+........ .++
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 346788999999874 34578899999999999999999998743221110 011
Q ss_pred c---CccCCCCCCCHHHHHHHH
Q 007490 527 L---SYEDPADRPSMATIVLAL 545 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L 545 (601)
+ ...+|.+||++.+|++.|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCC
Confidence 1 116899999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-33 Score=290.87 Aligned_cols=180 Identities=28% Similarity=0.391 Sum_probs=152.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|+..+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999854 5889999998643 2334567888999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc---
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--- 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--- 469 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999987655 569999999999999999999999999999998754321100
Q ss_pred ------------------------------cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 470 ------------------------------GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 470 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00123479999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=271.70 Aligned_cols=208 Identities=31% Similarity=0.505 Sum_probs=167.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+..++|++.++||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++||||+++++.+. .+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 44567999999999999999999987777899999875332 3467899999999999999999999875 456899999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|..++ ++|+.+|+||||||+||++++++.+||+|||.++.+...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 99999886554 459999999999999999999999999999999866433211 1
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc---
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL--- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~--- 527 (601)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......... +++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 239 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 122345678999999988899999999999999999999 78787543221110 011
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+||++.++++.|+.
T Consensus 240 l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 240 WRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ccCCcccCCCHHHHHHHHHH
Confidence 11799999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=285.42 Aligned_cols=197 Identities=25% Similarity=0.325 Sum_probs=160.3
Q ss_pred CcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+++. .+|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999998753 2233456788999999999999999999999999999999999999
Q ss_pred Cccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 422 SLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 422 sL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
+|..++ |+|+ .+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccC
Confidence 886544 6696 799999999999999999999999999987532211 12234578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-------------------c---cCccCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-------------------L---LSYEDPADR 535 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-------------------l---~~~~dP~~R 535 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||.....+.... + +...||.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 999999999999999999999999999999999999986543221111 1 112799999
Q ss_pred C-----CHHHHHHH
Q 007490 536 P-----SMATIVLA 544 (601)
Q Consensus 536 P-----t~~evl~~ 544 (601)
+ ++.++++.
T Consensus 239 ~~~~~~~~~~il~h 252 (325)
T cd05594 239 LGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHhcC
Confidence 6 89988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-33 Score=273.74 Aligned_cols=172 Identities=28% Similarity=0.436 Sum_probs=140.2
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe-----eEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE-----KILV 414 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----~~lv 414 (601)
.|...+++|.|+||.||+|.. ..+++||||+...+... -.+|+++|+.++|||||+++-+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466778999999999999995 45789999998654332 2469999999999999999998874332 3489
Q ss_pred EeccCCCCc--------------------------ccccccccceeeccccccCcEEEccC-CCcEEeecccceecCCCC
Q 007490 415 YEFVPNKSL--------------------------DYFLYDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 415 ~E~~~~gsL--------------------------~~~l~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 467 (601)
|||||.... +.+.|+|+.+|.||||||.|+|+|.+ |.+||+|||.|+.+..++
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 999986211 11227899999999999999999976 899999999999886544
Q ss_pred CccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.. .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|....
T Consensus 181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 32 34567889999999987 469999999999999999999998887644
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=275.35 Aligned_cols=212 Identities=29% Similarity=0.466 Sum_probs=170.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
++..++|++.+.||+|+||.||+|...+ +..|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3456788999999999999999998542 3689999986543 33456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc---------------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 409 DEKILVYEFVPNKSLDYFL---------------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l---------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
...++||||+++++|..++ ++|+.+|+||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 9999999999998886543 5599999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE---------- 524 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~---------- 524 (601)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999976543322222223456788999999988889999999999999999998 88887543311100
Q ss_pred ----------cc---cCccCCCCCCCHHHHHHHHhc
Q 007490 525 ----------DL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 525 ----------~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
++ +...+|.+|||+.++++.|++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11 112799999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=270.85 Aligned_cols=204 Identities=32% Similarity=0.468 Sum_probs=165.1
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
.+|++.+.||+|+||.||++.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45788899999999999999987777899999864332 34568889999999999999999999999999999999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|.+++ ++|+.+|+||||||+||+++.++.+||+|||+++........ .....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 161 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGT 161 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCC
Confidence 99887654 569999999999999999999999999999999765422111 11112
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc---CccC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL---SYED 531 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~---~~~d 531 (601)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||......... +++ ...+
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 33457999999998999999999999999999999 78888644322111 111 1169
Q ss_pred CCCCCCHHHHHHHH
Q 007490 532 PADRPSMATIVLAL 545 (601)
Q Consensus 532 P~~RPt~~evl~~L 545 (601)
|.+|||+.|+++.|
T Consensus 242 p~~Rpt~~~~l~~l 255 (256)
T cd05059 242 PEDRPAFKKLLSQL 255 (256)
T ss_pred hhhCcCHHHHHHHh
Confidence 99999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=271.24 Aligned_cols=208 Identities=32% Similarity=0.508 Sum_probs=167.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+..++|++.++||+|+||.||++..+++..||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 44567899999999999999999987888999999865433 3467899999999999999999999875 456899999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|..++ ++|+.+|+||||||+||++++++.++|+|||++..+...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99998886654 569999999999999999999999999999999876432211 1
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc---
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL--- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~--- 527 (601)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......... +++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 112235668999999988889999999999999999999 88888543321111 111
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+|||+.++.+.|+.
T Consensus 240 l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 240 WKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cccCcccCcCHHHHHHHHhc
Confidence 11699999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=286.59 Aligned_cols=196 Identities=32% Similarity=0.490 Sum_probs=167.4
Q ss_pred cccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCccc
Q 007490 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDY 425 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~ 425 (601)
+||+|.||+||.|++.+ ...+|||.+........+.+.+||.+.++|+|.|||+++|.+.+++..-|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999655 55799999988877778889999999999999999999999999999999999999999988
Q ss_pred cc--------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCCCCCcccccccccc
Q 007490 426 FL--------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 426 ~l--------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
++ |+|++.|||||||-+||||+. .|.+||+|||-++.+. .-...+..+.||
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETFTGT 739 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc--cCCccccccccc
Confidence 77 789999999999999999974 7899999999998764 233456678899
Q ss_pred ccccCcccccCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc--------------cc-----------CccC
Q 007490 479 YGYMSPEYAMHG--QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED--------------LL-----------SYED 531 (601)
Q Consensus 479 ~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~--------------l~-----------~~~d 531 (601)
..|||||++..+ .|+.++|||||||++.||.||++||.........- -+ ..+|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd 819 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPD 819 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCC
Confidence 999999999876 48899999999999999999999996433221110 00 0179
Q ss_pred CCCCCCHHHHHHH
Q 007490 532 PADRPSMATIVLA 544 (601)
Q Consensus 532 P~~RPt~~evl~~ 544 (601)
|.+||++.++++.
T Consensus 820 ~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 820 PCDRPSAKDLLQD 832 (1226)
T ss_pred cccCccHHHhccC
Confidence 9999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=275.94 Aligned_cols=175 Identities=29% Similarity=0.474 Sum_probs=142.1
Q ss_pred CCCCcCCcccccCcceEEeeecC--CCceeeEEEeccCC--hhhHHHHHHHHHHHHHc---CCCCccceEEEEEe-----
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP--HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKL---QHRNLVRLLGFCLE----- 407 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~----- 407 (601)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999852 46789999886532 22234556777777766 69999999999863
Q ss_pred CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 408 GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
....++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 3458999999974 443322 67999999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.... .......|++.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 5432 2233457899999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=271.49 Aligned_cols=206 Identities=30% Similarity=0.469 Sum_probs=161.1
Q ss_pred CCcCCcccccCcceEEeeecCCC-c--eeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------Ce
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPHG-Q--EIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------DE 410 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 410 (601)
|.+.++||+|+||.||+|++.+. . .||+|.++.. .....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999996543 2 5899988654 344457788999999999999999999987532 24
Q ss_pred eEEEEeccCCCCccccc-----------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
.+++|||+++++|..++ ++|+.+|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999999875442 5699999999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-----------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA----------------- 523 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~----------------- 523 (601)
...............+++.|++||++.+..++.++||||||+++|||++ |+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 7643322111222345678999999999999999999999999999999 7888754322110
Q ss_pred ---ccc---cCccCCCCCCCHHHHHHHHhc
Q 007490 524 ---EDL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 ---~~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
.++ +...||.+|||+.+|++.|+.
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 001 111799999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=282.41 Aligned_cols=176 Identities=27% Similarity=0.340 Sum_probs=148.6
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCC-CccceEEEEEeCCeeEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHR-NLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~ 415 (601)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999954 4788999998653 223456678899999999765 5888999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|..++ |+|+.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--Cce
Confidence 999999986544 6799999999999999999999999999999987532111 123
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 3457899999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=274.38 Aligned_cols=209 Identities=33% Similarity=0.515 Sum_probs=166.0
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
..++|.+.+.||+|++|.||+|.+.. +..|++|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678999999999999999998643 5678999886543 3344568899999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc------------------------------ccccceeeccccccCcEEEccCC---CcEEeec
Q 007490 411 KILVYEFVPNKSLDYFL------------------------------YDSQLRIIHRDLKASNILLDVQM---NPKISDF 457 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------------~~h~~~iiHrdlkp~NIll~~~~---~~kL~Df 457 (601)
.++||||+++++|..++ ++|+.+++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 99999999999887643 56999999999999999998765 5899999
Q ss_pred ccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc-----------
Q 007490 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED----------- 525 (601)
Q Consensus 458 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~----------- 525 (601)
|+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.........+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 99986532221111112233568999999999999999999999999999997 888886533221111
Q ss_pred ---------c---cCccCCCCCCCHHHHHHHHh
Q 007490 526 ---------L---LSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 526 ---------l---~~~~dP~~RPt~~evl~~L~ 546 (601)
+ +...+|.+||++.+|++.|+
T Consensus 244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 11179999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=278.34 Aligned_cols=195 Identities=28% Similarity=0.380 Sum_probs=156.6
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.. +|+.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999964 58899999986532 22345567788888765 899999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCC
Confidence 9986544 6699999999999999999999999999999987532111 12334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------c---ccCccCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------D---LLSYEDPADR 535 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~---l~~~~dP~~R 535 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||......... + .+...||.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999999999999999999999999999999998654321110 1 1112799999
Q ss_pred CCHH-HHH
Q 007490 536 PSMA-TIV 542 (601)
Q Consensus 536 Pt~~-evl 542 (601)
|++. +++
T Consensus 239 ~~~~~~~~ 246 (316)
T cd05620 239 LGVVGNIR 246 (316)
T ss_pred CCChHHHH
Confidence 9985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=282.17 Aligned_cols=172 Identities=28% Similarity=0.389 Sum_probs=145.7
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.+ +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5889999998653 223345677888888877 699999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccccccc
Confidence 9986544 6699999999999999999999999999999987532211 12334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=277.64 Aligned_cols=214 Identities=29% Similarity=0.443 Sum_probs=170.8
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 406 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 406 (601)
++...++|+..+.||+|+||.||++.... ...+|+|.+... .......+.+|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 45666789999999999999999998532 367899998754 233446688999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEc
Q 007490 407 EGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLD 447 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~ 447 (601)
.++..+++|||+++++|..++ ++|+.+|+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999998876543 45999999999999999999
Q ss_pred cCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc---
Q 007490 448 VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--- 523 (601)
Q Consensus 448 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--- 523 (601)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987643322222222334678999999988899999999999999999997 8888754332111
Q ss_pred -----------------cccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 524 -----------------EDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 -----------------~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+++ ...||.+|||+.|+++.|++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111 117999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=280.63 Aligned_cols=178 Identities=28% Similarity=0.373 Sum_probs=150.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999954 5889999998642 2233456889999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|..++ ++|+++|+||||||+|||++.++.+||+|||++..+...... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-Q 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-c
Confidence 999999987655 569999999999999999999999999999999765432221 1
Q ss_pred cccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 223468999999999863 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=270.92 Aligned_cols=174 Identities=27% Similarity=0.409 Sum_probs=151.4
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|+..+.||+|+||.||+|+. .+++.||+|++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 46889999998654 334456788999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 418 VPNKSLDYFL-------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 418 ~~~gsL~~~l-------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
+++++|..+. ++|+.+|+|+||||+|||++.++.++|+|||++..+... ......++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~ 156 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGT 156 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCC
Confidence 9999886432 679999999999999999999999999999999765322 12335788
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 999999999998999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=274.16 Aligned_cols=175 Identities=33% Similarity=0.435 Sum_probs=150.3
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh---hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+|+..++||+|+||+||++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999995 3688999999865422 223457789999999999999999999999999999999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|..++ ++|+.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999986543 56999999999999999999999999999999987542221
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 22347899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-33 Score=283.61 Aligned_cols=214 Identities=33% Similarity=0.490 Sum_probs=183.6
Q ss_pred chhhhhhhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
...+|+....+....++||-|-||.||.|.|+. .-.||||.++.+ ....++|.+|..+|+.++|||+|+|+|+|..+.
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 446677777788888999999999999999865 567999999654 445688999999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 410 EKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
..|||+|||..|+|.+|| |+..+++|||||..+|+|+.++..+|++|||+++++.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999998887 5677899999999999999999999999999999986
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc--------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY-------------- 529 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~-------------- 529 (601)
.+....+. ...-...|.|||-+....++.|+|||+|||+||||.| |..||+.....+..+++..
T Consensus 417 gDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 417 GDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKV 495 (1157)
T ss_pred CCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHH
Confidence 55433222 2234678999999999999999999999999999998 7888877665555555554
Q ss_pred ---------cCCCCCCCHHHHHHHHh
Q 007490 530 ---------EDPADRPSMATIVLALN 546 (601)
Q Consensus 530 ---------~dP~~RPt~~evl~~L~ 546 (601)
.+|.+||+++||-+.++
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHHHHH
Confidence 69999999999988875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=284.10 Aligned_cols=177 Identities=28% Similarity=0.351 Sum_probs=147.8
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 409 (601)
..++|++.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999853 5899999998653 2334567789999999999999999999987543
Q ss_pred -eeEEEEeccCCCCccc--------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 410 -EKILVYEFVPNKSLDY--------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~--------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
..++||||++++.+.. +.++|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 176 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-- 176 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--
Confidence 4699999998753321 11679999999999999999999999999999999754322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 177 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 177 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred -ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 122335789999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=270.43 Aligned_cols=201 Identities=28% Similarity=0.408 Sum_probs=157.4
Q ss_pred CcccccCcceEEeeecCC---CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+|.+.+ +..+++|.+.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998533 4578999886543 233457889999999999999999999999999999999999999
Q ss_pred Cccccc----------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 422 SLDYFL----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 422 sL~~~l----------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+|.+++ ++|+.+++||||||+||+++.++++||+|||+++............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 986554 4589999999999999999999999999999997543222211222
Q ss_pred cccccccccCcccccCC-------CCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc---------------------
Q 007490 474 RIVGTYGYMSPEYAMHG-------QFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------- 524 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------- 524 (601)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||.........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 34567889999988642 35789999999999999996 99998643321110
Q ss_pred ----cccC--ccCCCCCCCHHHHHHHHh
Q 007490 525 ----DLLS--YEDPADRPSMATIVLALN 546 (601)
Q Consensus 525 ----~l~~--~~dP~~RPt~~evl~~L~ 546 (601)
+++. ..+|++|||+.||+..|+
T Consensus 241 ~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 0000 158999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=269.59 Aligned_cols=209 Identities=33% Similarity=0.497 Sum_probs=169.8
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 455678999999999999999999988899999999865443 3467889999999999999999999864 45789999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|.+++ ++|+.+++||||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 999999887654 569999999999999999999999999999999876422211
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc--
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL-- 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~-- 527 (601)
......++..|+|||++....++.++||||||+++|||++ |+.||........ .+++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1122345678999999998889999999999999999999 9999864332111 1111
Q ss_pred -CccCCCCCCCHHHHHHHHhc
Q 007490 528 -SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 -~~~dP~~RPt~~evl~~L~~ 547 (601)
...+|.+||++++++..|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 239 CWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HccCChhhCCCHHHHHHHhhc
Confidence 11799999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=286.51 Aligned_cols=214 Identities=27% Similarity=0.408 Sum_probs=171.7
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcC-CCCccceEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFC 405 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 405 (601)
+++...++|.+.++||+|+||.||+|++. .++.||||++.... ....+.+.+|++++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 36677778999999999999999999853 24679999997543 233457889999999997 99999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc----------------------------------------------------------
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL---------------------------------------------------------- 427 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l---------------------------------------------------------- 427 (601)
...+..++||||+++|+|.+++
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999885443
Q ss_pred ---------------------------------------------------------------ccccceeeccccccCcE
Q 007490 428 ---------------------------------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 428 ---------------------------------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
|+|+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 45889999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533222111223356788999999998889999999999999999998 8888764321110
Q ss_pred ---------------------cccc---CccCCCCCCCHHHHHHHHhc
Q 007490 524 ---------------------EDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 ---------------------~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
.+++ ...+|.+||++.||+..|+.
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0111 11799999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=269.42 Aligned_cols=207 Identities=28% Similarity=0.468 Sum_probs=169.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999954 6899999987542 2344457889999999999999999999999999999999
Q ss_pred eccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++++|..++ ++|+.+++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999886433 56999999999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------ccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-----------------------AED 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-----------------------~~~ 525 (601)
......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..+
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 1223467889999999988889999999999999999999999974322110 011
Q ss_pred ccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 526 LLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
++. ..+|.+||++.+|++.|+..
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 17999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=269.55 Aligned_cols=210 Identities=34% Similarity=0.520 Sum_probs=171.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++..++|++.++||+|+||.||++..++++.|+||.+.... ...+++.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678899999999999999999998778899999987543 33467899999999999999999999999989999999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|.+++ ++|+++++|+||||+||+++.++.+||+|||++..+......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT- 159 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence 999999886554 569999999999999999999999999999999876432111
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc--------------------cccc---
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG--------------------AEDL--- 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~--------------------~~~l--- 526 (601)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1112234568999999998889999999999999999998 898875433211 0011
Q ss_pred cCccCCCCCCCHHHHHHHHhc
Q 007490 527 LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~L~~ 547 (601)
+...+|.+||++.++++.|+.
T Consensus 240 ~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 240 CWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcccCcccCCCHHHHHHHHhc
Confidence 111799999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=267.53 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=165.5
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
++|+..+.||+|++|.||++.. .++++|++|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999985 458999999986432 1234568899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|+||+++++|.+++ ++|+.+|+||||+|+||++++++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999887654 5699999999999999999999999999999997654321111
Q ss_pred c-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------ccccC
Q 007490 471 N-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA---------------------EDLLS 528 (601)
Q Consensus 471 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~---------------------~~l~~ 528 (601)
. .....++..|+|||++.+..++.++||||||+++|||++|+.||........ .+++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence 1 1234578899999999998899999999999999999999999854321100 00111
Q ss_pred ---ccCCCCCCCHHHHHHH
Q 007490 529 ---YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 ---~~dP~~RPt~~evl~~ 544 (601)
..+|.+|||+.++++.
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 242 RTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhhcCcccCCCHHHHhhC
Confidence 1689999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=265.40 Aligned_cols=200 Identities=31% Similarity=0.452 Sum_probs=161.8
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCcc
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLD 424 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~ 424 (601)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999987889999999876543 33456889999999999999999999999999999999999999887
Q ss_pred ccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 425 YFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 425 ~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
.++ ++|+.+++||||||+||+++.++.+||+|||++......... ......++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~ 159 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIK 159 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCccc
Confidence 654 459999999999999999999999999999999754322111 1112234567
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc---CccCCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL---SYEDPADRP 536 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~---~~~dP~~RP 536 (601)
|+|||++....++.++||||||+++||+++ |..||........ .+++ ...+|.+||
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence 999999998899999999999999999998 8888854321110 0011 117999999
Q ss_pred CHHHHHHHHh
Q 007490 537 SMATIVLALN 546 (601)
Q Consensus 537 t~~evl~~L~ 546 (601)
++.|+++.|.
T Consensus 240 ~~~~l~~~l~ 249 (250)
T cd05085 240 KFSELQKELA 249 (250)
T ss_pred CHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=276.44 Aligned_cols=214 Identities=28% Similarity=0.424 Sum_probs=170.5
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC--------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGF 404 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 404 (601)
++...++|.+.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 4456778899999999999999999731 24579999886542 34456789999999999 89999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEE
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNIL 445 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIl 445 (601)
+......++||||+++++|..++ ++|+.||+||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999998876543 459999999999999999
Q ss_pred EccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc
Q 007490 446 LDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE 524 (601)
Q Consensus 446 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~ 524 (601)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999987643322222223345678999999998889999999999999999998 77776543322111
Q ss_pred c--------------------ccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 525 D--------------------LLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ~--------------------l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
+ ++. ..+|.+||++.|+++.|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1 111 17999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=266.05 Aligned_cols=201 Identities=33% Similarity=0.495 Sum_probs=162.7
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCcc
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLD 424 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~ 424 (601)
++||+|++|.||++...+++.|++|++...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999766999999998765433 5568899999999999999999999999999999999999998886
Q ss_pred ccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 425 YFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 425 ~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
.++ ++|+++++||||||+||+++.++.+||+|||++.................+..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 554 56999999999999999999999999999999976542211111112233567
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc---CccCCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL---SYEDPADRP 536 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~---~~~dP~~RP 536 (601)
|+|||.+.++.++.++||||||+++|||++ |..||........ .+++ ...+|.+||
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCc
Confidence 999999988899999999999999999999 7888754332111 0111 117999999
Q ss_pred CHHHHHHHHh
Q 007490 537 SMATIVLALN 546 (601)
Q Consensus 537 t~~evl~~L~ 546 (601)
++.|+++.|+
T Consensus 241 ~~~ell~~l~ 250 (251)
T cd05041 241 SFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHhh
Confidence 9999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=278.77 Aligned_cols=195 Identities=27% Similarity=0.403 Sum_probs=156.5
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+|+.. +++.||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 47889999987542 22344566778888764 999999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecC
Confidence 9986554 6699999999999999999999999999999987532211 12334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------ccc---CccCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DLL---SYEDPADR 535 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l~---~~~dP~~R 535 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||......... +++ ...||.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhc
Confidence 99999999999999999999999999999999999998643321110 111 11799999
Q ss_pred CCHH-HHH
Q 007490 536 PSMA-TIV 542 (601)
Q Consensus 536 Pt~~-evl 542 (601)
|++. ++.
T Consensus 239 ~~~~~~l~ 246 (316)
T cd05619 239 LGVKGDIR 246 (316)
T ss_pred CCChHHHH
Confidence 9997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=279.47 Aligned_cols=169 Identities=25% Similarity=0.380 Sum_probs=144.6
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 5789999998754 233445678899988877 899999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccC
Confidence 9986543 6799999999999999999999999999999987532111 12334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=281.05 Aligned_cols=177 Identities=27% Similarity=0.334 Sum_probs=149.1
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999854 57899999987542 22334566788888877 5899999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--Ccc
Confidence 999999986544 5699999999999999999999999999999997543221 123
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 34578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=270.25 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=155.1
Q ss_pred CcccccCcceEEeeecCC---CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997533 3468888775443 233456889999999999999999999999999999999999999
Q ss_pred Cccccc----------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 422 SLDYFL----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 422 sL~~~l----------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+|.+++ ++|+++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 987654 5699999999999999999999999999999986543221111122
Q ss_pred cccccccccCcccccC-------CCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-----------------c----
Q 007490 474 RIVGTYGYMSPEYAMH-------GQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA-----------------E---- 524 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~-----------------~---- 524 (601)
...++..|+|||++.. ..++.++||||||+++|||++ |..||........ .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3345678999998742 456889999999999999999 7778754331100 0
Q ss_pred ----cccC--ccCCCCCCCHHHHHHHHh
Q 007490 525 ----DLLS--YEDPADRPSMATIVLALN 546 (601)
Q Consensus 525 ----~l~~--~~dP~~RPt~~evl~~L~ 546 (601)
+++. ..||.+|||+.+|++.|.
T Consensus 241 ~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 241 DRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 0000 159999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=268.22 Aligned_cols=179 Identities=28% Similarity=0.417 Sum_probs=147.8
Q ss_pred cCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCC-ccceEEEEEeCC-----
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGD----- 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~----- 409 (601)
...|+..++||+|+||+||+|+ ..+|+.||+|++..... .......+|+.+++.|+|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777889999999999999 44689999999976533 23455689999999999999 999999999877
Q ss_pred -eeEEEEeccCCC-------------Cc-------------ccccccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 410 -EKILVYEFVPNK-------------SL-------------DYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 410 -~~~lv~E~~~~g-------------sL-------------~~~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..++|+||++.. -+ ..+-|+|+++|+||||||.||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 788999997531 11 111278999999999999999999999999999999997
Q ss_pred cCCCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
+..+.. .....++|..|+|||++.+. .|+...||||+|||+.||+++++-|....
T Consensus 170 ~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 170 FSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred hcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 654332 24456789999999999886 79999999999999999999988776544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=269.22 Aligned_cols=173 Identities=28% Similarity=0.430 Sum_probs=139.7
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHH--HcCCCCccceEEEEEeCC---
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVA--KLQHRNLVRLLGFCLEGD--- 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~hpnIv~l~~~~~~~~--- 409 (601)
.+....+..+.+.||+|.||+||+|.| .|+.||||++...+. ..+.+|.++.+ .|+|+||+.+++.-..++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345667888999999999999999999 899999999975544 34556666655 459999999999876554
Q ss_pred -eeEEEEeccCCCCccccc----------------------ccc--------cceeeccccccCcEEEccCCCcEEeecc
Q 007490 410 -EKILVYEFVPNKSLDYFL----------------------YDS--------QLRIIHRDLKASNILLDVQMNPKISDFG 458 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l----------------------~~h--------~~~iiHrdlkp~NIll~~~~~~kL~Dfg 458 (601)
++|||++|.+.|+|.+|| |+| +..|.|||||++|||+.+++.+.|+|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 579999999999999988 233 4569999999999999999999999999
Q ss_pred cceecCCCCCc--cccccccccccccCcccccCC----CC--CchhhHHhHHHHHHHHHhC
Q 007490 459 LARIFGVDQTQ--GNTSRIVGTYGYMSPEYAMHG----QF--SVKSDVYSFGVLALETITG 511 (601)
Q Consensus 459 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~--~~~sDvwSlGvvl~elltg 511 (601)
+|......... ......+||.+|||||++... .+ -..+||||||.|+||+...
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99876544222 234457899999999998542 12 2569999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=282.55 Aligned_cols=200 Identities=28% Similarity=0.367 Sum_probs=156.3
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHH-HHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEV-VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57789999986532 12223344444 457788999999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.||+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccC
Confidence 9886544 569999999999999999999999999999999753221 122334579
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---cCccCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---LSYEDPADR 535 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~~~~dP~~R 535 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||......... ++ +...||.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999999999999999999999999999999998653321110 01 112699999
Q ss_pred CCHHHHHHHHhc
Q 007490 536 PSMATIVLALNS 547 (601)
Q Consensus 536 Pt~~evl~~L~~ 547 (601)
|++.+.+..+.+
T Consensus 239 ~~~~~~~~~i~~ 250 (325)
T cd05602 239 LGAKDDFMEIKN 250 (325)
T ss_pred CCCCCCHHHHhc
Confidence 998765544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=273.16 Aligned_cols=208 Identities=29% Similarity=0.437 Sum_probs=166.6
Q ss_pred CCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
+|++.+.||+|+||.||+|+.. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999842 23568888886543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------------------------------ccccceeeccccccCcEEE
Q 007490 414 VYEFVPNKSLDYFL-----------------------------------------------YDSQLRIIHRDLKASNILL 446 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------------------------------~~h~~~iiHrdlkp~NIll 446 (601)
++||+++++|..++ ++|+.+|+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999886542 5599999999999999999
Q ss_pred ccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc
Q 007490 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED 525 (601)
Q Consensus 447 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 525 (601)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.........+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999976533222111222345678999999988889999999999999999998 988886443222111
Q ss_pred c-----------------------cCccCCCCCCCHHHHHHHHhcC
Q 007490 526 L-----------------------LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 l-----------------------~~~~dP~~RPt~~evl~~L~~~ 548 (601)
. +...+|.+||++.++++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 1117999999999999999763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=299.65 Aligned_cols=178 Identities=28% Similarity=0.445 Sum_probs=152.2
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999954 58999999986532 233567899999999999999999999999999999999
Q ss_pred eccCCCCccccc----------------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 416 EFVPNKSLDYFL----------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999886543 5699999999999999999999999999999998
Q ss_pred ecCCCCC----------------ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 462 IFGVDQT----------------QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 462 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....... ........||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 7621110 0011234689999999999999999999999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=272.26 Aligned_cols=169 Identities=33% Similarity=0.434 Sum_probs=145.0
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||+|+||+||++... +++.||+|++..... ...+.+..|++++++++||||+++.+++..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 688999999865422 2335678899999999999999999999999999999999999998
Q ss_pred cccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 424 DYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 424 ~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
..++ ++|+.+|+||||||+||+++.++.+||+|||++..+..... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 6432 56999999999999999999999999999999986643322 223357
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=278.59 Aligned_cols=170 Identities=25% Similarity=0.382 Sum_probs=145.6
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.. +++.||||++++. .......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999954 5889999999754 223345678899999998 799999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccC
Confidence 9986543 679999999999999999999999999999998742211 122334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 9999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=277.02 Aligned_cols=214 Identities=28% Similarity=0.418 Sum_probs=168.3
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC--------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLG 403 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 403 (601)
.+++..++|.+.+.||+|+||.||+++.. +...+|+|.+.... ......+.+|+.+++++ +||||+++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 34555678999999999999999999742 23469999987542 34456788899999999 7999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcE
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
++...+..++||||+++++|..++ ++|+.+++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999998775433 45899999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
+++.++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+..
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999999999999999876532211111222234568999999998889999999999999999998 8888754332111
Q ss_pred cc--------------------cc---CccCCCCCCCHHHHHHHHhc
Q 007490 524 ED--------------------LL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 ~~--------------------l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
.. ++ ...+|.+||++.+|++.|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 10 00 11699999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.73 Aligned_cols=200 Identities=34% Similarity=0.504 Sum_probs=159.4
Q ss_pred cccccCcceEEeeec---CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 347 KLGRGGFGEVYKGVL---PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+||+|+||.||+|.+ .+++.+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 357889999986543 334567899999999999999999999875 45678999999999
Q ss_pred Cccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc-ccccccc
Q 007490 422 SLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-NTSRIVG 477 (601)
Q Consensus 422 sL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~g 477 (601)
+|..++ ++|+++|+||||||.||+++.++.+||+|||+++......... ......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 887655 5699999999999999999999999999999998764332211 1112234
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc--------------------cccccC---ccCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG--------------------AEDLLS---YEDPA 533 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~--------------------~~~l~~---~~dP~ 533 (601)
+..|+|||.+....++.++||||||+++|||++ |+.||....... ..+++. ..||.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~ 240 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVD 240 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCch
Confidence 578999999988889999999999999999998 999986432211 111111 17999
Q ss_pred CCCCHHHHHHHHhc
Q 007490 534 DRPSMATIVLALNS 547 (601)
Q Consensus 534 ~RPt~~evl~~L~~ 547 (601)
+||++.+|++.|++
T Consensus 241 ~Rp~~~~i~~~l~~ 254 (257)
T cd05116 241 ERPGFAVVELRLRN 254 (257)
T ss_pred hCcCHHHHHHHHhc
Confidence 99999999999965
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=273.62 Aligned_cols=209 Identities=30% Similarity=0.470 Sum_probs=165.4
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-----------------CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCcc
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-----------------HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLV 399 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv 399 (601)
+.++|++.++||+|+||.||++... ++..||+|++... .......+.+|++++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3467999999999999999998532 2346899998754 334456889999999999999999
Q ss_pred ceEEEEEeCCeeEEEEeccCCCCccccc----------------------------------ccccceeeccccccCcEE
Q 007490 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------------------YDSQLRIIHRDLKASNIL 445 (601)
Q Consensus 400 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l----------------------------------~~h~~~iiHrdlkp~NIl 445 (601)
++++++...+..++||||+++++|..++ ++|+.+++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 9999999999999999999998886543 568999999999999999
Q ss_pred EccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCCCcc
Q 007490 446 LDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT--GKKNSSFYQTDGA 523 (601)
Q Consensus 446 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~ 523 (601)
++.++.++|+|||+++.+.............++..|++||...++.++.++|||||||++|||++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999986543222111222344678999999888899999999999999999998 6667643321110
Q ss_pred ---------------------------cccc---CccCCCCCCCHHHHHHHHh
Q 007490 524 ---------------------------EDLL---SYEDPADRPSMATIVLALN 546 (601)
Q Consensus 524 ---------------------------~~l~---~~~dP~~RPt~~evl~~L~ 546 (601)
.+++ ...||.+||++.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0011 1179999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=270.47 Aligned_cols=209 Identities=31% Similarity=0.499 Sum_probs=166.4
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCc----eeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQ----EIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|+..++||+|+||.||+|++ .+++ +||+|.+... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46788899999999999999984 3444 4899998654 33445678899999999999999999999875 4578
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+++||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999886654 56999999999999999999999999999999987653322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------c--
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------D-- 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~-- 525 (601)
........++..|+|||.+.+..++.++||||||+++|||++ |..||......... +
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIM 244 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHH
Confidence 211222344678999999998899999999999999999998 88888643321100 0
Q ss_pred -ccCccCCCCCCCHHHHHHHHhcC
Q 007490 526 -LLSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 -l~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+...||++||++.++++.|+..
T Consensus 245 ~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 245 VKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHh
Confidence 11127999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=271.58 Aligned_cols=168 Identities=29% Similarity=0.404 Sum_probs=143.2
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||+|+||.||+++.+ +|+.||+|++.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 58999999986432 12234456799999999999999999999999999999999999998
Q ss_pred cccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 424 DYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 424 ~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
..++ ++|+.+|+||||||+||+++.++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCC
Confidence 6543 5699999999999999999999999999999998654322 12234688
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.68 Aligned_cols=213 Identities=30% Similarity=0.439 Sum_probs=170.4
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL 406 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 406 (601)
++...++|.+.+.||+|+||.||++.. ..+..||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 445567899999999999999999973 134579999987543 33456789999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 407 EGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
..+..++||||+++++|..++ ++|+.+|+|+||||+|||++.++.+||+|||+++
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999886554 5699999999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc------------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG------------------ 522 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~------------------ 522 (601)
...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 6543322111222345678999999999999999999999999999998 888875432110
Q ss_pred ---cccc---cCccCCCCCCCHHHHHHHHhc
Q 007490 523 ---AEDL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 523 ---~~~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
..++ +...+|++||++.|+++.|+.
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0011 111799999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=277.78 Aligned_cols=171 Identities=30% Similarity=0.394 Sum_probs=142.3
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHH-HHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEV-VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
++||+|+||.||+++.. +++.||+|++.+.. ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 58899999986532 22233455554 467889999999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccC
Confidence 9886543 669999999999999999999999999999998753221 122334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 99999999999989999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=283.87 Aligned_cols=171 Identities=31% Similarity=0.375 Sum_probs=146.2
Q ss_pred CcccccCcceEEeeec----CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 346 NKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999987542 2234557789999999999999999999999999999999999
Q ss_pred CCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 420 NKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 420 ~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
+++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cceeccc
Confidence 99886544 6699999999999999999999999999999997653221 1233457
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 899999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=278.29 Aligned_cols=197 Identities=27% Similarity=0.340 Sum_probs=159.6
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.. +++.||||++.+.. ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 47899999987542 23445677899999888 799999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||+++++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccceec
Confidence 9986543 6799999999999999999999999999999987532211 12234568
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------c---ccCccCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------D---LLSYEDPADR 535 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~---l~~~~dP~~R 535 (601)
++.|+|||++.+..++.++|||||||++|||++|+.||......... + .+...||.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 99999999999999999999999999999999999998643321111 1 1112799999
Q ss_pred CCH-----HHHHHH
Q 007490 536 PSM-----ATIVLA 544 (601)
Q Consensus 536 Pt~-----~evl~~ 544 (601)
|++ .++++.
T Consensus 239 ~s~~~~~~~~ll~~ 252 (318)
T cd05570 239 LGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCCHHHHhcC
Confidence 999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=267.52 Aligned_cols=208 Identities=33% Similarity=0.514 Sum_probs=166.5
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+..++|++.+.||+|++|.||++.+..+..+|+|++.... ...+.+.+|++++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 3446788899999999999999998777789999886443 23467889999999999999999999875 456899999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|.+++ ++|+.+++|+||||+||++++++.++|+|||++......... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 99999886554 569999999999999999999999999999999876432211 1
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc---
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL--- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~--- 527 (601)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .+++
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 122345678999999988899999999999999999999 8888854322110 0111
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.+|++.|+.
T Consensus 240 l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 240 WKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCCcccCcCHHHHHHHHhc
Confidence 11799999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.43 Aligned_cols=203 Identities=33% Similarity=0.506 Sum_probs=168.8
Q ss_pred hcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
..++|++.+.||.|+||.||++.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 346788899999999999999987 588999999976544 567889999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|.+++ ++|+.+++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 9998887654 56999999999999999999999999999999986532211
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc---C
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL---S 528 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~---~ 528 (601)
....+..|+|||++....++.++||||||+++|||++ |+.||........ .+++ .
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence 2234567999999998899999999999999999997 8888755432211 1111 1
Q ss_pred ccCCCCCCCHHHHHHHHhc
Q 007490 529 YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~L~~ 547 (601)
..+|.+||++.|++++|++
T Consensus 237 ~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 237 ELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccChhhCcCHHHHHHHHhc
Confidence 1699999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=269.05 Aligned_cols=210 Identities=30% Similarity=0.526 Sum_probs=167.4
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC-C---ceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH-G---QEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..++|+..+.||+|+||.||+|+... + ..+++|.+... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 34578889999999999999999643 3 36899998654 3344567899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+||||+++++|..++ ++|+.+++||||||+||+++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999986654 56999999999999999999999999999999986643221
Q ss_pred ccc-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------------------c
Q 007490 469 QGN-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--------------------L 526 (601)
Q Consensus 469 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--------------------l 526 (601)
... ......+..|+|||++.+..++.++||||||+++|||++ |+.||.......... +
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 242 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL 242 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 111 111223457999999988889999999999999999997 999985433211110 0
Q ss_pred c---CccCCCCCCCHHHHHHHHhc
Q 007490 527 L---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+ ...+|.+||++.+|++.|++
T Consensus 243 i~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 243 MLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred HHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 11699999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=283.28 Aligned_cols=175 Identities=25% Similarity=0.404 Sum_probs=145.2
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----eeE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-----EKI 412 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 412 (601)
+|++.++||+|+||.||+++. .+++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999995 46899999998653 2334567889999999999999999999998776 789
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||+.+ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999975 332221 679999999999999999999999999999999865432221
Q ss_pred cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 160 -HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred -cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 22234678899999998774 478999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=269.60 Aligned_cols=208 Identities=30% Similarity=0.517 Sum_probs=165.5
Q ss_pred CCCCcCCcccccCcceEEeeecCC-C---ceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH-G---QEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.+|++.+.||+|+||.||+|++.. + ..|+||.+... ......++.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999643 3 35999998754 344567899999999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++++|..++ ++|+.+++|+||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999999987654 5699999999999999999999999999999987654322111
Q ss_pred c-ccccc--ccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------ccc
Q 007490 471 N-TSRIV--GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDL 526 (601)
Q Consensus 471 ~-~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l 526 (601)
. ..... .+..|+|||++.+..++.++||||||+++|||++ |..||........ .++
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 243 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQL 243 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHH
Confidence 1 11111 2457999999999999999999999999999886 9988854322110 111
Q ss_pred c---CccCCCCCCCHHHHHHHHhc
Q 007490 527 L---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+ ...+|.+||++.+|+.+|+.
T Consensus 244 i~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 244 MLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHh
Confidence 1 12799999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=312.63 Aligned_cols=199 Identities=25% Similarity=0.445 Sum_probs=159.9
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
...+...+.||+|+||.||+|+. .+++.||||++...... ..+|++.+++++|||||++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45678889999999999999995 57899999998654322 23568899999999999999999999999999999
Q ss_pred cCCCCccccc--------------------ccc---cceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 418 VPNKSLDYFL--------------------YDS---QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 418 ~~~gsL~~~l--------------------~~h---~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+++|+|.+++ |+| +.+|+||||||+||+++.++..++. ||....... ...
T Consensus 765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~ 837 (968)
T PLN00113 765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTK 837 (968)
T ss_pred CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCC
Confidence 9999997765 557 7799999999999999999888875 665543211 112
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-------------------ccc----------
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-------------------AED---------- 525 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-------------------~~~---------- 525 (601)
..+++.|+|||++.+..++.++|||||||++|||++|+.|+....... ...
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 367899999999999999999999999999999999999974321100 000
Q ss_pred -----------ccCccCCCCCCCHHHHHHHHhcC
Q 007490 526 -----------LLSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 -----------l~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+...||.+||||.||+++|+..
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 01127999999999999999765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=292.03 Aligned_cols=215 Identities=26% Similarity=0.351 Sum_probs=170.7
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCCC-ceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEE-EEe---
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPHG-QEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGF-CLE--- 407 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~-~~~--- 407 (601)
.+++...++++.+.|.+|||+.||.++...+ .++|+|++-..+....+.+++||++|++|+ |||||.+++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3456677788899999999999999997665 999999998888888999999999999996 9999999993 321
Q ss_pred ---CCeeEEEEeccCCCCccccc-------------------------ccccce--eeccccccCcEEEccCCCcEEeec
Q 007490 408 ---GDEKILVYEFVPNKSLDYFL-------------------------YDSQLR--IIHRDLKASNILLDVQMNPKISDF 457 (601)
Q Consensus 408 ---~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~--iiHrdlkp~NIll~~~~~~kL~Df 457 (601)
.-+.+|+||||++|.|-+++ ++|..+ |||||||-+||||..+++.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 12578999999998887766 346665 999999999999999999999999
Q ss_pred ccceecCCCCCccc-------cccccccccccCcccc---cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC------
Q 007490 458 GLARIFGVDQTQGN-------TSRIVGTYGYMSPEYA---MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------ 521 (601)
Q Consensus 458 g~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------ 521 (601)
|.+...-....... .-...-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||+....-
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 99964322211100 1112358999999987 4678999999999999999999999999764211
Q ss_pred -----------cccc---ccCccCCCCCCCHHHHHHHHhcC
Q 007490 522 -----------GAED---LLSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 522 -----------~~~~---l~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+.+ .+..+||.+||+|-+|+..+...
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1111 22238999999999999887543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=271.75 Aligned_cols=205 Identities=29% Similarity=0.457 Sum_probs=170.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|++.+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3457899999999999999999995 468999999997665555677889999999999999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 173 (297)
T cd06656 96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (297)
T ss_pred cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcC
Confidence 999999987654 56999999999999999999999999999999976543221 122
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------cccc---C
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------EDLL---S 528 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~~l~---~ 528 (601)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ .+++ .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence 34678899999999988899999999999999999999999854322110 0011 1
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..+|.+||++.++++
T Consensus 254 ~~~p~~Rps~~~il~ 268 (297)
T cd06656 254 EMDVDRRGSAKELLQ 268 (297)
T ss_pred cCChhhCcCHHHHhc
Confidence 168999999998876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=266.81 Aligned_cols=201 Identities=26% Similarity=0.433 Sum_probs=170.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
+-|.++.+||+|+||.||++.++ .|+.||||++... ...+++.+|+.+|++.+.|++|+++|.+.....+|||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34778899999999999999964 5999999998654 35678999999999999999999999999999999999999
Q ss_pred CCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 419 PNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 419 ~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
..|+..+.+ |+|..+-||||||..|||++.+|.+||+|||.+-.+.... .....
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNT 188 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNT 188 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCc
Confidence 998876654 7788999999999999999999999999999997664322 23445
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccC-------------------------c
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLS-------------------------Y 529 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~-------------------------~ 529 (601)
..||+.|||||++..-.|+.++||||||+...||..|++|+....+.....++. .
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999987654433222221 1
Q ss_pred cCCCCCCCHHHHHHH
Q 007490 530 EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ~dP~~RPt~~evl~~ 544 (601)
++|++|-|+.++++.
T Consensus 269 K~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 269 KKPEERKTALRLCEH 283 (502)
T ss_pred CCHHHHHHHHHHhhh
Confidence 789999998887764
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=284.52 Aligned_cols=200 Identities=31% Similarity=0.425 Sum_probs=164.8
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
...|..++.||.|+||.||-++. .+.+.||||++.-. +...+.++.+|++.|.+|+|||+|.+-|++..+...|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34477788999999999999995 45788999998754 334567889999999999999999999999999999999
Q ss_pred EeccCC-----------------------CCcccccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPN-----------------------KSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~-----------------------gsL~~~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||||-| |.|..+-|+|+.+.||||||..|||+++.|.|||+|||.+.... .
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------P 178 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------P 178 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------c
Confidence 999966 33445558999999999999999999999999999999998654 2
Q ss_pred cccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc------------------------cc
Q 007490 472 TSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG------------------------AE 524 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~------------------------~~ 524 (601)
...++|||.|||||++. .++|+-|+||||||++-.||...++|........ ..
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 44579999999999985 5789999999999999999999998864322111 11
Q ss_pred cccCccCCCCCCCHHHHHHH
Q 007490 525 DLLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l~~~~dP~~RPt~~evl~~ 544 (601)
+.+..+-|.+|||..+++..
T Consensus 259 d~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHhhCcccCCcHHHHhhc
Confidence 12222689999999987754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=271.66 Aligned_cols=211 Identities=30% Similarity=0.496 Sum_probs=168.1
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
+..++|+..+.||+|+||.||++... ++..||+|++.... ......+.+|+.++++++||||+++++++..++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 34578999999999999999999853 36789999987543 344567889999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc---------------------------------------------ccccceeeccccccCcE
Q 007490 410 EKILVYEFVPNKSLDYFL---------------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l---------------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
..++||||+++++|..++ ++|+.+++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999998875543 45999999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCC--
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTD-- 521 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~-- 521 (601)
+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876533221111222234667999999998899999999999999999997 77777432111
Q ss_pred ------------------ccccccC---ccCCCCCCCHHHHHHHHhc
Q 007490 522 ------------------GAEDLLS---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 522 ------------------~~~~l~~---~~dP~~RPt~~evl~~L~~ 547 (601)
...+++. ..+|.+|||+.|+++.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 1799999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=272.07 Aligned_cols=205 Identities=29% Similarity=0.457 Sum_probs=169.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....+|+..+.||+|++|.||+|+. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..+...++||
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 3456899999999999999999984 468899999997765555677889999999999999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~ 174 (296)
T cd06654 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (296)
T ss_pred cccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccC
Confidence 999999987654 56999999999999999999999999999999876432221 122
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------cccc---C
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------EDLL---S 528 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~~l~---~ 528 (601)
...+++.|+|||.+.+..++.++|||||||++|||++|+.||........ .+++ .
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 34688899999999988899999999999999999999999854332100 0001 1
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..+|.+||++.++++
T Consensus 255 ~~~p~~Rpt~~eil~ 269 (296)
T cd06654 255 DMDVEKRGSAKELLQ 269 (296)
T ss_pred cCCcccCcCHHHHhh
Confidence 168999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=289.69 Aligned_cols=208 Identities=33% Similarity=0.515 Sum_probs=180.8
Q ss_pred CCcCCcccccCcceEEeeec-CCC----ceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 342 FSSDNKLGRGGFGEVYKGVL-PHG----QEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.+..++||.|+||+||+|.| ++| -+||||++... ..+...++.+|+-+|.+|+|||+++++|++.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45678999999999999984 444 47899988654 4556788999999999999999999999998766 88999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+|++.|.|.+++ |+|+++++||||..+|||+.+-.++||.|||+++.+..+.....
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999998876 66888999999999999999999999999999999887766655
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc---------------------
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY--------------------- 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~--------------------- 529 (601)
.....-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+++.++++.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkC 936 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKC 936 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHH
Confidence 555556789999999999999999999999999999998 8899988888887777765
Q ss_pred --cCCCCCCCHHHHHHHHhcCCC
Q 007490 530 --EDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 530 --~dP~~RPt~~evl~~L~~~~~ 550 (601)
.|+..||+++++...+.+...
T Consensus 937 wmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 937 WMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hccCcccCccHHHHHHHHHHHhc
Confidence 799999999999988876543
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=271.90 Aligned_cols=209 Identities=30% Similarity=0.454 Sum_probs=166.9
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC-----------------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCcc
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH-----------------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLV 399 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv 399 (601)
..++|++.+.||+|+||.||++.... +..||+|.+.... ....+.+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 35678999999999999999987532 2458999987653 34567789999999999999999
Q ss_pred ceEEEEEeCCeeEEEEeccCCCCccccc----------------------------------ccccceeeccccccCcEE
Q 007490 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------------------YDSQLRIIHRDLKASNIL 445 (601)
Q Consensus 400 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l----------------------------------~~h~~~iiHrdlkp~NIl 445 (601)
++++++..++..+++|||+++++|..++ ++|+.+|+||||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9999999999999999999998776542 569999999999999999
Q ss_pred EccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh--CCCCCCCCCCCc-
Q 007490 446 LDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT--GKKNSSFYQTDG- 522 (601)
Q Consensus 446 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~- 522 (601)
++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|+.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 99999999999999986543322222333456778999999988889999999999999999998 566664322111
Q ss_pred --------------------------cccccC---ccCCCCCCCHHHHHHHHh
Q 007490 523 --------------------------AEDLLS---YEDPADRPSMATIVLALN 546 (601)
Q Consensus 523 --------------------------~~~l~~---~~dP~~RPt~~evl~~L~ 546 (601)
..+++. ..||.+|||+.||++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111 179999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=271.00 Aligned_cols=212 Identities=26% Similarity=0.425 Sum_probs=169.3
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC-----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe-CC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH-----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~ 409 (601)
+..++|++.+.||+|+||.||+|.+.+ +..|++|++... .......+.+|+.++++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456789999999999999999999755 688999988654 33445678899999999999999999998776 46
Q ss_pred eeEEEEeccCCCCccccc-------------------------------ccccceeeccccccCcEEEccCCCcEEeecc
Q 007490 410 EKILVYEFVPNKSLDYFL-------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFG 458 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg 458 (601)
..++++||+++++|..++ |+|+.+++||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999988876543 5589999999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------
Q 007490 459 LARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA-------------- 523 (601)
Q Consensus 459 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~-------------- 523 (601)
+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 9986543322211222345678999999998889999999999999999999 9998864321111
Q ss_pred ------cccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 524 ------EDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ------~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+++ ...||.+|||+.++++.|+..
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111 116999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.36 Aligned_cols=177 Identities=28% Similarity=0.352 Sum_probs=147.3
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 409 (601)
..++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999853 5889999998754 2334567788999999999999999999886443
Q ss_pred -eeEEEEeccCCCCccc--------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 410 -EKILVYEFVPNKSLDY--------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~--------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
..++||||++++.+.. +.++|+.||+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 173 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc-
Confidence 4699999998753321 116799999999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred --ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22335789999999999999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=266.09 Aligned_cols=209 Identities=31% Similarity=0.491 Sum_probs=169.8
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++..++|++.++||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++++.+.. ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45678899999999999999999997778889999886543 345678899999999999999999999887 7789999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|.+++ ++|+.+++|+||||+||+++.++.+||+|||.+..+......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 999999886654 569999999999999999999999999999999865432211
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------------------c---
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--------------------L--- 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--------------------l--- 526 (601)
......++..|+|||++....++.++|+||||+++||+++ |+.||.......... +
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 238 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence 1222345677999999998889999999999999999999 888886432211110 0
Q ss_pred cCccCCCCCCCHHHHHHHHhc
Q 007490 527 LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~L~~ 547 (601)
+...+|.+||++.+++++|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 239 CWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HcccCcccCcCHHHHHHHHhc
Confidence 111799999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=268.29 Aligned_cols=177 Identities=26% Similarity=0.441 Sum_probs=151.9
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..++|++.+.||+|+||.||+++. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 345788889999999999999985 4588999999876655555678899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|.+++ ++|+.+++|+||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 164 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRK 164 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccc
Confidence 99999987654 5699999999999999999999999999999987654221 2223
Q ss_pred cccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 474 RIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
...|+..|+|||++. ...++.++|||||||++|||++|+.|+.
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 457899999999874 4568899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.54 Aligned_cols=175 Identities=23% Similarity=0.288 Sum_probs=147.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC---CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP---HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
....+|++.+.||+|+||.||++... .++.|++|.+... ....+|++++++++||||+++++++...+..++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34567999999999999999999743 3578999988543 234689999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||++.+ +|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+.......
T Consensus 164 v~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 9999864 443322 6799999999999999999999999999999998665433333
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 33456799999999999999999999999999999999999999854
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=275.09 Aligned_cols=213 Identities=30% Similarity=0.423 Sum_probs=167.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC--------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
....++|.+.++||+|+||.||+++.. ....+|+|.+.... ......+.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 445567889999999999999999742 24568999887543 34456788999999999 699999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEE
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILL 446 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll 446 (601)
...+..+++|||+++++|..++ ++|+.||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999998875432 4589999999999999999
Q ss_pred ccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--
Q 007490 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA-- 523 (601)
Q Consensus 447 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~-- 523 (601)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999986543221111122234567999999998899999999999999999999 8888754322110
Q ss_pred ------------------ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 ------------------EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ------------------~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...+|.+||++.|+++.|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 011 1127999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=264.85 Aligned_cols=207 Identities=28% Similarity=0.465 Sum_probs=170.7
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|++|.||+|... +|+.|++|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999965 7899999988642 2334567899999999999999999999999999999999
Q ss_pred eccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++++|..++ ++|+.+|+||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999986543 45999999999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-----------------------cccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-----------------------GAED 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-----------------------~~~~ 525 (601)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred --ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 122346788999999999889999999999999999999999998543211 0000
Q ss_pred c---cCccCCCCCCCHHHHHHHHhcC
Q 007490 526 L---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+ +...+|.+||++.+|+++|+..
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 1127999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=266.71 Aligned_cols=206 Identities=27% Similarity=0.447 Sum_probs=169.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|++|.||+++. .+++.++||.+... ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 47899999987653 2334467889999999999999999999999999999999
Q ss_pred eccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++++|..++ ++|+.+++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999886543 56999999999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-----------------------cccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-----------------------GAED 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-----------------------~~~~ 525 (601)
......++..|+|||.+.+..++.++||||||+++|||++|..||.....+ ...+
T Consensus 162 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred --ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 122346888999999999888999999999999999999999998532211 0001
Q ss_pred cc---CccCCCCCCCHHHHHHHHhc
Q 007490 526 LL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
++ ...||.+|||+.+|++++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11 11699999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=267.83 Aligned_cols=208 Identities=30% Similarity=0.402 Sum_probs=163.5
Q ss_pred CC-CcCCcccccCcceEEeeec-----CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--Cee
Q 007490 341 KF-SSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEK 411 (601)
Q Consensus 341 ~f-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 411 (601)
+| +..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8889999999999987652 357789999987543 33456788999999999999999999988754 357
Q ss_pred EEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 412 ILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+++|||+++++|..++ ++|+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 8999999999987654 569999999999999999999999999999999866432211
Q ss_pred cc-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC---------------cc----------
Q 007490 470 GN-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD---------------GA---------- 523 (601)
Q Consensus 470 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~---------------~~---------- 523 (601)
.. .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 11 11224566799999998889999999999999999999999887532210 00
Q ss_pred ----------cccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 524 ----------EDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ----------~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+++ ...+|.+|||+.+|+++|+..
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0000 016999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.84 Aligned_cols=212 Identities=29% Similarity=0.451 Sum_probs=166.3
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEEEe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 407 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 407 (601)
+...++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 44567899999999999999999973 346789999997543 33446788999999999 78999999998865
Q ss_pred C-CeeEEEEeccCCCCccccc-----------------------------------------------------------
Q 007490 408 G-DEKILVYEFVPNKSLDYFL----------------------------------------------------------- 427 (601)
Q Consensus 408 ~-~~~~lv~E~~~~gsL~~~l----------------------------------------------------------- 427 (601)
. ...++||||+++|+|.+++
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4578999999998875432
Q ss_pred -------------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 428 -------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 428 -------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
++|+.+|+||||||+|||++.++.+||+|||++................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 5689999999999999999999999999999997653322211122234
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc---------------------cccc---cCccC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG---------------------AEDL---LSYED 531 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~---------------------~~~l---~~~~d 531 (601)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..++ +...|
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999998899999999999999999997 888875432110 0000 11169
Q ss_pred CCCCCCHHHHHHHHhc
Q 007490 532 PADRPSMATIVLALNS 547 (601)
Q Consensus 532 P~~RPt~~evl~~L~~ 547 (601)
|.+||++.||++.|+.
T Consensus 323 p~~Rps~~eil~~l~~ 338 (343)
T cd05103 323 PSQRPTFSELVEHLGN 338 (343)
T ss_pred hhhCcCHHHHHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=273.82 Aligned_cols=175 Identities=27% Similarity=0.443 Sum_probs=145.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|.+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999854 57889999986543 22334677899999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 162 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYS 162 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccc
Confidence 986 443322 66999999999999999999999999999999976432221 122
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3467889999998865 4688999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=267.53 Aligned_cols=209 Identities=29% Similarity=0.485 Sum_probs=166.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-C---CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-H---GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..+|++.+.||+|+||.||+|++. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888999999999999999853 2 3368999886543 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++++|..++ ++|+.+++||||||+|||++.++.++|+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999887654 569999999999999999999999999999999876432211
Q ss_pred cc-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc--------------------ccccc
Q 007490 470 GN-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG--------------------AEDLL 527 (601)
Q Consensus 470 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~--------------------~~~l~ 527 (601)
.. .....++..|+|||++.+..++.++|+||||+++||+++ |+.||......+ ..+++
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHH
Confidence 11 111223568999999998899999999999999999886 999985433211 11111
Q ss_pred C---ccCCCCCCCHHHHHHHHhc
Q 007490 528 S---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~---~~dP~~RPt~~evl~~L~~ 547 (601)
. ..+|.+||++.++++.|+.
T Consensus 243 ~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 243 LDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HHHcccCchhCCCHHHHHHHHHh
Confidence 1 1799999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=267.99 Aligned_cols=209 Identities=31% Similarity=0.512 Sum_probs=165.5
Q ss_pred cCCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 411 (601)
..+|++.+.||+|+||.||++.. .+++.|++|++........+.+.+|++++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35788899999999999999974 2478899999977766667789999999999999999999998754 3468
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|..++ ++|+.+|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 8999999999987665 5699999999999999999999999999999998764322
Q ss_pred Cccc-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-------------------------
Q 007490 468 TQGN-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------------- 521 (601)
Q Consensus 468 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------------- 521 (601)
.... .....++..|+|||++.+..++.++||||||+++|||++|..++......
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 2111 11122345699999999889999999999999999999987654221100
Q ss_pred -----------ccccccC---ccCCCCCCCHHHHHHHHhc
Q 007490 522 -----------GAEDLLS---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 522 -----------~~~~l~~---~~dP~~RPt~~evl~~L~~ 547 (601)
...+++. ..+|++|||+.||++.|+.
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0011111 1799999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=275.47 Aligned_cols=210 Identities=30% Similarity=0.506 Sum_probs=174.9
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC---CCc--eeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP---HGQ--EIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
.++........++||.|-||.||+|++. .|+ .||||..+.+ .....+.|..|..+|++++|||||+++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 3445555667789999999999999953 233 4888988764 45667889999999999999999999999976
Q ss_pred CeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
...|||||+++-|.|..+| |+|+.++|||||..+|||+....-+||+|||+++.+.
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 5789999999999998877 6799999999999999999999999999999999887
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc--------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY-------------- 529 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~-------------- 529 (601)
.+.... .+...-...|||||.+.-.+++.++|||-|||.+||+++ |.+||......+..-.++.
T Consensus 543 d~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 543 DDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred ccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence 554332 334455779999999999999999999999999999986 8899987665554444433
Q ss_pred ---------cCCCCCCCHHHHHHHHh
Q 007490 530 ---------EDPADRPSMATIVLALN 546 (601)
Q Consensus 530 ---------~dP~~RPt~~evl~~L~ 546 (601)
.+|.+||++.||...|.
T Consensus 622 YslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHHHHH
Confidence 69999999999877664
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=264.80 Aligned_cols=201 Identities=30% Similarity=0.439 Sum_probs=165.8
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||+|++|.||+++.. +++.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999954 5889999998643 344567788999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+.+++|+||||+||+++.++.++|+|||+++.+..... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hh
Confidence 9999987654 56999999999999999999999999999999987643322 12
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc--------------------cc---cCc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE--------------------DL---LSY 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~--------------------~l---~~~ 529 (601)
....+++.|+|||+..+..++.++|+||||+++|||++|+.||......... ++ +..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 2346788999999999999999999999999999999999998654321100 00 011
Q ss_pred cCCCCCCCHHHHHH
Q 007490 530 EDPADRPSMATIVL 543 (601)
Q Consensus 530 ~dP~~RPt~~evl~ 543 (601)
.+|++||++.++++
T Consensus 239 ~~p~~Rp~~~~ll~ 252 (256)
T cd08529 239 KDYRQRPDTFQLLR 252 (256)
T ss_pred CCcccCcCHHHHhh
Confidence 68999999998875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=269.02 Aligned_cols=204 Identities=28% Similarity=0.448 Sum_probs=166.7
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..+.|++.++||.|+||.||+|+.. +++.|++|.+........+.+.+|+.++++++||||+++++.+..++..++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 4567999999999999999999964 488999999987776677888999999999999999999999999999999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++++|..++ ++|+.+++||||||+||+++.++.+||+|||++....... ...
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 167 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRR 167 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--ccc
Confidence 99999886443 5699999999999999999999999999999987543221 112
Q ss_pred ccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccc
Q 007490 473 SRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AED 525 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~ 525 (601)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ..+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 3346788999999984 3457889999999999999999999985432110 001
Q ss_pred cc---CccCCCCCCCHHHHHH
Q 007490 526 LL---SYEDPADRPSMATIVL 543 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~ 543 (601)
++ ...+|.+||++.++++
T Consensus 248 li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhc
Confidence 11 1279999999998875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=274.89 Aligned_cols=178 Identities=28% Similarity=0.363 Sum_probs=149.7
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.++||+|+||.||+++.+ .++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 4778999998643 2223345788999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence 999999987665 56999999999999999999999999999999976532221 12
Q ss_pred cccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 23357899999999986 346889999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.56 Aligned_cols=177 Identities=27% Similarity=0.354 Sum_probs=148.6
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+|+..+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999854 58899999987532 233456778888988885 577888999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccc
Confidence 999999987654 6699999999999999999999999999999987543221 122
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 34568999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=273.62 Aligned_cols=216 Identities=27% Similarity=0.406 Sum_probs=170.6
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCC--------CceeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPH--------GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLG 403 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 403 (601)
+++....+|++.+.||+|+||.||+++... +..||+|.+... .....+++.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 345556679999999999999999997421 236899988654 234457889999999999 8999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcE
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
++...+..++++||+++++|..++ ++|+.+|+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 999999999999999998876542 45899999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
|++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999986543222111222234567999999999999999999999999999998 7888754332211
Q ss_pred ccc--------------------c---CccCCCCCCCHHHHHHHHhcCC
Q 007490 524 EDL--------------------L---SYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 524 ~~l--------------------~---~~~dP~~RPt~~evl~~L~~~~ 549 (601)
... + ...+|.+||++.|+++.|+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111 1 1169999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=279.83 Aligned_cols=177 Identities=28% Similarity=0.357 Sum_probs=147.0
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 408 (601)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999853 5889999998753 233456778999999999999999999987643
Q ss_pred CeeEEEEeccCCCCccc--------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 409 DEKILVYEFVPNKSLDY--------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~--------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
...++||||++++.+.. +.++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~- 180 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 180 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-
Confidence 35799999998743221 116799999999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 181 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred --cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 22335789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=270.39 Aligned_cols=206 Identities=31% Similarity=0.466 Sum_probs=162.7
Q ss_pred CCCCcCCcccccCcceEEeeecCC-Cc--eeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQ--EIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 414 (601)
++|++.+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998643 33 4688888643 334456789999999999 799999999999999999999
Q ss_pred EeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 415 YEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 415 ~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
+||+++++|.+++ ++|+.+|+||||||+|||+++++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 9999998885432 4589999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA----------- 523 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~----------- 523 (601)
|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||........
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred CcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999986432110 1111123457999999998899999999999999999997 9999854332110
Q ss_pred ---------ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 ---------EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ---------~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...+|.+||++.++++.|+..
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 1127999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=266.42 Aligned_cols=175 Identities=35% Similarity=0.554 Sum_probs=150.6
Q ss_pred CCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHH--HHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQ--EFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
|++.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999654 678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 419 PNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 419 ~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
++++|..++ ++|+.+|+|+||||+||++++++.++|+|||.+.... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999887655 5699999999999999999999999999999998642 122234455
Q ss_pred cccccccCccccc-CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 476 VGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 476 ~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.++..|+|||++. +..++.++||||+|+++|+|++|..|+...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc
Confidence 7899999999998 888999999999999999999999998765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.95 Aligned_cols=170 Identities=25% Similarity=0.369 Sum_probs=145.3
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57889999997542 23445678999999888 699999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccC
Confidence 9986543 6699999999999999999999999999999987532111 12334578
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=269.69 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=173.5
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+..-|.+.+.||+|.|..|-++++ -+|.+||||++.+... .....+.+|++.|+.++|||||+++++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688889999999999999983 4799999999987643 3346788999999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEc-cCCCcEEeecccceecCCCCCc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLD-VQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+|+-++|+|.+|+ |.|+..+|||||||+||.+- +-|-+||.|||++-.+.+++.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 9999999999887 56888899999999998765 568899999999988765543
Q ss_pred cccccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc-------------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY------------------- 529 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~------------------- 529 (601)
....+|+..|-|||++.+..|+ +++||||||||||-|+.|+.||....+.....++..
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence 4456999999999999999997 789999999999999999999987655433332221
Q ss_pred ---cCCCCCCCHHHHHHH
Q 007490 530 ---EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ---~dP~~RPt~~evl~~ 544 (601)
.||.+|.+..||+..
T Consensus 253 MLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHhcCchhhccHHHHhcc
Confidence 799999999998753
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=264.10 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=165.9
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
+|++.+.||+|+||.||++... +++.+++|.+... .....+.+.+|+.++++++||||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999954 5889999998643 3344567889999999999999999999999999999999999
Q ss_pred CCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 419 PNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 419 ~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
++++|..++ ++|+.+|+|+||||+||++++++.++|+|||.+........ ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccc
Confidence 998876543 56999999999999999999999999999999986643221 122
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------ccccC---cc
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------EDLLS---YE 530 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------~~l~~---~~ 530 (601)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||........ .+++. ..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 35688899999999988899999999999999999999999865332110 01111 16
Q ss_pred CCCCCCCHHHHHHH
Q 007490 531 DPADRPSMATIVLA 544 (601)
Q Consensus 531 dP~~RPt~~evl~~ 544 (601)
||.+||++.+|+..
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=270.85 Aligned_cols=210 Identities=32% Similarity=0.521 Sum_probs=165.1
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCc----eeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQ----EIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
..++|+..+.||+|+||.||+|.+. +|. .||+|.+.... .....++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3467888899999999999999853 344 47888886543 23345688999999999999999999998754 46
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++++||+++|+|.+++ ++|+.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 7999999999876554 5699999999999999999999999999999998764332
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc--------------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL-------------------- 526 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l-------------------- 526 (601)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||.........++
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 2222223345678999999998999999999999999999997 8888854322111111
Q ss_pred c---CccCCCCCCCHHHHHHHHhcC
Q 007490 527 L---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
+ ...+|++||++.++++.|+..
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 116999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=266.59 Aligned_cols=209 Identities=32% Similarity=0.523 Sum_probs=168.2
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-Cc----eeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQ----EIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..+|++.+.||+|+||.||+|.+++ |. .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4678888999999999999998543 33 58999886654 3445678899999999999999999999987 7889
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999987654 56999999999999999999999999999999987653322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc--------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL-------------------- 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~-------------------- 527 (601)
........++..|+|||.+....++.++|+||||+++||+++ |+.||.........+.+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVL 244 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 211112223568999999988899999999999999999998 99998664432211111
Q ss_pred ---CccCCCCCCCHHHHHHHHhcC
Q 007490 528 ---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~~L~~~ 548 (601)
...+|.+||++.++++.|+..
T Consensus 245 ~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 245 VKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHHcCCChhhCCCHHHHHHHHHHH
Confidence 116999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=263.26 Aligned_cols=205 Identities=32% Similarity=0.508 Sum_probs=166.0
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
.+|++.+.||+|+||.||++.+.++..+++|.+..... ....+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788999998864432 34578899999999999999999999999999999999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|..++ ++|+.+++||||||+||+++.++.+||+|||++......... .....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 161 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGT 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCC
Confidence 99886554 569999999999999999999999999999999765322111 11122
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc---CccC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL---SYED 531 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~---~~~d 531 (601)
.++..|+|||.+.++.++.++||||||+++|||++ |+.||......... +++ ...+
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 34678999999998899999999999999999998 88888643321110 111 1269
Q ss_pred CCCCCCHHHHHHHHh
Q 007490 532 PADRPSMATIVLALN 546 (601)
Q Consensus 532 P~~RPt~~evl~~L~ 546 (601)
|.+||++.+++++|.
T Consensus 242 p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 242 PEDRPSFSLLLHQLA 256 (256)
T ss_pred hhhCCCHHHHHHhhC
Confidence 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=263.54 Aligned_cols=195 Identities=27% Similarity=0.406 Sum_probs=154.9
Q ss_pred CcccccCcceEEeeecCC-------------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 346 NKLGRGGFGEVYKGVLPH-------------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
+.||+|+||.||+|++.. ..+|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899886655555567889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCC-------cEEeecccce
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMN-------PKISDFGLAR 461 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~-------~kL~Dfg~a~ 461 (601)
+||||+++++|+.++ |+|+.+|+||||||+|||++.++. ++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999876544 669999999999999999987664 8999999987
Q ss_pred ecCCCCCccccccccccccccCccccc-CCCCCchhhHHhHHHHHHHHH-hCCCCCCCCCCCc-----------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETI-TGKKNSSFYQTDG----------------- 522 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~p~~~~~~~~----------------- 522 (601)
..... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+.......
T Consensus 161 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd05077 161 TVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCK 234 (262)
T ss_pred cccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChH
Confidence 54321 2235778899999886 466899999999999999998 5777775432111
Q ss_pred -cccc---cCccCCCCCCCHHHHHHHHh
Q 007490 523 -AEDL---LSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 523 -~~~l---~~~~dP~~RPt~~evl~~L~ 546 (601)
..++ +...||.+||++.+|++.|+
T Consensus 235 ~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 235 ELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0111 11279999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=264.77 Aligned_cols=202 Identities=27% Similarity=0.448 Sum_probs=166.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|+..+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999954 58899999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++++|..++ ++|+.+++|+||+|+||++++++.++|+|||+++.+.... ......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccc
Confidence 9999887654 5699999999999999999999999999999998765332 122345
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------ccccc---CccC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------AEDLL---SYED 531 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------~~~l~---~~~d 531 (601)
.++..|+|||++.+..++.++||||||+++|||++|+.||....... ..+++ ...+
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence 67889999999998889999999999999999999999985432111 01111 1168
Q ss_pred CCCCCCHHHHHH
Q 007490 532 PADRPSMATIVL 543 (601)
Q Consensus 532 P~~RPt~~evl~ 543 (601)
|.+|||++++++
T Consensus 239 p~~Rpt~~~il~ 250 (274)
T cd06609 239 PKERPSAKELLK 250 (274)
T ss_pred hhhCcCHHHHhh
Confidence 888998888865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=270.21 Aligned_cols=205 Identities=28% Similarity=0.470 Sum_probs=169.9
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
...+|+..+.||.|++|.||+|+. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345789999999999999999984 4689999999976655556788999999999999999999999999999999999
Q ss_pred ccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 417 FVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 417 ~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
|+++++|..++ ++|+.+++||||||+||+++.++.+||+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRST 174 (296)
T ss_pred ecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCC
Confidence 99999987654 56999999999999999999999999999999876543221 1223
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccccc---Cc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDLL---SY 529 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l~---~~ 529 (601)
..++..|+|||.+.+..++.++|||||||++|||++|+.||....... ..+++ ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence 467889999999998889999999999999999999999986532210 00111 11
Q ss_pred cCCCCCCCHHHHHHH
Q 007490 530 EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ~dP~~RPt~~evl~~ 544 (601)
.||.+||++.+|+..
T Consensus 255 ~dp~~Rpt~~~il~~ 269 (296)
T cd06655 255 MDVEKRGSAKELLQH 269 (296)
T ss_pred cChhhCCCHHHHhhC
Confidence 799999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=265.34 Aligned_cols=210 Identities=27% Similarity=0.434 Sum_probs=167.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
+..++|.+.+.||+|+||.||+|.+.+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345668889999999999999998543 2468999886654 4556789999999999999999999998875 557
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ ++|+.+++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 8999999999987665 5699999999999999999999999999999998654332
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------ccc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDL 526 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l 526 (601)
... .....++..|+|||.+....++.++||||||+++||+++ |+.||........ .++
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 162 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred cee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 111 112234568999999988889999999999999999996 9999854432111 011
Q ss_pred ---cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 ---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...+|.+|||+.++++.|+..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1117999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.46 Aligned_cols=176 Identities=26% Similarity=0.376 Sum_probs=146.2
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-C-----CCccceEEEEEe
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-H-----RNLVRLLGFCLE 407 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~ 407 (601)
-+....+|++.+.||+|+||.|-+|.. .+++.||||+++... ....+...|+.+|..|+ | -|+|+++++|..
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 344455899999999999999999994 469999999996543 44566688999999996 4 389999999999
Q ss_pred CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccC--CCcEEeecccc
Q 007490 408 GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQ--MNPKISDFGLA 460 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~--~~~kL~Dfg~a 460 (601)
.++.+||+|.+.. +|.+++ .+|+.+|||.||||+||||.+- ..+||+|||.+
T Consensus 260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999998743 343333 6799999999999999999754 36999999999
Q ss_pred eecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...... ....+.+..|+|||++.+.+|+.+.||||||||+.||++|.+-|+.
T Consensus 339 c~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 339 CFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 875422 2245778899999999999999999999999999999999766644
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=270.53 Aligned_cols=170 Identities=26% Similarity=0.446 Sum_probs=136.4
Q ss_pred CCcccccCcceEEeeecC---CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeEEEEeccC
Q 007490 345 DNKLGRGGFGEVYKGVLP---HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKILVYEFVP 419 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~ 419 (601)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986543 23456789999999999999999999864 456789999986
Q ss_pred CCCccc--------------------------------ccccccceeeccccccCcEEE----ccCCCcEEeecccceec
Q 007490 420 NKSLDY--------------------------------FLYDSQLRIIHRDLKASNILL----DVQMNPKISDFGLARIF 463 (601)
Q Consensus 420 ~gsL~~--------------------------------~l~~h~~~iiHrdlkp~NIll----~~~~~~kL~Dfg~a~~~ 463 (601)
+. |.. +-++|+.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 HD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CC-HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 53 211 116799999999999999999 45678999999999876
Q ss_pred CCCCCc-cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 464 GVDQTQ-GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 464 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...... .......+|+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 433211 123345789999999998774 589999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=263.20 Aligned_cols=200 Identities=34% Similarity=0.469 Sum_probs=162.0
Q ss_pred CcccccCcceEEeeecCC--C--ceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLPH--G--QEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3689999977655 566789999999999999999999999988 889999999999
Q ss_pred CCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc-ccccc
Q 007490 421 KSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ-GNTSR 474 (601)
Q Consensus 421 gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~ 474 (601)
++|..++ ++|+.+++|+||||+||+++.++.+||+|||+++.+...... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 8887543 559999999999999999999999999999999876432211 11123
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc---------------------ccc---cCc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA---------------------EDL---LSY 529 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~---------------------~~l---~~~ 529 (601)
..++..|+|||++.+..++.++||||||+++|||++ |+.||......+. .++ +..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWA 239 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCC
Confidence 456788999999998899999999999999999999 9999853221110 011 112
Q ss_pred cCCCCCCCHHHHHHHHh
Q 007490 530 EDPADRPSMATIVLALN 546 (601)
Q Consensus 530 ~dP~~RPt~~evl~~L~ 546 (601)
.+|.+||++.++++.|.
T Consensus 240 ~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 240 HNPADRPTFAALREFLP 256 (257)
T ss_pred CCcccCCCHHHHHHHhc
Confidence 79999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=262.23 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=166.8
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|+..+.||+|++|.||+|+..+ ++.+++|.+..... .+.+.+|++++++++||||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4679999999999999999999754 78999999865433 67899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++++|.+++ ++|+.+++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence 9999887654 56999999999999999999999999999999986543221 122
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------ccccC---
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------EDLLS--- 528 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~~l~~--- 528 (601)
...++..|+|||++.+..++.++||||||+++|||++|+.|+........ .+++.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 34578899999999988999999999999999999999999864322110 01111
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+|||+.|+++
T Consensus 238 ~~~P~~Rps~~~il~ 252 (256)
T cd06612 238 VKDPEERPSAIQLLQ 252 (256)
T ss_pred hcChhhCcCHHHHhc
Confidence 168999999998875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=262.08 Aligned_cols=201 Identities=38% Similarity=0.554 Sum_probs=164.7
Q ss_pred CcccccCcceEEeeecCC----CceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999653 788999999765433 367889999999999999999999999999999999999998
Q ss_pred CCccccc--------------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 421 KSLDYFL--------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 421 gsL~~~l--------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++|..++ ++|+.+++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 8876543 45899999999999999999999999999999987654332
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc---------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL--------------------- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l--------------------- 526 (601)
........++..|+|||.+....++.++||||||+++|||++ |+.||.........+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELM 240 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHH
Confidence 222334567889999999988899999999999999999999 5888865432211111
Q ss_pred --cCccCCCCCCCHHHHHHHHh
Q 007490 527 --LSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~~L~ 546 (601)
+...+|.+||++.|++..|+
T Consensus 241 ~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 241 LSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHccCCcccCcCHHHHHHhhC
Confidence 11169999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=282.12 Aligned_cols=204 Identities=26% Similarity=0.432 Sum_probs=168.6
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.+.|.++..||.|+||.||++..++ +-..|.|++...+....+.+.-||+||...+||+||++++.|...+.+||+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3446677889999999999999654 444577888777888888999999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|.||-.+.++ |+|+++|||||||..|||++-+|.++|+|||.+.... .+.....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD 188 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence 9999765543 7899999999999999999999999999999986532 2223455
Q ss_pred cccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------ccccC-----------
Q 007490 474 RIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA---------EDLLS----------- 528 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~---------~~l~~----------- 528 (601)
.+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|......... ..++.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 689999999999874 57899999999999999999999998754432211 11111
Q ss_pred -----ccCCCCCCCHHHHHHH
Q 007490 529 -----YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 -----~~dP~~RPt~~evl~~ 544 (601)
..||..||+++++++.
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhC
Confidence 1799999999998764
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=262.90 Aligned_cols=201 Identities=32% Similarity=0.466 Sum_probs=163.1
Q ss_pred cCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEE-eCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL-EGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 417 (601)
.++|++.+.||+|+||.||++.. .|..|++|.+.... ..+.+.+|+.++++++|+||+++++++. .++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788899999999999999987 58889999886433 3467889999999999999999999765 45678999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+.+++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 9998886544 5699999999999999999999999999999987643221
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cccc---C
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDLL---S 528 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l~---~ 528 (601)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||........ .+++ .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 12234568999999998899999999999999999997 8888764332111 1111 1
Q ss_pred ccCCCCCCCHHHHHHHHhc
Q 007490 529 YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~L~~ 547 (601)
..+|.+|||+.++++.|+.
T Consensus 237 ~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 237 HLDAATRPSFLQLREQLEH 255 (256)
T ss_pred cCChhhCcCHHHHHHHHhc
Confidence 1799999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=276.99 Aligned_cols=178 Identities=27% Similarity=0.355 Sum_probs=150.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999954 5788999998653 2223455788999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||++......... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-e
Confidence 999999987665 459999999999999999999999999999999876433221 1
Q ss_pred cccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....|++.|+|||++.+ +.++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 223568999999999875 56789999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=267.68 Aligned_cols=174 Identities=33% Similarity=0.456 Sum_probs=149.3
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999954 58899999986542 2223457789999999999999999999999999999999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|..++ ++|+.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 99999986554 56999999999999999999999999999999976532221
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 1234689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=263.16 Aligned_cols=178 Identities=26% Similarity=0.430 Sum_probs=154.1
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|+..+.||.|++|.||++... +++.+++|.+........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999964 5788999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++++|..++ ++|+.+|+|+||+|+||++++++.+||+|||++....... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccc
Confidence 9998887644 5699999999999999999999999999999997654321 1122
Q ss_pred cccccccccCcccccCC---CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHG---QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 34678899999998776 8899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=285.28 Aligned_cols=174 Identities=26% Similarity=0.436 Sum_probs=140.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-------
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------- 408 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------- 408 (601)
...++|++.++||+|+||.||+|+. .+++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3457899999999999999999995 458899999885432 2345799999999999999999987532
Q ss_pred -CeeEEEEeccCCCCccc--------------------------ccccccceeeccccccCcEEEccCC-CcEEeecccc
Q 007490 409 -DEKILVYEFVPNKSLDY--------------------------FLYDSQLRIIHRDLKASNILLDVQM-NPKISDFGLA 460 (601)
Q Consensus 409 -~~~~lv~E~~~~gsL~~--------------------------~l~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a 460 (601)
...++||||++++.... +.|+|+.+|+||||||+|||++.++ .+||+|||++
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23679999998642111 1167999999999999999999665 6999999999
Q ss_pred eecCCCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
+.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||..
T Consensus 219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8654322 12235789999999998764 689999999999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=265.73 Aligned_cols=179 Identities=30% Similarity=0.484 Sum_probs=149.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeC-----
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG----- 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----- 408 (601)
+.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356778999999999999999999854 58889999986543 3446788999999999 799999999998753
Q ss_pred -CeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 409 -DEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 409 -~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
...+++|||+++++|..++ ++|+.+|+||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4579999999998887654 56999999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..... .......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 161 LDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred ccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 53221 2233456889999999986 34578899999999999999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.26 Aligned_cols=207 Identities=29% Similarity=0.417 Sum_probs=166.4
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
++..++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456667777789999999999999954 577899999887766667789999999999999999999999999999999
Q ss_pred EEeccCCCCccccc--------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCCC
Q 007490 414 VYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVD 466 (601)
Q Consensus 414 v~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~ 466 (601)
|+||+++++|..++ ++|+.+|+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999887654 558999999999999999986 678999999998765322
Q ss_pred CCccccccccccccccCcccccCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQ--FSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------- 523 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------- 523 (601)
. .......++..|+|||++.... ++.++||||||+++|||++|+.|+........
T Consensus 163 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 163 N--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred C--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 1 1122345788999999986643 78999999999999999999999854321100
Q ss_pred -ccccC---ccCCCCCCCHHHHHH
Q 007490 524 -EDLLS---YEDPADRPSMATIVL 543 (601)
Q Consensus 524 -~~l~~---~~dP~~RPt~~evl~ 543 (601)
.+++. ..+|.+|||+.|+++
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111 168999999998875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=282.92 Aligned_cols=170 Identities=25% Similarity=0.291 Sum_probs=142.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
...|.+.+.||+|+||.||++++. .++.||||.... ..+.+|++++++|+||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 446999999999999999999965 478899996422 2356899999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+.+ +|..++ |+|+.+|+||||||+|||++.++.+||+|||+++............
T Consensus 242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 864 443332 6799999999999999999999999999999998764332222223
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
...||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 457999999999999999999999999999999999887543
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=262.21 Aligned_cols=200 Identities=31% Similarity=0.476 Sum_probs=158.1
Q ss_pred cccccCcceEEeeecC---CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCC
Q 007490 347 KLGRGGFGEVYKGVLP---HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS 422 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gs 422 (601)
.||+|+||.||+|++. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 35579999986653 334567899999999999999999999885 457899999999999
Q ss_pred ccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc-cccccc
Q 007490 423 LDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN-TSRIVG 477 (601)
Q Consensus 423 L~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~g 477 (601)
|.+++ ++|+.+++||||||+|||++.++.+||+|||++........... .....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 87655 55999999999999999999999999999999986543322111 111223
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc--------------------ccccc---CccCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG--------------------AEDLL---SYEDPA 533 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~--------------------~~~l~---~~~dP~ 533 (601)
+..|+|||.+....++.++||||||+++||+++ |..||....... ..+++ ...+|+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~ 240 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWE 240 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 568999999988889999999999999999996 999986432211 11111 127999
Q ss_pred CCCCHHHHHHHHhc
Q 007490 534 DRPSMATIVLALNS 547 (601)
Q Consensus 534 ~RPt~~evl~~L~~ 547 (601)
+||++.+|.+.|+.
T Consensus 241 ~Rp~~~~i~~~l~~ 254 (257)
T cd05115 241 DRPNFAKVEERMRT 254 (257)
T ss_pred hCcCHHHHHHHHhh
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=249.93 Aligned_cols=215 Identities=24% Similarity=0.321 Sum_probs=172.1
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC---
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD--- 409 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--- 409 (601)
++.+..++|++.++||+|||+-||.++ ..+++.+|+|++...+.++.+..++|++..++++||||++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 345667899999999999999999999 6678999999998888888889999999999999999999999876443
Q ss_pred --eeEEEEeccCCCCccccc---------------------------ccccce--eeccccccCcEEEccCCCcEEeecc
Q 007490 410 --EKILVYEFVPNKSLDYFL---------------------------YDSQLR--IIHRDLKASNILLDVQMNPKISDFG 458 (601)
Q Consensus 410 --~~~lv~E~~~~gsL~~~l---------------------------~~h~~~--iiHrdlkp~NIll~~~~~~kL~Dfg 458 (601)
..||+++|...|+|.+.+ ++|+.. ++||||||.|||+.+.+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 489999999999887655 458777 9999999999999999999999999
Q ss_pred cceecCCCCCcc-------ccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-c----
Q 007490 459 LARIFGVDQTQG-------NTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-A---- 523 (601)
Q Consensus 459 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~---- 523 (601)
.+......-... .......|..|+|||.+. +...+.++|||||||+||+|+.|..||+.....+ .
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 997543211000 011234688999999884 4567899999999999999999999996422111 0
Q ss_pred ------------------ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 ------------------EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ------------------~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...||.+||++.+++..+...
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 001 1117999999999999988653
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=265.77 Aligned_cols=174 Identities=30% Similarity=0.417 Sum_probs=148.9
Q ss_pred CCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 342 FSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++|+||+++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999985 468899999986542 22334578899999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+.+|+||||||+||++++++.+||+|||++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cc
Confidence 9999886543 5699999999999999999999999999999997653221 12
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....|+..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 2346899999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=262.94 Aligned_cols=177 Identities=32% Similarity=0.520 Sum_probs=151.2
Q ss_pred CCCcCCcccccCcceEEeeecCCCceeeEEEeccCC------hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+|+..+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998789999999886432 12235688999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC----
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ---- 467 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---- 467 (601)
+||+++++|..++ ++|+.+|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 9999999987765 5589999999999999999999999999999987643211
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 11112334688899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=270.76 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=166.5
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
+.|.....||+|+||.||++.. .++..||||.+........+.+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 3455567899999999999985 358899999987665556677899999999999999999999999999999999999
Q ss_pred CCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 419 PNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 419 ~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
++++|..++ ++|+.+|+||||||+||++++++.++|+|||++....... .......
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 999887654 5699999999999999999999999999999987543221 1123346
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccc---ccCccC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AED---LLSYED 531 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~---l~~~~d 531 (601)
++..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+ .+...|
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCC
Confidence 8899999999988889999999999999999999999985432110 000 111279
Q ss_pred CCCCCCHHHHHHH
Q 007490 532 PADRPSMATIVLA 544 (601)
Q Consensus 532 P~~RPt~~evl~~ 544 (601)
|.+|||+.++++.
T Consensus 260 P~~Rpt~~~il~~ 272 (292)
T cd06658 260 PSQRATAQELLQH 272 (292)
T ss_pred hhHCcCHHHHhhC
Confidence 9999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=266.86 Aligned_cols=208 Identities=29% Similarity=0.482 Sum_probs=164.7
Q ss_pred CCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--Cee
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEK 411 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 411 (601)
..|++.+.||+|+||.||++++ .++..||+|.+.... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4478889999999999999973 347889999987543 44456789999999999999999999998875 568
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|..++ ++|+.||+||||||+||+++.++.+||+|||+++.+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999987654 5699999999999999999999999999999998764322
Q ss_pred Cc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC--------------------------
Q 007490 468 TQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT-------------------------- 520 (601)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~-------------------------- 520 (601)
.. .......++..|+|||++.+..++.++||||||+++|||++++.|......
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 21 112234567789999999888899999999999999999998765321000
Q ss_pred ---------Ccccccc---CccCCCCCCCHHHHHHHHhc
Q 007490 521 ---------DGAEDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 521 ---------~~~~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
....+++ ...||.+||++.++++.|+.
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0001111 12799999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=262.46 Aligned_cols=203 Identities=33% Similarity=0.525 Sum_probs=162.9
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh---------hHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ---------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999853 5789999988654221 23568899999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.++||||+++++|..++ ++|+.+++||||+|+||++++++.+||+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999886554 5699999999999999999999999999999998764221
Q ss_pred Cc----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------
Q 007490 468 TQ----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 468 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------- 523 (601)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence 11 111234578899999999988899999999999999999999999865321100
Q ss_pred cccc---CccCCCCCCCHHHHHH
Q 007490 524 EDLL---SYEDPADRPSMATIVL 543 (601)
Q Consensus 524 ~~l~---~~~dP~~RPt~~evl~ 543 (601)
.+++ ...||.+||++.||++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhh
Confidence 0011 1168999999988875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=266.60 Aligned_cols=175 Identities=29% Similarity=0.446 Sum_probs=149.4
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999964 4778899998766666677889999999999999999999999999999999999999
Q ss_pred CCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 421 KSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 421 gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
++|..++ ++|+.+|+||||||+||+++.++.+||+|||++....... .......
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFI 164 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccccccc
Confidence 9886543 5699999999999999999999999999999987643221 1223356
Q ss_pred ccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 477 GTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 477 gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
++..|+|||++. +..++.++|||||||++|||++|++||...
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 889999999884 455788999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.34 Aligned_cols=173 Identities=28% Similarity=0.389 Sum_probs=149.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.++||+|+||.||++... ++..+++|.+... ......++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999854 5788999988654 333456688999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++++|..++ |+|+ .+++||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~ 156 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccc
Confidence 9999997665 5586 58999999999999999999999999998754321 123
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 3578899999999988889999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=267.01 Aligned_cols=205 Identities=27% Similarity=0.432 Sum_probs=167.4
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+.++|++.+.||.|++|.||++... +++.||+|.+........+.+.+|++++++++||||+++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467899999999999999999964 588999999977766667789999999999999999999999999999999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++++|..++ ++|+.+|+|+||||+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKR 160 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--ccc
Confidence 99999886654 5699999999999999999999999999999987543221 122
Q ss_pred ccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccc
Q 007490 473 SRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AED 525 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~ 525 (601)
....++..|+|||.+. ...++.++||||||+++|||++|+.||....... ..+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 3346889999999874 3457789999999999999999999986532111 001
Q ss_pred cc---CccCCCCCCCHHHHHHH
Q 007490 526 LL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~ 544 (601)
++ ...+|.+||++.++++.
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcC
Confidence 11 12789999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=264.44 Aligned_cols=194 Identities=29% Similarity=0.392 Sum_probs=153.1
Q ss_pred cccccCcceEEeeecCC-------------------------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccce
Q 007490 347 KLGRGGFGEVYKGVLPH-------------------------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 401 (601)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998866555555678899999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCC-------
Q 007490 402 LGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQM------- 450 (601)
Q Consensus 402 ~~~~~~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~------- 450 (601)
++++......++||||+++++|..++ |+|+++|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 99999999999999999999987654 56999999999999999998654
Q ss_pred CcEEeecccceecCCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHH-hCCCCCCCCCCCc------
Q 007490 451 NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETI-TGKKNSSFYQTDG------ 522 (601)
Q Consensus 451 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg~~p~~~~~~~~------ 522 (601)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 162 ~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 235 (274)
T cd05076 162 FIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235 (274)
T ss_pred eeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 3799999988643211 12356788999998865 56899999999999999995 6888875432211
Q ss_pred ------------ccccc---CccCCCCCCCHHHHHHHHh
Q 007490 523 ------------AEDLL---SYEDPADRPSMATIVLALN 546 (601)
Q Consensus 523 ------------~~~l~---~~~dP~~RPt~~evl~~L~ 546 (601)
..+++ ...+|.+||++.+|++.|+
T Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 236 KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 1179999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=270.19 Aligned_cols=206 Identities=34% Similarity=0.495 Sum_probs=162.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCc--eeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQ--EIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.+.||+|+||.||+|++. ++. .+++|.+... .......+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999964 344 4577777543 334456788999999999 89999999999999999999
Q ss_pred EEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcEE
Q 007490 414 VYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
||||+++++|..++ ++|+.+|+||||||+|||++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 99999998875432 559999999999999999999999999
Q ss_pred eecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc-----------
Q 007490 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG----------- 522 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~----------- 522 (601)
+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 166 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05088 166 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242 (303)
T ss_pred CccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence 999998642211 11111234567999999988889999999999999999998 998885432111
Q ss_pred ---------ccccc---CccCCCCCCCHHHHHHHHhc
Q 007490 523 ---------AEDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 523 ---------~~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
..+++ ...+|.+||++.+++++|+.
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00111 12799999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=253.78 Aligned_cols=204 Identities=28% Similarity=0.430 Sum_probs=166.9
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC----hh----hHHHHHHHHHHHHHc-CCCCccceEEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS----GQ----GAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 407 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~----~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 407 (601)
.-..|...+.||+|..+.|-++.. ++|++.|+|++.... .. -.+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345688889999999999998885 468999999985421 11 123456799999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 408 GDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
+...++|+|.|+.|.|.++| |+|.+.|+||||||+|||++++.++||+|||++..+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999998887 6799999999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccc------CCCCCchhhHHhHHHHHHHHHhCCCCCCCC-----------------CC-
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAM------HGQFSVKSDVYSFGVLALETITGKKNSSFY-----------------QT- 520 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~-----------------~~- 520 (601)
.+. .....+|||+|+|||.+. ...|+..+|+|++|||+|.|+.|.+||... .+
T Consensus 175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred Cch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 543 345579999999999885 346889999999999999999999998421 11
Q ss_pred -----Ccccccc---CccCCCCCCCHHHHHHH
Q 007490 521 -----DGAEDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 521 -----~~~~~l~---~~~dP~~RPt~~evl~~ 544 (601)
....+++ ...||.+|.|+.|.++.
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1112222 22799999999998653
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=261.80 Aligned_cols=203 Identities=30% Similarity=0.460 Sum_probs=157.0
Q ss_pred CcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEE-eCCeeEEEEeccC
Q 007490 346 NKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL-EGDEKILVYEFVP 419 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~~~ 419 (601)
+.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 457999998543 3345677889999999999999999999876 4556789999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc--cccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--GNTS 473 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~ 473 (601)
+++|..++ ++|+.+++||||||+|||++.++.+||+|||+++........ ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99887654 569999999999999999999999999999999755322111 1111
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhC-CCCCCCCCCC--------------------cccccc---Cc
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG-KKNSSFYQTD--------------------GAEDLL---SY 529 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~--------------------~~~~l~---~~ 529 (601)
...++..|+|||.+.+..++.++||||||+++|||++| .+|+...... ...+++ ..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 240 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWH 240 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcC
Confidence 23456789999999888999999999999999999995 4555422110 011111 12
Q ss_pred cCCCCCCCHHHHHHHHhcC
Q 007490 530 EDPADRPSMATIVLALNSH 548 (601)
Q Consensus 530 ~dP~~RPt~~evl~~L~~~ 548 (601)
.+|.+||++.+|++.|+..
T Consensus 241 ~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 241 PKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CChhhCCCHHHHHHHHHHH
Confidence 7999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=265.79 Aligned_cols=203 Identities=28% Similarity=0.468 Sum_probs=165.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999854 57889999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++++|..++ ++|+.+++|+||+|+||++++++.++|+|||++..+..... .....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcc
Confidence 9999886654 56999999999999999999999999999999976543221 12234
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------cccc---cCccCC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDL---LSYEDP 532 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l---~~~~dP 532 (601)
.++..|+|||++.+..++.++||||||+++|||++|+.|+....... ..++ +...+|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 57889999999998899999999999999999999999975322111 0011 112799
Q ss_pred CCCCCHHHHHHH
Q 007490 533 ADRPSMATIVLA 544 (601)
Q Consensus 533 ~~RPt~~evl~~ 544 (601)
.+||++.+++..
T Consensus 242 ~~Rp~~~~il~~ 253 (277)
T cd06642 242 RFRPTAKELLKH 253 (277)
T ss_pred ccCcCHHHHHHh
Confidence 999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.21 Aligned_cols=202 Identities=35% Similarity=0.538 Sum_probs=160.3
Q ss_pred CcccccCcceEEeeecCC----CceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
++||+|+||.||+|++.. +..+|+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997432 26899999876543 34567899999999999999999999876 4568999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc-ccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN-TSRIV 476 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~ 476 (601)
++|.+++ ++|..+++||||||+|||++.++.+||+|||+++.......... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 9987655 56999999999999999999999999999999987643322111 11122
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------cccC---ccCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLLS---YEDP 532 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~~---~~dP 532 (601)
++..|+|||.+.+..++.++||||||+++|||++ |..||......... +++. ..+|
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCCh
Confidence 3467999999998899999999999999999998 99998653321110 1111 1799
Q ss_pred CCCCCHHHHHHHHhcC
Q 007490 533 ADRPSMATIVLALNSH 548 (601)
Q Consensus 533 ~~RPt~~evl~~L~~~ 548 (601)
.+||++.+|++.|+..
T Consensus 240 ~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 240 EDRPTFSELESTFRRD 255 (257)
T ss_pred hhCcCHHHHHHHHHhc
Confidence 9999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.57 Aligned_cols=201 Identities=21% Similarity=0.348 Sum_probs=152.7
Q ss_pred CcccccCcceEEeeecCCCc---eeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 346 NKLGRGGFGEVYKGVLPHGQ---EIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.||+|+||.||+|+..++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999854433 45677665443 344568899999999999999999999999999999999999999
Q ss_pred Cccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 422 SLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 422 sL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+|..++ ++|+.+++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 987544 56899999999999999999999999999999864321111112223
Q ss_pred ccccccccCcccccC-------CCCCchhhHHhHHHHHHHHHhC-CCCCCCCCCCcc---------c-------------
Q 007490 475 IVGTYGYMSPEYAMH-------GQFSVKSDVYSFGVLALETITG-KKNSSFYQTDGA---------E------------- 524 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~---------~------------- 524 (601)
..++..|+|||++.. ..++.++||||||+++|||+++ ..||........ .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 467889999998753 2457899999999999999974 567643221100 0
Q ss_pred ---cccC--ccCCCCCCCHHHHHHHHh
Q 007490 525 ---DLLS--YEDPADRPSMATIVLALN 546 (601)
Q Consensus 525 ---~l~~--~~dP~~RPt~~evl~~L~ 546 (601)
+++. ..+|.+||++.+|++.|.
T Consensus 241 ~~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 0000 158999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=257.66 Aligned_cols=189 Identities=26% Similarity=0.325 Sum_probs=163.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
+..++|+.+++||+|.||.|.+++- ..++.+|+|++++.- ......-..|-++|+..+||.+..+--.|+..+.++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4557899999999999999999984 468999999998753 333344567889999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||..||.|..+| |+|+.+||.||||.+|+|+|.+|++||+|||+++.-- ...
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--ccc
Confidence 999999999997766 7899999999999999999999999999999997532 222
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL 527 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~ 527 (601)
..+..++|||.|+|||++....|..++|+|.+||++|||+.|+.||.....+.+.+++
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 3466789999999999999999999999999999999999999999876655554444
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=273.76 Aligned_cols=205 Identities=28% Similarity=0.422 Sum_probs=175.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.....|.+.+.||+|.|+.|.++++ .++.+||||.+.+.. ......+.+|+++|+.|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456789999999999999999994 469999999998753 3344568899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||..+|.+.+++ |+|++.|+|||||++||||+.+.++||+|||++..+... .
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---L 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc---c
Confidence 99999999998877 779999999999999999999999999999999988633 2
Q ss_pred ccccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccccC--
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDLLS-- 528 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l~~-- 528 (601)
.....+|++.|.|||+..+.+|. +.+|+||+|++||-|+.|..||+....... ++++.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence 34567999999999999998875 899999999999999999999986443222 22222
Q ss_pred -ccCCCCCCCHHHHHHH
Q 007490 529 -YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 -~~dP~~RPt~~evl~~ 544 (601)
..+|.+|+++++|.+.
T Consensus 290 lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hccCccccCCHHHhhhh
Confidence 2799999999998764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=266.55 Aligned_cols=173 Identities=31% Similarity=0.498 Sum_probs=140.1
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHc---CCCCccceEEEEEeC-----C
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEG-----D 409 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~-----~ 409 (601)
+|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999954 588999999865321 2223456677777665 799999999988642 4
Q ss_pred eeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 410 EKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
..++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 57899999985 443322 6699999999999999999999999999999998654
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
... ......++..|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 160 CQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred Ccc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 221 12234678999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.01 Aligned_cols=202 Identities=26% Similarity=0.419 Sum_probs=166.0
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||.|+||.||.++. .+++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999884 45889999998654 344556788999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+.+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence 9998886544 56999999999999999999999999999999987643321 22
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc--------------------cc---cCc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE--------------------DL---LSY 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~--------------------~l---~~~ 529 (601)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||......... ++ +..
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 3456889999999998888999999999999999999999998653321110 00 111
Q ss_pred cCCCCCCCHHHHHHH
Q 007490 530 EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ~dP~~RPt~~evl~~ 544 (601)
.+|.+||++.++++.
T Consensus 239 ~~p~~R~s~~~ll~~ 253 (256)
T cd08221 239 QDPEKRPTADEVLDQ 253 (256)
T ss_pred cCcccCCCHHHHhhC
Confidence 689999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=267.71 Aligned_cols=183 Identities=31% Similarity=0.421 Sum_probs=160.2
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
+.+..+.|+.-++||+|+||+||-++. .+|+.+|.|++.+. .........+|-.+|.+++.+.||.+--.++..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 345567789999999999999999984 46999999988654 23445567899999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 KILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
+++|+..|.||+|..+| ++|+.+||.|||||+|||+|+.|+++|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888 44888999999999999999999999999999998765
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT 520 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 520 (601)
.+. ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||.....
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 443 2334899999999999999999999999999999999999999976543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=262.21 Aligned_cols=203 Identities=27% Similarity=0.455 Sum_probs=167.4
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
..|+..++||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999964 58899999987543 34557789999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++++|.+++ ++|+.+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccc
Confidence 9999987755 56999999999999999999999999999999976543221 12234
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc--------------------cc---cCccCC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE--------------------DL---LSYEDP 532 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~--------------------~l---~~~~dP 532 (601)
.++..|+|||++.+..++.++|+||||+++|||++|+.|+......... ++ +...+|
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCc
Confidence 6788999999999888999999999999999999999998643211100 11 112799
Q ss_pred CCCCCHHHHHHH
Q 007490 533 ADRPSMATIVLA 544 (601)
Q Consensus 533 ~~RPt~~evl~~ 544 (601)
.+||++.+++..
T Consensus 242 ~~Rp~~~~il~~ 253 (277)
T cd06640 242 SFRPTAKELLKH 253 (277)
T ss_pred ccCcCHHHHHhC
Confidence 999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=264.14 Aligned_cols=212 Identities=25% Similarity=0.409 Sum_probs=166.8
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEE-
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCL- 406 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~- 406 (601)
+.+..+..+.++|++.+.||+|+||.||+++.. +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 345667778899999999999999999999854 57899999876432 2235678899999999 6999999999884
Q ss_pred ----eCCeeEEEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 407 ----EGDEKILVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 407 ----~~~~~~lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
.++..++||||+++++|..++ ++|+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999986543 5699999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-------- 522 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-------- 522 (601)
|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+.......
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9999986543221 1223468899999998753 457889999999999999999999975432110
Q ss_pred --------------ccccc---CccCCCCCCCHHHHHHH
Q 007490 523 --------------AEDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 523 --------------~~~l~---~~~dP~~RPt~~evl~~ 544 (601)
..+++ ...||.+||++.||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00011 11689999999998864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=260.74 Aligned_cols=178 Identities=29% Similarity=0.425 Sum_probs=148.4
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--Cee
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEK 411 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 411 (601)
.+|+..+.||+|+||.||++... +++.|++|++.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999854 58899999886432 22345688999999999999999999988753 567
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++++||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999887654 56999999999999999999999999999999976532111
Q ss_pred -ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 -QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 1112234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=273.36 Aligned_cols=208 Identities=29% Similarity=0.391 Sum_probs=169.3
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEecc--CChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSR--SSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
+.+....|+++++||+||.+.||++...+.+.+|+|++.. .+.+..+-+.+|+.+|.+| .|.+||++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4556678999999999999999999988888899988754 3566778899999999999 589999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
||||||-+ .+|..+| +.|+.||||-||||.|+|+- .|.+||+|||+|..+..+.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 99999753 2333322 45999999999999999886 5789999999999888776
Q ss_pred CccccccccccccccCcccccCC-----------CCCchhhHHhHHHHHHHHHhCCCCCCCCCCC---------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHG-----------QFSVKSDVYSFGVLALETITGKKNSSFYQTD--------------- 521 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--------------- 521 (601)
+.......+||+.||+||.+... +.+.++||||||||||+|+.|+.||..+...
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 66666677999999999988532 2568899999999999999999999654310
Q ss_pred -------c-cccc---cCccCCCCCCCHHHHHHH
Q 007490 522 -------G-AEDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 522 -------~-~~~l---~~~~dP~~RPt~~evl~~ 544 (601)
+ ..++ +...||.+||++.|+++.
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 0 1111 112799999999999864
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=261.28 Aligned_cols=178 Identities=28% Similarity=0.409 Sum_probs=148.5
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--Cee
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEK 411 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 411 (601)
++|++.+.||+|+||.||++.. .+++.|+||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788899999999999999995 458899999875321 22346788999999999999999999988764 467
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+++|||+++++|..++ ++|+.+|+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999987654 56999999999999999999999999999999976532111
Q ss_pred -ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 -QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 1112234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=296.91 Aligned_cols=188 Identities=27% Similarity=0.341 Sum_probs=163.4
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEE
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 405 (601)
-...+++...++|+++++||+|+||.|..++.+ +++.+|+|++++. .......|..|-.+|..-+.+-|++++-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 345667788899999999999999999999965 4788999999773 344456788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.+++++|+|||||+||+|-.++ .+|+.|+|||||||+|||||..|++||+|||.+-.
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999987666 34999999999999999999999999999999988
Q ss_pred cCCCCCccccccccccccccCccccc----C-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAM----H-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
+..+.. ......+|||.|++||++. + +.|+..+|+||+||++|||+.|..||...
T Consensus 225 m~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 225 MDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred cCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 765443 3345579999999999985 3 67999999999999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=273.73 Aligned_cols=174 Identities=29% Similarity=0.426 Sum_probs=144.9
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 408 (601)
..++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999985 468899999986542 22345677899999999999999999987643
Q ss_pred CeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 409 DEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
...++++|++ +++|..++ |+|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 3468999987 55664432 679999999999999999999999999999999865322
Q ss_pred CCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 172 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred -----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 233578999999999876 5688999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=263.40 Aligned_cols=202 Identities=35% Similarity=0.575 Sum_probs=160.6
Q ss_pred CcccccCcceEEeeecCC-------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPH-------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+.||+|+||.||+|+..+ ++.++||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 2578999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------------ccccceeeccccccCcEEEccCC-----CcEEeeccccee
Q 007490 418 VPNKSLDYFL------------------------------YDSQLRIIHRDLKASNILLDVQM-----NPKISDFGLARI 462 (601)
Q Consensus 418 ~~~gsL~~~l------------------------------~~h~~~iiHrdlkp~NIll~~~~-----~~kL~Dfg~a~~ 462 (601)
+++++|..++ ++|+.+++|+||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9998886543 55899999999999999999887 899999999976
Q ss_pred cCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc-------------------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG------------------- 522 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~------------------- 522 (601)
..............++..|+|||++.++.++.++||||||+++|||++ |+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD 240 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchH
Confidence 543222212222345678999999999999999999999999999998 998875432111
Q ss_pred -cccccC---ccCCCCCCCHHHHHHHHhc
Q 007490 523 -AEDLLS---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 523 -~~~l~~---~~dP~~RPt~~evl~~L~~ 547 (601)
..+++. ..+|.+||++.+|++.|+.
T Consensus 241 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 241 KIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011111 1799999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=267.21 Aligned_cols=175 Identities=28% Similarity=0.443 Sum_probs=145.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|+..++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999854 57899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++ +|..++ ++|+.+|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 162 (301)
T cd07873 86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYS 162 (301)
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--ccc
Confidence 975 554332 66999999999999999999999999999999976432211 122
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3356889999998865 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=263.49 Aligned_cols=195 Identities=29% Similarity=0.461 Sum_probs=155.5
Q ss_pred CcccccCcceEEeeecCC--------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPH--------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+.||+|+||.||+|.... ..+|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998532 235888888665555567889999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCC--------cEEeecccceecCC
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMN--------PKISDFGLARIFGV 465 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~--------~kL~Dfg~a~~~~~ 465 (601)
+++++|..++ ++|+.+|+||||||+||+++.++. ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 9999987665 569999999999999999988765 58999998865432
Q ss_pred CCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCC-CCCCCCCCCc------------------ccc
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGK-KNSSFYQTDG------------------AED 525 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~-~p~~~~~~~~------------------~~~ 525 (601)
.....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ..+
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd05078 161 ------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN 234 (258)
T ss_pred ------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHH
Confidence 1234678899999999864 5789999999999999999995 5543322110 111
Q ss_pred cc---CccCCCCCCCHHHHHHHHh
Q 007490 526 LL---SYEDPADRPSMATIVLALN 546 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~ 546 (601)
++ ...||.+|||+.+|++.|+
T Consensus 235 li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 235 LINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHhccChhhCCCHHHHHHhcC
Confidence 11 1279999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=267.59 Aligned_cols=201 Identities=27% Similarity=0.429 Sum_probs=164.7
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999854 6899999998765555566788999999999999999999999999999999999999
Q ss_pred CCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 421 KSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 421 gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
++|..++ ++|+.+++||||||+||+++.++.+||+|||++..+..... ......++
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~ 180 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGT 180 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecC
Confidence 9886554 56999999999999999999999999999999875533221 12335688
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccccc---CccCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDLL---SYEDPA 533 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l~---~~~dP~ 533 (601)
..|+|||++.+..++.++||||||+++|||++|+.||....... ..+++ ...+|.
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~ 260 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ 260 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcc
Confidence 99999999998899999999999999999999999985332110 00111 117999
Q ss_pred CCCCHHHHHHH
Q 007490 534 DRPSMATIVLA 544 (601)
Q Consensus 534 ~RPt~~evl~~ 544 (601)
+||++.++++.
T Consensus 261 ~Rps~~~ll~~ 271 (297)
T cd06659 261 ERATAQELLDH 271 (297)
T ss_pred cCcCHHHHhhC
Confidence 99999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=257.53 Aligned_cols=203 Identities=38% Similarity=0.556 Sum_probs=163.8
Q ss_pred CCcCCcccccCcceEEeeecCC-----CceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPH-----GQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+++.+.||.|+||.||+++..+ +..||+|++...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999654 378999999665433 5678899999999999999999999999999999999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|..++ ++|+.+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999998886544 5599999999999999999999999999999998765432221
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc-----------------------cc
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE-----------------------DL 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~-----------------------~l 526 (601)
.. ...+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......... ..
T Consensus 161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 11 2236789999999988889999999999999999998 77777543221110 01
Q ss_pred cCccCCCCCCCHHHHHHHH
Q 007490 527 LSYEDPADRPSMATIVLAL 545 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~L 545 (601)
+...||.+|||+.|+++.|
T Consensus 240 ~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 240 CWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HCcCChhhCcCHHHHHhhC
Confidence 1117999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=259.08 Aligned_cols=199 Identities=35% Similarity=0.540 Sum_probs=161.9
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999985 78889999986543 346788999999999999999999998764 5799999999
Q ss_pred CCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 420 NKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 420 ~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+++|..++ ++|+.+++||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 156 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN 156 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence 99987654 559999999999999999999999999999999764321 112
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------ccc---Ccc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DLL---SYE 530 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l~---~~~ 530 (601)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.||......... +++ ...
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 234567999999988899999999999999999998 88887543321100 111 116
Q ss_pred CCCCCCCHHHHHHHHhc
Q 007490 531 DPADRPSMATIVLALNS 547 (601)
Q Consensus 531 dP~~RPt~~evl~~L~~ 547 (601)
+|.+||++.+|++.|+.
T Consensus 237 ~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 237 EPKKRPSFHKLREKLEK 253 (254)
T ss_pred ChhhCcCHHHHHHHHcc
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=258.87 Aligned_cols=193 Identities=31% Similarity=0.524 Sum_probs=154.1
Q ss_pred CcccccCcceEEeeecCCCc-----------eeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 346 NKLGRGGFGEVYKGVLPHGQ-----------EIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999975432 4778877544333 6788999999999999999999999988 778999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCC-------CcEEeecccceec
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQM-------NPKISDFGLARIF 463 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~-------~~kL~Dfg~a~~~ 463 (601)
|||+++++|..++ ++|+.+|+||||||+|||++.++ .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 9999999987655 56999999999999999999888 7999999999865
Q ss_pred CCCCCccccccccccccccCcccccCC--CCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-----------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA----------------- 523 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~----------------- 523 (601)
.. .....++..|+|||++.+. .++.++||||||+++|||++ |..|+........
T Consensus 159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T cd05037 159 LS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE 232 (259)
T ss_pred cc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchH
Confidence 32 1223566789999999876 78999999999999999999 4666644321110
Q ss_pred -ccccC---ccCCCCCCCHHHHHHHHh
Q 007490 524 -EDLLS---YEDPADRPSMATIVLALN 546 (601)
Q Consensus 524 -~~l~~---~~dP~~RPt~~evl~~L~ 546 (601)
.+++. ..+|.+|||+.+|++.|+
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 233 LANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 169999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.34 Aligned_cols=209 Identities=33% Similarity=0.494 Sum_probs=167.4
Q ss_pred CCCCcCCcccccCcceEEeeecC-----CCceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEe--CCee
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-----HGQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEK 411 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 411 (601)
++|+..+.||+|+||.||++++. .++.||||.+...... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3678999999765443 56789999999999999999999999887 5578
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+++|||+++++|..++ ++|+.+++||||||+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 9999999999987655 5699999999999999999999999999999998765322
Q ss_pred Ccc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------
Q 007490 468 TQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------- 523 (601)
Q Consensus 468 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------- 523 (601)
... ......++..|++||.+.+..++.++||||||+++|||++|+.|+........
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 111 11122345679999999888999999999999999999999988754321110
Q ss_pred ------------cccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 524 ------------EDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ------------~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+++ ...+|.+|||+.||+++|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0111 116999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.04 Aligned_cols=177 Identities=25% Similarity=0.340 Sum_probs=140.8
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCC------CccceEEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR------NLVRLLGFCL 406 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~ 406 (601)
+++...++|++.++||+|+||+||+|+.. .++.||||++.... .....+..|+.+++.++|. +|+++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34556789999999999999999999854 57889999986432 2334556788888877654 5888888887
Q ss_pred eC-CeeEEEEeccCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCC-----------
Q 007490 407 EG-DEKILVYEFVPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQM----------- 450 (601)
Q Consensus 407 ~~-~~~~lv~E~~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~----------- 450 (601)
.. ...++|||++. ++|..++ |+|+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~g-~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKYG-PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEeccC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 64 46889999884 4443322 6797 6999999999999998765
Q ss_pred -----CcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 451 -----NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 451 -----~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 281 ~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999876422 122346789999999999999999999999999999999999999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=261.07 Aligned_cols=206 Identities=28% Similarity=0.425 Sum_probs=161.6
Q ss_pred CCcCCcccccCcceEEeeecC----CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC------
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD------ 409 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 409 (601)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3688999998654 3344667889999999999999999999887543
Q ss_pred eeEEEEeccCCCCccccc-----------------------------ccccceeeccccccCcEEEccCCCcEEeecccc
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
..++++||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247889999998875432 569999999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc----------------
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA---------------- 523 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~---------------- 523 (601)
+...............+++.|++||.+....++.++||||||+++|||++ |+.|+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 86543322212223345678999999998889999999999999999999 8888754322110
Q ss_pred ----cccc---CccCCCCCCCHHHHHHHHhc
Q 007490 524 ----EDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 ----~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
.+++ ...+|.+||++.++++.|++
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0111 11799999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.82 Aligned_cols=199 Identities=35% Similarity=0.510 Sum_probs=156.8
Q ss_pred CcccccCcceEEeeecCC-Cc--eeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLPH-GQ--EIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+|++.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999644 43 4688888643 344556788999999999 899999999999999999999999999
Q ss_pred CCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 421 KSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 421 gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
++|..++ ++|+.+++||||||+||++++++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 8875442 4589999999999999999999999999999986
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-----------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA----------------- 523 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~----------------- 523 (601)
..... ........+..|+|||++....++.++||||||+++|||++ |..||........
T Consensus 161 ~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 161 GQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 32211 01111223567999999988889999999999999999997 9988854321110
Q ss_pred ---cccc---CccCCCCCCCHHHHHHHHhc
Q 007490 524 ---EDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 ---~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
.+++ ...||.+|||+.+++..|+.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0111 11799999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=257.83 Aligned_cols=175 Identities=33% Similarity=0.525 Sum_probs=150.9
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999965 68999999986543 23456789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+||+++++|..++ ++|+.+|+|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999887654 5699999999999999999999999999999998654322 2
Q ss_pred cccccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....++..|++||.+.... ++.++|+||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 23456888999999987766 899999999999999999999998543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=257.82 Aligned_cols=201 Identities=27% Similarity=0.377 Sum_probs=162.0
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEe-CCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E 416 (601)
+|++.+.||+|++|.||++... +++.|++|++.... ....+.+.+|++++++++||||+++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999954 47889999986532 3345678899999999999999999998764 446789999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++++|.+++ ++|+.+|+||||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--M 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--c
Confidence 99998886543 56999999999999999999999999999999987643221 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc--------------------c---cC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED--------------------L---LS 528 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~--------------------l---~~ 528 (601)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||.......... + +.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 234567889999999999999999999999999999999999986433211100 0 01
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+||++.+++.
T Consensus 239 ~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 239 SKRPEKRPSVKSILR 253 (257)
T ss_pred ccCcccCCCHHHHhc
Confidence 168999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.67 Aligned_cols=178 Identities=31% Similarity=0.496 Sum_probs=152.1
Q ss_pred CCCcCCcccccCcceEEeee-cCCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC------eeE
Q 007490 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD------EKI 412 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~ 412 (601)
.|...+.||+|+||.||+|+ ...|+.||||.+... .....+...+|+++|++|+|||||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35566899999999999999 557999999999764 3445677889999999999999999999876544 468
Q ss_pred EEEeccCCCCccccc--------------------------ccccceeeccccccCcEEEcc--CCC--cEEeeccccee
Q 007490 413 LVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDV--QMN--PKISDFGLARI 462 (601)
Q Consensus 413 lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~--~~~--~kL~Dfg~a~~ 462 (601)
+|||||.+|+|+..+ |+|++||+||||||.||++-. +|+ -||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999998776 679999999999999999853 344 69999999998
Q ss_pred cCCCCCccccccccccccccCccccc-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 521 (601)
+..+. .....+||..|.+||... .+.|+..+|.|||||++||..||..||......
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 76544 456789999999999998 488999999999999999999999999665443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=262.38 Aligned_cols=174 Identities=32% Similarity=0.496 Sum_probs=144.4
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|++.+.||+|++|.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999964 68899999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCccccc--------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++ +|..++ ++|+.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--V 157 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--c
Confidence 974 443222 66999999999999999999999999999999976543211 1
Q ss_pred cccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....+++.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2223568899999988654 578999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.65 Aligned_cols=176 Identities=29% Similarity=0.420 Sum_probs=148.9
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999965 58999999986542 2234567899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|..++ ++|+.+++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--ccc
Confidence 99988776543 66999999999999999999999999999999987643321 122
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 3457789999999876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=258.16 Aligned_cols=203 Identities=27% Similarity=0.426 Sum_probs=163.8
Q ss_pred CCCcCCcccccCcceEEeeecCC--CceeeEEEeccC----------ChhhHHHHHHHHHHHHH-cCCCCccceEEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPH--GQEIAVKRLSRS----------SGQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLE 407 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~ 407 (601)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999654 678999987532 12234557788888875 799999999999999
Q ss_pred CCeeEEEEeccCCCCccccc---------------------------cccc-ceeeccccccCcEEEccCCCcEEeeccc
Q 007490 408 GDEKILVYEFVPNKSLDYFL---------------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l---------------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
++..+++|||+++++|..++ ++|+ .+++|+||+|+||+++.++.+||+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999998886543 5585 7899999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC------------------
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------ 521 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------ 521 (601)
+....... ......++..|++||.+.+..++.++||||||+++|||++|+.||......
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 98754322 233456888999999999888999999999999999999999997543210
Q ss_pred ---ccccc---cCccCCCCCCCHHHHHHHHh
Q 007490 522 ---GAEDL---LSYEDPADRPSMATIVLALN 546 (601)
Q Consensus 522 ---~~~~l---~~~~dP~~RPt~~evl~~L~ 546 (601)
...++ +...||.+||++.|+.++++
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00011 11279999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.59 Aligned_cols=176 Identities=30% Similarity=0.422 Sum_probs=151.0
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|++.+.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999954 58899999886543 3445778999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++++|..++ ++|+ .+++||||||+||+++.++.++|+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IA 159 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----cc
Confidence 99999986543 4575 58999999999999999999999999998654221 12
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 2357899999999998889999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=260.82 Aligned_cols=207 Identities=32% Similarity=0.474 Sum_probs=165.4
Q ss_pred cCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.++|+..+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 367888999999999999999853 2457899988655443 457789999999999999999999999998999
Q ss_pred EEEEeccCCCCccccc--------------------------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 412 ILVYEFVPNKSLDYFL--------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l--------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
++||||+++++|.+++ ++|+.+|+||||||+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999998887543 56999999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc----------------
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG---------------- 522 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~---------------- 522 (601)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred ccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 875432211 11223355778999999988889999999999999999998 777774322111
Q ss_pred -----ccccc---CccCCCCCCCHHHHHHHHh
Q 007490 523 -----AEDLL---SYEDPADRPSMATIVLALN 546 (601)
Q Consensus 523 -----~~~l~---~~~dP~~RPt~~evl~~L~ 546 (601)
..+++ ...+|.+||++.|++.+|.
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01111 1179999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.99 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=161.1
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.+.||+|+||.||+++.. .++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999965 6899999988654 333456788999999999999999999999999999999999
Q ss_pred cCCCCccccc--------------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 418 VPNKSLDYFL--------------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 418 ~~~gsL~~~l--------------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
+++++|..++ ++|+ .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence 9998876543 4575 59999999999999999999999999999765322
Q ss_pred ccccccccccccCcccccCC------CCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc--------------------
Q 007490 471 NTSRIVGTYGYMSPEYAMHG------QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------- 524 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------- 524 (601)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||.........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 12234578899999998554 3578999999999999999999998543221110
Q ss_pred ---c---ccCccCCCCCCCHHHHHH
Q 007490 525 ---D---LLSYEDPADRPSMATIVL 543 (601)
Q Consensus 525 ---~---l~~~~dP~~RPt~~evl~ 543 (601)
+ .+...+|.+||++.+++.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhc
Confidence 0 011168999999998876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=291.95 Aligned_cols=208 Identities=29% Similarity=0.413 Sum_probs=162.3
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG- 408 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 408 (601)
...+...++|++.++||+|+||+||+++.. .++.||+|.+... .......+..|+.++++|+|||||++++++...
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344556678999999999999999999954 4778899988643 333456788999999999999999999988653
Q ss_pred -CeeEEEEeccCCCCccccc---------------------------ccccc-------eeeccccccCcEEEccC----
Q 007490 409 -DEKILVYEFVPNKSLDYFL---------------------------YDSQL-------RIIHRDLKASNILLDVQ---- 449 (601)
Q Consensus 409 -~~~~lv~E~~~~gsL~~~l---------------------------~~h~~-------~iiHrdlkp~NIll~~~---- 449 (601)
...||||||+++++|..++ |+|+. +||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 5689999999999986544 55774 59999999999999642
Q ss_pred -------------CCcEEeecccceecCCCCCccccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCC
Q 007490 450 -------------MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKN 514 (601)
Q Consensus 450 -------------~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p 514 (601)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 348999999998654322 1234578999999999864 4588999999999999999999999
Q ss_pred CCCCCCC--------------------ccccc---cCccCCCCCCCHHHHHH
Q 007490 515 SSFYQTD--------------------GAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 515 ~~~~~~~--------------------~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
|...... .+.++ +...+|.+||++.|++.
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 8643210 00011 11279999999999984
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=262.75 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=169.1
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 47899999999999999999984 46789999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++++|..++ ++|+.+++||||||+||+++.++.+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 175 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 175 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccc
Confidence 9999987654 56999999999999999999999999999999876543221 12234
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------------ccc---Ccc
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------------DLL---SYE 530 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------------~l~---~~~ 530 (601)
.+++.|++||.+.+..++.++||||||+++||+++|+.||......... +++ ...
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccC
Confidence 6888999999998888999999999999999999999998643321100 011 116
Q ss_pred CCCCCCCHHHHHHH
Q 007490 531 DPADRPSMATIVLA 544 (601)
Q Consensus 531 dP~~RPt~~evl~~ 544 (601)
+|.+||++.+++.+
T Consensus 256 ~p~~Rp~~~~il~h 269 (293)
T cd06647 256 DVEKRGSAKELLQH 269 (293)
T ss_pred ChhhCcCHHHHhcC
Confidence 89999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=267.06 Aligned_cols=174 Identities=22% Similarity=0.299 Sum_probs=142.2
Q ss_pred cCCccccc--CcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 344 SDNKLGRG--GFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 344 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
+.++||+| +|++||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7889999985 468999999986542 333456788999999999999999999999999999999999
Q ss_pred CCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc----
Q 007490 419 PNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ---- 469 (601)
Q Consensus 419 ~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---- 469 (601)
++++|.+++ |+|+.+|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999886554 569999999999999999999999999999875433211100
Q ss_pred -cccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 -GNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122346778999999876 4689999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=273.80 Aligned_cols=169 Identities=27% Similarity=0.366 Sum_probs=138.7
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc---CCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
||+|+||+||+|+.. +++.||||++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 58999999986532 12223445666776665 699999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ |+|+.+|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccC
Confidence 9886543 6799999999999999999999999999999987532221 12334578
Q ss_pred cccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 478 TYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 478 t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 9999999998764 4789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.39 Aligned_cols=171 Identities=26% Similarity=0.440 Sum_probs=136.1
Q ss_pred CCcccccCcceEEeeecC---CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeEEEEeccC
Q 007490 345 DNKLGRGGFGEVYKGVLP---HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKILVYEFVP 419 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~ 419 (601)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999854 35789999886543 23457889999999999999999999854 456799999987
Q ss_pred CCCccc-------------------------------ccccccceeeccccccCcEEE----ccCCCcEEeecccceecC
Q 007490 420 NKSLDY-------------------------------FLYDSQLRIIHRDLKASNILL----DVQMNPKISDFGLARIFG 464 (601)
Q Consensus 420 ~gsL~~-------------------------------~l~~h~~~iiHrdlkp~NIll----~~~~~~kL~Dfg~a~~~~ 464 (601)
+..+.. +.++|+.+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 632110 116799999999999999999 566789999999998764
Q ss_pred CCCCc-cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 465 VDQTQ-GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 465 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..... .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 33221 12234568999999999876 4588999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=264.81 Aligned_cols=209 Identities=22% Similarity=0.318 Sum_probs=165.9
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|+..+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999954 57899999986543 233457889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc---
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--- 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--- 469 (601)
||+++++|..++ ++|+.+++||||||+||+++.++.+||+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999987665 569999999999999999999999999999998642111000
Q ss_pred ----------cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------
Q 007490 470 ----------GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------- 522 (601)
Q Consensus 470 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------- 522 (601)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 01112357889999999988889999999999999999999999986432111
Q ss_pred -----cccccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 523 -----AEDLLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 523 -----~~~l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
..+++. ..||.+||+..++.+.|+..
T Consensus 241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 001111 17899999987777777553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=262.26 Aligned_cols=175 Identities=31% Similarity=0.424 Sum_probs=152.4
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999954 58999999986532 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|..++ ++|+.+|+||||+|+||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 999999886654 569999999999999999999999999999999875432 2
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....+++.|+|||.+.+...+.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 33468899999999988889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=256.81 Aligned_cols=179 Identities=30% Similarity=0.453 Sum_probs=152.3
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.+.||.|++|+||+|... ++..+++|++.... ......+.+|+++++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999954 57889999986543 33567789999999999999999999999999999999999
Q ss_pred cCCCCccccc--------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc-
Q 007490 418 VPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG- 470 (601)
Q Consensus 418 ~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~- 470 (601)
+++++|..++ ++|+.+|+||||+|+||++++++.++|+|||++..+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9998876554 4589999999999999999999999999999997765432221
Q ss_pred -ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 471 -NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 471 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
......++..|+|||++... .++.++|+||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 22334688999999998776 7899999999999999999999998643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=275.73 Aligned_cols=206 Identities=33% Similarity=0.474 Sum_probs=168.2
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC--Cc--eeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH--GQ--EIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..++..+.++||+|.||.|++|.|.. |+ .||||.+...... ..+.|.+|+.+|.+|+|||+++|+|+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 34445667899999999999999864 43 6899999776544 67899999999999999999999999887 7788
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+|||+++.|+|.+.| |+..+++|||||..+|+|+-....+||+|||+.+.++...
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999997765 5567899999999999999999999999999999887654
Q ss_pred Cccc-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc----------------
Q 007490 468 TQGN-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY---------------- 529 (601)
Q Consensus 468 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~---------------- 529 (601)
.... .....-...|.|||.+....++.++|||+|||+||||+| |+.||......++.+.+..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence 4332 222334668999999999999999999999999999998 6778866443322222221
Q ss_pred -------cCCCCCCCHHHHHHH
Q 007490 530 -------EDPADRPSMATIVLA 544 (601)
Q Consensus 530 -------~dP~~RPt~~evl~~ 544 (601)
.+|++|||+..|.+.
T Consensus 347 imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHhccCCccccccHHHHHHh
Confidence 799999999999744
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=270.02 Aligned_cols=169 Identities=24% Similarity=0.347 Sum_probs=140.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999964 4678999975332 2356999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|++.+ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 137 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~ 212 (357)
T PHA03209 137 PHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA 212 (357)
T ss_pred EccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence 99865 443332 679999999999999999999999999999999753221 12
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
.....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 23456899999999999999999999999999999999865443
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=258.40 Aligned_cols=177 Identities=30% Similarity=0.485 Sum_probs=147.4
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh----------hhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG----------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
+|...+.||.|++|.||+|.. .+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999985 3688999998753211 12346788999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
..++||||+++++|..++ ++|+.+++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999886554 569999999999999999999999999999999765322
Q ss_pred CCccccccccccccccCcccccCCC--CCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQ--FSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..........++..|+|||.+.... ++.++|+||||+++||+++|..|+..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 2222233346788999999987654 78999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=261.75 Aligned_cols=177 Identities=28% Similarity=0.437 Sum_probs=145.7
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++++|.+.+.||+|+||.||+|.. .+++.|++|++..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999985 4688999999865432 22346778999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++ +|..++ ++|+.+|+|+||||+||+++.++.+||+|||+++....... .
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 159 (291)
T cd07870 83 EYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T 159 (291)
T ss_pred ecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence 99974 432211 56999999999999999999999999999999975432211 1
Q ss_pred cccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2233568899999998754 578899999999999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=263.51 Aligned_cols=176 Identities=29% Similarity=0.423 Sum_probs=148.3
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|+..++||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999965 588999998865432 234568899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|..+. ++|+.+++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccC
Confidence 99988775432 6799999999999999999999999999999998654322 1222
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...++..|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 3467889999999875 4578899999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=256.60 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=164.2
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|++.++||+|+||.||+++. .+|+.|++|++... ......++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 578899999999999999985 46889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hh
Confidence 9998875543 56999999999999999999999999999999986543221 12
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------ccccc---Cc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDLL---SY 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l~---~~ 529 (601)
....+++.|+|||++.+..++.++|+||||++++||++|+.|+....... ..+++ ..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 23457889999999998889999999999999999999999885432111 01111 11
Q ss_pred cCCCCCCCHHHHHH
Q 007490 530 EDPADRPSMATIVL 543 (601)
Q Consensus 530 ~dP~~RPt~~evl~ 543 (601)
.+|.+||++.+|++
T Consensus 239 ~~p~~Rp~~~~vl~ 252 (256)
T cd08218 239 RNPRDRPSVNSILE 252 (256)
T ss_pred CChhhCcCHHHHhh
Confidence 68999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=254.69 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=163.5
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||+|++|.||++.. .+++.++||.+... .......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999985 46889999998654 233456789999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++++|.+++ ++|+++++|+||+|+||+++.++ .+||+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---c
Confidence 9999876554 56999999999999999998654 57999999998764322 1
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------ccccc---C
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDLL---S 528 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l~---~ 528 (601)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+++ .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence 223467889999999998889999999999999999999999986533110 00111 1
Q ss_pred ccCCCCCCCHHHHHHH
Q 007490 529 YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~ 544 (601)
..+|.+|||+.|+++.
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 1699999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=256.77 Aligned_cols=178 Identities=29% Similarity=0.470 Sum_probs=150.1
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC------hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 568999999986432 1234678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~ 469 (601)
|+||+++++|..++ ++|+.+++|+||+|+||+++.++ .+||+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 99999999987655 56999999999999999998776 5999999999776432111
Q ss_pred --cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 470 --GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 470 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.......++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1122346788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=256.86 Aligned_cols=203 Identities=25% Similarity=0.433 Sum_probs=166.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+-|+..++||.|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3477889999999999999985 468899999886443 33456788999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++++|..++ ++|+.+++|+||+|+||+++.++.++|+|||++..+.... ......
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccc
Confidence 9999887654 5699999999999999999999999999999987654321 112234
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------cccc---cCccCC
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDL---LSYEDP 532 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l---~~~~dP 532 (601)
.++..|+|||.+.+..++.++|+||||+++|||++|..|+....... ..++ +...+|
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 67889999999988889999999999999999999999986432111 0011 112689
Q ss_pred CCCCCHHHHHHH
Q 007490 533 ADRPSMATIVLA 544 (601)
Q Consensus 533 ~~RPt~~evl~~ 544 (601)
.+||++.+++..
T Consensus 242 ~~Rp~~~~~l~~ 253 (277)
T cd06641 242 SFRPTAKELLKH 253 (277)
T ss_pred hhCcCHHHHHhC
Confidence 999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=255.46 Aligned_cols=203 Identities=29% Similarity=0.416 Sum_probs=168.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.+.||+|++|.||+++.. +++.|+||++..... .....+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999965 489999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++++|..++ ++|+ .+++||||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--cc
Confidence 9999987765 5699 99999999999999999999999999999876433221 22
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC------------------------cccccc--
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------------GAEDLL-- 527 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------------~~~~l~-- 527 (601)
...++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ...+++
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence 346788999999999889999999999999999999999998655310 011111
Q ss_pred -CccCCCCCCCHHHHHHH
Q 007490 528 -SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 -~~~dP~~RPt~~evl~~ 544 (601)
...+|.+||++.++++.
T Consensus 239 ~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 239 CLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HccCChhhCCCHHHHHhC
Confidence 11689999999888764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=260.20 Aligned_cols=211 Identities=27% Similarity=0.399 Sum_probs=165.3
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEe
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 407 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 407 (601)
+....+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34455667789999999999999999999995 468899999986532 2345678899999999 89999999999875
Q ss_pred C-----CeeEEEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 408 G-----DEKILVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 408 ~-----~~~~lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
. +..++||||+++++|..++ ++|+.+|+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 4 3589999999999886543 4699999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-c------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-----QFSVKSDVYSFGVLALETITGKKNSSFYQTDG-A------ 523 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~------ 523 (601)
|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.|+....... .
T Consensus 171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 9999876542221 12234678899999987543 36899999999999999999999985432110 0
Q ss_pred ---------------cccc---CccCCCCCCCHHHHHH
Q 007490 524 ---------------EDLL---SYEDPADRPSMATIVL 543 (601)
Q Consensus 524 ---------------~~l~---~~~dP~~RPt~~evl~ 543 (601)
.+++ ...+|++||++.|+++
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011 1168999999998875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=261.07 Aligned_cols=176 Identities=30% Similarity=0.453 Sum_probs=145.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|+..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999965 588999999865432 223456789999999999999999999999999999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++ +|..++ ++|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence 9985 665433 56999999999999999999999999999999875432211 11
Q ss_pred ccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....++..|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22346788999998875 4588999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=256.25 Aligned_cols=201 Identities=29% Similarity=0.505 Sum_probs=163.4
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCeeEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.|+..+.||+|+||.||+|.+ .+++.|++|.+... ......++.+|+.++++++ ||||+++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999995 46889999998654 3344567889999999997 999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
||+++++|..++ ++|+.+|+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRS 159 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccc
Confidence 999999887654 56999999999999999999999999999999987654321 223
Q ss_pred cccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc---------------------c---cC
Q 007490 474 RIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED---------------------L---LS 528 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~---------------------l---~~ 528 (601)
...|+..|+|||.+.++ .++.++|+||||+++|||++|+.||.......... + +.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHc
Confidence 34688899999988654 46899999999999999999999985433211100 0 01
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+||++.+++.
T Consensus 240 ~~~p~~R~~~~~il~ 254 (277)
T cd06917 240 DEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccCcCHHHHhh
Confidence 168999999988875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=260.07 Aligned_cols=173 Identities=29% Similarity=0.448 Sum_probs=144.8
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh-----hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+|+..+.||+|++|.||+|... +++.|+||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999954 5899999999765322 335577899999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+ +++|..++ ++|+.+|+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 77776554 56999999999999999999999999999999987643221
Q ss_pred ccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
......++..|+|||.+.+ ..++.++|||||||++|||++|.++|.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 1222356788999998865 467899999999999999999977664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=258.47 Aligned_cols=174 Identities=28% Similarity=0.446 Sum_probs=147.6
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|++.+.||+|++|.||+|+.. +|+.|++|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999954 68999999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+ +++|..++ ++|+.+++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYS 158 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cccc
Confidence 9 88886543 56999999999999999999999999999999987643321 1122
Q ss_pred cccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
...++..|+|||.+.+. .++.++||||+|+++|||++|+++|.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 34688899999998654 46899999999999999999987764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=263.22 Aligned_cols=179 Identities=27% Similarity=0.356 Sum_probs=151.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|+..+.||+|++|.||++... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999965 489999999976532 24567889999999999999999999999999999999
Q ss_pred eccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc-
Q 007490 416 EFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ- 469 (601)
Q Consensus 416 E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 469 (601)
||+.+++|..++ ++|+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999887654 569999999999999999999999999999998754321110
Q ss_pred --------------------------cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 470 --------------------------GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 470 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 0112346788999999999888999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-32 Score=297.29 Aligned_cols=208 Identities=30% Similarity=0.428 Sum_probs=171.1
Q ss_pred hhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..+-++.....||.|.||.||.+. .++|.-.|+|.+... .......+.+|+.++..|+|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345578888999999999999999 556888999987654 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC--C
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ--T 468 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--~ 468 (601)
.||||++|+|.+++ ++|+.|||||||||.||+++.+|.+|++|||.|..+.... .
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 99999999998766 6799999999999999999999999999999999876542 1
Q ss_pred ccccccccccccccCcccccCC---CCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------ccc-----
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHG---QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------DLL----- 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------~l~----- 527 (601)
........||+.|||||++.+. ....+.||||+|||+.||+||++||.....+... +.+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 1223457899999999999753 4568899999999999999999999765543211 111
Q ss_pred ------CccCCCCCCCHHHHHHH
Q 007490 528 ------SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 ------~~~dP~~RPt~~evl~~ 544 (601)
...||.+|-++.|+++.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHh
Confidence 11789999888777664
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=259.41 Aligned_cols=210 Identities=27% Similarity=0.443 Sum_probs=164.8
Q ss_pred chhhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEe-
Q 007490 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE- 407 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~- 407 (601)
++..+..+.+.|++.+.||.|+||.||+|+. .+++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3445556778999999999999999999995 458899999886543 3345688899999999 79999999999863
Q ss_pred -----CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeec
Q 007490 408 -----GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDF 457 (601)
Q Consensus 408 -----~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Df 457 (601)
.+..+++|||+++++|..++ ++|+.+|+|+||||+||++++++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 45789999999998886554 569999999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------
Q 007490 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------- 522 (601)
Q Consensus 458 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------- 522 (601)
|++....... .......++..|+|||.+. +..++.++||||||+++|||++|+.||.......
T Consensus 166 g~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 166 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred cchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 9987553211 1223356889999999875 3467889999999999999999999985432110
Q ss_pred -----------ccccc---CccCCCCCCCHHHHHH
Q 007490 523 -----------AEDLL---SYEDPADRPSMATIVL 543 (601)
Q Consensus 523 -----------~~~l~---~~~dP~~RPt~~evl~ 543 (601)
..+++ ...||.+||++.||++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00111 1168999999988864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=253.99 Aligned_cols=202 Identities=29% Similarity=0.450 Sum_probs=163.1
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKILVY 415 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 415 (601)
+|++.+.||.|+||.||++.. .+++.|++|.+... .....+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 46789999998653 33445678899999999999999999998764 44679999
Q ss_pred eccCCCCccccc---------------------------ccc-----cceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 416 EFVPNKSLDYFL---------------------------YDS-----QLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 416 E~~~~gsL~~~l---------------------------~~h-----~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
||+++++|..++ ++| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999886543 558 889999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------- 523 (601)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 43321 12234688999999999988899999999999999999999999865421110
Q ss_pred cccc---CccCCCCCCCHHHHHHH
Q 007490 524 EDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 ~~l~---~~~dP~~RPt~~evl~~ 544 (601)
.+++ ...+|.+||++.+|++.
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhC
Confidence 0111 11689999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=257.54 Aligned_cols=175 Identities=29% Similarity=0.413 Sum_probs=151.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|+..+.||+|++|.||++... +++.|++|++.... .....++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999965 58899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL------------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+++++|..++ ++|+ .+++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----
Confidence 9988887655 5699 9999999999999999999999999999876532211
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1256788999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=279.45 Aligned_cols=176 Identities=22% Similarity=0.359 Sum_probs=138.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC--CceeeEE------------------EeccCChhhHHHHHHHHHHHHHcCCC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH--GQEIAVK------------------RLSRSSGQGAQEFKNEVVLVAKLQHR 396 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~hp 396 (601)
...++|++.++||+|+||+||++.++. +..+++| .+. ........+.+|+.+|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987432 2222222 111 1222345688999999999999
Q ss_pred CccceEEEEEeCCeeEEEEeccCCCCccc---------------------------ccccccceeeccccccCcEEEccC
Q 007490 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDY---------------------------FLYDSQLRIIHRDLKASNILLDVQ 449 (601)
Q Consensus 397 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~---------------------------~l~~h~~~iiHrdlkp~NIll~~~ 449 (601)
||+++++++...+..++|+|++.+..+.. +-|+|+++|+||||||+|||++.+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999875432211 116799999999999999999999
Q ss_pred CCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCC
Q 007490 450 MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKN 514 (601)
Q Consensus 450 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 514 (601)
+.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 304 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999987653322 122345789999999999999999999999999999999998753
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=260.07 Aligned_cols=177 Identities=28% Similarity=0.410 Sum_probs=150.8
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.+.||+|++|.||+|... +++.|++|++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999965 5889999998653 23345678999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|++++.+..+. ++|+.+++|+||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLT 159 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cccc
Confidence 99987665432 56999999999999999999999999999999987654322 1223
Q ss_pred cccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 35678899999999888 889999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=252.83 Aligned_cols=178 Identities=31% Similarity=0.515 Sum_probs=152.4
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||+|+||.||+|... +++.|++|.+..... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999854 688999999876544 3567899999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc--c
Q 007490 418 VPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN--T 472 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~--~ 472 (601)
+++++|.+++ ++|+.+|+|+||+|+||++++++.+||+|||++........... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999887654 56999999999999999999999999999999987643322111 1
Q ss_pred ccccccccccCcccccCCC---CCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQ---FSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....++..|+|||++.+.. ++.++||||||+++||+++|+.||...
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 1346788999999998766 889999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=257.59 Aligned_cols=201 Identities=28% Similarity=0.423 Sum_probs=164.1
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
+|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455668999999999999985 4688999999876555556678899999999999999999999999999999999999
Q ss_pred CCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 420 NKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 420 ~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
+++|..++ ++|+.+|+||||+|+||+++.++.++|+|||.+........ ......|
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~ 177 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVG 177 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccC
Confidence 99987654 56999999999999999999999999999998875432211 1223468
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC----------------------cccccc---CccCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD----------------------GAEDLL---SYEDP 532 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~----------------------~~~~l~---~~~dP 532 (601)
+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+++ ...+|
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccCh
Confidence 89999999998888999999999999999999999997542210 000111 11689
Q ss_pred CCCCCHHHHHH
Q 007490 533 ADRPSMATIVL 543 (601)
Q Consensus 533 ~~RPt~~evl~ 543 (601)
.+||++.++++
T Consensus 258 ~~Rpt~~~il~ 268 (285)
T cd06648 258 AQRATAAELLN 268 (285)
T ss_pred hhCcCHHHHcc
Confidence 99999988875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.25 Aligned_cols=178 Identities=28% Similarity=0.431 Sum_probs=145.3
Q ss_pred CCCcCCcccccCcceEEeeecC---CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP---HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKI 412 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 412 (601)
+|++.++||+|++|.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999964 47899999997633 33446678899999999999999999999988 7899
Q ss_pred EEEeccCCCCccc---------------------------ccccccceeeccccccCcEEEcc----CCCcEEeecccce
Q 007490 413 LVYEFVPNKSLDY---------------------------FLYDSQLRIIHRDLKASNILLDV----QMNPKISDFGLAR 461 (601)
Q Consensus 413 lv~E~~~~gsL~~---------------------------~l~~h~~~iiHrdlkp~NIll~~----~~~~kL~Dfg~a~ 461 (601)
+||||+++..+.. +.++|+.+|+||||||+||+++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999997633211 11669999999999999999999 8999999999998
Q ss_pred ecCCCCC-ccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 462 IFGVDQT-QGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 462 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 6543322 1122334678899999988764 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=254.90 Aligned_cols=204 Identities=28% Similarity=0.451 Sum_probs=162.5
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCC-----
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~----- 409 (601)
.+.++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999964 578899999865543 346789999999999 7999999999997654
Q ss_pred -eeEEEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 410 -EKILVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
..++||||+++++|.+++ ++|+.+++|+||+|+||++++++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999998775443 5699999999999999999999999999999987
Q ss_pred ecCCCCCccccccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC---------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFYQTD--------------- 521 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--------------- 521 (601)
...... .......++..|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 162 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 162 QLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 653222 12233468889999998753 34678999999999999999999998643210
Q ss_pred -------ccccccC---ccCCCCCCCHHHHHH
Q 007490 522 -------GAEDLLS---YEDPADRPSMATIVL 543 (601)
Q Consensus 522 -------~~~~l~~---~~dP~~RPt~~evl~ 543 (601)
...+++. ..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011111 168999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=260.20 Aligned_cols=172 Identities=28% Similarity=0.465 Sum_probs=142.8
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||+|+||.||+|+.. +|+.|++|++.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999964 58899999986532 22235678899999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++ +|..++ ++|+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcC
Confidence 975 443322 66999999999999999999999999999999986543221 122
Q ss_pred cccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
...++..|+|||++.+. .++.++|||||||++|||++|+.|+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 34578899999998764 4789999999999999999998885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=259.24 Aligned_cols=201 Identities=29% Similarity=0.425 Sum_probs=161.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...+.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 44567999999999999999999954 58899999986432 233457889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+||||+++. |..++ ++|+.+|+||||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~g~-l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCLGS-ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhCCC-HHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 999999753 32211 669999999999999999999999999999998764322
Q ss_pred ccccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------cc
Q 007490 469 QGNTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------AE 524 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------~~ 524 (601)
....++..|+|||++. ...++.++||||||+++|||++|+.|+....... ..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2346788999999874 4568899999999999999999999875422100 01
Q ss_pred ccc---CccCCCCCCCHHHHHHH
Q 007490 525 DLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l~---~~~dP~~RPt~~evl~~ 544 (601)
+++ ...+|.+||++.+|+..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 111 12799999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=256.74 Aligned_cols=174 Identities=31% Similarity=0.517 Sum_probs=143.8
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||.|++|.||+|+.. +++.|+||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999854 68899999886543 22345788999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
+.+ +|..++ ++|+.+++||||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (284)
T cd07860 81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 157 (284)
T ss_pred ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence 964 443322 67999999999999999999999999999999876543221 12
Q ss_pred ccccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2235678899999887644 68899999999999999999998854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=248.74 Aligned_cols=200 Identities=35% Similarity=0.534 Sum_probs=166.7
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++||||+++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999965 688999999977655566789999999999999999999999999999999999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|.+++ ++|..+++||||+|+||++++++.++|+|||.+........ ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTM 157 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccce
Confidence 88887654 56899999999999999999999999999999987643321 2345
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccccc---Ccc
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDLL---SYE 530 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l~---~~~ 530 (601)
.++..|++||.+.+..++.++||||||+++|+|++|+.|+....... ..+++ ...
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 67889999999988889999999999999999999999986541100 01111 126
Q ss_pred CCCCCCCHHHHHH
Q 007490 531 DPADRPSMATIVL 543 (601)
Q Consensus 531 dP~~RPt~~evl~ 543 (601)
||.+|||+.++++
T Consensus 238 ~p~~R~t~~~~l~ 250 (253)
T cd05122 238 NPEKRPTAEQLLK 250 (253)
T ss_pred ChhhCCCHHHHhc
Confidence 8899999988875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=257.30 Aligned_cols=199 Identities=28% Similarity=0.416 Sum_probs=163.1
Q ss_pred cCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCC
Q 007490 344 SDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS 422 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gs 422 (601)
...+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 346899999999999986 4689999999866555556778999999999999999999999999999999999999998
Q ss_pred ccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 423 LDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 423 L~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
|..++ ++|+.|++||||+|+||++++++.++|+|||++........ ......++..
T Consensus 104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 181 (292)
T cd06657 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPY 181 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCcc
Confidence 87654 56999999999999999999999999999999876543211 1223467889
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------c--------------ccc---cCccCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------A--------------EDL---LSYEDPADR 535 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------~--------------~~l---~~~~dP~~R 535 (601)
|++||.+.+..++.++|+||||+++|||++|..||....... . .++ +...+|.+|
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 261 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccC
Confidence 999999988889999999999999999999999985432110 0 000 111789999
Q ss_pred CCHHHHHHH
Q 007490 536 PSMATIVLA 544 (601)
Q Consensus 536 Pt~~evl~~ 544 (601)
|++.+++..
T Consensus 262 ~~~~~ll~~ 270 (292)
T cd06657 262 ATAAELLKH 270 (292)
T ss_pred cCHHHHhcC
Confidence 999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=255.33 Aligned_cols=206 Identities=29% Similarity=0.474 Sum_probs=168.8
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
....+.|+..+.||+|++|.||++.+. +++.|++|++..... ..+.+.+|++++++++|+||+++++.+...+..++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677899999999999999999975 588999999976544 556788999999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
+||+++++|.+++ ++|+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 9999998887665 56999999999999999999999999999999875532211
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccccc-
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDLL- 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l~- 527 (601)
......++..|++||.+.+..++.++||||||+++|||++|+.|+....... ..+++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 1223457889999999988889999999999999999999999976533210 00011
Q ss_pred --CccCCCCCCCHHHHHHH
Q 007490 528 --SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 --~~~dP~~RPt~~evl~~ 544 (601)
...+|.+||++.++++.
T Consensus 252 ~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 11689999999988753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=256.42 Aligned_cols=187 Identities=27% Similarity=0.333 Sum_probs=157.1
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 410 (601)
.+...+|..+.+||+|+||.|.++..+. .+.+|||++++.- ....+--..|-++|... +-|.+++++.+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4456678999999999999999998654 5678999997752 22233345677777766 57899999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+|.||||+.||+|-+.+ ++|++|||.||||.+|||+|.+|++||+|||+++.--.+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~- 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD- 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence 99999999999997665 679999999999999999999999999999999853222
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 524 (601)
...+..++||+.|+|||++...+|+..+|+|||||+||||+.|++||+....+...
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 23356789999999999999999999999999999999999999999876655443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=283.51 Aligned_cols=206 Identities=32% Similarity=0.488 Sum_probs=152.0
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE----- 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 410 (601)
-..+|+.++.||+||||.||+++.+ ||+.+|||++... +......+.+|+++|++|+|||||+++..|.+...
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4567899999999999999999944 8999999999765 33445678899999999999999998876543221
Q ss_pred --------------------------------------------------------------------------------
Q 007490 411 -------------------------------------------------------------------------------- 410 (601)
Q Consensus 411 -------------------------------------------------------------------------------- 410 (601)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ----------------------------------eEEEEeccCCCCccccc------------------------ccccc
Q 007490 411 ----------------------------------KILVYEFVPNKSLDYFL------------------------YDSQL 432 (601)
Q Consensus 411 ----------------------------------~~lv~E~~~~gsL~~~l------------------------~~h~~ 432 (601)
+||-||||+..+|++++ |.|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 13334444433332222 56999
Q ss_pred eeeccccccCcEEEccCCCcEEeecccceecC----------------CCCCccccccccccccccCcccccCC---CCC
Q 007490 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFG----------------VDQTQGNTSRIVGTYGYMSPEYAMHG---QFS 493 (601)
Q Consensus 433 ~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~ 493 (601)
|||||||||.||+++++..|||+|||++.... ........+..+||.-|+|||++.+. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998721 01111234567899999999999764 499
Q ss_pred chhhHHhHHHHHHHHHh-----------------CCCCCC---CCCCC----ccccccCccCCCCCCCHHHHHH
Q 007490 494 VKSDVYSFGVLALETIT-----------------GKKNSS---FYQTD----GAEDLLSYEDPADRPSMATIVL 543 (601)
Q Consensus 494 ~~sDvwSlGvvl~ellt-----------------g~~p~~---~~~~~----~~~~l~~~~dP~~RPt~~evl~ 543 (601)
.|+|+||||||++||+. |..|++ +.... .....+...||.+|||+.|++.
T Consensus 797 ~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 99999999999999985 233333 11100 1111222379999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.36 Aligned_cols=175 Identities=30% Similarity=0.401 Sum_probs=146.1
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 408 (601)
..++|+..+.||+|+||.||+++. .+++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999995 46899999998643 233445677899999999999999999988644
Q ss_pred CeeEEEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 409 DEKILVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
...++||||+++ +|...+ ++|+.||+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 346999999975 443321 6799999999999999999999999999999998754321
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 173 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred ---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 1223467889999999999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=256.90 Aligned_cols=175 Identities=30% Similarity=0.458 Sum_probs=142.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 413 (601)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999964 589999999865432 2233567899999999999999999998765 46899
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++ +|..++ ++|+.+++||||||+||+++.++.+||+|||++........
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 9999975 443222 66999999999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 164 -PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred -CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 1222345788999999865 457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=253.30 Aligned_cols=175 Identities=28% Similarity=0.371 Sum_probs=148.3
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 415 (601)
++|+..++||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999964 58899999987543 24456789999999999999999999988654 4689999
Q ss_pred eccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++++|.+++ ++|+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 999999886542 5699999999999999999999999999999987543221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 160 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 12345678899999999899999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=260.92 Aligned_cols=178 Identities=25% Similarity=0.428 Sum_probs=144.4
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----ee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-----EK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~ 411 (601)
.++|++.++||+|+||.||+|+. .+|+.||||++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 46899999998643 2334566788999999999999999999876543 57
Q ss_pred EEEEeccCCCCcccc----------------------cccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 412 ILVYEFVPNKSLDYF----------------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~----------------------l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
++|+||+++ +|..+ .++|+.+|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 999999975 43322 2679999999999999999999999999999999865432211
Q ss_pred c-ccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 G-NTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223467899999998754 5688999999999999999999998853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=247.84 Aligned_cols=203 Identities=31% Similarity=0.484 Sum_probs=167.4
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKILVY 415 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 415 (601)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 688999999866542 4567889999999999999999999999988 8899999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|.+++ ++|+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 999999887654 569999999999999999999999999999999876544321112
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC--------------c--------cccc---c
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD--------------G--------AEDL---L 527 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--------------~--------~~~l---~ 527 (601)
....++..|++||.+.+...+.++||||||+++|+|++|+.||...... . ..++ +
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 240 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHh
Confidence 3456788999999998888999999999999999999999998654310 0 0000 1
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...||.+||++.+++.
T Consensus 241 l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 241 LRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCChhhCCCHHHHhh
Confidence 1168999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=255.10 Aligned_cols=175 Identities=30% Similarity=0.428 Sum_probs=144.7
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 414 (601)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999965 588999999865432 2234567899999999999999999999877 889999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++ +|..++ ++|+.+++|+||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-- 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--
Confidence 999975 554332 66999999999999999999999999999999987653321
Q ss_pred ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234578899999988764 468999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=253.78 Aligned_cols=176 Identities=32% Similarity=0.428 Sum_probs=152.8
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
+|++.+.||.|+||.||+++.. +++.|++|.+.... ....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 58999999987542 2446788999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|..++ ++|+.+++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 99999886554 5699999999999999999999999999999998654322 223
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 3467889999999988889999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=249.07 Aligned_cols=179 Identities=30% Similarity=0.440 Sum_probs=148.9
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-----ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--Cee
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEK 411 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 411 (601)
.+|++.+.||+|+||.||+++. .+++.|++|.+... .......+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999995 45899999987532 223446788999999999999999999998764 457
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++++||+++++|..++ ++|+.+++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999999886544 56999999999999999999999999999999986532111
Q ss_pred c-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 Q-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
. .......++..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1 1122346888999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=250.10 Aligned_cols=201 Identities=27% Similarity=0.425 Sum_probs=161.9
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||+|+||.||++... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999964 58899999986542 23446788999999999999999999999999999999999
Q ss_pred cCCCCccccc-------------------------ccccceeeccccccCcEEEccCCC-cEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMN-PKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++++|..++ ++|+.+++|+||||+||++++++. +||+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--L 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--c
Confidence 9998876543 568999999999999999998864 69999999976643221 1
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------ccccc---C
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDLL---S 528 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l~---~ 528 (601)
.....|++.|+|||++.+..++.++|+||||+++|||++|+.|+....... ..+++ .
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 223458889999999988889999999999999999999999986432110 01111 1
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..+|.+|||+.|++.
T Consensus 239 ~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 239 KVSPRDRPSITSILK 253 (257)
T ss_pred ccChhhCcCHHHHhh
Confidence 168999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=251.85 Aligned_cols=174 Identities=31% Similarity=0.528 Sum_probs=145.0
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
+|+..++||.|++|.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999964 588999999876532 23456778999999999999999999999999999999999
Q ss_pred CCCCccccc--------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 419 PNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 419 ~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
++ +|..++ ++|+.+++||||||+||++++++.++|+|||++........ ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cc
Confidence 86 443322 56999999999999999999999999999999976543211 12
Q ss_pred ccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....++..|++||++.+. .++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 234568899999988664 568999999999999999999998864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=252.98 Aligned_cols=210 Identities=17% Similarity=0.207 Sum_probs=149.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccCChhhH-----------HHHHHHHHHHHHcCCCCccc
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSSGQGA-----------QEFKNEVVLVAKLQHRNLVR 400 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~ 400 (601)
++..++|++.++||+|+||.||+|.+.+ +..+++|+......... .....+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3456789999999999999999999644 34566665432221110 11123334455678999999
Q ss_pred eEEEEEeCC----eeEEEEeccCCCCc----------------------ccccccccceeeccccccCcEEEccCCCcEE
Q 007490 401 LLGFCLEGD----EKILVYEFVPNKSL----------------------DYFLYDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 401 l~~~~~~~~----~~~lv~E~~~~gsL----------------------~~~l~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
+++++.... ..++++|++..... ..+-++|+.+|+||||||+|||++.++.++|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 999776544 34678887643210 0111679999999999999999999999999
Q ss_pred eecccceecCCCCCc-----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc------
Q 007490 455 SDFGLARIFGVDQTQ-----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA------ 523 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~------ 523 (601)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876432211 112234689999999999999999999999999999999999999976522110
Q ss_pred ---cccc---------------------CccCCCCCCCHHHHHHHH
Q 007490 524 ---EDLL---------------------SYEDPADRPSMATIVLAL 545 (601)
Q Consensus 524 ---~~l~---------------------~~~dP~~RPt~~evl~~L 545 (601)
...+ ...+|.+||++.+|++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 016899999999998876
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=252.07 Aligned_cols=200 Identities=26% Similarity=0.397 Sum_probs=154.2
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHH-HHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVL-VAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.+.||+|+||.||+++.. +|+.||+|++.... ......+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999964 58999999987542 2233445556664 666799999999999999999999999
Q ss_pred ccCCCCccccc---------------------------ccccc-eeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 417 FVPNKSLDYFL---------------------------YDSQL-RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 417 ~~~~gsL~~~l---------------------------~~h~~-~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|+++ +|..++ ++|+. +++||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 9974 443222 56887 99999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccC----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC----------------------c
Q 007490 469 QGNTSRIVGTYGYMSPEYAMH----GQFSVKSDVYSFGVLALETITGKKNSSFYQTD----------------------G 522 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~----------------------~ 522 (601)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 1122467889999998864 45688999999999999999999998532210 0
Q ss_pred cccc---cCccCCCCCCCHHHHHH
Q 007490 523 AEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 523 ~~~l---~~~~dP~~RPt~~evl~ 543 (601)
..++ +...+|.+||++.++++
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 11169999999998876
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=245.71 Aligned_cols=201 Identities=30% Similarity=0.472 Sum_probs=165.1
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999854 578999999976543 4567889999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+++++|.+++ ++|+.||+||||+|+||+++.++.++|+|||.+......... ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccc
Confidence 9998887654 569999999999999999999999999999999876533221 233
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------------cccccC---ccC
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------AEDLLS---YED 531 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------~~~l~~---~~d 531 (601)
..++..|+|||...+..++.++|||++|+++|+|++|+.|+....... ..+++. ..+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 467889999999988888999999999999999999999985432110 001111 168
Q ss_pred CCCCCCHHHHHH
Q 007490 532 PADRPSMATIVL 543 (601)
Q Consensus 532 P~~RPt~~evl~ 543 (601)
|++||++.+++.
T Consensus 239 p~~R~~~~~~l~ 250 (254)
T cd06627 239 PNLRPTAKQLLK 250 (254)
T ss_pred hhhCcCHHHHhc
Confidence 899999888863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=252.56 Aligned_cols=173 Identities=32% Similarity=0.516 Sum_probs=143.3
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
|+..+.||.|++|.||+|... +|+.|++|++.... ......+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999854 68999999986543 223456888999999999999999999999999999999999
Q ss_pred CCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 419 PNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 419 ~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+ ++|..++ ++|+.+++||||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccC
Confidence 5 4554433 56899999999999999999999999999999976532211 112
Q ss_pred cccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 23568899999988664 578999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=255.89 Aligned_cols=199 Identities=30% Similarity=0.445 Sum_probs=159.4
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+.|+..+.||+|+||.||+++. .++..||+|++.... ......+.+|++++++++|||++++++++..++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4477889999999999999995 458899999986432 233457889999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++ +|.+++ ++|+.+|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99976 433222 56999999999999999999999999999999875432
Q ss_pred cccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------cccc-
Q 007490 472 TSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------AEDL- 526 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------~~~l- 526 (601)
.....++..|+|||++. .+.++.++||||||+++|||++|+.||....... ..++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 22346788999999874 4568899999999999999999999875432110 0011
Q ss_pred --cCccCCCCCCCHHHHHHHH
Q 007490 527 --LSYEDPADRPSMATIVLAL 545 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~~L 545 (601)
+...+|.+||++.+|++.+
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHccCCcccCcCHHHHHhCh
Confidence 1126999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=250.63 Aligned_cols=168 Identities=33% Similarity=0.449 Sum_probs=142.9
Q ss_pred ccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||+|+||+||++.. .+|+.|++|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 468899999986532 22344567899999999999999999999999999999999999988
Q ss_pred cccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 424 DYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 424 ~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
.+++ ++|+.+++||||+|+||+++.++.+||+|||.+....... ......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCC
Confidence 7554 5699999999999999999999999999999987654211 12234578
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 8999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=236.33 Aligned_cols=175 Identities=27% Similarity=0.455 Sum_probs=140.9
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++.+.+..||.|+.|.||+.+.. .|..+|||.+.+. +....+++...++++.+-+ .|+||+.+|+|..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34455678999999999999954 5889999999775 4455677888888777664 8999999999999999999999
Q ss_pred ccCC----------CCccccc-------------cc-ccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPN----------KSLDYFL-------------YD-SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~----------gsL~~~l-------------~~-h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
.|.. +..-+.+ |+ ...+|||||+||+|||+|+.|++||+|||++-.+-.... .
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---h 248 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---H 248 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc---c
Confidence 7642 1111111 22 456899999999999999999999999999987654332 3
Q ss_pred ccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
+...|-+.|||||.+.- ..|+.++||||||+.++||.||+.||..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 34578899999999853 4689999999999999999999999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=252.61 Aligned_cols=175 Identities=26% Similarity=0.391 Sum_probs=142.0
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCe-----
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDE----- 410 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~----- 410 (601)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999954 689999998765432 23456788999999995 6999999999987665
Q ss_pred eEEEEeccCCCCccccc----------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccce
Q 007490 411 KILVYEFVPNKSLDYFL----------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLAR 461 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~ 461 (601)
.++||||+++ +|..++ ++|+.+|+||||||+||+++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 443321 669999999999999999998 8899999999998
Q ss_pred ecCCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 6533211 1122356788999998865 4578999999999999999999998854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=245.59 Aligned_cols=201 Identities=29% Similarity=0.444 Sum_probs=166.2
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|+..+.||.|++|.||++... ++++|++|++..... .....+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999964 588999999876533 4566789999999999999999999999999999999999
Q ss_pred cCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 418 VPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 418 ~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
+++++|..++ ++|+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 9998876543 5589999999999999999999999999999998764332 1
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------ccc---c
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------EDL---L 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------~~l---~ 527 (601)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.|+........ .++ +
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 22334678899999999888899999999999999999999999865421111 011 1
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...+|.+||++.++++
T Consensus 239 l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 239 LQKDPEERPSIAQILQ 254 (258)
T ss_pred cCCChhhCcCHHHHhc
Confidence 1268999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=247.38 Aligned_cols=199 Identities=29% Similarity=0.426 Sum_probs=164.1
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|++.++||+|++|.||+++. .+++.+++|.+... .......+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999984 46789999998654 233456778899999999999999999999999999999999
Q ss_pred cCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 418 VPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 418 ~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
+++++|..++ ++|+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 9999886543 569999999999999999999999999999999876433
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------cccc---
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------EDLL--- 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------~~l~--- 527 (601)
......++..|++||.+.+..++.++|+||||+++|||++|+.||........ .+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence 12224578899999999998999999999999999999999999865432111 0111
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...+|.+||++.++++
T Consensus 237 l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 237 LQVKPKLRPNCDKILA 252 (256)
T ss_pred cCCCcccCCCHHHHhc
Confidence 1168999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=249.59 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=160.1
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||.|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999999865433 4456788999999999999999999999999999999999999888
Q ss_pred cccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC------cccccc
Q 007490 424 DYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT------QGNTSR 474 (601)
Q Consensus 424 ~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------~~~~~~ 474 (601)
..++ ++|+.+++|+||+|+||++++++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 6554 56999999999999999999999999999999875433211 012233
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------cccc---Ccc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA---------------------EDLL---SYE 530 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~---------------------~~l~---~~~ 530 (601)
..++..|++||.......+.++||||||+++|||++|+.||........ .+++ ...
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence 4678899999999888899999999999999999999999864332110 0111 116
Q ss_pred CCCCCCCHHHHHHHHhc
Q 007490 531 DPADRPSMATIVLALNS 547 (601)
Q Consensus 531 dP~~RPt~~evl~~L~~ 547 (601)
+|.+|||+.++.+.|+.
T Consensus 241 ~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 241 DPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CHhhcCCCccHHHHhcC
Confidence 88888888666666643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=253.89 Aligned_cols=178 Identities=29% Similarity=0.435 Sum_probs=142.3
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD------ 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 409 (601)
-++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999954 58899999886432 222345678999999999999999999987654
Q ss_pred --eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 410 --EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 410 --~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
..++||||+.+ +|..++ ++|+.+++|+||||+||+++.++.+||+|||++..+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 34999999975 443221 679999999999999999999999999999999866
Q ss_pred CCCCCc--cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 464 GVDQTQ--GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 464 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 432211 112234567889999988664 478899999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=258.28 Aligned_cols=179 Identities=30% Similarity=0.457 Sum_probs=145.8
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeC--Cee
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG--DEK 411 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~ 411 (601)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4577899999999999999999964 5889999988543 233445677899999999 999999999998654 368
Q ss_pred EEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 412 ILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
++||||+++ +|..++ ++|+.+|+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 85 YLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 999999974 554432 679999999999999999999999999999999866433221
Q ss_pred ---cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 ---GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 12234568899999998765 4578999999999999999999998853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=251.99 Aligned_cols=175 Identities=30% Similarity=0.475 Sum_probs=143.3
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|+..+.||+|++|.||+|+.. +|+.|++|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999964 688999999865422 234568899999999999999999999999999999999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCCCCCcc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|+++ +|..++ ++|+.+++||||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-- 158 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-- 158 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--
Confidence 9965 332211 669999999999999999985 55799999999976543211
Q ss_pred ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12233568899999988664 578999999999999999999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=258.87 Aligned_cols=191 Identities=25% Similarity=0.368 Sum_probs=158.3
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
++..+....-|..++.||-|+||+|.+++ .++...+|.|.+.+.+ .......+.|-.||...+.+-||+|+-.|.+
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 34444556678899999999999999998 4457788999987653 3344567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 408 GDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
++.+|+||||++||++-.+| +-|..|+|||||||+|||||.+|++||.|||++.-+.
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999987665 3499999999999999999999999999999986442
Q ss_pred CCCC----------------------------------------ccccccccccccccCcccccCCCCCchhhHHhHHHH
Q 007490 465 VDQT----------------------------------------QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVL 504 (601)
Q Consensus 465 ~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 504 (601)
.... .......+||+.|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCc
Q 007490 505 ALETITGKKNSSFYQTDG 522 (601)
Q Consensus 505 l~elltg~~p~~~~~~~~ 522 (601)
||||+.|+.||......+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999997655443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=246.71 Aligned_cols=169 Identities=27% Similarity=0.386 Sum_probs=146.6
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||.|++|.||+++.. +++.|++|++.... ....+.+.+|++++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999964 48899999986543 23456789999999999999999999999999999999999999998
Q ss_pred cccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 424 DYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 424 ~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
..++ ++|+.+++|+||+|+||+++.++.++|+|||++....... ......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 7654 5699999999999999999999999999999998764332 1223467889
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
|++||.+.+..++.++|+||||+++|||++|..||....
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 999999988889999999999999999999999986554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=248.33 Aligned_cols=168 Identities=30% Similarity=0.422 Sum_probs=135.9
Q ss_pred cccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHHHH---HcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 347 KLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVLVA---KLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999954 588999998865421 12223344544433 3479999999999999999999999999
Q ss_pred CCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 420 NKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 420 ~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
+++|..++ ++|+.+|+||||||+|||+++++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcC
Confidence 99997554 5699999999999999999999999999999987553221 12346
Q ss_pred ccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 477 GTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 477 gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 8999999998864 56889999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=251.05 Aligned_cols=174 Identities=31% Similarity=0.453 Sum_probs=142.0
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999954 58999999987543 334567889999999996 9999999999999999999999
Q ss_pred ccCCCCccc----------------------------cccccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 417 FVPNKSLDY----------------------------FLYDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 417 ~~~~gsL~~----------------------------~l~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
|+.. +|.. +-++|+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9864 2211 115576 599999999999999999999999999997653221
Q ss_pred CccccccccccccccCcccccCC---CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHG---QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 12233678899999998766 689999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=249.43 Aligned_cols=174 Identities=29% Similarity=0.440 Sum_probs=144.5
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeEEEEe
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKILVYE 416 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 416 (601)
|++.+.||+|++|.||+|+.. +++.+++|++.... ......+.+|++++++++||||+++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999965 48899999997653 33446688999999999999999999999988 78999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++ +|..++ ++|+.+++|+||+|+||++++++.+||+|||++......... ..
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DY 158 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cc
Confidence 9975 544332 569999999999999999999999999999999876543211 12
Q ss_pred ccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 23356788999998765 4578999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=254.26 Aligned_cols=178 Identities=26% Similarity=0.415 Sum_probs=143.1
Q ss_pred cCCCCc-CCcccccCcceEEeeecC-CCceeeEEEeccCChhh--------------HHHHHHHHHHHHHcCCCCccceE
Q 007490 339 TNKFSS-DNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQG--------------AQEFKNEVVLVAKLQHRNLVRLL 402 (601)
Q Consensus 339 ~~~f~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~l~ 402 (601)
.++|.. .+.||.|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 577999999999999954 68999999986542211 12477899999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 403 GFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 403 ~~~~~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
+++..++..++||||+++ +|..++ ++|+.+|+|+||+|+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999999974 554433 56999999999999999999999999999999
Q ss_pred ceecCCCC------------CccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 460 ARIFGVDQ------------TQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 460 a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
+....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 98664111 01111223467889999998764 468999999999999999999998854
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=254.61 Aligned_cols=177 Identities=30% Similarity=0.455 Sum_probs=146.7
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe-CCe
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GDE 410 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~ 410 (601)
+...+++|+..+.||.|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999844 6899999988643 22345677899999999999999999999876 557
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
.++++||+. ++|..++ ++|+.+|+||||+|+||++++++.+||+|||.+......
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 899999985 4554332 669999999999999999999999999999998754321
Q ss_pred ccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 223456888999998766 5689999999999999999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=245.81 Aligned_cols=167 Identities=27% Similarity=0.340 Sum_probs=138.6
Q ss_pred CcccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHH-HHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVL-VAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+||||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999854 588999999865432 122234445444 4455899999999999999999999999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 477 (601)
++|..++ ++|+.+++||||+|+||+++.++.+||+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 9987654 66999999999999999999999999999999875432 223467
Q ss_pred cccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 478 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
+..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 88999999998888999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=254.95 Aligned_cols=177 Identities=29% Similarity=0.428 Sum_probs=146.1
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC--
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-- 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-- 409 (601)
+....++|++.+.||+|+||.||++.. .+++.||||++... .......+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344578899999999999999999984 46899999998643 2233456889999999999999999999987654
Q ss_pred ----eeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 410 ----EKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 410 ----~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
..++||||+ +++|..++ ++|+.+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 55664432 679999999999999999999999999999999765
Q ss_pred CCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 169 DSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred ccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 321 223456889999998876 4588999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=257.45 Aligned_cols=178 Identities=22% Similarity=0.395 Sum_probs=145.2
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEe----CCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 411 (601)
.++|++.+.||+|++|.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368899999999999999999954 58999999987542 2345677889999999999999999998763 3468
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+.+ +|..++ ++|+.+|+||||||+||++++++.+||+|||++........
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999964 554433 56999999999999999999999999999999976543221
Q ss_pred c--cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 Q--GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 1 11123468889999998865 4688999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=248.05 Aligned_cols=176 Identities=28% Similarity=0.398 Sum_probs=147.9
Q ss_pred CCCcCCcccccCcceEEeeec----CCCceeeEEEeccCC----hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999986532 22346678999999999 699999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+++++|..++ ++|+.+++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999887654 56999999999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccCC--CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 122235688899999998753 467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=247.26 Aligned_cols=171 Identities=25% Similarity=0.347 Sum_probs=138.4
Q ss_pred CCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcC-CCCccceEEEEEeC--CeeEEEEe
Q 007490 342 FSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--DEKILVYE 416 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~E 416 (601)
|++.++||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999995 468899999986542 222234457888999885 99999999999987 88999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+++ +|..++ ++|+.+++||||+|+||+++. +.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---Y 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---c
Confidence 9975 433222 669999999999999999999 9999999999986643221 1
Q ss_pred ccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 23457889999997654 5578999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-30 Score=242.74 Aligned_cols=177 Identities=30% Similarity=0.444 Sum_probs=141.2
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh-hhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.++.+.+..||.|+||+|+|-.+ +.|+..|||++..... ...+++..|.+...+- +.||||+++|....++.-||-|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 34455667899999999999885 4699999999976543 5567788888765554 7899999999999999999999
Q ss_pred eccCCCCccccc----------------------------cc-ccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 416 EFVPNKSLDYFL----------------------------YD-SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------------~~-h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
|+|+- +|+.+- |+ ....|||||+||+|||++..|.+||+|||++-.+...
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 99853 443321 11 3567999999999999999999999999999765422
Q ss_pred CCccccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
...+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+....
T Consensus 222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 12233467788999999853 458999999999999999999999986543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=255.83 Aligned_cols=176 Identities=27% Similarity=0.440 Sum_probs=143.7
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----Ce
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----DE 410 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 410 (601)
.++|.+.+.||+|+||.||+++. .+++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999995 46899999998653 233345677899999999999999999988654 34
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.++|+||+.+ +|..++ ++|+.+++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 7999999964 443322 6799999999999999999999999999999998654321
Q ss_pred CccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 11223467889999998865 4688999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=249.02 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=162.4
Q ss_pred CCCcCCcccccCcceEEeeec----CCCceeeEEEeccCC----hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
+|++.+.||+|++|.||+++. .+++.||||.+.+.. ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 357889999986432 22345678999999999 699999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+++++|..++ ++|+.+++||||+|+||+++.++.++|+|||+++.+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 9999999998886544 56999999999999999999999999999999876543321
Q ss_pred ccccccccccccccCcccccCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------c
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQ--FSVKSDVYSFGVLALETITGKKNSSFYQTDG-----------------------A 523 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-----------------------~ 523 (601)
. ......++..|+|||.+.+.. .+.++||||||+++|||++|..||....... .
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 161 E-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 1 122346788999999987655 7889999999999999999999985322110 0
Q ss_pred ccc---cCccCCCCCCCHHHHHHHHhc
Q 007490 524 EDL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 ~~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
.++ +...||.+|||+.++.+.|+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111 111689999998888777755
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=250.43 Aligned_cols=181 Identities=28% Similarity=0.439 Sum_probs=145.6
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC---
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD--- 409 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--- 409 (601)
+...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999964 58899999986543 223456788999999999999999999987655
Q ss_pred -------eeEEEEeccCCCCccc-----------------------ccccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 410 -------EKILVYEFVPNKSLDY-----------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 410 -------~~~lv~E~~~~gsL~~-----------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
..++|+||+++..+.. +.++|+.+|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 7899999998732211 1167999999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||..
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 163 ARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred cccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9866433211 1122345778999998865 4578999999999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=250.45 Aligned_cols=173 Identities=22% Similarity=0.236 Sum_probs=140.6
Q ss_pred cCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 344 SDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445555666666666655 7999999998754 3445678999999999999999999999999999999999999999
Q ss_pred Cccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC-----ccc
Q 007490 422 SLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT-----QGN 471 (601)
Q Consensus 422 sL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~~~ 471 (601)
+|..++ ++|+.+|+||||||+||+++.++.+||+|||.+........ ...
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 887654 56999999999999999999999999999999875532211 011
Q ss_pred cccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....++..|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 223456778999999876 3588999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=250.64 Aligned_cols=201 Identities=32% Similarity=0.448 Sum_probs=159.2
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..+.|+..+.||+|++|.||+|+.. +++.+++|.+... ......++.+|+++++.++|+|++++++++...+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3445777899999999999999954 5788999988642 22334567889999999999999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+.+ +|..++ ++|+.+++||||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9999975 443322 569999999999999999999999999999998765321
Q ss_pred cccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------cc
Q 007490 470 GNTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA---------------------ED 525 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~---------------------~~ 525 (601)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+........ .+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 2346788999999874 35678899999999999999999998754321100 01
Q ss_pred c---cCccCCCCCCCHHHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVLAL 545 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~L 545 (601)
+ +...+|.+||++.+++...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCc
Confidence 1 1116999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=254.34 Aligned_cols=189 Identities=26% Similarity=0.331 Sum_probs=162.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCc-eeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQ-EIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.+.-.+++.+..||-|+||.|=++...... .+|+|++++. +....+.+..|-.+|...+.|.||+++..|.+....
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 344566777889999999999998864433 3888888654 455567788999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|++||-|-||.|...+ |+|+++||+|||||+|++++.+|-+||.|||+|+.+..+
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 9999999998775544 789999999999999999999999999999999988644
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~ 527 (601)
..+..++||+.|.|||++.+...+.++|.||||+++|||++|.+||..........++
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I 631 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI 631 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 3467789999999999999999999999999999999999999999876655444443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=244.67 Aligned_cols=168 Identities=32% Similarity=0.440 Sum_probs=136.4
Q ss_pred cccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHH---HHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 347 KLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVV---LVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
.||+|+||.||+++.. +++.||+|.+..... .....+..|.. +++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 588999999865421 11222334433 4445589999999999999999999999999
Q ss_pred CCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 420 NKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 420 ~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
+++|..++ ++|+.+|+||||||+||+++.++.+||+|||++..+.... .....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcC
Confidence 99986544 5699999999999999999999999999999987553221 22346
Q ss_pred ccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 477 GTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 477 gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 89999999998754 6899999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=246.91 Aligned_cols=173 Identities=28% Similarity=0.449 Sum_probs=145.6
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 688999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 419 PNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 419 ~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
++ +|..++ ++|+.+|+|+||||+||+++.++.+||+|||.+....... .....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccC
Confidence 76 444332 5699999999999999999999999999999998765432 11223
Q ss_pred ccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 475 IVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 4577889999998776 789999999999999999999988854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=237.32 Aligned_cols=176 Identities=26% Similarity=0.369 Sum_probs=149.6
Q ss_pred CcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
+.||+|+|+.|-.++ +.+|.++|||++.+.......++.+|++++.+. .|+||++++++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999988 668999999999988778888999999999999 599999999999999999999999999998
Q ss_pred cccc-----------------------ccccceeeccccccCcEEEccCCC---cEEeecccceecCCCC-----Ccccc
Q 007490 424 DYFL-----------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLARIFGVDQ-----TQGNT 472 (601)
Q Consensus 424 ~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~-----~~~~~ 472 (601)
..++ ++|.+||.||||||+|||-.+... +||+||.+..-+.... .....
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 7766 569999999999999999976544 7999998875432211 11223
Q ss_pred ccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 521 (601)
...+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.....+
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence 3467899999999873 245889999999999999999999999775543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=238.18 Aligned_cols=176 Identities=27% Similarity=0.421 Sum_probs=143.3
Q ss_pred CCCCcCCcccccCcceEEeeecCC-----CceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEe-CCee
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH-----GQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GDEK 411 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~ 411 (601)
..|+....||+|.||.||++...+ .+.+|||+++.... .......+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468889999999999999996322 34799999976532 123456789999999999999999999987 7789
Q ss_pred EEEEeccCCCCc---------------------------ccccccccceeeccccccCcEEEccC----CCcEEeecccc
Q 007490 412 ILVYEFVPNKSL---------------------------DYFLYDSQLRIIHRDLKASNILLDVQ----MNPKISDFGLA 460 (601)
Q Consensus 412 ~lv~E~~~~gsL---------------------------~~~l~~h~~~iiHrdlkp~NIll~~~----~~~kL~Dfg~a 460 (601)
++++||.+...+ +.+.|+|++=|+||||||.|||+..+ |.+||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 999999876322 12227789999999999999999887 89999999999
Q ss_pred eecCCCCCcc-ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 461 RIFGVDQTQG-NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 461 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
+.+...-..- .....+-|..|+|||.+.+. .|+.+.|||+.|||+.||++-++-|
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 9986543322 34456789999999999875 6899999999999999999977655
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=248.21 Aligned_cols=196 Identities=31% Similarity=0.441 Sum_probs=155.7
Q ss_pred CCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 342 FSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
|...++||+|+||.||+|+. .+++.|++|++.... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999985 358899999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+.+ +|..++ ++|+.+++|+||+|+||+++.++.+||+|||++.... ...
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~ 175 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PAN 175 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CCC
Confidence 965 332221 6699999999999999999999999999999986432 122
Q ss_pred cccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------cccc---
Q 007490 474 RIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------AEDL--- 526 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------~~~l--- 526 (601)
...++..|+|||++. ...++.++||||||+++|||++|..|+....... ..++
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 346888999999984 4568899999999999999999999875432100 0111
Q ss_pred cCccCCCCCCCHHHHHHH
Q 007490 527 LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~ 544 (601)
+...+|.+||++.+++..
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 112789999999988754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=248.46 Aligned_cols=179 Identities=29% Similarity=0.452 Sum_probs=152.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 414 (601)
++|.+.+.||+|++|.||+++.. +++.|++|++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999964 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc--
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ-- 469 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 469 (601)
|||+++++|.+++ ++|+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999987655 569999999999999999999999999999999866432211
Q ss_pred ----------------cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 470 ----------------GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 470 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.......++..|+|||......++.++||||||++++|+++|+.|+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1223346788999999998888999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=255.12 Aligned_cols=178 Identities=26% Similarity=0.420 Sum_probs=143.8
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC---------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--------- 408 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------- 408 (601)
..+|+..+.||.|+||.||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999995 45889999998776666667788999999999999999999876543
Q ss_pred -----CeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEcc-CCCcEEeecccc
Q 007490 409 -----DEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLA 460 (601)
Q Consensus 409 -----~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a 460 (601)
...++||||+++ +|..++ ++|+.||+||||||+||+++. ++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 357899999975 554332 679999999999999999974 567899999999
Q ss_pred eecCCCCCc-cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 461 RIFGVDQTQ-GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 461 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 765322111 11122357889999998754 5678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.69 Aligned_cols=176 Identities=30% Similarity=0.450 Sum_probs=147.6
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----eeE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-----EKI 412 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 412 (601)
+|++.+.||+|++|.||+++.. .++.|+||++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999964 48999999987643 344567899999999999999999999998775 789
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
++|||+++ +|..++ ++|+.||+||||||+|||++.++.++|+|||++.........
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999985 443322 669999999999999999999999999999999876543210
Q ss_pred -cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 -GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 -~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.......++..|+|||++.+. .++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 112334678899999999887 789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=251.15 Aligned_cols=179 Identities=28% Similarity=0.414 Sum_probs=141.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh--hHHHHHHHHHHHHHcCCCCccceEEEEEeCC------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ--GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD------ 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 409 (601)
.++|++.++||+|++|.||+|+.. +++.|+||++...... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999954 5889999998654322 2345678999999999999999999876443
Q ss_pred --eeEEEEeccCCCCccc-----------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 410 --EKILVYEFVPNKSLDY-----------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 410 --~~~lv~E~~~~gsL~~-----------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
..++|+||+.+..+.. +-++|+.+|+|+||||+||++++++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 4699999987532211 116799999999999999999999999999999997654
Q ss_pred CCCCcc---------ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 465 VDQTQG---------NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 465 ~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...... ......+++.|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 322111 11223567889999987654 578999999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=254.28 Aligned_cols=173 Identities=29% Similarity=0.446 Sum_probs=142.7
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD------ 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 409 (601)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999995 468999999986532 223456789999999999999999999987543
Q ss_pred eeEEEEeccCCCCcccc---------------------cccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 410 EKILVYEFVPNKSLDYF---------------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~---------------------l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
..++|+||+.. +|..+ .++|+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--- 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--- 169 (342)
T ss_pred eEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---
Confidence 46899999864 44322 167999999999999999999999999999999875422
Q ss_pred ccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 1223467889999999876 4688999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.38 Aligned_cols=172 Identities=26% Similarity=0.334 Sum_probs=138.5
Q ss_pred Cccccc--CcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRG--GFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
..||+| +||+||+++. ..|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999995 468999999986532 33456788999999999999999999999999999999999999
Q ss_pred CCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc-----
Q 007490 421 KSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG----- 470 (601)
Q Consensus 421 gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----- 470 (601)
++|..++ ++|+.+|+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 8876654 5699999999999999999999999999998654322111100
Q ss_pred ccccccccccccCcccccCC--CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01112345679999998764 478999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=252.52 Aligned_cols=180 Identities=29% Similarity=0.499 Sum_probs=153.0
Q ss_pred CCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 345 DNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
.+.||.|-||+||-|++ ++|+.||||++.+. ..+..+.+.+|+.||.+++||.||.+.-.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999995 46999999999764 3445578999999999999999999999999999999999999775
Q ss_pred Cccccc------------------------ccccceeeccccccCcEEEccC---CCcEEeecccceecCCCCCcccccc
Q 007490 422 SLDYFL------------------------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 422 sL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
-|+-.| |+|.++|+|.||||+|||+.+. -++||+|||++++++... ....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhh
Confidence 554332 7899999999999999999764 359999999999987543 3445
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY 529 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~ 529 (601)
.+||+.|+|||+++.+.|...-|+||.|||+|--++|..||. .++++.+.++.
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQN 778 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQN 778 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhc
Confidence 799999999999999999999999999999999999998875 34445444443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=247.61 Aligned_cols=205 Identities=26% Similarity=0.439 Sum_probs=157.8
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCC-hhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 412 (601)
...-++|++.+.||+|++|.||+|.+.+ ++.||||++.... ......+..|+.++.++. ||||+++++++.+....+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3455778899999999999999999754 8999999987543 233455667877777774 999999999999999999
Q ss_pred EEEeccCCCCcccc------------------------ccccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 413 LVYEFVPNKSLDYF------------------------LYDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 413 lv~E~~~~gsL~~~------------------------l~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++|||+++ +|..+ .++|+ .+|+||||+|+||++++++.+||+|||++..+....
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99999865 32221 16686 699999999999999999999999999987654322
Q ss_pred CccccccccccccccCcccccCCC----CCchhhHHhHHHHHHHHHhCCCCCCCCCCC-------------c--------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQ----FSVKSDVYSFGVLALETITGKKNSSFYQTD-------------G-------- 522 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~-------------~-------- 522 (601)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence 1 12235778999999987553 789999999999999999999998642110 0
Q ss_pred --ccccc---CccCCCCCCCHHHHHHH
Q 007490 523 --AEDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 523 --~~~l~---~~~dP~~RPt~~evl~~ 544 (601)
..+++ ...||.+||++.+++..
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 11689999999888754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=258.56 Aligned_cols=197 Identities=28% Similarity=0.419 Sum_probs=157.1
Q ss_pred CcCCcccccCcceEEeeecC-CCceeeEEEecc----CChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe--eEEEE
Q 007490 343 SSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSR----SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE--KILVY 415 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~lv~ 415 (601)
+...+||+|+|-+||+|.+. +|.+||--.++. ..+...++|..|+.+|+.|+||||++++.+|.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44578999999999999964 488887433322 245556889999999999999999999999997665 77899
Q ss_pred eccCCCCccccc-----------------------cc--ccceeeccccccCcEEEcc-CCCcEEeecccceecCCCCCc
Q 007490 416 EFVPNKSLDYFL-----------------------YD--SQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~--h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
|++..|+|+.|+ |+ |...|||||||-+||+|+. .|.|||+|+|+|......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 999999998766 33 5568999999999999986 588999999999987533
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-cccccc---------------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-GAEDLL--------------------- 527 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-~~~~l~--------------------- 527 (601)
.....+|||.|||||+.. ..|+..+||||||+.++||+|+..||..-... .+...+
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 233479999999999876 88999999999999999999999998643211 111111
Q ss_pred Cc--cCCCCCCCHHHHHHH
Q 007490 528 SY--EDPADRPSMATIVLA 544 (601)
Q Consensus 528 ~~--~dP~~RPt~~evl~~ 544 (601)
.. ....+|||+.|++..
T Consensus 278 ekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLATKSERLSAKELLKD 296 (632)
T ss_pred HHHhcCchhccCHHHHhhC
Confidence 11 347889999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=252.58 Aligned_cols=179 Identities=30% Similarity=0.430 Sum_probs=146.3
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG- 408 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 408 (601)
.++....++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556678999999999999999999984 468899999987542 23345678899999999999999999988643
Q ss_pred -----CeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 409 -----DEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 409 -----~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
...+++++++ +++|..++ ++|+.+|+||||||+||++++++.+||+|||++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3467888876 55664332 6799999999999999999999999999999987
Q ss_pred ecCCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 169 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5432 1223467889999998866 5688999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=243.75 Aligned_cols=173 Identities=31% Similarity=0.493 Sum_probs=141.8
Q ss_pred CCcCCcccccCcceEEeeecCC-CceeeEEEeccCCh--hhHHHHHHHHHHHHHc---CCCCccceEEEEEeCCe-----
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSG--QGAQEFKNEVVLVAKL---QHRNLVRLLGFCLEGDE----- 410 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~----- 410 (601)
|++.+.||+|+||.||+|+... ++.||+|++..... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999754 89999999864322 2234566788877766 59999999999998776
Q ss_pred eEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 KILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.+++|||+++ +|..++ ++|+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 8999999875 443322 56999999999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
... .....++..|+|||++.+..++.++||||||+++|||++|++||...
T Consensus 160 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 160 EMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred Ccc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 321 22335788999999999999999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=240.88 Aligned_cols=169 Identities=25% Similarity=0.327 Sum_probs=138.6
Q ss_pred cCCCCcCCcc--cccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKL--GRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.+ |+|+||.||+++. .+++.+|+|.+....... .|+.....+ +||||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 4566666666 9999999999995 457889999886532211 122222222 799999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++++|..++ ++|+.+++||||||+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----
Confidence 9999999997655 56999999999999999999998 9999999999765422
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2236788999999999989999999999999999999999998643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=217.84 Aligned_cols=177 Identities=29% Similarity=0.440 Sum_probs=145.3
Q ss_pred CCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+|...++||+|.||+||+|+. +.++.||+|++... +........+|+-+++.|+|+|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466778999999999999994 45888999998654 333456778999999999999999999999999999999999
Q ss_pred cCC----------CCcc-------------cccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 418 VPN----------KSLD-------------YFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 418 ~~~----------gsL~-------------~~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+.. |.++ .+-+.|+.++.||||||.|+||+.+|++||+|||+++.++..- ...+.
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rcysa 160 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSA 160 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eeeec
Confidence 864 2222 2226799999999999999999999999999999999876442 12334
Q ss_pred ccccccccCcccccCCC-CCchhhHHhHHHHHHHHHh-CCCCCCCCC
Q 007490 475 IVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETIT-GKKNSSFYQ 519 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~ellt-g~~p~~~~~ 519 (601)
.+-|..|.+|.++.+.+ |+...|+||-|||+.|+.. |++-|+...
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 46789999999998865 7899999999999999986 555555433
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=243.69 Aligned_cols=172 Identities=28% Similarity=0.382 Sum_probs=141.9
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEecc
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
|++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999965 478899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 419 PNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 419 ~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++|..++ ++|+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YT 156 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cC
Confidence 66664322 56999999999999999999999999999999986543221 22
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...++..|+|||++.. ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 3467889999998754 5578999999999999999999988853
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=234.34 Aligned_cols=182 Identities=24% Similarity=0.351 Sum_probs=156.6
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCC
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGD 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 409 (601)
+....++|.++.+||+|+|..|..++++ +.+.+|+|++++. .....+-.+.|-.+..+. +||.+|.++.+|+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3455678999999999999999999964 5778999998764 334445567787777777 7999999999999999
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.+++|.||++||+|-.++ ++|+.|||.||||.+|+|+|..|++||.|+|+++.--
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 999999999999985443 6799999999999999999999999999999998532
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....++.++||+.|+|||++.+..|...+|+|+|||+++||+.|+.||+..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 2233467789999999999999999999999999999999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=248.30 Aligned_cols=176 Identities=26% Similarity=0.399 Sum_probs=140.4
Q ss_pred CCCcCCcccccCcceEEeeecC-C--CceeeEEEeccC--ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeC----Ce
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-H--GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG----DE 410 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----~~ 410 (601)
+|++.+.||+|+||.||+++.. . ++.||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999954 3 778999998643 222345678899999999 599999999976432 45
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.++++||+.+ +|..++ ++|+.||+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 7889998864 554432 6799999999999999999999999999999998654322
Q ss_pred Cc--cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 468 TQ--GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 468 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.. .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 11 11233568999999998765 4689999999999999999999998854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=254.93 Aligned_cols=198 Identities=27% Similarity=0.342 Sum_probs=161.8
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.+..|.....+|.|+|+.|-.+.. .+++..++|++.+... +-.+|+.++... +||||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 366788889999999999999884 4688999999976522 235677666555 8999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEE-ccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILL-DVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll-~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|.+.++-|...+ ++|++|++||||||+|||+ ++.++++|+|||.++..... .
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~ 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C 470 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence 999998664433 6799999999999999999 58999999999999876533 2
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-cccc--------------------ccCccC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-GAED--------------------LLSYED 531 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-~~~~--------------------l~~~~d 531 (601)
...+-|..|.|||++....|++++||||||++||+||+|+.||.....+ ++.. .+...|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~d 550 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVD 550 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCC
Confidence 2335688999999999999999999999999999999999998765543 1111 112279
Q ss_pred CCCCCCHHHHHHH
Q 007490 532 PADRPSMATIVLA 544 (601)
Q Consensus 532 P~~RPt~~evl~~ 544 (601)
|.+||++.++...
T Consensus 551 P~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 551 PALRLGADEIGAH 563 (612)
T ss_pred hhhCcChhhhccC
Confidence 9999999998654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=243.33 Aligned_cols=173 Identities=34% Similarity=0.509 Sum_probs=145.1
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
|+..+.||+|++|.||+|+.. ++++|++|++.... ....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999965 48999999987653 333467788999999999999999999999999999999999
Q ss_pred CCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 419 PNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 419 ~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
++ +|..++ ++|+.+|+||||+|+||++++++.+||+|||.+........ ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCc
Confidence 84 665433 56999999999999999999999999999999986543221 1222
Q ss_pred ccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 475 IVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3457789999998776 789999999999999999999988854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=257.54 Aligned_cols=212 Identities=27% Similarity=0.450 Sum_probs=171.7
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEe
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 407 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 407 (601)
..+..+...++.|++.+.||.|.+|.||+++ .++++.+|+|++.... ...++++.|.++++.+ .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455666778889999999999999999999 4568899999886554 3346778899999988 69999999999874
Q ss_pred -----CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeec
Q 007490 408 -----GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDF 457 (601)
Q Consensus 408 -----~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Df 457 (601)
++.+|||||||.+|+..+++ |+|...+||||||-.|||++.++.+||.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 56799999999999865543 779999999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCc---
Q 007490 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY--- 529 (601)
Q Consensus 458 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~--- 529 (601)
|++..+. .+.......+||+.|||||++.- ..|+..+|+||||++..||--|.+|+.........-++..
T Consensus 168 GvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 168 GVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 9998764 33445566799999999999953 3477889999999999999999998755433221111111
Q ss_pred ----------------------cCCCCCCCHHHHHHH
Q 007490 530 ----------------------EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ----------------------~dP~~RPt~~evl~~ 544 (601)
+|-..||++.++++.
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 688899999888754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=268.42 Aligned_cols=122 Identities=28% Similarity=0.415 Sum_probs=108.9
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|.+.++||+|+||.||+|++. +++.||||++.... ......+.+|+.+++.++||||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999965 58899999986542 333467889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
||+++++|..++ |+|..+|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999987654 6699999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=252.22 Aligned_cols=175 Identities=30% Similarity=0.459 Sum_probs=145.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe---
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE--- 410 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--- 410 (601)
...++|+..+.||+|++|.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999964 5789999998653 22334567889999999999999999998876554
Q ss_pred ---eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 ---KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 ---~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.++|+||+ +++|..++ ++|+.||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999998 45665443 56999999999999999999999999999999986532
Q ss_pred CCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2 223467888999998865 4678999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=235.62 Aligned_cols=217 Identities=27% Similarity=0.375 Sum_probs=176.2
Q ss_pred chhhhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEE
Q 007490 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 403 (601)
..+++.+...+++....+.+|.||.||+|.|. +.+.|.+|.++.. +.-....+..|--++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34566777888999999999999999999654 3456888888654 4445677889999999999999999999
Q ss_pred EEEeC-CeeEEEEeccCCCCccccc-------------------------------ccccceeeccccccCcEEEccCCC
Q 007490 404 FCLEG-DEKILVYEFVPNKSLDYFL-------------------------------YDSQLRIIHRDLKASNILLDVQMN 451 (601)
Q Consensus 404 ~~~~~-~~~~lv~E~~~~gsL~~~l-------------------------------~~h~~~iiHrdlkp~NIll~~~~~ 451 (601)
++.++ ...+.++.++.-|+|..++ |+|+.+|||.||..+|.+||+..+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 98765 4578899999999998877 569999999999999999999999
Q ss_pred cEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc-
Q 007490 452 PKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY- 529 (601)
Q Consensus 452 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~- 529 (601)
+||+|=.+++.+-+....-..........||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+.+..+..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 99999999987654443332333345678999999999999999999999999999998 7888866554433333222
Q ss_pred ----------------------cCCCCCCCHHHHHHHHhc
Q 007490 530 ----------------------EDPADRPSMATIVLALNS 547 (601)
Q Consensus 530 ----------------------~dP~~RPt~~evl~~L~~ 547 (601)
..|++||++++++.-|.+
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 689999999999988754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=234.97 Aligned_cols=170 Identities=32% Similarity=0.442 Sum_probs=145.8
Q ss_pred ccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 348 LGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
||+|+||.||++... +++.+++|.+..... .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 488999999876432 2456788999999999999999999999999999999999999888
Q ss_pred cccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccccc
Q 007490 424 DYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 424 ~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
.+++ ++|+.+++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 7654 5699999999999999999999999999999998754321 12334567889
Q ss_pred ccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 481 YMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 481 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
|++||...+...+.++|+||||+++|||++|+.||....
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999988888999999999999999999999986443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=238.46 Aligned_cols=174 Identities=32% Similarity=0.440 Sum_probs=141.9
Q ss_pred CCCcCCcccccCcceEEeeecCC-CceeeEEEeccC-----ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+|.+.+.||+|+||.||+++... +..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998543 445666655432 122334567899999999999999999999999999999
Q ss_pred EeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 415 YEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 415 ~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
|||+++++|..++ ++|+.+++|+||+|+||+++. +.+||+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999886543 569999999999999999975 569999999997754322
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+..
T Consensus 160 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 160 D--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred c--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 22234678899999999888899999999999999999999998853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=262.85 Aligned_cols=214 Identities=31% Similarity=0.466 Sum_probs=170.4
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC----C----CceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP----H----GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLG 403 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 403 (601)
.++...++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 67777788888889999999999999842 1 3469999997653 35567899999999999 6999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcE
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
++...+..++|+||+..|+|..++ |+++.++|||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 999999999999999999886655 33556789999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCcccccccc--ccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCC-C
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIV--GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQ-T 520 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~-~ 520 (601)
|+.++..+||+|||+++........... ... -...|||||.+....|+.|+|||||||+||||+| |..|+.... .
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 9999999999999999965433322211 111 2456999999999999999999999999999998 667776522 1
Q ss_pred CccccccCc-----------------------cCCCCCCCHHHHHHHHhcC
Q 007490 521 DGAEDLLSY-----------------------EDPADRPSMATIVLALNSH 548 (601)
Q Consensus 521 ~~~~~l~~~-----------------------~dP~~RPt~~evl~~L~~~ 548 (601)
.+..+.+.. .+|++||++.++++.++.+
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111111111 6999999999999999884
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-29 Score=232.10 Aligned_cols=179 Identities=27% Similarity=0.429 Sum_probs=140.4
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------- 408 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------- 408 (601)
.+.|+...+||+|.||+||+++.. .|++||+|++-.. .........+|+++|..|+|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345777889999999999999954 5888998876432 222234567899999999999999999887532
Q ss_pred -CeeEEEEeccCC---CCccc--------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 409 -DEKILVYEFVPN---KSLDY--------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 409 -~~~~lv~E~~~~---gsL~~--------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
...|+|+++++. |.|.. +-|.|+..|+|||+|+.|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 347999999875 12211 226799999999999999999999999999999998775
Q ss_pred CCCCcc--ccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 465 VDQTQG--NTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 465 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...... .....+-|..|++||.+.+ ..|+++.|||.-|||+.||+++.+-+..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 443221 1223456999999999876 5689999999999999999998765543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=229.22 Aligned_cols=200 Identities=24% Similarity=0.287 Sum_probs=159.0
Q ss_pred hhcCCCCcC-CcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEe----CC
Q 007490 337 VATNKFSSD-NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE----GD 409 (601)
Q Consensus 337 ~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~ 409 (601)
..+++|++. ++||-|-.|.|-.+..+ +++++|+|++... ....+|+++.-.. .|||||.+++++.+ ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 345666654 68999999999999854 5889999998432 3346788877666 69999999999874 34
Q ss_pred eeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc---CCCcEEeecccce
Q 007490 410 EKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLAR 461 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Dfg~a~ 461 (601)
.+++|||.|+||.|...+ |+|+.+|.||||||+|+|... |..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 578999999999997655 779999999999999999974 5569999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----cc------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----ED------------ 525 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----~~------------ 525 (601)
.-.. .......+-|+.|.|||++...+|+...|+||+||++|-|+.|.+||.......+ ..
T Consensus 213 ~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 6432 2334456789999999999999999999999999999999999999865432111 11
Q ss_pred --------------ccCccCCCCCCCHHHHHHH
Q 007490 526 --------------LLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 --------------l~~~~dP~~RPt~~evl~~ 544 (601)
.+...+|.+|-|+.+++..
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1112799999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=214.75 Aligned_cols=179 Identities=28% Similarity=0.418 Sum_probs=143.3
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
+++..+....+..||+|++|.|-+-++ .+|+..|+|++... ..+..+++.+|+.+..+- .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 566677777788999999999988874 46899999999765 334456677888876655 799999999999999999
Q ss_pred EEEEeccCCCCccccc---------------------------ccc-cceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 412 ILVYEFVPNKSLDYFL---------------------------YDS-QLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l---------------------------~~h-~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
||.||.|.. +|+.+- |+| +..+||||+||+||||+.+|++|++|||++-.+
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999998853 333221 444 468999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcccccC----CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMH----GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...-. .+.-.|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 53321 122356778999998853 4799999999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=228.13 Aligned_cols=157 Identities=23% Similarity=0.226 Sum_probs=131.4
Q ss_pred cCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCccccc--
Q 007490 351 GGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-- 427 (601)
Q Consensus 351 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l-- 427 (601)
|.+|.||+++. .+++.+|+|++.... .+.+|...+....||||+++++++...+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 468899999986543 2334555566678999999999999999999999999999986654
Q ss_pred ---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCccc
Q 007490 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486 (601)
Q Consensus 428 ---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 486 (601)
++|+.+|+||||||+||+++.++.++|+|||.+...... .....++..|+|||.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~ 153 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEV 153 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcc
Confidence 569999999999999999999999999999988655322 122345678999999
Q ss_pred ccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 487 AMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 487 ~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
+.+..++.++||||+|+++|||++|+.|+..
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9888899999999999999999999977643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=232.99 Aligned_cols=188 Identities=34% Similarity=0.475 Sum_probs=151.8
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCC--h-----hhHHHHHHHHHHHHHcCCCCccceEE
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS--G-----QGAQEFKNEVVLVAKLQHRNLVRLLG 403 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~hpnIv~l~~ 403 (601)
|+.-....++|-.+.+||+|+|++||++. +...+.||||+-..+. . ...+...+|.+|.+.|+||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 34445556789999999999999999999 4457889999753221 1 12244678999999999999999999
Q ss_pred EEEe-CCeeEEEEeccCCCCcccccccc-------------------------cceeeccccccCcEEEcc---CCCcEE
Q 007490 404 FCLE-GDEKILVYEFVPNKSLDYFLYDS-------------------------QLRIIHRDLKASNILLDV---QMNPKI 454 (601)
Q Consensus 404 ~~~~-~~~~~lv~E~~~~gsL~~~l~~h-------------------------~~~iiHrdlkp~NIll~~---~~~~kL 454 (601)
++.- .+..+-|+||++|.+|+.+|..| +..|||-||||.|||+-. .|.+||
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 9974 45678999999999999988544 346999999999999954 577999
Q ss_pred eecccceecCCCCCc-----cccccccccccccCcccccCC----CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 455 SDFGLARIFGVDQTQ-----GNTSRIVGTYGYMSPEYAMHG----QFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.|||+++++..+... ..++...||.+|++||.+.-+ +.+.|+||||+|||+|..+.|++||....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 999999998755433 235567899999999987533 46889999999999999999999997644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=243.27 Aligned_cols=178 Identities=25% Similarity=0.345 Sum_probs=132.1
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-----------------CCCceeeEEEeccCChhhHHH--------------HHH
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-----------------PHGQEIAVKRLSRSSGQGAQE--------------FKN 385 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~ 385 (601)
...++|++.++||+|+||.||+|.+ ..++.||||++........++ ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3577899999999999999999963 235679999986543322222 334
Q ss_pred HHHHHHHcCCCCc-----cceEEEEEe--------CCeeEEEEeccCCCCccccc-------------------------
Q 007490 386 EVVLVAKLQHRNL-----VRLLGFCLE--------GDEKILVYEFVPNKSLDYFL------------------------- 427 (601)
Q Consensus 386 E~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l------------------------- 427 (601)
|+.++.+++|.++ +++++++.. .+..+|||||+++++|.+++
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788876654 677777753 35689999999998875433
Q ss_pred ----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcc
Q 007490 428 ----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485 (601)
Q Consensus 428 ----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 485 (601)
++|+.+|+||||||+|||++.++.+||+|||++......... ......+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 458899999999999999999999999999999765332211 111223478999999
Q ss_pred cccCCCC----------------------CchhhHHhHHHHHHHHHhCCC-CC
Q 007490 486 YAMHGQF----------------------SVKSDVYSFGVLALETITGKK-NS 515 (601)
Q Consensus 486 ~~~~~~~----------------------~~~sDvwSlGvvl~elltg~~-p~ 515 (601)
.+..... ..+.||||+||+++||++|.. |+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 8754321 134799999999999999875 54
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-27 Score=250.62 Aligned_cols=198 Identities=31% Similarity=0.449 Sum_probs=157.3
Q ss_pred CCCcCCcccccCcce-EEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEecc
Q 007490 341 KFSSDNKLGRGGFGE-VYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
-|...+.+|.|+.|+ ||+|.. +|++||||++-.. .....++|+..|+.- +|||||++++.-.+....||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355667899999986 799998 8899999998543 234567899999888 7999999999999999999999987
Q ss_pred CCCCccccc---------------------------ccccceeeccccccCcEEEcc---C--CCcEEeecccceecCCC
Q 007490 419 PNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDV---Q--MNPKISDFGLARIFGVD 466 (601)
Q Consensus 419 ~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~---~--~~~kL~Dfg~a~~~~~~ 466 (601)
.. +|++++ |+|+.+||||||||.||||+. + .+++|+|||+++.+..+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 43 333322 779999999999999999976 3 45899999999988655
Q ss_pred CCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhC-CCCCCCCCCC--------------------ccc
Q 007490 467 QTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG-KKNSSFYQTD--------------------GAE 524 (601)
Q Consensus 467 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~--------------------~~~ 524 (601)
... .......||.+|+|||++....-+.++||||+|||+|+.++| ..||...-.. ...
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~ 744 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAK 744 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHH
Confidence 433 234557899999999999998888899999999999999987 7888653222 111
Q ss_pred cccC---ccCCCCCCCHHHHHH
Q 007490 525 DLLS---YEDPADRPSMATIVL 543 (601)
Q Consensus 525 ~l~~---~~dP~~RPt~~evl~ 543 (601)
+++. ..+|..||++.+|+.
T Consensus 745 dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 745 DLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHhcCCCcccCCCHHHHhC
Confidence 2221 279999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=222.04 Aligned_cols=189 Identities=34% Similarity=0.471 Sum_probs=156.2
Q ss_pred CcceEEeeecC-CCceeeEEEeccCChhh-HHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCccccc--
Q 007490 352 GFGEVYKGVLP-HGQEIAVKRLSRSSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-- 427 (601)
Q Consensus 352 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l-- 427 (601)
+||.||+|+.. +++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48999999997665444 678999999999999999999999999999999999999998887654
Q ss_pred ---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCccc
Q 007490 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486 (601)
Q Consensus 428 ---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 486 (601)
++|+.+++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV 157 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence 5589999999999999999999999999999998765332 2334567889999999
Q ss_pred ccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC-CCCc----------------------ccccc---CccCCCCCCCHHH
Q 007490 487 AMHGQFSVKSDVYSFGVLALETITGKKNSSFY-QTDG----------------------AEDLL---SYEDPADRPSMAT 540 (601)
Q Consensus 487 ~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~-~~~~----------------------~~~l~---~~~dP~~RPt~~e 540 (601)
+.+..++.++|||+||+++|+|++|..|+... .... ..+++ ...+|.+||++.+
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 98888999999999999999999999998651 1110 00111 1168999999999
Q ss_pred HHH
Q 007490 541 IVL 543 (601)
Q Consensus 541 vl~ 543 (601)
+++
T Consensus 238 ~~~ 240 (244)
T smart00220 238 ALQ 240 (244)
T ss_pred Hhh
Confidence 876
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=231.73 Aligned_cols=179 Identities=26% Similarity=0.327 Sum_probs=144.2
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCC--C----CccceEEEE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH--R----NLVRLLGFC 405 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv~l~~~~ 405 (601)
......+++|.+.+.+|+|.||.|-++... .+..||||+++.-. ...+..+-|+++|.++.+ | -+|++.+||
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 334455899999999999999999999843 47889999985433 334556789999999932 3 278889999
Q ss_pred EeCCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc------------
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV------------ 448 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~------------ 448 (601)
...++.+||+|.+. .++.+++ ++|+.+++|-||||+|||+.+
T Consensus 161 dyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 99999999999873 3443333 679999999999999999821
Q ss_pred --------CCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 449 --------QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 449 --------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
+..+||+|||.|..-... ...++.|..|.|||++.+-.++.++||||+||||.|+.+|..-|...
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 234899999999875432 25578899999999999999999999999999999999998766543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=214.53 Aligned_cols=174 Identities=22% Similarity=0.463 Sum_probs=144.8
Q ss_pred hcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCC--eeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGD--EKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~~l 413 (601)
..++|++.+++|+|.+++||.|. ..++++++||+++.-. .+.+.+|+++|..|. ||||++++++..+.. ..-|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35689999999999999999999 4578899999996543 356889999999997 999999999988765 4579
Q ss_pred EEeccCCCCcccc--------------------cccccceeeccccccCcEEEccC-CCcEEeecccceecCCCCCcccc
Q 007490 414 VYEFVPNKSLDYF--------------------LYDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 414 v~E~~~~gsL~~~--------------------l~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+||+.+.+...+ -|.|+.||+|||+||.|++||.. -.++|+|+|+|.+..+...-
T Consensus 113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY--- 189 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--- 189 (338)
T ss_pred HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee---
Confidence 9999988654322 27799999999999999999964 45999999999988765433
Q ss_pred ccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||-.
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 23356778899999876 4588899999999999999999999854
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-26 Score=249.73 Aligned_cols=174 Identities=24% Similarity=0.308 Sum_probs=122.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-C----CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEE------E
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-H----GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGF------C 405 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~ 405 (601)
...++|++.++||+|+||.||+|++. + +..||||++...... +...+| .+....+.++..++.. .
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 35678999999999999999999964 4 689999987643221 111111 1122222333322221 2
Q ss_pred EeCCeeEEEEeccCCCCccccc-------------------------------------------ccccceeeccccccC
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-------------------------------------------YDSQLRIIHRDLKAS 442 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-------------------------------------------~~h~~~iiHrdlkp~ 442 (601)
..+...+||+||+++++|.+++ |+|+.+|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 4556789999999998764321 569999999999999
Q ss_pred cEEEcc-CCCcEEeecccceecCCCCCccccccccccccccCcccccCC----------------------CCCchhhHH
Q 007490 443 NILLDV-QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG----------------------QFSVKSDVY 499 (601)
Q Consensus 443 NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvw 499 (601)
|||++. ++.+||+|||+++.+..... .......+++.|||||.+... .++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999986 57899999999986543322 122345789999999965322 234567999
Q ss_pred hHHHHHHHHHhCCCCC
Q 007490 500 SFGVLALETITGKKNS 515 (601)
Q Consensus 500 SlGvvl~elltg~~p~ 515 (601)
||||+||||+++..++
T Consensus 364 SlGviL~el~~~~~~~ 379 (566)
T PLN03225 364 SAGLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHHHhCcCCC
Confidence 9999999999876543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=234.19 Aligned_cols=173 Identities=24% Similarity=0.379 Sum_probs=144.4
Q ss_pred CCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCCh--------hhHHHHHHHHHHHHHcC---CCCccceEEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSG--------QGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 407 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 407 (601)
.+|...+.+|+|+||.|+.+.++. ..+|+||.+.+..- ...-.+-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 348889999999999999999654 66889998866421 11112456999999997 9999999999999
Q ss_pred CCeeEEEEeccC-CCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 408 GDEKILVYEFVP-NKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 408 ~~~~~lv~E~~~-~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
++.+||+||-.. +-+|.+++ ++|++||||||||-+||.++.+|-+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999764 34555555 679999999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCC
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~ 516 (601)
.. .....++||..|.|||++.+.+|- ..-|||++|++||.++..+.||.
T Consensus 721 ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 43 334567999999999999998875 66899999999999998888764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-27 Score=222.34 Aligned_cols=175 Identities=26% Similarity=0.418 Sum_probs=141.4
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----eeEE
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-----EKIL 413 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~l 413 (601)
.+..+.||.|+||.||..+++ +|+.|++|++..- +-...+.+.+|+++|..++|.|++..+++..... ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345588999999999999964 6999999998653 3334577889999999999999999998876543 3567
Q ss_pred EEeccCCCCc-----------------------ccccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSL-----------------------DYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL-----------------------~~~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
++|.|.. +| +.+-|+|+.+|.||||||.|+|++.+..+||+|||+++..+.++...
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 7887743 22 22338899999999999999999999999999999999876554433
Q ss_pred ccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....+-|..|.|||++++. .|+.+.||||.|||+.||+..+.-|...
T Consensus 214 -MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 214 -MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred -hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 3345668899999999875 6899999999999999999887666543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-26 Score=240.51 Aligned_cols=205 Identities=25% Similarity=0.411 Sum_probs=170.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|+...++|.|.||.|||++.. .++..|+|+++........-+++|+-+++..+||||+.++|.+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46788999999999999999999954 58899999998777777778889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+.+|+|++.- |+|+.|-+|||||-.|||+++.|.+|++|||.+-.+.. +-...
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKR 169 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhhhh
Confidence 999999987643 77999999999999999999999999999999976542 23345
Q ss_pred ccccccccccCcccc---cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--------------CCccccccCc------
Q 007490 473 SRIVGTYGYMSPEYA---MHGQFSVKSDVYSFGVLALETITGKKNSSFYQ--------------TDGAEDLLSY------ 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~--------------~~~~~~l~~~------ 529 (601)
..+.||+.|||||+. +.+.|..++|||++|+...|+-.-++|..... .....+.-.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 567999999999987 46779999999999999999877766643221 2222222222
Q ss_pred -------cCCCCCCCHHHHHH
Q 007490 530 -------EDPADRPSMATIVL 543 (601)
Q Consensus 530 -------~dP~~RPt~~evl~ 543 (601)
.+|.+||++..++.
T Consensus 250 fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHhcCCCccCCChhhhee
Confidence 79999999987654
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=187.24 Aligned_cols=103 Identities=45% Similarity=0.833 Sum_probs=77.7
Q ss_pred cCCCC-C-CCcc-CCCChHHHHHHHHHHhcccccccCCCCCCcceeeecCCCCCCCcEEEEEecCCCCChhhhHHHHHHH
Q 007490 32 AHFCP-N-TTTF-TRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVTFA 108 (601)
Q Consensus 32 ~~~C~-~-~~~~-~~~s~f~~nl~~ll~~l~~~a~~~~~~~~~~~~~~~g~~~~~~~vyg~~qC~~D~~~~~C~~Cl~~a 108 (601)
|+.|+ | .++| +++++|++||+.||+.|.++++... +.+|+++..|.++ ++|||++||++|+++.+|..||+.|
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~--~~~f~~~~~~~~~--~~vYgl~qC~~Dls~~dC~~Cl~~a 76 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS--SKGFATGSAGSGP--DTVYGLAQCRGDLSPSDCRACLADA 76 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT---TEEEEEE--ST-----EEEEEEE-TTS-HHHHHHHHHHH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc--ccCcEEeecCCCC--CeEEEEEEcCCCCChhhhHHHHHHH
Confidence 67898 4 3567 6788899999999999999985442 3579999887766 8999999999999999999999999
Q ss_pred HHHHhhcCCCCcceEEEccceEEEEecccc
Q 007490 109 TKNVTQRCPVEKRTTILFDECLLRYSNQSF 138 (601)
Q Consensus 109 ~~~~~~~C~~~~~~~~~~~~C~~ry~~~~f 138 (601)
+..+.++|+++++|+||++.|+||||+++|
T Consensus 77 ~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 77 VANISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=207.79 Aligned_cols=175 Identities=34% Similarity=0.511 Sum_probs=149.7
Q ss_pred CCcCCcccccCcceEEeeecCC-CceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccC
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
|++.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999765 889999999776544 56788999999999999999999999999999999999999
Q ss_pred CCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 420 NKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 420 ~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|..++ ++|+.+++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 159 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTV 159 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccce
Confidence 98876553 45888999999999999999999999999999987653321 122334
Q ss_pred cccccccCcccc-cCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 476 VGTYGYMSPEYA-MHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 476 ~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 677889999998 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-25 Score=211.70 Aligned_cols=174 Identities=29% Similarity=0.367 Sum_probs=141.0
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 409 (601)
...+|..++.+|.|.- .|-.+.+ -.+++||+|++... .....++..+|..++..++|+||++++.++.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3467888889999988 5555542 25899999988653 3344567789999999999999999999987543
Q ss_pred -eeEEEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 410 -EKILVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+.|+|||+|.. +|...+ |+|+.||+||||||+||++..++.+||.|||+++.-...
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 46899999964 332221 679999999999999999999999999999999864322
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
-..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 23456688999999999999889999999999999999999986554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=198.77 Aligned_cols=186 Identities=36% Similarity=0.567 Sum_probs=152.1
Q ss_pred ccccCcceEEeeecCC-CceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCCccc
Q 007490 348 LGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDY 425 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~ 425 (601)
||+|.+|.||++.... ++++++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998765432 35678999999999999999999999999999999999999888766
Q ss_pred cc------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCCCCCcccccccccccc
Q 007490 426 FL------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480 (601)
Q Consensus 426 ~l------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 480 (601)
++ ++|+.+++|+||+|.||+++. ++.++|+|||.+........ ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCC
Confidence 54 458899999999999999999 89999999999987643321 1223457788
Q ss_pred ccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccccCccCCCCCCCHHHHHHH
Q 007490 481 YMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 481 y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~~~~dP~~RPt~~evl~~ 544 (601)
|++||..... .++.+.|+|++|+++++| .........+...+|.+||++.+++..
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 9999998877 788999999999999999 111122222233799999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=219.79 Aligned_cols=180 Identities=23% Similarity=0.285 Sum_probs=144.7
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcC------CCCccceEEEEEe
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ------HRNLVRLLGFCLE 407 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~ 407 (601)
.+...++|.+....|+|-|++|.+|... .|+.||||++..+..- .+.=+.|+++|++|+ .-|+++++..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 4567788999999999999999999953 4889999999765422 233367999999995 3489999999999
Q ss_pred CCeeEEEEeccCCCCccccc--------------------------ccccceeeccccccCcEEEccC-CCcEEeecccc
Q 007490 408 GDEKILVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLA 460 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a 460 (601)
.++++||+|-+. -+|.++| .+...+|+|.||||+|||+++. ..+||||||.|
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999999763 2344333 3357799999999999999975 45899999999
Q ss_pred eecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT 520 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 520 (601)
....... .....-+..|.|||++.+.+|+...|+||.||.||||.||+.-|+....
T Consensus 585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 8765332 2223445679999999999999999999999999999999987766543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-22 Score=201.22 Aligned_cols=106 Identities=25% Similarity=0.430 Sum_probs=83.4
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcC-----C---CCccceEEEEEe--
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-----H---RNLVRLLGFCLE-- 407 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l~~~~~~-- 407 (601)
..+|.+.++||.|.|++||++.+.. .+.||+|+.+.. ....+....||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3789999999999999999999644 678999988533 333456788999999983 3 369999999974
Q ss_pred --CCeeEEEEeccCCCCccccc-------------------------cccc-ceeeccccccCcEEE
Q 007490 408 --GDEKILVYEFVPNKSLDYFL-------------------------YDSQ-LRIIHRDLKASNILL 446 (601)
Q Consensus 408 --~~~~~lv~E~~~~gsL~~~l-------------------------~~h~-~~iiHrdlkp~NIll 446 (601)
+.+.++|+|++.. +|..++ |+|+ .||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5578999999854 333322 5664 699999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=201.41 Aligned_cols=182 Identities=26% Similarity=0.395 Sum_probs=146.6
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCC
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGD 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 409 (601)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+ ...++.+|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445677999999999999999999843 46789999986654 345689999999999 5899999999999999
Q ss_pred eeEEEEeccCCCCccccc--------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCCCC-
Q 007490 410 EKILVYEFVPNKSLDYFL--------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQ- 467 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l--------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~- 467 (601)
...+|+||++.....++. +.|.+|||||||||+|+|.+. .+.-.|+|||++......+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999999999986654433 669999999999999999985 4668999999997221000
Q ss_pred ------------C-----------------------------ccccccccccccccCcccccCC-CCCchhhHHhHHHHH
Q 007490 468 ------------T-----------------------------QGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLA 505 (601)
Q Consensus 468 ------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl 505 (601)
. ........||++|.|||++... ..+.++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0001135689999999998764 568999999999999
Q ss_pred HHHHhCCCCCCCC
Q 007490 506 LETITGKKNSSFY 518 (601)
Q Consensus 506 ~elltg~~p~~~~ 518 (601)
+-+++++.||-..
T Consensus 269 Lslls~~~PFf~a 281 (418)
T KOG1167|consen 269 LSLLSRRYPFFKA 281 (418)
T ss_pred ehhhccccccccC
Confidence 9999999998543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=201.86 Aligned_cols=153 Identities=20% Similarity=0.197 Sum_probs=120.3
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC--CCceeeEEEeccC-----ChhhHHHHHHHHHHHHHcCCCCccceEEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP--HGQEIAVKRLSRS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 406 (601)
......++|++.+.||+|+||+||+|++. +++.||||++... .......+.+|+++|++++|+||++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 44566788999999999999999999854 4777899987533 12235668999999999999999853322
Q ss_pred eCCeeEEEEeccCCCCccccc----------------ccccceeecccc-ccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 407 EGDEKILVYEFVPNKSLDYFL----------------YDSQLRIIHRDL-KASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l----------------~~h~~~iiHrdl-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
.+..+|||||+++++|.... ++|+.||+|||| ||+|||++.++.+||+|||+++.+......
T Consensus 90 -~~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~ 168 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGAL 168 (365)
T ss_pred -cCCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcch
Confidence 24679999999998885321 569999999999 999999999999999999999977543322
Q ss_pred cc------cccccccccccCcccccC
Q 007490 470 GN------TSRIVGTYGYMSPEYAMH 489 (601)
Q Consensus 470 ~~------~~~~~gt~~y~aPE~~~~ 489 (601)
.. .....+++.|+|||.+..
T Consensus 169 ~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 169 YRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhhhccCccCCcccCCh
Confidence 11 134567889999999854
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=159.03 Aligned_cols=101 Identities=40% Similarity=0.769 Sum_probs=76.8
Q ss_pred eeecc---CcCC-CChhHHHHHHHHHHHHHHHHhccC-CCceeeeecccCCcceEEEEEeccCCCCHHhHHHHHHHHHhc
Q 007490 148 LSMWN---LQNV-TEPDKFNVFLGNLMNQVITQAVNN-PKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQ 222 (601)
Q Consensus 148 ~~~~~---~~~~-~~~~~f~~~~~~l~~~l~~~a~~~-~~~~~~~~~~~~~~~~vy~l~QC~~dls~~~C~~Cl~~~~~~ 222 (601)
|..|+ ..+. +++..|+..+..||..|...|+.+ ..+|++++. ..+.++||||+||++||++.+|..||+.++..
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 34566 3333 456669999999999999998865 578999886 35678999999999999999999999999999
Q ss_pred cccccCCCCCCeEecCccceeeeccCc
Q 007490 223 LPRCCSGRQGGRVLYPSCNLRYESYPF 249 (601)
Q Consensus 223 ~~~~c~~~~gg~v~~~~C~lry~~~~F 249 (601)
++.+|..+.||+|++++|++||+.++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999988
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-21 Score=181.79 Aligned_cols=174 Identities=25% Similarity=0.403 Sum_probs=136.1
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEE-EEeCCeeEEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGF-CLEGDEKILVY 415 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~ 415 (601)
.+.|.+.+.||+|.||.+-+++++. .+.+++|-+.... ....+|.+|..---.| .|.||+.-+++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678999999999999999999764 6789999886543 2346788887765555 58999987764 55667788999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEc--cCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLD--VQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||++.|+|..-+ +.|++++||||||.+||||- +..++||+|||..+..+..
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----- 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----- 176 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-----
Confidence 999999987544 66999999999999999994 2347999999999764321
Q ss_pred cccccccccccCcccccC---C--CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 472 TSRIVGTYGYMSPEYAMH---G--QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~---~--~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....-+..|.+||.... + ...+.+|||.||++++.++||+.||...
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 112234567999997643 2 3467899999999999999999999743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=180.28 Aligned_cols=158 Identities=13% Similarity=0.155 Sum_probs=124.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHH---H------HHHHHHHHHHcCCCCccceEEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQ---E------FKNEVVLVAKLQHRNLVRLLGFCL 406 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~hpnIv~l~~~~~ 406 (601)
....++|+..++||.|+||.||+... ++..+|||.+......... . +.+|++.+.+++||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 35678999999999999999999665 6778999999754332222 2 689999999999999999998866
Q ss_pred eC--------CeeEEEEeccCCCCccccc---------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 407 EG--------DEKILVYEFVPNKSLDYFL---------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 407 ~~--------~~~~lv~E~~~~gsL~~~l---------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
.. ...+|+|||++|.+|.++. ..|+.|++|||+||+||+++.++ ++|+|||.....
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence 43 3578999999999986643 45999999999999999999988 999999988754
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHH
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETI 509 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 509 (601)
...... ..+.....+..++|+|+||+.+.-+.
T Consensus 185 ~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 185 AQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 221111 01334455667999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-20 Score=176.72 Aligned_cols=181 Identities=25% Similarity=0.373 Sum_probs=151.6
Q ss_pred cCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.-+|++.++||+|+||.++.|+ +-++++||||.-...+ ..-++..|.+..+.| ..++|..++-+..++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4579999999999999999999 5689999999754433 335678899999988 46999999999889888999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEccCC-----CcEEeecccceecCCCC
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQM-----NPKISDFGLARIFGVDQ 467 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~-----~~kL~Dfg~a~~~~~~~ 467 (601)
++ |.+|+++. +.|++.+|.|||||+|+||...+ .+.|+|||+|+.+....
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 87 66777665 55999999999999999996433 48999999999886654
Q ss_pred Cccc-----cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc
Q 007490 468 TQGN-----TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG 522 (601)
Q Consensus 468 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~ 522 (601)
+..+ .....||.+||+-....+.+.+.+.|+-|||-++++.|-|..||.....+.
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 4432 334679999999999999999999999999999999999999998765443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-20 Score=217.61 Aligned_cols=152 Identities=22% Similarity=0.273 Sum_probs=104.3
Q ss_pred HcCC-CCccceEEEE-------EeCCeeEEEEeccCCCCccccc------------------------ccccceeecccc
Q 007490 392 KLQH-RNLVRLLGFC-------LEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDL 439 (601)
Q Consensus 392 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdl 439 (601)
.++| +||+++++++ ......++++|++ +++|..++ |+|++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5777788877 2334567778877 44665444 679999999999
Q ss_pred ccCcEEEcc-------------------CCCcEEeecccceecCCCCC--------------ccccccccccccccCccc
Q 007490 440 KASNILLDV-------------------QMNPKISDFGLARIFGVDQT--------------QGNTSRIVGTYGYMSPEY 486 (601)
Q Consensus 440 kp~NIll~~-------------------~~~~kL~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~ 486 (601)
||+||||+. ++.+||+|||+++....... ........||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 44566667776654211000 000112357889999999
Q ss_pred ccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC-----------C-------ccccc---cCccCCCCCCCHHHHHHH
Q 007490 487 AMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT-----------D-------GAEDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 487 ~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~-----------~-------~~~~l---~~~~dP~~RPt~~evl~~ 544 (601)
+.+..++.++|||||||+||||++|..|+..... . ....+ +...+|.+||++.|+++.
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 9999999999999999999999999887643210 0 00001 123799999999999763
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=168.52 Aligned_cols=181 Identities=25% Similarity=0.373 Sum_probs=147.7
Q ss_pred hhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC-CCccceEEEEEeCCeeEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv 414 (601)
+..++|.++++||.|+||.+|.|. ..+|.+||||.-+.... ..++.-|.++...|+| ..|..+..+..+.+.-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 346789999999999999999999 56799999998654332 2356778999999975 6788888888888899999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccC---CCcEEeecccceecCCCC
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~ 467 (601)
||.+ |.+|+++. +.|..++|||||||+|.|..-+ ..+.|+|||+++.+....
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9987 66776654 6699999999999999999644 458899999999875443
Q ss_pred Cccc-----cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC
Q 007490 468 TQGN-----TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT 520 (601)
Q Consensus 468 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 520 (601)
+..+ .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||.....
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 3322 2346789999998888888889999999999999999999999987543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=178.90 Aligned_cols=178 Identities=25% Similarity=0.321 Sum_probs=141.5
Q ss_pred CCCcCCcccccCcceEEeeecCCC--ceeeEEEeccCChhhHHHHHHHHHHHHHcCC----CCccceEEEE-EeCCeeEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPHG--QEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH----RNLVRLLGFC-LEGDEKIL 413 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~~~l 413 (601)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996543 4788888765533333378889999999973 6899999999 47778899
Q ss_pred EEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccC-----CCcEEeecccceec
Q 007490 414 VYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQ-----MNPKISDFGLARIF 463 (601)
Q Consensus 414 v~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~-----~~~kL~Dfg~a~~~ 463 (601)
||+.+ |.+|.++. +.|+.|++||||||.|+++... ..+.|.|||+++.+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99976 44554432 5699999999999999999865 35899999999832
Q ss_pred C--CCCC----cc-c-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 464 G--VDQT----QG-N-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 464 ~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
. .... .. . .....||..|.+++...+...+.+.|+||++.++.|++.|..||....
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 2 1111 11 1 234569999999999999999999999999999999999999996544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=171.23 Aligned_cols=176 Identities=36% Similarity=0.510 Sum_probs=147.4
Q ss_pred CCcCCcccccCcceEEeeecCCCceeeEEEeccCChh---hHHHHHHHHHHHHHcCCC-CccceEEEEEeCCeeEEEEec
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ---GAQEFKNEVVLVAKLQHR-NLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~E~ 417 (601)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999975 78899998765332 467889999999999988 799999999777778999999
Q ss_pred cCCCCccccc--------------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCcc
Q 007490 418 VPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 418 ~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~ 470 (601)
+.++++..++ +.|+.+++|||+||+||+++..+ .++++|||.++.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 9998876322 46999999999999999999988 69999999998654433221
Q ss_pred ----ccccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 471 ----NTSRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 471 ----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
......++..|++||.+.+ ..+....|+||+|++++++++|..|+....
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2355689999999999987 578899999999999999999999965544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=156.38 Aligned_cols=170 Identities=16% Similarity=0.114 Sum_probs=127.2
Q ss_pred CcCCcccccCcceEEeeecCCCceeeEEEeccCCh----hhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEec
Q 007490 343 SSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG----QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.+...|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|++|+ |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 678888887754432 11235789999999995 5889999886 457999999
Q ss_pred cCCCCccccc----------------ccccceeecccc-ccCcEEEccCCCcEEeecccceecCCCCCc----c--c---
Q 007490 418 VPNKSLDYFL----------------YDSQLRIIHRDL-KASNILLDVQMNPKISDFGLARIFGVDQTQ----G--N--- 471 (601)
Q Consensus 418 ~~~gsL~~~l----------------~~h~~~iiHrdl-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----~--~--- 471 (601)
+.|.+|...+ +.|+.||+|||| ||.|||++.++.++|+|||++......... . .
T Consensus 80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ 159 (218)
T PRK12274 80 LAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRH 159 (218)
T ss_pred ecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence 9998885432 569999999999 799999999999999999999865432210 0 0
Q ss_pred --cccccccccccCcccccCC-CCC-chhhHHhHHHHHHHHHhCCCCCCC
Q 007490 472 --TSRIVGTYGYMSPEYAMHG-QFS-VKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 472 --~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......++.|++|+...-. ..+ ...++++.|.-+|.++|++.++-.
T Consensus 160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0112246677777754322 333 678999999999999999987543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=158.58 Aligned_cols=116 Identities=20% Similarity=0.196 Sum_probs=88.7
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChh--h------------------------HHHHHHHHHHHHHcCCCCc
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ--G------------------------AQEFKNEVVLVAKLQHRNL 398 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnI 398 (601)
...||+|++|.||+|...+|++||||+++..... . .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998654211 0 1122459999999998887
Q ss_pred cceEEEEEeCCeeEEEEeccCCCCccccc-----------------------cc-ccceeeccccccCcEEEccCCCcEE
Q 007490 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YD-SQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 399 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------------~~-h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
.....+.. ...+|||||++++++.... +. |+.||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 54443322 2348999999987654321 45 689999999999999998 578999
Q ss_pred eecccceec
Q 007490 455 SDFGLARIF 463 (601)
Q Consensus 455 ~Dfg~a~~~ 463 (601)
+|||++...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=164.07 Aligned_cols=196 Identities=23% Similarity=0.332 Sum_probs=148.6
Q ss_pred CcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 343 SSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
.+..+|.+...|+.|+|++ +|..+++|++... .......|..|.-.|+-+.||||+.++|.|....++.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3456788899999999999 7777888887543 233346788899999999999999999999999999999999999
Q ss_pred CCccccccc-------------------------ccce--eeccccccCcEEEccCCCcEEe--ecccceecCCCCCccc
Q 007490 421 KSLDYFLYD-------------------------SQLR--IIHRDLKASNILLDVQMNPKIS--DFGLARIFGVDQTQGN 471 (601)
Q Consensus 421 gsL~~~l~~-------------------------h~~~--iiHrdlkp~NIll~~~~~~kL~--Dfg~a~~~~~~~~~~~ 471 (601)
|+|..+++. |+.. |.---|.+..++||++.+++|+ |--++- .
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---------q 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------Q 342 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---------e
Confidence 999887743 3321 2334688999999999988874 322211 0
Q ss_pred cccccccccccCcccccCCCCC---chhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc---------------------
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFS---VKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL--------------------- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~--------------------- 527 (601)
.....-.+.||+||.+...+-+ .++|+|||++++|||.|.+.||......+..-.+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 1122346789999999876543 6799999999999999999999765543222111
Q ss_pred ---CccCCCCCCCHHHHHHHHhcC
Q 007490 528 ---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~~L~~~ 548 (601)
..+||.+||.+..|+-.|+..
T Consensus 423 ~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHhcCCCCcCCCcceehhhHHHh
Confidence 128999999999999888753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-18 Score=189.47 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=150.7
Q ss_pred CcCCcccccCcceEEeeecC-CCceeeEEEec----c-CCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 343 SSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLS----R-SSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.....+|.|++|.|+..... ..+..+.|... . ... .....+..|+-+-..|+|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45688999999977776632 23333433322 1 111 11122667788888899999988887777766666669
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc--c
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ--G 470 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~ 470 (601)
||++. +|..++ |+|..||.|||||++|++++.+|.+||+|||.+..+...... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 765443 679999999999999999999999999999999887655444 4
Q ss_pred ccccccccccccCcccccCCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCCCccc--c---------------c------
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSV-KSDVYSFGVLALETITGKKNSSFYQTDGAE--D---------------L------ 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~elltg~~p~~~~~~~~~~--~---------------l------ 526 (601)
....++|+..|+|||++.+.+|.+ ..||||.|+++..|++|+.||......+.. + +
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 456788999999999999999985 589999999999999999998654333221 0 0
Q ss_pred --------cCccCCCCCCCHHHHHHH
Q 007490 527 --------LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 527 --------~~~~dP~~RPt~~evl~~ 544 (601)
+...||.+|.|+.+|++.
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hHHHHHHHHccCChhheecHHHHhhC
Confidence 001799999999998753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.8e-17 Score=153.15 Aligned_cols=117 Identities=24% Similarity=0.240 Sum_probs=91.8
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChh---------------------h-----HHHHHHHHHHHHHcCCCCc
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ---------------------G-----AQEFKNEVVLVAKLQHRNL 398 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~hpnI 398 (601)
...||+|++|.||+|+..+|+.||||++...... . ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999778999999998754211 0 1224678999999999998
Q ss_pred cceEEEEEeCCeeEEEEeccCCCCcccc-c----------------------cccc-ceeeccccccCcEEEccCCCcEE
Q 007490 399 VRLLGFCLEGDEKILVYEFVPNKSLDYF-L----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 399 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL 454 (601)
.....+... ..+|||||++++++... + +.|. .||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 655544433 34899999998754221 1 4588 9999999999999999 889999
Q ss_pred eecccceecC
Q 007490 455 SDFGLARIFG 464 (601)
Q Consensus 455 ~Dfg~a~~~~ 464 (601)
+|||++....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05145 159 IDVSQAVELD 168 (190)
T ss_pred EEcccceecC
Confidence 9999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-18 Score=178.51 Aligned_cols=163 Identities=29% Similarity=0.373 Sum_probs=135.4
Q ss_pred cccccCcceEEeeec----CCCceeeEEEeccCChh--hHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEeccC
Q 007490 347 KLGRGGFGEVYKGVL----PHGQEIAVKRLSRSSGQ--GAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
.+|+|.||.|++++. +.|.-+|+|.+.+.... .......|..++...+ ||.+|+++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 34677888887654221 1124456788888886 9999999999999999999999999
Q ss_pred CCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccc
Q 007490 420 NKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 420 ~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
+|.|...+ ++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .+
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------AC 154 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------cc
Confidence 98876544 56999999999999999999999999999999987532221 18
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
||..|||||++. .....+|.||||++++||++|..||..
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 899999999988 667889999999999999999999876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.4e-17 Score=152.12 Aligned_cols=98 Identities=20% Similarity=0.192 Sum_probs=77.4
Q ss_pred ccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 440 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
||+|||++.++.+|+ ||+++...... ..|++.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 38 kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 38 KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred CcccEeEcCccceee--ccceEeecccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 999999999999999 99998754321 257899999999999999999999999999999999999985432
Q ss_pred CCc-----------------------------cccccC---ccCCCCCCCHHHHHHHHh
Q 007490 520 TDG-----------------------------AEDLLS---YEDPADRPSMATIVLALN 546 (601)
Q Consensus 520 ~~~-----------------------------~~~l~~---~~dP~~RPt~~evl~~L~ 546 (601)
... ..+++. ..+|.+||++.|+++.+.
T Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 109 ELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred hhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 100 001111 168999999999988764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=150.42 Aligned_cols=118 Identities=25% Similarity=0.380 Sum_probs=91.5
Q ss_pred CCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-----CCCCccceEEEEEeCC---eeE-
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-----QHRNLVRLLGFCLEGD---EKI- 412 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~~~- 412 (601)
+...+.||+|+||.||. +++....+||++........+.+.+|+++++++ +||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568899999999996 433333379988765444567789999999999 5799999999999874 333
Q ss_pred EEEec--cCCCCccccc---------------------ccccceeeccccccCcEEEccC----CCcEEee-cccce
Q 007490 413 LVYEF--VPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQ----MNPKISD-FGLAR 461 (601)
Q Consensus 413 lv~E~--~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~----~~~kL~D-fg~a~ 461 (601)
+|+|| .++++|.+++ |+|+.+|+||||||+|||++.. ..++|+| ||...
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 78999 5567775443 6699999999999999999743 3799999 55443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-16 Score=176.46 Aligned_cols=176 Identities=20% Similarity=0.268 Sum_probs=138.5
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCee
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~ 411 (601)
.++....|.+.+.||+|+||.||+|...+|+.||+|+-+....-. |---.+++.+|+ -+.|..+...+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 455567788999999999999999998789999999876554321 111123334443 34566666677777888
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEcc-------CCCcEEeecccce
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDV-------QMNPKISDFGLAR 461 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~-------~~~~kL~Dfg~a~ 461 (601)
+||+||.+.|+|.+++ ++|..+|||+||||+|.||.. ...++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999999998776 569999999999999999942 3348999999997
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKK 513 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 513 (601)
.+..-..........+|-.+-.+|+..+.+++...|.|.|+.+++-||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 6644333334455678889999999999999999999999999999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-15 Score=143.65 Aligned_cols=124 Identities=21% Similarity=0.202 Sum_probs=97.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChh----------------------hHHHHHHHHHHHHHcC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ----------------------GAQEFKNEVVLVAKLQ 394 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 394 (601)
.....|.+.+.||+|+||.||++..++|+.||||++...... .......|+.++.++.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333347888999999999999999888999999987543210 1123577899999998
Q ss_pred CCC--ccceEEEEEeCCeeEEEEeccCCCCccccc-----------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 395 HRN--LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 395 hpn--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
|++ +.+.++ ....++||||+++++|..+. +.|+.+|+||||||+||++++++.++|+
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~li 167 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYII 167 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEE
Confidence 874 445544 24568999999998876544 4588999999999999999999999999
Q ss_pred ecccceecC
Q 007490 456 DFGLARIFG 464 (601)
Q Consensus 456 Dfg~a~~~~ 464 (601)
|||++....
T Consensus 168 Dfg~~~~~~ 176 (198)
T cd05144 168 DWPQMVSTD 176 (198)
T ss_pred ECCccccCC
Confidence 999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-16 Score=171.23 Aligned_cols=197 Identities=21% Similarity=0.290 Sum_probs=131.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....+|..++.|..|+||.||..+++. .+++|+|+ .++.. -+++ ++.....|.+| |=| ..++=.+
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv---gDc---~tllk~~ 145 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV---GDC---ATLLKNI 145 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee---chh---hhhcccC
Confidence 345678899999999999999998753 67788843 22211 0111 33334455544 111 0111111
Q ss_pred eccCCCCcccccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC-------------cccccccccccccc
Q 007490 416 EFVPNKSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT-------------QGNTSRIVGTYGYM 482 (601)
Q Consensus 416 E~~~~gsL~~~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-------------~~~~~~~~gt~~y~ 482 (601)
.-.+.......-|+|+.+|+|||+||+|.+|+.-|++|+.|||+++....... +-.....+||+.|+
T Consensus 146 g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 146 GPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred CCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcccc
Confidence 11222222344588999999999999999999999999999999875321100 01123468999999
Q ss_pred CcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-----ccCc--cCCCCCCCHHHHHHHHhc
Q 007490 483 SPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-----LLSY--EDPADRPSMATIVLALNS 547 (601)
Q Consensus 483 aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-----l~~~--~dP~~RPt~~evl~~L~~ 547 (601)
|||++....|...+|+|++|+|+||.+.|..||.....+.+.. .+.+ .|+.--|-++++++.|-.
T Consensus 226 aPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~ 297 (1205)
T KOG0606|consen 226 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLR 297 (1205)
T ss_pred ChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHH
Confidence 9999999999999999999999999999999997764433222 2222 355555666666666643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.6e-16 Score=173.06 Aligned_cols=205 Identities=21% Similarity=0.265 Sum_probs=146.0
Q ss_pred CCCcCCcccccCcceEEeeecCCCceeeEEEeccCC-hhhHHHHH---HHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS-GQGAQEFK---NEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++...+.||.+.|=+|.+++++.|. |+||++-+.. .-..+.+. .|++ ...++|||.+++.-+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677899999999999999997887 9999986654 22334444 3444 556699999999888777777788888
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC-Ccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-TQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 472 (601)
|+.+ +|.+.+ ..|..||.|||||.+||||+.-..+.|+||..-+..-... .....
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 8754 443333 3499999999999999999999999999997765321111 11111
Q ss_pred c----cccccccccCcccccCC----------C-CCchhhHHhHHHHHHHHHh-CCCCCCCCC--------CCccccccC
Q 007490 473 S----RIVGTYGYMSPEYAMHG----------Q-FSVKSDVYSFGVLALETIT-GKKNSSFYQ--------TDGAEDLLS 528 (601)
Q Consensus 473 ~----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~ellt-g~~p~~~~~--------~~~~~~l~~ 528 (601)
. +...-..|+|||.+... . .+++-||||+||++.||++ |+++|...+ ..+.+.++.
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le 260 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE 260 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence 1 11223479999987431 2 5788999999999999997 577775421 112222222
Q ss_pred c---------------cCCCCCCCHHHHHHHHhcC
Q 007490 529 Y---------------EDPADRPSMATIVLALNSH 548 (601)
Q Consensus 529 ~---------------~dP~~RPt~~evl~~L~~~ 548 (601)
. .||.+|-++.+.++.-.+.
T Consensus 261 ~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 261 KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 2 7999999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.2e-15 Score=142.08 Aligned_cols=115 Identities=22% Similarity=0.338 Sum_probs=97.2
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChh--------hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ--------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
+.||+|++|.||+|.+ .|..|++|+....... ....+.+|++++..++|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 7788999986543211 124578899999999999998888888788889999999
Q ss_pred cCCCCccccc-------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 418 VPNKSLDYFL-------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 418 ~~~gsL~~~l-------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
++|++|.+++ +.|+.+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999987554 45899999999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.7e-15 Score=140.17 Aligned_cols=114 Identities=23% Similarity=0.359 Sum_probs=94.3
Q ss_pred cccccCcceEEeeecCCCceeeEEEeccCCh--------hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
.||+|++|.||+|.+ ++.+|++|+...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 678999998654321 11356778999999999988776666666777789999999
Q ss_pred CCCCccccc----------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 419 PNKSLDYFL----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 419 ~~gsL~~~l----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
+|++|..++ ++|+.+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999887543 46999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.1e-15 Score=162.00 Aligned_cols=127 Identities=20% Similarity=0.321 Sum_probs=101.3
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEe-ccC-C------hhhHHHHHHHHHHHHHcCCCCccceEEEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRL-SRS-S------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 406 (601)
.+.....|...+.||+|+||.||+|.+.. ..+++|+. .+. . ....+++.+|++++++++|++|+....++.
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 33444556778999999999999998744 34444443 221 1 112356889999999999999999888888
Q ss_pred eCCeeEEEEeccCCCCccccc---------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 407 EGDEKILVYEFVPNKSLDYFL---------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l---------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
..+..++||||+++++|.+++ ++|+.+|+||||||+|||+ .++.++|+|||+++..
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 878889999999999998765 5699999999999999999 6788999999999753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=142.90 Aligned_cols=119 Identities=19% Similarity=0.181 Sum_probs=92.4
Q ss_pred CCCcCCcccccCcceEEeee--cCCCceeeEEEeccCChh------------------------hHHHHHHHHHHHHHcC
Q 007490 341 KFSSDNKLGRGGFGEVYKGV--LPHGQEIAVKRLSRSSGQ------------------------GAQEFKNEVVLVAKLQ 394 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 394 (601)
-|++.+.||+|++|.||+|+ ..+|+.||||++...... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 568999999998643210 1123568999999997
Q ss_pred CCC--ccceEEEEEeCCeeEEEEeccCCCCccccc-----------------------ccccce-eeccccccCcEEEcc
Q 007490 395 HRN--LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLR-IIHRDLKASNILLDV 448 (601)
Q Consensus 395 hpn--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~-iiHrdlkp~NIll~~ 448 (601)
+.. +.+++++ ...++||||+++.+|.... ++|..| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444442 2358999999997764322 469999 99999999999999
Q ss_pred CCCcEEeecccceecC
Q 007490 449 QMNPKISDFGLARIFG 464 (601)
Q Consensus 449 ~~~~kL~Dfg~a~~~~ 464 (601)
++.++|+|||.+....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.9e-15 Score=146.06 Aligned_cols=177 Identities=18% Similarity=0.290 Sum_probs=111.9
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcC----------CCCccceEEEEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQ----------HRNLVRLLGFCL 406 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------hpnIv~l~~~~~ 406 (601)
.+...+.||.|+++.||.+++. +|+++|||++.... ....+.+++|.-....+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455688999999999999964 48999999875432 234566777765554432 222333333222
Q ss_pred e---------C---C-----eeEEEEeccCCCCccccc------------------------------ccccceeecccc
Q 007490 407 E---------G---D-----EKILVYEFVPNKSLDYFL------------------------------YDSQLRIIHRDL 439 (601)
Q Consensus 407 ~---------~---~-----~~~lv~E~~~~gsL~~~l------------------------------~~h~~~iiHrdl 439 (601)
. . . ..+++|+-+ .++|..++ ++|..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 124566655 33443332 569999999999
Q ss_pred ccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccC--------CCCCchhhHHhHHHHHHHHHhC
Q 007490 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH--------GQFSVKSDVYSFGVLALETITG 511 (601)
Q Consensus 440 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg 511 (601)
+|+|++++.+|.++|+||+.....+.... . ...+..|.+||.... -.++.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999998876542111 1 234567999997643 2578899999999999999999
Q ss_pred CCCCCCCCCCcc
Q 007490 512 KKNSSFYQTDGA 523 (601)
Q Consensus 512 ~~p~~~~~~~~~ 523 (601)
+.||.....+..
T Consensus 247 ~lPf~~~~~~~~ 258 (288)
T PF14531_consen 247 RLPFGLSSPEAD 258 (288)
T ss_dssp S-STCCCGGGST
T ss_pred cCCCCCCCcccc
Confidence 999987655433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.4e-15 Score=153.19 Aligned_cols=101 Identities=33% Similarity=0.486 Sum_probs=85.6
Q ss_pred eeEEEEeccCCCCccccccc-------------------c----cceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 EKILVYEFVPNKSLDYFLYD-------------------S----QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l~~-------------------h----~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
..||.|+++...+|.+++.. . -++.+|||+||.||+...+..+||.|||+.......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 46899999999999998821 1 167899999999999999999999999999876544
Q ss_pred C----CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh
Q 007490 467 Q----TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510 (601)
Q Consensus 467 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 510 (601)
. .........||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 3 1123345689999999999999999999999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.5e-14 Score=140.90 Aligned_cols=123 Identities=25% Similarity=0.280 Sum_probs=87.1
Q ss_pred CCCCccceEEEEEe---------------------------CCeeEEEEeccCCCCccccc-------------------
Q 007490 394 QHRNLVRLLGFCLE---------------------------GDEKILVYEFVPNKSLDYFL------------------- 427 (601)
Q Consensus 394 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l------------------- 427 (601)
+|||||++.++|.+ +..+|+||.-.+. +|+.++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999987753 2235788875533 444443
Q ss_pred ---ccccceeeccccccCcEEEc--cCCC--cEEeecccceecCCCC----CccccccccccccccCcccccCCC-----
Q 007490 428 ---YDSQLRIIHRDLKASNILLD--VQMN--PKISDFGLARIFGVDQ----TQGNTSRIVGTYGYMSPEYAMHGQ----- 491 (601)
Q Consensus 428 ---~~h~~~iiHrdlkp~NIll~--~~~~--~kL~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----- 491 (601)
|+|++||.|||+|++|||+. +|+. +.|+|||.+---.... ........-|...-||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 77999999999999999994 4443 6899999985322110 011122335677889999875422
Q ss_pred -CCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 492 -FSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 492 -~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
--.|+|.|+.|.+.||+++..-||..
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccc
Confidence 12689999999999999999988865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.7e-13 Score=128.45 Aligned_cols=115 Identities=22% Similarity=0.283 Sum_probs=84.5
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChh--hHHH----------------------HHHHHHHHHHcCCCC--c
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ--GAQE----------------------FKNEVVLVAKLQHRN--L 398 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--I 398 (601)
.+.||+|+||.||+|...++++||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5789999999999999878999999998653211 1111 135666777775443 4
Q ss_pred cceEEEEEeCCeeEEEEeccCCC-----Cccccc-----------------cccc-ceeeccccccCcEEEccCCCcEEe
Q 007490 399 VRLLGFCLEGDEKILVYEFVPNK-----SLDYFL-----------------YDSQ-LRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 399 v~l~~~~~~~~~~~lv~E~~~~g-----sL~~~l-----------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
.+.++. ...++||||++++ .|.... +.|. .+|+||||||+||+++ ++.++|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 455443 2468999999994 332221 4588 9999999999999999 8999999
Q ss_pred ecccceecC
Q 007490 456 DFGLARIFG 464 (601)
Q Consensus 456 Dfg~a~~~~ 464 (601)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.6e-14 Score=147.29 Aligned_cols=129 Identities=28% Similarity=0.454 Sum_probs=104.1
Q ss_pred HHHcCCCCccceEEEEEeCCeeEEEEeccCCCCccccc------------------------cccccee-eccccccCcE
Q 007490 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRI-IHRDLKASNI 444 (601)
Q Consensus 390 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~i-iHrdlkp~NI 444 (601)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+ |+|.-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45789999999999999999999999999999998876 4465555 9999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCC-------CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-------QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
++|....+||+|||+....................-|.|||.+... ..+.+.||||||++++|+++.+.||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999999876421111111222345679999998763 146779999999999999999999876
Q ss_pred C
Q 007490 518 Y 518 (601)
Q Consensus 518 ~ 518 (601)
.
T Consensus 161 ~ 161 (484)
T KOG1023|consen 161 R 161 (484)
T ss_pred c
Confidence 3
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.7e-13 Score=131.51 Aligned_cols=118 Identities=22% Similarity=0.230 Sum_probs=91.8
Q ss_pred CCccc-ccCcceEEeeecCCCceeeEEEeccCC-------------hhhHHHHHHHHHHHHHcCCCCc--cceEEEEEeC
Q 007490 345 DNKLG-RGGFGEVYKGVLPHGQEIAVKRLSRSS-------------GQGAQEFKNEVVLVAKLQHRNL--VRLLGFCLEG 408 (601)
Q Consensus 345 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~ 408 (601)
...|| .|+.|+||.+.. .+..++||++.... ......+.+|++++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 889999999887 47789999885321 1223567889999999998885 6777765433
Q ss_pred Ce----eEEEEeccCC-CCccccc------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 409 DE----KILVYEFVPN-KSLDYFL------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 409 ~~----~~lv~E~~~~-gsL~~~l------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
.. .++|||++++ .+|..++ ++|+.||+||||||.|||++.++.++|+|||.+...
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 22 3599999997 5775543 569999999999999999999999999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.5e-14 Score=153.21 Aligned_cols=182 Identities=24% Similarity=0.317 Sum_probs=146.2
Q ss_pred cCCCCcCCcccccCcceEEeeecCC--CceeeEEEeccCC--hhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH--GQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 413 (601)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567788889999999998877533 3446666665442 333455566888888886 9999999999999999999
Q ss_pred EEeccCCCCccccc-------------------------ccc-cceeeccccccCcEEEccCC-CcEEeecccceecCC-
Q 007490 414 VYEFVPNKSLDYFL-------------------------YDS-QLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGV- 465 (601)
Q Consensus 414 v~E~~~~gsL~~~l-------------------------~~h-~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~- 465 (601)
++||..++++...+ +.| ..++.||||||+|.+++..+ ..+++|||++..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99998887765443 568 89999999999999999999 999999999988766
Q ss_pred CCCccccccccc-cccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCC
Q 007490 466 DQTQGNTSRIVG-TYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSFYQT 520 (601)
Q Consensus 466 ~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~ 520 (601)
..........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 444444555678 99999999998854 45789999999999999999999876443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=117.81 Aligned_cols=116 Identities=22% Similarity=0.188 Sum_probs=97.0
Q ss_pred cCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC--CCccceEEEEEeCCeeEEEEeccCCC
Q 007490 344 SDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4578999999999999974 47899999865443 4678899999999977 58999999988888899999999998
Q ss_pred Ccccc-----c-----------cccc---ceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 422 SLDYF-----L-----------YDSQ---LRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 422 sL~~~-----l-----------~~h~---~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.+..+ . ..|. .+++|+|++|+||++++++.++++|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77531 0 3355 5799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-12 Score=137.03 Aligned_cols=120 Identities=20% Similarity=0.248 Sum_probs=87.4
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhH----------------------------------------HHHH
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGA----------------------------------------QEFK 384 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 384 (601)
.+.||.|++|.||+|++.+|++||||+......... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421110 0134
Q ss_pred HHHHHHHHcC----CCCccceEEEE-EeCCeeEEEEeccCCCCccccc----------------------ccccceeecc
Q 007490 385 NEVVLVAKLQ----HRNLVRLLGFC-LEGDEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHR 437 (601)
Q Consensus 385 ~E~~~l~~l~----hpnIv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHr 437 (601)
+|.+.+.+++ |.+-+.+-.++ ......+|||||++|++|.++. ..|..|++|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~ 281 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA 281 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence 4555555552 32223322222 2244579999999998886543 2377899999
Q ss_pred ccccCcEEEccCCCcEEeecccceecC
Q 007490 438 DLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 438 dlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
|+||.||+++.+++++|+|||++..+.
T Consensus 282 D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 282 DLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.5e-12 Score=135.70 Aligned_cols=126 Identities=17% Similarity=0.203 Sum_probs=89.7
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChh----------------------------------hHHH-
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQ----------------------------------GAQE- 382 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 382 (601)
-..|+. +.||.|++|.||+|++++ |++||||++.+.... ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999877 999999999754211 0111
Q ss_pred -----HHHHHHHHHHcC----CCCccceEEEEEe-CCeeEEEEeccCCCCcccccc----------------------cc
Q 007490 383 -----FKNEVVLVAKLQ----HRNLVRLLGFCLE-GDEKILVYEFVPNKSLDYFLY----------------------DS 430 (601)
Q Consensus 383 -----~~~E~~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~----------------------~h 430 (601)
+.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++.. ..
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 333444444442 4444444344332 456789999999998865321 14
Q ss_pred cceeeccccccCcEEEccCC----CcEEeecccceecCC
Q 007490 431 QLRIIHRDLKASNILLDVQM----NPKISDFGLARIFGV 465 (601)
Q Consensus 431 ~~~iiHrdlkp~NIll~~~~----~~kL~Dfg~a~~~~~ 465 (601)
..|++|+|+||.||+++.++ +++++|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 57899999999999999988 899999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.5e-10 Score=105.09 Aligned_cols=113 Identities=19% Similarity=0.128 Sum_probs=85.7
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCcc-ceEEEEEeCCeeEEEEeccCCCCc
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
.+.|+.|..+.||+++. .++.+++|....... ....+.+|+++++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 36789999999999987 478899998754432 223467899999999765554 455443 3346899999999888
Q ss_pred ccc---------------cccccce-----eeccccccCcEEEccCCCcEEeeccccee
Q 007490 424 DYF---------------LYDSQLR-----IIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 424 ~~~---------------l~~h~~~-----iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
... ..+|..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 631 1457666 59999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.4e-09 Score=99.03 Aligned_cols=115 Identities=22% Similarity=0.294 Sum_probs=90.6
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCC---hh-----hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS---GQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
..+++|+-+.+|.+.+ -|.++++|.-.++. +. ...+-.+|.+++.+++--.|..-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4678999999999977 45556666532221 11 124467899999999877777777777888889999999
Q ss_pred cCCCCccccc----------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 418 VPNKSLDYFL----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 418 ~~~gsL~~~l----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
++|..|.+.+ .+|..||+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999988666 45999999999999999998665 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.2e-10 Score=117.16 Aligned_cols=175 Identities=25% Similarity=0.307 Sum_probs=133.6
Q ss_pred cCCCCcCCcccc--cCcceEEeeec---CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCe
Q 007490 339 TNKFSSDNKLGR--GGFGEVYKGVL---PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 339 ~~~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 410 (601)
...|...+.+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+....++ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 445677889999 99999999986 35788999984332 223333335677666677 59999999999999999
Q ss_pred eEEEEeccCCCCccc----------------------------ccccccceeeccccccCcEEEccC-CCcEEeecccce
Q 007490 411 KILVYEFVPNKSLDY----------------------------FLYDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLAR 461 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~----------------------------~l~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~ 461 (601)
.++-+|++.. +|.. +-++|...++|-|+||.||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 9999998763 3322 225699999999999999999999 889999999999
Q ss_pred ecCCCCCccc---cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 462 IFGVDQTQGN---TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 462 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
.++....... .....|...|++||.. .+-++.+.|+|++|.++.|...+....
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 8865432211 1223577889999966 456788999999999999998876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.4e-09 Score=112.32 Aligned_cols=147 Identities=18% Similarity=0.198 Sum_probs=110.2
Q ss_pred cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCC------------------
Q 007490 361 LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS------------------ 422 (601)
Q Consensus 361 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gs------------------ 422 (601)
..++.+|.|...+...........+-++.|+.|+||||+++++.++.+...|||+|-+.--.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHH
Confidence 44688999998877666555667889999999999999999999999999999999764321
Q ss_pred cccccccc-cceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhH
Q 007490 423 LDYFLYDS-QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSF 501 (601)
Q Consensus 423 L~~~l~~h-~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 501 (601)
|..+.++| +.+++|++|.-..|++++.|..||++|.++.....-.. ......--..|..|+.+.... ...|.|-|
T Consensus 114 l~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~L 189 (690)
T KOG1243|consen 114 LAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGL 189 (690)
T ss_pred HHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhH
Confidence 12233664 78899999999999999999999999998865322111 111112223466666543222 45699999
Q ss_pred HHHHHHHHhC
Q 007490 502 GVLALETITG 511 (601)
Q Consensus 502 Gvvl~elltg 511 (601)
|++++|++.|
T Consensus 190 g~li~el~ng 199 (690)
T KOG1243|consen 190 GCLIEELFNG 199 (690)
T ss_pred HHHHHHHhCc
Confidence 9999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.8e-08 Score=91.39 Aligned_cols=118 Identities=25% Similarity=0.327 Sum_probs=90.6
Q ss_pred cCCcccccCcceEEeeecCCCceeeEEEec-cC-------ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 344 SDNKLGRGGFGEVYKGVLPHGQEIAVKRLS-RS-------SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....|-+|+-+.|+++.+ .|+...||.-. +. ..-...+.++|+++|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567888999999999998 78877777532 21 1123456788999999997667766666777777888999
Q ss_pred eccCC-CCccccc-------------------------ccccceeeccccccCcEEEccCCC---cEEeeccccee
Q 007490 416 EFVPN-KSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLARI 462 (601)
Q Consensus 416 E~~~~-gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~~ 462 (601)
||+++ .++.+++ .+|..+|+|+||..+||++..++. +.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 3444443 459999999999999999987654 48999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.2e-08 Score=92.49 Aligned_cols=115 Identities=15% Similarity=0.128 Sum_probs=82.7
Q ss_pred CCcccccCcceEEeeecCC-------CceeeEEEeccCC----------------------hhhHHHHH----HHHHHHH
Q 007490 345 DNKLGRGGFGEVYKGVLPH-------GQEIAVKRLSRSS----------------------GQGAQEFK----NEVVLVA 391 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~ 391 (601)
...||.|--+.||.|...+ +..+|||+.+... ......+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 4789999874210 01122233 8999999
Q ss_pred HcCC--CCccceEEEEEeCCeeEEEEeccCCCC-----ccccc------------------cc-ccceeeccccccCcEE
Q 007490 392 KLQH--RNLVRLLGFCLEGDEKILVYEFVPNKS-----LDYFL------------------YD-SQLRIIHRDLKASNIL 445 (601)
Q Consensus 392 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~gs-----L~~~l------------------~~-h~~~iiHrdlkp~NIl 445 (601)
++.. -++.+.+++ ...+|||||+.+.. |.+.. .+ |+.||+|+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9954 456666654 56789999997642 21111 23 8899999999999999
Q ss_pred EccCCCcEEeecccceecC
Q 007490 446 LDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 446 l~~~~~~kL~Dfg~a~~~~ 464 (601)
++ ++.+.|+|||.+....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.5e-09 Score=108.75 Aligned_cols=172 Identities=23% Similarity=0.191 Sum_probs=128.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeec--CCCceeeEEEeccCChhhHHH--HHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL--PHGQEIAVKRLSRSSGQGAQE--FKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
....+|..+..||.|.|+.|++... .++..+++|.+.+......++ -..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4566899999999999999998773 357788999887654333222 23566666666 588999988888888888
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccC-CCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 467 (601)
||--||++++++.... +.|+..++|+|+||+||++..+ +..++.|||.+..+....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence 8999999998764332 5589999999999999999886 788999999986432111
Q ss_pred Ccccccccccccccc--CcccccCCCCCchhhHHhHHHHHHHHHhCCC
Q 007490 468 TQGNTSRIVGTYGYM--SPEYAMHGQFSVKSDVYSFGVLALETITGKK 513 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 513 (601)
. .....-+++ +++......+-.+.|++|||.-+.|.+++..
T Consensus 422 ~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 422 G-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred c-----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence 1 112223344 5555566778899999999999999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.3e-08 Score=90.48 Aligned_cols=104 Identities=26% Similarity=0.317 Sum_probs=70.0
Q ss_pred eEEeeecCCCceeeEEEeccCC-------------h-------------hhHHHHHHHHHHHHHcCCC--CccceEEEEE
Q 007490 355 EVYKGVLPHGQEIAVKRLSRSS-------------G-------------QGAQEFKNEVVLVAKLQHR--NLVRLLGFCL 406 (601)
Q Consensus 355 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~ 406 (601)
.||.|...+|.++|||+..... . ......++|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999874310 0 0113467899999999766 456666542
Q ss_pred eCCeeEEEEeccC--CCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 407 EGDEKILVYEFVP--NKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 407 ~~~~~~lv~E~~~--~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
...|||||++ |..+..+. ..|..||+|+||.+.|||++++ .+.|+|||.+..
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 4579999999 54332211 1379999999999999999987 899999999875
Q ss_pred c
Q 007490 463 F 463 (601)
Q Consensus 463 ~ 463 (601)
.
T Consensus 156 ~ 156 (188)
T PF01163_consen 156 S 156 (188)
T ss_dssp T
T ss_pred c
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-08 Score=111.87 Aligned_cols=188 Identities=18% Similarity=0.197 Sum_probs=129.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEecc---CChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSR---SSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
....+.+.+.+-+.+|.++.++.+.-. .|.-.++|.... ......+....+-.++-..+||-+++..--+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345667888889999999999887632 233333333221 1111122223333333334556666555455566788
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC--
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD-- 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~-- 466 (601)
+|+++|..+++|...+ ++|...+.|+|++|.|+|+..+++.++.|||.......-
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999888887665 456667899999999999999999999999843322100
Q ss_pred -----------------------CCc----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 467 -----------------------QTQ----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 467 -----------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
... .......+|+.|.+||...+......+|+|++|++++|.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 000 11234578999999999999999999999999999999999999987655
Q ss_pred CCcc
Q 007490 520 TDGA 523 (601)
Q Consensus 520 ~~~~ 523 (601)
.+..
T Consensus 1040 pq~~ 1043 (1205)
T KOG0606|consen 1040 PQQI 1043 (1205)
T ss_pred hhhh
Confidence 4433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.2e-07 Score=90.11 Aligned_cols=117 Identities=19% Similarity=0.264 Sum_probs=89.2
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCC--CccceEEEEEeCC---eeEEEEeccC
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHR--NLVRLLGFCLEGD---EKILVYEFVP 419 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~~---~~~lv~E~~~ 419 (601)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|.++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999986678999998755432 2345788999999999764 4677787776543 5689999999
Q ss_pred CCCccccc----------------------ccc-----------------------------------------------
Q 007490 420 NKSLDYFL----------------------YDS----------------------------------------------- 430 (601)
Q Consensus 420 ~gsL~~~l----------------------~~h----------------------------------------------- 430 (601)
+.++...+ .+|
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 87664421 001
Q ss_pred ---------cceeeccccccCcEEEcc--CCCcEEeeccccee
Q 007490 431 ---------QLRIIHRDLKASNILLDV--QMNPKISDFGLARI 462 (601)
Q Consensus 431 ---------~~~iiHrdlkp~NIll~~--~~~~kL~Dfg~a~~ 462 (601)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999988763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.8e-08 Score=94.24 Aligned_cols=157 Identities=23% Similarity=0.319 Sum_probs=107.6
Q ss_pred HHHHHHHcCCCCccceEEEEEeCC-----eeEEEEeccCCCCccccc---------------------------ccc--c
Q 007490 386 EVVLVAKLQHRNLVRLLGFCLEGD-----EKILVYEFVPNKSLDYFL---------------------------YDS--Q 431 (601)
Q Consensus 386 E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l---------------------------~~h--~ 431 (601)
-..-|-++.|-|||+++.|+.+.. ...+++|||..|+|..+| |+| .
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 344566778999999999987544 367899999999998777 344 4
Q ss_pred ceeeccccccCcEEEccCCCcEEeecccceecCCC---CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHH
Q 007490 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD---QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508 (601)
Q Consensus 432 ~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 508 (601)
..|+|+++..+.|++..+|-+|+.----.. .... ..........+-++|.+||.-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 579999999999999999988875311111 0000 001112233567899999987777788899999999999999
Q ss_pred HhCCCCCCCCCC-----C---------------ccccccCccCCCCCCCHHHHHH
Q 007490 509 ITGKKNSSFYQT-----D---------------GAEDLLSYEDPADRPSMATIVL 543 (601)
Q Consensus 509 ltg~~p~~~~~~-----~---------------~~~~l~~~~dP~~RPt~~evl~ 543 (601)
..+..-...... + +.........|..||+|.+++-
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence 887643211110 0 1111112268999999998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=7.9e-07 Score=86.02 Aligned_cols=117 Identities=21% Similarity=0.286 Sum_probs=89.5
Q ss_pred CCcCCcccccCcceEEeeecCCCceeeEEEeccCC------------------h----hhHHHHHHHHHHHHHcCCC--C
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS------------------G----QGAQEFKNEVVLVAKLQHR--N 397 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~----~~~~~~~~E~~~l~~l~hp--n 397 (601)
..+.++||-|--+.||.|..+.|.++|||.=.... . -.....++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999532110 0 0123457899999999755 6
Q ss_pred ccceEEEEEeCCeeEEEEeccCCCCccccc------------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 398 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
+.+.+++ +...+||||++|-.|...- ..-..||||+|+++-||++++||.+.++||--
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence 7776655 5668999999986554322 11367999999999999999999999999976
Q ss_pred cee
Q 007490 460 ARI 462 (601)
Q Consensus 460 a~~ 462 (601)
+..
T Consensus 249 ~v~ 251 (304)
T COG0478 249 AVP 251 (304)
T ss_pred ccc
Confidence 653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.5e-07 Score=96.54 Aligned_cols=119 Identities=16% Similarity=0.249 Sum_probs=84.6
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChhhH------------------------------H----------HHHH
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGA------------------------------Q----------EFKN 385 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 385 (601)
+.|+.++-|.||+|++++|++||||+..+.-.... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 78999999999999999999999999865421100 0 1233
Q ss_pred HHHHHHHcC-----CCCccceEEEEEeCCeeEEEEeccCCCCccccccc----------------------ccceeeccc
Q 007490 386 EVVLVAKLQ-----HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD----------------------SQLRIIHRD 438 (601)
Q Consensus 386 E~~~l~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~----------------------h~~~iiHrd 438 (601)
|..-+.+++ .|+|.=-.=++.-.....|+|||++|..+.+...+ -..|+.|.|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaD 290 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHAD 290 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccC
Confidence 444444442 23322222223345677999999999887766422 235799999
Q ss_pred cccCcEEEccCCCcEEeecccceecC
Q 007490 439 LKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 439 lkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
.+|.||+++.+|++.+.|||+...+.
T Consensus 291 pHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 291 PHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999998764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.5e-06 Score=86.48 Aligned_cols=110 Identities=16% Similarity=0.137 Sum_probs=77.4
Q ss_pred CcceEEeeecCCCceeeEEEeccCChh-----------hHHHHHHHHHHHHHcCCCCc--cceEEEEEe-----CCeeEE
Q 007490 352 GFGEVYKGVLPHGQEIAVKRLSRSSGQ-----------GAQEFKNEVVLVAKLQHRNL--VRLLGFCLE-----GDEKIL 413 (601)
Q Consensus 352 ~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~-----~~~~~l 413 (601)
....|.+..+ +|+.+.||+....... ....+.+|...+.+|...+| .+.+++.+. ...-+|
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3344667666 6788999977443211 11147789999998855444 344556543 234689
Q ss_pred EEeccCCC-Cccccc-------------------------ccccceeeccccccCcEEEcc-------CCCcEEeecccc
Q 007490 414 VYEFVPNK-SLDYFL-------------------------YDSQLRIIHRDLKASNILLDV-------QMNPKISDFGLA 460 (601)
Q Consensus 414 v~E~~~~g-sL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~-------~~~~kL~Dfg~a 460 (601)
|||++++. +|.+++ .+|..||+|+|++++|||++. +..+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999885 665443 349999999999999999985 467899999988
Q ss_pred ee
Q 007490 461 RI 462 (601)
Q Consensus 461 ~~ 462 (601)
+.
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 64
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.1e-05 Score=76.66 Aligned_cols=124 Identities=12% Similarity=0.102 Sum_probs=83.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHH---------HHHHHHHHHHcCCCCc---cceEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQE---------FKNEVVLVAKLQHRNL---VRLLGF 404 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnI---v~l~~~ 404 (601)
...++|...+++-......|.+-.. +|+.+++|..........+. ..+++..+.+++...+ ..++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567788888888777777777666 67889999876544332222 2334444444533332 232222
Q ss_pred EE-----eCCeeEEEEeccCCCCccccc---------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 405 CL-----EGDEKILVYEFVPNKSLDYFL---------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 405 ~~-----~~~~~~lv~E~~~~gsL~~~l---------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.. .....+|+|||++|..|.++. ..|+.|+.|+|.+|.|++++.++ ++++||+..+.
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 22 123457899999998775422 45999999999999999998655 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.06 E-value=9.6e-06 Score=84.63 Aligned_cols=143 Identities=25% Similarity=0.310 Sum_probs=107.4
Q ss_pred cceEEeee-cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEE----eCCeeEEEEeccCC-CCcccc
Q 007490 353 FGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL----EGDEKILVYEFVPN-KSLDYF 426 (601)
Q Consensus 353 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lv~E~~~~-gsL~~~ 426 (601)
-.+.|++. ..+|..+++|+++............-++.++++.|+|||++.+++. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45678888 4579999999996554444434456788999999999999999887 34568999999986 233222
Q ss_pred c--------------------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 427 L--------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 427 l--------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
. +.|+.|+.-+-|.+++||++.+.+++|+..|....+..+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~ 448 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT 448 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC
Confidence 1 34999999999999999999999999999888876643321
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKN 514 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 514 (601)
|-+.. -.+-|.=.||.+++-|.+|...
T Consensus 449 ----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 449 ----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 11111 2356899999999999999654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.2e-05 Score=75.95 Aligned_cols=167 Identities=16% Similarity=0.136 Sum_probs=103.9
Q ss_pred CcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEE------EeCCe-eEEE
Q 007490 343 SSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC------LEGDE-KILV 414 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~------~~~~~-~~lv 414 (601)
.....||+|+-+.+|..- .-...+.|++.........+. +..|... .||-+-.=+.|= -+... .-++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 456789999999998643 112235577765544332222 2223332 455433311111 01111 3455
Q ss_pred EeccCCCC-------------------ccccc-----------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 415 YEFVPNKS-------------------LDYFL-----------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 415 ~E~~~~gs-------------------L~~~l-----------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
|..+++.- ...++ .+|..|.+-+|++++|+|+.+++.+.|.|-..-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence 66555431 11111 3589999999999999999999999999865444321
Q ss_pred CCCCccccccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhC-CCCCCC
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITG-KKNSSF 517 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~p~~~ 517 (601)
........+|...|.+||... +..-+...|-|.||+++++++.| +.||..
T Consensus 169 ---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 169 ---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 111223357889999999764 34456789999999999999987 888865
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2e-05 Score=84.84 Aligned_cols=120 Identities=17% Similarity=0.254 Sum_probs=82.6
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhH-------------------------------H------HHHHHH
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGA-------------------------------Q------EFKNEV 387 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~~~E~ 387 (601)
.+.||.-+.|.||+|++++|+.||||+-++.-.... + .|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 367999999999999999999999998765421110 0 123333
Q ss_pred HHH----HHcCCCCccc---eEEEEE-eCCeeEEEEeccCCCCccccccc----------------------ccceeecc
Q 007490 388 VLV----AKLQHRNLVR---LLGFCL-EGDEKILVYEFVPNKSLDYFLYD----------------------SQLRIIHR 437 (601)
Q Consensus 388 ~~l----~~l~hpnIv~---l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~----------------------h~~~iiHr 437 (601)
+-. +.++|-++.. +=.++. -.....|+||||+|..+.++.+. -..|++|.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffHa 325 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFHA 325 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCccC
Confidence 322 2334555111 222222 23467999999999888776532 23579999
Q ss_pred ccccCcEEEcc----CCCcEEeecccceecC
Q 007490 438 DLKASNILLDV----QMNPKISDFGLARIFG 464 (601)
Q Consensus 438 dlkp~NIll~~----~~~~kL~Dfg~a~~~~ 464 (601)
|-+|.||++.. ++.+.+-|||+...+.
T Consensus 326 DPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 326 DPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 99999999984 6779999999998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=3e-05 Score=70.53 Aligned_cols=114 Identities=22% Similarity=0.309 Sum_probs=85.2
Q ss_pred CCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccc-eEEEEEeCCeeEEEEeccCC
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR-LLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~~~lv~E~~~~ 420 (601)
.+..+.|++|.+|.||+|.+ .|.++|+|+-..+++ ...++.|.++|..++-.++-+ ++.+. ..++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 44568899999999999998 666899998755443 467889999999998776654 44443 33456999999
Q ss_pred CCccccc----------------ccccceeeccccc-cCcEEEccCCCcEEeeccccee
Q 007490 421 KSLDYFL----------------YDSQLRIIHRDLK-ASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 421 gsL~~~l----------------~~h~~~iiHrdlk-p~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..|...- .+...||-|+.|. |..++|-.+..+.|+||..|..
T Consensus 97 ~~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7775543 2245789999995 5555665666899999999874
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.90 E-value=2.4e-05 Score=75.19 Aligned_cols=84 Identities=23% Similarity=0.227 Sum_probs=64.5
Q ss_pred HHHHHHHHHHHHHcCCCC--ccceEEEEEeCC----eeEEEEeccCCC-Cccccc-----------------------cc
Q 007490 380 AQEFKNEVVLVAKLQHRN--LVRLLGFCLEGD----EKILVYEFVPNK-SLDYFL-----------------------YD 429 (601)
Q Consensus 380 ~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l-----------------------~~ 429 (601)
.....+|...+..|.... +.+.+++..... ..+||+|++++. +|.+++ .+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346788999888885443 456677666532 358999999874 565554 34
Q ss_pred ccceeeccccccCcEEEccCC---CcEEeecccceec
Q 007490 430 SQLRIIHRDLKASNILLDVQM---NPKISDFGLARIF 463 (601)
Q Consensus 430 h~~~iiHrdlkp~NIll~~~~---~~kL~Dfg~a~~~ 463 (601)
|..||+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.89 E-value=7e-05 Score=73.00 Aligned_cols=111 Identities=18% Similarity=0.223 Sum_probs=82.1
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEEEEeCCeeEEEEeccCCCC-
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGFCLEGDEKILVYEFVPNKS- 422 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~~gs- 422 (601)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 35567888876433 2345688999999996443 4677888877778889999999963
Q ss_pred ccccc-------------------ccc-------------------------------------------cceeeccccc
Q 007490 423 LDYFL-------------------YDS-------------------------------------------QLRIIHRDLK 440 (601)
Q Consensus 423 L~~~l-------------------~~h-------------------------------------------~~~iiHrdlk 440 (601)
+...+ ..| ...++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11100 001 1236899999
Q ss_pred cCcEEEccCCCcEEeeccccee
Q 007490 441 ASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 441 p~NIll~~~~~~kL~Dfg~a~~ 462 (601)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.3e-06 Score=89.19 Aligned_cols=171 Identities=19% Similarity=0.125 Sum_probs=124.4
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC-ccceEEEEEeCCee
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGDEK 411 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~ 411 (601)
-+++..+..+...+-+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 3445555666667788999999999988534444445555332 34456899999999999 77777777777888
Q ss_pred EEEEeccCCC-C-ccc----------cc-------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNK-S-LDY----------FL-------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~g-s-L~~----------~l-------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
+++++++..+ + ... +. ++|+..-+|+| ||+..+ +..|..||+....+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999877 2 111 11 33444457777 777765 67899999998766533
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
. ......+++.|+|||+.....+..+.|+|++|+--.++--|.+|-.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2 2345678999999999999999999999999987777777766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=8.9e-05 Score=70.31 Aligned_cols=114 Identities=17% Similarity=0.144 Sum_probs=80.9
Q ss_pred ccccCcceEEeeecCCCceeeEEEeccCC------hhhHHHHHHHHHHHHHcCCCC--ccceEEEEEeC----CeeEEEE
Q 007490 348 LGRGGFGEVYKGVLPHGQEIAVKRLSRSS------GQGAQEFKNEVVLVAKLQHRN--LVRLLGFCLEG----DEKILVY 415 (601)
Q Consensus 348 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~----~~~~lv~ 415 (601)
-|+||-+.|++-.+ +|+.+-+|+-.... +.....|.+|+..|.+|..-+ +.+.+...... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999776 55678999875221 345678999999999995432 44554222221 1357999
Q ss_pred eccCC-CCccccc-------------------------ccccceeeccccccCcEEEccCCC--cEEeeccccee
Q 007490 416 EFVPN-KSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMN--PKISDFGLARI 462 (601)
Q Consensus 416 E~~~~-gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~--~kL~Dfg~a~~ 462 (601)
|-+++ .+|.+++ .+|+.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 96654 3454332 349999999999999999987777 99999987754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00016 Score=71.36 Aligned_cols=111 Identities=16% Similarity=0.165 Sum_probs=80.2
Q ss_pred cccccCc-ceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEeccCCCCcc
Q 007490 347 KLGRGGF-GEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEFVPNKSLD 424 (601)
Q Consensus 347 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~ 424 (601)
.|..|.. ..||+...+ +.++.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 789998764 4788888875443 345678999998884 444667788777766789999999986654
Q ss_pred ccc-----------------cc----------------------------------------------------------
Q 007490 425 YFL-----------------YD---------------------------------------------------------- 429 (601)
Q Consensus 425 ~~l-----------------~~---------------------------------------------------------- 429 (601)
... .+
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 220 00
Q ss_pred ccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 430 h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11247999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=6.9e-06 Score=88.68 Aligned_cols=90 Identities=19% Similarity=0.319 Sum_probs=68.1
Q ss_pred ccccccc-cceeeccccccCcEEEccCCCcEEeecccceecCCCCCc-------cccccccccccccCcccccCCCCCch
Q 007490 424 DYFLYDS-QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ-------GNTSRIVGTYGYMSPEYAMHGQFSVK 495 (601)
Q Consensus 424 ~~~l~~h-~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~ 495 (601)
+.+.++| +.++||++|.|++|.++.++.+||+.|+.+......... ...........|.|||++.+...+.+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~ 189 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA 189 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc
Confidence 3445555 468999999999999999999999999998654331110 11111234568999999999888999
Q ss_pred hhHHhHHHHHHHHHhCCC
Q 007490 496 SDVYSFGVLALETITGKK 513 (601)
Q Consensus 496 sDvwSlGvvl~elltg~~ 513 (601)
+|+||+|+++|.+..|..
T Consensus 190 sd~fSlG~li~~i~~~gk 207 (700)
T KOG2137|consen 190 SDVFSLGVLIYTIYNGGK 207 (700)
T ss_pred ccceeeeeEEEEEecCCc
Confidence 999999999999995443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00012 Score=71.38 Aligned_cols=115 Identities=25% Similarity=0.311 Sum_probs=78.8
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEEEEeC---CeeEEEEeccC
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGFCLEG---DEKILVYEFVP 419 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~---~~~~lv~E~~~ 419 (601)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.|.... +.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578899999999999766 68999987544 45567889999999985443 45667654332 34689999999
Q ss_pred CCCccccc--------------------------------------------------------c---------------
Q 007490 420 NKSLDYFL--------------------------------------------------------Y--------------- 428 (601)
Q Consensus 420 ~gsL~~~l--------------------------------------------------------~--------------- 428 (601)
+..+.... .
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 87665500 0
Q ss_pred ----cccceeeccccccCcEEEc-cCCCcEEeeccccee
Q 007490 429 ----DSQLRIIHRDLKASNILLD-VQMNPKISDFGLARI 462 (601)
Q Consensus 429 ----~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~a~~ 462 (601)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 0235699999999999999 566667999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00023 Score=67.52 Aligned_cols=115 Identities=21% Similarity=0.359 Sum_probs=84.5
Q ss_pred cCCcccccCcceEEeeecCCCceeeEEEeccCC----------------hhhHHHHHHHHHHHHHcC------CCCccce
Q 007490 344 SDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS----------------GQGAQEFKNEVVLVAKLQ------HRNLVRL 401 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~l 401 (601)
....||+|+.-.||. +++....+||+..... .....+..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456899999999997 4566678888886554 123456677777776666 8899999
Q ss_pred EEEEEeCCeeEEEEeccCC------CCccccc------------------ccccceeeccccccCcEEEccCC----CcE
Q 007490 402 LGFCLEGDEKILVYEFVPN------KSLDYFL------------------YDSQLRIIHRDLKASNILLDVQM----NPK 453 (601)
Q Consensus 402 ~~~~~~~~~~~lv~E~~~~------gsL~~~l------------------~~h~~~iiHrdlkp~NIll~~~~----~~k 453 (601)
+|+.+++...-+|+|.+.+ .+|.+++ ++-+.+|+.+||+|.||++.... .+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lv 162 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLV 162 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEE
Confidence 9999999999999998744 2344444 33467899999999999996532 467
Q ss_pred Eee-cccc
Q 007490 454 ISD-FGLA 460 (601)
Q Consensus 454 L~D-fg~a 460 (601)
|+| ||..
T Consensus 163 lIDG~G~~ 170 (199)
T PF10707_consen 163 LIDGLGEK 170 (199)
T ss_pred EEeCCCCc
Confidence 777 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00015 Score=68.28 Aligned_cols=115 Identities=27% Similarity=0.393 Sum_probs=85.7
Q ss_pred CCCCcCCcccccCc-ceEEeeecCCCceeeEEEecc---CCh------------------hhHHHHHHHHHHHHHcC---
Q 007490 340 NKFSSDNKLGRGGF-GEVYKGVLPHGQEIAVKRLSR---SSG------------------QGAQEFKNEVVLVAKLQ--- 394 (601)
Q Consensus 340 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 394 (601)
.+++.++.||.|.. |.||+++. +|+.+|+|.+.. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67788899999999 99999998 788999999321 100 11235778888777774
Q ss_pred CCCc--cceEEEEEeCC------------------eeEEEEeccCCCC----------cccccccccceeeccccccCcE
Q 007490 395 HRNL--VRLLGFCLEGD------------------EKILVYEFVPNKS----------LDYFLYDSQLRIIHRDLKASNI 444 (601)
Q Consensus 395 hpnI--v~l~~~~~~~~------------------~~~lv~E~~~~gs----------L~~~l~~h~~~iiHrdlkp~NI 444 (601)
+.++ |+.+||..-.. ..-||.||++... ++++...|..||+-+|+++.|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny 195 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRNY 195 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCccccc
Confidence 5566 99999985321 1358999988754 2344467999999999999997
Q ss_pred EEccCCCcEEeecccc
Q 007490 445 LLDVQMNPKISDFGLA 460 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a 460 (601)
. .-||+|||.+
T Consensus 196 ~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 196 R-----GGKLVDFSSS 206 (207)
T ss_pred c-----CCEEEecccC
Confidence 5 3689999865
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00028 Score=67.93 Aligned_cols=127 Identities=20% Similarity=0.263 Sum_probs=82.9
Q ss_pred hhhhhhcCCCCcCC---cccccCcceEEeeecCCCceeeEEEeccCChh-------------------hHHH-----HHH
Q 007490 333 KTIEVATNKFSSDN---KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQ-------------------GAQE-----FKN 385 (601)
Q Consensus 333 ~~~~~~~~~f~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----~~~ 385 (601)
+.+.....+..+.. .|+.|.-+.||+|...++..+|||++...... ...+ ..+
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 33444444444444 45567777899999878999999998543211 1111 245
Q ss_pred HHHHHHHcC--CCCccceEEEEEeCCeeEEEEeccCCC-----Cccccc-------------------ccccceeecccc
Q 007490 386 EVVLVAKLQ--HRNLVRLLGFCLEGDEKILVYEFVPNK-----SLDYFL-------------------YDSQLRIIHRDL 439 (601)
Q Consensus 386 E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~E~~~~g-----sL~~~l-------------------~~h~~~iiHrdl 439 (601)
|..-|.++. +=.+.+-+++. .-.|||||+... .|.+.- -.+..++||+||
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDL 193 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDL 193 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccc
Confidence 777777774 33344444443 347999998654 122221 114578999999
Q ss_pred ccCcEEEccCCCcEEeecccceecC
Q 007490 440 KASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 440 kp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
+.=|||+. ++.+.|+|||-+....
T Consensus 194 SEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 194 SEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hhhheEEE-CCeEEEEECccccccC
Confidence 99999999 8899999999987653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00063 Score=71.48 Aligned_cols=74 Identities=12% Similarity=0.179 Sum_probs=53.9
Q ss_pred CcccccCcceEEeeecCCC-ceeeEEEeccC-----C--hhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCeeEEE
Q 007490 346 NKLGRGGFGEVYKGVLPHG-QEIAVKRLSRS-----S--GQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 414 (601)
+.||.|.+..||++...+| +.|+||.-... . +...++...|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998776 58999985321 1 224466777888888763 2457777776 34557899
Q ss_pred EeccCCC
Q 007490 415 YEFVPNK 421 (601)
Q Consensus 415 ~E~~~~g 421 (601)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998863
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0011 Score=65.93 Aligned_cols=110 Identities=17% Similarity=0.130 Sum_probs=74.7
Q ss_pred cccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEeccCCCCccc
Q 007490 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYEFVPNKSLDY 425 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~gsL~~ 425 (601)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++.... .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456678889998874 577888887654322211235789999999865434 34444332 378999999866542
Q ss_pred c-------c--------ccc-----------------------------------------------cceeeccccccCc
Q 007490 426 F-------L--------YDS-----------------------------------------------QLRIIHRDLKASN 443 (601)
Q Consensus 426 ~-------l--------~~h-----------------------------------------------~~~iiHrdlkp~N 443 (601)
- . .+| ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 0 000 1247999999999
Q ss_pred EEEccCCCcEEeeccccee
Q 007490 444 ILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 444 Ill~~~~~~kL~Dfg~a~~ 462 (601)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 79999988864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0011 Score=64.94 Aligned_cols=111 Identities=19% Similarity=0.248 Sum_probs=72.3
Q ss_pred CcccccCcc-eEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCC---CccceEEEEEeCC---eeEEEEecc
Q 007490 346 NKLGRGGFG-EVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR---NLVRLLGFCLEGD---EKILVYEFV 418 (601)
Q Consensus 346 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~~---~~~lv~E~~ 418 (601)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..|... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766666 58875 235777765432 2345788999999988532 3444554433322 348899999
Q ss_pred CCCCccccc------------------c----------------------------------------------------
Q 007490 419 PNKSLDYFL------------------Y---------------------------------------------------- 428 (601)
Q Consensus 419 ~~gsL~~~l------------------~---------------------------------------------------- 428 (601)
+|.++.... |
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 886653210 0
Q ss_pred ----cccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 429 ----DSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 429 ----~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
....+++|+|+.+.||+++.+...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 0122489999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0018 Score=63.40 Aligned_cols=73 Identities=18% Similarity=0.270 Sum_probs=47.8
Q ss_pred CcccccCcceEEeeecCC--CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEeccCCCC
Q 007490 346 NKLGRGGFGEVYKGVLPH--GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYEFVPNKS 422 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~gs 422 (601)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.+++.+...++ .++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999988654 678889977543222 1233578999998854444 44444332 247999988855
Q ss_pred c
Q 007490 423 L 423 (601)
Q Consensus 423 L 423 (601)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0018 Score=75.49 Aligned_cols=78 Identities=13% Similarity=0.316 Sum_probs=57.2
Q ss_pred CCcccccCcceEEeeecCCC---ceeeEEEeccCC-hhhHHHHHHHHHHHHHcC-CCCc--cceEEEEEeC---CeeEEE
Q 007490 345 DNKLGRGGFGEVYKGVLPHG---QEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQ-HRNL--VRLLGFCLEG---DEKILV 414 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv 414 (601)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.+| .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999876543 467888764432 223456889999999995 6665 7788887664 357899
Q ss_pred EeccCCCC
Q 007490 415 YEFVPNKS 422 (601)
Q Consensus 415 ~E~~~~gs 422 (601)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0015 Score=66.51 Aligned_cols=114 Identities=18% Similarity=0.144 Sum_probs=79.2
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEE------EEeCCeeEEEEe
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGDEKILVYE 416 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~E 416 (601)
.+.|..|....+|+.... +..+++|+... .....+..|++++..|.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 567778888899998763 45788898754 23456778888888885433 4444431 223455689999
Q ss_pred ccCCCCccccc--------------cc---------------------------------------------------cc
Q 007490 417 FVPNKSLDYFL--------------YD---------------------------------------------------SQ 431 (601)
Q Consensus 417 ~~~~gsL~~~l--------------~~---------------------------------------------------h~ 431 (601)
|++|..+...- |. -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 99987653210 00 01
Q ss_pred ceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 432 LRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 432 ~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3589999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00072 Score=47.70 Aligned_cols=45 Identities=38% Similarity=0.581 Sum_probs=33.3
Q ss_pred CCCCCCCCCCCceeeccCCCCCCCccccccCCCCCCCC--CCCCCCceeeccccCC
Q 007490 548 HSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKS--MPWSVDEASITEVYPR 601 (601)
Q Consensus 548 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 601 (601)
+...||.|++|+|+..+..... +++++.. ..+|.|++|+|.+++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~---------~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSET---------DSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCc---------CCCcccccCCCCCeeeEEEEeEecC
Confidence 4568999999999997754321 2233333 5789999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0036 Score=64.11 Aligned_cols=114 Identities=19% Similarity=0.166 Sum_probs=75.7
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEE------EEeCCeeEEEEe
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGDEKILVYE 416 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~E 416 (601)
.+.++.|....+|+....+| .+++|+..... ..+.+..|++++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 46677887789999876444 67788765432 2344567778888774322 3444431 122455789999
Q ss_pred ccCCCCccccc--------------c------------------------------------------------------
Q 007490 417 FVPNKSLDYFL--------------Y------------------------------------------------------ 428 (601)
Q Consensus 417 ~~~~gsL~~~l--------------~------------------------------------------------------ 428 (601)
|++|..+.... |
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432100 0
Q ss_pred cccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 429 ~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
....+++|+|+++.||+++.++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 012569999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0056 Score=63.03 Aligned_cols=114 Identities=17% Similarity=0.134 Sum_probs=73.8
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEE------EEEeCCeeEEEEe
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLG------FCLEGDEKILVYE 416 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~------~~~~~~~~~lv~E 416 (601)
.+.|+.|....+|+....+| .+++|++... ..+.+..|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788789999886555 6888987521 2234455666776664222 333332 1223456789999
Q ss_pred ccCCCCccccc--------------------------------------------------------------c-c----
Q 007490 417 FVPNKSLDYFL--------------------------------------------------------------Y-D---- 429 (601)
Q Consensus 417 ~~~~gsL~~~l--------------------------------------------------------------~-~---- 429 (601)
|++|..+...- . .
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886432100 0 0
Q ss_pred --ccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 430 --SQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 430 --h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
-..+++|+|++|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123799999999999999765568999998853
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00073 Score=67.32 Aligned_cols=118 Identities=19% Similarity=0.191 Sum_probs=87.5
Q ss_pred CCCcCCcccccCcceEEeeecCCCceeeEEEecc--C----------------Chhh----HHHHHHHHHHHHHcCC--C
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSR--S----------------SGQG----AQEFKNEVVLVAKLQH--R 396 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~----------------~~~~----~~~~~~E~~~l~~l~h--p 396 (601)
-+...++||-|.-+.||.+-..+|++.++|.-.. . ...+ .-...+|...|+.|.. =
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4678899999999999999998899999884211 0 0011 1224578888988843 2
Q ss_pred CccceEEEEEeCCeeEEEEeccCCCCccccc-----------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 397 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
-+.+.+++ +..++|||++.+..|.... .+...|+||+|..-=||++++++.++++||--
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 24444443 5678999999998876544 23567999999999999999999999999976
Q ss_pred cee
Q 007490 460 ARI 462 (601)
Q Consensus 460 a~~ 462 (601)
...
T Consensus 249 mvS 251 (465)
T KOG2268|consen 249 MVS 251 (465)
T ss_pred hhc
Confidence 543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0067 Score=61.74 Aligned_cols=78 Identities=10% Similarity=0.066 Sum_probs=57.0
Q ss_pred CcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC---CCccceEEEEEeC---CeeEEEEe
Q 007490 343 SSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH---RNLVRLLGFCLEG---DEKILVYE 416 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~~---~~~~lv~E 416 (601)
...+.||.|..+.||+....++ .+++|..+.. .....+..|.+.|+.|.. -.+.++++++... +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3457899999999999876455 4667764321 123578899999999853 3678888887643 56899999
Q ss_pred ccCCCCc
Q 007490 417 FVPNKSL 423 (601)
Q Consensus 417 ~~~~gsL 423 (601)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9987654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.015 Score=58.73 Aligned_cols=75 Identities=21% Similarity=0.276 Sum_probs=48.9
Q ss_pred CcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCeeEEEEeccC
Q 007490 343 SSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEKILVYEFVP 419 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~~ 419 (601)
+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334678889999999987 478889999875 233356788888888883 3457789999888888899999998
Q ss_pred CC
Q 007490 420 NK 421 (601)
Q Consensus 420 ~g 421 (601)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.016 Score=60.79 Aligned_cols=73 Identities=11% Similarity=0.102 Sum_probs=50.6
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccC----C---hhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCeeEEE
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS----S---GQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 414 (601)
.+.||.|....||+... .++.++||+-... . +....+-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999886 4567999986521 1 113344455666666653 247888888876 456789
Q ss_pred EeccCC
Q 007490 415 YEFVPN 420 (601)
Q Consensus 415 ~E~~~~ 420 (601)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.014 Score=59.54 Aligned_cols=73 Identities=29% Similarity=0.457 Sum_probs=46.5
Q ss_pred CcccccCcceEEeeecCC-------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPH-------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~ 417 (601)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345566667889887654 5788999875543 223455788888888854333 355555432 357888
Q ss_pred cCCCCc
Q 007490 418 VPNKSL 423 (601)
Q Consensus 418 ~~~gsL 423 (601)
++|..+
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 777544
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.013 Score=60.44 Aligned_cols=72 Identities=17% Similarity=0.185 Sum_probs=48.0
Q ss_pred cccccCcceEEeeecCCC-ceeeEEEecc-------CChhhHHHHHHHHHHHHHcC--CC-CccceEEEEEeCCeeEEEE
Q 007490 347 KLGRGGFGEVYKGVLPHG-QEIAVKRLSR-------SSGQGAQEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~~~~lv~ 415 (601)
.||.|....||++..++| +.|+||.-.. .-+-..++..-|.+.|+... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 6899997432 11334456667777776653 24 44555544 445567999
Q ss_pred eccCC
Q 007490 416 EFVPN 420 (601)
Q Consensus 416 E~~~~ 420 (601)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.03 Score=58.22 Aligned_cols=110 Identities=24% Similarity=0.322 Sum_probs=73.4
Q ss_pred cccccCcceEEeeecCC-----CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCcc-ceEEEEEeCCeeEEEEeccCC
Q 007490 347 KLGRGGFGEVYKGVLPH-----GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~ 420 (601)
.|-.|-.-.+|+....+ ++.|++|+.........++ .+|..+++.+..-++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44456677888876432 3678899876544333333 7799999998654444 556655332 57899877
Q ss_pred CCcccc-------c-----------------------------c-----------------------------------c
Q 007490 421 KSLDYF-------L-----------------------------Y-----------------------------------D 429 (601)
Q Consensus 421 gsL~~~-------l-----------------------------~-----------------------------------~ 429 (601)
.+|..- + + .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665310 0 0 1
Q ss_pred ccceeeccccccCcEEEcc-CCCcEEeecccce
Q 007490 430 SQLRIIHRDLKASNILLDV-QMNPKISDFGLAR 461 (601)
Q Consensus 430 h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~ 461 (601)
+...+.|+|+++.|||+++ ++.++|+||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2235899999999999986 4679999998875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.064 Score=51.31 Aligned_cols=76 Identities=18% Similarity=0.234 Sum_probs=53.1
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCeeEEEEeccCCC
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~~~g 421 (601)
.+.+.-|.--+-|.... ...++.||+-. ......|..|+.-|..|. --.+.+++.+....++.|+|+||++-+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34455555555555543 56788888642 334466778877777764 355778888888999999999999987
Q ss_pred Ccc
Q 007490 422 SLD 424 (601)
Q Consensus 422 sL~ 424 (601)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.018 Score=60.15 Aligned_cols=74 Identities=12% Similarity=0.127 Sum_probs=50.3
Q ss_pred CCcccccCcceEEeeecCC-CceeeEEEecc------CChhhHHHHHHHHHHHHHcC--CC-CccceEEEEEeCCeeEEE
Q 007490 345 DNKLGRGGFGEVYKGVLPH-GQEIAVKRLSR------SSGQGAQEFKNEVVLVAKLQ--HR-NLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~~~~lv 414 (601)
.+.||.|.-..||++...+ ++.|+||.-.. .-+-..++..-|.+.|+.+. -| ++.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999743 56799997432 12334566677888887763 34 45556544 44456788
Q ss_pred EeccCC
Q 007490 415 YEFVPN 420 (601)
Q Consensus 415 ~E~~~~ 420 (601)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.097 Score=53.31 Aligned_cols=115 Identities=21% Similarity=0.343 Sum_probs=75.0
Q ss_pred CcccccCcceEEeeecCCCceeeEEEecc--CChhhHHHHHHHHHHHHHcCC--CCccceEEEEEeCC--eeEEEEeccC
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSR--SSGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGD--EKILVYEFVP 419 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~--~~~lv~E~~~ 419 (601)
+.+..|..-.+|.... .+++++++ ... ..........+|.++|+.+.- --+.+.++.|.++. ..|.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3333343344454444 37778888 331 233344566788888888853 23345566666655 5699999998
Q ss_pred CCCccc----------cc--------------------------------------------------------------
Q 007490 420 NKSLDY----------FL-------------------------------------------------------------- 427 (601)
Q Consensus 420 ~gsL~~----------~l-------------------------------------------------------------- 427 (601)
|..+.. +.
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 832211 10
Q ss_pred -----ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 428 -----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 428 -----~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..+...++|+|+++.||+++.++-+-+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 01344699999999999999988899999999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.092 Score=53.97 Aligned_cols=107 Identities=24% Similarity=0.342 Sum_probs=71.6
Q ss_pred CcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc------cceEE----EEEeCCeeEEEEeccCCC
Q 007490 352 GFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL------VRLLG----FCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 352 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI------v~l~~----~~~~~~~~~lv~E~~~~g 421 (601)
.-..+|+....+|+. ++|+.... ....++..|+..|..|.-..| ..+=| ........+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888766666 88887655 445677788888888832221 11111 111123677899999998
Q ss_pred Cccc-cc---------------------------------cc-------------------------------------c
Q 007490 422 SLDY-FL---------------------------------YD-------------------------------------S 430 (601)
Q Consensus 422 sL~~-~l---------------------------------~~-------------------------------------h 430 (601)
.+.. .. +. .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7772 11 00 1
Q ss_pred cce--eeccccccCcEEEccCCC-cEEeecccce
Q 007490 431 QLR--IIHRDLKASNILLDVQMN-PKISDFGLAR 461 (601)
Q Consensus 431 ~~~--iiHrdlkp~NIll~~~~~-~kL~Dfg~a~ 461 (601)
..+ +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 123 999999999999998875 8899999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.17 Score=50.81 Aligned_cols=30 Identities=27% Similarity=0.521 Sum_probs=25.4
Q ss_pred eeeccccccCcEEEccCCC-cEEeeccccee
Q 007490 433 RIIHRDLKASNILLDVQMN-PKISDFGLARI 462 (601)
Q Consensus 433 ~iiHrdlkp~NIll~~~~~-~kL~Dfg~a~~ 462 (601)
.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.047 Score=51.47 Aligned_cols=76 Identities=26% Similarity=0.290 Sum_probs=58.1
Q ss_pred HHHHHHHHHcCC-CCccceEEEEEeCCeeEEEEeccCCCCc-------cccc----------------------ccccce
Q 007490 384 KNEVVLVAKLQH-RNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYFL----------------------YDSQLR 433 (601)
Q Consensus 384 ~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~gsL-------~~~l----------------------~~h~~~ 433 (601)
.+|.-+++.+++ +++.+++|+| ..++|+||.+.+++ .++. +.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468888999976 6999999998 34789999987644 2322 011123
Q ss_pred eeccccccCcEEEccCCCcEEeecccceec
Q 007490 434 IIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 434 iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777899999999999999999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.12 Score=52.72 Aligned_cols=29 Identities=28% Similarity=0.320 Sum_probs=25.2
Q ss_pred ceeeccccccCcEEEccCCCcEEeecccce
Q 007490 432 LRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 432 ~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999987 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.0032 Score=74.07 Aligned_cols=132 Identities=13% Similarity=-0.019 Sum_probs=96.8
Q ss_pred HHHHHHHHHHcCCCCccceEEEEEe--CCeeEEEEeccCCCCccccccc----------------c--------------
Q 007490 383 FKNEVVLVAKLQHRNLVRLLGFCLE--GDEKILVYEFVPNKSLDYFLYD----------------S-------------- 430 (601)
Q Consensus 383 ~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~----------------h-------------- 430 (601)
...|...++..+|+++.....-... ..+.+.+++|+.+|.+...+-. |
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3345555666789988766544432 3356888899888876655410 1
Q ss_pred --cceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHH
Q 007490 431 --QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALET 508 (601)
Q Consensus 431 --~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 508 (601)
..-.+|++||+-|.+|..+.++|+.++|+.+..... ........+++.|+.|++...-.++.++|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 122589999999999999999999999999843222 1223345678889999998888899999999999999999
Q ss_pred HhCCCCCC
Q 007490 509 ITGKKNSS 516 (601)
Q Consensus 509 ltg~~p~~ 516 (601)
-.|..++-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.18 Score=48.48 Aligned_cols=94 Identities=24% Similarity=0.274 Sum_probs=55.1
Q ss_pred CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEeccCCCCcccc--c-------------
Q 007490 364 GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYEFVPNKSLDYF--L------------- 427 (601)
Q Consensus 364 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~gsL~~~--l------------- 427 (601)
++.|+||+..... ...-.-..|..+++.+..-++ .++++.+.. .+|+||+++..|..- .
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888876553 333455789999998865555 455555432 257799877554220 0
Q ss_pred ----------------------c--------c--------------------------------ccceeeccccccCcEE
Q 007490 428 ----------------------Y--------D--------------------------------SQLRIIHRDLKASNIL 445 (601)
Q Consensus 428 ----------------------~--------~--------------------------------h~~~iiHrdlkp~NIl 445 (601)
| . ....+.|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 1 0 1234789999999999
Q ss_pred E-ccCCCcEEeeccccee
Q 007490 446 L-DVQMNPKISDFGLARI 462 (601)
Q Consensus 446 l-~~~~~~kL~Dfg~a~~ 462 (601)
+ +.++.++|+||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999988864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.57 Score=47.92 Aligned_cols=30 Identities=23% Similarity=0.304 Sum_probs=27.5
Q ss_pred eeeccccccCcEEEccCCCcEEeeccccee
Q 007490 433 RIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 433 ~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.57 Score=48.30 Aligned_cols=70 Identities=13% Similarity=0.110 Sum_probs=43.9
Q ss_pred CcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceE---E--EEEeCCeeEEEEeccCCCC
Q 007490 352 GFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLL---G--FCLEGDEKILVYEFVPNKS 422 (601)
Q Consensus 352 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~~gs 422 (601)
.-..||+...+++..+++|+.... ......+..|++.+..|.... ++... | ....++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345689988777888999987532 234566778888888774221 22211 1 1223456778899887753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.36 Score=49.53 Aligned_cols=118 Identities=20% Similarity=0.233 Sum_probs=78.3
Q ss_pred cCCcccccCcceEEeeecCCCceeeEEEeccCC---------------------hhh-HH----HHHHHHHHHHHcCCCC
Q 007490 344 SDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS---------------------GQG-AQ----EFKNEVVLVAKLQHRN 397 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------------~~~-~~----~~~~E~~~l~~l~hpn 397 (601)
+...|..|--+.||.+.-.+|..+|||+++-.- ... .+ -..+|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788899999999998899999999874210 000 01 1356888888887655
Q ss_pred ccceEEEEEeCCeeEEEEeccCCCC-----ccccc-------------------ccccceeeccccccCcEEEccCCCcE
Q 007490 398 LVRLLGFCLEGDEKILVYEFVPNKS-----LDYFL-------------------YDSQLRIIHRDLKASNILLDVQMNPK 453 (601)
Q Consensus 398 Iv~l~~~~~~~~~~~lv~E~~~~gs-----L~~~l-------------------~~h~~~iiHrdlkp~NIll~~~~~~k 453 (601)
|.----+.. ....|||+|+.... |.+.- --+..++||.||.-=|+|+. +|.+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence 432111111 13468999986432 11110 11677899999999999986 56899
Q ss_pred EeecccceecC
Q 007490 454 ISDFGLARIFG 464 (601)
Q Consensus 454 L~Dfg~a~~~~ 464 (601)
|+|-+-+....
T Consensus 305 iIDVSQSVE~D 315 (520)
T KOG2270|consen 305 IIDVSQSVEHD 315 (520)
T ss_pred EEEccccccCC
Confidence 99998876543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.51 Score=56.34 Aligned_cols=31 Identities=35% Similarity=0.468 Sum_probs=25.9
Q ss_pred ceeeccccccCcEEEccCC--CcE-Eeeccccee
Q 007490 432 LRIIHRDLKASNILLDVQM--NPK-ISDFGLARI 462 (601)
Q Consensus 432 ~~iiHrdlkp~NIll~~~~--~~k-L~Dfg~a~~ 462 (601)
.++||+|+.+.|||++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3589999999999999875 555 999998853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.24 Score=47.17 Aligned_cols=139 Identities=14% Similarity=0.109 Sum_probs=82.5
Q ss_pred CcceEEeeecCCCceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCC--------
Q 007490 352 GFGEVYKGVLPHGQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS-------- 422 (601)
Q Consensus 352 ~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gs-------- 422 (601)
+.++.-++..+- -+..+|++....-. ...-+.++.+++++++ .|+++..= +.-..-++.|.|-...
T Consensus 74 gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~~~N~i~ 148 (308)
T PF07387_consen 74 GNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKINFSNFIT 148 (308)
T ss_pred CceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccchhHHHH
Confidence 444444444322 34556666443322 4455688889988875 46666511 2223457888764321
Q ss_pred --ccccc--ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhH
Q 007490 423 --LDYFL--YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498 (601)
Q Consensus 423 --L~~~l--~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv 498 (601)
|.++. |....+.+|+|-.|+||+-|+.|.+||.|-+....- +..|.--| ....+.++.+
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~---Y~~lT~~aE~ 211 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIE---YESLTQEAEV 211 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeee---ccccChHHHH
Confidence 22222 334568999999999999999999999997654311 11122211 2234667777
Q ss_pred HhHHHHHHHHHhCC
Q 007490 499 YSFGVLALETITGK 512 (601)
Q Consensus 499 wSlGvvl~elltg~ 512 (601)
-+|=.-++++....
T Consensus 212 ~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 212 KVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHH
Confidence 77777777776644
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.23 Score=49.10 Aligned_cols=77 Identities=21% Similarity=0.173 Sum_probs=51.6
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc-CCCCc
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV-PNKSL 423 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~~gsL 423 (601)
...+..|..+.|+.++..+|.++++|+........ .+ ......|+..+-...|++++.-. ....|++|.+ ++.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E-~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HE-ARGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hh-hhHHhHhheeCCCCceeeecccc--ccchhhhhhccCCCch
Confidence 35567899999999998899999999886443211 11 11224577777788899988753 3456777877 44455
Q ss_pred cc
Q 007490 424 DY 425 (601)
Q Consensus 424 ~~ 425 (601)
.+
T Consensus 83 ~~ 84 (253)
T PF04655_consen 83 AS 84 (253)
T ss_pred hh
Confidence 43
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=92.00 E-value=0.14 Score=34.30 Aligned_cols=28 Identities=32% Similarity=0.479 Sum_probs=17.5
Q ss_pred ceEEeehhHHHHHHHHHHhhheehhhhh
Q 007490 279 STIIAIVAPIVVIAVLFIAGLCFLRRRA 306 (601)
Q Consensus 279 ~~ii~iv~~~~v~~~l~i~~~~~~~rr~ 306 (601)
.+.++++++++++++++++++++++||+
T Consensus 12 aIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 12 AIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred EEEEEEEechHHHHHHHHHHhheEEecc
Confidence 3445667777777776666666555543
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.87 E-value=0.67 Score=47.90 Aligned_cols=72 Identities=14% Similarity=0.225 Sum_probs=44.5
Q ss_pred cccccCcceEEeeecCC----CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCcc-ceEEEEEeCCeeEEEEeccCCC
Q 007490 347 KLGRGGFGEVYKGVLPH----GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 347 ~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~g 421 (601)
.|..|-.-.+|+....+ +..|++|+........ -.-.+|..+++.+..-++- ++++++.. . +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence 34446666788876432 2378888876543322 2236799999999665553 55665532 2 488888776
Q ss_pred Cc
Q 007490 422 SL 423 (601)
Q Consensus 422 sL 423 (601)
.|
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 54
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 601 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-30 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 327 bits (842), Expect = e-109
Identities = 96/311 (30%), Positives = 135/311 (43%), Gaps = 79/311 (25%)
Query: 316 QNADNDITTLESLQFDFKTIEVATNKFSS------DNKLGRGGFGEVYKGVLPHGQEIAV 369
+N +++ F F ++ TN F NK+G GGFG VYKG + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAV 59
Query: 370 KRLS----RSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDY 425
K+L+ ++ + Q+F E+ ++AK QH NLV LLGF +GD+ LVY ++PN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 426 FLYDSQ----------LRI----------------IHRDLKASNILLDVQMNPKISDFGL 459
L +I IHRD+K++NILLD KISDFGL
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519
AR TSRIVGT YM+PE + G+ + KSD+YSFGV+ LE ITG ++
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 520 TDGAEDLLSY---------------------------------------EDPADRPSMAT 540
+ LL E RP +
Sbjct: 239 EP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 541 IVLALNSHSVT 551
+ L + +
Sbjct: 297 VQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-102
Identities = 91/288 (31%), Positives = 136/288 (47%), Gaps = 73/288 (25%)
Query: 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQ-EFKNEVV 388
F + ++VA++ FS+ N LGRGGFG+VYKG L G +AVKRL QG + +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLY-------------------- 428
+++ HRNL+RL GFC+ E++LVY ++ N S+ L
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 429 ----------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478
+IIHRD+KA+NILLD + + DFGLA++ T T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED--LLSY------- 529
G+++PEY G+ S K+DV+ +GV+ LE ITG++ + +D LL +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 530 --------------------------------EDPADRPSMATIVLAL 545
P +RP M+ +V L
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 3e-97
Identities = 93/305 (30%), Positives = 141/305 (46%), Gaps = 68/305 (22%)
Query: 308 KKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI 367
K N++ + + + + ES + +E ATN F +G G FG+VYKGVL G ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 368 AVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL 427
A+KR + S QG +EF+ E+ ++ +H +LV L+GFC E +E IL+Y+++ N +L L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 428 YDSQLR---------------------------IIHRDLKASNILLDVQMNPKISDFGLA 460
Y S L IIHRD+K+ NILLD PKI+DFG++
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 461 RIF-GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519
+ +DQT +T + GT GY+ PEY + G+ + KSDVYSFGV+ E + +
Sbjct: 187 KKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 520 TDGAEDLLSY---------------------------------------EDPADRPSMAT 540
+L + DRPSM
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 541 IVLAL 545
++ L
Sbjct: 306 VLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-74
Identities = 55/307 (17%), Positives = 96/307 (31%), Gaps = 88/307 (28%)
Query: 327 SLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNE 386
+ + + + RG FG V+K + +AVK Q + + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYE 68
Query: 387 VVLVAKLQHRNLVRLLGFCLEGD----EKILVYEFVPNKSLDYFLYDSQL---------- 432
V + ++H N+++ +G G + L+ F SL FL + +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE 128
Query: 433 ----------------------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470
I HRD+K+ N+LL + I+DFGLA F ++ G
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 471 NTSRIVGTYGYMSPEYAMHG-----QFSVKSDVYSFGVLALETITGKKNSSF----YQTD 521
+T VGT YM+PE ++ D+Y+ G++ E + + Y
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 522 GAEDLLS-----------------------------------------YEDPADRPSMAT 540
E++ D R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 541 IVLALNS 547
+ +
Sbjct: 309 VGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-57
Identities = 58/331 (17%), Positives = 97/331 (29%), Gaps = 103/331 (31%)
Query: 328 LQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNE- 386
++ + + +GRG +G VYKG L + +AVK S ++ Q F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEK 56
Query: 387 -VVLVAKLQHRNLVRLLGFCLEGD-----EKILVYEFVPNKSLDYFLYDSQL-------- 432
+ V ++H N+ R + E +LV E+ PN SL +L
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL 116
Query: 433 -----------------------RIIHRDLKASNILLDVQMNPKISDFGLARIF------ 463
I HRDL + N+L+ ISDFGL+
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 464 GVDQTQGNTSRIVGTYGYMSPEYAM-------HGQFSVKSDVYSFGVLALETITGKKNSS 516
+ VGT YM+PE + D+Y+ G++ E +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 517 FYQT---------------DGAEDLLS--------------------------------- 528
++ ED+
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 529 YEDPADRPSMATIVLALNSHSVTLSVPRQPA 559
+D R + + + + +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-55
Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 61/288 (21%)
Query: 318 ADNDITTLESLQF----DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLS 373
+D DI T E+L F D +++ + K+G G FG V++ HG ++AVK L
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM 69
Query: 374 RS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQ 431
+ EF EV ++ +L+H N+V +G + +V E++ SL L+ S
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 432 LR----------------------------IIHRDLKASNILLDVQMNPKISDFGLARIF 463
R I+HR+LK+ N+L+D + K+ DFGL+R+
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL- 188
Query: 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK---KNSSFYQT 520
T ++ GT +M+PE + KSDVYSFGV+ E T + N + Q
Sbjct: 189 -KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247
Query: 521 DGA------------------EDLLSY---EDPADRPSMATIVLALNS 547
A ++ +P RPS ATI+ L
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-52
Identities = 73/263 (27%), Positives = 102/263 (38%), Gaps = 66/263 (25%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIAVKRL----SRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
+G GGFG+VY+ G E+AVK Q + + E L A L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 402 LGFCLEGDEKILVYEFVPNKSLDYFLYDSQL-------------------------RIIH 436
G CL+ LV EF L+ L ++ IIH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 437 RDLKASNILLDVQMNP--------KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
RDLK+SNIL+ ++ KI+DFGLAR + G Y +M+PE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAPEVIR 187
Query: 489 HGQFSVKSDVYSFGVLALETITGK---KNSSFYQTDGA------------------EDLL 527
FS SDV+S+GVL E +TG+ + L+
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247
Query: 528 SY---EDPADRPSMATIVLALNS 547
DP RPS I+ L +
Sbjct: 248 EDCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 67/289 (23%)
Query: 346 NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404
LG+G FG+ K G+ + +K L R + + F EV ++ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 405 CLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLK 440
+ + E++ +L + Y + IIHRDL
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR------------IVGTYGYMSPEYAM 488
+ N L+ N ++DFGLAR+ ++TQ R +VG +M+PE
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 489 HGQFSVKSDVYSFGVLALETITGKK---NSSFYQTDGAEDLLSY---------------- 529
+ K DV+SFG++ E I + D ++ +
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 530 ------EDPADRPSMATIVLALNS--HSVTLSVPRQPALFIGSRTERSF 570
DP RPS + L + + +P P L + +R F
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL---EQLDRGF 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-50
Identities = 73/314 (23%), Positives = 120/314 (38%), Gaps = 71/314 (22%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
+ + + +GRG FG V K +++A+K++ S + F E+ ++++ H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNH 60
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR---------------------- 433
N+V+L G CL + LV E+ SL L+ ++
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 434 -------IIHRDLKASNILLDVQMN-PKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
+IHRDLK N+LL KI DFG A Q + + G+ +M+PE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
Query: 486 YAMHGQFSVKSDVYSFGVLALETITGKK-----NSSFYQTDGA----------------- 523
+S K DV+S+G++ E IT +K ++ A
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 524 EDLLSY---EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFP-EREFECSD 579
E L++ +DP+ RPSM IV + +P + + S P +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY---PCQHSLPPGEDGRVEP 290
Query: 580 KSTSKSMP--WSVD 591
WSVD
Sbjct: 291 YVDFAEFYRLWSVD 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-50
Identities = 67/297 (22%), Positives = 113/297 (38%), Gaps = 81/297 (27%)
Query: 318 ADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS 376
++ IE + ++G+GGFG V+KG + +A+K L
Sbjct: 4 GGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 377 GQGA-------QEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD 429
+G QEF+ EV +++ L H N+V+L G +V EFVP L + L D
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 430 SQLR--------------------------IIHRDLKASNILLD-----VQMNPKISDFG 458
I+HRDL++ NI L + K++DFG
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 459 LARIFGVDQTQGNTSRIVGTYGYMSPE--YAMHGQFSVKSDVYSFGVLALETITGK---K 513
L++ + + S ++G + +M+PE A ++ K+D YSF ++ +TG+
Sbjct: 175 LSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 514 NSSFYQTDGAEDLLSY-----------------------EDPADRPSMATIVLALNS 547
S+ + + DP RP + IV L+
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-48
Identities = 52/260 (20%), Positives = 87/260 (33%), Gaps = 66/260 (25%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
KL GE++KG G +I VK L S + +++F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 404 FCLEGDEKIL--VYEFVPNKSLDYFLYDSQLR---------------------------I 434
C + ++P SL L++ I
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ--- 491
L + ++++D M +IS + F Q+ G +++PE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAPAWVAPEALQKKPEDT 187
Query: 492 FSVKSDVYSFGVLALETITGK---KNSSFYQTDGA------------------EDLLSY- 529
+D++SF VL E +T + + S + L+
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKIC 247
Query: 530 --EDPADRPSMATIVLALNS 547
EDPA RP IV L
Sbjct: 248 MNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-47
Identities = 57/279 (20%), Positives = 104/279 (37%), Gaps = 72/279 (25%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRL--SRSSGQGAQEFKNEVV 388
F+ +E+ +G+G FG+VY G HG E+A++ + R + + FK EV+
Sbjct: 31 PFEQLEI-------GELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVM 81
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR--------------- 433
+ +H N+V +G C+ ++ ++L + D+++
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 434 ---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI---VGTYGY 481
I+H+DLK+ N+ D I+DFGL I GV Q ++ G +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 482 MSPE---------YAMHGQFSVKSDVYSFGVLALETITGK---KNSSFYQTDGA------ 523
++PE FS SDV++ G + E + K
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 524 ------------EDLLSY---EDPADRPSMATIVLALNS 547
D+L + + +RP+ ++ L
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 60/259 (23%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
++G G FG VYKG HG ++AVK L+ + + Q Q FKNEV ++ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 404 FCLEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------IIHRDL 439
+ I V ++ SL + L+ S+ + IIHRDL
Sbjct: 88 YSTAPQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE---YAMHGQFSVKS 496
K++NI L KI DFGLA ++ G+ +M+PE +S +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 497 DVYSFGVLALETITGK---KNSSFYQT----------------------DGAEDLLSY-- 529
DVY+FG++ E +TG+ N + + L++
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266
Query: 530 -EDPADRPSMATIVLALNS 547
+ +RPS I+ +
Sbjct: 267 KKKRDERPSFPRILAEIEE 285
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 67/267 (25%), Positives = 101/267 (37%), Gaps = 60/267 (22%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRL-SRSSGQGAQEFKNEVVLVAKL 393
+ ++GRG FGEV+ G L +AVK +F E ++ +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YD 429
H N+VRL+G C + +V E V FL Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY----MSPE 485
IHRDL A N L+ + KISDFG++R ++ G + G +PE
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPE 285
Query: 486 YAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLS 528
+G++S +SDV+SFG+L ET + N + + D +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV- 344
Query: 529 YE--------DPADRPSMATIVLALNS 547
+ +P RPS +TI L S
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 63/205 (30%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 345 DNKLGRGGFGEVYKGVL--PHGQEI--AVKRL---SRSSGQGAQEFKNEVVLVAKLQHRN 397
KLG G FG V +G P G+ + AVK L S + +F EV + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 398 LVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL------------------------YDSQL 432
L+RL G L + +V E P SL L Y
Sbjct: 83 LIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAMH 489
R IHRDL A N+LL + KI DFGL R + + + +PE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKT 198
Query: 490 GQFSVKSDVYSFGVLALETIT-GKK 513
FS SD + FGV E T G++
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 48/210 (22%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNE--VVLVAKLQHRNLVRLLG 403
+G+G +GEV++G G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 404 FCLEGDEKI----LVYEFVPNKSLDYFLYDSQL--------------------------- 432
+ L+ + SL +L + L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 433 ---RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI--VGTYGYMSPE-- 485
I HRDLK+ NIL+ I+D GLA + Q + VGT YM+PE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 486 ----YAMHGQFSVKSDVYSFGVLALETITG 511
+ D+++FG++ E
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 48/211 (22%)
Query: 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNE--VVLVAKLQHRNLVRLL 402
++G+G +GEV+ G G+++AVK + E + ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 403 GFCLEGDEKI----LVYEFVPNKSLDYFLYDSQL-------------------------- 432
++G L+ ++ N SL +L + L
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 433 ----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI--VGTYGYMSPE- 485
I HRDLK+ NIL+ I+D GLA F D + + VGT YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 486 -----YAMHGQFSVKSDVYSFGVLALETITG 511
H Q + +D+YSFG++ E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 40/201 (19%)
Query: 346 NKLGRGGFGEVYKGVLP-----HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG+G FG V G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 401 LLGFCLEGDEK--ILVYEFVPNKSLDYFL------------------------YDSQLRI 434
G C + L+ E++P SL +L Y R
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-----TQGNTSRIVGTYGYMSPEYAMH 489
IHRDL NIL++ + KI DFGL ++ D+ + S I + +PE
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAPESLTE 191
Query: 490 GQFSVKSDVYSFGVLALETIT 510
+FSV SDV+SFGV+ E T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 69/263 (26%), Positives = 107/263 (40%), Gaps = 56/263 (21%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
+ ++ + ++G G FG V+ G + ++A+K + R ++F E ++ KL H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 62
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQ 431
LV+L G CLE LV EF+ + L +L Y +
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY--MSPEYAMH 489
+IHRDL A N L+ K+SDFG+ R DQ TS + SPE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSF 179
Query: 490 GQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE-- 530
++S KSDV+SFGVL E + + NS + A + Y+
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV-YQIM 238
Query: 531 ------DPADRPSMATIVLALNS 547
P DRP+ + ++ L
Sbjct: 239 NHCWRERPEDRPAFSRLLRQLAE 261
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 60/256 (23%), Positives = 89/256 (34%), Gaps = 42/256 (16%)
Query: 316 QNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVK 370
+ + L D LG G FG+V G+ +AVK
Sbjct: 9 HHHHGALEVLFQGPGDPT--VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK 66
Query: 371 RLSRSSGQGA-QEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK--ILVYEFVPNKSLDYFL 427
L +G +K E+ ++ L H ++++ G C + LV E+VP SL +L
Sbjct: 67 ALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126
Query: 428 ----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
Y IHRDL A N+LLD KI DFGLA+
Sbjct: 127 PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
Query: 466 DQ-----TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQ 519
+ S + + +PE +F SDV+SFGV E +T + S
Sbjct: 187 GHEYYRVREDGDSPV----FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
Query: 520 TDGAEDLLSYEDPADR 535
++
Sbjct: 243 KFLELIGIAQGQMTVL 258
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 42/201 (20%)
Query: 345 DNKLGRGGFGEVYKGVL-PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
D +LG G FG V +GV ++I A+K L + +E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 401 LLGFCLEGDEKI-LVYEFVPNKSLDYFL------------------------YDSQLRII 435
L+G C E + LV E L FL Y + +
Sbjct: 75 LIGVCQA--EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG------YMSPEYAMH 489
HRDL A N+LL + KISDFGL++ G D + + +PE
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINF 187
Query: 490 GQFSVKSDVYSFGVLALETIT 510
+FS +SDV+S+GV E ++
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 69/278 (24%), Positives = 110/278 (39%), Gaps = 78/278 (28%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLV 390
E+ ++ + +G G GEV G L P +++ A+K L + + + ++F +E ++
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------- 427
+ H N++RL G G ++V E++ N SLD FL
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 428 -YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY----- 481
Y S L +HRDL A N+L+D + K+SDFGL+R+ D
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTG 213
Query: 482 -------MSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT------- 520
+PE FS SDV+SFGV+ E + N +
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL 273
Query: 521 ---DGAEDLLSYE--------DPADRPSMATIVLALNS 547
G L ++ D A RP + IV L++
Sbjct: 274 PAPMGCPHAL-HQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 346 NKLGRGGFGEVYKGVLP-----HGQEIAVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNLV 399
LG G FG+V G+++AVK L S G + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 400 RLLGFCLEGDEK--ILVYEFVPNKSLDYFL------------------------YDSQLR 433
+ G C E L+ EF+P+ SL +L Y +
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-----TQGNTSRIVGTYGYMSPEYAM 488
+HRDL A N+L++ + KI DFGL + D+ S + + +PE M
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYAPECLM 202
Query: 489 HGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSYEDP 532
+F + SDV+SFGV E +T +SS ++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 40/201 (19%)
Query: 346 NKLGRGGFGEVYKGVLP-----HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
+LG+G FG V G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 401 LLGFCLEGDEK--ILVYEFVPNKSLDYFL------------------------YDSQLRI 434
G C + L+ E++P SL +L Y R
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-----TQGNTSRIVGTYGYMSPEYAMH 489
IHRDL NIL++ + KI DFGL ++ D+ + S I + +PE
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAPESLTE 222
Query: 490 GQFSVKSDVYSFGVLALETIT 510
+FSV SDV+SFGV+ E T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 58/264 (21%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + +LG G FG V G ++A+K + + EF E ++ L H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 78
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQ 431
LV+L G C + ++ E++ N L +L Y
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAM 488
+ +HRDL A N L++ Q K+SDFGL+R D+ + VG+ + PE M
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLM 194
Query: 489 HGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE- 530
+ +FS KSD+++FGVL E + NS + A + + Y
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV-YTI 253
Query: 531 -------DPADRPSMATIVLALNS 547
+RP+ ++ +
Sbjct: 254 MYSCWHEKADERPTFKILLSNILD 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 60/205 (29%), Positives = 84/205 (40%), Gaps = 43/205 (20%)
Query: 345 DNKLGRGGFGEVYKGVL-PHGQEI--AVKRL--SRSSGQGAQEFKNEVVLVAKLQHRNLV 399
D +LG G FG V KG AVK L + E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 400 RLLGFCLEGDEKI-LVYEFVPNKSLDYFL-----------------------YDSQLRII 435
R++G C E LV E L+ +L Y + +
Sbjct: 82 RMIGICEA--ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG------YMSPEYAMH 489
HRDL A N+LL Q KISDFGL++ D+ + +PE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINY 194
Query: 490 GQFSVKSDVYSFGVLALETIT-GKK 513
+FS KSDV+SFGVL E + G+K
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-38
Identities = 70/287 (24%), Positives = 110/287 (38%), Gaps = 73/287 (25%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--------PHGQEIAVKRLSRSSGQGAQEFKNEV 387
++ + LG+G F +++KGV H E+ +K L ++ ++ F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------- 427
+++KL H++LV G C+ GDE ILV EFV SLD +L
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 428 ----YDSQLRIIHRDLKASNILLDVQMNP--------KISDFGLARIFGVDQTQGNTSRI 475
+ + +IH ++ A NILL + + K+SD G++ V RI
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERI 181
Query: 476 VGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSYE--- 530
++ PE + ++ +D +SFG E + G K D L YE
Sbjct: 182 ----PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK--PLSALDSQRKLQFYEDRH 235
Query: 531 --------------------DPADRPSMATIVLALNSHSVTLSVPRQ 557
+P RPS I+ LNS VPR
Sbjct: 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 56/282 (19%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ 394
E+ + +KLG G +GEVY+GV + +AVK L + +EF E ++ +++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 67
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YD 429
H NLV+LLG C ++ EF+ +L +L Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-TQGNTSRIVGTYGYMSPEYAM 488
+ IHRDL A N L+ K++DFGL+R+ D T ++ + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 489 HGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE- 530
+ +FS+KSDV++FGVL E T G S Y+ +G + + YE
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV-YEL 244
Query: 531 -------DPADRPSMATIVLALNSHSVTLSVPRQPALFIGSR 565
+P+DRPS A I A + S+ + +G R
Sbjct: 245 MRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 58/264 (21%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + + +LG G FG V G ++AVK + + EF E + KL H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSH 62
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQ 431
LV+ G C + +V E++ N L +L +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAM 488
+ IHRDL A N L+D + K+SDFG+ R DQ VGT + +PE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFH 178
Query: 489 HGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE- 530
+ ++S KSDV++FG+L E + NS A D + Y+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI-YQI 237
Query: 531 -------DPADRPSMATIVLALNS 547
P RP+ ++ ++
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEP 261
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 65/268 (24%), Positives = 100/268 (37%), Gaps = 72/268 (26%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
+ + +G+G FG+V G G ++AVK + + AQ F E ++ +L+H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRH 73
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------------------YD 429
NLV+LLG +E + +V E++ SL +L Y
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG------YMS 483
+HRDL A N+L+ K+SDFGL + + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EAS-------STQDTGKLPVKWTA 182
Query: 484 PEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDL 526
PE +FS KSDV+SFG+L E + DG
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242
Query: 527 LSYE--------DPADRPSMATIVLALN 546
+ YE D A RPS + L
Sbjct: 243 V-YEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 42/205 (20%)
Query: 345 DNKLGRGGFGEVYKGVLPHGQE-----IAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNL 398
LG G FG VYKG+ E +A+K L ++ A +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRI 434
RLLG CL L+ + +P L ++ Y R+
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG-----YMSPEYAMH 489
+HRDL A N+L+ + KI+DFGLA++ G ++ + + G +M+ E +H
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILH 193
Query: 490 GQFSVKSDVYSFGVLALETIT-GKK 513
++ +SDV+S+GV E +T G K
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 77/313 (24%), Positives = 128/313 (40%), Gaps = 68/313 (21%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLV 390
E+ S D +G G FGEV G L P +EI A+K L + + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------- 427
+ H N++RL G + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 428 -YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMS 483
Y S + +HRDL A NIL++ + K+SDFGL R+ D T+R G + S
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTS 218
Query: 484 PEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY------------- 529
PE + +F+ SDV+S+G++ E ++ G++ Y +D++
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 530 -------------EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFE 576
+D +RP IV L+ + P + + S +
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKL---IRNPGSLKIITSAAARPSNLLLDQS 332
Query: 577 CSDKSTSKSMP-W 588
D +T ++ W
Sbjct: 333 NVDITTFRTTGDW 345
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 62/269 (23%), Positives = 97/269 (36%), Gaps = 72/269 (26%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
+ + +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 245
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------------------YD 429
NLV+LLG +E + +V E++ SL +L Y
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG------YMS 483
+HRDL A N+L+ K+SDFGL + + +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 354
Query: 484 PEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDL 526
PE +FS KSDV+SFG+L E + DG
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 414
Query: 527 LSYE--------DPADRPSMATIVLALNS 547
+ Y+ D A RP+ + L
Sbjct: 415 V-YDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 40/201 (19%)
Query: 346 NKLGRGGFGEVYKGVLP-----HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
++LG+G FG V G +AVK+L S ++F+ E+ ++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 401 LLGFCLEGDEK--ILVYEFVPNKSLDYFL------------------------YDSQLRI 434
G + LV E++P+ L FL Y R
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-----TQGNTSRIVGTYGYMSPEYAMH 489
+HRDL A NIL++ + + KI+DFGLA++ +D+ + S I + +PE
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI----FWYAPESLSD 204
Query: 490 GQFSVKSDVYSFGVLALETIT 510
FS +SDV+SFGV+ E T
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 75/275 (27%), Positives = 121/275 (44%), Gaps = 56/275 (20%)
Query: 323 TTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQ 381
T+ + ++ E+ + +KLG G +GEVY+GV + +AVK L + +
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE 261
Query: 382 EFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------- 427
EF E ++ +++H NLV+LLG C ++ EF+ +L +L
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 428 -----------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ-TQGNTSRI 475
Y + IHR+L A N L+ K++DFGL+R+ D T ++
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT-------- 520
+ +PE + +FS+KSDV++FGVL E T G S Y+
Sbjct: 382 --PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439
Query: 521 --DGAEDLLSYE--------DPADRPSMATIVLAL 545
+G + + YE +P+DRPS A I A
Sbjct: 440 RPEGCPEKV-YELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 71/275 (25%), Positives = 109/275 (39%), Gaps = 70/275 (25%)
Query: 335 IEVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRLSRSSGQGA-QEFKNEVVL 389
I ++ + +GRG FG VY G L G++I AVK L+R + G +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 390 VAKLQHRNLVRLLGFCLEGDEKIL-VYEFVPNKSLDYFL--------------------- 427
+ H N++ LLG CL + L V ++ + L F+
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 428 ---YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG---- 480
Y + + +HRDL A N +LD + K++DFGLAR D + G
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLP 195
Query: 481 --YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY-------- 529
+M+ E +F+ KSDV+SFGVL E +T G Y D+ Y
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLLQGRRLL 252
Query: 530 ------------------EDPADRPSMATIVLALN 546
RPS + +V ++
Sbjct: 253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 42/215 (19%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRL-SRSSGQGAQEFKNEVVL 389
E+ + + +G G FGEVYKG+L +A+K L + + + +F E +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------------------- 427
+ + H N++RL G + +++ E++ N +LD FL
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 428 --YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG----- 480
Y + + +HRDL A NIL++ + K+SDFGL+R+ D T+ G
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPI 214
Query: 481 -YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKK 513
+ +PE + +F+ SDV+SFG++ E +T G++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 60/265 (22%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
EV +LG G FGEV+ G ++AVK L + F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 396 RNLVRLLGFCLEGDEKIL-VYEFVPNKSLDYFL-------------------------YD 429
+ LVRL + E I + E++ N SL FL +
Sbjct: 68 QRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY--MSPEYA 487
+ IHRDL+A+NIL+ ++ KI+DFGLAR+ ++ T+R + +PE
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAI 182
Query: 488 MHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE 530
+G F++KSDV+SFG+L E +T G N Q D + L Y+
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL-YQ 241
Query: 531 --------DPADRPSMATIVLALNS 547
P DRP+ + L
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLED 266
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 61/268 (22%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRLSR-SSGQGAQEFKNEVVLV 390
+A + LG G FGEVY+GV G++I AVK + + ++F +E V++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------- 427
L H ++V+L+G E + ++ E P L ++L
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 428 -YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRI-VGTYGYMSP 484
Y + +HRD+ NIL+ K+ DFGL+R I D + + +R+ + +MSP
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMSP 183
Query: 485 EYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLL 527
E +F+ SDV+ F V E ++ +N D +L
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243
Query: 528 SYE--------DPADRPSMATIVLALNS 547
Y DP+DRP +V +L+
Sbjct: 244 -YTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 43/202 (21%)
Query: 345 DNKLGRGGFGEVYKGVL-PHGQEI----AVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNL 398
LG G FG V+KGV P G+ I +K + SG+ + Q + ++ + L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 399 VRLLGFCLEGDEKI-LVYEFVPNKSLDYFL------------------------YDSQLR 433
VRLLG C + LV +++P SL + Y +
Sbjct: 78 VRLLGLCPG--SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG-----YMSPEYAM 488
++HR+L A N+LL +++DFG+A + D Q S +M+ E
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESIH 190
Query: 489 HGQFSVKSDVYSFGVLALETIT 510
G+++ +SDV+S+GV E +T
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 65/265 (24%), Positives = 101/265 (38%), Gaps = 70/265 (26%)
Query: 345 DNKLGRGGFGEVYKGVL--PHGQEI--AVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLV 399
D +G+G FG VY G I A+K LSR + + F E +L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 400 RLLGFCLEGDEKIL-VYEFVPNKSLDYFL------------------------YDSQLRI 434
L+G L + + ++ + L F+ Y ++ +
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145
Query: 435 IHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYG-----YMSPEYAM 488
+HRDL A N +LD K++DFGLAR I + + + + E
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ----HRHARLPVKWTALESLQ 201
Query: 489 HGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY------------------ 529
+F+ KSDV+SFGVL E +T G Y+ DL +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258
Query: 530 --------EDPADRPSMATIVLALN 546
DPA RP+ +V +
Sbjct: 259 QVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 48/211 (22%)
Query: 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNE--VVLVAKLQHRNLVRLL 402
+G+G FGEV++G G+E+AVK S + + + E + L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 403 GFCLEGDEKI----LVYEFVPNKSLDYFLYDSQL-------------------------- 432
+ + LV ++ + SL +L +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 433 ----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI--VGTYGYMSPE- 485
I HRDLK+ NIL+ I+D GLA + + VGT YM+PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 486 -----YAMHGQFSVKSDVYSFGVLALETITG 511
H + ++D+Y+ G++ E
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG G FGEV+ ++AVK + + + F E ++ LQH
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 242
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDS 430
LV+L + + ++ EF+ SL FL +
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY--MSPEYAM 488
Q IHRDL+A+NIL+ + KI+DFGLAR+ ++ T+R + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 358
Query: 489 HGQFSVKSDVYSFGVLALETIT 510
G F++KSDV+SFG+L +E +T
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 57/277 (20%), Positives = 105/277 (37%), Gaps = 61/277 (22%)
Query: 327 SLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRL-SRSSGQGAQ 381
++ + E+ + +G G FG+V++G+ P + A+K + +S +
Sbjct: 2 AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE 61
Query: 382 EFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL------------- 427
+F E + + + H ++V+L+G E + ++ E L FL
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 428 -----------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRI 475
Y R +HRD+ A N+L+ K+ DFGL+R + + + ++
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQT-------- 520
+M+PE +F+ SDV+ FGV E + G KN+
Sbjct: 180 --PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237
Query: 521 --DGAEDLLSYE--------DPADRPSMATIVLALNS 547
L Y DP+ RP + L++
Sbjct: 238 MPPNCPPTL-YSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 87/280 (31%)
Query: 346 NKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
+LG G FG+V+ +AVK L + ++F+ E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------------- 427
+ G C +GD I+V+E++ + L+ FL
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 428 -------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTS-----R 474
Y + +HRDL N L+ + KI DFG++R ++ D + R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY---- 529
+M PE M+ +F+ +SDV+SFGV+ E T GK + +++
Sbjct: 201 ------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGK---QPWFQLSNTEVIECITQG 251
Query: 530 ----------------------EDPADRPSMATIVLALNS 547
+P R ++ I L++
Sbjct: 252 RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 54/274 (19%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDS 430
LV+L E + +V E++ SL FL Y
Sbjct: 239 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
++ +HRDL+A+NIL+ + K++DFGLAR+ ++ + +PE A++G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 491 QFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE--- 530
+F++KSDV+SFG+L E T G N + L ++
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 415
Query: 531 -----DPADRPSMATIVLALNSHSVTLSVPRQPA 559
+P +RP+ + L + + QP
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 70/275 (25%), Positives = 109/275 (39%), Gaps = 70/275 (25%)
Query: 335 IEVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRLSRSSGQGA-QEFKNEVVL 389
I ++ + +GRG FG VY G L G++I AVK L+R + G +F E ++
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 390 VAKLQHRNLVRLLGFCLEGDEKIL-VYEFVPNKSLDYFL--------------------- 427
+ H N++ LLG CL + L V ++ + L F+
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 428 ---YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG---- 480
+ + + +HRDL A N +LD + K++DFGLAR D + G
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLP 259
Query: 481 --YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY-------- 529
+M+ E +F+ KSDV+SFGVL E +T G Y D+ Y
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLLQGRRLL 316
Query: 530 ------------------EDPADRPSMATIVLALN 546
RPS + +V ++
Sbjct: 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 67/287 (23%), Positives = 109/287 (37%), Gaps = 86/287 (29%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL----PHGQEI--AVKRLSRSSGQGAQEFKNEVVL 389
+ +LG G FG+V+ P ++ AVK L +S Q+F+ E L
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------------------- 427
+ LQH+++VR G C EG ++V+E++ + L+ FL
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 428 ----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQG 470
Y + L +HRDL N L+ + KI DFG++R I+ D +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR- 215
Query: 471 NTSRIVGTYG-----YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE 524
VG +M PE ++ +F+ +SDV+SFGV+ E T GK +
Sbjct: 216 -----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK---QPWYQLSNT 267
Query: 525 DLLSY--------------------------EDPADRPSMATIVLAL 545
+ + +P R S+ + L
Sbjct: 268 EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-35
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 345 DNKLGRGGFGEVYKGVL-PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
D +LG G FG V +GV ++I A+K L + +E E ++ +L + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIH 436
L+G C + +LV E L FL Y + +H
Sbjct: 401 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT---YGYMSPEYAMHGQFS 493
R+L A N+LL + KISDFGL++ G D + + +PE +FS
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFS 517
Query: 494 VKSDVYSFGVLALETIT 510
+SDV+S+GV E ++
Sbjct: 518 SRSDVWSYGVTMWEALS 534
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 76/291 (26%)
Query: 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQE----IAVKRLSR--SSGQG 379
E LQ + + + N LG G FG V +G L +AVK + SS +
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 380 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-----EKILVYEFVPNKSLDYFL------- 427
+EF +E + H N++RLLG C+E + +++ F+ L +L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 428 ----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFG 464
Y S +HRDL A N +L M ++DFGL++ I+
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
Query: 465 VDQ-TQGNTSRI-VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTD 521
D QG +++ V +++ E ++ KSDV++FGV E T G Y
Sbjct: 200 GDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---YPGV 253
Query: 522 GAEDLLSY--------------------------EDPADRPSMATIVLALN 546
++ Y DP DRP+ + + L L
Sbjct: 254 QNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 41/201 (20%)
Query: 345 DNKLGRGGFGEVYKGVLPHGQE-----IAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNL 398
LG G FG VYKG+ E +A+K L ++ A +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRI 434
RLLG CL L+ + +P L ++ Y R+
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG-----YMSPEYAMH 489
+HRDL A N+L+ + KI+DFGLA++ G ++ + + G +M+ E +H
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILH 193
Query: 490 GQFSVKSDVYSFGVLALETIT 510
++ +SDV+S+GV E +T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 40/235 (17%)
Query: 316 QNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS 375
+ + L + F+++ V +S ++G GG +V++ + Q A+K ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 376 --SGQGAQEFKNEVVLVAKLQHRNL--VRLLGFCLEGDEKILVYEFVPNKSLDYFL---- 427
Q ++NE+ + KLQ + +RL + + +V E N L+ +L
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK 122
Query: 428 ---------YDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468
Y + I+H DLK +N L+ K+ DFG+A D T
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181
Query: 469 QGNTSRIVGTYGYMSPE-----------YAMHGQFSVKSDVYSFGVLALETITGK 512
VGT YM PE + S KSDV+S G + GK
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 73/298 (24%), Positives = 112/298 (37%), Gaps = 87/298 (29%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRL-SRSSGQGAQEFKNEVV 388
EV + LG G FGEVY+G + P ++AVK L S Q +F E +
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 428 ---------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLAR-IFGVDQTQGNTSR 474
Y + IHRD+ A N LL KI DFG+AR I+ +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----- 200
Query: 475 IVGTYGY-----MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS 528
G M PE M G F+ K+D +SFGVL E + G Y + +++L
Sbjct: 201 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG---YMPYPSKSNQEVLE 256
Query: 529 Y--------------------------EDPADRPSMATIVLAL-----NSHSVTLSVP 555
+ P DRP+ A I+ + + + ++P
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 314
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 69/305 (22%), Positives = 114/305 (37%), Gaps = 77/305 (25%)
Query: 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHG----QEIAVKRL--SRSSGQG 379
+ L+ + + + +F+ LG+G FG V + L ++AVK L +
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 380 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI------LVYEFVPNKSLDYFL------ 427
+EF E + + H ++ +L+G L K ++ F+ + L FL
Sbjct: 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 428 -----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IF 463
Y S IHRDL A N +L M ++DFGL+R I+
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 464 GVDQ-TQGNTSRI-VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQT 520
D QG S++ V +++ E ++V SDV++FGV E +T G+ Y
Sbjct: 189 SGDYYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---YAG 242
Query: 521 DGAEDLLSY--------------------------EDPADRPSMATIVLALNSHSVTLSV 554
++ +Y DP RPS + + L + LSV
Sbjct: 243 IENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
Query: 555 PRQPA 559
Sbjct: 303 LSTSQ 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-35
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 54/274 (19%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 321
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDS 430
LV+L E + +V E++ SL FL Y
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
++ +HRDL+A+NIL+ + K++DFGLAR+ ++ + +PE A++G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 491 QFSVKSDVYSFGVLALETIT-------GKKNSSFYQT----------DGAEDLLSYE--- 530
+F++KSDV+SFG+L E T G N + L ++
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-HDLMC 498
Query: 531 -----DPADRPSMATIVLALNSHSVTLSVPRQPA 559
+P +RP+ + L + + QP
Sbjct: 499 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 88/281 (31%)
Query: 346 NKLGRGGFGEVYKGVL------PHGQEIAVKRL-SRSSGQGAQEFKNEVVLVAKLQHRNL 398
+LG FG+VYKG L Q +A+K L ++ G +EF++E +L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------------- 427
V LLG + +++ + + L FL
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 428 --------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVD--QTQGNTS--- 473
Y S ++H+DL N+L+ ++N KISD GL R ++ D + GN+
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY--- 529
R +M+PE M+G+FS+ SD++S+GV+ E + G + Y +D++
Sbjct: 195 R------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGYSNQDVVEMIRN 245
Query: 530 -----------------------EDPADRPSMATIVLALNS 547
E P+ RP I L +
Sbjct: 246 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 70/283 (24%), Positives = 109/283 (38%), Gaps = 82/283 (28%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRL-SRSSGQGAQEFKNEVV 388
EVA K + +LG+G FG VY+GV +A+K + +S + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
++ + ++VRLLG +G +++ E + L +L
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 428 ------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSR 474
Y + + +HRDL A N ++ KI DFG+ R I+ D +
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----- 195
Query: 475 IVGTYGY-----MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS 528
G G MSPE G F+ SDV+SFGV+ E T ++ YQ E +L
Sbjct: 196 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLR 251
Query: 529 Y--------------------------EDPADRPSMATIVLAL 545
+ +P RPS I+ ++
Sbjct: 252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 73/298 (24%), Positives = 112/298 (37%), Gaps = 87/298 (29%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRL-SRSSGQGAQEFKNEVV 388
EV + LG G FGEVY+G + P ++AVK L S Q +F E +
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 428 ---------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLAR-IFGVDQTQGNTSR 474
Y + IHRD+ A N LL KI DFG+AR I+ +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----- 241
Query: 475 IVGTYGY-----MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS 528
G M PE M G F+ K+D +SFGVL E + G Y + +++L
Sbjct: 242 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG---YMPYPSKSNQEVLE 297
Query: 529 Y--------------------------EDPADRPSMATIVLAL-----NSHSVTLSVP 555
+ P DRP+ A I+ + + + ++P
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 40/218 (18%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLV 390
+ I V +S ++G GG +V++ + Q A+K ++ Q ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 391 AKLQHRNL--VRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------YDSQL--- 432
KLQ + +RL + + +V E N L+ +L Y +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 433 -------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
I+H DLK +N L+ K+ DFG+A D T VGT YM PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 486 -----------YAMHGQFSVKSDVYSFGVLALETITGK 512
+ S KSDV+S G + GK
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 61/263 (23%), Positives = 97/263 (36%), Gaps = 69/263 (26%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL 398
F +G GGFG+V+K G+ +KR+ ++ ++ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 399 VRLLGFCLEGDEKI----------------LVYEFVPNKSLDYFL--------------- 427
V G D + EF +L+ ++
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 428 YDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
Q+ ++I+RDLK SNI L KI DFGL + G +R G
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKG 183
Query: 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKN----------------SSFYQTD 521
T YMSPE + + D+Y+ G++ E + S +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKK 243
Query: 522 GAEDLLSY---EDPADRPSMATI 541
+ LL + P DRP+ + I
Sbjct: 244 -EKTLLQKLLSKKPEDRPNTSEI 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 71/285 (24%), Positives = 110/285 (38%), Gaps = 83/285 (29%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLVA 391
+ N + +G G FG+V K + G + A+KR+ +S ++F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 392 KL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------- 427
KL H N++ LLG C L E+ P+ +L FL
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 428 ----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471
Y SQ + IHRDL A NIL+ KI+DFGL+R V +
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 472 TS---RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL 527
R +M+ E + ++ SDV+S+GVL E ++ G + Y +L
Sbjct: 201 GRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPYCGMTCAELY 251
Query: 528 SY--------------------------EDPADRPSMATIVLALN 546
E P +RPS A I+++LN
Sbjct: 252 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 66/293 (22%), Positives = 106/293 (36%), Gaps = 91/293 (31%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH--------GQEIAVKRL-SRSSGQGAQEFKNE 386
E +K + LG G FG+V +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------ 427
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGV 465
Y + + IHRDL A N+L+ KI+DFGLAR I +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 466 DQTQGNTSRIVGTYG-----YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQ 519
D T G +M+PE ++ +SDV+SFGVL E T G S Y
Sbjct: 211 D------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG---SPYP 261
Query: 520 TDGAEDLLSY--------------------------EDPADRPSMATIVLALN 546
E+L P+ RP+ +V L+
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 71/300 (23%), Positives = 113/300 (37%), Gaps = 96/300 (32%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHG------QEIAVKRL-SRSSGQGAQEFKNEVV 388
E N +G G FG V++ P +AVK L +S +F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
L+A+ + N+V+LLG C G L++E++ L+ FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 428 --------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461
Y S+ + +HRDL N L+ M KI+DFGL+R
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 462 -IFGVD--QTQGNTS---RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKN 514
I+ D + GN + R +M PE + +++ +SDV+++GV+ E + G
Sbjct: 223 NIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-- 274
Query: 515 SSFYQTDGAEDLLSY--------------------------EDPADRPSMATIVLALNSH 548
Y E+++ Y + PADRPS +I L
Sbjct: 275 -QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 38/201 (18%)
Query: 345 DNKLGRGGFGEVYKGV-LPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRL 401
D ++GRG F VYKG+ E+A + + + Q FK E ++ LQH N+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 402 LGFCLEGDEK----ILVYEFVPNKSL-DY------------------------FLYDSQL 432
+ +LV E + + +L Y FL+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 433 RIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
IIHRDLK NI + + KI D GLA + + ++GT +M+PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YEEK 205
Query: 492 FSVKSDVYSFGVLALETITGK 512
+ DVY+FG+ LE T +
Sbjct: 206 YDESVDVYAFGMCMLEMATSE 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 66/293 (22%), Positives = 106/293 (36%), Gaps = 91/293 (31%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--------PHGQEIAVKRL-SRSSGQGAQEFKNE 386
E +K + LG G FG+V +AVK L ++ + + +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------ 427
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGV 465
Y + + IHRDL A N+L+ KI+DFGLAR I +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 466 DQTQGNTSRIVGTYG-----YMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQ 519
D T G +M+PE ++ +SDV+SFGVL E T G S Y
Sbjct: 257 D------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG---SPYP 307
Query: 520 TDGAEDLLSY--------------------------EDPADRPSMATIVLALN 546
E+L P+ RP+ +V L+
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 52/220 (23%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
+ F LG+G FG+V K + A+K++ + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYF---------LYD------------------S 430
+VR LE + V KS + LYD
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 431 QL----------RIIHRDLKASNILLDVQMNPKISDFGLARIF------------GVDQT 468
Q+ IIHRDLK NI +D N KI DFGLA+ + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 469 QGNTSRIVGTYGYMSPE-YAMHGQFSVKSDVYSFGVLALE 507
N + +GT Y++ E G ++ K D+YS G++ E
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRL---SRSSGQGAQEFKNEVVLVAKLQH 395
F + K+GRG F EVY+ L G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------YDSQL------ 432
N+++ +E +E +V E L + Y QL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 433 ----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
R++HRD+K +N+ + K+ D GL R F T ++ +VGT YMSPE
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIH 209
Query: 489 HGQFSVKSDVYSFGVLALETITGK 512
++ KSD++S G L E +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 30/201 (14%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHR 396
K+ K+G G FG+ G++ +K +SR S + +E + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------------YDSQL--------- 432
N+V+ E +V ++ L + + Q+
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 433 -RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
+I+HRD+K+ NI L ++ DFG+AR+ +GT Y+SPE +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKP 201
Query: 492 FSVKSDVYSFGVLALETITGK 512
++ KSD+++ G + E T K
Sbjct: 202 YNNKSDIWALGCVLYELCTLK 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 32/195 (16%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
LG+G +G VY G L + IA+K + + +Q E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 407 EGDEKILVYEFVPNKSLDYFL----------------YDSQL----------RIIHRDLK 440
E + E VP SL L Y Q+ +I+HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 441 ASNILLDVQM-NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ--FSVKSD 497
N+L++ KISDFG ++ T GT YM+PE G + +D
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 498 VYSFGVLALETITGK 512
++S G +E TGK
Sbjct: 208 IWSLGCTIIEMATGK 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 65/299 (21%), Positives = 106/299 (35%), Gaps = 96/299 (32%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHG------QEIAVKRL-SRSSGQGAQEFKNEVV 388
E LG G FG+V K H +AVK L +S ++ +E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------- 427
++ ++ H ++++L G C + +L+ E+ SL FL
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 428 --------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461
Y ++++++HRDL A NIL+ KISDFGL+R
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 462 -IFGVDQTQGNTS-----RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKN 514
++ D + + +M+ E ++ +SDV+SFGVL E +T G
Sbjct: 199 DVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG-- 250
Query: 515 SSFYQTDGAEDLLSY--------------------------EDPADRPSMATIVLALNS 547
+ Y E L + ++P RP A I L
Sbjct: 251 -NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 40/218 (18%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLV 390
+ I V +S ++G GG +V++ + Q A+K ++ Q ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 391 AKLQHRNL--VRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------YDSQL--- 432
KLQ + +RL + + +V E N L+ +L Y +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 433 -------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
I+H DLK +N L+ K+ DFG+A D T VG YM PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 486 -----------YAMHGQFSVKSDVYSFGVLALETITGK 512
+ S KSDV+S G + GK
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 54/226 (23%), Positives = 84/226 (37%), Gaps = 33/226 (14%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS 373
E + + E L+ + + ++GRG FGEV++ G + AVK++
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92
Query: 374 RSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------ 427
+ E+V A L +V L G EG + E + SL +
Sbjct: 93 LEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL 147
Query: 428 -------YDSQL----------RIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQ 469
Y Q RI+H D+KA N+LL + + DFG A D
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 470 GNTSR---IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
+ I GT +M+PE M K D++S + L + G
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 33/205 (16%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEI--AVKRL-SRSSGQGAQEFKNEVVLV 390
E+ + +G G FG+V++G+ P + A+K + +S ++F E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------- 427
+ H ++V+L+G E + ++ E L FL
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 428 -YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGYMSPE 485
Y R +HRD+ A N+L+ K+ DFGL+R + + + ++ +M+PE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 562
Query: 486 YAMHGQFSVKSDVYSFGVLALETIT 510
+F+ SDV+ FGV E +
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 87/291 (29%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRL-SRSSGQGAQEFKNE 386
E+ ++ LG G FG+V ++AVK L S ++ + + +E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------ 427
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR-IFGV 465
Y + + IHRDL A N+L+ KI+DFGLAR I +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 466 DQTQGNTS-----RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-------GKK 513
D + T+ + +M+PE ++ +SDV+SFGVL E T G
Sbjct: 245 DYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298
Query: 514 NSSFYQT----------DGAEDLLSYE--------DPADRPSMATIVLALN 546
++ + L Y P+ RP+ +V L+
Sbjct: 299 VEELFKLLKEGHRMDKPSNCTNEL-YMMMRDCWHAVPSQRPTFKQLVEDLD 348
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 67/302 (22%), Positives = 109/302 (36%), Gaps = 89/302 (29%)
Query: 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRL-SRSSGQ 378
E L +D E ++ LGRG FG+V + + +AVK L ++
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 379 GAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILV-YEFVPNKSLDYFL--------- 427
+ +E+ ++ + H N+V LLG C + ++V EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 428 ------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDF 457
+ + + IHRDL A NILL + KI DF
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 458 GLAR-IFGVDQTQGNTSRIVGTYG-----YMSPEYAMHGQFSVKSDVYSFGVLALETIT- 510
GLAR I+ + +M+PE ++++SDV+SFGVL E +
Sbjct: 193 GLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 511 GKKNSSFYQTDGAEDLLSY--------------------------EDPADRPSMATIVLA 544
G S + E+ +P+ RP+ + +V
Sbjct: 247 GA--SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 545 LN 546
L
Sbjct: 305 LG 306
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 66/299 (22%), Positives = 96/299 (32%), Gaps = 104/299 (34%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQE------IAVKRLSRSSGQGA-QEFKNEVV 388
E N+ S LG G FG+V + + +AVK L S+ + +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 389 LVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------- 427
+++ L H N+V LLG C G +++ E+ L FL
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466
+ + IHRDL A NILL KI DFGLAR
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD---- 194
Query: 467 QTQGNTSRIVGTYGY------------MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKK 513
I Y M+PE + ++ +SDV+S+G+ E + G
Sbjct: 195 --------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS- 245
Query: 514 NSSFYQT-DGAEDLLSY--------------------------EDPADRPSMATIVLAL 545
S Y DP RP+ IV +
Sbjct: 246 --SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 68/294 (23%), Positives = 101/294 (34%), Gaps = 96/294 (32%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQE------IAVKRL-SRSSGQGAQEFKNEVV 388
E N LG G FG+V + + +AVK L S + + +E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 389 LVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------- 427
+++ L QH N+V LLG C G +++ E+ L FL
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 428 -----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470
+ + IHRD+ A N+LL KI DFGLAR
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-------- 213
Query: 471 NTSRIVGTYGY------------MSPEYAMHGQFSVKSDVYSFGVLALETIT-------- 510
I+ Y M+PE ++V+SDV+S+G+L E +
Sbjct: 214 ----IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 511 GKKNSSFYQT----------DGAEDLLSYE--------DPADRPSMATIVLALN 546
NS FY+ A + Y +P RP+ I L
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNI-YSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 65/253 (25%), Positives = 92/253 (36%), Gaps = 60/253 (23%)
Query: 341 KFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQE---FKNEVVLVAKL-QH 395
F ++LG G +GEV+K G+ AVKR S S +G ++ EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------YDSQL--------- 432
VRL EG L E SL Y
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 433 -RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
++H D+K +NI L + K+ DFGL G T G G YM+PE + G
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE-LLQGS 231
Query: 492 FSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL------------LSYE--------- 530
+ +DV+S G+ LE + + +G + L LS E
Sbjct: 232 YGTAADVFSLGLTILEVACNME--LPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMML 289
Query: 531 --DPADRPSMATI 541
DP R + +
Sbjct: 290 EPDPKLRATAEAL 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 65/276 (23%), Positives = 101/276 (36%), Gaps = 77/276 (27%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRN 397
F LGRGGFG V++ A+KR+ + + A ++ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 398 LVRLLGFCLEGDE---------KILVY---EFVPNKSL-------------------DYF 426
+VR LE + K+ +Y + ++L F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 427 LYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT---- 472
L Q+ ++HRDLK SNI + K+ DFGL D+ +
Sbjct: 125 L---QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 473 ------SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALE-------------TITGKK 513
+ VGT YMSPE +S K D++S G++ E T+T +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVR 241
Query: 514 NSSF-----YQTDGAEDLLSY---EDPADRPSMATI 541
N F + ++ P +RP I
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 62/340 (18%), Positives = 106/340 (31%), Gaps = 108/340 (31%)
Query: 303 RRRAEKKYNAVLEQNADNDITTLESLQFDFKTI-EVATNKFSSDNKLGRGGFGEVYKGVL 361
R + + ++DN+ ++ ++++ E LG G FG+V
Sbjct: 7 FRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATA 66
Query: 362 PHGQE------IAVKRL-SRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413
+ +AVK L ++ + +E+ ++ +L H N+V LLG C L
Sbjct: 67 YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126
Query: 414 VYEFVPNKSLDYFL---------------------------------------------- 427
++E+ L +L
Sbjct: 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186
Query: 428 YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY------ 481
+ +HRDL A N+L+ KI DFGLAR I+ Y
Sbjct: 187 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD------------IMSDSNYVVRGNA 234
Query: 482 ------MSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY----- 529
M+PE G +++KSDV+S+G+L E + G + + +
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPYPGIPVDANFYKLIQNGF 292
Query: 530 ---------------------EDPADRPSMATIVLALNSH 548
D RPS + L
Sbjct: 293 KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 53/245 (21%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQHRNLVRLLG 403
LG+GGF + ++ + A K + +S ++ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 404 FCLEGDEKI-LVYEFVPNKSL----------------DYF-------LYDSQLRIIHRDL 439
E ++ + +V E +SL Y Y + R+IHRDL
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
K N+ L+ + KI DFGLA D + + GT Y++PE S + DV+
Sbjct: 142 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVW 199
Query: 500 SFGVLALETITGK---------------KNSSF----YQTDGAEDLLS---YEDPADRPS 537
S G + + GK K + + + A L+ DP RP+
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 259
Query: 538 MATIV 542
+ ++
Sbjct: 260 INELL 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 32/195 (16%)
Query: 347 KLGRGGFGEVYKG---VLPHGQEIAVK--RLSRSSGQGAQE-FKNEVVLVAKLQHRNLVR 400
KLG GG VY +L ++A+K + + + F+ EV ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFLYDS-----------------------QLRIIHR 437
++ E D LV E++ +L ++ +RI+HR
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHR 135
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
D+K NIL+D KI DFG+A+ + + T+ ++GT Y SPE A +D
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 498 VYSFGVLALETITGK 512
+YS G++ E + G+
Sbjct: 195 IYSIGIVLYEMLVGE 209
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 52/276 (18%), Positives = 87/276 (31%), Gaps = 67/276 (24%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVA 391
+ + + KLG GGF V L G A+KR+ Q +E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 392 KLQHRNLVRLLGFCLE----GDEKILVYEFVPNKSLDYFL-----------------YDS 430
H N++RL+ +CL E L+ F +L +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 431 QL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV---- 476
+ HRDLK +NILL + P + D G + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 477 ---GTYGYMSPE---YAMHGQFSVKSDVYSFGVL----------------ALETITGKKN 514
T Y +PE H ++DV+S G + +++
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 515 SSFYQ------TDGAEDLLSY---EDPADRPSMATI 541
+ + LL+ DP RP + +
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 53/245 (21%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQHRNLVRLLG 403
LG+GGF + ++ + A K + +S ++ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 404 FCLEGDEKI-LVYEFVPNKSL----------------DYF-------LYDSQLRIIHRDL 439
E ++ + +V E +SL Y Y + R+IHRDL
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
K N+ L+ + KI DFGLA D + + GT Y++PE S + DV+
Sbjct: 168 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVW 225
Query: 500 SFGVLALETITGK---------------KNSSF----YQTDGAEDLLS---YEDPADRPS 537
S G + + GK K + + + A L+ DP RP+
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 285
Query: 538 MATIV 542
+ ++
Sbjct: 286 INELL 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 56/246 (22%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRS----SGQGAQEFKNEVVLVAKLQHRNLVRLL 402
LG+G F VY+ + G E+A+K + + +G + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 403 GFCLEGDEKI-LVYEFVPNKSLDYFL--------------YDSQL----------RIIHR 437
E + LV E N ++ +L + Q+ I+HR
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
DL SN+LL MN KI+DFGLA + + T + GT Y+SPE A ++SD
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESD 194
Query: 498 VYSFGVLALETITGK---------------KNSSF----YQTDGAEDLLS---YEDPADR 535
V+S G + + G+ + + + + A+DL+ +PADR
Sbjct: 195 VWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADR 254
Query: 536 PSMATI 541
S++++
Sbjct: 255 LSLSSV 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 60/263 (22%), Positives = 94/263 (35%), Gaps = 64/263 (24%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHR 396
+ +G G +G K G+ + K + Q +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 397 NLVRLLGFCLEGDEKIL--VYEFVPNKSLDYFL-----------------YDSQL----- 432
N+VR ++ L V E+ L + +QL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 433 ----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
++HRDLK +N+ LD + N K+ DFGLARI D + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETITGK-----KN----------------SSFYQTD 521
SPE ++ KSD++S G L E + Y +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 522 GAEDLLS---YEDPADRPSMATI 541
++++ RPS+ I
Sbjct: 244 -LNEIITRMLNLKDYHRPSVEEI 265
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 58/280 (20%), Positives = 98/280 (35%), Gaps = 66/280 (23%)
Query: 323 TTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQE 382
+ + + V F + LG G G + + +++AVKR+ A
Sbjct: 7 LEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD- 65
Query: 383 FKNEVVLVAKL-QHRNLVRLLGFCLEGDEKI--LVYEFVP--------NKSLDYFLYDS- 430
EV L+ + +H N++R FC E D + + E K + +
Sbjct: 66 --REVQLLRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121
Query: 431 --------------QLRIIHRDLKASNILL-----DVQMNPKISDFGLARIFGVDQ-TQG 470
L I+HRDLK NIL+ ++ ISDFGL + V + +
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 471 NTSRIVGTYGYMSPEY---AMHGQFSVKSDVYSFGVLALETITG---------------- 511
S + GT G+++PE + D++S G + I+
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241
Query: 512 KKNSSF-------YQTDGAEDLLS---YEDPADRPSMATI 541
S ++ A +L+ DP RPS +
Sbjct: 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 9e-29
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 45/218 (20%)
Query: 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQ 394
+ + + + LG+G V++G G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 395 HRNLVRLLGF--CLEGDEKILVYEFVPNKSLDYFLYD----------------SQL---- 432
H+N+V+L K+L+ EF P SL L + +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 433 ------RIIHRDLKASNILL----DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
I+HR++K NI+ D Q K++DFG AR D Q + + GT Y+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 483 SPE--------YAMHGQFSVKSDVYSFGVLALETITGK 512
P+ ++ D++S GV TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 43/193 (22%), Positives = 72/193 (37%), Gaps = 28/193 (14%)
Query: 347 KLGRGGFGEVYKGVLPH-GQEIAVKRLSR--SSGQGAQE-FKNEVVLVAKLQHRNLVRLL 402
+GRGG G+VY+ + +A+K +S SS + + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 403 GFCLEGDEKILVYEFVPNKSLDYFLYDS-----------------------QLRIIHRDL 439
F + + + L L HRD+
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDV 160
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
K NIL+ + DFG+A D+ VGT YM+PE + ++D+Y
Sbjct: 161 KPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 500 SFGVLALETITGK 512
+ + E +TG
Sbjct: 220 ALTCVLYECLTGS 232
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 53/197 (26%), Positives = 103/197 (52%), Gaps = 25/197 (12%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
K++ K+G+G G VY + + GQE+A+++++ + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQL----------------------RII 435
+V L L GDE +V E++ SL + ++ + ++I
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K+ NILL + + K++DFG +Q++ +T +VGT +M+PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196
Query: 496 SDVYSFGVLALETITGK 512
D++S G++A+E I G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 39/196 (19%)
Query: 347 KLGRGGFGEVYKG---VLPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNLVRLL 402
+ GG G +Y + +G+ + +K L S AQ E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 403 GFCLEGDEKI-----LVYEFVPNKSLDYFL-----------YDSQL----------RIIH 436
F D +V E+V +SL Y ++ +++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVY 205
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKS 496
DLK NI+L + K+ D G + + GT G+ +PE G +V +
Sbjct: 206 NDLKPENIMLT-EEQLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRTGP-TVAT 257
Query: 497 DVYSFGVLALETITGK 512
D+Y+ G
Sbjct: 258 DIYTVGRTLAALTLDL 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 45/218 (20%)
Query: 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQ 394
+ + + + LG+G V++G G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 395 HRNLVRLLGF--CLEGDEKILVYEFVPNKSLDYFLYD----------------SQL---- 432
H+N+V+L K+L+ EF P SL L + +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 433 ------RIIHRDLKASNILL----DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
I+HR++K NI+ D Q K++DFG AR D Q + + GT Y+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 483 SPE--------YAMHGQFSVKSDVYSFGVLALETITGK 512
P+ ++ D++S GV TG
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 65/253 (25%), Positives = 105/253 (41%), Gaps = 57/253 (22%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRS----SGQGAQEFKNEVVLVAKLQ 394
F LG+G FG VY +A+K L ++ +G Q + EV + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 395 HRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------YDSQL-------- 432
H N++RL G+ ++ L+ E+ P ++ L Y ++L
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 433 --RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
R+IHRD+K N+LL KI+DFG + ++ + GT Y+ PE
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPEMIEGR 182
Query: 491 QFSVKSDVYSFGVLALETITGK---------------KNSSF----YQTDGAEDLLS--- 528
K D++S GVL E + GK F + T+GA DL+S
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 529 YEDPADRPSMATI 541
+P+ RP + +
Sbjct: 243 KHNPSQRPMLREV 255
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
S K+G G G V G+++AVK + Q + NEVV++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQL----------------------RII 435
+V + L G+E ++ EF+ +L + +L +I
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRD+K+ +ILL + K+SDFG D + + +VGT +M+PE ++ +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATE 221
Query: 496 SDVYSFGVLALETITGK 512
D++S G++ +E + G+
Sbjct: 222 VDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 334 TIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFK---NEV-V 388
++EV + +LGRG +G V K +P GQ +AVKR+ + QE K ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58
Query: 389 LVAKLQHRNLVRLLG-FCLEGDEKIL----------VYEFVPNKS--------------- 422
+ + V G EGD I Y+ V +K
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 423 ---LDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY 479
L++ L+ S+L +IHRD+K SN+L++ K+ DFG++ VD + G
Sbjct: 119 VKALEH-LH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCK 173
Query: 480 GYMSPE----YAMHGQFSVKSDVYSFGVLALETITGK 512
YM+PE +SVKSD++S G+ +E +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 345 DNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNLVRLL 402
+LG GGFG V + + G+++A+K+ + +E + E+ ++ KL H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 403 ------GFCLEGDEKILVYEFVPNKSLDYFLYD----------------SQL-------- 432
D +L E+ L +L S +
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 433 --RIIHRDLKASNILLDV---QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
RIIHRDLK NI+L ++ KI D G A+ VGT Y++PE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGTLQYLAPELL 195
Query: 488 MHGQFSVKSDVYSFGVLALETITGK 512
+++V D +SFG LA E ITG
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEF- 383
L K E+ + F ++LG G G V+K P G +A K + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78
Query: 384 KNEVVLVAKLQHRNLVRLLG-FCLEGDEKILVYEFVPNKSLDYFLYD------------- 429
E+ ++ + +V G F +G+ I E + SLD L
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKAGRIPEQILGKVS 137
Query: 430 -----------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478
+ +I+HRD+K SNIL++ + K+ DFG++ + N+ VGT
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS--FVGT 193
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
YMSPE +SV+SD++S G+ +E G+
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 36/200 (18%)
Query: 347 KLGRGGFGEVYKG---VLPHGQEIAVK--RLSRSSGQGAQE-FKNEVVLVAKLQHRNLVR 400
LG GG EV+ +++AVK R + F+ E A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 401 LL--GFCLEGDEKI--LVYEFVPNKSLDYFLYDS-----------------------QLR 433
+ G + +V E+V +L ++ Q
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLAR-IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
IIHRD+K +NI++ K+ DFG+AR I + T+ ++GT Y+SPE A
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 493 SVKSDVYSFGVLALETITGK 512
+SDVYS G + E +TG+
Sbjct: 197 DARSDVYSLGCVLYEVLTGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 26/195 (13%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAKLQHRNLV 399
F+ K+G+G FGEV+KG+ + +A+K + + ++ + E+ ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 400 RLLGFCLEGDEKILVYEF---------VPNKSLD-----YFLYDS--------QLRIIHR 437
+ G L+ + ++ E+ + LD L + + IHR
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSD 497
D+KA+N+LL K++DFG+A Q + NT VGT +M+PE + K+D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKAD 201
Query: 498 VYSFGVLALETITGK 512
++S G+ A+E G+
Sbjct: 202 IWSLGITAIELARGE 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 52/275 (18%), Positives = 90/275 (32%), Gaps = 79/275 (28%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKR--LSRSSGQGAQEFKNEVVLVAKL-Q 394
T +F K+G G FG V+K V G A+KR + Q EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------YDSQL----- 432
H ++VR E D ++ E+ SL + Q+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 433 -----RIIHRDLKASNILLD-------------------VQMNPKISDFGLARIFGVDQT 468
++H D+K SNI + ++ KI D G Q
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 469 QGNTSRIVGTYGYMSPEYAMHGQFS--VKSDVYSFGVLALETITGK---KNSSFYQ---- 519
+ G +++ E + ++ K+D+++ + + + +N +
Sbjct: 190 E------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
Query: 520 ----------TDGAEDLLS---YEDPADRPSMATI 541
+ +LL + DP RPS +
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 57/245 (23%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRS----SGQGAQEFKNEVVLVAKLQHRNLVRLL 402
LG+G FG VY + +A+K L +S G Q + E+ + + L+H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 403 GFCLEGDEKI-LVYEFVPNKSLDYFL-------------YDSQL----------RIIHRD 438
+ ++I L+ EF P L L + +L ++IHRD
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
+K N+L+ + KI+DFG + + T GT Y+ PE K D+
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVH--APSLRRRTM--CGTLDYLPPEMIEGKTHDEKVDL 195
Query: 499 YSFGVLALETITGK-----KNSS--------------FYQTDGAEDLLS---YEDPADRP 536
+ GVL E + G + + + +DG++DL+S P R
Sbjct: 196 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRL 255
Query: 537 SMATI 541
+ +
Sbjct: 256 PLKGV 260
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 46/235 (19%), Positives = 84/235 (35%), Gaps = 39/235 (16%)
Query: 304 RRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSS----DNKLGRGGFGEVYKG 359
+ KY+ + D + ++ + +EV +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWK-KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70
Query: 360 VLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416
V G+ K ++ KNE+ ++ +L H L+ L + E +L+ E
Sbjct: 71 V--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128
Query: 417 FVP---------NKSLDYFLYDS---------------QLRIIHRDLKASNILLDVQMNP 452
F+ + + + I+H D+K NI+ + +
Sbjct: 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 188
Query: 453 --KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
KI DFGLA D+ T + +PE +D+++ GVL
Sbjct: 189 SVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 46/219 (21%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFK---NEV- 387
+ + ++GRG +G V K V P GQ +AVKR+ + + +E K ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLD 72
Query: 388 VLVAKLQHRNLVRLLG---------FCLE----GDEKIL--VYEFVPN------------ 420
V++ +V+ G C+E +K VY + +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 421 ---KSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
K+L++ L L+IIHRD+K SNILLD N K+ DFG++ + G
Sbjct: 133 ATVKALNH-LK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AG 187
Query: 478 TYGYMSPE----YAMHGQFSVKSDVYSFGVLALETITGK 512
YM+PE A + V+SDV+S G+ E TG+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 27/225 (12%), Positives = 61/225 (27%), Gaps = 45/225 (20%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV------LPHGQEIAVKRLSRSSGQGAQEFKNE 386
++ + + LG G F +VY+ + Q+ +K ++
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 387 VVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL------------------DYFLY 428
+ + ++ L + +LV E +L +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 429 DSQL----------RIIHRDLKASNILLDVQMNP-----------KISDFGLARIFGVDQ 467
++ IIH D+K N +L + D G + +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
+ T G+ E + ++ + D + + G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 70/280 (25%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVA 391
+T+E+ + L GGF VY+ + G+E A+KRL + + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 392 KLQ-HRNLVRLLGFCLEGDEK--------ILVYEFVPNKSLDYF---------------- 426
KL H N+V+ G E+ +L+ E + +++
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 427 -----------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475
++ + IIHRDLK N+LL Q K+ DFG A +++
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 476 ----------VGTYGYMSPE-YAMHGQFSV--KSDVYSFGVLALETITGK---------- 512
T Y +PE ++ F + K D+++ G + +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 513 -KNSSF------YQTDGAEDLLSY---EDPADRPSMATIV 542
N + Q L+ +P +R S+A +V
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 32/204 (15%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
+ +LG G FG+VYK G A K + S + +++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLD----------------YFLYDS--------QLR 433
+V+LLG + ++ EF P ++D R
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
IIHRDLKA N+L+ ++ + +++DFG++ + ++ +GT +M+PE M
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 195
Query: 494 -----VKSDVYSFGVLALETITGK 512
K+D++S G+ +E +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIE 219
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 328 LQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN- 385
L + + N + ++G G G+V+K G IAVK++ RS + +E K
Sbjct: 13 LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRI 70
Query: 386 --EV-VLVAKLQHRNLVRLLG-FCLEGD------------------------EKIL---V 414
++ V++ +V+ G F D E+IL
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMT 130
Query: 415 YEFVPNKSLDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474
V K+L Y L + +IHRD+K SNILLD + K+ DFG++ VD + S
Sbjct: 131 VAIV--KALYY-LK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRS- 184
Query: 475 IVGTYGYMSPE-----YAMHGQFSVKSDVYSFGVLALETITGK 512
G YM+PE + +++DV+S G+ +E TG+
Sbjct: 185 -AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 29/199 (14%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
F KLG G +G VYK + GQ +A+K++ QE E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 398 LVRLLGFCLEGDEKILVYEF-----------VPNKSLD-----YFLYDS--------QLR 433
+V+ G + + +V E+ + NK+L L + +R
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
IHRD+KA NILL+ + + K++DFG+A + NT ++GT +M+PE ++
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYN 203
Query: 494 VKSDVYSFGVLALETITGK 512
+D++S G+ A+E GK
Sbjct: 204 CVADIWSLGITAIEMAEGK 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 35/207 (16%)
Query: 327 SLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEF 383
S + + +++ LG+G FGEV K QE AVK ++++ +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 384 KNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSL-DYFL-------------- 427
EV L+ KL H N+++L E +V E L D +
Sbjct: 69 LREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 428 --------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIV 476
Y + I+HRDLK NILL + + KI DFGL+ F + +
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI 184
Query: 477 GTYGYMSPEYAMHGQFSVKSDVYSFGV 503
GT Y++PE + G + K DV+S GV
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 53/204 (25%), Positives = 82/204 (40%), Gaps = 35/204 (17%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQH 395
+ + KLG G +GEV E A+K + ++ S + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSL-------DYF----------------LYDSQ 431
N+++L F E LV E L F Y +
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 432 LRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
I+HRDLK N+LL + KI DFGL+ +F + +GT Y++PE +
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VL 210
Query: 489 HGQFSVKSDVYSFGVLALETITGK 512
++ K DV+S GV+ + G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGY 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 31/192 (16%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
++ +N +GRG +GEV V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSL-DYFL----------------------YDSQLRI 434
++RL + + LV E L + + Y +L +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 435 IHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
HRDLK N L K+ DFGLA F + VGT Y+SP+ + G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEGL 183
Query: 492 FSVKSDVYSFGV 503
+ + D +S GV
Sbjct: 184 YGPECDEWSAGV 195
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 65/248 (26%), Positives = 108/248 (43%), Gaps = 51/248 (20%)
Query: 304 RRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH 363
+ N V D+ ++ L D KT E +++ +G G FG V++ L
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 364 GQEIAVKRLSRSSGQGAQEFKN-EVVLVAKLQHRNLVRLLGFCLEGDEKI------LVYE 416
E+A+K++ + + FKN E+ ++ ++H N+V L F +K LV E
Sbjct: 64 SDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 417 FVP-------------NKSLD-----YFLYDSQL----------RIIHRDLKASNILLDV 448
+VP +++ ++Y QL I HRD+K N+LLD
Sbjct: 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMY--QLLRSLAYIHSIGICHRDIKPQNLLLDP 176
Query: 449 QMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFG-VL 504
K+ DFG A+I + N S I Y Y +PE + G ++ D++S G V+
Sbjct: 177 PSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVM 232
Query: 505 ALETITGK 512
A E + G+
Sbjct: 233 A-ELMQGQ 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQE--FKNEVVLVAKL 393
+++ LG+G FGEV K QE AVK ++++S + EV L+ KL
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFVPNKSL-DYFL----------------------YDS 430
H N+++L + +V E L D + Y
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 431 QLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
+ I+HRDLK NILL + + KI DFGL+ F + +GT Y++PE
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-V 194
Query: 488 MHGQFSVKSDVYSFGV 503
+ G + K DV+S GV
Sbjct: 195 LRGTYDEKCDVWSAGV 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 48/198 (24%), Positives = 77/198 (38%), Gaps = 38/198 (19%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHR 396
+ F KLG G FG+V+ G E +K +++ Q E + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 397 NLVRLLGFCLEGDEKI-LVYEFVPNKSL-DYFLYDS------------------------ 430
N++++ E + +V E L + +
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 431 --QLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
++H+DLK NIL KI DFGLA +F D+ + GT YM+PE
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPE 196
Query: 486 YAMHGQFSVKSDVYSFGV 503
+ K D++S GV
Sbjct: 197 -VFKRDVTFKCDIWSAGV 213
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 46/253 (18%), Positives = 92/253 (36%), Gaps = 66/253 (26%)
Query: 316 QNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSR 374
++ ++ + L L K + N + L +G F ++ + A+K+ +
Sbjct: 7 KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEK 64
Query: 375 SSGQGAQEF-----------------KNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYE 416
S + ++F KNE+ ++ +++ + G + +++ ++YE
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYE 123
Query: 417 FVPNKSL-DYFLYD-------------------------------SQLRIIHRDLKASNI 444
++ N S+ + Y ++ I HRD+K SNI
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183
Query: 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE-----YAMHGQFSVKSDVY 499
L+D K+SDFG + GTY +M PE + +G K D++
Sbjct: 184 LMDKNGRVKLSDFGESEYM----VDKKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIW 236
Query: 500 SFGVLALETITGK 512
S G+
Sbjct: 237 SLGICLYVMFYNV 249
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 34/196 (17%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQ 394
++++ LG+G FGEV GQE AVK +S+ + + EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYF----------------LYDSQ 431
H N+++L F + LV E L F Y +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 432 LRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
+I+HRDLK N+LL N +I DFGL+ F + +GT Y++PE +
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VL 200
Query: 489 HGQFSVKSDVYSFGVL 504
HG + K DV+S GV+
Sbjct: 201 HGTYDEKCDVWSTGVI 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 57/284 (20%), Positives = 90/284 (31%), Gaps = 87/284 (30%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEV-VLVAKLQHRNL 398
N S+ LG G G V G+ +AVKR+ A E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71
Query: 399 VRLLGFCLEGDEK----------------ILVYEFVPNKSLDYFLYDS------------ 430
+R +C E ++ + Y+
Sbjct: 72 IRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 431 ---QLRIIHRDLKASNILLDVQMNP-------------KISDFGLARIFGVDQT--QGNT 472
L+IIHRDLK NIL+ ISDFGL + Q+ + N
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 473 SRIVGTYGYMSPE-------YAMHGQFSVKSDVYSFGVLALETITG-------------- 511
+ GT G+ +PE + + D++S G + ++
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 512 --KKNSSFYQ---------TDGAEDLLS---YEDPADRPSMATI 541
+ S + A DL+S DP RP+ +
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 40/211 (18%)
Query: 330 FDFKTIEVATNKFSSD------NKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGA 380
FD + + +S LG G FG+V+K G ++A K + +
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE--ETATGLKLAAKIIKTRGMKDK 130
Query: 381 QEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVP---------NKSLDY------ 425
+E KNE+ ++ +L H NL++L ++ +LV E+V ++S +
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 426 -FL--------YDSQLRIIHRDLKASNILLDVQMNP--KISDFGLARIFGVDQTQGNTSR 474
F+ + Q+ I+H DLK NIL + KI DFGLAR + +
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KV 247
Query: 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
GT +++PE + S +D++S GV+A
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 47/236 (19%), Positives = 88/236 (37%), Gaps = 39/236 (16%)
Query: 303 RRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSS----DNKLGRGGFGEVYK 358
+ + + N DN + + Q+ + +E+ + +LG G FG V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWK-QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175
Query: 359 GVLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415
G A K + + + E+ ++ L+H LV L + +E +++Y
Sbjct: 176 VT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233
Query: 416 EFVPNKSL-DYFLYDS-----------------------QLRIIHRDLKASNILLDVQMN 451
EF+ L + + + +H DLK NI+ + +
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 293
Query: 452 P--KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
K+ DFGL Q + GT + +PE A +D++S GVL+
Sbjct: 294 NELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 42/196 (21%)
Query: 347 KLGRGGFGEVYKGVLPH---GQEIAVK-----RLSRSSGQGAQEFKNEVVLVAKLQHRNL 398
+G+G F V + + + GQ+ AVK + + S G ++ K E + L+H ++
Sbjct: 31 VIGKGPFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 399 VRLLGFCLEGDEKILVYEFVP---------NKSLDYFLY---DS---------------Q 431
V LL +V+EF+ ++ F+Y +
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 432 LRIIHRDLKASNILLDVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
IIHRD+K +LL + N K+ FG+A G VGT +M+PE
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVK 206
Query: 489 HGQFSVKSDVYSFGVL 504
+ DV+ GV+
Sbjct: 207 REPYGKPVDVWGCGVI 222
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 36/204 (17%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS---RSSGQGAQEFKNEVVLVAKLQ 394
FS ++G G FG VY + + + +A+K++S + S + Q+ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 395 HRNLVRLLGFCLEGDEKILVYEF----------VPNKSLD-----YFLYDS--------Q 431
H N ++ G L LV E+ V K L + +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-- 489
+IHRD+KA NILL K+ DFG A I N+ VGT +M+PE +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVGTPYWMAPEVILAMD 226
Query: 490 -GQFSVKSDVYSFGVLALETITGK 512
GQ+ K DV+S G+ +E K
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERK 250
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 43/215 (20%), Positives = 71/215 (33%), Gaps = 45/215 (20%)
Query: 339 TNKFSSDNKLGRG--GFGEVYKGV-LPHGQEIAVKR--LSRSSGQGAQEFKNEVVLVAKL 393
+ +G+G V P G+ + V+R L S + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFVPNKS----------------------------LDY 425
H N+V + +E +V F+ S LDY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 426 FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-----SRIVGTYG 480
+ +HR +KAS+IL+ V +S + V
Sbjct: 144 I---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 481 YMSPE---YAMHGQFSVKSDVYSFGVLALETITGK 512
++SPE + G + KSD+YS G+ A E G
Sbjct: 201 WLSPEVLQQNLQG-YDAKSDIYSVGITACELANGH 234
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 40/196 (20%), Positives = 71/196 (36%), Gaps = 35/196 (17%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
K+ LGRG FG V++ V + K + G K E+ ++ +H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCV--ETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARH 60
Query: 396 RNLVRLLGFCLEGDEKILVYEFVP---------NKSLDYFLYDS---------------Q 431
RN++ L +E ++++EF+ + + +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 432 LRIIHRDLKASNILLDVQMNP--KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
I H D++ NI+ + + KI +FG AR + Y +PE H
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 490 GQFSVKSDVYSFGVLA 505
S +D++S G L
Sbjct: 178 DVVSTATDMWSLGTLV 193
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS-RSSGQGAQEFKNEVVLVAKLQHRN 397
+ + +G G V P +++A+KR++ E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 398 LVRLLGFCLEGDEKILVYEF------------------VPNKSLD-----YFLYDS---- 430
+V + DE LV + + LD L +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 431 ----QLRIIHRDLKASNILLDVQMNPKISDFGL-ARIFGVDQTQGNTSR--IVGTYGYMS 483
+ IHRD+KA NILL + +I+DFG+ A + N R VGT +M+
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 484 PEYAMHGQ-FSVKSDVYSFGVLALETITGK 512
PE + + K+D++SFG+ A+E TG
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 56/208 (26%), Positives = 83/208 (39%), Gaps = 46/208 (22%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA-------------QEFK 384
+ KLG G +GEV E A+K + +S +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 385 NEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSL-------DYF---------- 426
NE+ L+ L H N+++L E + LV EF L F
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 427 ------LYDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
Y + I+HRD+K NILL + +N KI DFGL+ F D +G
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLG 210
Query: 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
T Y++PE + +++ K DV+S GV+
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRS------SGQGAQE 382
FK +V + + +LG G F V K G E A K + + G +E
Sbjct: 5 FKQQKV-EDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 383 FKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYF--------- 426
+ EV ++ ++ H N++ L + +L+ E V L +
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 427 -------LYDSQLRIIHRDLKASNILLDVQMNP----KISDFGLARIFGVDQTQGNTSRI 475
Y +I H DLK NI+L + P K+ DFGLA I
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
GT +++PE + +++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSS------GQGAQE 382
FK +V + + +LG G F V K G E A K + + G +E
Sbjct: 5 FKQQKV-EDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 383 FKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYF--------- 426
+ EV ++ ++ H N++ L + +L+ E V L +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 427 -------LYDSQLRIIHRDLKASNILLDVQMNP----KISDFGLARIFGVDQTQGNTSRI 475
Y +I H DLK NI+L + P K+ DFGLA I
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
GT +++PE + +++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 68/251 (27%)
Query: 348 LGRGGFGEVYKGVLPH---GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+G+G F +V H G+E+A+K + ++ + Q+ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLAR--HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 403 GFCLEGDEKI-LVYEFVPNKSL-DYFL----------------------YDSQLRIIHRD 438
+E ++ + L+ E+ + DY + Y Q RI+HRD
Sbjct: 81 E-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE------YAMHGQF 492
LKA N+LLD MN KI+DFG + F V + G Y +PE Y
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAF--CGAPPYAAPELFQGKKYD----- 191
Query: 493 SVKSDVYSFGVL--AL---------ETI--------TGKKNSSFYQTDGAEDLLSY---E 530
+ DV+S GV+ L + + GK FY + E+LL
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 531 DPADRPSMATI 541
+P R ++ I
Sbjct: 252 NPIKRGTLEQI 262
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 36/196 (18%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKL 393
++ + +LG+G F V + V H G E A K ++ S + Q+ + E + KL
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFVPNKSL-DYFL----------------------YDS 430
QH N+VRL E LV++ V L + + Y
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 431 QLRIIHRDLKASNILLDVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
I+HR+LK N+LL + K++DFGLA + GT GY+SPE
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVL 179
Query: 488 MHGQFSVKSDVYSFGV 503
+S D+++ GV
Sbjct: 180 KKDPYSKPVDIWACGV 195
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 57/246 (23%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN------EVVLVAKLQHR--NL 398
LG GGFG VY G+ + +A+K + + E N EVVL+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 399 VRLLGFCLEGDEKI-LVYEFV-PNKSL-DY-----FLYDSQLR----------------- 433
+RLL + E + L+ E P + L D+ L + R
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 434 IIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
++HRD+K NIL+D+ + K+ DFG + + GT Y PE+ + ++
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRY 225
Query: 493 S-VKSDVYSFGVL--AL-----------ETITGKKNSSFYQTDGAEDLLSY---EDPADR 535
+ V+S G+L + E I G+ + + L+ + P+DR
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 285
Query: 536 PSMATI 541
P+ I
Sbjct: 286 PTFEEI 291
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 49/192 (25%), Positives = 75/192 (39%), Gaps = 31/192 (16%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
F LG G F EV+ G+ A+K + +S +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 398 LVRLLGFCLEGDEKILVYEFVP-----------------------NKSLDYFLYDSQLRI 434
+V L LV + V + L Y + I
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 435 IHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
+HRDLK N+L + I+DFGL+++ G S GT GY++PE
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKP 183
Query: 492 FSVKSDVYSFGV 503
+S D +S GV
Sbjct: 184 YSKAVDCWSIGV 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 39/143 (27%), Positives = 53/143 (37%), Gaps = 33/143 (23%)
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS----------RIVGTYG 480
++HRDLK SNI + K+ DFGL D+ + VGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 481 YMSPEYAMHGQFSVKSDVYSFGVLALE-------------TITGKKNSSF------YQTD 521
YMSPE +S K D++S G++ E IT +N F
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQ 301
Query: 522 GAE---DLLSYEDPADRPSMATI 541
D+LS P +RP I
Sbjct: 302 EHMMVQDMLS-PSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 13/130 (10%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVV 388
DF+ I+ +GRGGFG V++ A+KR+ + + A+E EV
Sbjct: 7 DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLRIIHR-DLKASNILLD 447
+AKL+H +VR LE + E D +D
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 448 VQMNPKISDF 457
Sbjct: 117 PFSTKNTVGQ 126
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 41/203 (20%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRS------SGQGAQEFKNEVVL 389
+ + +LG G F V K G+E A K + + G +E + EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYF---------------- 426
+ +++H N++ L + +L+ E V L +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 427 LYDSQLRIIHRDLKASNILLDVQMNP----KISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
Y RI H DLK NI+L + P K+ DFG+A I GT ++
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFV 178
Query: 483 SPEYAMHGQFSVKSDVYSFGVLA 505
+PE + +++D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 20/226 (8%), Positives = 44/226 (19%), Gaps = 66/226 (29%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
L G V+ + ++ A+K + S + A+L +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 404 FC----------LEGDEKI----------------LVYEFV------------------- 418
++ L+
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 419 PNKSLDYFLYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468
L + +QL ++H N+ + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--- 246
Query: 469 QGNTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFGVLALETITGK 512
Y E+ F+ + + G+
Sbjct: 247 --RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 67/259 (25%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--------SGQGAQEFKNEVVLVA 391
K+S+ + LG G FG V+ V +E+ VK + + + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 392 KLQHRNLVRLLGFCLEGDEKI-LVYEF-----------VPNKSLD------YFL------ 427
+++H N++++L E LV E + LD F
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 428 -YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-SRIVGTYGYMSPE 485
Y IIHRD+K NI++ K+ DFG A +G GT Y +PE
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFCGTIEYCAPE 199
Query: 486 ------YAMHGQFSVKSDVYSFGVL--AL-----------ETITGKKNSSFYQTDGAEDL 526
Y G + +++S GV L ET+ + + + L
Sbjct: 200 VLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254
Query: 527 LSY---EDPADRPSMATIV 542
+S P R ++ +V
Sbjct: 255 VSGLLQPVPERRTTLEKLV 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 41/212 (19%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHR 396
F +G G +G+VYKG + GQ A+K + +G +E K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81
Query: 397 NLVRLLG-----FCLEGDEKI-LVYEF------------VPNKSLD-----YFLYDS--- 430
N+ G D+++ LV EF +L Y +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 431 -----QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
Q ++IHRD+K N+LL K+ DFG++ + NT +GT +M+PE
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 199
Query: 486 YAMHGQFS-----VKSDVYSFGVLALETITGK 512
+ KSD++S G+ A+E G
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 36/188 (19%)
Query: 347 KLGRGGFGEVYKGVLPH---GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRL 401
+LG+G F V + V H G E A K ++ S + Q+ + E + KLQH N+VRL
Sbjct: 36 ELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 402 LGFCLEGDEKILVYEFVPNKSL-DYFL----------------------YDSQLRIIHRD 438
E LV++ V L + + Y I+HR+
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 439 LKASNILLDVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
LK N+LL + K++DFGLA + GT GY+SPE +S
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKP 210
Query: 496 SDVYSFGV 503
D+++ GV
Sbjct: 211 VDIWACGV 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 63/250 (25%), Positives = 96/250 (38%), Gaps = 61/250 (24%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 405
LG G +GEV V + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 406 LEGDEKILVYEFVPNKSL-DYFLYDSQLR----------------------IIHRDLKAS 442
EG+ + L E+ L D D + I HRD+K
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 443 NILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE------YAMHGQFSVKS 496
N+LLD + N KISDFGLA +F + + +++ GT Y++PE + H +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF--HAE---PV 189
Query: 497 DVYSFGVLALETITG----------------KKNSSFYQTD------GAEDLLS---YED 531
DV+S G++ + G K Y LL E+
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249
Query: 532 PADRPSMATI 541
P+ R ++ I
Sbjct: 250 PSARITIPDI 259
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 42/210 (20%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRL------SRSSGQGAQE 382
F+ V + + + +LG G F V K G + A K + S G ++
Sbjct: 4 FRQENV-DDYYDTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 383 FKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYF--------- 426
+ EV ++ ++QH N++ L + IL+ E V L +
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 427 -------LYDSQLRIIHRDLKASNILLDVQMNP----KISDFGLARIFGVDQTQGNTSRI 475
Y L+I H DLK NI+L + P KI DFGLA I
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNI 177
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
GT +++PE + +++D++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 59/248 (23%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN------EVVLVAKL----QHR 396
LG+GGFG V+ G L ++A+K + R+ G + EV L+ K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 397 NLVRLLGFCLEGDEKI-LVYEF-----------VPNKSLD------YF-------LYDSQ 431
++RLL + E E LV E L +F +
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 432 LRIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
++HRD+K NIL+D++ K+ DFG + + GT Y PE+
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPEWISRH 213
Query: 491 QFS-VKSDVYSFGVL--AL-----------ETITGKKNSSFYQTDGAEDLLSY---EDPA 533
Q+ + + V+S G+L + E + + + + + L+ P+
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPS 273
Query: 534 DRPSMATI 541
RPS+ I
Sbjct: 274 SRPSLEEI 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 47/207 (22%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGA---------QEFKNE 386
+ LGRG V + + H +E AVK + + G + E
Sbjct: 16 YENYEPKEILGRGVSSVVRRCI--HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSL-DYFL----------------- 427
V ++ K+ H N+++L LV++ + L DY
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 428 -----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
+L I+HRDLK NILLD MN K++DFG + + + GT Y+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYL 190
Query: 483 SPE------YAMHGQFSVKSDVYSFGV 503
+PE H + + D++S GV
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 46/230 (20%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKR 371
+N E D+ + K+ + +GRG V + V H G E AVK
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV--HRATGHEFAVKI 126
Query: 372 LSRSSGQGAQE--------FKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKS 422
+ ++ + + E + E ++ ++ H +++ L+ LV++ +
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 423 L-DYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459
L DY + I+HRDLK NILLD M ++SDFG
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246
Query: 460 ARIFGVDQTQGNTSRIVGTYGYMSPE------YAMHGQFSVKSDVYSFGV 503
+ + + GT GY++PE H + + D+++ GV
Sbjct: 247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 64/250 (25%), Positives = 97/250 (38%), Gaps = 61/250 (24%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 405
LG G +GEV V + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 406 LEGDEKILVYEFVPNKSL-DYFLYDSQLR----------------------IIHRDLKAS 442
EG+ + L E+ L D D + I HRD+K
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 443 NILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE------YAMHGQFSVKS 496
N+LLD + N KISDFGLA +F + + +++ GT Y++PE + H +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF--HAE---PV 189
Query: 497 DVYSFGV-----LA-----------LETITGKKNSSFYQTD------GAEDLLS---YED 531
DV+S G+ LA + + K Y LL E+
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249
Query: 532 PADRPSMATI 541
P+ R ++ I
Sbjct: 250 PSARITIPDI 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 52/214 (24%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKN-EVVLVAKLQHR 396
++ +G G FG VY+ L G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 397 NLVRLLGFCLEGDEKI------LVYEFVP-------------NKSLD-----YFLYDSQL 432
N+VRL F EK LV ++VP ++L ++Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY--QL 165
Query: 433 ----------RIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGY 481
I HRD+K N+LLD K+ DFG A+ + + N S I Y Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 222
Query: 482 MSPEYAMHG--QFSVKSDVYSFG-VLALETITGK 512
+PE + G ++ DV+S G VLA E + G+
Sbjct: 223 RAPE-LIFGATDYTSSIDVWSAGCVLA-ELLLGQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 54/248 (21%), Positives = 91/248 (36%), Gaps = 59/248 (23%)
Query: 308 KKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNK-----------LGRGGFGEV 356
K L N ++I S F ++ + S K LG G GEV
Sbjct: 94 KGKRRPLNNN--SEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151
Query: 357 YKGVLPH---GQEIAVKRLSRSSGQGAQE--------FKNEVVLVAKLQHRNLVRLLGFC 405
+++A++ +S+ + E+ ++ KL H ++++ F
Sbjct: 152 KLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209
Query: 406 LEGDEKILVYEFVPNKSL----------------DYFL-------YDSQLRIIHRDLKAS 442
+ ++ +V E + L YF Y + IIHRDLK
Sbjct: 210 -DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE 268
Query: 443 NILLDVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE---YAMHGQFSVKS 496
N+LL Q KI+DFG ++I G + GT Y++PE ++
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAV 325
Query: 497 DVYSFGVL 504
D +S GV+
Sbjct: 326 DCWSLGVI 333
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 39/193 (20%)
Query: 347 KLGRGGFGEVYKGVLPH---GQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHR-NLVR 400
+LGRG F V + + GQE A K + R E +E+ ++ + ++
Sbjct: 36 ELGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 401 LLGFCLEGDEKILVYEFVP---------NKSLDYF----------------LYDSQLRII 435
L E IL+ E+ + + Y Q I+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 436 HRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
H DLK NILL + KI DFG++R G I+GT Y++PE +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPI 210
Query: 493 SVKSDVYSFGVLA 505
+ +D+++ G++A
Sbjct: 211 TTATDMWNIGIIA 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 46/205 (22%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQE--------FKNEV 387
+++ LG G GEV +++A+K +S+ + E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSL----------------DYFL---- 427
++ KL H ++++ F + ++ +V E + L YF
Sbjct: 67 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 428 ---YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
Y + IIHRDLK N+LL Q KI+DFG ++I G + GT Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 182
Query: 482 MSPE---YAMHGQFSVKSDVYSFGV 503
++PE ++ D +S GV
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 58/253 (22%), Positives = 90/253 (35%), Gaps = 63/253 (24%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQHRNLVRLL 402
LG G +G+V + + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 403 G-FCLEGDEKI-LVYEFVPNKSLDYFLYDS--------------QL----------RIIH 436
E +K+ +V E+ + QL I+H
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV-GTYGYMSPEYAM-----HG 490
+D+K N+LL KIS G+A +T R G+ + PE A G
Sbjct: 133 KDIKPGNLLLTTGGTLKISALGVAEALH-PFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191
Query: 491 QFSVKSDVYSFGVLALETITGK---------------KNSSF----YQTDGAEDLLS--- 528
K D++S GV TG S+ DLL
Sbjct: 192 F---KVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGML 248
Query: 529 YEDPADRPSMATI 541
+PA R S+ I
Sbjct: 249 EYEPAKRFSIRQI 261
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 31/194 (15%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA--QEFKNEVVLVAKLQH 395
T ++ +LG+G F V + V + GQE A ++ Q+ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSL-------DYF----------------LYDSQL 432
N+VRL E L+++ V L +Y+ L+ Q+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 433 RIIHRDLKASNILLDVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
++HR+LK N+LL ++ K++DFGLA +Q GT GY+SPE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRK 187
Query: 490 GQFSVKSDVYSFGV 503
+ D+++ GV
Sbjct: 188 DPYGKPVDLWACGV 201
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 5e-20
Identities = 34/329 (10%), Positives = 73/329 (22%), Gaps = 88/329 (26%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQ--------- 394
LG+ + G+ V + + ++ K EV+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 395 -------------HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD------------ 429
+++ L+ + ++ F + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 430 ------------SQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467
Q+ ++H L+ +I+LD + ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-AS 264
Query: 468 TQGNTSRIVGTYGYMSPE-----YAMHGQFSVKSDVYSFGVLALETITGK---KNSSFYQ 519
R + + D ++ G+ + +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324
Query: 520 T------------DGAEDLLS---YEDPADRPSMATIVLALNSHSVTLSVPRQPALFIGS 564
LL DR + + + L+
Sbjct: 325 GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTD 384
Query: 565 RTERSFPEREFECSDKSTSKSMPWSVDEA 593
P RE TS+ EA
Sbjct: 385 GE----PTREGGAPPSGTSQPDEAGAAEA 409
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-20
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 43/206 (20%)
Query: 348 LGRGGFGEVYKGVLPHGQEI-AVKRLSRS---SGQGAQEFKNE---VVLVAKLQHRNLVR 400
+GRGGFGEVY ++ A+K L + QG NE + LV+ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 401 LLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS-----------------------QLRIIH 436
+ + +K+ + + + L Y L +++
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ---FS 493
RDLK +NILLD + +ISD GLA F + VGT+GYM+PE G S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSS 371
Query: 494 VKSDVYSFGVLALETITGKKNSSFYQ 519
D +S G + + + G S F Q
Sbjct: 372 A--DWFSLGCMLFKLLRGH--SPFRQ 393
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 45/215 (20%)
Query: 338 ATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN-----EVVLVA 391
AT+++ ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 392 KLQ---HRNLVRLL----GFCLEGDEKI-LVYEFV-----------PNKSLD-----YFL 427
+L+ H N+VRL+ + + K+ LV+E V P L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 428 YDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
Q I+HRDLK NIL+ K++DFGLARI+ T +V
Sbjct: 127 R--QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVV- 181
Query: 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
T Y +PE + ++ D++S G + E K
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 47/182 (25%)
Query: 347 KLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
K+GRG +G VYK ++ A+K++ +G + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 404 FCLE-GDEKI-LVYEFV------------------PNKSLD-----YFLYDSQL------ 432
L D K+ L++++ L LY Q+
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY--QILDGIHY 143
Query: 433 ----RIIHRDLKASNILLDVQMNP----KISDFGLARIFGV-DQTQGNTSRIVGTYGYMS 483
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 484 PE 485
PE
Sbjct: 204 PE 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 47/192 (24%), Positives = 81/192 (42%), Gaps = 32/192 (16%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
++ F +++LGRG VY+ + A+K L ++ + + + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSL-------DYF----------------LYDSQLRI 434
+++L E LV E V L Y+ Y + I
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 435 IHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
+HRDLK N+L KI+DFGL++I + GT GY +PE
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCA 226
Query: 492 FSVKSDVYSFGV 503
+ + D++S G+
Sbjct: 227 YGPEVDMWSVGI 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 43/179 (24%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKN--------EVVLVA 391
K+ K+G G +G VYK G+ +A+KR+ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 392 KLQHRNLVRLLGFCLEGDEKILVYEFVPN---KSLD------------YFLYDSQL---- 432
+L H N+V L+ LV+EF+ K LD +LY QL
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY--QLLRGV 132
Query: 433 ------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
RI+HRDLK N+L++ K++DFGLAR FG+ + T +V T Y +P+
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPD 189
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 66/253 (26%), Positives = 99/253 (39%), Gaps = 71/253 (28%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LG G FG+V G G ++AVK L+R S + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 404 FCLEGDEKI-LVYEFVPNKSL-DYFL----------------------YDSQLRIIHRDL 439
+ +V E+V L DY Y + ++HRDL
Sbjct: 79 -VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGN---TSRIVGTYGYMSPE------YAMHG 490
K N+LLD MN KI+DFGL+ + + G TS G+ Y +PE Y G
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPEVISGRLY--AG 189
Query: 491 QFSVKSDVYSFGVL--AL---------ETI--------TGKKNSSFYQTDGAEDLLSY-- 529
+ D++S GV+ AL E + G Y LL +
Sbjct: 190 P---EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML 246
Query: 530 -EDPADRPSMATI 541
DP R ++ I
Sbjct: 247 QVDPLKRATIKDI 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 42/181 (23%), Positives = 67/181 (37%), Gaps = 46/181 (25%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVV---------L 389
K+ K+G G +G V+K GQ +A+K+ + + V+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVP----------NKSLD-----YFLYDSQL-- 432
+ +L+H NLV LL LV+E+ + + + Q
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW--QTLQ 113
Query: 433 --------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSP 484
IHRD+K NIL+ K+ DFG AR+ + + T Y SP
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSP 171
Query: 485 E 485
E
Sbjct: 172 E 172
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 53/184 (28%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLS-------------RSSGQGAQEFKNE 386
K+ K+G G +G VYK +G+ A+K++ R E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-----------E 50
Query: 387 VVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV----------PNKSLD-----YFLYDSQ 431
+ ++ +L+H N+V+L +LV+E + L+ FL Q
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL--Q 108
Query: 432 L----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
L R++HRDLK N+L++ + KI+DFGLAR FG+ + T IV T Y
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWY 166
Query: 482 MSPE 485
+P+
Sbjct: 167 RAPD 170
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 28/284 (9%), Positives = 64/284 (22%), Gaps = 95/284 (33%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE---FKNEVVLVAKLQ--------- 394
LG+ + G+ V + + K EV+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 395 ----------------HRNLVRLLGF--------------CLEGDEKILVYEFVPNKSLD 424
+ ++R+ ++ + + + + S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 425 YFLYDS-------QL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467
L Q+ ++H L+ +I+LD + ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260
Query: 468 TQGNTSRIVGTYGYMSPEY-----------AMHGQFSVKSDVYSFGVLALETITGK---K 513
+ G+ PE + D ++ G++
Sbjct: 261 V------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 514 NSSFYQT------------DGAEDLLS---YEDPADRPSMATIV 542
+ LL DR +
Sbjct: 315 KDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 36/176 (20%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN----EVVLVAKLQ 394
K+ + +G G +G V K G+ +A+K+ S + K E+ L+ +L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82
Query: 395 HRNLVRLLGFCLEGDEKILVYEFV----------PNKSLDY-----FLYDSQL------- 432
H NLV LL C + LV+EFV LDY +L+ Q+
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF--QIINGIGFC 140
Query: 433 ---RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
IIHRD+K NIL+ K+ DFG AR + + T Y +PE
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPE 194
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 49/195 (25%), Positives = 72/195 (36%), Gaps = 38/195 (19%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFC 405
LG G V + L QE AVK + + G EV ++ + Q HRN++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 406 LEGDEKILVYEFVPNKSL-------DYF----------------LYDSQLRIIHRDLKAS 442
E D LV+E + S+ +F + I HRDLK
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 443 NILLDVQMNP---KISDFGLARIF-----GVDQTQGNTSRIVGTYGYMSPE-----YAMH 489
NIL + KI DF L + G+ YM+PE
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 490 GQFSVKSDVYSFGVL 504
+ + D++S GV+
Sbjct: 201 SIYDKRCDLWSLGVI 215
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 45/181 (24%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN--------EVVLV 390
F K+G G +G VYK G+ +A+K++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFV-----------PNKSLD-----YFLYDSQL-- 432
+L H N+V+LL ++ LV+EF+ + +L+ QL
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF--QLLQ 114
Query: 433 --------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSP 484
R++HRDLK N+L++ + K++DFGLAR FGV + T +V T Y +P
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWYRAP 172
Query: 485 E 485
E
Sbjct: 173 E 173
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 9e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 42/207 (20%)
Query: 348 LGRGGFGEVYKGVLPHGQEI-AVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LG+GGFGEV + ++ A K+L + +G NE ++ K+ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 404 FCLEGDEKI-LVYEFVPNKSLDYFLYDS-------------------------QLRIIHR 437
+ E + + LV + L + +Y + RI++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE---YAMHGQFSV 494
DLK NILLD + +ISD GLA QT VGT GYM+PE + FS
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYT-FSP 366
Query: 495 KSDVYSFGVLALETITGKKNSSFYQTD 521
D ++ G L E I G+ S F Q
Sbjct: 367 --DWWALGCLLYEMIAGQ--SPFQQRK 389
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 70/217 (32%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEF----------------------- 383
+G+G +G V A+K LS+ F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 384 ---KNEVVLVAKLQHRNLVRLLGFCLE-----GDEKI-LVYEFVPNKSL----------- 423
E+ ++ KL H N+V+L+ E ++ + +V+E V +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 424 ----DYFLYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469
YF L +IIHRD+K SN+L+ + KI+DFG++ F
Sbjct: 137 DQARFYF---QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 470 GNTSRIVGTYGYMSPE--YAMHGQFS-VKSDVYSFGV 503
+ + VGT +M+PE FS DV++ GV
Sbjct: 194 LSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 58/220 (26%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKN----EVVLVAKL 393
++F + G+G FG V G G +A+K++ + F+N + +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 394 QHRNLVRLLGFCLEGDEK-------ILVYEFVP-------------NKSLD-----YFLY 428
H N+V+L + E+ +V E+VP + FL+
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 429 DSQL------------RIIHRDLKASNILLDVQMNP-KISDFGLARIFGVDQTQGNTSRI 475
QL + HRD+K N+L++ K+ DFG A+ + N + I
Sbjct: 137 --QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYI 192
Query: 476 VGTYGYMSPEYAMHG--QFSVKSDVYSFG-VLALETITGK 512
Y Y +PE + G ++ D++S G + A E + G+
Sbjct: 193 CSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFA-EMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 65/222 (29%)
Query: 340 NKFSSDNKLGRGGFGEVYKG--VLPHGQEIAVKRLS-------------RSSGQGAQEFK 384
++ ++G G +G+V+K + G+ +A+KR+ R
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------- 60
Query: 385 NEVVLVAKLQ---HRNLVRLL----GFCLEGDEKI-LVYEFV-----------PNKSLD- 424
EV ++ L+ H N+VRL + + K+ LV+E V P +
Sbjct: 61 -EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 425 ----YFLYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470
++ QL R++HRDLK NIL+ K++DFGLARI+
Sbjct: 120 ETIKDMMF--QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL- 176
Query: 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
TS +V T Y +PE + ++ D++S G + E K
Sbjct: 177 -TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 37/189 (19%)
Query: 346 NKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLL 402
+G G + + + H E AVK + +S +E +L+ QH N++ L
Sbjct: 28 EDIGVGSYSVCKRCI--HKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLK 82
Query: 403 GFCLEGDEKILVYEFVPNKSL-DYFL----------------------YDSQLRIIHRDL 439
+G +V E + L D L Y ++HRDL
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142
Query: 440 KASNILL-DVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
K SNIL D NP +I DFG A+ + T T +++PE +
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAA 200
Query: 496 SDVYSFGVL 504
D++S GVL
Sbjct: 201 CDIWSLGVL 209
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 39/210 (18%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEF---KNE 386
DFK ++ LG G F V A+K L + + E
Sbjct: 31 DFKFGKI----------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 387 VVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------YDSQ- 431
++++L H V+L F + DEK+ + N L ++ Y ++
Sbjct: 81 RDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 432 ---------LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
IIHRDLK NILL+ M+ +I+DFG A++ + Q + VGT Y+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETITGK 512
SPE SD+++ G + + + G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 35/177 (19%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKN----EVVLVAKL 393
++ + LG G F VYK Q +A+K++ A++ E+ L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFV----------PNKSLD-----YFLYDSQL------ 432
H N++ LL LV++F+ + L ++
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML--MTLQGLEY 127
Query: 433 ----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
I+HRDLK +N+LLD K++DFGLA+ FG + T ++V T Y +PE
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYRAPE 182
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 62/252 (24%), Positives = 102/252 (40%), Gaps = 70/252 (27%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LG G FG+V Q++A+K +SR + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 404 FCLEGDEKI-LVYEFV---------------PNKSLDYFL-------YDSQLRIIHRDLK 440
+ I +V E+ ++ +F Y + +I+HRDLK
Sbjct: 77 V-ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGN---TSRIVGTYGYMSPE------YAMHGQ 491
N+LLD +N KI+DFGL+ I T GN TS G+ Y +PE Y G
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIM----TDGNFLKTS--CGSPNYAAPEVINGKLY--AGP 187
Query: 492 FSVKSDVYSFGVL--AL---------ETI--------TGKKNSSFYQTDGAEDLLSY--- 529
+ DV+S G++ + E I + + + GA+ L+
Sbjct: 188 ---EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIV 244
Query: 530 EDPADRPSMATI 541
DP R ++ I
Sbjct: 245 ADPMQRITIQEI 256
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 40/205 (19%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKN-----EVVLVAKL 393
+ +KLG G + VYKG +A+K + +GA EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 394 QHRNLVRLLGFCLEGDEKILVYEFV----------PNKSLD-----YFLYDSQL------ 432
+H N+V L LV+E++ ++ FL+ QL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF--QLLRGLAY 115
Query: 433 ----RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
+++HRDLK N+L++ + K++DFGLAR + T+ + +V T Y P+ +
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDILL 173
Query: 489 HG-QFSVKSDVYSFGVLALETITGK 512
+S + D++ G + E TG+
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 44/184 (23%)
Query: 338 ATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN-----EVVLVA 391
++++F KLG G + VYKG+ G +A+K + S +G E+ L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMK 58
Query: 392 KLQHRNLVRLLGFCLEGDEKILVYEFVPN---KSLD-----------------YFLYDSQ 431
+L+H N+VRL ++ LV+EF+ N K +D YF + Q
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--Q 116
Query: 432 L----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
L +I+HRDLK N+L++ + K+ DFGLAR FG+ +S +V T Y
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLWY 174
Query: 482 MSPE 485
+P+
Sbjct: 175 RAPD 178
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 46/181 (25%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN--------EVVLV 390
K+ K+G G +G V+K + +A+KR+ + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLL 55
Query: 391 AKLQHRNLVRLLGFCLEGDEKI-LVYEFV----------PNKSLD-----YFLYDSQL-- 432
+L+H+N+VRL L D+K+ LV+EF N LD FL+ QL
Sbjct: 56 KELKHKNIVRLHD-VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF--QLLK 112
Query: 433 --------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSP 484
++HRDLK N+L++ K+++FGLAR FG+ + ++ +V T Y P
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPP 170
Query: 485 E 485
+
Sbjct: 171 D 171
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 65/253 (25%), Positives = 101/253 (39%), Gaps = 71/253 (28%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LG G FG+V G G ++AVK L+R S + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 404 FCLEGDEKI-LVYEFVPNKSL-DYFL----------------------YDSQLRIIHRDL 439
+ I +V E+V L DY Y + ++HRDL
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGN---TSRIVGTYGYMSPE------YAMHG 490
K N+LLD MN KI+DFGL+ + + G TS G+ Y +PE YA
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTS--CGSPNYAAPEVISGRLYA--- 193
Query: 491 QFSVKSDVYSFGVL--AL---------ETI--------TGKKNSSFYQTDGAEDLLSY-- 529
+ D++S GV+ AL + + G + Y LL +
Sbjct: 194 --GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML 251
Query: 530 -EDPADRPSMATI 541
DP R ++ I
Sbjct: 252 QVDPMKRATIKDI 264
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-18
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 348 LGRGGFGEVYKGVLPHGQEI-AVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLG 403
LGRGGFGEV+ + ++ A K+L++ +G Q E ++AK+ R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 404 FCLEGDEKI-LVYEFVPNKSLDYFLYDS---------------------------QLRII 435
+ E + LV + + Y +Y+ Q II
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE---YAMHGQF 492
+RDLK N+LLD N +ISD GLA QT+ GT G+M+PE + F
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYD-F 368
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTD 521
SV D ++ GV E I + F
Sbjct: 369 SV--DYFALGVTLYEMIAAR--GPFRARG 393
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 44/220 (20%), Positives = 74/220 (33%), Gaps = 52/220 (23%)
Query: 326 ESLQFDFKTIEVATNKFSSD-----NKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSG 377
L+ F+ E + D LG G G+V + H GQ+ A+K L S
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECF--HRRTGQKCALKLLYDS-- 65
Query: 378 QGAQEFKNEV-VLVAKLQHRNLVRLLGFCLEGDEKI----LVYEFVP---------NKSL 423
+ + EV ++V +L ++ E + +
Sbjct: 66 ---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122
Query: 424 DYF----------------LYDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFG 464
F + I HRD+K N+L + K++DFG A+
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET- 181
Query: 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVL 504
TQ T Y++PE ++ D++S GV+
Sbjct: 182 ---TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 55/219 (25%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRL---SRSSGQGAQEFKN----EVVLVA 391
+K+ K+G+G FGEV+K GQ++A+K++ + G F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----FPITALREIKILQ 71
Query: 392 KLQHRNLVRLLGFCLEGDEKI--------LVYEFV----------PNKSLD-----YFLY 428
L+H N+V L+ C LV++F +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 429 DSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN---TSRI 475
L +I+HRD+KA+N+L+ K++DFGLAR F + + T+R+
Sbjct: 132 --MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 476 VGTYGYMSPEYAMHG-QFSVKSDVYSFG-VLALETITGK 512
V T Y PE + + D++ G ++A E T
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMA-EMWTRS 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 47/192 (24%), Positives = 71/192 (36%), Gaps = 37/192 (19%)
Query: 343 SSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNL 398
D LG G F K V H Q AVK +S+ + E+ + + H N+
Sbjct: 14 LKDKPLGEGSFSICRKCV--HKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNI 68
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSL-------DYF----------------LYDSQLRII 435
V+L + LV E + L +F + + ++
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 436 HRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
HRDLK N+L + + KI DFG AR+ D T T Y +PE +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGY 186
Query: 493 SVKSDVYSFGVL 504
D++S GV+
Sbjct: 187 DESCDLWSLGVI 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 53/249 (21%), Positives = 99/249 (39%), Gaps = 84/249 (33%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN-EVVLVAKL 393
E ++ K+S LG G FG V + + G+ A+K++ + +KN E+ ++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 394 QHRNLVRLLGFCLEGDEKI--------------------------------------LVY 415
H N+++L+ + ++ ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 416 EFVP-------------NKSLD-----YFLYDSQL----------RIIHRDLKASNILLD 447
E+VP +S+ ++Y QL I HRD+K N+L++
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIY--QLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 448 VQMNP-KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFG-V 503
+ N K+ DFG A+ ++ + + I + Y +PE M G +++ D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL-MLGATEYTPSIDLWSIGCV 231
Query: 504 LALETITGK 512
E I GK
Sbjct: 232 FG-ELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 327 SLQFDFKTIEVATNKFSSDNK------LGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSG 377
+F ++E+ + F+ + +G G G V + +A+K+LSR +
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 65
Query: 378 QGAQEFKNEVVLVAKLQHRNLVRLL-----GFCLEGDEKI-LVYEF-------VPNKSLD 424
A+ E+VL+ + H+N++ LL LE + + +V E V LD
Sbjct: 66 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125
Query: 425 -----YFLYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469
Y LY Q+ IIHRDLK SNI++ KI DFGLAR +
Sbjct: 126 HERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSF 181
Query: 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
T V T Y +PE + + D++S G + E I G
Sbjct: 182 MMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 42/212 (19%)
Query: 336 EVATNKFSSD------NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVV 388
E ++ + KLGRG + EV++ + + + +++ VK L ++ K E+
Sbjct: 26 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIK 82
Query: 389 LVAKLQ-HRNLVRLLGFCLEGDEK--ILVYEFVPNKSLD------------YFLYDSQL- 432
++ L+ N++ L + + LV+E V N +++Y ++
Sbjct: 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY--EIL 140
Query: 433 ---------RIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
I+HRD+K N+++D ++ D+GLA + Q R+ Y +
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRY-FK 197
Query: 483 SPEYAMHGQFSVKS-DVYSFGVLALETITGKK 513
PE + Q S D++S G + I K+
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 58/189 (30%), Positives = 80/189 (42%), Gaps = 58/189 (30%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLS-------------RSSGQGAQEFKN 385
+++ KLG G +GEVYK + + +A+KR+ R
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----------- 82
Query: 386 EVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN---KSLD-----------YFLYDSQ 431
EV L+ +LQHRN++ L L++E+ N K +D FLY Q
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY--Q 140
Query: 432 L----------RIIHRDLKASNILLDVQMNP-----KISDFGLARIFGVDQTQGNTSRIV 476
L R +HRDLK N+LL V KI DFGLAR FG+ + T I+
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199
Query: 477 GTYGYMSPE 485
T Y PE
Sbjct: 200 -TLWYRPPE 207
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 39/213 (18%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSGQGAQEFKNEVV 388
KT + S +G G +G V + G+++A+K+LSR S A+ E++
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL 75
Query: 389 LVAKLQHRNLVRLL-----GFCLEGDEKI-LVYEF-------VPNKSLD-----YFLYDS 430
L+ +QH N++ LL L LV F + Y +Y
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-- 133
Query: 431 Q-LR---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYG 480
Q L+ ++HRDLK N+ ++ KI DFGLAR + T V T
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRW 188
Query: 481 YMSPEYAM-HGQFSVKSDVYSFGVLALETITGK 512
Y +PE + ++ D++S G + E +TGK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 38/192 (19%), Positives = 75/192 (39%), Gaps = 48/192 (25%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN---------EVV 388
+++ + +G G +G V + + +A+K++ R F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 389 LVAKLQHRNLVRLLGFC----LEGDEKI-LVYEFVP---------NKSLD-----YFLYD 429
++ +L H ++V++L +E +++ +V E L LY
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 430 SQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY 479
L I+HRDLK +N L++ + K+ DFGLAR + + I
Sbjct: 164 -NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 480 GYMSPEYAMHGQ 491
M+ H +
Sbjct: 223 DDMNLVTFPHTK 234
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 52/230 (22%), Positives = 81/230 (35%), Gaps = 53/230 (23%)
Query: 331 DFKTIEVATNKFSSDNK------LGRGGFGEVYKGVLPHGQEIAVKRLSR--SSGQGAQE 382
+ ++ + + + G +G V GV G +A+KR+ S G+
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 383 FKN---------EVVLVAKLQHRNLVRLLG----FCLEGDEKI-LVYEFV---------- 418
+ E+ L+ H N++ L F K+ LV E +
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126
Query: 419 PNKSLD-----YFLYDSQ-LR---------IIHRDLKASNILLDVQMNPKISDFGLARIF 463
+ YF+Y L ++HRDL NILL + I DF LAR
Sbjct: 127 QRIVISPQHIQYFMY--HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 464 GVDQTQGNTSRIVGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGK 512
D N + V Y +PE M F+ D++S G + E K
Sbjct: 185 TADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 327 SLQFDFKTIEVATNKFSSDNK------LGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSG 377
+ F ++EV + F+ + +G G G V + +A+K+LSR +
Sbjct: 43 KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 102
Query: 378 QGAQEFKNEVVLVAKLQHRNLVRLL-----GFCLEGDEKI-LVYEF-------VPNKSLD 424
A+ E+VL+ + H+N++ LL LE + + LV E V LD
Sbjct: 103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 162
Query: 425 -----YFLYDSQLR---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470
Y LY L IIHRDLK SNI++ KI DFGLAR G T
Sbjct: 163 HERMSYLLY-QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSF 218
Query: 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
+ V T Y +PE + + D++S G + E + K
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 31/149 (20%)
Query: 428 YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ--TQGNTSRIVGTYGYMSPE 485
+ + + IHRDL A NILL + KI DFGLAR D + +R+ +M+PE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPE 265
Query: 486 YAMHGQFSVKSDVYSFGVLALETIT-G-------KKNSSFYQT----------DGAEDLL 527
++++SDV+SFGVL E + G K + F + D +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325
Query: 528 SYE--------DPADRPSMATIVLALNSH 548
Y+ +P+ RP+ + +V L +
Sbjct: 326 -YQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 9/111 (8%)
Query: 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQG 379
E L +D E ++ LGRG FG+V + + +AVK L +
Sbjct: 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 380 A-QEFKNEV-VLVAKLQHRNLVRLLGFCLEGDEKILV-YEFVPNKSLDYFL 427
+ +E+ +L+ H N+V LLG C + ++V EF +L +L
Sbjct: 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 41/213 (19%), Positives = 78/213 (36%), Gaps = 53/213 (24%)
Query: 334 TIEVATNKFSSD-----NKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKN 385
+++ N D LG G G+V + + ++ A+K L + +
Sbjct: 51 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIF--NKRTQEKFALKMLQDC-----PKARR 103
Query: 386 EV-VLVAKLQHRNLVRLLGFC---LEGDEKI-LVYEFVP---------NKSLDYF----- 426
EV + Q ++VR++ G + + +V E + ++ F
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 163
Query: 427 -----------LYDSQLRIIHRDLKASNILLDVQMNP----KISDFGLARIFGVDQTQGN 471
Y + I HRD+K N+L P K++DFG A+ +
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLY-TSKRPNAILKLTDFGFAKETTSHNS--- 219
Query: 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVL 504
+ T Y++PE ++ D++S GV+
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
+G G FG + +AVK + R + + E++ L+H N+VR L
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86
Query: 407 EGDEKILVYEFVPNKSL-DYFL------------YDSQL----------RIIHRDLKASN 443
++ E+ L + + QL +I HRDLK N
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLEN 146
Query: 444 ILLD--VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE------YAMHGQFSVK 495
LLD KI DFG ++ V +Q ++ VGT Y++PE Y G+
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSS-VLHSQPKST--VGTPAYIAPEVLLRQEYD--GK---I 198
Query: 496 SDVYSFGV 503
+DV+S GV
Sbjct: 199 ADVWSCGV 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 23/220 (10%), Positives = 55/220 (25%), Gaps = 65/220 (29%)
Query: 347 KLGRGGFGEVYKG---VLPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQHRNLVR 400
G + ++ L +++A+ + QE + + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 401 LLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR----------------------IIHRD 438
+L ++V E++ SL D+ +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPVGAIRAMQSLAAAADAAHRAGVALSI 154
Query: 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDV 498
S + +S G + M + + D+
Sbjct: 155 DHPSRVR--------VSIDGDVV--------------LAYPATMPDA-------NPQDDI 185
Query: 499 YSFGVLALETITGKKNSSFYQTDGAEDLLS--YEDPADRP 536
G + + G L+ D A +P
Sbjct: 186 RGIGASLYALLVNR---WPLPEAGVRSGLAPAERDTAGQP 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 38/244 (15%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLS 373
E+N + + K + + F +GRG FGEV L + ++ A+K L+
Sbjct: 49 EKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108
Query: 374 RSSGQGAQE---FKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVP--------NK 421
+ E F+ E ++ + + L + + D + LV ++ +K
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK 167
Query: 422 SLDYFLYDS----------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465
D + QL +HRD+K NIL+D+ + +++DFG
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 466 DQTQGNTSRIVGTYGYMSPE-----YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT 520
D T +S VGT Y+SPE G++ + D +S GV E + G+ + FY
Sbjct: 228 DGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAE 284
Query: 521 DGAE 524
E
Sbjct: 285 SLVE 288
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSGQGAQEFKNEVV 388
KTI ++ + + +G G +G V G +AVK+LSR S A+ E+
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 389 LVAKLQHRNLVRLL-----GFCLEGDEKI-LVYEFVP--------NKSLD-----YFLYD 429
L+ ++H N++ LL LE + LV + + L + +Y
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY- 139
Query: 430 SQ-LR---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY 479
Q LR IIHRDLK SN+ ++ KI DFGLAR + T V T
Sbjct: 140 -QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YVATR 193
Query: 480 GYMSPEYAM-HGQFSVKSDVYSFGVLALETITGK 512
Y +PE + ++ D++S G + E +TG+
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 55/247 (22%), Positives = 100/247 (40%), Gaps = 42/247 (17%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLS 373
++ + + E + K + + + F +GRG F EV + ++ A+K ++
Sbjct: 36 DKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95
Query: 374 RSS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVP--------N 420
+ G+ + F+ E ++ R + +L F + + + LV E+ +
Sbjct: 96 KWDMLKRGEVSC-FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS 153
Query: 421 KSLDYF------LYDS----------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464
K + Y + +L +HRD+K NILLD + +++DFG
Sbjct: 154 KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 465 VDQTQGNTSRIVGTYGYMSPE-------YAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517
D T + VGT Y+SPE G + + D ++ GV A E G+ + F
Sbjct: 214 ADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPF 270
Query: 518 YQTDGAE 524
Y AE
Sbjct: 271 YADSTAE 277
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/222 (22%), Positives = 97/222 (43%), Gaps = 52/222 (23%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN----- 385
+ ++++ + +G G +G V + +A+K++S F++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70
Query: 386 ----EVVLVAKLQHRNLVRLLGF----CLEGDEKI-LVYEF--------VPNKSLD---- 424
E+ ++ + +H N++ + +E + + +V + + + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 425 -YFLYDSQ-LR---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT- 472
YFLY Q LR ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 131 CYFLY--QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 473 SRIVGTYGYMSPEYAM-HGQFSVKSDVYSFG-VLALETITGK 512
+ V T Y +PE + ++ D++S G +LA E ++ +
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA-EMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 46/221 (20%)
Query: 331 DFKTIEVATNKFSSDNK------LGRGGFGEVYKGV-LPHGQEIAVKRLSR--SSGQGAQ 381
F EV + +G G +G V V G ++A+K+L R S A+
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 69
Query: 382 EFKNEVVLVAKLQHRNLVRLL-----GFCLEGDEKI-LVYEF--------VPNKSLD--- 424
E+ L+ ++H N++ LL L+ LV F + ++ L
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 129
Query: 425 --YFLYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472
+ +Y Q+ IIHRDLK N+ ++ KI DFGLAR + T
Sbjct: 130 IQFLVY--QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--- 184
Query: 473 SRIVGTYGYMSPEYAM-HGQFSVKSDVYSFGVLALETITGK 512
V T Y +PE + +++ D++S G + E ITGK
Sbjct: 185 --YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 39/192 (20%), Positives = 72/192 (37%), Gaps = 48/192 (25%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN---------EVV 388
+ + + +GRG +G VY + +A+K+++R F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77
Query: 389 LVAKLQHRNLVRLLGFC----LEGDEKI-LVYEFVP---------NKSLD-----YFLYD 429
++ +L+ ++RL L +++ +V E L LY
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136
Query: 430 SQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTY 479
L IIHRDLK +N LL+ + K+ DFGLAR ++ + +
Sbjct: 137 -NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 480 GYMSPEYAMHGQ 491
+ Q
Sbjct: 196 EPGPHNKNLKKQ 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 41/199 (20%)
Query: 348 LGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKN---EVVLVAKLQHRNLVRLLG 403
+G+G FG+V +++ A+K +++ E +N E+ ++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 404 FCLEGDEKI-LVYEFVPNKSLDYFLYDSQ-----------------------LRIIHRDL 439
+ + +E + +V + + L Y L + RIIHRD+
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE------YAMHGQFS 493
K NILLD + I+DF +A + + + + GT YM+PE A + F+
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYS-FA 197
Query: 494 VKSDVYSFGVLALETITGK 512
V D +S GV A E + G+
Sbjct: 198 V--DWWSLGVTAYELLRGR 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 43/215 (20%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN 397
+++ LG GG G V+ V + +A+K++ + Q + E+ ++ +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 398 LVRLL--------------GFCLEGDEKILVYEFVP--------NKSLD-----YFLYDS 430
+V++ G E + +V E++ L F+Y
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY-- 127
Query: 431 QL----------RIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNT-SRIVGT 478
QL ++HRDLK +N+ ++ + + KI DFGLARI + S + T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 479 YGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGK 512
Y SP + ++ D+++ G + E +TGK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 51/192 (26%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN------ 385
+ + ++ F + LG G +G V P G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 386 ---EVVLVAKLQHRNLVRLLGF----CLEGDEKI-LVYEFVP--------NKSLD----- 424
E+ ++ +H N++ + E ++ ++ E + + L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 425 YFLYDSQ-LR---------IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474
YF+Y Q LR +IHRDLK SN+L++ + K+ DFGLAR +D++ + S
Sbjct: 116 YFIY--QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSE 171
Query: 475 IVGTYGYMSPEY 486
G M E+
Sbjct: 172 PTGQQSGMV-EF 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 39/231 (16%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLS 373
+N DN ++ + + + + + +GRG FGEV +++ A+K LS
Sbjct: 44 NKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 103
Query: 374 RSSGQGAQE---FKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-- 427
+ + F E ++A +V+L + + D + +V E++P L +
Sbjct: 104 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSN 162
Query: 428 ----------YDSQ----------LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467
Y ++ + IHRD+K N+LLD + K++DFG +
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 468 TQGNTSRIVGTYGYMSPE-------YAMHGQFSVKSDVYSFGVLALETITG 511
VGT Y+SPE +G+ D +S GV E + G
Sbjct: 223 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGR-EC--DWWSVGVFLYEMLVG 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 46/189 (24%), Positives = 85/189 (44%), Gaps = 45/189 (23%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKN------ 385
+ K+ KLG+G +G V+K + G+ +AVK++ + F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 386 ---EVVLVAKLQ-HRNLVRLLG-FCLEGDEKI-LVYEFVP--------NKSLD-----YF 426
E++++ +L H N+V LL + D + LV++++ L+ Y
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV 114
Query: 427 LYDSQL----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476
+Y QL ++HRD+K SNILL+ + + K++DFGL+R F + N +
Sbjct: 115 VY--QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 477 GTYGYMSPE 485
+ +
Sbjct: 173 INENTENFD 181
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 6/81 (7%)
Query: 431 QLRIIHRDLKASNILL--DVQMNPKISDFGLARIFGVDQTQGNT--SRIVGTYGYMSPE- 485
I HRD+K N L + K+ DFGL++ F + GT +++PE
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 486 -YAMHGQFSVKSDVYSFGVLA 505
+ + K D +S GVL
Sbjct: 246 LNTTNESYGPKCDAWSAGVLL 266
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 26/114 (22%), Positives = 48/114 (42%), Gaps = 8/114 (7%)
Query: 317 NADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVK----- 370
+ + + E+L F ++ K+ +G+G +G V + A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 371 RLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSL 423
++ + + + + K EV L+ KL H N+ RL E ++ I LV E L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHL 115
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 47/243 (19%)
Query: 315 EQNADNDITTLESLQFDFKTIEVATNKFSSDN-----KLGRGGFGEVYKGVLPHGQEI-A 368
EQ + + F K + N D LG G FG V A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 369 VKRLSRSSGQGAQEF---KNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLD 424
+K L + ++ NE ++ + LV+L F + + + +V E+V +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMF 129
Query: 425 YFLYDSQ-----------------------LRIIHRDLKASNILLDVQMNPKISDFGLAR 461
L L +I+RDLK N+L+D Q +++DFG A+
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 462 IFGVDQTQGNTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFY 518
G T + GT ++PE + + + +V D ++ GVL E G F+
Sbjct: 190 RVK-----GRTWTLCGTPEALAPEIILSKGYNK-AV--DWWALGVLIYEMAAGY--PPFF 239
Query: 519 QTD 521
Sbjct: 240 ADQ 242
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 62/246 (25%)
Query: 328 LQFDFKTIEVATNKFSSDNK-----------LGRGGFGEVY---KGVLPHGQEI-AVKRL 372
++ K I + + K LG+G FG+V+ K +++ A+K L
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 373 SRSSGQGAQEFKNEV-------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLD 424
+++ + ++ V +L ++ H +V+L + + + K+ L+ +F+ L
Sbjct: 61 KKATLKV----RDRVRTKMERDIL-VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLF 114
Query: 425 YFLYDS-----------------------QLRIIHRDLKASNILLDVQMNPKISDFGLAR 461
L L II+RDLK NILLD + + K++DFGL++
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 462 IFGVDQTQGNTSRIVGTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518
+D + GT YM+PE H Q S D +SFGVL E +TG F
Sbjct: 175 E-SIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQ-SA--DWWSFGVLMFEMLTGT--LPFQ 227
Query: 519 QTDGAE 524
D E
Sbjct: 228 GKDRKE 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVY---KGVLPHGQEI-AVKRLSRSSGQGAQEF--- 383
+F+ ++V LG G +G+V+ K ++ A+K L +++ +
Sbjct: 55 NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 384 -KNE-VVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS---------- 430
+ E VL Q LV L + + + K+ L+ +++ L L
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 163
Query: 431 -------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
+L II+RD+K NILLD + ++DFGL++ F D+T+ G
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCG 222
Query: 478 TYGYMSPE---YAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
T YM+P+ G +V D +S GVL E +TG S F
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDGEKNS 270
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 85/464 (18%), Positives = 141/464 (30%), Gaps = 93/464 (20%)
Query: 101 CQDCVTFA----TKNVTQRCPVEKRTTILFDECLLRYSNQSFFSNSDMSSQLSMWNLQNV 156
C C+ NV C + + + L + +
Sbjct: 133 CDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGL 192
Query: 157 TEPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCL 216
++P + + ++ + FQ S + D ++
Sbjct: 193 SDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTS 252
Query: 217 RGA-LGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNESAIAVPPSPPPPASVTRLQGKSG 275
R +G L S Q V L E ++N + K G
Sbjct: 253 RNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG 312
Query: 276 LSSSTIIAIVAPIVVIAVLFIAGLCFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTI 335
+ + + N + D L DF +
Sbjct: 313 QGTKA----------------------PEEKTANTISKFDNNGNRDRMKLT----DFNFL 346
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV------- 387
V LG+G FG+V E+ AVK L + ++V
Sbjct: 347 MV----------LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDDDVECTMVEK 392
Query: 388 -VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS--------------- 430
VL + L +L C + +++ V E+V L Y +
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 431 --------QLRIIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYG 480
II+RDLK N++LD + + KI+DFG+ + I+ T T GT
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT--FCGTPD 507
Query: 481 YMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
Y++PE Y +G SV D ++FGVL E + G+ + F D
Sbjct: 508 YIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 546
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 31/167 (18%), Positives = 58/167 (34%), Gaps = 43/167 (25%)
Query: 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGAQEFKNE 386
K + + + LG G G+V + + ++ A+K L + + E
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIF--NKRTQEKFALKMLQDC-----PKARRE 60
Query: 387 V-VLVAKLQHRNLVRLLGFC---LEGDEKI-LVYEFVP---------NKSLDYF------ 426
V + Q ++VR++ G + + +V E + ++ F
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 427 ----------LYDSQLRIIHRDLKASNILL---DVQMNPKISDFGLA 460
Y + I HRD+K N+L K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 61/233 (26%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVY---KGVLPHGQEI-AVKRLSRSSGQGAQEFKNE 386
F+ + V LG+GG+G+V+ K + +I A+K L ++ +
Sbjct: 18 CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKD 64
Query: 387 V--------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS------- 430
+L +++H +V L+ + + K+ L+ E++ L L
Sbjct: 65 TAHTKAERNIL-EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT 122
Query: 431 ----------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474
Q II+RDLK NI+L+ Q + K++DFGL + D T +T
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-- 180
Query: 475 IVGTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
GT YM+PE + H + +V D +S G L + +TG F + +
Sbjct: 181 FCGTIEYMAPEILMRSGHNR-AV--DWWSLGALMYDMLTGA--PPFTGENRKK 228
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 62/229 (27%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV-- 387
DF + V LG+G FG+V E+ AVK L + ++V
Sbjct: 21 DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVEC 66
Query: 388 ------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS---------- 430
VL + L +L C + +++ V E+V L Y +
Sbjct: 67 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 431 -------------QLRIIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRI 475
II+RDLK N++LD + + KI+DFG+ + I+ T T
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT--F 181
Query: 476 VGTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
GT Y++PE Y +G SV D ++FGVL E + G+ + F D
Sbjct: 182 CGTPDYIAPEIIAYQPYG-KSV--DWWAFGVLLYEMLAGQ--APFEGED 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 58/227 (25%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV-- 387
+F+ I V LG+G FG+V + ++ AVK L + ++V
Sbjct: 24 NFEFIRV----------LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ----DDDVEC 69
Query: 388 ------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS---------- 430
+L H L +L C + +++ V EFV L + + S
Sbjct: 70 TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 128
Query: 431 -------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
II+RDLK N+LLD + + K++DFG+ + + T G
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCG 186
Query: 478 TYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
T Y++PE ++G +V D ++ GVL E + G + F +
Sbjct: 187 TPDYIAPEILQEMLYG-PAV--DWWAMGVLLYEMLCGH--APFEAEN 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 60/231 (25%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV-- 387
+F+ +++ LG+G FG+V A+K L + K+EV
Sbjct: 149 EFEYLKL----------LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA----KDEVAH 194
Query: 388 ------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYD----------- 429
VL +H L L + + +++ V E+ L + L
Sbjct: 195 TLTENRVL-QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 252
Query: 430 -------------SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476
S+ +++RDLK N++LD + KI+DFGL + D T
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FC 310
Query: 477 GTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
GT Y++PE +G+ +V D + GV+ E + G+ FY D +
Sbjct: 311 GTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQDHEK 356
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 52/215 (24%)
Query: 348 LGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV--------VLVAKLQHRNL 398
+G+G FG+V + AVK L + + K E VL+ ++H L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVLLKNVKHPFL 101
Query: 399 VRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS-----------------------QLRI 434
V L F + +K+ V +++ L Y L L I
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 435 IHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPE---YAMH 489
++RDLK NILLD Q + ++DFGL + I T +T GT Y++PE +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST--FCGTPEYLAPEVLHKQPY 216
Query: 490 GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
+V D + G + E + G FY + AE
Sbjct: 217 D-RTV--DWWCLGAVLYEMLYGL--PPFYSRNTAE 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 50/212 (23%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEF---KNE 386
DF+ + LG G FG V+ H A+K L + ++ +E
Sbjct: 7 DFQILRT----------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 56
Query: 387 VVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDSQ-------------- 431
++++ + H ++R+ + ++I ++ +++ L L SQ
Sbjct: 57 RLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 432 ---------LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
II+RDLK NILLD + KI+DFG A+ T + GT Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYI 170
Query: 483 SPE---YAMHGQFSVKSDVYSFGVLALETITG 511
+PE + + S+ D +SFG+L E + G
Sbjct: 171 APEVVSTKPYNK-SI--DWWSFGILIYEMLAG 199
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 60/220 (27%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV-- 387
DF + V +GRG + +V L I A+K + + ++
Sbjct: 10 DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND----DEDIDW 55
Query: 388 ------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS---------- 430
V H LV L C + + ++ V E+V L + +
Sbjct: 56 VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 431 -------------QLRIIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRI 475
+ II+RDLK N+LLD + + K++D+G+ + + D T +T
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--ST--F 170
Query: 476 VGTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGK 512
GT Y++PE +G FSV D ++ GVL E + G+
Sbjct: 171 CGTPNYIAPEILRGEDYG-FSV--DWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 62/232 (26%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV-- 387
DF ++ LG+G FG+V+ + A+K L + ++V
Sbjct: 18 DFILHKM----------LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM----DDDVEC 63
Query: 388 ------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS---------- 430
VL +H L + + E + V E++ L Y +
Sbjct: 64 TMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 122
Query: 431 -------------QLRIIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRI 475
I++RDLK NILLD + KI+DFG+ + + G +T NT
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT--F 178
Query: 476 VGTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE 524
GT Y++PE + SV D +SFGVL E + G+ S F+ D E
Sbjct: 179 CGTPDYIAPEILLGQKYN-HSV--DWWSFGVLLYEMLIGQ--SPFHGQDEEE 225
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 50/203 (24%)
Query: 348 LGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV--------VLVAKLQHRNL 398
+GRG + +V L I A++ + + ++ V H L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND----DEDIDWVQTEKHVFEQASNHPFL 115
Query: 399 VRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDS-----------------------QLRI 434
V L C + + ++ V E+V L + + + I
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 435 IHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRIVGTYGYMSPE---YAMH 489
I+RDLK N+LLD + + K++D+G+ + + D T +T GT Y++PE +
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--ST--FCGTPNYIAPEILRGEDY 230
Query: 490 GQFSVKSDVYSFGVLALETITGK 512
G FSV D ++ GVL E + G+
Sbjct: 231 G-FSV--DWWALGVLMFEMMAGR 250
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 63/229 (27%)
Query: 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEI-AVKRLSRSSGQGAQEFKNEV-- 387
DF +++ LG+G FG+V A+K L + K+EV
Sbjct: 6 DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKEVIIA----KDEVAH 51
Query: 388 ------VLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDSQ--------- 431
VL +H L L + + +++ V E+ L + L +
Sbjct: 52 TVTESRVL-QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 432 --------------LRIIHRDLKASNILLDVQMNPKISDFGLAR--IFGVDQTQGNTSRI 475
+++RD+K N++LD + KI+DFGL + I T
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT--F 165
Query: 476 VGTYGYMSPE---YAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521
GT Y++PE +G+ +V D + GV+ E + G+ FY D
Sbjct: 166 CGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQD 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/253 (24%), Positives = 98/253 (38%), Gaps = 58/253 (22%)
Query: 301 FLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTI--EVATNKFSSDNKLGRGGFGEVYK 358
F + KK V D+D +D+ E +++ D+ +G+G FG+V K
Sbjct: 20 FQSMSSHKKERKVYNDGYDDD-------NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVK 72
Query: 359 GV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR------NLVRLLGF------- 404
+ +A+K + ++ + + EV L+ + +V L
Sbjct: 73 AYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131
Query: 405 CL--EGDEKIL---VYEFV-PNK----SLDY-------------FLYDSQLRIIHRDLKA 441
CL E +L +Y+ + SL+ FL +L IIH DLK
Sbjct: 132 CLVFE----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187
Query: 442 SNILLDVQMNP--KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
NILL KI DFG + G Q SR Y SPE + + + D++
Sbjct: 188 ENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGMPYDLAIDMW 242
Query: 500 SFGVLALETITGK 512
S G + +E TG+
Sbjct: 243 SLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 41/179 (22%), Positives = 69/179 (38%), Gaps = 39/179 (21%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH-RN 397
N++ K+G G FG++Y G + G+E+A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------ 433
+ + EGD ++V E + SL+ L++ R
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 434 -IIHRDLKASNILLDVQMNPK---ISDFGLARIFGVDQTQG-----NTSRIVGTYGYMS 483
IHRD+K N L+ + I DFGLA+ + +T + GT Y S
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 44/213 (20%), Positives = 82/213 (38%), Gaps = 53/213 (24%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ----------- 394
KLG G F V+ + + +A+K + R + ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 395 HRNLVRLLG-FCLEGDEKI---LVYEF----------------VPNKSLDYFLYD----- 429
++++LL F +G + +V+E +P +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 430 ----SQLRIIHRDLKASNILLDVQMNP------KISDFGLARIFGVDQTQGNTSRIVGTY 479
+ IIH D+K N+L+++ +P KI+D G A + T +R
Sbjct: 145 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE---- 200
Query: 480 GYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
Y SPE + + +D++S L E ITG
Sbjct: 201 -YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 31/197 (15%), Positives = 62/197 (31%), Gaps = 55/197 (27%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEI------AVKRLSRSSGQGAQEFK-----NEVV 388
+ +G+GGFG +Y + + + VK +G E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 389 LVAKLQHRNLVRLLGFC----------LEGDEKILVYEFVPNKSLDYFLYDSQLR----- 433
+ K ++ LG + ++ + L +Y++ +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRK 152
Query: 434 --------------------IIHRDLKASNILLDVQMNPKI--SDFGLARIFGVDQT--- 468
+H D+KASN+LL+ + ++ D+GLA + +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 469 --QGNTSRIVGTYGYMS 483
GT + S
Sbjct: 213 YAADPKRCHDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 41/182 (22%), Positives = 63/182 (34%), Gaps = 43/182 (23%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH-RN 397
F K+G G FGE+ G L + +A+K S + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------ 433
+ ++ F G +V E + SL+ L+D R
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 434 -IIHRDLKASNILLDVQMNPK-----ISDFGLARIFGVDQTQG------NTSRIVGTYGY 481
+I+RD+K N L+ N I DF LA+ + +D + GT Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPETKKHIPYREHKSLTGTARY 183
Query: 482 MS 483
MS
Sbjct: 184 MS 185
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 37/183 (20%), Positives = 66/183 (36%), Gaps = 45/183 (24%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHR 396
+ ++G G FG +++G L + Q++A+K R S Q E++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR---TYKLLAGCT 66
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR----------------------- 433
+ + F EG +LV + + SL+ L D R
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 434 --IIHRDLKASNILLDVQMNPK-----ISDFGLARIFGVDQTQGN------TSRIVGTYG 480
+++RD+K N L+ + + DFG+ + + D + GT
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLSGTAR 183
Query: 481 YMS 483
YMS
Sbjct: 184 YMS 186
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 31/197 (15%), Positives = 59/197 (29%), Gaps = 55/197 (27%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV---------LPHGQEIAVKRLSRSSGQGAQEFKNEVVLV 390
++ + R G +Y+ P Q+ ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 391 AKLQHRNLVRL-----LGF-------CLEGDEKILVYEFVPNKSLDYFLYDSQLR----- 433
LQ +L L + + LV + +SL L S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 434 --------------------IIHRDLKASNILLDVQMNPKI--SDFGLARIF-----GVD 466
+H ++ A NI +D + ++ + +G A + V
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 467 QTQGNTSRIVGTYGYMS 483
+G+ S G ++S
Sbjct: 220 YVEGSRSPHEGDLEFIS 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 39/179 (21%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL 398
NKF K+G G FGE+Y G + +E+A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 399 V-RLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------ 433
+ + F +EGD +LV + + SL+ L++ R
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 434 -IIHRDLKASNILLDVQMNPK---ISDFGLARIFGVDQTQG-----NTSRIVGTYGYMS 483
+HRD+K N L+ + I DFGLA+ + T + GT Y S
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 34/193 (17%), Positives = 63/193 (32%), Gaps = 50/193 (25%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIA---VKRLSRSSGQGAQEFK-----NEVVLV 390
N++ K+G GGFG +Y ++ A VK + +G E K + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 391 AKLQHRNLVRLLGF----------CLEGDEKILVYEFVPNKSL-DYFLYDSQL------- 432
K R + LG + +V E + L +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQ 155
Query: 433 ---------------RIIHRDLKASNILLDVQMNPKI--SDFGLARIFGVDQT-----QG 470
+H D+KA+N+LL + ++ +D+GL+ + + +
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 471 NTSRIVGTYGYMS 483
GT + S
Sbjct: 216 PRKGHNGTIEFTS 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 47/214 (21%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ 394
+ ++ +G+G FG+V K Q +A+K + R+ + ++ E+ ++ L+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLR 151
Query: 395 HR------NLVRLLGF-------CL--EGDEKIL---VYEFVPNKSLDYF------LYDS 430
+ N++ +L C+ E +L +YE + F +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKFQGFSLPLVRKFAH 207
Query: 431 QL----------RIIHRDLKASNILLDVQMNP--KISDFGLARIFGVDQTQGNTSRIVGT 478
+ RIIH DLK NILL Q K+ DFG + Q + +
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQR---VYTYIQS 262
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
Y +PE + ++ + D++S G + E +TG
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 5e-07
Identities = 86/601 (14%), Positives = 170/601 (28%), Gaps = 174/601 (28%)
Query: 10 FLFLCF-------VSNFLGFTTAADPNY------LAHFC----PNTTTF--TRNSTFQSN 50
LF V F+ NY + T + R+ + N
Sbjct: 66 RLFWTLLSKQEEMVQKFVE--EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 51 LNLFLSSLPTNASRSNGFSG---CFYNATAGQPSYSDRVYGLFRCRGD--LGSTACQDC- 104
+F N SR + +P+ + + G+ G + C
Sbjct: 124 -QVFA---KYNVSRLQPYLKLRQALLEL---RPAKNVLIDGVLGS-GKTWVALDVCLSYK 175
Query: 105 --VTFATK----NVTQRCPVEKRTTILFDECLLRYSNQSFFSNSDMSSQLSMWNLQNVTE 158
K N+ E +L + LL + ++ S SD SS + + + ++
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEML--QKLLYQIDPNWTSRSDHSSNIKL-RIHSIQ- 231
Query: 159 PDKFNVFLGNLMNQ---VITQAVNNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVC 215
+ L + + ++ V N K + AF + C L++R +V
Sbjct: 232 -AELRRLLKSKPYENCLLVLLNVQNAKAWN-------AFN-----LSCKILLTTRFKQVT 278
Query: 216 LRGALGQLPRCCSGRQGGRVLYPSCNLRYESYPFYNE-------SAIAVPPSPPPPASVT 268
L + S L + S + + P P +T
Sbjct: 279 D--FLS----------AATTTHIS--LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324
Query: 269 RLQGKSGLSSSTIIAIVAPIVV--IAVLFIAGLC---FLRRRAEKKYNAVLEQNADNDIT 323
P + IA GL + K ++E +
Sbjct: 325 ----------------TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE-------S 361
Query: 324 TLESLQFD-----FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS-- 376
+L L+ F + V F + ++ V+ + V +L + S
Sbjct: 362 SLNVLEPAEYRKMFDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417
Query: 377 GQGAQEFK---NEVVLVAKLQ-------HRNLVR----LLGFCLEG------DEKI---L 413
+ +E + L K++ HR++V F + D+ +
Sbjct: 418 EKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI 477
Query: 414 VY-----------EFVPNKSLDY-FLYDSQLRIIHRDL--KASNILLDVQMNPKISDFGL 459
+ LD+ FL + +I H AS +L+ +
Sbjct: 478 GHHLKNIEHPERMTLFRMVFLDFRFL---EQKIRHDSTAWNASGSILNT-----LQQLKF 529
Query: 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519
+ + D R+V P+ + S +D+ +AL ++ + ++
Sbjct: 530 YKPYICDN-DPKYERLVNAILDFLPKIEENLICSKYTDLLR---IALMA----EDEAIFE 581
Query: 520 T 520
Sbjct: 582 E 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 9e-06
Identities = 36/262 (13%), Positives = 74/262 (28%), Gaps = 77/262 (29%)
Query: 357 YKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH-------RNLVRLLGFCLEGD 409
YK +L ++ V + Q+ ++ ++ H + L + L
Sbjct: 18 YKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 410 EKILVYEFV-----PN--------------KSLDYFLYDSQLRIIHRDLKASNILLDVQM 450
++ +V +FV N S+ +Y Q ++ D
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND------------ 122
Query: 451 NPKISDFGLARIFGVDQ-----TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505
N + + ++R+ + + ++ V G + G S K+ +A
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG-------VLG--SGKT------WVA 167
Query: 506 LETITGKK------NSSFYQTDGAEDLLSYEDPADRPSM-----ATIVLALNSHSVTLSV 554
L+ K F+ + P M I S S S
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLK-----NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 555 PRQPALFIGSRTERSFPEREFE 576
+ I + R + +E
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYE 244
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 9e-07
Identities = 34/225 (15%), Positives = 62/225 (27%), Gaps = 75/225 (33%)
Query: 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS--------GQGAQEFKNEVV 388
+ T K K+G G FGEV++ + H +A+K ++ + +E E++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 389 LVAKLQ---------HRNLVRLLGFCL------------------------------EGD 409
+ +L + L + D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 410 EKILVYEFVPN-KSLDYF----------------------LYDSQLRIIHRDLKASNILL 446
+ +V EF L+ + ++ LR HRDL N+LL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
K+ + + + V Y G
Sbjct: 196 KKTSLKKLHYTLNGKSSTI----PSCGLQVSIIDYTLSRLERDGI 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 30/141 (21%), Positives = 46/141 (32%), Gaps = 56/141 (39%)
Query: 421 KSLDYFLYDSQLRIIHRDLKASNILLDV-------------------------------- 448
+ LDY ++ RIIH D+K NILL V
Sbjct: 157 QGLDYL--HTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 449 -----------------QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
++ KI+D G A T+ + T Y S E +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSG 269
Query: 492 FSVKSDVYSFGVLALETITGK 512
++ +D++S +A E TG
Sbjct: 270 YNTPADIWSTACMAFELATGD 290
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 30/202 (14%), Positives = 57/202 (28%), Gaps = 38/202 (18%)
Query: 296 IAGL----CFLRRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSD---NKL 348
A + + V + D + +T + ++ D +
Sbjct: 39 HARIGEEKARNILKYLSDLRVVQNRQKDYEGSTFTFIGLSLYSLHRLVRSGKVDAIGKLM 98
Query: 349 GRGGFGEVYKGVLPHGQEIAVK--RLSRSS--------GQGAQEFKNEVVLVAKLQHRNL 398
G G V+ E VK ++ +S G F + A+ + R L
Sbjct: 99 GEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158
Query: 399 VRLLGFC----LEGDEKILVYEFV-------PNKSLDYFLYD---------SQLRIIHRD 438
+L G + ++ E + + D I+H D
Sbjct: 159 QKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGD 218
Query: 439 LKASNILLDVQMNPKISDFGLA 460
L N+L+ + I DF +
Sbjct: 219 LSQYNVLVSEEG-IWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 601 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.95 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.87 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.5 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.61 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.93 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.55 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.25 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.04 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.12 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.88 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.54 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 85.45 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.94 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=390.11 Aligned_cols=211 Identities=29% Similarity=0.480 Sum_probs=177.3
Q ss_pred hcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
..++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++|+|||||+++|++.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3467888899999999999999853 3678999999877777778899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 412 ILVYEFVPNKSLDYFL------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
+|||||+++|+|.+++ |+|+++||||||||+||||++++++||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999997654 5699999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc---------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--------- 525 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--------- 525 (601)
|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......+...
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 250 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 250 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999987654433333344578999999999999999999999999999999999 899997644222111
Q ss_pred -----------cc---CccCCCCCCCHHHHHHHHhcC
Q 007490 526 -----------LL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 -----------l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ ...||.+|||+.||++.|++.
T Consensus 251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 251 RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 117999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=393.26 Aligned_cols=211 Identities=31% Similarity=0.495 Sum_probs=170.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++|+|||||+++|++.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456777889999999999999853 47889999998777777788999999999999999999999999999999
Q ss_pred EEEeccCCCCccccc--------------------------------------ccccceeeccccccCcEEEccCCCcEE
Q 007490 413 LVYEFVPNKSLDYFL--------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 413 lv~E~~~~gsL~~~l--------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
|||||+++|+|.+++ |+|+++||||||||+||||++++++||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 999999999997653 669999999999999999999999999
Q ss_pred eecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc------
Q 007490 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL------ 527 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~------ 527 (601)
+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||...........+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~ 279 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987654433333445679999999999999999999999999999999999 89998754322111111
Q ss_pred -----------------CccCCCCCCCHHHHHHHHhcCC
Q 007490 528 -----------------SYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 528 -----------------~~~dP~~RPt~~evl~~L~~~~ 549 (601)
...||.+|||+.||+++|+...
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 1179999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=387.19 Aligned_cols=210 Identities=31% Similarity=0.499 Sum_probs=175.3
Q ss_pred cCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
..++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|++.+++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 345667789999999999999862 4678999999754 334467899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCc
Q 007490 412 ILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNP 452 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~ 452 (601)
+|||||+++|+|.++| |+|+++||||||||+||||++++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 9999999999997654 5689999999999999999999999
Q ss_pred EEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccC---
Q 007490 453 KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS--- 528 (601)
Q Consensus 453 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~--- 528 (601)
||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+....+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~ 264 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987654433333445689999999999999999999999999999999998 899987654322211111
Q ss_pred --------------------ccCCCCCCCHHHHHHHHhcC
Q 007490 529 --------------------YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 529 --------------------~~dP~~RPt~~evl~~L~~~ 548 (601)
..||.+|||+.||++.|++-
T Consensus 265 ~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 265 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 17999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=384.67 Aligned_cols=216 Identities=30% Similarity=0.476 Sum_probs=171.3
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.|++..+++++.++||+|+||+||+|++. ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 35666788899999999999999999974 35999998653 34556789999999999999999999998865 568
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+|||||+++|+|.+++ |+|+++||||||||+||||++++++||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999998766 6799999999999999999999999999999998765433
Q ss_pred CccccccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------- 523 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------- 523 (601)
.........||+.|||||++.+ ++|+.++|||||||+||||+||+.||........
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 3333455689999999999863 4689999999999999999999999965332100
Q ss_pred ----cccc---CccCCCCCCCHHHHHHHHhcCCCCC
Q 007490 524 ----EDLL---SYEDPADRPSMATIVLALNSHSVTL 552 (601)
Q Consensus 524 ----~~l~---~~~dP~~RPt~~evl~~L~~~~~~~ 552 (601)
.+++ ...||.+|||+.||+++|+.....+
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 0011 1179999999999999987654333
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=386.10 Aligned_cols=203 Identities=28% Similarity=0.407 Sum_probs=174.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356888999999999999999954 6999999999766555567789999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|+|.+++ |+|+++||||||||+||||+.++++||+|||+++.+.... ......
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCC
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccccc
Confidence 9999998766 7799999999999999999999999999999999765432 234457
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------------cc---cCcc
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------------DL---LSYE 530 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------------~l---~~~~ 530 (601)
+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ++ +...
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999654321110 11 1127
Q ss_pred CCCCCCCHHHHHH
Q 007490 531 DPADRPSMATIVL 543 (601)
Q Consensus 531 dP~~RPt~~evl~ 543 (601)
||.+|||+.|+++
T Consensus 311 dP~~R~ta~e~l~ 323 (346)
T 4fih_A 311 DPAQRATAAELLK 323 (346)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=386.18 Aligned_cols=202 Identities=27% Similarity=0.412 Sum_probs=167.0
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|+++++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++|+|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 46999999999754 34456789999999999999999999999999999999999
Q ss_pred ccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 417 FVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 417 ~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|+++|+|.+++ |+|+++||||||||+||||+.++++||+|||+++.+.... ..
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--EL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--cc
Confidence 99999997765 6699999999999999999999999999999998764221 12
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------ccc---cC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------EDL---LS 528 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------~~l---~~ 528 (601)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .++ +.
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 261 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 3446899999999999999999999999999999999999999975432111 111 11
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+|||+.|+++
T Consensus 262 ~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 262 KRNPRDRPSVNSILE 276 (350)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhHCcCHHHHhc
Confidence 279999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=379.38 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=173.7
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++|+|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999995 46899999999753 2334577899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|+|.+++ |+|+++|+||||||+|||++.++++||+|||+++.+.........
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 999999998776 679999999999999999999999999999999987655444455
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-------------------c---cCcc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-------------------L---LSYE 530 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-------------------l---~~~~ 530 (601)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||.......... + +...
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~ 271 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCS
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccC
Confidence 66799999999999999999999999999999999999999997543221111 1 1127
Q ss_pred CCCCCCCHHHHH
Q 007490 531 DPADRPSMATIV 542 (601)
Q Consensus 531 dP~~RPt~~evl 542 (601)
||.+|||+.|++
T Consensus 272 dp~~R~t~~e~~ 283 (311)
T 4aw0_A 272 DATKRLGCEEME 283 (311)
T ss_dssp SGGGSTTSGGGT
T ss_pred CHhHCcChHHHc
Confidence 899999888763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.55 Aligned_cols=204 Identities=28% Similarity=0.412 Sum_probs=175.8
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 346799999999999999999995 4699999999987666666778999999999999999999999999999999999
Q ss_pred ccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 417 FVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 417 ~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
|+++|+|.+++ |+|+++||||||||+||||+.+|.+||+|||+++.+.... .....
T Consensus 229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~ 306 (423)
T 4fie_A 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 306 (423)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCC
T ss_pred CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccc
Confidence 99999998766 7799999999999999999999999999999998765432 23445
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------ccc---cCc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------EDL---LSY 529 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~~l---~~~ 529 (601)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .++ +..
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 7899999999999999999999999999999999999999965432111 011 112
Q ss_pred cCCCCCCCHHHHHH
Q 007490 530 EDPADRPSMATIVL 543 (601)
Q Consensus 530 ~dP~~RPt~~evl~ 543 (601)
.||.+|||+.|+++
T Consensus 387 ~dP~~R~ta~ell~ 400 (423)
T 4fie_A 387 RDPAQRATAAELLK 400 (423)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhc
Confidence 79999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=377.81 Aligned_cols=205 Identities=26% Similarity=0.319 Sum_probs=169.1
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..+.|++.++||+|+||.||+|++ .+|+.||||+++.... ..+|+.++++|+|||||++++++.+++..|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 345688889999999999999995 4589999999975432 2479999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCcc--
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQG-- 470 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~-- 470 (601)
|+++|+|.+++ |+|+++||||||||+||||+.++ ++||+|||+++.+.......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999998876 67999999999999999999987 69999999999875432211
Q ss_pred -ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc----------------------cc
Q 007490 471 -NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED----------------------LL 527 (601)
Q Consensus 471 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~----------------------l~ 527 (601)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... ++
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 290 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHH
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHH
Confidence 2234679999999999999999999999999999999999999997543322111 00
Q ss_pred ---CccCCCCCCCHHHHHHHHhc
Q 007490 528 ---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+|||+.||++.|..
T Consensus 291 ~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 291 QEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHH
Confidence 11799999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=377.28 Aligned_cols=222 Identities=30% Similarity=0.442 Sum_probs=183.8
Q ss_pred cccccchhhhhhhcCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCC-CC
Q 007490 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQH-RN 397 (601)
Q Consensus 326 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pn 397 (601)
+.+.++..++++..++|++.++||+|+||+||+|++.. ++.||||++.... ....+.|.+|+++|.+++| ||
T Consensus 50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 34566777889999999999999999999999998532 3579999997654 3445679999999999965 99
Q ss_pred ccceEEEEEeC-CeeEEEEeccCCCCccccc---------------------------------------ccccceeecc
Q 007490 398 LVRLLGFCLEG-DEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHR 437 (601)
Q Consensus 398 Iv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHr 437 (601)
||+++|+|.+. +..+|||||+++|+|.++| |+|+++||||
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR 209 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 209 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC
Confidence 99999999764 5689999999999997654 5689999999
Q ss_pred ccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCC
Q 007490 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSS 516 (601)
Q Consensus 438 dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 516 (601)
||||+|||+++++++||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997755444334455678999999999999999999999999999999998 899997
Q ss_pred CCCCCc-ccccc-----------------------CccCCCCCCCHHHHHHHHhc
Q 007490 517 FYQTDG-AEDLL-----------------------SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 517 ~~~~~~-~~~l~-----------------------~~~dP~~RPt~~evl~~L~~ 547 (601)
...... ....+ ...||.+|||+.||++.|+.
T Consensus 290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 644221 11110 01799999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.90 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=155.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ......+.+|+++|++++|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999995 469999999997542 334567899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+ +|+|.+++ |+|+++|+||||||+|||+++++++||+|||+|+...... ..
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~ 168 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FL 168 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---cc
Confidence 999 56776554 6799999999999999999999999999999998754322 23
Q ss_pred ccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---cCc
Q 007490 473 SRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---LSY 529 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~~~ 529 (601)
...+||+.|||||++.+..+ +.++||||+||++|||++|+.||........ .++ +..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSC
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 34689999999999998876 5899999999999999999999975432111 111 112
Q ss_pred cCCCCCCCHHHHHH
Q 007490 530 EDPADRPSMATIVL 543 (601)
Q Consensus 530 ~dP~~RPt~~evl~ 543 (601)
.||.+|||+.|+++
T Consensus 249 ~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 249 VNPLNRISIHEIMQ 262 (275)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHc
Confidence 79999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=358.64 Aligned_cols=196 Identities=30% Similarity=0.439 Sum_probs=160.9
Q ss_pred CcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe----CCeeEEEE
Q 007490 343 SSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GDEKILVY 415 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 415 (601)
++.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++|+|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999954 5889999998653 34456789999999999999999999999875 34579999
Q ss_pred eccCCCCccccc-----------------------ccccce--eeccccccCcEEEcc-CCCcEEeecccceecCCCCCc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLR--IIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~--iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||+++|+|.+++ |+|+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----
Confidence 999999998776 679888 999999999999984 79999999999986432
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------cccc-
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDL- 526 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l- 526 (601)
......+||+.|||||++.+ +|+.++|||||||++|||++|+.||....... ..++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 22345689999999998864 69999999999999999999999996432110 0011
Q ss_pred --cCccCCCCCCCHHHHHH
Q 007490 527 --LSYEDPADRPSMATIVL 543 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~ 543 (601)
+...||.+|||+.|+++
T Consensus 264 ~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 11179999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=366.89 Aligned_cols=178 Identities=29% Similarity=0.347 Sum_probs=149.0
Q ss_pred CCCCcCCcccccCcceEEeeecC----CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
++|++.+.||+|+||+||+|+.. .++.||||++.+.. ......+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999842 46789999996542 2233468899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++|+|.+++ |+|+++|+||||||+|||++.++++||+|||+|+...... .
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--c
Confidence 99999999998766 6799999999999999999999999999999998654322 2
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 2345689999999999999999999999999999999999999997543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.55 Aligned_cols=174 Identities=27% Similarity=0.366 Sum_probs=141.1
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC----eeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----EKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~ 415 (601)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...++.|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 6899999999654322 223345677778899999999999998754 579999
Q ss_pred eccCCCCccccc----------------------ccccc--------eeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 416 EFVPNKSLDYFL----------------------YDSQL--------RIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~--------~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
||+++|+|.+++ |+|+. +||||||||+||||+.++++||+|||+++....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999998876 55765 999999999999999999999999999987654
Q ss_pred CCCcc--ccccccccccccCcccccCC------CCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 466 DQTQG--NTSRIVGTYGYMSPEYAMHG------QFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 466 ~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
..... .....+||+.|||||++.+. .++.++|||||||+||||+||++|+
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 33221 22345799999999998754 4778999999999999999997765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=353.86 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=154.5
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC--------
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-------- 409 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 409 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999995 468999999997544 344567899999999999999999999987654
Q ss_pred ----eeEEEEeccCCCCccccc--------------------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 410 ----EKILVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 410 ----~~~lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
..||||||+++|+|.+++ |+|+++|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 368999999999987654 67999999999999999999999999999999
Q ss_pred ceecCCCCCcc----------ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC--------
Q 007490 460 ARIFGVDQTQG----------NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-------- 521 (601)
Q Consensus 460 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-------- 521 (601)
|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||......
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 98775432211 1234579999999999999999999999999999999996 55321100
Q ss_pred -------------ccccc---cCccCCCCCCCHHHHHH
Q 007490 522 -------------GAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 522 -------------~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
...++ +...||.+|||+.|+++
T Consensus 242 ~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011 12279999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=352.75 Aligned_cols=179 Identities=23% Similarity=0.371 Sum_probs=149.7
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------C
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------D 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 409 (601)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++|+|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46799999999999999999995 469999999997542 34456788999999999999999999997643 5
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
..||||||++ |+|..++ |+|++|||||||||+|||++.++.+||+|||+++.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 6899999997 4565544 779999999999999999999999999999999876432
Q ss_pred C--CccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 Q--TQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
. ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 2 12234457899999999998875 4689999999999999999999999653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.32 Aligned_cols=180 Identities=24% Similarity=0.349 Sum_probs=151.6
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCC
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGD 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 409 (601)
+....++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3345688999999999999999999742 46789999986543 345678999999998 6999999999999999
Q ss_pred eeEEEEeccCCCCccccc--------------------ccccceeeccccccCcEEEccC-CCcEEeecccceecCCCCC
Q 007490 410 EKILVYEFVPNKSLDYFL--------------------YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l--------------------~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~ 468 (601)
..||||||+++++|.+++ |+|++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 999999999999987765 7799999999999999999877 7899999999986543211
Q ss_pred c--------------------------cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 469 Q--------------------------GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 469 ~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
. ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 0 112345799999999999876 48999999999999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=360.71 Aligned_cols=203 Identities=24% Similarity=0.364 Sum_probs=174.3
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++|+|||||++++++.+++..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999995 46999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccC--CCcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQ--MNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~--~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++|+|.+++ |+|+++|+||||||+|||++.+ +.+||+|||+++.+.... .
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---E
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---c
Confidence 9999986654 6799999999999999999854 889999999999875432 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------ccc--
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------EDL-- 526 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~l-- 526 (601)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .++
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 3446899999999999999999999999999999999999999965432111 111
Q ss_pred -cCccCCCCCCCHHHHHHH
Q 007490 527 -LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 527 -~~~~dP~~RPt~~evl~~ 544 (601)
+...||.+|||+.|+++.
T Consensus 393 ~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 122799999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.81 Aligned_cols=177 Identities=30% Similarity=0.408 Sum_probs=151.0
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHH---HHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFK---NEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
-++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+. .++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999954 69999999996532 12223333 345666777999999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||||||++||+|..++ |+|++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 9999999999998766 7799999999999999999999999999999998765332
Q ss_pred ccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||....
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 345689999999999975 579999999999999999999999996543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.14 Aligned_cols=220 Identities=37% Similarity=0.605 Sum_probs=186.0
Q ss_pred ccchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 329 QFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 329 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
.+.+.+++...++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34556677788999999999999999999999888999999998877666778899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 409 DEKILVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999997665 5589999999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc----------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED---------------- 525 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~---------------- 525 (601)
...............||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 7543333223344568999999999999999999999999999999999999986533221110
Q ss_pred -----------------------ccCccCCCCCCCHHHHHHHHhcC
Q 007490 526 -----------------------LLSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 -----------------------l~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+...||.+|||+.|+++.|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11127999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.49 Aligned_cols=205 Identities=28% Similarity=0.441 Sum_probs=174.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 3457899999999999999999984 568999999997666556678899999999999999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 174 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (297)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBC
T ss_pred ECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccC
Confidence 999999998765 67999999999999999999999999999999987654332 233
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------cccc---cC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDL---LS 528 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l---~~ 528 (601)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..++ +.
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence 4579999999999999999999999999999999999999986543210 0111 11
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+|||+.|+++
T Consensus 255 ~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 255 EMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred cCChhHCcCHHHHhh
Confidence 279999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.44 Aligned_cols=217 Identities=30% Similarity=0.447 Sum_probs=171.1
Q ss_pred chhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
+...+++..++|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 4455667788999999999999999999987 68899999987653 34456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc--------------------------ccccce--eeccccccCcEEEccCCCcEEeecccc
Q 007490 409 DEKILVYEFVPNKSLDYFL--------------------------YDSQLR--IIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l--------------------------~~h~~~--iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
+..++||||+++++|..++ ++|+.+ |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999999987655 569999 999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE---------------- 524 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~---------------- 524 (601)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 3p86_A 187 RLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred ccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 8643321 1233457899999999999999999999999999999999999999754322111
Q ss_pred -----cc---cCccCCCCCCCHHHHHHHHhcCCC
Q 007490 525 -----DL---LSYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 525 -----~l---~~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
++ +...||.+|||+.++++.|+....
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11 112799999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.88 Aligned_cols=211 Identities=27% Similarity=0.440 Sum_probs=177.3
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.++||+|+||.||++++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467888999999999999999954 5899999999777777788899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc---
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG--- 470 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--- 470 (601)
+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 9999997665 5699999999999999999999999999999998764332211
Q ss_pred ---------ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-----------------
Q 007490 471 ---------NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------- 524 (601)
Q Consensus 471 ---------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------- 524 (601)
......||+.|+|||++.+..++.++||||||+++|||++|..|+.........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTC
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCC
Confidence 111457999999999999999999999999999999999999988654332211
Q ss_pred -----cc---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 525 -----DL---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 525 -----~l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
++ +...||.+|||+.++++.|+...
T Consensus 249 ~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 249 PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 11279999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.01 Aligned_cols=222 Identities=40% Similarity=0.710 Sum_probs=184.1
Q ss_pred cccchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEE
Q 007490 328 LQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406 (601)
Q Consensus 328 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 406 (601)
..+++.+++...++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 35678899999999999999999999999999988899999999976432 22346899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCccccc---------------------------ccccc---eeeccccccCcEEEccCCCcEEee
Q 007490 407 EGDEKILVYEFVPNKSLDYFL---------------------------YDSQL---RIIHRDLKASNILLDVQMNPKISD 456 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l---------------------------~~h~~---~iiHrdlkp~NIll~~~~~~kL~D 456 (601)
..+..++||||+++++|..++ ++|+. +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 999999999999999987654 55888 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-----------------
Q 007490 457 FGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ----------------- 519 (601)
Q Consensus 457 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~----------------- 519 (601)
||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 178 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999987653322 22334569999999999998999999999999999999999999985110
Q ss_pred -CCc--------------------cccc---cCccCCCCCCCHHHHHHHHhcCCC
Q 007490 520 -TDG--------------------AEDL---LSYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 520 -~~~--------------------~~~l---~~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
... ..++ +...||.+|||+.||+++|++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 000 0011 112799999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.16 Aligned_cols=212 Identities=28% Similarity=0.427 Sum_probs=176.0
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC--------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
+...++|++.+.||+|+||.||+|++. ++..||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 445678999999999999999999742 35579999997653 34567799999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEE
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILL 446 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll 446 (601)
.+.+..++||||+++|+|.+++ |+|+.+|+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 9999999999999999986543 5699999999999999999
Q ss_pred ccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc
Q 007490 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED 525 (601)
Q Consensus 447 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 525 (601)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987654433333344567889999999999999999999999999999999 999987644322111
Q ss_pred c-----------------------cCccCCCCCCCHHHHHHHHhc
Q 007490 526 L-----------------------LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 526 l-----------------------~~~~dP~~RPt~~evl~~L~~ 547 (601)
. +...||.+||++.|+++.|+.
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 111799999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.25 Aligned_cols=205 Identities=27% Similarity=0.435 Sum_probs=173.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
...++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999995 57999999998654 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--- 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence 99999999987665 6699999999999999999999999999999998664332
Q ss_pred ccccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---c
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---L 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~ 527 (601)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||......... ++ +
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 248 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 23456799999999999888775 8999999999999999999999754322111 11 1
Q ss_pred CccCCCCCCCHHHHHHH
Q 007490 528 SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~ 544 (601)
...||.+|||+.|+++.
T Consensus 249 L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 249 LVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCSSTTTSCCHHHHTTC
T ss_pred CCCChhHCcCHHHHhcC
Confidence 22799999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.98 Aligned_cols=212 Identities=25% Similarity=0.331 Sum_probs=172.3
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC----e
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----E 410 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~ 410 (601)
+....++|++.++||+|+||.||+|++ .++.||||++..... ......+|+.++++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 345567899999999999999999987 489999999965433 3345567999999999999999999998754 3
Q ss_pred eEEEEeccCCCCccccc----------------------ccccc----------eeeccccccCcEEEccCCCcEEeecc
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQL----------RIIHRDLKASNILLDVQMNPKISDFG 458 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~----------~iiHrdlkp~NIll~~~~~~kL~Dfg 458 (601)
.++||||+++++|.+++ ++|+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 69999999999998765 56888 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------
Q 007490 459 LARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------- 522 (601)
Q Consensus 459 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------- 522 (601)
+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9988765444334445679999999999986 356678999999999999999999986432110
Q ss_pred -------------------------------cccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 523 -------------------------------AEDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 523 -------------------------------~~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
..++ +...||.+|||+.||++.|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 1127999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.80 Aligned_cols=214 Identities=30% Similarity=0.439 Sum_probs=175.6
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.++...++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 45566778999999999999999999975 68999999987543 33445688999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999987665 6699999999999999999999999999999998654322
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------cc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DL 526 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l 526 (601)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......... ++
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111122345778999999998999999999999999999998 99998654321111 11
Q ss_pred c---CccCCCCCCCHHHHHHHHhc
Q 007490 527 L---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+ ...||.+|||+.+|++.|+.
T Consensus 348 i~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHHHHH
Confidence 1 12799999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.77 Aligned_cols=201 Identities=27% Similarity=0.429 Sum_probs=171.1
Q ss_pred CCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 342 FSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666789999999999999965 6999999999876666677899999999999999999999999999999999999999
Q ss_pred CCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccccccc
Q 007490 421 KSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478 (601)
Q Consensus 421 gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 478 (601)
++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++........ ......||
T Consensus 127 ~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt 204 (321)
T 2c30_A 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGT 204 (321)
T ss_dssp CBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSC
T ss_pred CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCC
Confidence 9987754 66999999999999999999999999999999987653322 23345799
Q ss_pred ccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------cccc---cCccCCC
Q 007490 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDL---LSYEDPA 533 (601)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l---~~~~dP~ 533 (601)
+.|+|||++.+..++.++||||||+++|||++|+.||....... ..++ +...||.
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999999999999986432110 0111 1127999
Q ss_pred CCCCHHHHHHH
Q 007490 534 DRPSMATIVLA 544 (601)
Q Consensus 534 ~RPt~~evl~~ 544 (601)
+|||+.|+++.
T Consensus 285 ~Rps~~ell~h 295 (321)
T 2c30_A 285 ERATAQELLDH 295 (321)
T ss_dssp TSCCHHHHHTS
T ss_pred hCcCHHHHhcC
Confidence 99999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.82 Aligned_cols=204 Identities=25% Similarity=0.316 Sum_probs=170.8
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.||+|+||.||+++.. +|+.||||++.+. .......+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999954 6899999999654 233456788999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++|+|..++ ++|+++|+||||||+|||++.++++||+|||+++...... ..
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--Cc
Confidence 9999999986654 6799999999999999999999999999999998643221 22
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---cCc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---LSY 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~~~ 529 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ++ +..
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 34568999999999999999999999999999999999999998654322111 11 112
Q ss_pred cCCCCCC-----CHHHHHHH
Q 007490 530 EDPADRP-----SMATIVLA 544 (601)
Q Consensus 530 ~dP~~RP-----t~~evl~~ 544 (601)
.||.+|| ++.||++.
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTS
T ss_pred cCHHHhcCCCCCCHHHHHcC
Confidence 7999999 89998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=305.43 Aligned_cols=219 Identities=42% Similarity=0.602 Sum_probs=182.2
Q ss_pred cccchhhhhhhcCCCCcC------CcccccCcceEEeeecCCCceeeEEEeccC----ChhhHHHHHHHHHHHHHcCCCC
Q 007490 328 LQFDFKTIEVATNKFSSD------NKLGRGGFGEVYKGVLPHGQEIAVKRLSRS----SGQGAQEFKNEVVLVAKLQHRN 397 (601)
Q Consensus 328 ~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpn 397 (601)
..|.+.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457778888888888877 8999999999999997 7889999998653 2334577899999999999999
Q ss_pred ccceEEEEEeCCeeEEEEeccCCCCccccc--------------------------ccccceeeccccccCcEEEccCCC
Q 007490 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQMN 451 (601)
Q Consensus 398 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~~ 451 (601)
|+++++++.+.+..++||||+++++|.+++ ++|+.+|+||||||+||+++.++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence 999999999999999999999999986654 569999999999999999999999
Q ss_pred cEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------
Q 007490 452 PKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE------- 524 (601)
Q Consensus 452 ~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~------- 524 (601)
+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (307)
T 2nru_A 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250 (307)
T ss_dssp EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH
T ss_pred EEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh
Confidence 99999999987654333333344678999999998764 5899999999999999999999998754432110
Q ss_pred ---------------------------cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 525 ---------------------------DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ---------------------------~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ +...||.+|||+.+|++.|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00 1127999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.93 Aligned_cols=212 Identities=32% Similarity=0.506 Sum_probs=172.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44678999999999999999999964 3445999999765 344567799999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999997765 5699999999999999999999999999999998765432
Q ss_pred Ccc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------c
Q 007490 468 TQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------D 525 (601)
Q Consensus 468 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~ 525 (601)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......... +
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 285 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence 221 1223345778999999999999999999999999999999 99998654322111 1
Q ss_pred cc---CccCCCCCCCHHHHHHHHhcC
Q 007490 526 LL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ ...||.+|||+.+|+++|+..
T Consensus 286 li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 127999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=305.16 Aligned_cols=213 Identities=29% Similarity=0.435 Sum_probs=177.8
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
++...++|++.+.||+|+||.||++++.++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 3456778999999999999999999988888999999975433 346789999999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 160 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV- 160 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence 9999999987665 569999999999999999999999999999999876543222
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------ccc---
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDL--- 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l--- 526 (601)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHH
Confidence 2233456778999999998899999999999999999999 9999865432111 111
Q ss_pred cCccCCCCCCCHHHHHHHHhcCC
Q 007490 527 LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
+...||.+|||+.|+++.|+...
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HcCCChhhCcCHHHHHHHHHHhh
Confidence 11279999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.98 Aligned_cols=210 Identities=31% Similarity=0.477 Sum_probs=175.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 445678999999999999999999987889999999975432 3467899999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 163 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 163 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence 999999987665 56999999999999999999999999999999986543221 12
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------cc---c
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DL---L 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l---~ 527 (601)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......... ++ +
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 243 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence 223456788999999999999999999999999999999 89998654321111 11 1
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.++++.|+.
T Consensus 244 l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCcccCcCHHHHHHHHHH
Confidence 12799999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.39 Aligned_cols=204 Identities=25% Similarity=0.351 Sum_probs=171.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh------hHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
...++|++.+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 34577999999999999999999954 5899999999764322 3577899999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC----CcEEeeccccee
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM----NPKISDFGLARI 462 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~----~~kL~Dfg~a~~ 462 (601)
..++||||+++++|.+++ |+|+.||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999997765 66999999999999999998877 799999999987
Q ss_pred cCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA------------------- 523 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~------------------- 523 (601)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 169 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 169 IEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp CCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred cCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 65432 23345799999999999999999999999999999999999999965432111
Q ss_pred ----ccc---cCccCCCCCCCHHHHHH
Q 007490 524 ----EDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 524 ----~~l---~~~~dP~~RPt~~evl~ 543 (601)
.++ +...||.+|||+.|+++
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 11279999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.55 Aligned_cols=209 Identities=29% Similarity=0.526 Sum_probs=164.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCce----eeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQE----IAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467899999999999999999953 4554 577877543 3345678999999999999999999999998754 78
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+|+||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999987655 66999999999999999999999999999999987755444
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc--------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL-------------------- 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~-------------------- 527 (601)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 252 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHH
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 333444567889999999999999999999999999999999 99999765433222111
Q ss_pred ---CccCCCCCCCHHHHHHHHhcC
Q 007490 528 ---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~~L~~~ 548 (601)
...||.+||++.|+++.|+..
T Consensus 253 ~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 253 VKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhhCCCHHHHHHHHHHH
Confidence 117999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.85 Aligned_cols=206 Identities=28% Similarity=0.442 Sum_probs=169.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999954 689999999865432 334668899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++.+..........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 99999987765 5699999999999999999999999999999998765443333344
Q ss_pred cccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------------c---cc
Q 007490 474 RIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------------D---LL 527 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------------~---l~ 527 (601)
...||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... + .+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHH
Confidence 5689999999999988776 78999999999999999999999654332110 0 11
Q ss_pred CccCCCCCCCHHHHHHH
Q 007490 528 SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~ 544 (601)
...||.+|||+.|+++.
T Consensus 246 L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 246 LVENPSARITIPDIKKD 262 (323)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred ccCChhhCcCHHHHhhC
Confidence 12799999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=318.37 Aligned_cols=221 Identities=29% Similarity=0.448 Sum_probs=180.8
Q ss_pred ccccchhhhhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCc
Q 007490 327 SLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNL 398 (601)
Q Consensus 327 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI 398 (601)
...++...++...++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 44567778889999999999999999999999973 346789999997643 34456789999999999 89999
Q ss_pred cceEEEEEeCCe-eEEEEeccCCCCccccc--------------------------------------------------
Q 007490 399 VRLLGFCLEGDE-KILVYEFVPNKSLDYFL-------------------------------------------------- 427 (601)
Q Consensus 399 v~l~~~~~~~~~-~~lv~E~~~~gsL~~~l-------------------------------------------------- 427 (601)
+++++++.+.+. .++||||+++|+|.+++
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999987654 89999999998875432
Q ss_pred ---------------------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 428 ---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 428 ---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 56899999999999999999999999999999987654433
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc---------------------ccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA---------------------EDL 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~---------------------~~l 526 (601)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .++
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 333445578899999999999999999999999999999998 9999865432210 011
Q ss_pred ---cCccCCCCCCCHHHHHHHHhc
Q 007490 527 ---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~L~~ 547 (601)
+...||.+|||+.|++++|+.
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHH
Confidence 112799999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.36 Aligned_cols=212 Identities=31% Similarity=0.493 Sum_probs=162.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34568999999999999999999864 5778999999764 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999998765 5699999999999999999999999999999998765332
Q ss_pred Ccc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------c
Q 007490 468 TQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------D 525 (601)
Q Consensus 468 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~ 525 (601)
... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......... +
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 281 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence 211 1122345778999999999999999999999999999998 99998643321111 1
Q ss_pred c---cCccCCCCCCCHHHHHHHHhcC
Q 007490 526 L---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+ +...||.+||++.+|+++|+..
T Consensus 282 li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 282 LMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1 1127999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=320.56 Aligned_cols=213 Identities=31% Similarity=0.476 Sum_probs=173.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
+...++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345678999999999999999999842 3668999999654 344556788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc------------------------------ccccceeeccccccCcEEEccCC---CcEEe
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------------YDSQLRIIHRDLKASNILLDVQM---NPKIS 455 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------------~~h~~~iiHrdlkp~NIll~~~~---~~kL~ 455 (601)
+..++||||+++++|..++ ++|+.+|+||||||+|||++.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999886654 56999999999999999999555 59999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE---------- 524 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~---------- 524 (601)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999986543332233344567899999999999999999999999999999998 99998654322111
Q ss_pred ----------cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 525 ----------DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ----------~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ +...||.+||++.+|++.|+..
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1127999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.30 Aligned_cols=218 Identities=27% Similarity=0.435 Sum_probs=161.9
Q ss_pred chhhhhhhcCCCCcCCcccccCcceEEeeecCCC----ceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEE
Q 007490 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHG----QEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 404 (601)
.++++....++|++.+.||+|+||.||+|++... ..||||++... .....+.+.+|++++++++||||++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 4456667788999999999999999999996543 27999998764 34456789999999999999999999999
Q ss_pred EEeCCee------EEEEeccCCCCccccc-----------------------------ccccceeeccccccCcEEEccC
Q 007490 405 CLEGDEK------ILVYEFVPNKSLDYFL-----------------------------YDSQLRIIHRDLKASNILLDVQ 449 (601)
Q Consensus 405 ~~~~~~~------~lv~E~~~~gsL~~~l-----------------------------~~h~~~iiHrdlkp~NIll~~~ 449 (601)
+...+.. ++||||+++++|..++ ++|+.+|+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9887665 9999999999987554 5699999999999999999999
Q ss_pred CCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc---
Q 007490 450 MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--- 525 (601)
Q Consensus 450 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--- 525 (601)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999999987654333333334456789999999999999999999999999999999 899987543322111
Q ss_pred -----------------c---cCccCCCCCCCHHHHHHHHhcC
Q 007490 526 -----------------L---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 -----------------l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+ +...||.+|||+.++++.|+..
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1127999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.28 Aligned_cols=211 Identities=27% Similarity=0.425 Sum_probs=171.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3467899999999999999999995 46889999998543 3344567899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL- 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence 999999999998765 66999999999999999999999999999999986543221
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc------------------------ccc
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG------------------------AED 525 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~------------------------~~~ 525 (601)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 22334578999999999999999999999999999999999999997543211 000
Q ss_pred c---cCccCCCCCC-CHHHHHHHHhcC
Q 007490 526 L---LSYEDPADRP-SMATIVLALNSH 548 (601)
Q Consensus 526 l---~~~~dP~~RP-t~~evl~~L~~~ 548 (601)
+ +...||.+|| ++.++.+.|+..
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1 1127999998 999999999765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.47 Aligned_cols=214 Identities=28% Similarity=0.437 Sum_probs=175.1
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...++...++|++.+.||+|+||.||++.+.++..||||++..... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3455667788999999999999999999988888999999975433 346789999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999987665 5699999999999999999999999999999998654321
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------cc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------DL 526 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~l 526 (601)
. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......... ++
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 1 11223456788999999998999999999999999999998 99998654321111 11
Q ss_pred ---cCccCCCCCCCHHHHHHHHhc
Q 007490 527 ---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~L~~ 547 (601)
+...||.+|||+.++++.|+.
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHH
Confidence 122799999999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.47 Aligned_cols=181 Identities=32% Similarity=0.470 Sum_probs=151.6
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
+...++|++.++||+|+||.||+|+..+|+.||+|++.... ......+.+|++++++++||||+++++++.+++..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 44567899999999999999999998889999999986543 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9999986 443322 67999999999999999999999999999999987643222
Q ss_pred cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 2334578999999999876 568999999999999999999999996543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.34 Aligned_cols=215 Identities=30% Similarity=0.474 Sum_probs=179.1
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...+++..++|++.+.||+|+||.||+|++.++..||||++.... ...+.+.+|+++|++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 455677888999999999999999999998888999999997543 34678999999999999999999999986 5678
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
++||||+++|+|.+++ |+|+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999997765 569999999999999999999999999999999875432
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cc
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------ED 525 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~ 525 (601)
.. .......++..|+|||++....++.++||||||+++|||++ |+.||........ .+
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 11223346788999999998999999999999999999999 9999865432111 11
Q ss_pred cc---CccCCCCCCCHHHHHHHHhcCC
Q 007490 526 LL---SYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~~~~ 549 (601)
++ ...||.+|||+.+|++.|+...
T Consensus 417 li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11 1279999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.58 Aligned_cols=219 Identities=30% Similarity=0.486 Sum_probs=175.2
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...+++..++|++.++||+|+||.||+|++.++..||||++.... ...+.+.+|+++|++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 345667778899999999999999999998778889999997543 345679999999999999999999999876 678
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
++||||+++|+|.+++ ++|+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999997765 569999999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cc
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------ED 525 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~ 525 (601)
.. .......++..|+|||++.+..++.++||||||+++|||++ |+.||........ .+
T Consensus 334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 11223456789999999999999999999999999999999 8999865432111 11
Q ss_pred cc---CccCCCCCCCHHHHHHHHhcCCCCCC
Q 007490 526 LL---SYEDPADRPSMATIVLALNSHSVTLS 553 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~~~~~~~~ 553 (601)
++ ...||.+|||+.+|++.|+.......
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11 12799999999999999988654443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.82 Aligned_cols=216 Identities=27% Similarity=0.403 Sum_probs=178.6
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC--------CCceeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLG 403 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 403 (601)
.++...++|.+.++||+|+||.||+|+.. .+..||||++... .......+.+|+++++++ +||||+++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 34666788999999999999999999842 2457999999765 344457789999999999 9999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcE
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
++..++..++||||+++++|.+++ ++|+.+|+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999999886543 45899999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654433333444567889999999999999999999999999999999 9999865432211
Q ss_pred cc--------------------c---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 524 ED--------------------L---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 524 ~~--------------------l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
.. + +...||.+|||+.||++.|+...
T Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1 11279999999999999997653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.20 Aligned_cols=203 Identities=22% Similarity=0.297 Sum_probs=170.9
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..++|++.+.||+|+||.||+++.. +++.||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999954 58899999986543 345678899999999999999999999999999999999
Q ss_pred ccCCCCccccc------------------------ccccceeeccccccCcEEEcc--CCCcEEeecccceecCCCCCcc
Q 007490 417 FVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDV--QMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 417 ~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|+++++|.+++ ++|+.+|+||||||+|||++. ++.+||+|||+++.+....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--- 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence 99999986654 569999999999999999997 7899999999998765332
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cc--
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------ED-- 525 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~-- 525 (601)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 23345789999999999998899999999999999999999999965432111 11
Q ss_pred -ccCccCCCCCCCHHHHHHH
Q 007490 526 -LLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 -l~~~~dP~~RPt~~evl~~ 544 (601)
.+...||.+|||+.|+++.
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 1122799999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.26 Aligned_cols=188 Identities=27% Similarity=0.354 Sum_probs=160.9
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEE
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 405 (601)
+.+.+++...++|++.++||+|+||+||+|+.. +++.||+|++.+.. ......+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677788899999999999999999999965 47889999996532 12223478999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
.+.+..++||||+++|+|..++ ++|+.+|+||||||+|||++.++.+||+|||+++
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999997665 5699999999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp ECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 7643322 1233468999999999987 567899999999999999999999999653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.75 Aligned_cols=215 Identities=32% Similarity=0.492 Sum_probs=179.4
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
+..++...++|++.++||+|+||.||+|++.. +..||||++.... ...+.+.+|+.+|++++||||+++++++...+.
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 34456667789999999999999999999754 8899999997543 346789999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 KILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.+|||||+++++|.+++ |+|+++|+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999987665 56999999999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc------------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL------------------ 526 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l------------------ 526 (601)
... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 371 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp CCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred Cce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 221 12223456789999999999999999999999999999999 9999865443222111
Q ss_pred -----cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 -----LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 -----~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...||.+|||+.+|++.|+..
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1117999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=308.22 Aligned_cols=215 Identities=29% Similarity=0.431 Sum_probs=178.1
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 405 (601)
.+++...++|.+.+.||+|+||.||+++. .+++.||||++... .....+.+.+|++++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34556678899999999999999999984 23578999999754 344567889999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-----------------------------------------------ccccceeeccc
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-----------------------------------------------YDSQLRIIHRD 438 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-----------------------------------------------~~h~~~iiHrd 438 (601)
.+.+..++||||+++++|.+++ ++|+.+|+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 9999999999999999886543 45899999999
Q ss_pred cccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCC
Q 007490 439 LKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSF 517 (601)
Q Consensus 439 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~ 517 (601)
|||+|||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433333344567889999999999999999999999999999999 9999875
Q ss_pred CCCCcccccc-----------------------CccCCCCCCCHHHHHHHHhc
Q 007490 518 YQTDGAEDLL-----------------------SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 518 ~~~~~~~~l~-----------------------~~~dP~~RPt~~evl~~L~~ 547 (601)
.........+ ...||.+||++.|+++.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 4432221111 11799999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.57 Aligned_cols=205 Identities=25% Similarity=0.352 Sum_probs=164.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
...++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999954 5899999999754 233456678999999998 799999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+++++|..++ |+|+.+|+||||||+|||++.++++||+|||+++......
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 9999999999997655 6799999999999999999999999999999998543221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL--- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l--- 526 (601)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ++
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 257 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2234568999999999999889999999999999999999999999754432111 11
Q ss_pred cCccCCCCCCCH------HHHHH
Q 007490 527 LSYEDPADRPSM------ATIVL 543 (601)
Q Consensus 527 ~~~~dP~~RPt~------~evl~ 543 (601)
+...||.+||++ .|+++
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HhhhCHHHccCCcccCCHHHHhh
Confidence 112799999998 66654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.86 Aligned_cols=210 Identities=29% Similarity=0.445 Sum_probs=168.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCce----eeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQE----IAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467899999999999999999953 4554 6777764432 233456788999999999999999999986 46689
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999987654 56999999999999999999999999999999988755444
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc---------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL--------------------- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l--------------------- 526 (601)
........++..|+|||++.+..++.++||||||+++|||++ |+.||.........+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 250 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVM 250 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHH
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHH
Confidence 333445677889999999999999999999999999999999 9999976443222111
Q ss_pred --cCccCCCCCCCHHHHHHHHhcCC
Q 007490 527 --LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
+...||.+||++.++++.|+...
T Consensus 251 ~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 251 VKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11279999999999999997653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.39 Aligned_cols=218 Identities=29% Similarity=0.468 Sum_probs=178.5
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEE
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGF 404 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 404 (601)
+..++...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445667889999999999999999999963 34789999997653 3445778999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc-----------------------------------------------ccccceeecc
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL-----------------------------------------------YDSQLRIIHR 437 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l-----------------------------------------------~~h~~~iiHr 437 (601)
+.+.+..++||||+++++|.+++ ++|+.+|+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999886543 4589999999
Q ss_pred ccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCC
Q 007490 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSS 516 (601)
Q Consensus 438 dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 516 (601)
||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643332223334567899999999999999999999999999999999 999986
Q ss_pred CCCCCccc--------------------cc---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 517 FYQTDGAE--------------------DL---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 517 ~~~~~~~~--------------------~l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
........ ++ +...||.+||++.+|++.|+...
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 54321111 11 11279999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.65 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=167.5
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
-++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999995 568999999986532 22345789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+ +|+|.+++ ++|+.||+||||||+|||++.++.+||+|||++....... .
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---F 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---T
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---c
Confidence 9999 56665443 6799999999999999999999999999999998654332 2
Q ss_pred cccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc----------------------cC
Q 007490 472 TSRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL----------------------LS 528 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l----------------------~~ 528 (601)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........... +.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 334579999999999988776 6899999999999999999999975433222211 11
Q ss_pred ccCCCCCCCHHHHHHH
Q 007490 529 YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~ 544 (601)
..||.+|||+.|+++.
T Consensus 244 ~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 244 VADPMQRITIQEIRRD 259 (336)
T ss_dssp CSSGGGSCCHHHHTTC
T ss_pred CCChhHCcCHHHHHhC
Confidence 2799999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.63 Aligned_cols=187 Identities=25% Similarity=0.329 Sum_probs=159.8
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
+.+++...++|++.++||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556677889999999999999999999964 58899999986531 1223457899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 408 GDEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.+..++||||+++|+|..++ |+|+.+|+||||||+|||++.++++||+|||+++....
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999997665 67999999999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcccccCCC----CCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQ----FSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 321 1233568999999999997655 8899999999999999999999996543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=307.54 Aligned_cols=204 Identities=26% Similarity=0.394 Sum_probs=171.0
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh------hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
..++|++.+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3466899999999999999999954 589999999875432 235779999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC----CcEEeecccceec
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM----NPKISDFGLARIF 463 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~----~~kL~Dfg~a~~~ 463 (601)
.++||||+++++|.+++ ++|+.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999997765 66999999999999999999887 7999999999876
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------- 523 (601)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 169 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp CTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 5332 22345799999999999999999999999999999999999999864332110
Q ss_pred ---ccc---cCccCCCCCCCHHHHHHH
Q 007490 524 ---EDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 ---~~l---~~~~dP~~RPt~~evl~~ 544 (601)
.++ +...||.+|||+.|+++.
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011 122799999999999873
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.90 Aligned_cols=203 Identities=27% Similarity=0.399 Sum_probs=167.8
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++|++.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999985 468999999985421 224577899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCC---cEEeeccccee
Q 007490 413 LVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLARI 462 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~~ 462 (601)
+||||+++++|..++ |+|+.+|+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999985433 669999999999999999987655 99999999987
Q ss_pred cCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC---------------------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD--------------------- 521 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--------------------- 521 (601)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 183 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 183 LGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp CCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCC
Confidence 654321 233457999999999999999999999999999999999999998653211
Q ss_pred -ccccc---cCccCCCCCCCHHHHHH
Q 007490 522 -GAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 522 -~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
...++ +...||.+|||+.|+++
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111 11279999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=302.40 Aligned_cols=203 Identities=27% Similarity=0.365 Sum_probs=161.9
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh--------------------------hhHHHHHHHHHHHH
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG--------------------------QGAQEFKNEVVLVA 391 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 391 (601)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999985 4688999999865421 11356889999999
Q ss_pred HcCCCCccceEEEEEe--CCeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEc
Q 007490 392 KLQHRNLVRLLGFCLE--GDEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLD 447 (601)
Q Consensus 392 ~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~ 447 (601)
+++||||+++++++.+ .+..++||||+++++|..++ ++|+.+|+||||||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999987 56789999999999887654 67999999999999999999
Q ss_pred cCCCcEEeecccceecCCCCCccccccccccccccCcccccCCC---CCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--
Q 007490 448 VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ---FSVKSDVYSFGVLALETITGKKNSSFYQTDG-- 522 (601)
Q Consensus 448 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-- 522 (601)
.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999987653321 233457999999999997765 4788999999999999999999986432110
Q ss_pred -------------------cccc---cCccCCCCCCCHHHHHH
Q 007490 523 -------------------AEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 523 -------------------~~~l---~~~~dP~~RPt~~evl~ 543 (601)
..++ +...||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 0111 11279999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.77 Aligned_cols=206 Identities=27% Similarity=0.353 Sum_probs=169.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
...++|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456799999999999999999984 468999999987643 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEc---cCCCcEEeecccceecCCCC
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLD---VQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~ 467 (601)
||||+++++|.+++ |+|+.+|+||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999986544 67999999999999999998 46789999999998764332
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------cc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-----------------------AE 524 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-----------------------~~ 524 (601)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 168 --~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 168 --QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred --ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 22334679999999999999999999999999999999999999985433111 01
Q ss_pred cc---cCccCCCCCCCHHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 11 112799999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=306.72 Aligned_cols=200 Identities=27% Similarity=0.378 Sum_probs=169.0
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999954 68999999996542 23456788999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----c
Confidence 9999999987765 66999999999999999999999999999999987542 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---cCc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---LSY 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~~~ 529 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .++ +..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 3345799999999999999999999999999999999999999865332111 111 112
Q ss_pred cCCCCCC-----CHHHHHH
Q 007490 530 EDPADRP-----SMATIVL 543 (601)
Q Consensus 530 ~dP~~RP-----t~~evl~ 543 (601)
.||.+|| ++.|+++
T Consensus 240 ~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHT
T ss_pred cCHHHcCCCcCCCHHHHhc
Confidence 7999999 8888874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.02 Aligned_cols=207 Identities=22% Similarity=0.281 Sum_probs=172.4
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 357899999999999999999994 5789999999865432 24578999999999 9999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCC-----cEEeecccceecCCC
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMN-----PKISDFGLARIFGVD 466 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~-----~kL~Dfg~a~~~~~~ 466 (601)
||+ +++|.+++ ++|+.+|+||||||+|||++.++. +||+|||+++.+...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999 88887665 569999999999999999998887 999999999876443
Q ss_pred CCcc-----ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc--------------
Q 007490 467 QTQG-----NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL-------------- 527 (601)
Q Consensus 467 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~-------------- 527 (601)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+.+
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 2211 123567999999999999999999999999999999999999999865433221111
Q ss_pred ---------------CccCCCCCCCHHHHHHHHhc
Q 007490 528 ---------------SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ---------------~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.+|++.|+.
T Consensus 244 ~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 244 LCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 01699999999999998864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.39 Aligned_cols=178 Identities=24% Similarity=0.362 Sum_probs=153.5
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 412 (601)
..++|++.++||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4567999999999999999999954 57899999997542 23345678899999887 8999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||+++|+|..++ ++|+.+|+||||||+|||++.++++||+|||+++..... .
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~ 207 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--G 207 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC--C
Confidence 999999999987654 679999999999999999999999999999999853222 1
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 234456899999999999999999999999999999999999999964
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=320.80 Aligned_cols=207 Identities=29% Similarity=0.429 Sum_probs=172.5
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-ee
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-EK 411 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~ 411 (601)
..++...++|++.+.||+|+||.||+|.+ .|+.||||+++... ..+.+.+|++++++++||||+++++++...+ ..
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 34556677899999999999999999997 57899999997543 4577899999999999999999999987765 78
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
++||||+++|+|.+++ |+|+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999987665 569999999999999999999999999999999864322
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc------------------
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL------------------ 527 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~------------------ 527 (601)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...........+
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 112356889999999999999999999999999999998 99998765433221111
Q ss_pred -----CccCCCCCCCHHHHHHHHhc
Q 007490 528 -----SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 -----~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+|||+.+|++.|+.
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11799999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.34 Aligned_cols=204 Identities=26% Similarity=0.421 Sum_probs=169.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
+..++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567999999999999999999954 58899999986532 234567889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||+++|+|..++ |+|+.||+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--- 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence 999999999987655 679999999999999999999999999999999876432
Q ss_pred cccccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc---------------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED--------------------- 525 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~--------------------- 525 (601)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHH
Confidence 22345689999999999864 458999999999999999999999997543322111
Q ss_pred ----ccCccCCCCCCC-HHHHHH
Q 007490 526 ----LLSYEDPADRPS-MATIVL 543 (601)
Q Consensus 526 ----l~~~~dP~~RPt-~~evl~ 543 (601)
.+...||.+||+ +.+|..
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHhcCCHhHhcccHHHHHc
Confidence 111279999998 777654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.87 Aligned_cols=219 Identities=28% Similarity=0.442 Sum_probs=180.5
Q ss_pred chhhhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEE
Q 007490 331 DFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLG 403 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~ 403 (601)
..+++++..++|++.+.||+|+||.||+|++. .++.||||++.... ......+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34567788899999999999999999999854 36789999997543 344567899999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc---------------------------------ccccceeeccccccCcEEEccCC
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL---------------------------------YDSQLRIIHRDLKASNILLDVQM 450 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------~~h~~~iiHrdlkp~NIll~~~~ 450 (601)
++.+.+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999987654 45999999999999999999999
Q ss_pred CcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc------
Q 007490 451 NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA------ 523 (601)
Q Consensus 451 ~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~------ 523 (601)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999999986643332222334467889999999999999999999999999999999 8888865432111
Q ss_pred --------------ccc---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 524 --------------EDL---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 524 --------------~~l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
.++ +...||.+|||+.|+++.|+...
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 011 11279999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.09 Aligned_cols=205 Identities=28% Similarity=0.386 Sum_probs=169.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
...++|++.+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567999999999999999999954 5899999999654 33445678999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC---CcEEeecccceecCCCC
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM---NPKISDFGLARIFGVDQ 467 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~ 467 (601)
||||+++++|.+++ |+|+.+|+||||||+|||++.++ .+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999986544 67999999999999999998654 59999999998765322
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------cc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-----------------------AE 524 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-----------------------~~ 524 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 186 ---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp ---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred ---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 2234579999999999999999999999999999999999999986432110 01
Q ss_pred cc---cCccCCCCCCCHHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112799999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=311.92 Aligned_cols=205 Identities=26% Similarity=0.396 Sum_probs=168.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 410 (601)
....++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999964 58899999997542 23456678899999987 99999999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.++||||+++|+|..++ ++|+.||+||||||+|||++.++++||+|||+++......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999997665 6799999999999999999999999999999998643222
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------ccc-
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DLL- 527 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l~- 527 (601)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +++
T Consensus 173 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (345)
T 1xjd_A 173 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred --CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 2244568999999999999999999999999999999999999998654321111 111
Q ss_pred --CccCCCCCCCHH-HHH
Q 007490 528 --SYEDPADRPSMA-TIV 542 (601)
Q Consensus 528 --~~~dP~~RPt~~-evl 542 (601)
...||.+||++. +|+
T Consensus 251 ~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 251 KLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHSCSSGGGSBTTBSCGG
T ss_pred HHhcCCHhHcCCChHHHH
Confidence 127999999997 664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=305.27 Aligned_cols=212 Identities=30% Similarity=0.469 Sum_probs=169.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--C
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--D 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 409 (601)
...++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3457889999999999999999983 35889999999877777778899999999999999999999998654 4
Q ss_pred eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 589999999999997765 56999999999999999999999999999999987643
Q ss_pred CCCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC------------------------
Q 007490 466 DQTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT------------------------ 520 (601)
Q Consensus 466 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~------------------------ 520 (601)
.... .......++..|+|||++.+..++.++||||||+++|||++|..|+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 3221 112234567789999999999999999999999999999999888653211
Q ss_pred ------------Ccccccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 521 ------------DGAEDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 521 ------------~~~~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
....+++ ...||.+|||+.|+++.|+..
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011111 127999999999999999764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.90 Aligned_cols=216 Identities=29% Similarity=0.432 Sum_probs=177.5
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCC-C-----ceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-G-----QEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGF 404 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 404 (601)
..++...++|++.+.||+|+||.||+|+... + +.||+|.+.... ....+.+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3567778999999999999999999998532 2 479999997653 34557789999999999 89999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc-------------------------------------ccccceeeccccccCcEEEc
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL-------------------------------------YDSQLRIIHRDLKASNILLD 447 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l-------------------------------------~~h~~~iiHrdlkp~NIll~ 447 (601)
+...+..++||||+++++|.+++ ++|+.+|+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999998886643 46999999999999999999
Q ss_pred cCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc---
Q 007490 448 VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--- 523 (601)
Q Consensus 448 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--- 523 (601)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999987654333222334567889999999999999999999999999999998 8888865432210
Q ss_pred ------------------ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 ------------------EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ------------------~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...||.+|||+.||++.|+..
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 011 1127999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=302.04 Aligned_cols=215 Identities=33% Similarity=0.496 Sum_probs=179.2
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
+..++...++|++.+.||+|+||.||+|++.. ++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45667788899999999999999999999654 8889999986543 345778999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 KILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.++||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999998887655 56999999999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc------------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL------------------ 526 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l------------------ 526 (601)
... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242 (288)
T ss_dssp SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence 322 22333456888999999999999999999999999999999 9988865443222111
Q ss_pred -----cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 -----LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 -----~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...||.+|||+.+++++|+..
T Consensus 243 ~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 243 ELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1127999999999999998653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.05 Aligned_cols=213 Identities=33% Similarity=0.484 Sum_probs=175.9
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
.++++..++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 34667778899999999999999999998788899999986543 34577899999999999999999999986 45689
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999997765 5699999999999999999999999999999998765332
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------ccc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDL 526 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l 526 (601)
. .......++..|+|||++.+..++.++||||||+++|||++ |+.||........ .++
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 2 12223456788999999998899999999999999999999 8988865332111 011
Q ss_pred ---cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 ---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...||.+|||+.++++.|+..
T Consensus 243 i~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHHHHHHH
Confidence 1127999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=304.86 Aligned_cols=215 Identities=30% Similarity=0.436 Sum_probs=178.0
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
.++...++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 4566778899999999999999999974 346789999997653 34457789999999999 999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-----------------------------------------ccccceeeccccccCcE
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-----------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-----------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
..++..++||||+++++|.+++ ++|+.+|+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999998886543 45899999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
|++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999987654433333334567889999999999999999999999999999999 9999865432210
Q ss_pred ---------------------ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 ---------------------EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ---------------------~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...||.+|||+.|+++.|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 011 1127999999999999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.63 Aligned_cols=226 Identities=28% Similarity=0.420 Sum_probs=168.4
Q ss_pred cccccccchhhhhhhcCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCC
Q 007490 324 TLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRN 397 (601)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpn 397 (601)
..+.+...++.+....++|.+.+.||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++++++|||
T Consensus 18 ~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 97 (313)
T 3brb_A 18 GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97 (313)
T ss_dssp ------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred chHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCC
Confidence 344455666777888899999999999999999999853 3458999998754 3444577899999999999999
Q ss_pred ccceEEEEEeCCe-----eEEEEeccCCCCccccc-----------------------------ccccceeeccccccCc
Q 007490 398 LVRLLGFCLEGDE-----KILVYEFVPNKSLDYFL-----------------------------YDSQLRIIHRDLKASN 443 (601)
Q Consensus 398 Iv~l~~~~~~~~~-----~~lv~E~~~~gsL~~~l-----------------------------~~h~~~iiHrdlkp~N 443 (601)
|+++++++.+.+. .++||||+++++|..++ ++|+.+|+||||||+|
T Consensus 98 iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 177 (313)
T 3brb_A 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177 (313)
T ss_dssp BCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGG
T ss_pred eeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 9999999987653 49999999999986654 5699999999999999
Q ss_pred EEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc
Q 007490 444 ILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG 522 (601)
Q Consensus 444 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~ 522 (601)
||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 9999999999999999987654332222334467889999999999999999999999999999999 888886543322
Q ss_pred ccc--------------------c---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 523 AED--------------------L---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 523 ~~~--------------------l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
... + +...||.+|||+.++++.|+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 258 MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1 11279999999999999997653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.04 Aligned_cols=203 Identities=24% Similarity=0.319 Sum_probs=171.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999954 6889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEcc--CCCcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDV--QMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++++|.+++ ++|+.+|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---I 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---C
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc---c
Confidence 9999986654 569999999999999999974 4779999999998765332 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------ccc---
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-----------------------AED--- 525 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-----------------------~~~--- 525 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 233578999999999999999999999999999999999999986543110 011
Q ss_pred ccCccCCCCCCCHHHHHHH
Q 007490 526 LLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l~~~~dP~~RPt~~evl~~ 544 (601)
.+...||.+|||+.|+++.
T Consensus 287 ~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTS
T ss_pred HHcCCChhHCcCHHHHhhC
Confidence 1122799999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.58 Aligned_cols=217 Identities=27% Similarity=0.392 Sum_probs=176.9
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
+++...++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4567788999999999999999999985 23568999999754 233457789999999999 999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc----------------------------------------------ccccceeecccc
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL----------------------------------------------YDSQLRIIHRDL 439 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l----------------------------------------------~~h~~~iiHrdl 439 (601)
...+..++||||+++++|.+++ ++|+.||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999999886543 458999999999
Q ss_pred ccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCC
Q 007490 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFY 518 (601)
Q Consensus 440 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~ 518 (601)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654433333344567889999999999999999999999999999998 99998664
Q ss_pred CCCcc---------------------ccc---cCccCCCCCCCHHHHHHHHhcCCC
Q 007490 519 QTDGA---------------------EDL---LSYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 519 ~~~~~---------------------~~l---~~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
..... .++ +...||.+|||+.+|++.|+....
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 42210 001 112799999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.96 Aligned_cols=188 Identities=27% Similarity=0.348 Sum_probs=161.5
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEE
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 405 (601)
+.+++++...++|++.+.||+|+||.||+++.+ +|+.||||++.+.. ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456667778899999999999999999999964 68999999996532 22334578999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
.+.+..|+||||+++|+|..++ |+|+.+|+||||||+|||++.++++||+|||+++
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999997765 5699999999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCccccc-------CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAM-------HGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 7654322 1223458999999999987 457899999999999999999999999654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=300.81 Aligned_cols=212 Identities=25% Similarity=0.411 Sum_probs=162.2
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
+.+...++|++.+.||+|+||.||+|++.. +..||+|++... .....+.+.+|+.++++++||||+++++++. +
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 345667889999999999999999998643 456999998754 3444577899999999999999999999984 5
Q ss_pred CeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 6789999999999887655 5699999999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc------------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED------------------ 525 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~------------------ 525 (601)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 246 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 33221 2223456789999999998999999999999999999997 999987544322111
Q ss_pred --c---cCccCCCCCCCHHHHHHHHhc
Q 007490 526 --L---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 526 --l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
+ +...||.+|||+.|+++.|+.
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 111799999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.79 Aligned_cols=201 Identities=26% Similarity=0.302 Sum_probs=169.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467899999999999999999964 68999999986542 23456788999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----
Confidence 9999999997665 669999999999999999999999999999999876422
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---cCc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---LSY 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~~~ 529 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ++ +..
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 23457999999999999999999999999999999999999998654321111 11 112
Q ss_pred cCCCCCCC-----HHHHHHH
Q 007490 530 EDPADRPS-----MATIVLA 544 (601)
Q Consensus 530 ~dP~~RPt-----~~evl~~ 544 (601)
.||.+||+ +.||++.
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTS
T ss_pred cCHHhccCCccCCHHHHHhC
Confidence 79999998 8887653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.69 Aligned_cols=175 Identities=29% Similarity=0.492 Sum_probs=146.8
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999987799999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccc
Confidence 986 544332 6799999999999999999999999999999998764322 1223
Q ss_pred cccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...+|+.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 34789999999998764 589999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.14 Aligned_cols=216 Identities=27% Similarity=0.409 Sum_probs=176.8
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecC--------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLL 402 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~ 402 (601)
..++...++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 345566788999999999999999999852 46789999997653 34567789999999999 999999999
Q ss_pred EEEEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCc
Q 007490 403 GFCLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASN 443 (601)
Q Consensus 403 ~~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~N 443 (601)
+++...+..++||||+++++|.+++ ++|+.+|+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 9999999999999999999886543 4589999999999999
Q ss_pred EEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc
Q 007490 444 ILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG 522 (601)
Q Consensus 444 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~ 522 (601)
||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999987654433223334467889999999998899999999999999999999 999986543221
Q ss_pred cc--------------------cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 523 AE--------------------DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 523 ~~--------------------~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.. ++ +...||.+|||+.|+++.|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 11 1127999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.41 Aligned_cols=174 Identities=28% Similarity=0.454 Sum_probs=148.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999964 58899999997543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCcccc-----------------------cccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYF-----------------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~-----------------------l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|++++.+..+ .++|+.||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cccc
Confidence 9986443322 16799999999999999999999999999999998764332 2233
Q ss_pred cccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
...+|+.|+|||++.+.. ++.++||||||+++|||++|..|+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 457899999999998766 799999999999999999988875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=298.23 Aligned_cols=206 Identities=36% Similarity=0.542 Sum_probs=161.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCC----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+|++ .++.||||++.... ....+.+.+|++++++++||||+++++++.+++..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 3457899999999999999999997 58999999986543 233567899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc----------------------ccccce---eeccccccCcEEEcc--------CCCcEEeeccc
Q 007490 413 LVYEFVPNKSLDYFL----------------------YDSQLR---IIHRDLKASNILLDV--------QMNPKISDFGL 459 (601)
Q Consensus 413 lv~E~~~~gsL~~~l----------------------~~h~~~---iiHrdlkp~NIll~~--------~~~~kL~Dfg~ 459 (601)
+||||+++++|..++ ++|+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999987664 568888 999999999999986 77899999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------- 522 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------- 522 (601)
+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 98654322 223478999999999999999999999999999999999999987543211
Q ss_pred ----ccccc---CccCCCCCCCHHHHHHHHhc
Q 007490 523 ----AEDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 523 ----~~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
..+++ ...||.+|||+.|++++|+.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 01111 12799999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=303.05 Aligned_cols=177 Identities=25% Similarity=0.369 Sum_probs=154.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457899999999999999999964 5889999999754 334456788999999998 89999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++++|..++ ++|+.+|+||||||+|||++.++++||+|||+++...... .
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~ 165 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 165 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--C
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC--C
Confidence 99999999997655 6799999999999999999999999999999998532221 2
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 23456899999999999999999999999999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=296.91 Aligned_cols=209 Identities=20% Similarity=0.298 Sum_probs=173.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 414 (601)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+||+++++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 4567899999999999999999994 578999999986543 234578899999999 899999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCC-----cEEeecccceecCC
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMN-----PKISDFGLARIFGV 465 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~-----~kL~Dfg~a~~~~~ 465 (601)
|||+ +++|.+++ ++|+.+|+||||||+|||++.++. +||+|||+++....
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999 88887765 569999999999999999987776 99999999987654
Q ss_pred CCCc-----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc---------------
Q 007490 466 DQTQ-----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED--------------- 525 (601)
Q Consensus 466 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~--------------- 525 (601)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 3221 12344679999999999999999999999999999999999999997643221111
Q ss_pred ------------ccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 526 ------------LLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 ------------l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
++. ..||.+||++.+|++.|+..
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 111 17999999999999999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.74 Aligned_cols=182 Identities=17% Similarity=0.216 Sum_probs=156.3
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeee------cCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC---CCCccceEE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV------LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ---HRNLVRLLG 403 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~ 403 (601)
.+++...++|++.++||+|+||.||+|+ ..+++.||||++.... ..++..|+++++.++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4556677889999999999999999994 4468899999997543 346778888888886 999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc----------------------------ccccceeeccccccCcEEEcc-------
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL----------------------------YDSQLRIIHRDLKASNILLDV------- 448 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l----------------------------~~h~~~iiHrdlkp~NIll~~------- 448 (601)
++...+..++||||+++|+|.+++ |+|+.+|+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999997765 569999999999999999998
Q ss_pred ----CCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 449 ----QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 449 ----~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999876433333334456799999999999999999999999999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.47 Aligned_cols=197 Identities=28% Similarity=0.347 Sum_probs=161.5
Q ss_pred cCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCCCC
Q 007490 344 SDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS 422 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gs 422 (601)
..+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999985 4689999999987766677889999999999999999999999999999999999999999
Q ss_pred ccccc------------------------ccccceeeccccccCcEEE--ccCCCcEEeecccceecCCCCCcccccccc
Q 007490 423 LDYFL------------------------YDSQLRIIHRDLKASNILL--DVQMNPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 423 L~~~l------------------------~~h~~~iiHrdlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
|.+++ ++|+.+|+||||||+|||+ +.++.+||+|||+++....... .....
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~ 249 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNF 249 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccccc
Confidence 86544 5699999999999999999 5667899999999987653322 23347
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cc---ccCcc
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------ED---LLSYE 530 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~---l~~~~ 530 (601)
||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+ .+...
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 329 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK 329 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence 99999999999999999999999999999999999999865432110 01 11227
Q ss_pred CCCCCCCHHHHHH
Q 007490 531 DPADRPSMATIVL 543 (601)
Q Consensus 531 dP~~RPt~~evl~ 543 (601)
||.+|||+.|+++
T Consensus 330 dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 330 EKSWRISASEALK 342 (373)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.29 Aligned_cols=206 Identities=28% Similarity=0.369 Sum_probs=160.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeec----CCCceeeEEEeccCC----hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
...++|++.+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 3456799999999999999999985 468999999997642 23345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 409 DEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
+..++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999886654 66999999999999999999999999999999975432
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL 526 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l 526 (601)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .++
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 251 (327)
T 3a62_A 174 DG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL 251 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred CC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 22 123345799999999999999999999999999999999999999965432111 111
Q ss_pred ---cCccCCCCCC-----CHHHHHHH
Q 007490 527 ---LSYEDPADRP-----SMATIVLA 544 (601)
Q Consensus 527 ---~~~~dP~~RP-----t~~evl~~ 544 (601)
+...||.+|| ++.|+++.
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1127999999 77787653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.67 Aligned_cols=207 Identities=26% Similarity=0.371 Sum_probs=165.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHH--cCCCCccceEEEEEeC----Ce
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEG----DE 410 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~----~~ 410 (601)
...++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4567899999999999999999998 7899999998643 33455667777776 7999999999987643 45
Q ss_pred eEEEEeccCCCCccccc----------------------ccc--------cceeeccccccCcEEEccCCCcEEeecccc
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDS--------QLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h--------~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
.++||||+++++|.+++ ++| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred eEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 79999999999998765 568 999999999999999999999999999999
Q ss_pred eecCCCCCcc--ccccccccccccCcccccCC------CCCchhhHHhHHHHHHHHHhC----------CCCCCCCCCCc
Q 007490 461 RIFGVDQTQG--NTSRIVGTYGYMSPEYAMHG------QFSVKSDVYSFGVLALETITG----------KKNSSFYQTDG 522 (601)
Q Consensus 461 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~p~~~~~~~~ 522 (601)
+......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8764432221 12334789999999999876 556899999999999999999 77775432111
Q ss_pred -------------------------------ccccc---CccCCCCCCCHHHHHHHHhc
Q 007490 523 -------------------------------AEDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 523 -------------------------------~~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
..+++ ...||.+|||+.||++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 00111 12799999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=305.12 Aligned_cols=213 Identities=24% Similarity=0.302 Sum_probs=170.0
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-----ChhhHHHHHHHHHHHHHcCCCCccceEEEE
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-----SGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 405 (601)
-..+....++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 344566778899999999999999999985 45888999998643 234567899999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc----------------------------------------------------------
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL---------------------------------------------------------- 427 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l---------------------------------------------------------- 427 (601)
.+.+..++||||+++++|.+++
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999886533
Q ss_pred -----ccccceeeccccccCcEEEccCC--CcEEeecccceecCCCCCcc--ccccccccccccCcccccC--CCCCchh
Q 007490 428 -----YDSQLRIIHRDLKASNILLDVQM--NPKISDFGLARIFGVDQTQG--NTSRIVGTYGYMSPEYAMH--GQFSVKS 496 (601)
Q Consensus 428 -----~~h~~~iiHrdlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~s 496 (601)
++|+.+|+||||||+|||++.++ .+||+|||+++.+....... ......||+.|+|||++.+ ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 45899999999999999998776 89999999998764322111 2334578999999999875 6789999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------cccc---cCccCCCCCCCHHHHHHH
Q 007490 497 DVYSFGVLALETITGKKNSSFYQTDG-----------------------AEDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 497 DvwSlGvvl~elltg~~p~~~~~~~~-----------------------~~~l---~~~~dP~~RPt~~evl~~ 544 (601)
||||||+++|||++|+.||....... ..++ +...||.+||++.|+++.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999986533211 0111 112799999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=300.43 Aligned_cols=211 Identities=31% Similarity=0.466 Sum_probs=166.3
Q ss_pred cCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
.++|++.+.||+|+||.||++++ .++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 45788899999999999999997 5788999998643 34567899999999999999999999876 4589999999
Q ss_pred CCCCccccc--------------------------cccc---ceeeccccccCcEEEccCCC-cEEeecccceecCCCCC
Q 007490 419 PNKSLDYFL--------------------------YDSQ---LRIIHRDLKASNILLDVQMN-PKISDFGLARIFGVDQT 468 (601)
Q Consensus 419 ~~gsL~~~l--------------------------~~h~---~~iiHrdlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~ 468 (601)
++++|.+++ ++|+ .+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 999986654 4577 89999999999999998887 799999999765322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------ccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------EDL 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~~l 526 (601)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .++
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 2234689999999999999999999999999999999999999875332110 011
Q ss_pred ---cCccCCCCCCCHHHHHHHHhcCCCCCCCCCCCc
Q 007490 527 ---LSYEDPADRPSMATIVLALNSHSVTLSVPRQPA 559 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~ 559 (601)
+...||.+|||+.++++.|+......+.+..|.
T Consensus 237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 112799999999999999987655555444443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.88 Aligned_cols=182 Identities=20% Similarity=0.268 Sum_probs=155.5
Q ss_pred hhcCCCCcCCccccc--CcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRG--GFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...++|++.++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 445679999999999 99999999965 68999999997542 44457788999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
++||||+++++|.+++ |+|+.+|+||||||+|||++.++.+||+|||.+......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999987654 669999999999999999999999999999998754322
Q ss_pred CC-----ccccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QT-----QGNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 11 111223478999999999987 67999999999999999999999999653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.07 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=164.0
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD------- 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------- 409 (601)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356889999999999999999965 78999999997543 345678999999999999999999999986644
Q ss_pred --------------------------------------------------eeEEEEeccCCCCccccc------------
Q 007490 410 --------------------------------------------------EKILVYEFVPNKSLDYFL------------ 427 (601)
Q Consensus 410 --------------------------------------------------~~~lv~E~~~~gsL~~~l------------ 427 (601)
..++||||+++++|.+++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999987654
Q ss_pred --------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc----------cccccccccccccC
Q 007490 428 --------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ----------GNTSRIVGTYGYMS 483 (601)
Q Consensus 428 --------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~a 483 (601)
++|+.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 669999999999999999999999999999999877543211 11234579999999
Q ss_pred cccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC------------------CCcccccc---CccCCCCCCCHHHHH
Q 007490 484 PEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ------------------TDGAEDLL---SYEDPADRPSMATIV 542 (601)
Q Consensus 484 PE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~------------------~~~~~~l~---~~~dP~~RPt~~evl 542 (601)
||++.+..++.++||||||+++|||++|..|+.... .....+++ ...||.+|||+.|++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 324 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHh
Confidence 999999999999999999999999999977642110 00011111 227999999999998
Q ss_pred HH
Q 007490 543 LA 544 (601)
Q Consensus 543 ~~ 544 (601)
+.
T Consensus 325 ~~ 326 (332)
T 3qd2_B 325 EN 326 (332)
T ss_dssp HS
T ss_pred hc
Confidence 63
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.47 Aligned_cols=178 Identities=28% Similarity=0.339 Sum_probs=146.8
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 408 (601)
..++|++.++||+|+||.||+|+. .+++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999984 45899999999754 344567788999999999999999999999755
Q ss_pred CeeEEEEeccCCCCccc--------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 409 DEKILVYEFVPNKSLDY--------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~--------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
...+|||||++++.+.. +.|+|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 217 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 217 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C--
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--
Confidence 35799999998764322 11779999999999999999999999999999999876432
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 218 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp -CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2234468999999999999999999999999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=297.96 Aligned_cols=210 Identities=31% Similarity=0.464 Sum_probs=174.3
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
....++|++.+.||+|+||.||++++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 344577899999999999999999987888999999976543 3467899999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 161 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence 999999987665 56999999999999999999999999999999986532211 11
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------ccc---c
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------EDL---L 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~l---~ 527 (601)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||........ .++ +
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence 223456788999999998899999999999999999999 8989865332111 011 1
Q ss_pred CccCCCCCCCHHHHHHHHhc
Q 007490 528 SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~L~~ 547 (601)
...||.+||++.++++.|+.
T Consensus 242 l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp TCSSGGGSCCHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHH
Confidence 12799999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.39 Aligned_cols=181 Identities=27% Similarity=0.331 Sum_probs=156.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCee
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 411 (601)
...++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44578999999999999999999965 48899999997542 23456788999999988 899999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
++||||+++|+|..++ ++|+.||+||||||+|||++.++++||+|||+++......
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 9999999999997665 6699999999999999999999999999999998643221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 22445689999999999999999999999999999999999999997543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.52 Aligned_cols=183 Identities=28% Similarity=0.401 Sum_probs=148.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe--
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE-- 410 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 410 (601)
...++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4567899999999999999999995 568999999997643 3345678899999999999999999999886553
Q ss_pred --eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 --KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 --~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 49999999999987765 56999999999999999999999999999999987643
Q ss_pred CCCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 466 DQTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 466 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 12334568999999999999999999999999999999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.42 Aligned_cols=177 Identities=33% Similarity=0.525 Sum_probs=137.5
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999854 58999999987543 2344678899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 417 FVPNKSLDYFL-----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
|+++ +|..++ ++|+.||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 9985 654332 6699999999999999999999999999999998764322
Q ss_pred CccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
. ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 163 N--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp C--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 2234578999999999876 46899999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.60 Aligned_cols=208 Identities=28% Similarity=0.392 Sum_probs=163.6
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCC--CCccceEEEEEeCCe
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQH--RNLVRLLGFCLEGDE 410 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~ 410 (601)
+.+..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++++++| |||+++++++..++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34556789999999999999999999888999999998654 34445778999999999987 999999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.++|||+ .+++|.+++ ++|+.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999994 566776554 67999999999999999997 6789999999998765443
Q ss_pred CccccccccccccccCcccccC-----------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC---------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH-----------GQFSVKSDVYSFGVLALETITGKKNSSFYQTD--------------- 521 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--------------- 521 (601)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 3333345679999999999864 67899999999999999999999998643211
Q ss_pred -------ccccc---cCccCCCCCCCHHHHHHH
Q 007490 522 -------GAEDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 522 -------~~~~l---~~~~dP~~RPt~~evl~~ 544 (601)
...++ +...||.+|||+.|+++.
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 01111 112799999999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.99 Aligned_cols=222 Identities=29% Similarity=0.452 Sum_probs=181.0
Q ss_pred cccccchhhhhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCC
Q 007490 326 ESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRN 397 (601)
Q Consensus 326 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpn 397 (601)
+.+.++..+++...++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +|||
T Consensus 13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 345566677888889999999999999999999973 346889999997653 33456789999999999 7999
Q ss_pred ccceEEEEEeCC-eeEEEEeccCCCCccccc---------------------------------------ccccceeecc
Q 007490 398 LVRLLGFCLEGD-EKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHR 437 (601)
Q Consensus 398 Iv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHr 437 (601)
|+++++++...+ ..++||||+++++|..++ ++|+.+|+||
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~ 172 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 999999988755 489999999998886543 4589999999
Q ss_pred ccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCC
Q 007490 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSS 516 (601)
Q Consensus 438 dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 516 (601)
||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654433333344567889999999999999999999999999999998 999986
Q ss_pred CCCCCcc---------------------ccc---cCccCCCCCCCHHHHHHHHhc
Q 007490 517 FYQTDGA---------------------EDL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 517 ~~~~~~~---------------------~~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
....... .++ +...||.+|||+.|+++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 5432210 001 111799999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=327.17 Aligned_cols=217 Identities=30% Similarity=0.492 Sum_probs=178.7
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
...+++..++|++.++||+|+||.||+|++.++..||||++.... ...+.+.+|+++|++++||||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 445677788899999999999999999998778889999997544 345679999999999999999999999876 678
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
+|||||+++++|.+++ |+|+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999987665 569999999999999999999999999999999865422
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------cc
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA--------------------ED 525 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~--------------------~~ 525 (601)
.. .......++..|+|||++.+..++.++|||||||+||||++ |+.||........ .+
T Consensus 417 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 417 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp HH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 11223356788999999999999999999999999999999 8999865432111 11
Q ss_pred cc---CccCCCCCCCHHHHHHHHhcCCCC
Q 007490 526 LL---SYEDPADRPSMATIVLALNSHSVT 551 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~~~~~~ 551 (601)
++ ...||.+|||+.+|+++|+.....
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11 127999999999999999876443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=304.50 Aligned_cols=211 Identities=29% Similarity=0.522 Sum_probs=164.4
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCcee----eEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEI----AVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
..++|++.++||+|+||.||+|++. +++.| ++|.+... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 3578999999999999999999953 45554 66666443 3445678999999999999999999999998765 7
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++|+||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 8999999999987655 5699999999999999999999999999999998765443
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc-------------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL------------------- 527 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~------------------- 527 (601)
.........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 251 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 3333344567889999999999999999999999999999999 99998764433221111
Q ss_pred ----CccCCCCCCCHHHHHHHHhcCC
Q 007490 528 ----SYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 528 ----~~~dP~~RPt~~evl~~L~~~~ 549 (601)
...||.+||++.|+++.|+...
T Consensus 252 i~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1279999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.29 Aligned_cols=178 Identities=28% Similarity=0.407 Sum_probs=152.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC--eeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD--EKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~ 412 (601)
...++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34567999999999999999999964 48999999997543 334567889999999999999999999998765 679
Q ss_pred EEEeccCCCCccccc--------------------------ccccceeeccccccCcEEE----ccCCCcEEeeccccee
Q 007490 413 LVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILL----DVQMNPKISDFGLARI 462 (601)
Q Consensus 413 lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll----~~~~~~kL~Dfg~a~~ 462 (601)
+||||+++++|..++ ++|+.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999987654 5699999999999999999 7778899999999987
Q ss_pred cCCCCCccccccccccccccCccccc--------CCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAM--------HGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 65432 223457899999999886 57889999999999999999999999853
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.76 Aligned_cols=184 Identities=29% Similarity=0.373 Sum_probs=159.8
Q ss_pred ccccchhhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-----CCCccc
Q 007490 327 SLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-----HRNLVR 400 (601)
Q Consensus 327 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~ 400 (601)
...+.+++.....++|++.++||+|+||.||+|+. .+++.||||++.. .......+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34566777788899999999999999999999995 4688999999864 3344566788999999996 999999
Q ss_pred eEEEEEeCCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc-------
Q 007490 401 LLGFCLEGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV------- 448 (601)
Q Consensus 401 l~~~~~~~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~------- 448 (601)
+++++...+..++||||+ +++|.+++ ++|+.+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 88876554 669999999999999999975
Q ss_pred ------------------CCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh
Q 007490 449 ------------------QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT 510 (601)
Q Consensus 449 ------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 510 (601)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 788999999999864322 234578999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 007490 511 GKKNSSF 517 (601)
Q Consensus 511 g~~p~~~ 517 (601)
|+.||..
T Consensus 255 g~~pf~~ 261 (360)
T 3llt_A 255 GSLLFRT 261 (360)
T ss_dssp SSCSCCC
T ss_pred CCCCCCC
Confidence 9999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.38 Aligned_cols=203 Identities=26% Similarity=0.410 Sum_probs=170.9
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4567999999999999999999964 69999999996542 2235678999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--- 170 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--- 170 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc---
Confidence 99999999987665 6699999999999999999999999999999998765332
Q ss_pred ccccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---c
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---L 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~ 527 (601)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .++ +
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHM 250 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHH
Confidence 2334579999999999988776 6899999999999999999999975432111 111 1
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...||.+|||+.|+++
T Consensus 251 L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 251 LQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCSSTTTSCCHHHHHT
T ss_pred cCCCchhCcCHHHHHh
Confidence 1279999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.42 Aligned_cols=214 Identities=31% Similarity=0.486 Sum_probs=163.4
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
...++..++|++.++||+|+||.||+|++. ..||||++... .....+.+.+|++++++++||||++++++. ..+.
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 345677889999999999999999999863 35999998654 344567799999999999999999999965 5567
Q ss_pred eEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 KILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999886654 569999999999999999999999999999999865433
Q ss_pred CCccccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------- 522 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------- 522 (601)
..........||+.|+|||++. +..++.++||||||+++|||++|+.||.......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 3233334457899999999986 6678899999999999999999999986532210
Q ss_pred ----ccccc---CccCCCCCCCHHHHHHHHhcCC
Q 007490 523 ----AEDLL---SYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 523 ----~~~l~---~~~dP~~RPt~~evl~~L~~~~ 549 (601)
..+++ ...||.+|||+.+++++|+...
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 01111 1279999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.36 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=170.7
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC-C-------ceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH-G-------QEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
+..++|++.+.||+|+||.||+|+... + ..||+|++........+.+.+|++++++++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 345678999999999999999998543 3 46999999776666778899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCC--------cEEee
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMN--------PKISD 456 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~--------~kL~D 456 (601)
+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++. +||+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999997765 569999999999999999999887 99999
Q ss_pred cccceecCCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCC-CCCCCCC--------------
Q 007490 457 FGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKK-NSSFYQT-------------- 520 (601)
Q Consensus 457 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~-p~~~~~~-------------- 520 (601)
||++..... .....+++.|+|||++.+ ..++.++||||||+++|||++|.. |+.....
T Consensus 165 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (289)
T 4fvq_A 165 PGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238 (289)
T ss_dssp CCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence 999865421 223467889999999987 678999999999999999999654 4432211
Q ss_pred ----Ccccccc---CccCCCCCCCHHHHHHHHhcCC
Q 007490 521 ----DGAEDLL---SYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 521 ----~~~~~l~---~~~dP~~RPt~~evl~~L~~~~ 549 (601)
....+++ ...||.+|||+.|+++.|+...
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1111111 2279999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.76 Aligned_cols=204 Identities=27% Similarity=0.386 Sum_probs=155.0
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
+...++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999965 57889999997543 345688999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEcc---CCCcEEeecccceecCCCCC
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|||+++++|.+++ ++|+.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 9999999986654 569999999999999999975 8899999999998654321
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc------------------------cc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG------------------------AE 524 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~------------------------~~ 524 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 2234578999999999999999999999999999999999999986433211 00
Q ss_pred cc---cCccCCCCCCCHHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 11 112799999999998863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.37 Aligned_cols=213 Identities=21% Similarity=0.287 Sum_probs=165.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC----CCceeeEEEeccCChh-----------hHHHHHHHHHHHHHcCCCCccce
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRSSGQ-----------GAQEFKNEVVLVAKLQHRNLVRL 401 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~l 401 (601)
...++|++.+.||+|+||.||+|+.. .+..||||++...... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 34578999999999999999999965 5788999998765322 11235678889999999999999
Q ss_pred EEEEEe----CCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC--Cc
Q 007490 402 LGFCLE----GDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM--NP 452 (601)
Q Consensus 402 ~~~~~~----~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~--~~ 452 (601)
++++.. ....++||||+ +++|.+++ ++|+.+|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 67899999999 88887665 56999999999999999999887 99
Q ss_pred EEeecccceecCCCCCc-----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC------
Q 007490 453 KISDFGLARIFGVDQTQ-----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------ 521 (601)
Q Consensus 453 kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------ 521 (601)
||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999876433211 1123457899999999999999999999999999999999999999542111
Q ss_pred ------------------------ccccccC---ccCCCCCCCHHHHHHHHhcCCC
Q 007490 522 ------------------------GAEDLLS---YEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 522 ------------------------~~~~l~~---~~dP~~RPt~~evl~~L~~~~~ 550 (601)
...+++. ..||.+||++.+|++.|+....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111 1799999999999999988654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=298.83 Aligned_cols=204 Identities=25% Similarity=0.360 Sum_probs=171.1
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh------hHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ------GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
..++|++.+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567999999999999999999954 5899999998754321 35779999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC----CcEEeecccceec
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM----NPKISDFGLARIF 463 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~----~~kL~Dfg~a~~~ 463 (601)
.++||||+++++|.+++ ++|+.+|+||||||+|||++.++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999997765 56999999999999999999888 7999999999876
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------------- 522 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------------- 522 (601)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred Cccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 5332 2234578999999999999999999999999999999999999986533211
Q ss_pred --cccc---cCccCCCCCCCHHHHHHH
Q 007490 523 --AEDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 523 --~~~l---~~~~dP~~RPt~~evl~~ 544 (601)
..++ +...||.+|||+.|+++.
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111 122799999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=293.89 Aligned_cols=204 Identities=33% Similarity=0.552 Sum_probs=166.3
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhh-------HHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQG-------AQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
...++|++.+.||+|+||.||+|++ .+++.||||++....... .+.+.+|++++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3457899999999999999999995 468999999986543221 16789999999999999999999998765
Q ss_pred CeeEEEEeccCCCCccccc------------------------ccccce--eeccccccCcEEEccCCC-----cEEeec
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------YDSQLR--IIHRDLKASNILLDVQMN-----PKISDF 457 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------~~h~~~--iiHrdlkp~NIll~~~~~-----~kL~Df 457 (601)
. ++||||+++++|.+++ ++|+.+ |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 4 7999999999986544 569999 999999999999988776 999999
Q ss_pred ccceecCCCCCccccccccccccccCcccc--cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc------------
Q 007490 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYA--MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA------------ 523 (601)
Q Consensus 458 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~------------ 523 (601)
|+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||........
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 99975432 23345789999999998 455678999999999999999999999975443221
Q ss_pred -----------ccc---cCccCCCCCCCHHHHHHHHhc
Q 007490 524 -----------EDL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 -----------~~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
.++ +...||.+|||+.|+++.|+.
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 001 111799999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=292.88 Aligned_cols=204 Identities=28% Similarity=0.393 Sum_probs=169.5
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999854 5889999998654 334457788999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCC---cEEeecccceecCCCCC
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLARIFGVDQT 468 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~ 468 (601)
|||+++++|..++ ++|+.+|+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 9999999985543 679999999999999999987655 9999999998765332
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-----------------------ccc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-----------------------AED 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-----------------------~~~ 525 (601)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 163 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp --BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred --cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2234578999999999999999999999999999999999999985433211 011
Q ss_pred c---cCccCCCCCCCHHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~ 544 (601)
+ +...||.+|||+.|+++.
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHcccChhhCCCHHHHhcC
Confidence 1 112799999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=293.78 Aligned_cols=202 Identities=27% Similarity=0.369 Sum_probs=169.3
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..++|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567899999999999999999964 477899999977666667889999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCCCCcc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|+++++|.+++ ++|+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---
Confidence 99999986654 6699999999999999999 788999999999998765332
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------ccc-
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------EDL- 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~l- 526 (601)
......||+.|+|||++.+. ++.++||||||+++|||++|+.||........ .++
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI 242 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence 23345789999999988654 89999999999999999999999865432111 111
Q ss_pred --cCccCCCCCCCHHHHHH
Q 007490 527 --LSYEDPADRPSMATIVL 543 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~ 543 (601)
+...||.+|||+.++++
T Consensus 243 ~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 11279999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.40 Aligned_cols=206 Identities=26% Similarity=0.330 Sum_probs=159.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHH-HHHcCCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVL-VAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457889999999999999999964 57889999997543 2233456667766 567899999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++|+|..++ ++|+++|+||||||+|||++.++++||+|||+++...... .
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~ 194 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--S 194 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC--C
Confidence 99999999987655 6799999999999999999999999999999998643221 2
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---cC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---LS 528 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~~ 528 (601)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ++ +.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL 274 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 274 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHT
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHc
Confidence 344568999999999999999999999999999999999999998654322111 11 11
Q ss_pred ccCCCCCCCHHHHHHHHh
Q 007490 529 YEDPADRPSMATIVLALN 546 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~L~ 546 (601)
..||.+||++.+.++.+.
T Consensus 275 ~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 275 QKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CSSGGGSTTTTTTHHHHH
T ss_pred ccCHHhCCCCCCCHHHHh
Confidence 279999999865444443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.97 Aligned_cols=181 Identities=29% Similarity=0.471 Sum_probs=141.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCC--e
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGD--E 410 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~ 410 (601)
...++|++.+.||+|+||.||+|+. .+|+.||||++... .......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 46899999998653 3445567889999999997 999999999998654 6
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC-
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ- 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~- 467 (601)
.++||||+++ +|..++ |+|+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 8999999985 554433 6799999999999999999999999999999998754211
Q ss_pred ------------------CccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 468 ------------------TQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 468 ------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0112234579999999999986 67899999999999999999999999653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.64 Aligned_cols=204 Identities=26% Similarity=0.359 Sum_probs=159.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 34578999999999999999999964 689999999965432 3366889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCC--cEEeecccceecCCCCCcc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMN--PKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~ 470 (601)
||+++++|..++ ++|+.||+||||||+|||++.++. +||+|||+++..... .
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~ 172 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 172 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---C
Confidence 999999997654 679999999999999999987765 999999999753322 1
Q ss_pred ccccccccccccCcccccCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------------c
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVK-SDVYSFGVLALETITGKKNSSFYQTDGA-------------------------E 524 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------------~ 524 (601)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ .
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 2234579999999999988887655 8999999999999999999965332110 0
Q ss_pred cc---cCccCCCCCCCHHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHHhC
Confidence 11 112799999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=305.91 Aligned_cols=211 Identities=19% Similarity=0.229 Sum_probs=165.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCC------CceeeEEEeccCChhhH-----------HHHHHHHHHHHHcCCCCcc
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQGA-----------QEFKNEVVLVAKLQHRNLV 399 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv 399 (601)
...++|++.+.||+|+||.||+|++.. ++.||||++........ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456789999999999999999998654 47899999876543211 1233456667778899999
Q ss_pred ceEEEEEeC----CeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEc--cC
Q 007490 400 RLLGFCLEG----DEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLD--VQ 449 (601)
Q Consensus 400 ~l~~~~~~~----~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~--~~ 449 (601)
++++++... ...+|||||+ +++|..++ |+|+.+|+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998865 4589999999 88887655 66999999999999999999 88
Q ss_pred CCcEEeecccceecCCCCCcc-----ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--
Q 007490 450 MNPKISDFGLARIFGVDQTQG-----NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-- 522 (601)
Q Consensus 450 ~~~kL~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-- 522 (601)
+.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 999999999998765332211 1133459999999999999999999999999999999999999997432110
Q ss_pred ----------------------------ccccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 523 ----------------------------AEDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 523 ----------------------------~~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
..+++ ...||.+||++.+|++.|+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 01111 127999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=298.75 Aligned_cols=210 Identities=30% Similarity=0.466 Sum_probs=169.1
Q ss_pred hcCCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--C
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--D 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 409 (601)
..++|++.+.||+|+||.||++++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... +
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 356688999999999999999983 358899999997543 34457889999999999999999999999876 6
Q ss_pred eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 689999999999997765 56999999999999999999999999999999987654
Q ss_pred CCCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-------------------------
Q 007490 466 DQTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ------------------------- 519 (601)
Q Consensus 466 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~------------------------- 519 (601)
.... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 3321 12334567888999999999999999999999999999999988742210
Q ss_pred ----------CCccccc---cCccCCCCCCCHHHHHHHHhc
Q 007490 520 ----------TDGAEDL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 520 ----------~~~~~~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
.....++ +...||.+|||+.+++++|+.
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0011111 122799999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.28 Aligned_cols=212 Identities=29% Similarity=0.450 Sum_probs=172.3
Q ss_pred hhhcCCCCcCC-cccccCcceEEeeecC---CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDN-KLGRGGFGEVYKGVLP---HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
....++|.+.+ .||+|+||.||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++ ..+.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 34456677776 9999999999999853 5778999999764 344567899999999999999999999999 5567
Q ss_pred eEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 KILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.++||||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 89999999999887765 569999999999999999999999999999999876533
Q ss_pred CCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc-------------------
Q 007490 467 QTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED------------------- 525 (601)
Q Consensus 467 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~------------------- 525 (601)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 243 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence 221 11223456889999999988899999999999999999998 999986543221111
Q ss_pred ----ccCccCCCCCCCHHHHHHHHhcC
Q 007490 526 ----LLSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 ----l~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.+...||.+||++.++++.|+..
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11127999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.83 Aligned_cols=218 Identities=23% Similarity=0.312 Sum_probs=173.1
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe----
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE---- 407 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---- 407 (601)
+.+.+..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34455678899999999999999999995 5689999999977777777889999999999999999999999873
Q ss_pred CCeeEEEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccc
Q 007490 408 GDEKILVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
....++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 34689999999999986544 569999999999999999999999999999998
Q ss_pred eecCCCCCcc-------ccccccccccccCcccccCCC---CCchhhHHhHHHHHHHHHhCCCCCCCCCC----------
Q 007490 461 RIFGVDQTQG-------NTSRIVGTYGYMSPEYAMHGQ---FSVKSDVYSFGVLALETITGKKNSSFYQT---------- 520 (601)
Q Consensus 461 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~---------- 520 (601)
.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 7653211110 012345799999999987654 68999999999999999999999843100
Q ss_pred ------------Cccccc---cCccCCCCCCCHHHHHHHHhcCCC
Q 007490 521 ------------DGAEDL---LSYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 521 ------------~~~~~l---~~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
....++ +...||.+|||+.++++.|+....
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 001111 112799999999999999988643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.43 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=170.1
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357889999999999999999964 68999999986543 3445778999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.............
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 99999987765 5699999999999999999999999999999998764333222334
Q ss_pred cccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------------c---cc
Q 007490 474 RIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------------D---LL 527 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------------~---l~ 527 (601)
...|++.|+|||++.+..+ +.++||||||+++|||++|+.||......... + .+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHH
Confidence 5678999999999987775 78999999999999999999999754332100 0 01
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...||.+|||+.|+++
T Consensus 246 l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 246 LVENPSARITIPDIKK 261 (276)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred CCCCchhCCCHHHHhc
Confidence 1179999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.90 Aligned_cols=212 Identities=30% Similarity=0.427 Sum_probs=174.3
Q ss_pred cCCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEE--eCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL--EGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~ 411 (601)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46789999999999999999983 358899999998777777788999999999999999999999987 45568
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 9999999999997765 5699999999999999999999999999999998765332
Q ss_pred Cc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-------------------------
Q 007490 468 TQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------------- 521 (601)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------------- 521 (601)
.. .......+|..|+|||++.+..++.++||||||+++|||++|+.||.....+
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 21 1223346788899999999999999999999999999999999887432110
Q ss_pred ----------ccccc---cCccCCCCCCCHHHHHHHHhcCCC
Q 007490 522 ----------GAEDL---LSYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 522 ----------~~~~l---~~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
...++ +...||.+|||+.|+++.|+....
T Consensus 262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01111 112799999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.16 Aligned_cols=210 Identities=30% Similarity=0.482 Sum_probs=168.5
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
....++|++.+.||+|+||.||+|++.. +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4556789999999999999999998532 346999998765 34456789999999999999999999999765 45
Q ss_pred eEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 KILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 78999999999987665 569999999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------c
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------D 525 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------~ 525 (601)
.. .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......... +
T Consensus 167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (281)
T 3cc6_A 167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 245 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 21 12233456889999999998999999999999999999998 99998643322211 1
Q ss_pred c---cCccCCCCCCCHHHHHHHHhc
Q 007490 526 L---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
+ +...||.+||++.|+++.|+.
T Consensus 246 li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHHHHH
Confidence 1 112799999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.74 Aligned_cols=206 Identities=26% Similarity=0.323 Sum_probs=161.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+++. .+|+.||||++... .......+.+|++++++++||||+++++++...+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3456799999999999999999995 46899999999653 3334456788999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
+||||+++++|..++ |+|+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999999986654 6797 899999999999999999999999999997543222
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL--- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l--- 526 (601)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ++
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 382 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 2234468999999999999999999999999999999999999999654322111 11
Q ss_pred cCccCCCCCC-----CHHHHHHH
Q 007490 527 LSYEDPADRP-----SMATIVLA 544 (601)
Q Consensus 527 ~~~~dP~~RP-----t~~evl~~ 544 (601)
+...||.+|| ++.|+++.
T Consensus 383 ~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 383 LLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HcccCHHHhCCCCCCCHHHHHhC
Confidence 1127999999 99999763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.52 Aligned_cols=180 Identities=26% Similarity=0.353 Sum_probs=148.3
Q ss_pred cCCCCcC-CcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEE
Q 007490 339 TNKFSSD-NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 339 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.+.|++. +.||+|+||.||+++. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567774 7899999999999995 46899999999776666677899999999995 7999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCC---cEEeecccceecCCCCC-
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLARIFGVDQT- 468 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~- 468 (601)
||+++++|.+++ ++|+.+|+||||||+|||++.++. +||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 999999987665 669999999999999999998776 99999999976542211
Q ss_pred ----ccccccccccccccCcccccC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 ----QGNTSRIVGTYGYMSPEYAMH-----GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 111223468999999999875 56889999999999999999999999654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.24 Aligned_cols=180 Identities=32% Similarity=0.448 Sum_probs=157.5
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+++.. +|+.||||++.+.. ......+.+|+++|++++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45677999999999999999999964 68999999996532 234566889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+||||+++|+|..++ |+|+.+|+||||||+|||++.++++||+|||+++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999999997654 5699999999999999999999999999999998764332
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 341 ---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 341 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp ---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 2234589999999999999999999999999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.13 Aligned_cols=177 Identities=28% Similarity=0.383 Sum_probs=147.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999964 58999999986543 2335678899999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|+++++|..++ ++|+.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccC
Confidence 99998776543 67999999999999999999999999999999987643222 223
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
...+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 4578999999999876 66899999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=313.98 Aligned_cols=172 Identities=24% Similarity=0.441 Sum_probs=131.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----Ce
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----DE 410 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 410 (601)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+++|++++||||+++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999854 6899999998653 344557789999999999999999999999543 56
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.|+||||+. ++|..++ |+|+.+|+||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 899999985 4554432 6799999999999999999999999999999998764322
Q ss_pred Cc-------------------------cccccccccccccCcccc-cCCCCCchhhHHhHHHHHHHHHhC
Q 007490 468 TQ-------------------------GNTSRIVGTYGYMSPEYA-MHGQFSVKSDVYSFGVLALETITG 511 (601)
Q Consensus 468 ~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg 511 (601)
.. ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 11 122345789999999986 466799999999999999999993
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.19 Aligned_cols=201 Identities=26% Similarity=0.303 Sum_probs=157.2
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
..++|++.++||+|+||+||+|+.. +|+.||||++.... .........|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999965 69999999986542 23334455666666555 99999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+ +++|..++ ++|+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 99999 55665433 6799999999999999999999999999999998764322
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC------------------Cccccc---cC
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT------------------DGAEDL---LS 528 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~------------------~~~~~l---~~ 528 (601)
......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ....++ +.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 2334568999999998875 799999999999999999999766532110 011111 12
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+|||+.|+++
T Consensus 290 ~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 290 EPDPKLRATAEALLA 304 (311)
T ss_dssp CSSTTTSCCHHHHHT
T ss_pred CCChhhCcCHHHHHh
Confidence 279999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.90 Aligned_cols=206 Identities=28% Similarity=0.394 Sum_probs=163.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcC--CCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...+..+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 445669999999999999999999878999999998654 3445678899999999996 599999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||| +.+++|..++ |+|+.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 5677776554 67999999999999999995 588999999999876543332
Q ss_pred cccccccccccccCcccccC-----------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-----------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMH-----------GQFSVKSDVYSFGVLALETITGKKNSSFYQTD----------------- 521 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~----------------- 521 (601)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 23345679999999999865 46899999999999999999999999653211
Q ss_pred -----cccccc---CccCCCCCCCHHHHHHH
Q 007490 522 -----GAEDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 522 -----~~~~l~---~~~dP~~RPt~~evl~~ 544 (601)
...+++ ...||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 001111 12799999999999865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=292.03 Aligned_cols=203 Identities=31% Similarity=0.510 Sum_probs=147.6
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45789999999999999999995 468999999986532 22346789999999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999998886654 56999999999999999999999999999999987643221
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-------------------c---cC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-------------------L---LS 528 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-------------------l---~~ 528 (601)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... + +.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 247 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHS
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHc
Confidence 2233578999999999999899999999999999999999999987543221111 1 11
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+|||+.++++
T Consensus 248 ~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 248 RRNPADRLSLSSVLD 262 (278)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred ccCHhhCCCHHHHhc
Confidence 279999999998874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=294.45 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=166.6
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567999999999999999999854 57789999986532 2235678899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc----
Confidence 99999999886554 679999999999999999999999999999998654322
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---cC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---LS 528 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~~ 528 (601)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .++ +.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHh
Confidence 22345789999999999999999999999999999999999999875432111 111 12
Q ss_pred ccCCCCCCCHHHHHHH
Q 007490 529 YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~ 544 (601)
..||.+|||+.|+++.
T Consensus 243 ~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEH 258 (279)
T ss_dssp CSSGGGSCCHHHHHHC
T ss_pred ccChhhCCCHHHHhhC
Confidence 2799999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.16 Aligned_cols=204 Identities=24% Similarity=0.348 Sum_probs=167.8
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh--------hhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999984 4688999999875431 1234577899999999999999999999999
Q ss_pred CeeEEEEeccCCC-Cccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 409 DEKILVYEFVPNK-SLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 409 ~~~~lv~E~~~~g-sL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
+..++||||+.+| +|..++ ++|+.+|+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999776 765544 6799999999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCc-------------cccc---c
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDG-------------AEDL---L 527 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~-------------~~~l---~ 527 (601)
... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ..++ +
T Consensus 182 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~ 258 (335)
T 3dls_A 182 RGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGL 258 (335)
T ss_dssp TTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHH
T ss_pred CCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHH
Confidence 332 2234578999999999988877 789999999999999999999986432110 1111 1
Q ss_pred CccCCCCCCCHHHHHHH
Q 007490 528 SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~~ 544 (601)
...||.+|||+.++++.
T Consensus 259 L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 259 LQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCSSGGGSCCHHHHHHC
T ss_pred ccCChhhCcCHHHHhcC
Confidence 12799999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.21 Aligned_cols=212 Identities=22% Similarity=0.300 Sum_probs=164.4
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
-++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999954 68899999987543 23347789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-cc
Confidence 9999999987765 56999999999999999999999999999999976543221 12
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------ccccc--
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDLL-- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l~-- 527 (601)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||....... ..+++
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 271 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHH
Confidence 234578999999999999999999999999999999999999986532110 11111
Q ss_pred -CccCCCCCC-CHHHHHHHHhcCCCC
Q 007490 528 -SYEDPADRP-SMATIVLALNSHSVT 551 (601)
Q Consensus 528 -~~~dP~~RP-t~~evl~~L~~~~~~ 551 (601)
...||.+|| ++.++++.|+.....
T Consensus 272 ~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 272 GMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred hccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 127999999 999999999876443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=293.38 Aligned_cols=201 Identities=28% Similarity=0.418 Sum_probs=162.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
.++|.+.++||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46789999999999999999995 458899999987643 3346788999999999999999999999999999999999
Q ss_pred ccCCCCccccc---------------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCC
Q 007490 417 FVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 417 ~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~ 466 (601)
|+++++|.+++ ++|+.+|+||||||+|||+ +.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999886544 5699999999999999999 45678999999999865432
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------c
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------E 524 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~ 524 (601)
. ......||+.|+|||++. ..++.++||||||+++|||++|+.||........ .
T Consensus 181 ~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 181 E---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred c---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 2 233457899999999875 5689999999999999999999999865432111 0
Q ss_pred cc---cCccCCCCCCCHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~ 543 (601)
++ +...||.+|||+.|+++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 11 11279999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=300.38 Aligned_cols=213 Identities=31% Similarity=0.495 Sum_probs=166.4
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCC-----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH-----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
+...++|+..+.||+|+||.||+|++.. +..||||++... .......+.+|++++++++||||+++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3456778889999999999999998543 235999999754 3344567899999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
..++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999987665 56999999999999999999999999999999987643
Q ss_pred CCCcc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------
Q 007490 466 DQTQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 466 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~-------------------- 523 (601)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence 32111 1222346788999999999999999999999999999999 9999864332111
Q ss_pred ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...||.+||++.++++.|+..
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 1127999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=299.61 Aligned_cols=216 Identities=26% Similarity=0.318 Sum_probs=158.3
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEE----
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCL---- 406 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~---- 406 (601)
..++....+|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.+++++. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 44566677899999999999999999995 468999999997777777788999999999996 999999999994
Q ss_pred ----eCCeeEEEEeccCCCCccccc--------------------------ccccce--eeccccccCcEEEccCCCcEE
Q 007490 407 ----EGDEKILVYEFVPNKSLDYFL--------------------------YDSQLR--IIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 407 ----~~~~~~lv~E~~~~gsL~~~l--------------------------~~h~~~--iiHrdlkp~NIll~~~~~~kL 454 (601)
.....++||||++ |+|.+++ ++|+.+ |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 3345799999997 4554433 669988 999999999999999999999
Q ss_pred eecccceecCCCCCcc----------ccccccccccccCcccc---cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC
Q 007490 455 SDFGLARIFGVDQTQG----------NTSRIVGTYGYMSPEYA---MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 521 (601)
+|||+++......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765322111 11134689999999998 5677899999999999999999999998643221
Q ss_pred c-----------------cccc---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 522 G-----------------AEDL---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 522 ~-----------------~~~l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
. ..++ +...||.+|||+.|+++.|+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1111 12279999999999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=300.96 Aligned_cols=213 Identities=32% Similarity=0.490 Sum_probs=169.0
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
+...++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34567899999999999999999984 24678999999654 344556789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc------------------------------ccccceeeccccccCcEEEcc---CCCcEEe
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------------YDSQLRIIHRDLKASNILLDV---QMNPKIS 455 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~ 455 (601)
+..++||||+++++|.+++ ++|+.+|+||||||+|||++. +..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999998886654 558999999999999999994 4469999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE---------- 524 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~---------- 524 (601)
|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence 9999976543332223334567899999999999999999999999999999998 88888654321111
Q ss_pred ----------cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 525 ----------DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ----------~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ +...||.+||++.+|++.|+..
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 1127999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.54 Aligned_cols=180 Identities=32% Similarity=0.434 Sum_probs=157.1
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+++.. +|+.||||++.+.. ......+.+|++++++++||||+++++++.+.+..+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34567899999999999999999964 68999999996542 233567889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 413 LVYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
+||||+++|+|..++ |+|+.+|+||||||+|||++.++++||+|||+++.+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999986543 56999999999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 322 233458999999999999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=303.24 Aligned_cols=199 Identities=31% Similarity=0.448 Sum_probs=163.2
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588889999999999999994 578999999987543 23346788999999999999999999999999999999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 999985 443322 67999999999999999999999999999999986532
Q ss_pred ccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------cccc
Q 007490 471 NTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------AEDL 526 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------~~~l 526 (601)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||....... ..++
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 22357899999999984 5678999999999999999999999986432110 0111
Q ss_pred ---cCccCCCCCCCHHHHHHH
Q 007490 527 ---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~ 544 (601)
+...||.+|||+.++++.
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHcccChhhCcCHHHHhhC
Confidence 112799999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=294.85 Aligned_cols=214 Identities=31% Similarity=0.457 Sum_probs=169.8
Q ss_pred hhhhhcCCCCcCC-cccccCcceEEeeec---CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 334 TIEVATNKFSSDN-KLGRGGFGEVYKGVL---PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 334 ~~~~~~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
++....++|++.+ .||+|+||.||+|.+ ..++.||||++.... ....+.+.+|++++++++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3445567788888 999999999999953 347889999997543 33357799999999999999999999999 5
Q ss_pred CCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 408 GDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
.+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 67789999999999987765 5699999999999999999999999999999998765
Q ss_pred CCCCcc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc------------------
Q 007490 465 VDQTQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE------------------ 524 (601)
Q Consensus 465 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~------------------ 524 (601)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 432211 1222346788999999998889999999999999999999 99998654321111
Q ss_pred --cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 525 --DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 --~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ +...||.+||++.++++.|+..
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1127999999999999999753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=292.95 Aligned_cols=205 Identities=30% Similarity=0.425 Sum_probs=163.9
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-CeeEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-DEKIL 413 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~l 413 (601)
+....++|++.+.||+|+||.||+++. +|+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 344567899999999999999999987 58899999986543 456789999999999999999999997655 46899
Q ss_pred EEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 414 VYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 414 v~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999987654 569999999999999999999999999999999765322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc---------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL--------------------- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l--------------------- 526 (601)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 122356889999999999999999999999999999998 9999875443221111
Q ss_pred --cCccCCCCCCCHHHHHHHHhc
Q 007490 527 --LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~~L~~ 547 (601)
+...||.+||++.|+++.|+.
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHHHHH
Confidence 112799999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=291.89 Aligned_cols=204 Identities=25% Similarity=0.360 Sum_probs=168.7
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--CeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG--DEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 412 (601)
...++|++.+.||+|+||.||+|++ +++.||||++... .....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3456789999999999999999998 5889999999764 344456799999999999999999999999887 7789
Q ss_pred EEEeccCCCCccccc-------------------------ccccce--eeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLR--IIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~--iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
+||||+++++|.+++ ++|+.+ |+||||||+|||++.++.++|.|||+.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999987665 568889 9999999999999999999999999876432
Q ss_pred CCCccccccccccccccCcccccCCCCCc---hhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSV---KSDVYSFGVLALETITGKKNSSFYQTDGA------------------- 523 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~p~~~~~~~~~------------------- 523 (601)
.....+|+.|+|||++.+..++. ++||||||+++|||++|+.||........
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 12346899999999998765554 89999999999999999999865432111
Q ss_pred --ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 --EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 --~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...||.+|||+.|+++.|+..
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 011 1127999999999999999763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.41 Aligned_cols=211 Identities=30% Similarity=0.444 Sum_probs=166.5
Q ss_pred hcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEE-eCCee
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL-EGDEK 411 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~ 411 (601)
...+|++.+.||+|+||.||+|++.+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568889999999999999998533 235899998764 3345677899999999999999999999865 45678
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999999997765 5699999999999999999999999999999998764332
Q ss_pred Cc--cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc--------------------
Q 007490 468 TQ--GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE-------------------- 524 (601)
Q Consensus 468 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~-------------------- 524 (601)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.........
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 262 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 11 12233467889999999999999999999999999999999 55555443322111
Q ss_pred cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 525 DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ +...||.+|||+.|++++|+..
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1127999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.09 Aligned_cols=169 Identities=27% Similarity=0.357 Sum_probs=129.1
Q ss_pred CCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEeccCCCC
Q 007490 345 DNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEFVPNKS 422 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~gs 422 (601)
.+.||+|+||.||+++.. +++.||||++... ....+.+|+.++++++ ||||+++++++.+.+..++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 5899999998643 3456789999999997 9999999999999999999999999999
Q ss_pred ccccc-----------------------ccccceeeccccccCcEEEccCC---CcEEeecccceecCCCCCcccccccc
Q 007490 423 LDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM---NPKISDFGLARIFGVDQTQGNTSRIV 476 (601)
Q Consensus 423 L~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~ 476 (601)
|.+++ ++|+.+|+||||||+|||++.++ .+||+|||+++....... ......
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~ 170 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPC 170 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccC
Confidence 87655 67999999999999999998765 799999999987543322 233457
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999999999999999999999999999999653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.25 Aligned_cols=202 Identities=26% Similarity=0.373 Sum_probs=166.5
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
..++|++.+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567899999999999999999954 689999999986655555678999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCCCCcc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|+++++|.+++ ++|+.+|+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----
Confidence 99999986654 5699999999999999999 78899999999999754321
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cccc
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------EDLL 527 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~l~ 527 (601)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........ .+++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 22335689999999999999999999999999999999999999865322110 0111
Q ss_pred ---CccCCCCCCCHHHHHH
Q 007490 528 ---SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~ 543 (601)
...||.+|||+.|+++
T Consensus 243 ~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 1179999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=303.46 Aligned_cols=177 Identities=28% Similarity=0.389 Sum_probs=154.1
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
...++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 44678999999999999999999964 6889999998765 344567789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccc-eeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQL-RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~-~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
|||+++++|.+++ ++|+. +|+||||||+|||++.++.+||+|||++......
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 9999999997765 56875 8999999999999999999999999999755321
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22345789999999999999999999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.10 Aligned_cols=209 Identities=29% Similarity=0.392 Sum_probs=166.5
Q ss_pred CCCcCCcccccCcceEEeeecCC----CceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee-EEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK-ILV 414 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~lv 414 (601)
.|...++||+|+||.||+|++.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998432 2369999987543 34567889999999999999999999999877665 999
Q ss_pred EeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC--
Q 007490 415 YEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT-- 468 (601)
Q Consensus 415 ~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 468 (601)
|||+.+++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999987665 56999999999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCC-CCCCCCCccc--------------------cc-
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKN-SSFYQTDGAE--------------------DL- 526 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p-~~~~~~~~~~--------------------~l- 526 (601)
........+++.|+|||.+.+..++.++||||||+++|||++|..| +......... ++
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 261 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVM 261 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHH
Confidence 1223345678899999999999999999999999999999996555 4332221111 11
Q ss_pred --cCccCCCCCCCHHHHHHHHhcCC
Q 007490 527 --LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 527 --~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
+...||.+|||+.+++++|+...
T Consensus 262 ~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 262 QQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 11179999999999999997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=323.82 Aligned_cols=212 Identities=28% Similarity=0.447 Sum_probs=167.0
Q ss_pred hhhcCCCCcCC-cccccCcceEEeeecC---CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDN-KLGRGGFGEVYKGVLP---HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
....+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++|++++||||+++++++.. +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 33444555555 7999999999999853 46679999997653 3456789999999999999999999999976 56
Q ss_pred eEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 KILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.++||||+++|+|..++ |+|+.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 89999999999997765 569999999999999999999999999999999876433
Q ss_pred CCcc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccc------------------
Q 007490 467 QTQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDL------------------ 526 (601)
Q Consensus 467 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l------------------ 526 (601)
.... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 2211 1122345689999999999999999999999999999998 9999976443221111
Q ss_pred -----cCccCCCCCCCHHHHHHHHhcC
Q 007490 527 -----LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 -----~~~~dP~~RPt~~evl~~L~~~ 548 (601)
+...||.+||++.+|++.|+..
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1127999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=289.09 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=166.8
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh------hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456889999999999999999965 589999999865421 2357899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC----CcEEeecccceecC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM----NPKISDFGLARIFG 464 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~----~~kL~Dfg~a~~~~ 464 (601)
++||||+++++|.+++ ++|+.+|+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 9999999999997765 56999999999999999999877 79999999998764
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------- 522 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------- 522 (601)
... ......+++.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 164 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred CCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 322 2234568999999999999999999999999999999999999986543211
Q ss_pred -ccc---ccCccCCCCCCCHHHHHH
Q 007490 523 -AED---LLSYEDPADRPSMATIVL 543 (601)
Q Consensus 523 -~~~---l~~~~dP~~RPt~~evl~ 543 (601)
..+ .+...||.+|||+.|+++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHh
Confidence 011 111279999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=288.94 Aligned_cols=208 Identities=24% Similarity=0.346 Sum_probs=165.3
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEE-EeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC-LEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~ 415 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+|++++++++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 5689999998754432 23578899999999988877766655 5677889999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+ +++|.+++ ++|+.+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 88887664 5699999999999999999 7899999999999987654332
Q ss_pred cc-----ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc-----------------
Q 007490 469 QG-----NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL----------------- 526 (601)
Q Consensus 469 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l----------------- 526 (601)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh
Confidence 11 22345789999999999999999999999999999999999999976433221111
Q ss_pred ----------cC---ccCCCCCCCHHHHHHHHhcC
Q 007490 527 ----------LS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 527 ----------~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
+. ..||.+|||+.+|++.|+..
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11 17999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=292.21 Aligned_cols=205 Identities=25% Similarity=0.437 Sum_probs=171.8
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
..+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 345689999999999999999985 468899999987543 345678999999999999999999999999999999999
Q ss_pred eccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 416 EFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 100 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 177 (303)
T 3a7i_A 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 177 (303)
T ss_dssp ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBC
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccC
Confidence 999999887655 56999999999999999999999999999999987653321 233
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------ccc---cCcc
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------EDL---LSYE 530 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------~~l---~~~~ 530 (601)
...|++.|+|||++.+..++.++||||||+++|||++|+.||........ .++ +...
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCC
Confidence 45789999999999999999999999999999999999999865332110 111 1127
Q ss_pred CCCCCCCHHHHHHH
Q 007490 531 DPADRPSMATIVLA 544 (601)
Q Consensus 531 dP~~RPt~~evl~~ 544 (601)
||.+|||+.|+++.
T Consensus 258 dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 258 EPSFRPTAKELLKH 271 (303)
T ss_dssp SGGGSCCHHHHTTC
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=305.47 Aligned_cols=210 Identities=30% Similarity=0.428 Sum_probs=159.1
Q ss_pred CCCCcCCcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe-CCeeEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GDEKIL 413 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l 413 (601)
..|++.+.||+|+||.||+|++.+ +..||||.+... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346778999999999999998532 246899998654 33456789999999999999999999998764 457899
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999987765 569999999999999999999999999999999865432211
Q ss_pred --cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------------------c
Q 007490 470 --GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--------------------L 526 (601)
Q Consensus 470 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--------------------l 526 (601)
.......+++.|+|||++.+..++.++||||||+++|||++ |.+||......+... +
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~l 328 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 328 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11233457789999999999999999999999999999999 677775543322111 1
Q ss_pred ---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 527 ---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
+...||.+|||+.|+++.|+...
T Consensus 329 i~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 329 MLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11179999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.02 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=168.8
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3467899999999999999999964 57889999986532 2234678999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---- 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---- 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS----
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc----
Confidence 99999998886654 569999999999999999999999999999999765422
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---cC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---LS 528 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~~ 528 (601)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........ .++ +.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 247 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHS
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHh
Confidence 12345789999999999999999999999999999999999999865432111 111 11
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+||++.++++
T Consensus 248 ~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 248 RYHPPQRLPLKGVME 262 (284)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred hcCHhhCCCHHHHhh
Confidence 279999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.75 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=163.8
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
..++|++.+.||+|+||.||+++.. +|+.||||++...... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999964 5889999999765432 35688888888 7999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccC-C---CcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ-M---NPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~-~---~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++|+|.+++ ++|+.||+||||||+|||+..+ + .+||+|||+++.......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999987654 6799999999999999998543 3 499999999987643322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc------------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE------------------------ 524 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~------------------------ 524 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence 233457899999999998888999999999999999999999999753221111
Q ss_pred --cc---cCccCCCCCCCHHHHHHH
Q 007490 525 --DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 --~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+||++.|+++.
T Consensus 254 ~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 254 AKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 112799999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=322.52 Aligned_cols=182 Identities=27% Similarity=0.332 Sum_probs=156.4
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 410 (601)
....++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999954 5788999999753 223456778899999988 79999999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.||||||+++|+|..++ |+|+.+|+||||||+||||+.++++||+|||+++......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999999997665 6799999999999999999999999999999998643222
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 497 --~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 497 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp --CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 23445689999999999999999999999999999999999999997644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.49 Aligned_cols=178 Identities=31% Similarity=0.488 Sum_probs=146.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-----hhhHHHHHHHHHHHHHcC---CCCccceEEEEEe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-----GQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLE 407 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 407 (601)
...++|++.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999995 468999999986432 122345677888777775 9999999999987
Q ss_pred CC-----eeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeec
Q 007490 408 GD-----EKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDF 457 (601)
Q Consensus 408 ~~-----~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Df 457 (601)
.. ..++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 47999999974 665543 669999999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 458 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 165 GLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred ccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998654322 234467899999999999999999999999999999999999998543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.22 Aligned_cols=204 Identities=26% Similarity=0.405 Sum_probs=157.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--------hhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
...++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4568899999999999999999985 458999999986532 112234789999999999999999999975
Q ss_pred CCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccC---CCcEEeecccce
Q 007490 408 GDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLAR 461 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~ 461 (601)
.+..++||||+++++|.+++ |+|+.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45689999999999997765 6699999999999999999754 459999999998
Q ss_pred ecCCCCCccccccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-cc-------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-AE------------- 524 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~------------- 524 (601)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 291 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 291 ILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred ecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 76432 22334679999999999863 678899999999999999999999997543221 00
Q ss_pred ----------cc---cCccCCCCCCCHHHHHHH
Q 007490 525 ----------DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ----------~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 01 111799999999998863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.66 Aligned_cols=210 Identities=26% Similarity=0.428 Sum_probs=162.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688999999999999999995 46899999998753 344567789999999999999999999999999999999
Q ss_pred EeccCCCCccccc---------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 415 YEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 415 ~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
|||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999987654 5699999999999999999999999999999998654322
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-----------------------ccc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-----------------------GAE 524 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-----------------------~~~ 524 (601)
. ......+++.|+|||++.+..++.++||||||+++|||++|+.||...... ...
T Consensus 191 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 268 (310)
T 2wqm_A 191 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHH
T ss_pred c--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHH
Confidence 1 223456899999999999999999999999999999999999998543211 001
Q ss_pred cc---cCccCCCCCCCHHHHHHHHhcCCC
Q 007490 525 DL---LSYEDPADRPSMATIVLALNSHSV 550 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~L~~~~~ 550 (601)
++ +...||.+|||+.+|++.|+....
T Consensus 269 ~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 269 QLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11 112799999999999999977543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.95 Aligned_cols=201 Identities=13% Similarity=0.169 Sum_probs=158.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHH---HHHHHcCCCCccceE------
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEV---VLVAKLQHRNLVRLL------ 402 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~l~------ 402 (601)
....++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34567899999999999999999995 46999999999743 334567889999 555566899999998
Q ss_pred -EEEEeCCe-----------------eEEEEeccCCCCccccc------------------------------cccccee
Q 007490 403 -GFCLEGDE-----------------KILVYEFVPNKSLDYFL------------------------------YDSQLRI 434 (601)
Q Consensus 403 -~~~~~~~~-----------------~~lv~E~~~~gsL~~~l------------------------------~~h~~~i 434 (601)
+++...+. .++||||+ +|+|.+++ |+|+.+|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77665532 78999999 56776543 5699999
Q ss_pred eccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCC-----------CCCchhhHHhHHH
Q 007490 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-----------QFSVKSDVYSFGV 503 (601)
Q Consensus 435 iHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGv 503 (601)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcccccc------------------CccCCCCCCCHHHHHH
Q 007490 504 LALETITGKKNSSFYQTDGAEDLL------------------SYEDPADRPSMATIVL 543 (601)
Q Consensus 504 vl~elltg~~p~~~~~~~~~~~l~------------------~~~dP~~RPt~~evl~ 543 (601)
++|||++|+.||...........+ ...||.+|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999654432221111 1179999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.58 Aligned_cols=211 Identities=29% Similarity=0.392 Sum_probs=170.2
Q ss_pred hcCCC-CcCCcccccCcceEEeeec-----CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC--
Q 007490 338 ATNKF-SSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-- 408 (601)
Q Consensus 338 ~~~~f-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 408 (601)
..++| ++.++||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34455 8899999999999988753 257899999997653 34567789999999999999999999999874
Q ss_pred CeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 409 DEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
...++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 5789999999999998765 569999999999999999999999999999999876543
Q ss_pred CCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC------------------------
Q 007490 467 QTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------------ 521 (601)
Q Consensus 467 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------------ 521 (601)
... .......++..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 221 1223346788899999999999999999999999999999999887532110
Q ss_pred -----------ccccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 522 -----------GAEDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 522 -----------~~~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
...++ +...||.+|||+.|+++.|+..
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 01111 1127999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=302.22 Aligned_cols=197 Identities=22% Similarity=0.274 Sum_probs=154.8
Q ss_pred CCCCcC-CcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHH-cCCCCccceEEEEEe----CCeeE
Q 007490 340 NKFSSD-NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAK-LQHRNLVRLLGFCLE----GDEKI 412 (601)
Q Consensus 340 ~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~----~~~~~ 412 (601)
++|.+. +.||+|+||.||+++.. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 78999999999999954 5889999998532 456788888754 489999999999875 56789
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc---CCCcEEeecccceecC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLARIFG 464 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Dfg~a~~~~ 464 (601)
|||||+++|+|.+++ |+|+.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999999886654 669999999999999999998 7889999999998754
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------- 523 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------- 523 (601)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 216 SHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp --------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred CCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 321 23345789999999999999999999999999999999999999865432110
Q ss_pred ------ccc---cCccCCCCCCCHHHHHHH
Q 007490 524 ------EDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 ------~~l---~~~~dP~~RPt~~evl~~ 544 (601)
.++ +...||.+|||+.|+++.
T Consensus 293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011 112799999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.95 Aligned_cols=179 Identities=30% Similarity=0.421 Sum_probs=148.4
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
.++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999964 48999999986543 333566889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 181 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VY 181 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--cc
Confidence 999998776543 67999999999999999999999999999999986543221 22
Q ss_pred ccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....+++.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 345789999999999875 78999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.00 Aligned_cols=175 Identities=30% Similarity=0.435 Sum_probs=144.4
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 409 (601)
..++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999995 46899999998653 3344567889999999999999999999998763
Q ss_pred -eeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 -EKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
..++||||+ +++|..++ ++|+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 459999999 66776554 679999999999999999999999999999999875422
Q ss_pred CCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 182 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 182 -----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp -----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999877 67999999999999999999999998653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=287.18 Aligned_cols=208 Identities=24% Similarity=0.348 Sum_probs=168.9
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEE-EeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC-LEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~ 415 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999995 5789999999865432 24688999999999998877666655 5677789999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+ +++|.+++ ++|+.+|+||||||+|||+ +.++.+||+|||++........
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 88887655 5699999999999999999 5889999999999987654332
Q ss_pred cc-----ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------
Q 007490 469 QG-----NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE------------------- 524 (601)
Q Consensus 469 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~------------------- 524 (601)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 11 123457899999999999999999999999999999999999999764322111
Q ss_pred --------cccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 525 --------DLLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 --------~l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
+++. ..||.+|||+.+|++.|+..
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 1111 17999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.55 Aligned_cols=205 Identities=26% Similarity=0.424 Sum_probs=171.1
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
..++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3467899999999999999999965 4788999998654 33456778899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG 470 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 470 (601)
||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--
Confidence 99999999887654 66999999999999999999999999999999987643222
Q ss_pred ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---cC
Q 007490 471 NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---LS 528 (601)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~~ 528 (601)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........ .++ +.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 23345789999999999998999999999999999999999999865432110 011 11
Q ss_pred ccCCCCCCCHHHHHHH
Q 007490 529 YEDPADRPSMATIVLA 544 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~ 544 (601)
..||.+|||+.|+++.
T Consensus 251 ~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 251 QTDPTARPTINELLND 266 (294)
T ss_dssp CSSGGGSCCGGGGGGS
T ss_pred ccChhhCcCHHHHhhC
Confidence 2799999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=288.68 Aligned_cols=205 Identities=26% Similarity=0.334 Sum_probs=163.2
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC----hhhHHHHHHHHHHHHHcCCCCccceEEEEE--eCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQHRNLVRLLGFCL--EGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~ 411 (601)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 58899999986542 234577899999999999999999999984 45578
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
++||||++++ |..++ ++|+.+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 22211 679999999999999999999999999999999876543
Q ss_pred CCccccccccccccccCcccccCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------cc
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQ--FSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------ED 525 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~ 525 (601)
..........|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ .+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~ 242 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence 3333334557899999999987644 47899999999999999999999875432111 11
Q ss_pred c---cCccCCCCCCCHHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~ 544 (601)
+ +...||.+|||+.|+++.
T Consensus 243 li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 243 LLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 1 112799999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=298.13 Aligned_cols=205 Identities=24% Similarity=0.382 Sum_probs=168.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--------hhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--------QGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
....++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445577999999999999999999964 699999999865431 1245678999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
...+..++||||+++++|.+++ ++|+.||+||||||+|||++.++.+||+|||++..
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 9999999999999999987665 66999999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccCcccccC------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc--------------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMH------GQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-------------- 522 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-------------- 522 (601)
+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 250 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 250 LEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 65332 2334579999999998863 368899999999999999999999986532110
Q ss_pred ---------cccc---cCccCCCCCCCHHHHHH
Q 007490 523 ---------AEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 523 ---------~~~l---~~~~dP~~RPt~~evl~ 543 (601)
..++ +...||.+|||+.|+++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11279999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.94 Aligned_cols=204 Identities=26% Similarity=0.424 Sum_probs=170.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
.++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999999999999964 4788999998654 334567789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--c
Confidence 9999999987654 67999999999999999999999999999999987643322 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---cCc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL---LSY 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l---~~~ 529 (601)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||........ .++ +..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcc
Confidence 3345789999999999999999999999999999999999999865432110 111 112
Q ss_pred cCCCCCCCHHHHHHH
Q 007490 530 EDPADRPSMATIVLA 544 (601)
Q Consensus 530 ~dP~~RPt~~evl~~ 544 (601)
.||.+|||+.|+++.
T Consensus 278 ~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 278 TDPTARPTINELLND 292 (335)
T ss_dssp SSGGGSCCGGGGGGS
T ss_pred CChhHCcCHHHHhcC
Confidence 799999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.66 Aligned_cols=179 Identities=28% Similarity=0.403 Sum_probs=143.7
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh-----hHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
...++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44678999999999999999999964 5899999998653221 12467899999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 KILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999986 443322 679999999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
. .......+|+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus 166 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 166 N--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp C--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 2 223345789999999998764 5899999999999999999999887643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=294.05 Aligned_cols=172 Identities=24% Similarity=0.445 Sum_probs=149.4
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEe--CCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLE--GDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv 414 (601)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46789999999999999999984 568999999986433 467889999999997 9999999999997 6678999
Q ss_pred EeccCCCCccccc--------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCccccc
Q 007490 415 YEFVPNKSLDYFL--------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 415 ~E~~~~gsL~~~l--------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
|||+++++|..++ ++|+.+|+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~ 188 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YN 188 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CC
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cc
Confidence 9999999987654 67999999999999999999777 799999999987653322 23
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 4578999999999877 678999999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.28 Aligned_cols=228 Identities=23% Similarity=0.366 Sum_probs=170.1
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
....+++...++|++.+.||+|+||.||+|+.. ..||+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 345667778899999999999999999999863 359999986542 2334567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 408 GDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
.+..++||||+++++|..++ ++|+.+|+||||||+|||++ ++.+||+|||++...
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999998887665 56999999999999999998 679999999998765
Q ss_pred CCCC---CccccccccccccccCcccccC---------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------
Q 007490 464 GVDQ---TQGNTSRIVGTYGYMSPEYAMH---------GQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------- 522 (601)
Q Consensus 464 ~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------- 522 (601)
.... .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 3211 1122233468999999999864 457899999999999999999999986543211
Q ss_pred ------------cccccC---ccCCCCCCCHHHHHHHHhcCCCCCCCCCCCce
Q 007490 523 ------------AEDLLS---YEDPADRPSMATIVLALNSHSVTLSVPRQPAL 560 (601)
Q Consensus 523 ------------~~~l~~---~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~ 560 (601)
..+++. ..||.+|||+.+++++|+...........|..
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~ 312 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------------
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcc
Confidence 111111 17999999999999999887554444334433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=289.92 Aligned_cols=205 Identities=29% Similarity=0.447 Sum_probs=168.5
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe---------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--------- 407 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------- 407 (601)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467889999999999999999965 68999999997554 346789999999999999999998864
Q ss_pred -------CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 408 -------GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 408 -------~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
....++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 44579999999999987665 5699999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC---------------C
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ---------------T 520 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~---------------~ 520 (601)
|||++....... ......+++.|+|||++.+..++.++||||||+++|||++|..|+.... .
T Consensus 165 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2a19_B 165 DFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFD 241 (284)
T ss_dssp CCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTSC
T ss_pred cchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccccCC
Confidence 999998765432 2233468999999999999999999999999999999999988763210 0
Q ss_pred Cccccc---cCccCCCCCCCHHHHHHHHhcCC
Q 007490 521 DGAEDL---LSYEDPADRPSMATIVLALNSHS 549 (601)
Q Consensus 521 ~~~~~l---~~~~dP~~RPt~~evl~~L~~~~ 549 (601)
....++ +...||.+|||+.|+++.|....
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011111 22289999999999999997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.88 Aligned_cols=203 Identities=29% Similarity=0.383 Sum_probs=166.6
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
..++|++.++||+|+||.||+++.. +++.||||++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999954 6899999998643 233457789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEc---cCCCcEEeecccceecCCCCC
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLD---VQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|||+++++|..++ |+|+.+|+||||||+|||++ .++.+||+|||+++......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 9999999986544 67999999999999999995 45679999999998664332
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------ED 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~ 525 (601)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ .+
T Consensus 179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 2334579999999999875 599999999999999999999999865432111 11
Q ss_pred c---cCccCCCCCCCHHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~ 544 (601)
+ +...||.+|||+.|+++.
T Consensus 256 li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 1 112799999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=296.15 Aligned_cols=180 Identities=27% Similarity=0.435 Sum_probs=147.9
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEe--------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-------- 407 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 407 (601)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999996 568999999986543 2334577899999999999999999999987
Q ss_pred CCeeEEEEeccCCCCccc-----------------------ccccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 408 GDEKILVYEFVPNKSLDY-----------------------FLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~-----------------------~l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
.+..++||||+++..+.. +.++|+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 446899999998632211 116799999999999999999999999999999998765
Q ss_pred CCCCc--cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 465 VDQTQ--GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 465 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 32221 22334578999999999876 45899999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=309.55 Aligned_cols=205 Identities=28% Similarity=0.358 Sum_probs=167.0
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-------------hhHHHHHHHHHHHHHcCCCCccce
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-------------QGAQEFKNEVVLVAKLQHRNLVRL 401 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~l 401 (601)
....++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345678999999999999999999954 578999999865421 235678999999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC---CcEEe
Q 007490 402 LGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM---NPKIS 455 (601)
Q Consensus 402 ~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~---~~kL~ 455 (601)
++++.+.+..++||||+++++|..++ |+|+.+|+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999999986544 67999999999999999999876 69999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-----------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------- 524 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------- 524 (601)
|||++....... ......||+.|+|||++. +.++.++|||||||++|||++|+.||.........
T Consensus 192 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 192 DFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999998765432 233457999999999886 56999999999999999999999999754322111
Q ss_pred ------------cc---cCccCCCCCCCHHHHHHH
Q 007490 525 ------------DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ------------~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 112799999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=305.25 Aligned_cols=177 Identities=25% Similarity=0.444 Sum_probs=144.3
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----C
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----D 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 409 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++|++++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999995 45889999999753 334557889999999999999999999999876 5
Q ss_pred eeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 EKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
..++||||+++ +|..++ |+|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 68999999875 665443 679999999999999999999999999999999876533
Q ss_pred CCc--------------------cccccccccccccCcccc-cCCCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 467 QTQ--------------------GNTSRIVGTYGYMSPEYA-MHGQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 467 ~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
... ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 211 123456889999999986 5567999999999999999999854443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.50 Aligned_cols=211 Identities=26% Similarity=0.370 Sum_probs=170.9
Q ss_pred chhhhhhhcCCCCcC-CcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 331 DFKTIEVATNKFSSD-NKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 331 ~~~~~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
.++..+...++|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 345566777788887 89999999999999954 58999999987542 33467889999999999 569999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc---CCCcEEeec
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDF 457 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Df 457 (601)
.+.+..++||||+++++|..++ ++|+.||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999887765 569999999999999999998 789999999
Q ss_pred ccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------
Q 007490 458 GLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------- 523 (601)
Q Consensus 458 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------- 523 (601)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 9998764322 22345789999999999999999999999999999999999999865432110
Q ss_pred ---------cc---ccCccCCCCCCCHHHHHHH
Q 007490 524 ---------ED---LLSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 ---------~~---l~~~~dP~~RPt~~evl~~ 544 (601)
.+ .+...||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 01 1112799999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.44 Aligned_cols=185 Identities=24% Similarity=0.323 Sum_probs=147.6
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCCh-----------hhHHHHHHHHHHHHHcCCCCc
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG-----------QGAQEFKNEVVLVAKLQHRNL 398 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~hpnI 398 (601)
..+.++....++|++.+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345677888999999999999999999999987899999999864321 123778999999999999999
Q ss_pred cceEEEEEeC-----CeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccC
Q 007490 399 VRLLGFCLEG-----DEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQ 449 (601)
Q Consensus 399 v~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~ 449 (601)
+++++++... ...++||||+++ +|..++ ++|+.+|+||||||+|||++.+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred cceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence 9999998543 357999999985 443322 6799999999999999999999
Q ss_pred CCcEEeecccceecCCCCCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 450 MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 450 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
+.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 171 ~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 171 NDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999997543222 2334578999999999877 67899999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=287.51 Aligned_cols=205 Identities=26% Similarity=0.416 Sum_probs=162.7
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 44578999999999999999999964 68999999986532 234567899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
+||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999999987665 5699999999999999999999999999999998754322
Q ss_pred cccccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------------ccc---
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------EDL--- 526 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------~~l--- 526 (601)
......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .++
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence 1233468999999999987765 6899999999999999999999865432111 111
Q ss_pred cCccCCCCCCCHHHHHHH
Q 007490 527 LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~~ 544 (601)
+...||.+|||+.|+++.
T Consensus 245 ~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 245 MLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HTCSSGGGSCCHHHHHHS
T ss_pred HccCChhhCCCHHHHHhC
Confidence 112799999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.47 Aligned_cols=202 Identities=28% Similarity=0.382 Sum_probs=163.0
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
..++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4457999999999999999999964 68899999987543 33457789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccC---CCcEEeecccceecCCCCC
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~ 468 (601)
|||+++++|.+++ |+|+.+|+||||||+|||++.. +.+||+|||++.......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999999986544 6799999999999999999764 459999999998765332
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------ED 525 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~ 525 (601)
......||+.|+|||++. ..++.++|||||||++|||++|+.||........ .+
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 233457999999999876 5699999999999999999999999965432111 01
Q ss_pred c---cCccCCCCCCCHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~ 543 (601)
+ +...||.+|||+.|+++
T Consensus 271 li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCChhhCccHHHHhc
Confidence 1 11279999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.75 Aligned_cols=207 Identities=28% Similarity=0.378 Sum_probs=167.2
Q ss_pred hcCCCCcCCcccccCcceEEeeec----CCCceeeEEEeccCC----hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeC
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEG 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 408 (601)
..++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346799999999999999999986 368999999986532 23345677899999999 699999999999999
Q ss_pred CeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 409 DEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
+..++||||+++++|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 9999999999999997665 67999999999999999999999999999999987643
Q ss_pred CCCccccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE------------------- 524 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~------------------- 524 (601)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 212 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 1vzo_A 212 DET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290 (355)
T ss_dssp GGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence 222 22334579999999999986 34789999999999999999999998643321110
Q ss_pred ----cc---cCccCCCCCC-----CHHHHHHHH
Q 007490 525 ----DL---LSYEDPADRP-----SMATIVLAL 545 (601)
Q Consensus 525 ----~l---~~~~dP~~RP-----t~~evl~~L 545 (601)
++ +...||.+|| ++.|+++..
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 1127999999 999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.87 Aligned_cols=176 Identities=27% Similarity=0.440 Sum_probs=141.5
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChh-hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ-GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999964 6889999998654322 122455799999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++ +|..++ ++|+.||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccc
Confidence 985 544332 6799999999999999999999999999999998654322 1223
Q ss_pred cccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
...+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4578999999999876 56899999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.41 Aligned_cols=180 Identities=29% Similarity=0.452 Sum_probs=141.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
....++|++.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34456799999999999999999984 4689999999965432 23456789999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEc-----cCCCcEEeecccceecC
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLD-----VQMNPKISDFGLARIFG 464 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~-----~~~~~kL~Dfg~a~~~~ 464 (601)
+||||+++ +|..++ ++|+.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999985 665543 67999999999999999995 44559999999998764
Q ss_pred CCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 189 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 189 IPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 322 123345689999999999874 4899999999999999999999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.89 Aligned_cols=177 Identities=28% Similarity=0.361 Sum_probs=142.1
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 409 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999985 46889999999753 3344567889999999999999999999998665
Q ss_pred -eeEEEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 410 -EKILVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
..++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred cceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 68999999986 343322 6799999999999999999999999999999998654221
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 182 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 182 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223457899999999999999999999999999999999999998643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.07 Aligned_cols=175 Identities=31% Similarity=0.446 Sum_probs=139.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHH--HHHHHHcCCCCccceEEEEEe-----CC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNE--VVLVAKLQHRNLVRLLGFCLE-----GD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~hpnIv~l~~~~~~-----~~ 409 (601)
...++|++.+.||+|+||.||+|+. +++.||||++..... ..+..| +..+..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4457899999999999999999987 789999999865432 333444 444556899999999986542 23
Q ss_pred eeEEEEeccCCCCccccc----------------------ccccc---------eeeccccccCcEEEccCCCcEEeecc
Q 007490 410 EKILVYEFVPNKSLDYFL----------------------YDSQL---------RIIHRDLKASNILLDVQMNPKISDFG 458 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l----------------------~~h~~---------~iiHrdlkp~NIll~~~~~~kL~Dfg 458 (601)
..++||||+++++|.+++ ++|+. +|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 568999999999998765 56888 99999999999999999999999999
Q ss_pred cceecCCCCC------ccccccccccccccCcccccC-------CCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 459 LARIFGVDQT------QGNTSRIVGTYGYMSPEYAMH-------GQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 459 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9987653221 112234579999999999976 45678999999999999999997665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.19 Aligned_cols=211 Identities=25% Similarity=0.363 Sum_probs=163.3
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHH--cCCCCccceEEEEEeC---
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEG--- 408 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~--- 408 (601)
......++|++.+.||+|+||.||+|+. .++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445567899999999999999999997 48999999985432 2334455555554 4999999999999887
Q ss_pred -CeeEEEEeccCCCCccccc----------------------ccccc--------eeeccccccCcEEEccCCCcEEeec
Q 007490 409 -DEKILVYEFVPNKSLDYFL----------------------YDSQL--------RIIHRDLKASNILLDVQMNPKISDF 457 (601)
Q Consensus 409 -~~~~lv~E~~~~gsL~~~l----------------------~~h~~--------~iiHrdlkp~NIll~~~~~~kL~Df 457 (601)
...++||||+++++|.+++ ++|+. +|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 6889999999999998765 56877 9999999999999999999999999
Q ss_pred ccceecCCCCCcc--ccccccccccccCcccccCCCCCch------hhHHhHHHHHHHHHhC----------CCCCCCCC
Q 007490 458 GLARIFGVDQTQG--NTSRIVGTYGYMSPEYAMHGQFSVK------SDVYSFGVLALETITG----------KKNSSFYQ 519 (601)
Q Consensus 458 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg----------~~p~~~~~ 519 (601)
|+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998764332221 1224579999999999987766654 9999999999999999 66664322
Q ss_pred CCc-------------------------------ccccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 520 TDG-------------------------------AEDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 520 ~~~-------------------------------~~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
... ..+++ ...||.+|||+.||++.|+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 111 00111 127999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.57 Aligned_cols=178 Identities=28% Similarity=0.405 Sum_probs=151.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC--eeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD--EKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~ 412 (601)
...++|++.++||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34567999999999999999999964 48999999997543 334567889999999999999999999998765 679
Q ss_pred EEEeccCCCCccccc--------------------------ccccceeeccccccCcEEE----ccCCCcEEeeccccee
Q 007490 413 LVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILL----DVQMNPKISDFGLARI 462 (601)
Q Consensus 413 lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll----~~~~~~kL~Dfg~a~~ 462 (601)
+||||+++++|..++ ++|+.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999887654 5699999999999999999 7777899999999987
Q ss_pred cCCCCCccccccccccccccCcccccC--------CCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMH--------GQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 64332 2234578999999999865 5678899999999999999999999853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.08 Aligned_cols=201 Identities=32% Similarity=0.466 Sum_probs=161.1
Q ss_pred CcccccCcceEEeeecC---CCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP---HGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999642 46789999997643 3446789999999999999999999999864 568899999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc-ccccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ-GNTSRIV 476 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~ 476 (601)
++|.+++ |+|+.+|+||||||+|||++.++.+||+|||+++.+...... .......
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 9987765 679999999999999999999999999999999876543221 1122345
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------------------c---cCccCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED--------------------L---LSYEDP 532 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~--------------------l---~~~~dP 532 (601)
+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......... + +...||
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP 613 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 613 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCH
Confidence 6788999999999999999999999999999998 999997644322111 1 112799
Q ss_pred CCCCCHHHHHHHHhc
Q 007490 533 ADRPSMATIVLALNS 547 (601)
Q Consensus 533 ~~RPt~~evl~~L~~ 547 (601)
.+||++.+|++.|+.
T Consensus 614 ~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 614 ENRPGFAAVELRLRN 628 (635)
T ss_dssp TTSCCHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHH
Confidence 999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=287.90 Aligned_cols=205 Identities=29% Similarity=0.424 Sum_probs=164.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|.....||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 3344566677999999999999995 468899999998766666778999999999999999999999999999999999
Q ss_pred eccCCCCccccc--------------------------ccccceeeccccccCcEEEcc-CCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDV-QMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+++++|..++ ++|+.+|+||||||+||+++. ++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 999998886654 569999999999999999997 8999999999998764322
Q ss_pred ccccccccccccccCcccccCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------cc
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQ--FSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AE 524 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~ 524 (601)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence 1223457899999999987654 7899999999999999999999985422110 00
Q ss_pred c---ccCccCCCCCCCHHHHHH
Q 007490 525 D---LLSYEDPADRPSMATIVL 543 (601)
Q Consensus 525 ~---l~~~~dP~~RPt~~evl~ 543 (601)
+ .+...||.+||++.|+++
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 1 111279999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.58 Aligned_cols=207 Identities=27% Similarity=0.386 Sum_probs=167.0
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 413 (601)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999964 6899999999754 33456778999999999999999999998854 567899
Q ss_pred EEeccCCCCccccc---------------------------ccccce-----eeccccccCcEEEccCCCcEEeecccce
Q 007490 414 VYEFVPNKSLDYFL---------------------------YDSQLR-----IIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------------------~~h~~~-----iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
||||+++++|.+++ ++|+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999887654 558888 9999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-----------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------- 524 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------- 524 (601)
....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCH
Confidence 6543211 122356899999999999999999999999999999999999998754321110
Q ss_pred ---cc---cCccCCCCCCCHHHHHHHHhc
Q 007490 525 ---DL---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 525 ---~l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
++ +...||.+||++.||++.+..
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 111799999999999986643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.02 Aligned_cols=204 Identities=18% Similarity=0.226 Sum_probs=166.2
Q ss_pred cCCCCcCCcccccCcceEEeeecCC---------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccc---------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH---------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR--------- 400 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 400 (601)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5789999999999999999999653 789999998654 35789999999999999887
Q ss_pred ------eEEEEEe-CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc
Q 007490 401 ------LLGFCLE-GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV 448 (601)
Q Consensus 401 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~ 448 (601)
+++++.. ++..++||||+ +++|.+++ ++|+.+|+||||||+|||++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6777776 67889999999 88887665 569999999999999999999
Q ss_pred CC--CcEEeecccceecCCCCCc-----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC
Q 007490 449 QM--NPKISDFGLARIFGVDQTQ-----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD 521 (601)
Q Consensus 449 ~~--~~kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 521 (601)
++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876533211 1123357899999999999999999999999999999999999999754311
Q ss_pred ------------------------------cccccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 522 ------------------------------GAEDLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 522 ------------------------------~~~~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
...+++ ...||.+||++.+|+++|+..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 001111 117999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=289.98 Aligned_cols=211 Identities=31% Similarity=0.414 Sum_probs=161.7
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC--CCc--eeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP--HGQ--EIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
...++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34568999999999999999999853 233 6899998654 2345678899999999999999999999998765
Q ss_pred eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.++||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 89999999999987654 56999999999999999999999999999999987653
Q ss_pred CCCcc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc--------------------
Q 007490 466 DQTQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 466 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~-------------------- 523 (601)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 32211 1223457888999999998889999999999999999999 9999865332111
Q ss_pred -ccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 524 -EDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 -~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
.++ +...||.+|||+.++++.|+..
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 011 1127999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.31 Aligned_cols=203 Identities=27% Similarity=0.448 Sum_probs=164.3
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999964 58999999986543 3467889999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|.+++ ++|+.+|+|+||||+||+++.++.+||+|||++........ .
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 181 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--K 181 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--C
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--c
Confidence 999999887655 56999999999999999999999999999999987643221 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------cccc---
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AEDL--- 526 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~~l--- 526 (601)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..++
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 334578999999999999999999999999999999999999986532110 0111
Q ss_pred cCccCCCCCCCHHHHHH
Q 007490 527 LSYEDPADRPSMATIVL 543 (601)
Q Consensus 527 ~~~~dP~~RPt~~evl~ 543 (601)
+...||.+|||+.++++
T Consensus 262 ~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 262 CLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HTCSCTTTSCCHHHHTT
T ss_pred HccCChhhCcCHHHHHh
Confidence 11279999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.27 Aligned_cols=205 Identities=26% Similarity=0.423 Sum_probs=163.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
...++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34578999999999999999999965 58899999997766666788999999999999999999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
||+++++|..++ ++|+.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cc
Confidence 999999887654 5699999999999999999999999999999975432111 11
Q ss_pred cccccccccccCcccc-----cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------cc
Q 007490 472 TSRIVGTYGYMSPEYA-----MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG----------------------AE 524 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----------------------~~ 524 (601)
.....|++.|+|||++ .+..++.++||||||+++|||++|+.||....... ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 2234789999999998 46778999999999999999999999986543210 00
Q ss_pred cc---cCccCCCCCCCHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~ 543 (601)
++ +...||.+|||+.++++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHcccChhhCCCHHHHhc
Confidence 11 11279999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.39 Aligned_cols=204 Identities=29% Similarity=0.395 Sum_probs=169.4
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567999999999999999999964 68999999986542 345678999999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCC
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~ 466 (601)
+||||+.+++|.+++ |+|+.+|+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999986544 6799999999999999999 56789999999999876433
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------- 523 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------- 523 (601)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 183 K---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp C---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred c---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 2 2334579999999999865 699999999999999999999999965432110
Q ss_pred ccc---cCccCCCCCCCHHHHHHH
Q 007490 524 EDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 ~~l---~~~~dP~~RPt~~evl~~ 544 (601)
.++ +...||.+|||+.|+++.
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHCCCChhHCcCHHHHhhC
Confidence 011 112799999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=293.71 Aligned_cols=212 Identities=30% Similarity=0.460 Sum_probs=171.9
Q ss_pred hhcCCCCcCCcccccCcceEEeeec-----CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC--
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL-----PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD-- 409 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-- 409 (601)
...++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3456789999999999999999983 358899999998776667788999999999999999999999987654
Q ss_pred eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 689999999999987665 56999999999999999999999999999999987654
Q ss_pred CCCcc-ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCC------------------------
Q 007490 466 DQTQG-NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT------------------------ 520 (601)
Q Consensus 466 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~------------------------ 520 (601)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32211 12234567789999999988999999999999999999999887642200
Q ss_pred ------------Cccccc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 521 ------------DGAEDL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 521 ------------~~~~~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
....++ +...||.+|||+.||++.|+..
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000011 1127999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=294.30 Aligned_cols=207 Identities=34% Similarity=0.478 Sum_probs=164.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCce--eeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQE--IAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.+.||+|+||.||+|+.. ++.. |+||++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367889999999999999999954 4554 499988653 334456789999999999 99999999999999999999
Q ss_pred EEeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcEE
Q 007490 414 VYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKI 454 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL 454 (601)
||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 99999999886654 458899999999999999999999999
Q ss_pred eecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc---------
Q 007490 455 SDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------- 524 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------- 524 (601)
+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 184 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 260 (327)
T 1fvr_A 184 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260 (327)
T ss_dssp CCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred cccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC
Confidence 999999743221 11223456889999999998899999999999999999998 99998654321111
Q ss_pred -----------cc---cCccCCCCCCCHHHHHHHHhcC
Q 007490 525 -----------DL---LSYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 -----------~l---~~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ +...||.+|||+.|+++.|+..
T Consensus 261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1127999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.89 Aligned_cols=201 Identities=29% Similarity=0.424 Sum_probs=163.0
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe----CCe
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GDE 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~ 410 (601)
....|++.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 344578888999999999999985 45788999998654 34456778999999999999999999999875 355
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccce--eeccccccCcEEEc-cCCCcEEeecccceecC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLR--IIHRDLKASNILLD-VQMNPKISDFGLARIFG 464 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~--iiHrdlkp~NIll~-~~~~~kL~Dfg~a~~~~ 464 (601)
.++||||+++++|..++ ++|+.+ |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 89999999999997765 569988 99999999999998 78999999999997543
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc----------------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------- 522 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------- 522 (601)
.. ......||+.|+|||++. +.++.++||||||+++|||++|+.||.......
T Consensus 184 ~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 AS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 22 223457899999999876 458999999999999999999999986532210
Q ss_pred cccc---cCccCCCCCCCHHHHHH
Q 007490 523 AEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 523 ~~~l---~~~~dP~~RPt~~evl~ 543 (601)
..++ +...||.+|||+.|+++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCCCHHHHhh
Confidence 0011 11279999999999885
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.67 Aligned_cols=181 Identities=23% Similarity=0.389 Sum_probs=150.8
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----Ce
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----DE 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 410 (601)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999854 68899999997543 34457789999999999999999999999765 36
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
.++||||+++ +|..++ ++|+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 8999999985 665433 67999999999999999999999999999999987653322
Q ss_pred cc-ccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 469 QG-NTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 469 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 21 1234579999999998754 558999999999999999999999996543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=297.56 Aligned_cols=175 Identities=29% Similarity=0.443 Sum_probs=135.6
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------ 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 408 (601)
..++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 457899999999999999999984 46899999998653 334556788999999999999999999999754
Q ss_pred CeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 409 DEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
...++|+|++ +++|..++ ++|+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 5579999998 56776544 679999999999999999999999999999999865321
Q ss_pred CCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 186 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 186 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999877 67899999999999999999999999654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=292.98 Aligned_cols=211 Identities=27% Similarity=0.460 Sum_probs=164.9
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEe
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE 407 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 407 (601)
+++.++....++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 45566777889999999999999999999995 468999999986543 3446789999999999 89999999999987
Q ss_pred ------CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEee
Q 007490 408 ------GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISD 456 (601)
Q Consensus 408 ------~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~D 456 (601)
.+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999998887654 56999999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------
Q 007490 457 FGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------- 522 (601)
Q Consensus 457 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------- 522 (601)
||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||.......
T Consensus 173 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 173 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 99998654321 1223457899999999987 5678999999999999999999999986533111
Q ss_pred ------------ccccc---CccCCCCCCCHHHHHH
Q 007490 523 ------------AEDLL---SYEDPADRPSMATIVL 543 (601)
Q Consensus 523 ------------~~~l~---~~~dP~~RPt~~evl~ 543 (601)
..+++ ...||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01111 1279999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.68 Aligned_cols=210 Identities=25% Similarity=0.345 Sum_probs=169.5
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHH--cCCCCccceEEEEEeCC---
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAK--LQHRNLVRLLGFCLEGD--- 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~--- 409 (601)
.+...++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345667899999999999999999998 6899999998643 34567889999888 79999999999998876
Q ss_pred -eeEEEEeccCCCCccccc----------------------ccc--------cceeeccccccCcEEEccCCCcEEeecc
Q 007490 410 -EKILVYEFVPNKSLDYFL----------------------YDS--------QLRIIHRDLKASNILLDVQMNPKISDFG 458 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l----------------------~~h--------~~~iiHrdlkp~NIll~~~~~~kL~Dfg 458 (601)
..++||||+++++|.+++ ++| +.+|+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 789999999999998765 568 8999999999999999999999999999
Q ss_pred cceecCCCCCcc--ccccccccccccCcccccCC------CCCchhhHHhHHHHHHHHHhC----------CCCCCCCCC
Q 007490 459 LARIFGVDQTQG--NTSRIVGTYGYMSPEYAMHG------QFSVKSDVYSFGVLALETITG----------KKNSSFYQT 520 (601)
Q Consensus 459 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~p~~~~~~ 520 (601)
++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 998765433211 22345789999999998765 344789999999999999999 677754321
Q ss_pred Cc-------------------------------cccccC---ccCCCCCCCHHHHHHHHhcC
Q 007490 521 DG-------------------------------AEDLLS---YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 521 ~~-------------------------------~~~l~~---~~dP~~RPt~~evl~~L~~~ 548 (601)
.. ..+++. ..||.+|||+.||++.|+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 10 001111 17999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.31 Aligned_cols=203 Identities=26% Similarity=0.362 Sum_probs=167.2
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---------hhhHHHHHHHHHHHHHcC-CCCccceEEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---------GQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCL 406 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 406 (601)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999964 58999999986543 122456789999999995 999999999999
Q ss_pred eCCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 407 EGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
..+..++||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 999999999999999997765 569999999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCccccc------CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAM------HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG--------------- 522 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~--------------- 522 (601)
.... ......+++.|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 175 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 5332 223457899999999885 4568899999999999999999999985433211
Q ss_pred --------ccccc---CccCCCCCCCHHHHHH
Q 007490 523 --------AEDLL---SYEDPADRPSMATIVL 543 (601)
Q Consensus 523 --------~~~l~---~~~dP~~RPt~~evl~ 543 (601)
..+++ ...||.+|||+.|+++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 01111 1279999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.71 Aligned_cols=176 Identities=11% Similarity=0.090 Sum_probs=135.6
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh---hhHHHHHHHHHHHHHc--CCCCccceE-------E
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG---QGAQEFKNEVVLVAKL--QHRNLVRLL-------G 403 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpnIv~l~-------~ 403 (601)
....+|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.| +||||++++ +
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 34556899999999999999999954 689999999977542 3456678886666655 599988755 4
Q ss_pred EEEeC-----------------CeeEEEEeccCCCCccccc------------------------------ccccceeec
Q 007490 404 FCLEG-----------------DEKILVYEFVPNKSLDYFL------------------------------YDSQLRIIH 436 (601)
Q Consensus 404 ~~~~~-----------------~~~~lv~E~~~~gsL~~~l------------------------------~~h~~~iiH 436 (601)
++... ...+|||||++ ++|.+++ |+|+++|+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 55433 33799999998 6775543 569999999
Q ss_pred cccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCC
Q 007490 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKN 514 (601)
Q Consensus 437 rdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p 514 (601)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875421 213466799999999987 6799999999999999999999999
Q ss_pred CCCC
Q 007490 515 SSFY 518 (601)
Q Consensus 515 ~~~~ 518 (601)
|...
T Consensus 293 f~~~ 296 (371)
T 3q60_A 293 FGLV 296 (371)
T ss_dssp TTBC
T ss_pred CCCc
Confidence 8765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.01 Aligned_cols=200 Identities=26% Similarity=0.351 Sum_probs=162.3
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999965 6899999998754 234456788999999999 99999999999999999999
Q ss_pred EEeccCCCCccccc---------------------------ccccceeeccccccCcEEEccC-----------------
Q 007490 414 VYEFVPNKSLDYFL---------------------------YDSQLRIIHRDLKASNILLDVQ----------------- 449 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------------------~~h~~~iiHrdlkp~NIll~~~----------------- 449 (601)
||||+++++|.+++ ++|+.+|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999997665 5699999999999999999844
Q ss_pred --CCcEEeecccceecCCCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCC------
Q 007490 450 --MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFYQT------ 520 (601)
Q Consensus 450 --~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~------ 520 (601)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|||++|.+++.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~ 242 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT
T ss_pred CceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc
Confidence 479999999998764322 23589999999999776 567899999999999999999876532210
Q ss_pred -----------Cccccc---cCccCCCCCCCHHHHHH
Q 007490 521 -----------DGAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 521 -----------~~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
....++ +...||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 011111 11279999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.22 Aligned_cols=179 Identities=26% Similarity=0.394 Sum_probs=155.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhh-----------------HHHHHHHHHHHHHcCCCCc
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQG-----------------AQEFKNEVVLVAKLQHRNL 398 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpnI 398 (601)
....++|++.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 34567899999999999999999999 99999999986532111 1789999999999999999
Q ss_pred cceEEEEEeCCeeEEEEeccCCCCcccc------c-------------------------cccc-ceeeccccccCcEEE
Q 007490 399 VRLLGFCLEGDEKILVYEFVPNKSLDYF------L-------------------------YDSQ-LRIIHRDLKASNILL 446 (601)
Q Consensus 399 v~l~~~~~~~~~~~lv~E~~~~gsL~~~------l-------------------------~~h~-~~iiHrdlkp~NIll 446 (601)
+++++++.+.+..++||||+++++|.++ + ++|+ .||+||||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999887 3 5588 999999999999999
Q ss_pred ccCCCcEEeecccceecCCCCCccccccccccccccCcccccCC-CCCc-hhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 447 DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSV-KSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 447 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
+.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999876432 23345789999999999887 6766 9999999999999999999986543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.84 Aligned_cols=180 Identities=27% Similarity=0.430 Sum_probs=144.4
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEE----------
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL---------- 406 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---------- 406 (601)
..++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999965 48999999998777777788999999999999999999999874
Q ss_pred ----eCCeeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEc-cCCCcEEeeccc
Q 007490 407 ----EGDEKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLD-VQMNPKISDFGL 459 (601)
Q Consensus 407 ----~~~~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~ 459 (601)
+.+..++||||++ ++|..++ ++|+.+|+||||||+|||++ +++.+||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 3467899999998 4665543 67999999999999999997 567899999999
Q ss_pred ceecCCCCC-ccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 460 ARIFGVDQT-QGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 460 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 987643211 112234467899999998865 67899999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.20 Aligned_cols=176 Identities=23% Similarity=0.306 Sum_probs=149.6
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHc------CCCCccceEEEEEeC
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL------QHRNLVRLLGFCLEG 408 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~~~ 408 (601)
+....+|++.++||+|+||.||+|+.. +++.||||++... ......+.+|+++++.+ +|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345678999999999999999999854 5889999999653 33456778899999888 567999999999999
Q ss_pred CeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCC--cEEeecccce
Q 007490 409 DEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMN--PKISDFGLAR 461 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~--~kL~Dfg~a~ 461 (601)
+..++||||+.+ +|.+++ |+|+.+|+||||||+|||++.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999999999974 554433 679999999999999999999887 9999999997
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 64322 23457899999999999999999999999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.28 Aligned_cols=176 Identities=26% Similarity=0.421 Sum_probs=142.6
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG----- 408 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 408 (601)
++...++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 355678899999999999999999985 56899999998654322 24799999999999999999998543
Q ss_pred ---------------------------------CeeEEEEeccCCCCccccc---------------------------c
Q 007490 409 ---------------------------------DEKILVYEFVPNKSLDYFL---------------------------Y 428 (601)
Q Consensus 409 ---------------------------------~~~~lv~E~~~~gsL~~~l---------------------------~ 428 (601)
...++||||+++ +|...+ |
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 347899999985 433222 6
Q ss_pred cccceeeccccccCcEEEc-cCCCcEEeecccceecCCCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHH
Q 007490 429 DSQLRIIHRDLKASNILLD-VQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLAL 506 (601)
Q Consensus 429 ~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~ 506 (601)
+|+.||+||||||+|||++ .++.+||+|||+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 7999999999999999998 68899999999998764332 22345789999999998775 4899999999999999
Q ss_pred HHHhCCCCCCCC
Q 007490 507 ETITGKKNSSFY 518 (601)
Q Consensus 507 elltg~~p~~~~ 518 (601)
||++|+.||...
T Consensus 234 ell~g~~pf~~~ 245 (383)
T 3eb0_A 234 ELILGKPLFSGE 245 (383)
T ss_dssp HHHHSSCSSCCS
T ss_pred HHHhCCCCCCCC
Confidence 999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=299.72 Aligned_cols=207 Identities=24% Similarity=0.348 Sum_probs=168.5
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC-CCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~ 415 (601)
..++|++.++||+|+||.||+|++ .+++.||||++...... ..+.+|+++++.|+| ++|..+..++...+..+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999995 56899999987654322 357889999999987 56666667777888899999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEE---ccCCCcEEeecccceecCCCCC
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||+ +++|.+++ |+|+.+|+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999 88887655 6699999999999999999 6889999999999987754332
Q ss_pred cc-----ccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc------------------
Q 007490 469 QG-----NTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED------------------ 525 (601)
Q Consensus 469 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~------------------ 525 (601)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 21 1225679999999999999999999999999999999999999997644321111
Q ss_pred ---------c---cCccCCCCCCCHHHHHHHHhc
Q 007490 526 ---------L---LSYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 526 ---------l---~~~~dP~~RPt~~evl~~L~~ 547 (601)
+ +...||.+||++.+|+++|+.
T Consensus 242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1 111799999999999998864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.27 Aligned_cols=176 Identities=26% Similarity=0.440 Sum_probs=132.4
Q ss_pred cCCCCc-CCcccccCcceEEeeecC---CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeE
Q 007490 339 TNKFSS-DNKLGRGGFGEVYKGVLP---HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKI 412 (601)
Q Consensus 339 ~~~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 412 (601)
.+.|++ .++||+|+||.||+|++. +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344655 568999999999999954 478999999965432 3467899999999999999999999964 67899
Q ss_pred EEEeccCCCCcccc--------------------------------cccccceeeccccccCcEEE----ccCCCcEEee
Q 007490 413 LVYEFVPNKSLDYF--------------------------------LYDSQLRIIHRDLKASNILL----DVQMNPKISD 456 (601)
Q Consensus 413 lv~E~~~~gsL~~~--------------------------------l~~h~~~iiHrdlkp~NIll----~~~~~~kL~D 456 (601)
+||||+++. |..+ .|+|+.+|+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSEE-HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCCC-HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 999999863 3221 16799999999999999999 6788999999
Q ss_pred cccceecCCCCCc-cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 457 FGLARIFGVDQTQ-GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 457 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999876532211 223346789999999999874 589999999999999999999999954
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=291.41 Aligned_cols=184 Identities=26% Similarity=0.399 Sum_probs=135.9
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
+....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4566789999999999999999999854 68899999986543 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-------------------------------ccccceeeccccccCcEEEccCCCcEEeecccce
Q 007490 413 LVYEFVPNKSLDYFL-------------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
+||||+++++|.+++ ++|+.+|+||||||+||+++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999886654 4599999999999999999999999999999997
Q ss_pred ecCCCCCc---cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 462 IFGVDQTQ---GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 462 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 65432111 11234578999999999876 56899999999999999999999998653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.24 Aligned_cols=175 Identities=29% Similarity=0.454 Sum_probs=146.4
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee---
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK--- 411 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~--- 411 (601)
..++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457899999999999999999985 46899999999764 333457788999999999999999999999877765
Q ss_pred ---EEEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ---ILVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ---~lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred eeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 999999984 554332 679999999999999999999999999999999865322
Q ss_pred CccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999887 67899999999999999999999999653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=287.72 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=151.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh--hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG--QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
++..++|++.+.||+|+||.||+++. .+|+.||||++..... ...+.+.++...++.++||||+++++++.+++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 45668899999999999999999995 4689999999976422 22334455566688889999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------------ccccc-eeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 413 LVYEFVPNKSLDYFL---------------------------YDSQL-RIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------------~~h~~-~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
+||||+++ +|..++ ++|+. +|+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999985 543322 66998 99999999999999999999999999998764
Q ss_pred CCCCccccccccccccccCcccc----cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-------------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYA----MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------- 521 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------- 521 (601)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 332 12234689999999996 5667899999999999999999999998642211
Q ss_pred ---ccccc---cCccCCCCCCCHHHHHH
Q 007490 522 ---GAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 522 ---~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
...++ +...||.+|||+.|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01111 12279999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=288.74 Aligned_cols=202 Identities=28% Similarity=0.402 Sum_probs=160.1
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh--------hhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999854 588999999865321 2234578999999999999999999998765
Q ss_pred CeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCC---cEEeeccccee
Q 007490 409 DEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLARI 462 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~~ 462 (601)
+ .++||||+++++|.+++ ++|+.+|+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 89999999999886654 669999999999999999987664 99999999987
Q ss_pred cCCCCCccccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-cc--------------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-AE-------------- 524 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~-------------- 524 (601)
..... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... ..
T Consensus 167 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 167 LGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 64321 123456899999999874 5678999999999999999999999986543221 00
Q ss_pred ---------cc---cCccCCCCCCCHHHHHH
Q 007490 525 ---------DL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 525 ---------~l---~~~~dP~~RPt~~evl~ 543 (601)
++ +...||.+||++.++++
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 01 11179999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.88 Aligned_cols=176 Identities=26% Similarity=0.415 Sum_probs=145.4
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe-----
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE----- 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 410 (601)
+....+|++.+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+.
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3445679999999999999999999877777999988654322 2369999999999999999999965443
Q ss_pred -eEEEEeccCCCCccc--------------------------ccccccceeeccccccCcEEEc-cCCCcEEeeccccee
Q 007490 411 -KILVYEFVPNKSLDY--------------------------FLYDSQLRIIHRDLKASNILLD-VQMNPKISDFGLARI 462 (601)
Q Consensus 411 -~~lv~E~~~~gsL~~--------------------------~l~~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~a~~ 462 (601)
.++||||++++.+.. +.|+|+.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 789999998754321 1267999999999999999999 799999999999987
Q ss_pred cCCCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 643322 2345789999999998765 5899999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.94 Aligned_cols=213 Identities=28% Similarity=0.402 Sum_probs=165.3
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcC--CCCccceEEEE
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQ--HRNLVRLLGFC 405 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~ 405 (601)
+.+..+....++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4456677778899999999999999999999888999999998654 3445678899999999997 59999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
...+..++||| +.+++|.+++ ++|+.+|+||||||+|||++ ++.+||+|||++..
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999999999 5567776554 66999999999999999996 48899999999987
Q ss_pred cCCCCCccccccccccccccCcccccC-----------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC----------
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMH-----------GQFSVKSDVYSFGVLALETITGKKNSSFYQTD---------- 521 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~---------- 521 (601)
..............|++.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 654333222334578999999999875 47889999999999999999999998653211
Q ss_pred ------------cccccc---CccCCCCCCCHHHHHHH
Q 007490 522 ------------GAEDLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 522 ------------~~~~l~---~~~dP~~RPt~~evl~~ 544 (601)
...+++ ...||.+||++.|+++.
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 011111 12799999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.25 Aligned_cols=178 Identities=25% Similarity=0.332 Sum_probs=148.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC--------CCCccceEEEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ--------HRNLVRLLGFCL 406 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~~~ 406 (601)
+...++|++.++||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 34468899999999999999999984 46889999999643 344567889999999996 788999999988
Q ss_pred ----eCCeeEEEEeccCCCCccccc------------------------ccccc-eeeccccccCcEEEccCC-------
Q 007490 407 ----EGDEKILVYEFVPNKSLDYFL------------------------YDSQL-RIIHRDLKASNILLDVQM------- 450 (601)
Q Consensus 407 ----~~~~~~lv~E~~~~gsL~~~l------------------------~~h~~-~iiHrdlkp~NIll~~~~------- 450 (601)
.....++||||+.++.+..++ ++|++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 556789999999554433221 67998 999999999999999775
Q ss_pred ------------------------------------------CcEEeecccceecCCCCCccccccccccccccCccccc
Q 007490 451 ------------------------------------------NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488 (601)
Q Consensus 451 ------------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 488 (601)
.+||+|||++...... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999876432 23347899999999999
Q ss_pred CCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 489 HGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 489 ~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
+..++.++|||||||++|||++|+.||....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999996533
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-33 Score=315.47 Aligned_cols=213 Identities=25% Similarity=0.418 Sum_probs=169.5
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
...+...++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3455667789999999999999999998632 456999998654 3344577899999999999999999999985
Q ss_pred CCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 408 GDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
++..++||||+++++|..++ |+|+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 46689999999999987665 569999999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc-------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA------------------- 523 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~------------------- 523 (601)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 43322 12223456789999999998999999999999999999997 9999865432111
Q ss_pred -cccc---CccCCCCCCCHHHHHHHHhc
Q 007490 524 -EDLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 524 -~~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
.+++ ...||.+|||+.+|++.|+.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111 12799999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-33 Score=291.44 Aligned_cols=181 Identities=23% Similarity=0.336 Sum_probs=137.3
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe--
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE-- 410 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 410 (601)
......++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556688999999999999999999964 68999999986543 233456778888999999999999999976443
Q ss_pred -----eEEEEeccCCCCcccc--------------------------cccc--cceeeccccccCcEEEcc-CCCcEEee
Q 007490 411 -----KILVYEFVPNKSLDYF--------------------------LYDS--QLRIIHRDLKASNILLDV-QMNPKISD 456 (601)
Q Consensus 411 -----~~lv~E~~~~gsL~~~--------------------------l~~h--~~~iiHrdlkp~NIll~~-~~~~kL~D 456 (601)
.++||||++++.+..+ -++| +.+|+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999987532211 1456 999999999999999997 89999999
Q ss_pred cccceecCCCCCccccccccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 457 FGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 457 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
||+++...... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 176 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 176 FGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp CTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 99998765332 223457899999999987654 899999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-33 Score=286.81 Aligned_cols=177 Identities=25% Similarity=0.377 Sum_probs=151.2
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec--CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC------ccceEEEEEe
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL--PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN------LVRLLGFCLE 407 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~ 407 (601)
+...++|++.+.||+|+||.||+++. .+++.||||++... ....+.+.+|++++++++|++ |+++++++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 45567899999999999999999985 36889999998643 344567889999999997665 9999999999
Q ss_pred CCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc--------------
Q 007490 408 GDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV-------------- 448 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~-------------- 448 (601)
.+..++||||+ +++|.+++ ++|+.+|+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 66765543 669999999999999999987
Q ss_pred -----CCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 449 -----QMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 449 -----~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999864322 234578999999999999999999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=289.56 Aligned_cols=180 Identities=24% Similarity=0.393 Sum_probs=148.6
Q ss_pred hcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----Ce
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----DE 410 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 410 (601)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4678999999999999999999964 68999999996543 34456788999999999999999999998764 67
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
.++||||+++ +|..++ ++|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 8999999974 665443 67999999999999999999999999999999987653221
Q ss_pred cc--------ccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 QG--------NTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1223578999999998764 67899999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=298.28 Aligned_cols=173 Identities=28% Similarity=0.429 Sum_probs=140.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC----C--ee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG----D--EK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~--~~ 411 (601)
..+|++.+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++||||+++++++... + ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346888999999999999999964 589999999865432 234799999999999999999998642 1 36
Q ss_pred EEEEeccCCCCcc--------------------------cccccccceeeccccccCcEEEccC-CCcEEeecccceecC
Q 007490 412 ILVYEFVPNKSLD--------------------------YFLYDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFG 464 (601)
Q Consensus 412 ~lv~E~~~~gsL~--------------------------~~l~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~ 464 (601)
++||||++++.+. .+.|+|+.+|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 7999999864221 1127799999999999999999965 568999999998764
Q ss_pred CCCCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 209 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp TTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 3322 2345789999999998765 7899999999999999999999998653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=288.31 Aligned_cols=174 Identities=29% Similarity=0.457 Sum_probs=145.8
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe-----
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE----- 410 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 410 (601)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999995 46899999999654 33345678899999999999999999999987654
Q ss_pred -eEEEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 -KILVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 -~~lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
.++||||+++ +|..++ ++|+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 179 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred eEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence 4999999984 665543 679999999999999999999999999999999764322
Q ss_pred ccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999877 67899999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=280.11 Aligned_cols=204 Identities=28% Similarity=0.383 Sum_probs=166.6
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
....++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999964 6899999998654 2345678899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccC---CCcEEeecccceecCCC
Q 007490 413 LVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ---MNPKISDFGLARIFGVD 466 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~---~~~kL~Dfg~a~~~~~~ 466 (601)
+||||+++++|..++ ++|+.+|+||||||+||+++.+ +.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999986544 5699999999999999999764 46999999999865432
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------- 523 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------- 523 (601)
. ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp S---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred C---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 2 1223468899999998865 489999999999999999999999865332110
Q ss_pred ccc---cCccCCCCCCCHHHHHH
Q 007490 524 EDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 524 ~~l---~~~~dP~~RPt~~evl~ 543 (601)
.++ +...||.+|||+.|+++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhc
Confidence 011 11279999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=283.87 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=144.0
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHH-HHHHcCCCCccceEEEEEeCCe
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVV-LVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
.++...++|++.+.||+|+||.||+|+.. +|+.||||++.... .....++..|+. +++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 34556788999999999999999999964 68999999997653 333445556665 7777899999999999999999
Q ss_pred eEEEEeccCCCCccccc----------------------------ccccc-eeeccccccCcEEEccCCCcEEeecccce
Q 007490 411 KILVYEFVPNKSLDYFL----------------------------YDSQL-RIIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------------~~h~~-~iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
.++||||+++ +|..++ ++|+. +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 433221 56888 99999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCcccc----cCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC--ccc-----------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYA----MHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD--GAE----------- 524 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~--~~~----------- 524 (601)
...... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ...
T Consensus 175 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 175 QLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred eccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 764322 12234689999999998 4567899999999999999999999998653210 000
Q ss_pred ------------cc---cCccCCCCCCCHHHHHH
Q 007490 525 ------------DL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 525 ------------~l---~~~~dP~~RPt~~evl~ 543 (601)
++ +...||.+|||+.++++
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00 11179999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-33 Score=284.62 Aligned_cols=178 Identities=29% Similarity=0.480 Sum_probs=147.8
Q ss_pred hhcCCCCcCCcccccCcceEEeeec--CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHc---CCCCccceEEEEE---
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVL--PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKL---QHRNLVRLLGFCL--- 406 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~--- 406 (601)
...++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999996 458899999986432 22233566787777776 8999999999987
Q ss_pred --eCCeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeeccc
Q 007490 407 --EGDEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459 (601)
Q Consensus 407 --~~~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~ 459 (601)
.....++||||++ ++|..++ ++|+.||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567899999998 4765543 56999999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
++...... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 167 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 98654221 233457899999999999999999999999999999999999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=287.58 Aligned_cols=179 Identities=28% Similarity=0.366 Sum_probs=150.0
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CC-----CccceEEE
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HR-----NLVRLLGF 404 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~ 404 (601)
....+...++|++.+.||+|+||.||+|+.. +++.||||++... ......+..|+++++.++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3445566789999999999999999999854 5889999999643 334567788999999885 55 39999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc-------------------------ccc--cceeeccccccCcEEEc--cCCCcEEe
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL-------------------------YDS--QLRIIHRDLKASNILLD--VQMNPKIS 455 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l-------------------------~~h--~~~iiHrdlkp~NIll~--~~~~~kL~ 455 (601)
+...+..++||||+++ +|.+++ ++| +.+|+||||||+|||++ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999975 665443 445 68999999999999995 47889999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999876422 2345789999999999999999999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=294.63 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=155.0
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
+.+...+|+..+.||+|+||+||.....+++.||||++...... .+.+|+++++++ +||||+++++++.+.+..+|
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 44556679999999999999966544558999999999654322 356899999999 89999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEcc-----CCCcEEeecccceecC
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDV-----QMNPKISDFGLARIFG 464 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~-----~~~~kL~Dfg~a~~~~ 464 (601)
||||+++ +|.+++ |+|+.+|+||||||+|||++. ...+||+|||+++...
T Consensus 96 v~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9999974 554433 679999999999999999953 2357899999998765
Q ss_pred CCCCc-cccccccccccccCccccc---CCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc----------------
Q 007490 465 VDQTQ-GNTSRIVGTYGYMSPEYAM---HGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA---------------- 523 (601)
Q Consensus 465 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~---------------- 523 (601)
..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence 33211 2233467999999999997 4567889999999999999999 8888854321110
Q ss_pred ------ccc---cCccCCCCCCCHHHHHH
Q 007490 524 ------EDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 524 ------~~l---~~~~dP~~RPt~~evl~ 543 (601)
.++ +...||.+|||+.|+++
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 12279999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=293.26 Aligned_cols=201 Identities=27% Similarity=0.350 Sum_probs=153.9
Q ss_pred cCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3445567889999999998766668999999998653 235678899999987 899999999999999999999999
Q ss_pred cCCCCccccc------------------------------ccccceeeccccccCcEEEccC-------------CCcEE
Q 007490 418 VPNKSLDYFL------------------------------YDSQLRIIHRDLKASNILLDVQ-------------MNPKI 454 (601)
Q Consensus 418 ~~~gsL~~~l------------------------------~~h~~~iiHrdlkp~NIll~~~-------------~~~kL 454 (601)
++ ++|.+++ |+|+.+|+||||||+|||++.+ +.+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 4664433 6699999999999999999754 47999
Q ss_pred eecccceecCCCCCcc--ccccccccccccCcccccC-------CCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCc--
Q 007490 455 SDFGLARIFGVDQTQG--NTSRIVGTYGYMSPEYAMH-------GQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDG-- 522 (601)
Q Consensus 455 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~-- 522 (601)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~ 249 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH
Confidence 9999998875432211 1234579999999999875 678999999999999999999 899986432110
Q ss_pred ----------------------cccc---cCccCCCCCCCHHHHHH
Q 007490 523 ----------------------AEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 523 ----------------------~~~l---~~~~dP~~RPt~~evl~ 543 (601)
..++ +...||.+|||+.||++
T Consensus 250 i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0111 11279999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-33 Score=285.33 Aligned_cols=207 Identities=26% Similarity=0.411 Sum_probs=165.5
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChh------hHHHHHHHHHHHHHcC--CCCccceEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQ------GAQEFKNEVVLVAKLQ--HRNLVRLLGF 404 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~l~~~ 404 (601)
+.+...++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3455678899999999999999999984 46899999998654221 2245678999999996 5999999999
Q ss_pred EEeCCeeEEEEeccCC-CCccccc-----------------------ccccceeeccccccCcEEEc-cCCCcEEeeccc
Q 007490 405 CLEGDEKILVYEFVPN-KSLDYFL-----------------------YDSQLRIIHRDLKASNILLD-VQMNPKISDFGL 459 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~-gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~ 459 (601)
+...+..++|||++.+ ++|.+++ ++|+.+|+||||||+|||++ +++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 6776544 67999999999999999999 788999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCC-------------Ccccc
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQT-------------DGAED 525 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~-------------~~~~~ 525 (601)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ....+
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 272 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHH
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHH
Confidence 98765322 234578999999999987766 6889999999999999999999864221 01111
Q ss_pred c---cCccCCCCCCCHHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~ 544 (601)
+ +...||.+|||+.||++.
T Consensus 273 li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 1 122799999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-33 Score=283.36 Aligned_cols=205 Identities=27% Similarity=0.432 Sum_probs=157.5
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChh------hHHHHHHHHHHHHHc----CCCCccceEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQ------GAQEFKNEVVLVAKL----QHRNLVRLLGF 404 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~l~~~ 404 (601)
+...++|++.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44567899999999999999999985 46889999999654321 223456799999999 89999999999
Q ss_pred EEeCCeeEEEEec-cCCCCccccc-----------------------ccccceeeccccccCcEEEc-cCCCcEEeeccc
Q 007490 405 CLEGDEKILVYEF-VPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLD-VQMNPKISDFGL 459 (601)
Q Consensus 405 ~~~~~~~~lv~E~-~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~-~~~~~kL~Dfg~ 459 (601)
+...+..++|||+ +.+++|.+++ ++|+.+|+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 7888887655 56999999999999999999 889999999999
Q ss_pred ceecCCCCCccccccccccccccCcccccCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCC-------------Ccccc
Q 007490 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS-VKSDVYSFGVLALETITGKKNSSFYQT-------------DGAED 525 (601)
Q Consensus 460 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~-------------~~~~~ 525 (601)
+....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||..... ....+
T Consensus 187 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (312)
T 2iwi_A 187 GALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA 262 (312)
T ss_dssp CEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHHH
T ss_pred hhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHHH
Confidence 98765322 2345689999999998877664 589999999999999999999854211 11111
Q ss_pred c---cCccCCCCCCCHHHHHHH
Q 007490 526 L---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 526 l---~~~~dP~~RPt~~evl~~ 544 (601)
+ +...||.+|||+.|+++.
T Consensus 263 li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 1 122799999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=277.99 Aligned_cols=204 Identities=30% Similarity=0.429 Sum_probs=155.3
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe----------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE---------- 407 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---------- 407 (601)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788999999999999999995 46899999998543 3445778999999999999999999998865
Q ss_pred ---CCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccc
Q 007490 408 ---GDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 408 ---~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
.+..++||||+++++|.+++ ++|+.+|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 35679999999999987665 569999999999999999999999999999999
Q ss_pred eecCCCCC------------ccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCC------------
Q 007490 461 RIFGVDQT------------QGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNS------------ 515 (601)
Q Consensus 461 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~------------ 515 (601)
........ ........|++.|+|||++.+. .++.++||||||+++|||+++..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~~~~~~ 243 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHS
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHHHhccc
Confidence 86542210 1122345689999999999764 6899999999999999999832110
Q ss_pred -----CCCCCC----ccccc---cCccCCCCCCCHHHHHH
Q 007490 516 -----SFYQTD----GAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 516 -----~~~~~~----~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
...... ...++ +...||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 000000 01112 22379999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=282.07 Aligned_cols=176 Identities=21% Similarity=0.352 Sum_probs=148.2
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CC-ceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC------ccceEEEEEeC
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HG-QEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN------LVRLLGFCLEG 408 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~~ 408 (601)
...++|++.+.||+|+||.||+|+.. ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 45678999999999999999999853 34 68999998643 344567889999999998766 89999999999
Q ss_pred CeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEE------------------
Q 007490 409 DEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILL------------------ 446 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll------------------ 446 (601)
+..++||||+.++.+..+. ++|+.+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 9999999999554332211 6799999999999999999
Q ss_pred -ccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 447 -DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 447 -~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999864322 23457899999999999999999999999999999999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=285.58 Aligned_cols=174 Identities=23% Similarity=0.367 Sum_probs=145.2
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-----------CCCccceEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-----------HRNLVRLLGFC 405 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~ 405 (601)
..++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 356899999999999999999995 46899999998643 334567889999999886 89999999999
Q ss_pred EeCC----eeEEEEeccCCCCccccc-------------------------ccccc-eeeccccccCcEEEcc------C
Q 007490 406 LEGD----EKILVYEFVPNKSLDYFL-------------------------YDSQL-RIIHRDLKASNILLDV------Q 449 (601)
Q Consensus 406 ~~~~----~~~lv~E~~~~gsL~~~l-------------------------~~h~~-~iiHrdlkp~NIll~~------~ 449 (601)
...+ ..++||||+ +++|..++ ++|++ +|+||||||+|||++. .
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 8654 689999999 76765543 56998 9999999999999954 3
Q ss_pred CCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 450 MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 450 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 47999999999876432 22347899999999999999999999999999999999999999743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=280.33 Aligned_cols=199 Identities=21% Similarity=0.248 Sum_probs=138.3
Q ss_pred hcCCCCcCC-cccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEe----CCee
Q 007490 338 ATNKFSSDN-KLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GDEK 411 (601)
Q Consensus 338 ~~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 411 (601)
..++|.+.+ .||+|+||.||+|+.. +|+.||||++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456788854 6999999999999965 68999999986432 222233344667799999999999976 4458
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc---CCCcEEeecccceec
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLARIF 463 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Dfg~a~~~ 463 (601)
++||||+++++|..++ ++|+.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999999887654 569999999999999999986 455999999999865
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------- 523 (601)
... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 182 TQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred ccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 422 22345789999999999889999999999999999999999999854332211
Q ss_pred -------ccc---cCccCCCCCCCHHHHHHH
Q 007490 524 -------EDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 -------~~l---~~~~dP~~RPt~~evl~~ 544 (601)
.++ +...||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001 112799999999999973
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=277.58 Aligned_cols=206 Identities=25% Similarity=0.411 Sum_probs=146.1
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCCh-hh-HHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-QG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
......++|++.+.||+|+||.||+|+.. +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34455678999999999999999999964 689999999976532 22 2344555567888899999999999999999
Q ss_pred eEEEEeccCCCCcccc------------------------cccccc-eeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 411 KILVYEFVPNKSLDYF------------------------LYDSQL-RIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~------------------------l~~h~~-~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
.++||||+. +.+..+ .++|+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999999993 333221 166885 999999999999999999999999999976543
Q ss_pred CCCccccccccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-------------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTD------------------- 521 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------------------- 521 (601)
.. ......+++.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 22 123346899999999984 456889999999999999999999998653211
Q ss_pred ----ccccc---cCccCCCCCCCHHHHHH
Q 007490 522 ----GAEDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 522 ----~~~~l---~~~~dP~~RPt~~evl~ 543 (601)
...++ +...||.+||++.++++
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00111 11279999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=304.42 Aligned_cols=203 Identities=23% Similarity=0.367 Sum_probs=162.5
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC--CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe--
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP--HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE-- 410 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 410 (601)
+...++|++.+.||+|+||.||++++. +|+.||||++... .......+.+|++++++++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 345689999999999999999999964 5899999998654 33455678899999999999999999999987665
Q ss_pred ---eEEEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 ---KILVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ---~~lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.||||||+++++|..++ |+|+.||+||||||+|||++.+ .+||+|||+++.....
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 69999999999987654 6799999999999999999986 8999999999876432
Q ss_pred CCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-------------ccc---cCcc
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------EDL---LSYE 530 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------~~l---~~~~ 530 (601)
....||+.|+|||++.+.. +.++|||||||++|||++|..|+........ .++ +...
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 307 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDP 307 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTCS
T ss_pred ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhccC
Confidence 3457999999999987654 8999999999999999999888754222111 111 1228
Q ss_pred CCCCCCC-HHHHHHHHh
Q 007490 531 DPADRPS-MATIVLALN 546 (601)
Q Consensus 531 dP~~RPt-~~evl~~L~ 546 (601)
||.+||+ +.++...|.
T Consensus 308 dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 308 DPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp SGGGSCSSHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHHH
Confidence 9999996 555555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=266.02 Aligned_cols=182 Identities=10% Similarity=0.081 Sum_probs=152.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34578999999999999999999964 48999999997653 334577899999999999999999999999999999
Q ss_pred EEEeccCCCCccccc---------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 413 LVYEFVPNKSLDYFL---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 413 lv~E~~~~gsL~~~l---------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+||||+++++|.+++ |+|+.||+||||||+|||++.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 999999999987765 6799999999999999999999999998442
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----c----------------------
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----D---------------------- 525 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----~---------------------- 525 (601)
|++| ++.++||||||+++|||++|+.||......... .
T Consensus 175 ---------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 3333 688999999999999999999999764432211 0
Q ss_pred cc---CccCCCCCCCHHHHHHHHhcC
Q 007490 526 LL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 526 l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
++ ...||.+| |+.|+++.|+..
T Consensus 239 li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHHHHHH
Confidence 00 01799999 999999999764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=294.91 Aligned_cols=176 Identities=32% Similarity=0.500 Sum_probs=149.8
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe------CCe
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE------GDE 410 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~ 410 (601)
.++|++.++||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999996 45899999998754 44456778999999999999999999998765 667
Q ss_pred eEEEEeccCCCCccccc--------------------------ccccceeeccccccCcEEEccCCC---cEEeecccce
Q 007490 411 KILVYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQMN---PKISDFGLAR 461 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~~---~kL~Dfg~a~ 461 (601)
.++||||+++++|..++ ++|+.||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 89999999999987654 569999999999999999997765 8999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 173 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 173 ELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp BTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 764332 23345789999999999999999999999999999999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=276.76 Aligned_cols=200 Identities=15% Similarity=0.169 Sum_probs=146.3
Q ss_pred hhhcCCCCcCCcccccCcceEEeee-cCCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCC-CCc---------cce
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQH-RNL---------VRL 401 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pnI---------v~l 401 (601)
.....+|...+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|+.+++.++| +|+ +..
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3445568888999999999999999 4569999999987432 2335778999999999987 321 111
Q ss_pred EEE------------EEe-----CCeeEEEEeccCCCCccccc------------------------------cccccee
Q 007490 402 LGF------------CLE-----GDEKILVYEFVPNKSLDYFL------------------------------YDSQLRI 434 (601)
Q Consensus 402 ~~~------------~~~-----~~~~~lv~E~~~~gsL~~~l------------------------------~~h~~~i 434 (601)
.+. ... ....+++|+++ +++|.+++ |+|+.+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 111 111 12346677755 44554332 6699999
Q ss_pred eccccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccc----------cCCCCCchhhHHhHHHH
Q 007490 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA----------MHGQFSVKSDVYSFGVL 504 (601)
Q Consensus 435 iHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvv 504 (601)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875422 334567 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCCCCcccccc------------------CccCCCCCCCHHHHH
Q 007490 505 ALETITGKKNSSFYQTDGAEDLL------------------SYEDPADRPSMATIV 542 (601)
Q Consensus 505 l~elltg~~p~~~~~~~~~~~l~------------------~~~dP~~RPt~~evl 542 (601)
+|||++|+.||...........+ ...||.+||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999764432222111 117999999976654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=257.30 Aligned_cols=177 Identities=22% Similarity=0.291 Sum_probs=141.7
Q ss_pred cCCCCcC-CcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHH-HHcCCCCccceEEEEEe----CCee
Q 007490 339 TNKFSSD-NKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLV-AKLQHRNLVRLLGFCLE----GDEK 411 (601)
Q Consensus 339 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~~~~ 411 (601)
.++|.+. +.||+|+||.||+++. .+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556666 7899999999999985 46899999998542 4567888888 55699999999999987 6778
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc---CCCcEEeecccceec
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLARIF 463 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Dfg~a~~~ 463 (601)
++||||+++++|.+++ ++|+.+|+||||||+|||++. ++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999999987655 569999999999999999998 788999999998753
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc--------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-------------------- 523 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-------------------- 523 (601)
. +..++.++||||||+++|||++|+.||........
T Consensus 171 ~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 171 T------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp T------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred c------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 2 23467899999999999999999999854322110
Q ss_pred -------ccc---cCccCCCCCCCHHHHHHH
Q 007490 524 -------EDL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 524 -------~~l---~~~~dP~~RPt~~evl~~ 544 (601)
.++ +...||.+|||+.|+++.
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001 111799999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=268.63 Aligned_cols=170 Identities=22% Similarity=0.252 Sum_probs=141.4
Q ss_pred hcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCC--------hhhHHHHHHHHHHHHHcC---------CCCccc
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS--------GQGAQEFKNEVVLVAKLQ---------HRNLVR 400 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpnIv~ 400 (601)
..++|++.++||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346789999999999999999998 78999999997642 223477899999999986 888888
Q ss_pred eEEEEE------------------------------eCCeeEEEEeccCCCCccccc----------------------c
Q 007490 401 LLGFCL------------------------------EGDEKILVYEFVPNKSLDYFL----------------------Y 428 (601)
Q Consensus 401 l~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l----------------------~ 428 (601)
+.+.+. ..+..+|||||+++|++...+ |
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 877653 267899999999998644332 6
Q ss_pred cc-cceeeccccccCcEEEccCC--------------------CcEEeecccceecCCCCCccccccccccccccCcccc
Q 007490 429 DS-QLRIIHRDLKASNILLDVQM--------------------NPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487 (601)
Q Consensus 429 ~h-~~~iiHrdlkp~NIll~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 487 (601)
+| +.+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGG
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhh
Confidence 79 99999999999999999987 8999999999876421 34799999999999
Q ss_pred cCCCCCchhhHHhHHHH-HHHHHhCCCCCC
Q 007490 488 MHGQFSVKSDVYSFGVL-ALETITGKKNSS 516 (601)
Q Consensus 488 ~~~~~~~~sDvwSlGvv-l~elltg~~p~~ 516 (601)
.+.. +.++|||||+++ .+++++|..||.
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 8766 899999998777 788889988874
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=208.12 Aligned_cols=107 Identities=20% Similarity=0.478 Sum_probs=96.0
Q ss_pred CcccccCCCCCCCccCCCChHHHHHHHHHHhcccccccCCCCCCcceeeecCCCCCCCcEEEEEecCCCCChhhhHHHHH
Q 007490 27 DPNYLAHFCPNTTTFTRNSTFQSNLNLFLSSLPTNASRSNGFSGCFYNATAGQPSYSDRVYGLFRCRGDLGSTACQDCVT 106 (601)
Q Consensus 27 ~~~~~~~~C~~~~~~~~~s~f~~nl~~ll~~l~~~a~~~~~~~~~~~~~~~g~~~~~~~vyg~~qC~~D~~~~~C~~Cl~ 106 (601)
++.++++.|++ ++|+++++|++||+.||++|+++++.+ +.+|+++..|..+ +++||||+|||||+++++|..||+
T Consensus 2 ~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~s---~~~~~t~~~~~~~-~~~vygl~qC~~Dls~~~C~~Cl~ 76 (108)
T 3a2e_A 2 NTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAFS---GYDYKTSRAGSGG-APTAYGRATCKQSISQSDCTACLS 76 (108)
T ss_dssp CCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGGT---TSEEEEEECCSTT-CCCEEEEEEECTTSCHHHHHHHHH
T ss_pred CcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCccc---cCCceEeeccCCC-CceEEEEEEEcCCCCHHHHHHHHH
Confidence 45688999965 789999999999999999999998665 4557777666543 389999999999999999999999
Q ss_pred HHHHHHhhcCCCCcceEEEccceEEEEecccc
Q 007490 107 FATKNVTQRCPVEKRTTILFDECLLRYSNQSF 138 (601)
Q Consensus 107 ~a~~~~~~~C~~~~~~~~~~~~C~~ry~~~~f 138 (601)
.|+.++.++||++++|+||++.|+||||+++|
T Consensus 77 ~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 77 NLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-27 Score=263.88 Aligned_cols=164 Identities=16% Similarity=0.123 Sum_probs=114.7
Q ss_pred CcccccCcceEEeee-cCCCceeeEEEeccCC----------hhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEE
Q 007490 346 NKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS----------GQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 413 (601)
...+.|++|.+..++ ...|+.+++|.+.+.. ....++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777777665 3358999999986531 23346799999999999 79999999999999999999
Q ss_pred EEeccCCCCccccc--------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 414 VYEFVPNKSLDYFL--------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 414 v~E~~~~gsL~~~l--------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
||||++|++|.+++ |+|++|||||||||+||||+++|++||+|||+++....... ...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~ 397 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPT 397 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSH
T ss_pred EEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--ccc
Confidence 99999999998876 67999999999999999999999999999999987653322 234
Q ss_pred cccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCC
Q 007490 474 RIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 512 (601)
..+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 398 t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 398 NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 5689999999999865 4677899999999988876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-24 Score=237.49 Aligned_cols=171 Identities=15% Similarity=0.202 Sum_probs=132.8
Q ss_pred CCcCCcccccCcceEEeeecCCCceeeEEEeccCCh--------hhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 342 FSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG--------QGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
+...++||+|+||.||++.. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..+|
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567999999999999965 678899998644321 113458999999999999999977777778888899
Q ss_pred EEeccCCCCccccc---------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc-----ccc
Q 007490 414 VYEFVPNKSLDYFL---------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-----NTS 473 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-----~~~ 473 (601)
||||+++++|.+++ |+|+++|+||||||+|||++. ++||+|||+++......... ...
T Consensus 417 VmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~ 494 (540)
T 3en9_A 417 MMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK 494 (540)
T ss_dssp EEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred EEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence 99999999997765 679999999999999999998 99999999999875332111 123
Q ss_pred cccccccccCcccccC--CCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 474 RIVGTYGYMSPEYAMH--GQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
...||+.|||||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5679999999999986 66888899999999999988888765
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=170.37 Aligned_cols=105 Identities=21% Similarity=0.407 Sum_probs=95.8
Q ss_pred CCceeeccCcCCCChhHHHHHHHHHHHHHHHHhccCCCceeeeecccCCcceEEEEEeccCCCCHHhHHHHHHHHHhccc
Q 007490 145 SSQLSMWNLQNVTEPDKFNVFLGNLMNQVITQAVNNPKRFEIRKTNYSAFQTVYSLVQCTPDLSSRDCEVCLRGALGQLP 224 (601)
Q Consensus 145 ~~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~~~~~~~~~~~vy~l~QC~~dls~~~C~~Cl~~~~~~~~ 224 (601)
...+..|+.+++++++.|+.+++.||..|..+|+.+..+|+++.....+.++||||+||+||+++.+|+.||+.++.+++
T Consensus 4 ~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~ 83 (108)
T 3a2e_A 4 AFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF 83 (108)
T ss_dssp CEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred ceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence 34456899999999999999999999999999988777788877665667899999999999999999999999999999
Q ss_pred cccCCCCCCeEecCccceeeeccCc
Q 007490 225 RCCSGRQGGRVLYPSCNLRYESYPF 249 (601)
Q Consensus 225 ~~c~~~~gg~v~~~~C~lry~~~~F 249 (601)
.+|+++.||+|++++|++||+.++|
T Consensus 84 ~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 84 SICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999988
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.4e-21 Score=191.55 Aligned_cols=134 Identities=18% Similarity=0.086 Sum_probs=107.2
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCCh------------------hhHHHHHHHHHHHHHcCCC
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG------------------QGAQEFKNEVVLVAKLQHR 396 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hp 396 (601)
+......|++.+.||+|+||.||+|++.+|+.||||.+..... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556777899999999999999997799999999864321 13456889999999999
Q ss_pred CccceEEEEEeCCeeEEEEeccCCCCccccc----------------ccccceeeccccccCcEEEccCCCcEEeecccc
Q 007490 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLA 460 (601)
Q Consensus 397 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a 460 (601)
| +++.+++.. +..++||||+++++|..+. ++|+.||+||||||+|||++ ++.+||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 4 666665433 5679999999999997731 67999999999999999999 999999999999
Q ss_pred eecCCCCCccccccccccccccCccccc
Q 007490 461 RIFGVDQTQGNTSRIVGTYGYMSPEYAM 488 (601)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 488 (601)
+.. ..++|||++.
T Consensus 240 ~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 240 VEV---------------GEEGWREILE 252 (282)
T ss_dssp EET---------------TSTTHHHHHH
T ss_pred eEC---------------CCCCHHHHHH
Confidence 742 2467888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=156.59 Aligned_cols=116 Identities=16% Similarity=0.161 Sum_probs=90.1
Q ss_pred CCcCCcccccCcceEEeeec-CCCce--eeEEEeccCChh------------------------hHHHHHHHHHHHHHcC
Q 007490 342 FSSDNKLGRGGFGEVYKGVL-PHGQE--IAVKRLSRSSGQ------------------------GAQEFKNEVVLVAKLQ 394 (601)
Q Consensus 342 f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 394 (601)
|++.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999997 67888 999987543111 1136789999999999
Q ss_pred CCCc--cceEEEEEeCCeeEEEEeccCC-C----Cccccc--------------------ccc-cceeeccccccCcEEE
Q 007490 395 HRNL--VRLLGFCLEGDEKILVYEFVPN-K----SLDYFL--------------------YDS-QLRIIHRDLKASNILL 446 (601)
Q Consensus 395 hpnI--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l--------------------~~h-~~~iiHrdlkp~NIll 446 (601)
|++| ..++++ +..+|||||+.+ | +|..+. ++| +.||+||||||+|||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl 204 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY 204 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 8864 444432 357899999942 3 443221 569 9999999999999999
Q ss_pred ccCCCcEEeecccceec
Q 007490 447 DVQMNPKISDFGLARIF 463 (601)
Q Consensus 447 ~~~~~~kL~Dfg~a~~~ 463 (601)
+. .++|+|||++...
T Consensus 205 ~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 205 ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SS--SEEECCCTTCEET
T ss_pred cC--cEEEEECcccccC
Confidence 98 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-14 Score=148.63 Aligned_cols=122 Identities=15% Similarity=0.166 Sum_probs=89.8
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCCh--------------hhHH--------HHHHHHHHHHHcCCCC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG--------------QGAQ--------EFKNEVVLVAKLQHRN 397 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~hpn 397 (601)
.-|++.+.||.|++|.||+|...+|+.||||+++.... .... ...+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999988999999998753210 0001 1235677777776555
Q ss_pred ccceEEEEEeCCeeEEEEeccCCCCccccc-----------------ccccceeeccccccCcEEEccCCC---------
Q 007490 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------YDSQLRIIHRDLKASNILLDVQMN--------- 451 (601)
Q Consensus 398 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l-----------------~~h~~~iiHrdlkp~NIll~~~~~--------- 451 (601)
+.-..-+... ..+|||||+++++|..+. ++|+.|||||||||.|||+++++.
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~ 252 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITL 252 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccccccc
Confidence 4322222222 347999999998876544 569999999999999999998773
Q ss_pred -cEEeecccceec
Q 007490 452 -PKISDFGLARIF 463 (601)
Q Consensus 452 -~kL~Dfg~a~~~ 463 (601)
+.|+||+-+...
T Consensus 253 ~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 253 TPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECCCTTCEET
T ss_pred ceEEEEeCCcccC
Confidence 889999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=2.9e-10 Score=112.19 Aligned_cols=122 Identities=16% Similarity=0.085 Sum_probs=97.3
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEecc
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
..|+....++.|+.+.||+... .++.+++|+...........+.+|+++++.+. +..+.+++++....+..|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4677888889999999999986 47899999986532223346889999999994 677889999999988999999999
Q ss_pred CCCCccccc------------------cccc-------------------------------------------------
Q 007490 419 PNKSLDYFL------------------YDSQ------------------------------------------------- 431 (601)
Q Consensus 419 ~~gsL~~~l------------------~~h~------------------------------------------------- 431 (601)
+|.+|...+ .+|+
T Consensus 93 ~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (263)
T 3tm0_A 93 DGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp SSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHH
T ss_pred CCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHH
Confidence 998875421 2243
Q ss_pred ----------ceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 432 ----------LRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 432 ----------~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..++|+|++|.|||++++..+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 5699999999999998765567999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=6.6e-10 Score=109.17 Aligned_cols=119 Identities=16% Similarity=0.114 Sum_probs=89.2
Q ss_pred CCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEEEEeCCeeEEEEecc
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~ 418 (601)
.+.+....+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443344466679999998777888999997543 2245788999999996544 556889888888899999999
Q ss_pred CCCCcc-------ccc--------cccc----------------------------------------------------
Q 007490 419 PNKSLD-------YFL--------YDSQ---------------------------------------------------- 431 (601)
Q Consensus 419 ~~gsL~-------~~l--------~~h~---------------------------------------------------- 431 (601)
+|.+|. ... .+|+
T Consensus 98 ~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (264)
T 1nd4_A 98 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 177 (264)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred CCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence 998875 000 1232
Q ss_pred ------ceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 432 ------LRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 432 ------~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 2399999999999998776677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.61 E-value=7.5e-08 Score=99.52 Aligned_cols=117 Identities=19% Similarity=0.306 Sum_probs=85.7
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEec--cCC-hhhHHHHHHHHHHHHHcC--CCCccceEEEEEeC---CeeEEEEe
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLS--RSS-GQGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEG---DEKILVYE 416 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~E 416 (601)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 467899999999999874 4678888875 322 123456788999999997 45688899988776 34899999
Q ss_pred ccCCCCcccc-c--------------------ccc---------------------------------------------
Q 007490 417 FVPNKSLDYF-L--------------------YDS--------------------------------------------- 430 (601)
Q Consensus 417 ~~~~gsL~~~-l--------------------~~h--------------------------------------------- 430 (601)
|++|..+... + .+|
T Consensus 122 ~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (359)
T 3dxp_A 122 FVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLM 201 (359)
T ss_dssp CCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHH
T ss_pred ecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHH
Confidence 9999877320 0 112
Q ss_pred -------------cceeeccccccCcEEEccCCC--cEEeeccccee
Q 007490 431 -------------QLRIIHRDLKASNILLDVQMN--PKISDFGLARI 462 (601)
Q Consensus 431 -------------~~~iiHrdlkp~NIll~~~~~--~kL~Dfg~a~~ 462 (601)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 202 ~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 202 DWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.2e-07 Score=95.62 Aligned_cols=163 Identities=18% Similarity=0.206 Sum_probs=102.0
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCC--ccceEEEEEeCC---eeEEEEecc
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRN--LVRLLGFCLEGD---EKILVYEFV 418 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~E~~ 418 (601)
.+.++.|....||+.. ..+++|+... ......+.+|.++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 5688898642 234567899999999984 333 345555443333 348999999
Q ss_pred CCCCccccc---------------------ccc-----------------------------------------------
Q 007490 419 PNKSLDYFL---------------------YDS----------------------------------------------- 430 (601)
Q Consensus 419 ~~gsL~~~l---------------------~~h----------------------------------------------- 430 (601)
+|.+|.... .+|
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 997765310 001
Q ss_pred -----------cceeeccccccCcEEEcc--CCCcEEeecccceecCCCCCcccccc------------ccccccccC-c
Q 007490 431 -----------QLRIIHRDLKASNILLDV--QMNPKISDFGLARIFGVDQTQGNTSR------------IVGTYGYMS-P 484 (601)
Q Consensus 431 -----------~~~iiHrdlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~------------~~gt~~y~a-P 484 (601)
...++|+|++|.||++++ +..+.|+||+.+..-........... .....+... |
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~ 258 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIP 258 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcH
Confidence 135899999999999998 45678999999875321100000000 000001111 1
Q ss_pred ccccCCCCCchhhHHhHHHHHHHHHhCCCCC
Q 007490 485 EYAMHGQFSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 485 E~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
+... ......+.|+++.++|++.+|..++
T Consensus 259 ~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 259 TVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2111 1122368999999999999998654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=9.9e-06 Score=79.74 Aligned_cols=113 Identities=21% Similarity=0.221 Sum_probs=82.4
Q ss_pred cccccCcc-eEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEeccCCCCc
Q 007490 347 KLGRGGFG-EVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 347 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~gsL 423 (601)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.|. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 68987754 4667899986432 3456788999999884 33367889999999999999999998654
Q ss_pred cccc---------------------c------------------------------------------------------
Q 007490 424 DYFL---------------------Y------------------------------------------------------ 428 (601)
Q Consensus 424 ~~~l---------------------~------------------------------------------------------ 428 (601)
.... +
T Consensus 108 ~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 108 FQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 3211 0
Q ss_pred --cccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 429 --DSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 429 --~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.+...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0123489999999999999877677999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.92 E-value=1.9e-05 Score=78.66 Aligned_cols=78 Identities=18% Similarity=0.263 Sum_probs=58.6
Q ss_pred CCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCC---CccceEEEEEeCCeeEEEEec
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR---NLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~~~~~lv~E~ 417 (601)
+....+.+|.|..+.||+.+..+|+.|++|+...........+..|.+.|+.|... -+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 44556789999999999999989999999987655544455688999999998422 345555542 34789999
Q ss_pred cCCCC
Q 007490 418 VPNKS 422 (601)
Q Consensus 418 ~~~gs 422 (601)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 88754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=72.01 Aligned_cols=74 Identities=20% Similarity=0.179 Sum_probs=54.7
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCC---CccceEEEEE-eCCeeEEEEeccCC
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR---NLVRLLGFCL-EGDEKILVYEFVPN 420 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~E~~~~ 420 (601)
.+.++.|....||+. |..+++|+.. .......+.+|.++|+.|.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5778888842 233456789999999999753 3566777764 44567899999999
Q ss_pred CCcc
Q 007490 421 KSLD 424 (601)
Q Consensus 421 gsL~ 424 (601)
..|.
T Consensus 98 ~~l~ 101 (306)
T 3tdw_A 98 QILG 101 (306)
T ss_dssp EECH
T ss_pred eECc
Confidence 7664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00016 Score=75.31 Aligned_cols=74 Identities=12% Similarity=0.159 Sum_probs=49.9
Q ss_pred CCcccccCcceEEeeecC-CCceeeEEEeccCCh-------hhHHHHHHHHHHHHHcCC--CC-ccceEEEEEeCCeeEE
Q 007490 345 DNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSG-------QGAQEFKNEVVLVAKLQH--RN-LVRLLGFCLEGDEKIL 413 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-Iv~l~~~~~~~~~~~l 413 (601)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899998643211 123456789999988843 33 4455544 3455789
Q ss_pred EEeccCC
Q 007490 414 VYEFVPN 420 (601)
Q Consensus 414 v~E~~~~ 420 (601)
|||++++
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999976
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00056 Score=68.71 Aligned_cols=76 Identities=22% Similarity=0.165 Sum_probs=60.8
Q ss_pred cCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC---CCCccceEEEEEeCCeeEEEEeccCC
Q 007490 344 SDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ---HRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999886 5778899987532 3567889999999884 35688899998888889999999988
Q ss_pred CCc
Q 007490 421 KSL 423 (601)
Q Consensus 421 gsL 423 (601)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00013 Score=74.84 Aligned_cols=80 Identities=8% Similarity=0.045 Sum_probs=55.9
Q ss_pred CCcc-cccCcceEEeeecC-------CCceeeEEEeccCC---hhhHHHHHHHHHHHHHcC-C--CCccceEEEEEeC--
Q 007490 345 DNKL-GRGGFGEVYKGVLP-------HGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQ-H--RNLVRLLGFCLEG-- 408 (601)
Q Consensus 345 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~-- 408 (601)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.|. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999988764 26788999764422 111245788999999884 3 3577888887665
Q ss_pred -CeeEEEEeccCCCCcc
Q 007490 409 -DEKILVYEFVPNKSLD 424 (601)
Q Consensus 409 -~~~~lv~E~~~~gsL~ 424 (601)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00058 Score=69.21 Aligned_cols=72 Identities=17% Similarity=0.307 Sum_probs=42.2
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC--CCccceEE------EEEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH--RNLVRLLG------FCLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~------~~~~~~~~~lv~E~ 417 (601)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.|.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999887544 5899988652 2344456666666531 12333332 12346678999999
Q ss_pred cCCCC
Q 007490 418 VPNKS 422 (601)
Q Consensus 418 ~~~gs 422 (601)
++|..
T Consensus 113 i~G~~ 117 (346)
T 2q83_A 113 IEGRP 117 (346)
T ss_dssp CCCBC
T ss_pred ecCcc
Confidence 98754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0017 Score=65.26 Aligned_cols=114 Identities=13% Similarity=0.043 Sum_probs=71.9
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEE------EEeCCeeEEEEec
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGF------CLEGDEKILVYEF 417 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~E~ 417 (601)
+.|+.|....+|+....+| .+++|+..... ..+.+..|+.++..|.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788889999886555 68899886521 2234567888888774222 2333321 1234567899999
Q ss_pred cCCCCcccc---------------------------------------------c-c----------------------c
Q 007490 418 VPNKSLDYF---------------------------------------------L-Y----------------------D 429 (601)
Q Consensus 418 ~~~gsL~~~---------------------------------------------l-~----------------------~ 429 (601)
++|..+... + . .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 987543210 0 0 0
Q ss_pred ccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 430 h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
...+++|+|+++.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 124689999999999999876568999988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.004 Score=62.65 Aligned_cols=113 Identities=19% Similarity=0.194 Sum_probs=75.9
Q ss_pred CcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC--ccceEEE-----EEeCCeeEEEEecc
Q 007490 346 NKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN--LVRLLGF-----CLEGDEKILVYEFV 418 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~-----~~~~~~~~lv~E~~ 418 (601)
..|+ |....||+....+|+.+++|...... .....+..|..+++.|.... +.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 77789999887678889999986332 13456777888888884222 3444432 12345568899999
Q ss_pred CCCCccc-----------------------------------c-------------cc----------------------
Q 007490 419 PNKSLDY-----------------------------------F-------------LY---------------------- 428 (601)
Q Consensus 419 ~~gsL~~-----------------------------------~-------------l~---------------------- 428 (601)
+|..+.. + +.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8743320 0 00
Q ss_pred --cccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 429 --DSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 429 --~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0234588999999999999 4 899999988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0033 Score=65.94 Aligned_cols=78 Identities=9% Similarity=0.096 Sum_probs=47.2
Q ss_pred cceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccccc--cccccCcccccCC---CCCchhhHHhHHHHH
Q 007490 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVG--TYGYMSPEYAMHG---QFSVKSDVYSFGVLA 505 (601)
Q Consensus 431 ~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvwSlGvvl 505 (601)
...++|+|+++.|||++.++ ++|+||+.+..-..... ...... ...|.+|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45689999999999999876 99999999875321100 000010 1345666544311 112334556777777
Q ss_pred HHHHhCC
Q 007490 506 LETITGK 512 (601)
Q Consensus 506 ~elltg~ 512 (601)
|+.+.++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8777653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0057 Score=63.01 Aligned_cols=112 Identities=24% Similarity=0.333 Sum_probs=72.9
Q ss_pred CcccccCcceEEeeecC--------CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC-ccceEEEEEeCCeeEEEEe
Q 007490 346 NKLGRGGFGEVYKGVLP--------HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E 416 (601)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.|...+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46767888889998864 2468899886332 223456678999999884333 3566666543 28999
Q ss_pred ccCCCCcccc-------------------------------c------c-------------------------------
Q 007490 417 FVPNKSLDYF-------------------------------L------Y------------------------------- 428 (601)
Q Consensus 417 ~~~~gsL~~~-------------------------------l------~------------------------------- 428 (601)
|++|..|..- + +
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988554210 0 0
Q ss_pred ------cccceeeccccccCcEEEccC----CCcEEeeccccee
Q 007490 429 ------DSQLRIIHRDLKASNILLDVQ----MNPKISDFGLARI 462 (601)
Q Consensus 429 ------~h~~~iiHrdlkp~NIll~~~----~~~kL~Dfg~a~~ 462 (601)
.....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 012358999999999999876 7899999988864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0075 Score=63.35 Aligned_cols=71 Identities=15% Similarity=0.271 Sum_probs=48.5
Q ss_pred CcccccCcceEEeeecCC--------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEe
Q 007490 346 NKLGRGGFGEVYKGVLPH--------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E 416 (601)
+.|+.|-...+|+....+ ++.+++|+..... ....+.+|..+++.|...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567788888999988643 4788999874321 12455689999998854444 567766532 38999
Q ss_pred ccCCCC
Q 007490 417 FVPNKS 422 (601)
Q Consensus 417 ~~~~gs 422 (601)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0072 Score=60.11 Aligned_cols=109 Identities=14% Similarity=0.135 Sum_probs=72.9
Q ss_pred CCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEecc-CCCC
Q 007490 345 DNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYEFV-PNKS 422 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~-~~gs 422 (601)
.+.|+.|....+|+. +.+++|+........ ....+|..+++.+....+ .+++++ +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678889999999998 568888876432211 123568888888754333 455554 344457899999 6655
Q ss_pred ccc--------cc--------cc-----------------------------------------------------ccce
Q 007490 423 LDY--------FL--------YD-----------------------------------------------------SQLR 433 (601)
Q Consensus 423 L~~--------~l--------~~-----------------------------------------------------h~~~ 433 (601)
|.. .. .+ ....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 00 00 1224
Q ss_pred eeccccccCcEEEccCCCcEEeeccccee
Q 007490 434 IIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 434 iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.033 Score=56.36 Aligned_cols=68 Identities=12% Similarity=0.093 Sum_probs=43.5
Q ss_pred cccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC---CCccceEEE------EEeCCeeEEEEeccC
Q 007490 349 GRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH---RNLVRLLGF------CLEGDEKILVYEFVP 419 (601)
Q Consensus 349 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~------~~~~~~~~lv~E~~~ 419 (601)
|.|....||+....+| .+++|+...... ..|+.+++.|.. |++.+.+.. ....+..+++|||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444678999987667 899998755431 356666666632 224444432 233567799999998
Q ss_pred CCCc
Q 007490 420 NKSL 423 (601)
Q Consensus 420 ~gsL 423 (601)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.55 E-value=0.039 Score=55.51 Aligned_cols=31 Identities=29% Similarity=0.473 Sum_probs=27.1
Q ss_pred ceeeccccccCcEEEccC----CCcEEeeccccee
Q 007490 432 LRIIHRDLKASNILLDVQ----MNPKISDFGLARI 462 (601)
Q Consensus 432 ~~iiHrdlkp~NIll~~~----~~~kL~Dfg~a~~ 462 (601)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 468999999999999874 6789999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.25 E-value=0.03 Score=57.34 Aligned_cols=72 Identities=8% Similarity=0.068 Sum_probs=43.7
Q ss_pred CcccccCcceEEeeecCC---------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC-ccceEEEEEeCCeeEEEE
Q 007490 346 NKLGRGGFGEVYKGVLPH---------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~ 415 (601)
+.|+.|....+|+....+ ++.+++|+...... .......|.++++.|...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888899988643 26788887654322 1122467888888885444 34666544 2 37899
Q ss_pred eccCCCC
Q 007490 416 EFVPNKS 422 (601)
Q Consensus 416 E~~~~gs 422 (601)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.01 E-value=0.071 Score=56.31 Aligned_cols=72 Identities=11% Similarity=0.046 Sum_probs=46.8
Q ss_pred CCcccccCcceEEeeecCC-CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEeccCCC
Q 007490 345 DNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYEFVPNK 421 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g 421 (601)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..+++.|...++ .++++.+. + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 3567888889999998754 47888988754322111 12589999999965555 56777662 2 2599998873
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.04 E-value=0.33 Score=50.50 Aligned_cols=73 Identities=12% Similarity=0.120 Sum_probs=47.4
Q ss_pred CCcccccCcceEEeeecCC--------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCC-ccceEEEEEeCCeeEEEE
Q 007490 345 DNKLGRGGFGEVYKGVLPH--------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN-LVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~ 415 (601)
.+.|..|-...+|+....+ ++.+++|+....... .-...+|.++++.|...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3566778888899988643 578899886543221 122367888888885333 34566533 2 37899
Q ss_pred eccCCCC
Q 007490 416 EFVPNKS 422 (601)
Q Consensus 416 E~~~~gs 422 (601)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998854
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.12 E-value=0.12 Score=34.61 Aligned_cols=20 Identities=25% Similarity=0.404 Sum_probs=8.4
Q ss_pred HHHHHHHHHhhheehhhhhh
Q 007490 288 IVVIAVLFIAGLCFLRRRAE 307 (601)
Q Consensus 288 ~~v~~~l~i~~~~~~~rr~~ 307 (601)
+++++++.++.++++|||+.
T Consensus 21 v~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 21 LLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHHHHHHHhhhhHh
Confidence 44433333333444444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.88 E-value=0.15 Score=53.79 Aligned_cols=62 Identities=6% Similarity=0.080 Sum_probs=19.4
Q ss_pred CcCCcccccCcceEEeeecCC-CceeeE------EEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEe
Q 007490 343 SSDNKLGRGGFGEVYKGVLPH-GQEIAV------KRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 407 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 407 (601)
.+.+.|| ||.||+|.+.. ..+||| |...... ......+.+|..++++++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 99999999754 468998 6654322 2233467889999999999999999888654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.54 E-value=2.4 Score=43.59 Aligned_cols=30 Identities=27% Similarity=0.372 Sum_probs=25.2
Q ss_pred eeeccccccCcEEE------ccCCCcEEeeccccee
Q 007490 433 RIIHRDLKASNILL------DVQMNPKISDFGLARI 462 (601)
Q Consensus 433 ~iiHrdlkp~NIll------~~~~~~kL~Dfg~a~~ 462 (601)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4466799999988864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=85.45 E-value=0.15 Score=33.07 Aligned_cols=28 Identities=29% Similarity=0.532 Sum_probs=16.4
Q ss_pred CCCCcceEEeehhHHHHHHHHHHhhhee
Q 007490 274 SGLSSSTIIAIVAPIVVIAVLFIAGLCF 301 (601)
Q Consensus 274 ~~~~~~~ii~iv~~~~v~~~l~i~~~~~ 301 (601)
++++.+.|.++++++++.+.+++...++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~ 33 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVF 33 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHH
Confidence 4556677788887766554444443333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.94 E-value=0.16 Score=34.02 Aligned_cols=21 Identities=14% Similarity=0.417 Sum_probs=8.5
Q ss_pred HHHHHHHHHhhheehhhhhhh
Q 007490 288 IVVIAVLFIAGLCFLRRRAEK 308 (601)
Q Consensus 288 ~~v~~~l~i~~~~~~~rr~~~ 308 (601)
+++++++.+..++++|||+.+
T Consensus 20 v~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHhhhhhhh
Confidence 333333333334444444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 601 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-59
Identities = 58/267 (21%), Positives = 109/267 (40%), Gaps = 60/267 (22%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + + ++G G FG VYKG + + ++ + Q Q FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR---------------------- 433
N++ +G+ + +V ++ SL + L+ + +
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 434 --IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH-- 489
IIHRDLK++NI L + KI DFGLA + ++ G+ +M+PE
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 490 -GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY------------------- 529
+S +SDVY+FG++ E +TG+ + + + ++
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 530 -----------EDPADRPSMATIVLAL 545
+ +RP I+ ++
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 50/254 (19%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
++ + ++G G FG V+ G + ++A+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRII 435
+L G CLE LV+EF+ + L +L Y + +I
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRDL A N L+ K+SDFG+ R DQ +++ + SPE ++S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 496 SDVYSFGVLALETITGKKNSSFYQTDG---------------------AEDLLSY---ED 531
SDV+SFGVL E + K +++ ++++ E
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 242
Query: 532 PADRPSMATIVLAL 545
P DRP+ + ++ L
Sbjct: 243 PEDRPAFSRLLRQL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 60/273 (21%), Positives = 98/273 (35%), Gaps = 37/273 (13%)
Query: 335 IEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA-QEFKNEVVLVAK 392
+E+ + F ++LG G G V+K P G +A K + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 393 LQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD----------------------- 429
+V G E + E + SLD L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 430 -SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
+ +I+HRD+K SNIL++ + K+ DFG++ + VGT YMSPE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQ 176
Query: 489 HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYE-----DPADRPSMATIVL 543
+SV+SD++S G+ +E G+ D E L + D A+ P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRY--PIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 544 ALNSHSVTLSVPRQPALFIGSRTERSFPEREFE 576
S S P + P +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 6e-55
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 56/275 (20%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 71
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS------------------------- 430
LV+L + +V E++ SL FL
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
++ +HRDL+A+NIL+ + K++DFGLAR+ ++ + +PE A++G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 491 QFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY--------------------- 529
+F++KSDV+SFG+L E T + Y ++L
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247
Query: 530 -----EDPADRPSMATIVLALNSHSVTLSVPRQPA 559
++P +RP+ + L + + QP
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-55
Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 52/259 (20%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
EV +LG G FGEV+ G ++AVK L + S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS------------------------- 430
+ LVRL + + ++ E++ N SL FL
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHG 490
+ IHRDL+A+NIL+ ++ KI+DFGLAR+ ++ + +PE +G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 491 QFSVKSDVYSFGVLALETITGKKNSSFYQT---------------------DGAEDLLSY 529
F++KSDV+SFG+L E +T + T + L+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 530 ---EDPADRPSMATIVLAL 545
E P DRP+ + L
Sbjct: 246 CWKERPEDRPTFDYLRSVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-53
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 55/280 (19%)
Query: 333 KTIEVATNKFS-SDNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQG-AQEFKNEV 387
K + + + +D +LG G FG V +GV ++A+K L + + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------------------- 427
++ +L + +VRL+G C + + +LV E L FL
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 428 ----YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN-TSRIVGTYGYM 482
Y + +HRDL A N+LL + KISDFGL++ G D + S +
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETIT-------GKKNSSFYQ--------------TD 521
+PE +FS +SDV+S+GV E ++ K
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 522 GAEDLLSY---EDPADRPSMATIVLALNSHSVTLSVPRQP 558
L+S DRP T+ + + +L+ +
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-52
Identities = 70/257 (27%), Positives = 103/257 (40%), Gaps = 54/257 (21%)
Query: 345 DNKLGRGGFGEVYKGVLPH---GQEIAVKRLSRSSGQGA--QEFKNEVVLVAKLQHRNLV 399
D +LG G FG V KG + +AVK L + A E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIH 436
R++G C E + +LV E L+ +L Y + +H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS-RIVGTYGYMSPEYAMHGQFSVK 495
RDL A N+LL Q KISDFGL++ D+ + +PE + +FS K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 496 SDVYSFGVLALETIT-------GKKNSSFYQ--------------TDGAEDLLSY---ED 531
SDV+SFGVL E + G K S DL++ D
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250
Query: 532 PADRPSMATIVLALNSH 548
+RP A + L L ++
Sbjct: 251 VENRPGFAAVELRLRNY 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-52
Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 50/251 (19%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV 399
+ +LG G FG V G ++A+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------II 435
+L G C + ++ E++ N L +L + + R +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 436 HRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVK 495
HRDL A N L++ Q K+SDFGL+R +D ++ + PE M+ +FS K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 496 SDVYSFGVLALETIT-------GKKNSSFYQ--------------TDGAEDLLSY---ED 531
SD+++FGVL E + NS + ++ ++ E
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241
Query: 532 PADRPSMATIV 542
+RP+ ++
Sbjct: 242 ADERPTFKILL 252
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 1e-51
Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 52/273 (19%)
Query: 325 LESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEF 383
++ ++ E+ + +KLG G +GEVY+GV +AVK L + + +EF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF 60
Query: 384 KNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS------------- 430
E ++ +++H NLV+LLG C ++ EF+ +L +L +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 431 ------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGT 478
+ IHRDL A N L+ K++DFGL+R+ D +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 179
Query: 479 YGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKK-------NSSFYQ------------ 519
+ +PE + +FS+KSDV++FGVL E T S Y+
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239
Query: 520 --TDGAEDLLSY---EDPADRPSMATIVLALNS 547
+ +L+ +P+DRPS A I A +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (450), Expect = 1e-51
Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 65/282 (23%)
Query: 330 FDFKTIEVATNKFSS---------DNKLGRGGFGEVYKGVLP----HGQEIAVKRLSRS- 375
F F+ A +F+ + +G G FGEV G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 376 SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYF--------- 426
+ + ++F +E ++ + H N++ L G + +++ EF+ N SLD F
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 427 ---------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471
Y + + +HRDL A NIL++ + K+SDFGL+R D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 472 TSRIVG---TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKK--------------- 513
+ +G + +PE + +F+ SDV+S+G++ E ++ +
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246
Query: 514 ------NSSFYQTDGAEDLLSY---EDPADRPSMATIVLALN 546
L+ +D RP IV L+
Sbjct: 247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-51
Identities = 64/262 (24%), Positives = 100/262 (38%), Gaps = 62/262 (23%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH 395
+ + +G+G FG+V G G ++AVK + + Q F E ++ +L+H
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 59
Query: 396 RNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL-------------------------YD 429
NLV+LLG +E + +V E++ SL +L Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
+HRDL A N+L+ K+SDFGL + Q G + +PE
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 490 GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY-------------------- 529
+FS KSDV+SFG+L E + + Y +D++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 530 ------EDPADRPSMATIVLAL 545
D A RPS + L
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQL 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-51
Identities = 66/288 (22%), Positives = 110/288 (38%), Gaps = 63/288 (21%)
Query: 321 DITTLES-LQFDFKTIEVATNKFSS--DNKLGRGGFGEVYKGVLPH----GQEIAVKRLS 373
D++ L L + + + + + +GRG FG VY G L AVK L+
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 374 RSSGQG-AQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFLYDSQ 431
R + G +F E +++ H N++ LLG CL + +V ++ + L F+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 432 ------------------------LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467
+ +HRDL A N +LD + K++DFGLAR +
Sbjct: 125 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 468 TQGNTSR--IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED 525
++ +M+ E +F+ KSDV+SFGVL E +T Y D
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFD 242
Query: 526 LLSY--------------------------EDPADRPSMATIVLALNS 547
+ Y RPS + +V +++
Sbjct: 243 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 7e-51
Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 55/269 (20%)
Query: 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQE-----IAVKRLSRSSGQGAQ-EFKNEV 387
T E+ + + +G G FGEVYKG+L +A+K L + + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 388 VLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKS------------------------L 423
++ + H N++RL G + +++ E++ N +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 424 DYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-SRIVGTYGYM 482
Y + + +HRDL A NIL++ + K+SDFGL+R+ D T S +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 483 SPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-------------------- 522
+PE + +F+ SDV+SFG++ E +T + + ++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
Query: 523 -AEDLLSY---EDPADRPSMATIVLALNS 547
L+ ++ A RP A IV L+
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (443), Expect = 1e-50
Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 82/298 (27%)
Query: 328 LQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQGAQ 381
L ++E N +G G FG V++ P +AVK L + Q
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 382 -EFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------- 427
+F+ E L+A+ + N+V+LLG C G L++E++ L+ FL
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 428 ----------------------------------YDSQLRIIHRDLKASNILLDVQMNPK 453
Y S+ + +HRDL N L+ M K
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180
Query: 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKK 513
I+DFGL+R +M PE + +++ +SDV+++GV+ E +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 514 NSSFYQTDGAEDLLSY--------------------------EDPADRPSMATIVLAL 545
Y E+++ Y + PADRPS +I L
Sbjct: 241 Q--PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-50
Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 51/253 (20%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVLVAKLQHRN 397
+ LG G +GEV V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRI 434
+V+ G EG+ + L E+ L + Y + I
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF-S 493
HRD+K N+LLD + N KISDFGLA +F + + +++ GT Y++PE +F +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 494 VKSDVYSFGVLALETITGKKNSSFYQ----------------------TDGAEDLLSY-- 529
DV+S G++ + G+ LL
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 530 -EDPADRPSMATI 541
E+P+ R ++ I
Sbjct: 245 VENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 5e-50
Identities = 63/258 (24%), Positives = 99/258 (38%), Gaps = 60/258 (23%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQG---AQEFKNEVVLVAKLQ 394
FS ++G G FG VY + + + +A+K++S S Q Q+ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQ 431
H N ++ G L LV E+ + D Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM--- 488
+IHRD+KA NILL K+ DFG A I + VGT +M+PE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMD 187
Query: 489 HGQFSVKSDVYSFGVLALETITGK---------------------KNSSFYQTDGAEDLL 527
GQ+ K DV+S G+ +E K S + ++ + +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 528 SY---EDPADRPSMATIV 542
+ P DRP+ ++
Sbjct: 248 DSCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 6e-50
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 51/270 (18%)
Query: 320 NDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQ 378
+D LE L+ ++ K++ K+G+G G VY + + GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 379 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS-------- 430
+ NE++++ + ++ N+V L L GDE +V E++ SL + ++
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA 119
Query: 431 --------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIV 476
++IHRD+K+ NILL + + K++DFG +Q++ S +V
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMV 177
Query: 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK-------KNSSFYQ---------- 519
GT +M+PE + K D++S G++A+E I G+ + Y
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 520 -----TDGAEDLLSY---EDPADRPSMATI 541
+ D L+ D R S +
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (428), Expect = 6e-49
Identities = 61/256 (23%), Positives = 108/256 (42%), Gaps = 58/256 (22%)
Query: 341 KFSSDN-----KLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQ---EFKNEVVLVA 391
+++ ++ LG+G FG VY +A+K L ++ + A + + EV + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 392 KLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------Y 428
L+H N++RL G+ + L+ E+ P ++ L Y
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
R+IHRD+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIE 177
Query: 489 HGQFSVKSDVYSFGVLALETITGK---KNSSFYQT----------------DGAEDLLSY 529
K D++S GVL E + GK + +++ +T +GA DL+S
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237
Query: 530 ---EDPADRPSMATIV 542
+P+ RP + ++
Sbjct: 238 LLKHNPSQRPMLREVL 253
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-48
Identities = 58/256 (22%), Positives = 96/256 (37%), Gaps = 63/256 (24%)
Query: 345 DNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRL 401
D ++GRG F VYKG+ E+A L + Q FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 402 LGFCLEGDEK----ILVYEFVPNKSLDY-------------------------FLYDSQL 432
+ +LV E + + +L FL+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 433 RIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
IIHRDLK NI + + KI D GLA + + ++GT +M+PE +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM-YEEK 188
Query: 492 FSVKSDVYSFGVLALETITGKK----------------------NSSFYQTDGAEDLLSY 529
+ DVY+FG+ LE T + + ++++
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248
Query: 530 ---EDPADRPSMATIV 542
++ +R S+ ++
Sbjct: 249 CIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 57/251 (22%)
Query: 346 NKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 404
+LG G FG+VYK A K + S + +++ E+ ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 405 CLEGDEKILVYEFVPNKSLDYFLYDS------------------------QLRIIHRDLK 440
+ ++ EF ++D + + +IIHRDLK
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137
Query: 441 ASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-----HGQFSVK 495
A NIL + + K++DFG++ +T +GT +M+PE M + K
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 496 SDVYSFGVLALETITGK---KNSSFYQT-------------------DGAEDLLSY---E 530
+DV+S G+ +E + + + +D L +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK 255
Query: 531 DPADRPSMATI 541
+ R + + +
Sbjct: 256 NVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 62/261 (23%), Positives = 108/261 (41%), Gaps = 57/261 (21%)
Query: 342 FSSDNKLGRGGFGEVYKGV-LPHGQE----IAVKRLSRS-SGQGAQEFKNEVVLVAKLQH 395
F LG G FG VYKG+ +P G++ +A+K L + S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQL 432
++ RLLG CL +++ LDY Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
R++HRDL A N+L+ + KI+DFGLA++ G ++ + + +M+ E +H +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 493 SVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY----------------------- 529
+ +SDV+S+GV E +T Y A ++ S
Sbjct: 191 THQSDVWSYGVTVWELMTFGS--KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 530 ---EDPADRPSMATIVLALNS 547
D RP +++ +
Sbjct: 249 CWMIDADSRPKFRELIIEFSK 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-47
Identities = 61/257 (23%), Positives = 95/257 (36%), Gaps = 62/257 (24%)
Query: 346 NKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGA--QEFKNEVVLVAKLQHRNLVRLL 402
+G G +G K G+ + K L S A Q +EV L+ +L+H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 403 GFCLEGDEKI--LVYEFVPNKSLDYFLY-------------------------------- 428
++ +V E+ L +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 429 DSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM 488
D ++HRDLK +N+ LD + N K+ DFGLARI D + VGT YMSPE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187
Query: 489 HGQFSVKSDVYSFGVLALETITGK---------------KNSSFYQ-----TDGAEDLLS 528
++ KSD++S G L E + F + +D ++++
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIIT 247
Query: 529 Y---EDPADRPSMATIV 542
RPS+ I+
Sbjct: 248 RMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-47
Identities = 63/311 (20%), Positives = 109/311 (35%), Gaps = 80/311 (25%)
Query: 317 NADNDITTLESLQFDF-KTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAV 369
++DN+ ++ ++++ E LG G FG+V ++AV
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 370 KRLSRSSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL 427
K L + +E +E+ ++ +L H N+V LLG C L++E+ L +L
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 428 YDSQLR----------------------------------------------IIHRDLKA 441
+ + +HRDL A
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192
Query: 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSF 501
N+L+ KI DFGLAR D +M+PE G +++KSDV+S+
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 502 GVLALETITGKK--------NSSFYQ--------------TDGAEDLLSY---EDPADRP 536
G+L E + +++FY+ T+ ++ D RP
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
Query: 537 SMATIVLALNS 547
S + L
Sbjct: 313 SFPNLTSFLGC 323
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 53/288 (18%), Positives = 92/288 (31%), Gaps = 90/288 (31%)
Query: 347 KLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406
+G+G FGEV++G G+E+AVK S + + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 407 EGDEKI----LVYEFVPNKSLDYFL------------------------------YDSQL 432
+ + LV ++ + SL +L +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIF--GVDQTQGNTSRIVGTYGYMSPEY---- 486
I HRDLK+ NIL+ I+D GLA D + VGT YM+PE
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 487 --AMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------- 522
H + ++D+Y+ G++ E ++
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 523 -----------------------AEDLLSYEDPADRPSMATIVLALNS 547
+ + A R + I L+
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYA-NGAARLTALRIKKTLSQ 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 69/275 (25%), Positives = 107/275 (38%), Gaps = 71/275 (25%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHG---QEIAVKRLSR-SSGQGAQEFKNEVVLVAKL-Q 394
N + +G G FG+V K + + A+KR+ +S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--------------------------- 427
H N++ LLG C L E+ P+ +L FL
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 428 ------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475
Y SQ + IHRDL A NIL+ KI+DFGL+R + +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMG 186
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT--------------- 520
+M+ E + ++ SDV+S+GVL E ++ T
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 521 ------DGAEDLLSY---EDPADRPSMATIVLALN 546
D DL+ E P +RPS A I+++LN
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-46
Identities = 68/270 (25%), Positives = 93/270 (34%), Gaps = 60/270 (22%)
Query: 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP----HGQEIAVKRLSR---SSGQGAQEFKNE 386
T + KLG G FG V +G +AVK L S + +F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 387 VVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQ--------------- 431
V + L HRNL+RL G L K+ V E P SL L Q
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 432 ---------LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-NTSRIVGTYGY 481
R IHRDL A N+LL + KI DFGL R + + +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------- 524
+PE FS SD + FGV E T + + +G++
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-EPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 525 ------DLLSY---EDPADRPSMATIVLAL 545
+++ P DRP+ + L
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 7e-46
Identities = 54/265 (20%), Positives = 94/265 (35%), Gaps = 55/265 (20%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSSGQGAQE-FKNEVVLV 390
E+ + +G G FG+V++G+ +A+K + +E F E + +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 391 AKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS-------------------- 430
+ H ++V+L+G E + ++ E L FL
Sbjct: 63 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 431 ----QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486
R +HRD+ A N+L+ K+ DFGL+R D T S+ +M+PE
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPES 180
Query: 487 AMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT---------------------DGAED 525
+F+ SDV+ FGV E +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 526 LLSY---EDPADRPSMATIVLALNS 547
L++ DP+ RP + L++
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-45
Identities = 65/301 (21%), Positives = 102/301 (33%), Gaps = 75/301 (24%)
Query: 320 NDITTLESLQFDF-KTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRL 372
N+ ++ Q + E N+ S LG G FG+V + +AVK L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 373 SRSSGQG-AQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL--- 427
S+ + +E+ +++ L H N+V LLG C G +++ E+ L FL
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 428 --------------------------------------YDSQLRIIHRDLKASNILLDVQ 449
+ + IHRDL A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 450 MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETI 509
KI DFGLAR D +M+PE + ++ +SDV+S+G+ E
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 510 TGKKNSSFYQT----------------------DGAEDLLSY---EDPADRPSMATIVLA 544
+ + D++ DP RP+ IV
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 545 L 545
+
Sbjct: 302 I 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-45
Identities = 53/250 (21%), Positives = 86/250 (34%), Gaps = 49/250 (19%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHR 396
F LG G F V L +E A+K L + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS-----------------------QLR 433
V+L + ++ + N L ++
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
IIHRDLK NILL+ M+ +I+DFG A++ + Q + VGT Y+SPE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 494 VKSDVYSFGVLALETITGK---KNSSFYQT----------------DGAEDLLSY---ED 531
SD+++ G + + + G + + Y A DL+ D
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 248
Query: 532 PADRPSMATI 541
R +
Sbjct: 249 ATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 64/276 (23%), Positives = 103/276 (37%), Gaps = 68/276 (24%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQGA-QEFKNEVV 388
EVA K + +LG+G FG VY+GV +A+K ++ ++ EF NE
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 389 LVAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDS------------------ 430
++ + ++VRLLG +G +++ E + L +L
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 431 ---------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475
+ +HRDL A N ++ KI DFG+ R +
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSY------ 529
+ +MSPE G F+ SDV+SFGV+ E T + YQ E +L +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVMEGGL 253
Query: 530 --------------------EDPADRPSMATIVLAL 545
+P RPS I+ ++
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (389), Expect = 2e-42
Identities = 48/255 (18%), Positives = 90/255 (35%), Gaps = 56/255 (21%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL 398
+ + +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------I 434
V L + +E +++YEF+ L + D +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 435 IHRDLKASNILLDVQMNP--KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
+H DLK NI+ + + K+ DFGL + + GT + +PE A
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 493 SVKSDVYSFGVLALETITGK---KNSSFYQT--------------------DGAEDLLSY 529
+D++S GVL+ ++G + +T + +D +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 530 ---EDPADRPSMATI 541
DP R ++
Sbjct: 263 LLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 2e-41
Identities = 52/284 (18%), Positives = 100/284 (35%), Gaps = 60/284 (21%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
+LG G FG V++ V G+ K ++ KNE+ ++ +L H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 406 LEGDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKA 441
+ E +L+ EF+ L + + + I+H D+K
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 442 SNILLDVQMNP--KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
NI+ + + KI DFGLA D+ T + +PE +D++
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMW 212
Query: 500 SFGVLALETITGK---KNSSFYQT--------------------DGAEDLLSY---EDPA 533
+ GVL ++G +T A+D + ++P
Sbjct: 213 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 272
Query: 534 DRPSMATIV----LALNSHSVTLSVPRQPALFIGSRTERSFPER 573
R ++ + L + ++T +P I + + + +
Sbjct: 273 KRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (369), Expect = 2e-40
Identities = 61/264 (23%), Positives = 100/264 (37%), Gaps = 58/264 (21%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA---QEFKNEVVLVAKLQ 394
++++ LG GG EV+ L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 395 HRNLVRLLGFCLE----GDEKILVYEFVPNKSLDYFL----------------------- 427
H +V + G +V E+V +L +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 428 YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-NTSRIVGTYGYMSPEY 486
+ Q IIHRD+K +NI++ K+ DFG+AR T+ ++GT Y+SPE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 487 AMHGQFSVKSDVYSFGVLALETITGKK-------NSSFYQ----------------TDGA 523
A +SDVYS G + E +TG+ S YQ +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 524 EDLLSY---EDPADRPSMATIVLA 544
+ ++ ++P +R A + A
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRA 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 61/286 (21%), Positives = 103/286 (36%), Gaps = 77/286 (26%)
Query: 336 EVATNKFSSDNKLGRGGFGEVYKGVLPH--------GQEIAVKRLSR-SSGQGAQEFKNE 386
E+ ++ LG G FG+V ++AVK L ++ + + +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 387 VVLVAKL-QHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------ 427
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 428 ---------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466
Y + + IHRDL A N+L+ KI+DFGLAR
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 467 QTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL 526
T+ +M+PE ++ +SDV+SFGVL E T S Y E+L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEEL 246
Query: 527 LSY--------------------------EDPADRPSMATIVLALN 546
P+ RP+ +V L+
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-40
Identities = 64/294 (21%), Positives = 101/294 (34%), Gaps = 75/294 (25%)
Query: 328 LQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH------GQEIAVKRLSRSSGQGAQ 381
L +D E ++ LGRG FG+V + + +AVK L +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 382 E--FKNEVVLVAKLQHRNLVRLLGFCLEGDEKI-LVYEFVPNKSLDYFL----------- 427
+L+ H N+V LLG C + + ++ EF +L +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 428 ----------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGL 459
+ + + IHRDL A NILL + KI DFGL
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 460 ARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519
AR D +M+PE ++++SDV+SFGVL E + S +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG 239
Query: 520 TDGAEDLLSY--------------------------EDPADRPSMATIVLALNS 547
E+ +P+ RP+ + +V L +
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (371), Expect = 8e-40
Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 35/204 (17%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRS---SGQGAQEFKNEVV---LVAK 392
N FS +GRGGFGEVY G+ A+K L + QG NE + LV+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 393 LQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YD 429
+V + D+ + + + L Y L +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
+++RDLK +NILLD + +ISD GLA F + VGT+GYM+PE
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQK 179
Query: 490 GQ-FSVKSDVYSFGVLALETITGK 512
G + +D +S G + + + G
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 1e-39
Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 57/264 (21%)
Query: 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE-FKNEVVL 389
+K E + + + LG G F EV + +A+K +++ + +G + +NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 390 VAKLQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL---------------------- 427
+ K++H N+V L G L+ + V L +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 428 -YDSQLRIIHRDLKASNILL---DVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMS 483
Y L I+HRDLK N+L D ISDFGL+++ S GT GY++
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVA 177
Query: 484 PEYAMHGQFSVKSDVYSFGVLALETITGK------KNSSFYQ-----------------T 520
PE +S D +S GV+A + G ++ ++ +
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 521 DGAEDLLSY---EDPADRPSMATI 541
D A+D + + +DP R +
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 4e-39
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQH 395
F LG G FG V+ H G+ A+K L + + + +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 396 RNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQL 432
++R+ G + + ++ +++ L L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 433 RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQF 492
II+RDLK NILLD + KI+DFG A+ T + GT Y++PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 493 SVKSDVYSFGVLALETITGKK 513
+ D +SFG+L E + G
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-39
Identities = 43/204 (21%), Positives = 85/204 (41%), Gaps = 30/204 (14%)
Query: 339 TNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQG-AQEFKNEVVLVAKLQHR 396
++++ + +G G +G V + +A+K++S Q Q E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD--------------------------S 430
N++ + + + ++ + LY
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 431 QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT-SRIVGTYGYMSPEYAMH 489
++HRDLK SN+LL+ + KI DFGLAR+ D + V T Y +PE ++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 490 GQFSVKS-DVYSFGVLALETITGK 512
+ KS D++S G + E ++ +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 55/255 (21%), Positives = 92/255 (36%), Gaps = 52/255 (20%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKN----EVVLVAKLQ 394
F LG+G FG+V+ Q A+K L + + + + VL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 395 HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQ 431
H L + + V E++ L Y + +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 432 LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ 491
I++RDLK NILLD + KI+DFG+ + + + NT GT Y++PE + +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179
Query: 492 FSVKSDVYSFGVLALETITGK---KNSSFYQT----------------DGAEDLLSY--- 529
++ D +SFGVL E + G+ + A+DLL
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 530 EDPADRPSMATIVLA 544
+P R + +
Sbjct: 240 REPEKRLGVRGDIRQ 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 46/248 (18%), Positives = 85/248 (34%), Gaps = 57/248 (22%)
Query: 347 KLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 405
LGRG FG V++ V + K + + G K E+ ++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 406 LEGDEKILVYEFVPNKSLDYFLYDSQLR------------------------IIHRDLKA 441
+E ++++EF+ + + S I H D++
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 442 SNILLDVQMNP--KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVY 499
NI+ + + KI +FG AR N + Y +PE H S +D++
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 500 SFGVLALETITGK------KNSSFYQ-----------------TDGAEDLLSY---EDPA 533
S G L ++G N + + A D + ++
Sbjct: 188 SLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247
Query: 534 DRPSMATI 541
R + +
Sbjct: 248 SRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 4e-38
Identities = 49/271 (18%), Positives = 88/271 (32%), Gaps = 65/271 (23%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL 398
N++ K+G G FG++Y G + G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 399 VRLLGFCL-EGDEKILVYEFVPNKSLDYFLYDS-----------------------QLRI 434
+ + +C EGD ++V E + D F + S
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 435 IHRDLKASNIL---LDVQMNPKISDFGLARIFGVDQTQGN-----TSRIVGTYGYMSPEY 486
IHRD+K N L I DFGLA+ + +T + + GT Y S
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 487 AMHGQFSVKSDVYSFGVLALETITGKKNSSFYQT-------------------------- 520
+ + S + D+ S G + + G +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 521 -DGAEDLLSY---EDPADRPSMATIVLALNS 547
L++ D+P + + +
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 2e-37
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 28/199 (14%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRN 397
K+ K+G G +G VYK +G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRI 434
+V+L +LV+E + Y R+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 435 IHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAM-HGQFS 493
+HRDLK N+L++ + KI+DFGLAR FG+ + + T Y +P+ M ++S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYS 179
Query: 494 VKSDVYSFGVLALETITGK 512
D++S G + E + G
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHRN 397
F K+G G +G VYK G+ +A+K RL + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL------------------------YDSQLR 433
+V+LL ++ LV+EF+ + + R
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE-YAMHGQF 492
++HRDLK N+L++ + K++DFGLAR FGV V T Y +PE +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYY 180
Query: 493 SVKSDVYSFGVLALETITGK 512
S D++S G + E +T +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-36
Identities = 53/253 (20%), Positives = 94/253 (37%), Gaps = 55/253 (21%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQE------FKNEVVLVAK 392
+++ LG GGFG VY G+ + +A+K + + E EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 393 LQ--HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL----------------------- 427
+ ++RLL + D +L+ E +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 428 -YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
+ ++HRD+K NIL+D+ K+ DFG + + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 486 YAMHGQF-SVKSDVYSFGVLALETITGK-----------KNSSFYQ--TDGAEDLLSY-- 529
+ + ++ + V+S G+L + + G F Q + + L+ +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239
Query: 530 -EDPADRPSMATI 541
P+DRP+ I
Sbjct: 240 ALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-36
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 35/213 (16%)
Query: 346 NKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQE-----FKNEVVLVAKLQHRNLV 399
+ LG G F VYK + Q +A+K++ A++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 400 RLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIH 436
LL LV++F+ Y Q I+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 437 RDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQ-FSVK 495
RDLK +N+LLD K++DFGLA+ FG + V T Y +PE + + V
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVG 181
Query: 496 SDVYSFGVLALETITGKKNSSFYQTDGAEDLLS 528
D+++ G + E + F D D L+
Sbjct: 182 VDMWAVGCILAELLLRV---PFLPGDSDLDQLT 211
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (338), Expect = 5e-36
Identities = 37/208 (17%), Positives = 77/208 (37%), Gaps = 37/208 (17%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRN- 397
+ ++G G FG +++G L + Q++A+K R S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 398 LVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YDSQLRI 434
+ + F EG +LV + + D + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 435 IHRDLKASNILLDVQMNP-----KISDFGLARIFGVDQTQGN-----TSRIVGTYGYMSP 484
++RD+K N L+ + + DFG+ + + T+ + + GT YMS
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 485 EYAMHGQFSVKSDVYSFGVLALETITGK 512
+ + S + D+ + G + + + G
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 55/262 (20%), Positives = 97/262 (37%), Gaps = 63/262 (24%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSS------GQGAQEFKNEVVLVAK 392
+ + + +LG G F V K G + A K + + G ++ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 393 LQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYD----------------------- 429
+QH N++ L + IL+ E V L FL +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 430 SQLRIIHRDLKASNILLDVQMNP----KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPE 485
L+I H DLK NI+L + P KI DFGLA I GT +++PE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPE 186
Query: 486 YAMHGQFSVKSDVYSFGVLALETITGKK---------------------NSSFYQ--TDG 522
+ +++D++S GV+ ++G ++ +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 523 AEDLLSY---EDPADRPSMATI 541
A+D + +DP R ++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 131 bits (331), Expect = 4e-35
Identities = 56/267 (20%), Positives = 92/267 (34%), Gaps = 69/267 (25%)
Query: 341 KFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA---------QEFKNEVVLV 390
+ LGRG V + + P +E AVK + + G + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 391 AKLQ-HRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFLYDSQ------------------ 431
K+ H N+++L LV++ + L +L +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 432 -----LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEY 486
L I+HRDLK NILLD MN K++DFG + + + GT Y++PE
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEI 180
Query: 487 AM------HGQFSVKSDVYSFGVLALETITGK---KNSSFYQT----------------- 520
H + + D++S GV+ + G +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 521 ---DGAEDLLSY---EDPADRPSMATI 541
D +DL+S P R +
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 39/211 (18%)
Query: 338 ATNKFSSDNKLGRGGFGEVYKG--VLPHGQEIAVKRLSRSSGQGAQE--FKNEVVLVAKL 393
A ++ ++G G +G+V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 394 ---QHRNLVRLLGFCLEGDEK-----ILVYEFVPNKSLDYFL------------------ 427
+H N+VRL C LV+E V Y
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 428 ------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGY 481
+ R++HRDLK NIL+ K++DFGLARI+ + +V T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 181
Query: 482 MSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
+PE + ++ D++S G + E K
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-34
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGA--QEFKNEVVLVAKLQHR 396
+K+ K+G+G FGEV+K GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 397 NLVRLLGFCLEGDEKI--------LVYEFVPNKSLDYFL--------------------- 427
N+V L+ C LV++F +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 428 --YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT--SRIVGTYGYMS 483
Y + +I+HRD+KA+N+L+ K++DFGLAR F + + + V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 484 PEYAMHGQ-FSVKSDVYSFGVLALETITGK 512
PE + + + D++ G + E T
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-33
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQEIAVK--RLSRSSGQGAQEFKNEVVLVAKLQHR 396
K+ K+G G +G V+K + +A+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 397 NLVRLLGFCLEGDEKILVYEFVPNKS-----------------------LDYFLYDSQLR 433
N+VRL + LV+EF L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 434 IIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
++HRDLK N+L++ K+++FGLAR FG+ ++ +V + +S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYS 180
Query: 494 VKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL 527
D++S G + E + + + +D L
Sbjct: 181 TSIDMWSAGCIFAELANAGR--PLFPGNDVDDQL 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-33
Identities = 46/203 (22%), Positives = 73/203 (35%), Gaps = 29/203 (14%)
Query: 337 VATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAK 392
V N F LG+G FG+V G+ A+K L + + E ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 393 LQHRNLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-----------------------YD 429
+H L L D V E+ L + L Y
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 430 SQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMH 489
+++RD+K N++LD + KI+DFGL + D GT Y++PE
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 179
Query: 490 GQFSVKSDVYSFGVLALETITGK 512
+ D + GV+ E + G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 40/205 (19%)
Query: 342 FSSDNKLGRGGFGEVYKGVLPH-GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVR 400
++ +G G FG VY+ L G+ +A+K++ + + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 401 LLGFCLEGDEK------ILVYEFVPNKSLDYFLYDS------------------------ 430
L F EK LV ++VP + S
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 431 --QLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYA 487
I HRD+K N+LLD K+ DFG A+ + + N S I Y
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 195
Query: 488 MHGQFSVKSDVYSFGVLALETITGK 512
++ DV+S G + E + G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 4e-30
Identities = 48/237 (20%), Positives = 90/237 (37%), Gaps = 36/237 (15%)
Query: 303 RRRAEKKYNAVLEQNADNDITTLESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGV-L 361
+ ++ L + ++ + E+ + ++ +F LG G FG V
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHK 63
Query: 362 PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418
G A+K L + + + NE ++ + LV+L + +V E+V
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 419 PNKSLDYFLYDS-----------------------QLRIIHRDLKASNILLDVQMNPKIS 455
+ L L +I+RDLK N+L+D Q +++
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
DFG A+ + +G T + GT ++PE + ++ D ++ GVL E G
Sbjct: 184 DFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-30
Identities = 55/314 (17%), Positives = 99/314 (31%), Gaps = 75/314 (23%)
Query: 348 LGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405
LG G G+V + ++ A+K L + + EV L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 406 ----LEGDEKILVYEFVPNKSLDYFLYDS-------------------------QLRIIH 436
++V E + L + D + I H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 437 RDLKASNILLDVQMNP---KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFS 493
RD+K N+L + K++DFG A+ + T Y++PE ++
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYD 191
Query: 494 VKSDVYSFGVLALETITGK----KNSSFYQTDG-----------------------AEDL 526
D++S GV+ + G N + G + L
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251
Query: 527 LSY---EDPADRPSMATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTS 583
+ +P R ++ +N + S SR + ER + ++ TS
Sbjct: 252 IRNLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTS 308
Query: 584 KSMPWSVDEASITE 597
VD I
Sbjct: 309 ALATMRVDYEQIKI 322
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 38/217 (17%)
Query: 331 DFKTIEVATNKFSSDNK------LGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQ 381
F ++EV + F+ + +G G G V + +A+K+LSR + A+
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 382 EFKNEVVLVAKLQHRNLVRLLGFCL------EGDEKILVYEFVPNKSLDYFLYDS----- 430
E+VL+ + H+N++ LL E + LV E + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 431 ---------------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475
IIHRDLK SNI++ KI DFGLAR G +
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPY 178
Query: 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK 512
V T Y +PE + + D++S G + E + K
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (289), Expect = 6e-29
Identities = 50/265 (18%), Positives = 103/265 (38%), Gaps = 43/265 (16%)
Query: 331 DFKTIEVATNKFSSDN------KLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEF 383
++ E ++ + + KLGRG + EV++ + + + +++ VK L ++
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 76
Query: 384 KNEVVLVAKLQ-HRNLVRLLGFCLEGDEK--ILVYEFVPNKSLDYFL------------- 427
K E+ ++ L+ N++ L + + LV+E V N
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY 136
Query: 428 -------YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFGVDQTQGNTSRIVGTY 479
Y + I+HRD+K N+++D + ++ D+GLA + Q + V +
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 480 GYMSPEYAM-HGQFSVKSDVYSFGVLALETITGK-----KNSSFYQTDGAEDLLSYEDPA 533
+ PE + + + D++S G + I K + ++ Q +L ED
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 534 DRPSMATIVLALNSHSVTLSVPRQP 558
D I L + + R+
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKR 278
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 55/211 (26%), Positives = 84/211 (39%), Gaps = 36/211 (17%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVL 389
KT + +G G +G V V G ++A+K+L R S A+ E+ L
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 390 VAKLQHRNLVRLLGFCLEGD------EKILVYEFVPNKS--------------------- 422
+ ++H N++ LL + + LV F+
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 423 LDYFLYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
L Y IIHRDLK N+ ++ KI DFGLAR Q + V T Y
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYR 185
Query: 483 SPEYAMHGQ-FSVKSDVYSFGVLALETITGK 512
+PE ++ ++ D++S G + E ITGK
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 6e-28
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 35/222 (15%)
Query: 325 LESLQFDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRSS---- 376
L + +V F LG G +G+V+ G+ A+K L +++
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 68
Query: 377 GQGAQEFKNEVVLVAKLQHR-NLVRLLGFCLEGDEKILVYEFVPNKSLDYFL-------- 427
+ + + E ++ ++ LV L + L+ +++ L L
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 128
Query: 428 ---------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472
+ +L II+RD+K NILLD + ++DFGL++ F D+T+
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RA 187
Query: 473 SRIVGTYGYMSPEYAMHGQ--FSVKSDVYSFGVLALETITGK 512
GT YM+P+ G D +S GVL E +TG
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-26
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 333 KTIEVATNKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRS--SGQGAQEFKNEVVL 389
KTI ++ + + +G G +G V G +AVK+LSR S A+ E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 390 VAKLQHRNLVRLLGFCLEGD-----EKILVYEFVPNKSLDYF------------LYDSQL 432
+ ++H N++ LL + + + L+ Q+
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 433 ----------RIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYM 482
IIHRDLK SN+ ++ KI DFGLAR + T +R Y
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YR 185
Query: 483 SPEYAMHGQ-FSVKSDVYSFGVLALETITGK 512
+PE ++ ++ D++S G + E +TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (256), Expect = 2e-24
Identities = 45/296 (15%), Positives = 96/296 (32%), Gaps = 49/296 (16%)
Query: 340 NKFSSDNKLGRGGFGEVYKGV-LPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL 398
++ KLG G F V+ + + +A+K + + ++E+ L+ ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 399 VRLLGFCLEGDEKILVYEFVPNKSLDYFLY------------------------------ 428
+ K+L + + + +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 429 ----------DSQLRIIHRDLKASNILLD-VQMNPKISDFGLARIFGVDQTQGNTSRIVG 477
+ IIH D+K N+L++ V + +A + + + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 478 TYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLLSYEDPADRPS 537
T Y SPE + + +D++S L E ITG F ++ SY D +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD--FLFE----PDEGHSYTKDDDHIA 245
Query: 538 MATIVLALNSHSVTLSVPRQPALFIGSRTERSFPEREFECSDKSTSKSMPWSVDEA 593
+L + + F R+ + +F + ++ +S DEA
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 3e-22
Identities = 26/146 (17%), Positives = 46/146 (31%), Gaps = 31/146 (21%)
Query: 346 NKLGRGGFGEVYKGVLPHGQEIAVK--RLSRSSGQ--------GAQEFKNEVVLVAKLQH 395
+G G V+ E VK ++ +S + G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 396 RNLVRLLGFC----LEGDEKILVYEFVPNKS----------------LDYFLYDSQLRII 435
R L +L G + ++ E + K L+ I+
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 436 HRDLKASNILLDVQMNPKISDFGLAR 461
H DL N+L+ + I DF +
Sbjct: 126 HGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 601 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.38 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=367.54 Aligned_cols=217 Identities=30% Similarity=0.494 Sum_probs=172.2
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
++++..++|++.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 35667789999999999999999999863 35999998654 34556789999999999999999999998754 568
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+|||||+++|+|.+++ |+|+++||||||||+|||++.++++||+|||+++......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999998766 6699999999999999999999999999999998765443
Q ss_pred CccccccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------- 523 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------- 523 (601)
.........||+.|||||++.+ ..++.++|||||||++|||+||+.||........
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 3334455689999999999864 4589999999999999999999999975432110
Q ss_pred ----ccccC---ccCCCCCCCHHHHHHHHhcCCCCCC
Q 007490 524 ----EDLLS---YEDPADRPSMATIVLALNSHSVTLS 553 (601)
Q Consensus 524 ----~~l~~---~~dP~~RPt~~evl~~L~~~~~~~~ 553 (601)
.+++. ..||.+|||+.||++.|+.....+|
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 00111 1799999999999999986544433
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=363.17 Aligned_cols=204 Identities=29% Similarity=0.449 Sum_probs=169.6
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999995 468999999997543 33446789999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+++|+|.+++ |+|+++|+||||||+|||+++++++||+|||+++.+...........
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 9999998876 66999999999999999999999999999999998754443334455
Q ss_pred ccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------------cc---cC
Q 007490 475 IVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------------DL---LS 528 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------------~l---~~ 528 (601)
.+||+.|||||++.+..+ +.++|||||||++|||++|+.||......... ++ +.
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 789999999999988876 57899999999999999999999654322110 11 11
Q ss_pred ccCCCCCCCHHHHHH
Q 007490 529 YEDPADRPSMATIVL 543 (601)
Q Consensus 529 ~~dP~~RPt~~evl~ 543 (601)
..||.+|||+.|+++
T Consensus 245 ~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 245 VENPSARITIPDIKK 259 (271)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 179999999999854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=363.39 Aligned_cols=203 Identities=29% Similarity=0.457 Sum_probs=174.2
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..||||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46799999999999999999995 46999999999766555667899999999999999999999999999999999999
Q ss_pred cCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccccc
Q 007490 418 VPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRI 475 (601)
Q Consensus 418 ~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 475 (601)
+++|+|..++ |+|++||+||||||+|||++.++++||+|||+++.+..... .....
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCC
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--ccccc
Confidence 9999997765 67999999999999999999999999999999997654322 23456
Q ss_pred cccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc----------------------ccc---cCcc
Q 007490 476 VGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------EDL---LSYE 530 (601)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------~~l---~~~~ 530 (601)
.||+.|||||++.+..++.++|||||||++|||++|+.||........ .++ +...
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 256 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccC
Confidence 899999999999999999999999999999999999999965332110 011 1117
Q ss_pred CCCCCCCHHHHHH
Q 007490 531 DPADRPSMATIVL 543 (601)
Q Consensus 531 dP~~RPt~~evl~ 543 (601)
||.+|||+.|+++
T Consensus 257 dP~~R~s~~eil~ 269 (293)
T d1yhwa1 257 DVEKRGSAKELLQ 269 (293)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=359.26 Aligned_cols=207 Identities=31% Similarity=0.478 Sum_probs=163.8
Q ss_pred cCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
.++|++.++||+|+||+||+|++.+++.||||++.... ...+++.+|++++++++|||||+++|++..++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35788899999999999999998888899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 419 PNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 419 ~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
++|+|.+++ |+|+.+|+||||||+|||+++++++||+|||+++........ ....
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~ 161 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 161 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce-eecc
Confidence 999998765 669999999999999999999999999999999876533222 2334
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHhC-CCCCCCCCCCcccc--------------------c---cCcc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITG-KKNSSFYQTDGAED--------------------L---LSYE 530 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~--------------------l---~~~~ 530 (601)
..||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.......... + +...
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccC
Confidence 5789999999999999999999999999999999995 55544322111111 1 1117
Q ss_pred CCCCCCCHHHHHHHHhc
Q 007490 531 DPADRPSMATIVLALNS 547 (601)
Q Consensus 531 dP~~RPt~~evl~~L~~ 547 (601)
||.+|||++||++.|+.
T Consensus 242 ~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 242 RPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp SGGGSCCHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHH
Confidence 99999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=359.38 Aligned_cols=212 Identities=33% Similarity=0.487 Sum_probs=174.4
Q ss_pred hhhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 333 KTIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
+++++..++|++.++||+|+||+||+|++++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34566778899999999999999999998888899999996543 345679999999999999999999998754 5679
Q ss_pred EEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 413 LVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 413 lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
+||||+++|+|.+++ |+|+++|+||||||+||||++++.+||+|||+++......
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999997654 6699999999999999999999999999999999875433
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCC-CCCCCCcc--------------------ccc
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNS-SFYQTDGA--------------------EDL 526 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~-~~~~~~~~--------------------~~l 526 (601)
. .......||+.|||||++.++.++.++|||||||++|||+||..|+ ........ .++
T Consensus 164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 2 2233457899999999999999999999999999999999965554 32221110 111
Q ss_pred c---CccCCCCCCCHHHHHHHHhc
Q 007490 527 L---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+ ...||.+|||+.||+++|+.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1 11799999999999998864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=356.64 Aligned_cols=200 Identities=28% Similarity=0.458 Sum_probs=170.4
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||+||+|+.+ +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999964 6889999998653 2334567899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|+|..++ |+|+++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RR 161 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CC
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC----cc
Confidence 999999997766 679999999999999999999999999999999865432 23
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-------------------cc---Ccc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-------------------LL---SYE 530 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-------------------l~---~~~ 530 (601)
....||+.|||||++.+..++.++|||||||++|||++|+.||.......... ++ ...
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccC
Confidence 34679999999999999999999999999999999999999997543221111 11 117
Q ss_pred CCCCCCCHHHHHH
Q 007490 531 DPADRPSMATIVL 543 (601)
Q Consensus 531 dP~~RPt~~evl~ 543 (601)
||.+|||+.|+++
T Consensus 242 dp~~R~t~~eil~ 254 (263)
T d2j4za1 242 NPSQRPMLREVLE 254 (263)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CHhHCcCHHHHHc
Confidence 9999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-44 Score=362.20 Aligned_cols=217 Identities=32% Similarity=0.476 Sum_probs=180.0
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG 408 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 408 (601)
..+.++++..++|++.++||+|+||+||+|++. +++.||||+++... ...+++.+|+++|++++|||||++++++.++
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 345667788889999999999999999999965 58899999986543 3457899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceec
Q 007490 409 DEKILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIF 463 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~ 463 (601)
+..+|||||+++|+|..++ |+|+++|+||||||+||||++++++||+|||+++..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999987665 669999999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC-CCCcccccc---------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY-QTDGAEDLL--------------- 527 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~-~~~~~~~l~--------------- 527 (601)
...... ......|++.|+|||++.+..++.++|||||||++|||++|..|+... ......+.+
T Consensus 166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHH
Confidence 543222 233346889999999999999999999999999999999977665322 211111111
Q ss_pred --------CccCCCCCCCHHHHHHHHhcC
Q 007490 528 --------SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 528 --------~~~dP~~RPt~~evl~~L~~~ 548 (601)
...||.+|||+.||++.|+..
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 117999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=358.59 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=171.1
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.+.|++.+.||+|+||+||+|++ .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 45689999999999999999995 46889999999877667778899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
+++|+|..++ |+|+++|+||||||+|||++.++++||+|||+++...... ....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~ 168 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 168 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHT
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cccc
Confidence 9999987764 6799999999999999999999999999999997653221 1233
Q ss_pred cccccccccCccccc-----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc----------------------cc
Q 007490 474 RIVGTYGYMSPEYAM-----HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE----------------------DL 526 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~----------------------~l 526 (601)
...||+.|||||++. +..|+.++|||||||++|||++|+.||......... ++
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 468999999999984 456899999999999999999999999654322110 01
Q ss_pred ---cCccCCCCCCCHHHHHH
Q 007490 527 ---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 527 ---~~~~dP~~RPt~~evl~ 543 (601)
+...||.+|||+.|+++
T Consensus 249 i~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 249 LKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 11179999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=349.09 Aligned_cols=207 Identities=29% Similarity=0.452 Sum_probs=177.0
Q ss_pred cCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEecc
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFV 418 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 418 (601)
.++|++.++||+|+||+||+|+++++++||||+++... ...+++.+|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36899999999999999999999888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 419 PNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 419 ~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
++|+|..++ |+|+.+|+||||||+|||+++++.+||+|||+++.+...... ....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 160 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVG 160 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecc
Confidence 999987664 679999999999999999999999999999999876543322 2334
Q ss_pred ccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccC-----------------------cc
Q 007490 475 IVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS-----------------------YE 530 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~-----------------------~~ 530 (601)
..+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...........+. ..
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccC
Confidence 578999999999999999999999999999999998 798987654332221111 17
Q ss_pred CCCCCCCHHHHHHHHhc
Q 007490 531 DPADRPSMATIVLALNS 547 (601)
Q Consensus 531 dP~~RPt~~evl~~L~~ 547 (601)
||.+|||+.||++.|..
T Consensus 241 dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 241 KADERPTFKILLSNILD 257 (258)
T ss_dssp SGGGSCCHHHHHHHHHC
T ss_pred CHhHCcCHHHHHHHhhC
Confidence 99999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=359.57 Aligned_cols=204 Identities=25% Similarity=0.346 Sum_probs=168.3
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999995 46899999998653 2334567899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|+|..++ |+|+.+|+||||||+|||+++++.+||+|||+++.+.........
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999999997765 679999999999999999999999999999999987654444444
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------cc---cCcc
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-------------------DL---LSYE 530 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-------------------~l---~~~~ 530 (601)
....||+.|||||++.+..++.++|||||||++|||++|+.||......... ++ +...
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 247 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCS
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccC
Confidence 5568999999999999999999999999999999999999999754321111 11 1127
Q ss_pred CCCCCCCHHHHHH
Q 007490 531 DPADRPSMATIVL 543 (601)
Q Consensus 531 dP~~RPt~~evl~ 543 (601)
||.+|||+.|++.
T Consensus 248 dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 248 DATKRLGCEEMEG 260 (288)
T ss_dssp SGGGSTTSGGGTC
T ss_pred CHhHCcCHHHHcC
Confidence 9999999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=364.88 Aligned_cols=178 Identities=29% Similarity=0.409 Sum_probs=156.8
Q ss_pred hhhcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
++..++|++.++||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+++..+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45578899999999999999999995 46899999999764 33445778999999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------cccc-ceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQ-LRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~-~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++|+|..++ |+|+ .||+||||||+|||++.++++||+|||+|+.+...
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 99999999998766 6786 58999999999999999999999999999876432
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.....+||+.|||||++.+.+|+.++||||+||++|||++|+.||..
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 23346899999999999999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-44 Score=358.72 Aligned_cols=209 Identities=29% Similarity=0.490 Sum_probs=161.8
Q ss_pred cCCCCcCCcccccCcceEEeeecCC-Cc---eeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPH-GQ---EIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.++|++.++||+|+||+||+|++.. ++ .||||++... .....+.|.+|+++|++++|||||+++|++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4568888999999999999999642 33 5889988654 44556789999999999999999999999999999999
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||||+++|+|..++ |+|+++|+||||||+||||+.++++||+|||+++.+......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999999997755 679999999999999999999999999999999876543322
Q ss_pred cc---cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccc--------------------
Q 007490 470 GN---TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAED-------------------- 525 (601)
Q Consensus 470 ~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~-------------------- 525 (601)
.. .....||+.|||||++.++.++.++|||||||++|||+| |+.||..........
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 264 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHH
Confidence 11 222457899999999999999999999999999999998 899986543322111
Q ss_pred ccC---ccCCCCCCCHHHHHHHHhc
Q 007490 526 LLS---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 526 l~~---~~dP~~RPt~~evl~~L~~ 547 (601)
++. ..||.+|||+.||++.|+.
T Consensus 265 li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 265 LMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111 1799999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=354.94 Aligned_cols=203 Identities=28% Similarity=0.394 Sum_probs=157.6
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--CCeeEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE--GDEKIL 413 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 413 (601)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+ ++..||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 35799999999999999999985 46899999998764 33445678999999999999999999999865 456899
Q ss_pred EEeccCCCCccccc---------------------------ccccce-----eeccccccCcEEEccCCCcEEeecccce
Q 007490 414 VYEFVPNKSLDYFL---------------------------YDSQLR-----IIHRDLKASNILLDVQMNPKISDFGLAR 461 (601)
Q Consensus 414 v~E~~~~gsL~~~l---------------------------~~h~~~-----iiHrdlkp~NIll~~~~~~kL~Dfg~a~ 461 (601)
||||+++|+|.+++ |+|+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999997765 568765 9999999999999999999999999998
Q ss_pred ecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc---------------
Q 007490 462 IFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL--------------- 526 (601)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l--------------- 526 (601)
.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 7653322 23456899999999999999999999999999999999999999975443221111
Q ss_pred --------cCccCCCCCCCHHHHHH
Q 007490 527 --------LSYEDPADRPSMATIVL 543 (601)
Q Consensus 527 --------~~~~dP~~RPt~~evl~ 543 (601)
+...||.+|||+.|+++
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01179999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=352.25 Aligned_cols=217 Identities=29% Similarity=0.464 Sum_probs=171.0
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
++++..++|++.+.||+|+||+||+|+++++++||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 4455567899999999999999999998888899999996543 345789999999999999999999999854 56899
Q ss_pred EEeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 414 VYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 414 v~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
||||+++|+|..++ |+|+++|+||||||+||||+.++++||+|||+++.......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999987654 66999999999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-CCcccccc--------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ-TDGAEDLL-------------------- 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~-~~~~~~l~-------------------- 527 (601)
.......||+.|+|||++.++.++.++|||||||++|||++|..|+.... .......+
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence 22334578999999999999999999999999999999999766553322 11111111
Q ss_pred ---CccCCCCCCCHHHHHHHHhcCCCCCC
Q 007490 528 ---SYEDPADRPSMATIVLALNSHSVTLS 553 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~~L~~~~~~~~ 553 (601)
...||++||++.+|+++|+......+
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 11799999999999999988654443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=356.95 Aligned_cols=206 Identities=27% Similarity=0.368 Sum_probs=156.7
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
+...+.|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+++|++++|||||++++++.+++..||
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345677999999999999999999954 68999999997643 2334567899999999999999999999999999999
Q ss_pred EEeccCCCCccccc-----------------------ccccceeeccccccCcEEEc---cCCCcEEeecccceecCCCC
Q 007490 414 VYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLD---VQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 414 v~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~ 467 (601)
||||+++|+|.+++ |+|+++|+||||||+|||+. +++.+||+|||+++......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999998766 67999999999999999995 57899999999998764332
Q ss_pred CccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------c
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------E 524 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~ 524 (601)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 165 ---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 165 ---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred ---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 23346799999999999999999999999999999999999999965432111 0
Q ss_pred cc---cCccCCCCCCCHHHHHHH
Q 007490 525 DL---LSYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 ~l---~~~~dP~~RPt~~evl~~ 544 (601)
++ +...||.+|||+.|+++.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 11 112799999999999873
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=352.10 Aligned_cols=209 Identities=29% Similarity=0.477 Sum_probs=171.3
Q ss_pred hcCCCCcCC-cccccCcceEEeeecC---CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeE
Q 007490 338 ATNKFSSDN-KLGRGGFGEVYKGVLP---HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKI 412 (601)
Q Consensus 338 ~~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 412 (601)
..++|.+.+ +||+|+||+||+|++. ++..||||+++.. .....++|.+|+++|++++|||||+++|++.. +..+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 345666667 4999999999999753 3557999999764 34456789999999999999999999999865 5689
Q ss_pred EEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 413 LVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 413 lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|||||+++|+|..++ |+|+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999998765 66999999999999999999999999999999998754332
Q ss_pred c-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccC------------------
Q 007490 469 Q-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS------------------ 528 (601)
Q Consensus 469 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~------------------ 528 (601)
. .......||+.|||||++.++.++.++|||||||++|||+| |+.||......+....+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 244 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 2 22334568999999999999999999999999999999998 899997644322111111
Q ss_pred -----ccCCCCCCCHHHHHHHHhc
Q 007490 529 -----YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 529 -----~~dP~~RPt~~evl~~L~~ 547 (601)
..||.+|||+.+|++.|+.
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1799999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=360.57 Aligned_cols=214 Identities=28% Similarity=0.412 Sum_probs=175.2
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCC-C-----ceeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPH-G-----QEIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
.+++..++|++.++||+|+||+||+|++.. + ..||+|++... .......+.+|+.+|.++ +|||||++++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 356677899999999999999999998543 2 36899998654 334456789999999998 899999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc----------------------------------------------ccccceeecccc
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL----------------------------------------------YDSQLRIIHRDL 439 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l----------------------------------------------~~h~~~iiHrdl 439 (601)
.+.+..+|||||+++|+|.+++ |+|+++|+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999987653 558999999999
Q ss_pred ccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCC
Q 007490 440 KASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFY 518 (601)
Q Consensus 440 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~ 518 (601)
||+|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654443333445678999999999999999999999999999999998 89998754
Q ss_pred CCCcc-cccc-----------------------CccCCCCCCCHHHHHHHHhc
Q 007490 519 QTDGA-EDLL-----------------------SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 519 ~~~~~-~~l~-----------------------~~~dP~~RPt~~evl~~L~~ 547 (601)
..... ...+ ...||.+|||++||+++|..
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 43211 1111 01799999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=350.00 Aligned_cols=212 Identities=30% Similarity=0.487 Sum_probs=164.0
Q ss_pred hhcCCCCcCCcccccCcceEEeeecCCC-----ceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCe
Q 007490 337 VATNKFSSDNKLGRGGFGEVYKGVLPHG-----QEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDE 410 (601)
Q Consensus 337 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 410 (601)
+..++|++.++||+|+||+||+|+++.. ..||||++... ......+|.+|++++++++|||||+++|++.+.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 4456788899999999999999986532 36999999654 33445678999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 411 KILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
.++||||+.++++..++ |+|+.+|+||||||+||||+.++.+||+|||+++.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999998876544 679999999999999999999999999999999876543
Q ss_pred CCc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-CCccc--------------------
Q 007490 467 QTQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ-TDGAE-------------------- 524 (601)
Q Consensus 467 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~-~~~~~-------------------- 524 (601)
... .......||+.|||||++.++.++.++|||||||++|||++|..|+.... .....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence 222 12334568999999999999999999999999999999999765543321 11111
Q ss_pred ccc---CccCCCCCCCHHHHHHHHhcC
Q 007490 525 DLL---SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 525 ~l~---~~~dP~~RPt~~evl~~L~~~ 548 (601)
+++ ...||.+|||+.||+++|+..
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 111 117999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-42 Score=357.00 Aligned_cols=203 Identities=24% Similarity=0.354 Sum_probs=173.8
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
-++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999995 46899999999877766778899999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEcc--CCCcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDV--QMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++|+|.+++ |+|++||+||||||+|||++. ++.+||+|||+++.+.... .
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---C
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---c
Confidence 9999997655 669999999999999999964 6789999999998765332 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-----------------------ccc-
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE-----------------------DLL- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-----------------------~l~- 527 (601)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......... +++
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 33468999999999999999999999999999999999999999654321110 111
Q ss_pred --CccCCCCCCCHHHHHHH
Q 007490 528 --SYEDPADRPSMATIVLA 544 (601)
Q Consensus 528 --~~~dP~~RPt~~evl~~ 544 (601)
...||.+|||+.|+++.
T Consensus 262 ~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 12799999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=347.89 Aligned_cols=201 Identities=32% Similarity=0.468 Sum_probs=162.8
Q ss_pred CcccccCcceEEeeecC---CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEeccCC
Q 007490 346 NKLGRGGFGEVYKGVLP---HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEFVPN 420 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 420 (601)
++||+|+||+||+|.+. .++.||||+++.. +....+++.+|+++|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999853 3568999999653 33345789999999999999999999999865 567899999999
Q ss_pred CCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc-cccccc
Q 007490 421 KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG-NTSRIV 476 (601)
Q Consensus 421 gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~ 476 (601)
|+|..++ |+|+.+|+||||||+|||++.++.+||+|||+++.+....... ......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 9998766 6799999999999999999999999999999998765433222 223457
Q ss_pred ccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcccccc-----------------------CccCC
Q 007490 477 GTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLL-----------------------SYEDP 532 (601)
Q Consensus 477 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~-----------------------~~~dP 532 (601)
||+.|||||++.+..++.++|||||||++|||++ |+.||...........+ ...||
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp 251 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSST
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCH
Confidence 8999999999999999999999999999999998 89998754432211111 11799
Q ss_pred CCCCCHHHHHHHHhc
Q 007490 533 ADRPSMATIVLALNS 547 (601)
Q Consensus 533 ~~RPt~~evl~~L~~ 547 (601)
.+|||+++|+++|+.
T Consensus 252 ~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 252 ENRPGFAAVELRLRN 266 (277)
T ss_dssp TTSCCHHHHHHHHHH
T ss_pred hHCcCHHHHHHHhhC
Confidence 999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-43 Score=353.00 Aligned_cols=217 Identities=28% Similarity=0.452 Sum_probs=179.3
Q ss_pred hhhhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEE
Q 007490 332 FKTIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGF 404 (601)
Q Consensus 332 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 404 (601)
+.+++.+.++|++.+.||+|+||+||+|+++ +++.||||++.... ....+++.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4567778899999999999999999999853 35789999997653 3345779999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCccccc-----------------------------------------------ccccceeecc
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL-----------------------------------------------YDSQLRIIHR 437 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l-----------------------------------------------~~h~~~iiHr 437 (601)
+...+..++||||+++|+|.+++ |+|+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 99999999999999999987754 5589999999
Q ss_pred ccccCcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCC-CCCC
Q 007490 438 DLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK-KNSS 516 (601)
Q Consensus 438 dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~p~~ 516 (601)
||||+|||++.++++||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998765444333444567899999999999999999999999999999999996 5665
Q ss_pred CCCCCccccccC-----------------------ccCCCCCCCHHHHHHHHhcC
Q 007490 517 FYQTDGAEDLLS-----------------------YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 517 ~~~~~~~~~l~~-----------------------~~dP~~RPt~~evl~~L~~~ 548 (601)
..........+. ..||.+|||+.||+++|+..
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 443222111110 17999999999999999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-42 Score=355.99 Aligned_cols=207 Identities=23% Similarity=0.325 Sum_probs=175.4
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999995 46999999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEc--cCCCcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLD--VQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++|+|.+++ |+|++||+||||||+||||+ .++.+||+|||+++.+.... .
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---I 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---C
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC---c
Confidence 9999996544 67999999999999999998 57899999999999875432 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------ccc--
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------EDL-- 526 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~l-- 526 (601)
.....||+.|||||++.+..++.++|||||||++|||++|+.||........ .++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 264 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 3345789999999999999999999999999999999999999965432111 111
Q ss_pred -cCccCCCCCCCHHHHHHH--HhcC
Q 007490 527 -LSYEDPADRPSMATIVLA--LNSH 548 (601)
Q Consensus 527 -~~~~dP~~RPt~~evl~~--L~~~ 548 (601)
+...||.+|||+.|+++. ++..
T Consensus 265 ~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 265 NLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHccCChhHCcCHHHHhcCHhhCCC
Confidence 112799999999999874 5443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=340.14 Aligned_cols=196 Identities=30% Similarity=0.441 Sum_probs=160.1
Q ss_pred CcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe----CCeeEEEE
Q 007490 343 SSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE----GDEKILVY 415 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 415 (601)
+..++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ +...+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999954 5889999998654 34456778999999999999999999999875 34579999
Q ss_pred eccCCCCccccc-----------------------ccccce--eeccccccCcEEEc-cCCCcEEeecccceecCCCCCc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLR--IIHRDLKASNILLD-VQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~--iiHrdlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
||+++|+|..++ |+|+++ |+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 999999998766 679888 99999999999996 5789999999999864322
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc-cc---------------------ccc
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDG-AE---------------------DLL 527 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~---------------------~l~ 527 (601)
......||+.|||||++.+ +++.++|||||||++|||++|+.||....... .. +++
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 2335689999999998865 69999999999999999999999996433211 00 001
Q ss_pred ---CccCCCCCCCHHHHHH
Q 007490 528 ---SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ---~~~dP~~RPt~~evl~ 543 (601)
...||++|||+.|+++
T Consensus 247 ~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHhC
Confidence 1179999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-43 Score=352.58 Aligned_cols=198 Identities=31% Similarity=0.452 Sum_probs=166.0
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
+.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588999999999999999984 468899999987643 233467889999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|+|..++ |+|++||+||||||+|||++.++++||+|||+++.... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence 999999886543 77999999999999999999999999999999986532 2
Q ss_pred ccccccccccCcccccC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCc---------------------ccccc-
Q 007490 473 SRIVGTYGYMSPEYAMH---GQFSVKSDVYSFGVLALETITGKKNSSFYQTDG---------------------AEDLL- 527 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---------------------~~~l~- 527 (601)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||....... ..+++
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 34579999999999864 468999999999999999999999986533211 01111
Q ss_pred --CccCCCCCCCHHHHHH
Q 007490 528 --SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 --~~~dP~~RPt~~evl~ 543 (601)
...||.+|||+.|+++
T Consensus 249 ~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHCcCChhHCcCHHHHHh
Confidence 1179999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=343.63 Aligned_cols=202 Identities=27% Similarity=0.413 Sum_probs=171.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC------hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS------GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 468999999986532 22357899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCC----CcEEeecccceecC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQM----NPKISDFGLARIFG 464 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~----~~kL~Dfg~a~~~~ 464 (601)
+|||||+++|+|.+++ |+|+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999998766 67999999999999999998776 49999999998765
Q ss_pred CCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc---------------------
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA--------------------- 523 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--------------------- 523 (601)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 169 ~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 169 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp TSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 332 23345789999999999999999999999999999999999999975432111
Q ss_pred --ccc---cCccCCCCCCCHHHHHH
Q 007490 524 --EDL---LSYEDPADRPSMATIVL 543 (601)
Q Consensus 524 --~~l---~~~~dP~~RPt~~evl~ 543 (601)
.++ +...||.+|||+.|+++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 011 11279999999999976
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-42 Score=348.69 Aligned_cols=175 Identities=27% Similarity=0.408 Sum_probs=156.0
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4689999999999999999995 46899999999653 2334577899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+++|+|..++ |+|+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----T 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----B
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----c
Confidence 999999986655 679999999999999999999999999999999876432 2
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 34689999999999999999999999999999999999999996543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=349.92 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=172.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
-++|++.+.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 45799999999999999999995 46999999999754 233457789999999999999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++|+|..++ |+|++||+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--cc
Confidence 9999999997665 6799999999999999999999999999999998654322 23
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-------------------cc---Cc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-------------------LL---SY 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-------------------l~---~~ 529 (601)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... ++ ..
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhcc
Confidence 445689999999999999999999999999999999999999987644322111 11 12
Q ss_pred cCCCCCCC-----HHHHHH
Q 007490 530 EDPADRPS-----MATIVL 543 (601)
Q Consensus 530 ~dP~~RPt-----~~evl~ 543 (601)
.||.+||+ +.|+++
T Consensus 242 ~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHT
T ss_pred CCchhhcccccccHHHHHc
Confidence 79999995 788765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=341.57 Aligned_cols=211 Identities=25% Similarity=0.412 Sum_probs=162.7
Q ss_pred hhhhcCCCCcCCcccccCcceEEeeecCC----CceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC
Q 007490 335 IEVATNKFSSDNKLGRGGFGEVYKGVLPH----GQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD 409 (601)
Q Consensus 335 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 409 (601)
+++..++|++.+.||+|+||.||+|++.. +..||||++... .....+.+.+|++++++++|||||++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45566789999999999999999998543 346889988654 3444577999999999999999999999986 46
Q ss_pred eeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 410 EKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
..++||||+++|+|..++ |+|+.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 789999999999887654 67999999999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccC----------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS---------------- 528 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~---------------- 528 (601)
... .......||+.|+|||++.+..++.++|||||||++|||++ |++||...........+.
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 322 22334578999999999999999999999999999999998 888887654432221111
Q ss_pred -------ccCCCCCCCHHHHHHHHhc
Q 007490 529 -------YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 529 -------~~dP~~RPt~~evl~~L~~ 547 (601)
..||.+|||+.||++.|+.
T Consensus 240 ~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 240 SLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1799999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=346.01 Aligned_cols=207 Identities=29% Similarity=0.536 Sum_probs=164.7
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCc----eeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQ----EIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKIL 413 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 413 (601)
.+|++.++||+|+||+||+|++. +|+ +||+|++... .....+++.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999853 444 5888888653 344567899999999999999999999999865 5678
Q ss_pred EEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 414 VYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 414 v~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
++||+.+++|..++ |+|+++|+||||||+|||++.++++||+|||+++........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 88999999886544 679999999999999999999999999999999987654444
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccC--------------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLS-------------------- 528 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~-------------------- 528 (601)
.......||+.|||||++.++.++.++|||||||++|||+| |+.||...........+.
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~ 247 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHH
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 44445578999999999999999999999999999999998 788887644332221111
Q ss_pred ---ccCCCCCCCHHHHHHHHhc
Q 007490 529 ---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 529 ---~~dP~~RPt~~evl~~L~~ 547 (601)
..||.+|||+.||++.|+.
T Consensus 248 ~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 248 KCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCChhhCcCHHHHHHHHHH
Confidence 1799999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=337.00 Aligned_cols=204 Identities=30% Similarity=0.442 Sum_probs=164.9
Q ss_pred hhhcCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-CeeEEE
Q 007490 336 EVATNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-DEKILV 414 (601)
Q Consensus 336 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv 414 (601)
++..++|++.+.||+|+||.||+|++ .|++||||+++... ..+.+.+|++++++++||||++++|++.++ +..++|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 44556788899999999999999998 68899999996543 446789999999999999999999998654 568999
Q ss_pred EeccCCCCccccc-------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 415 YEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 415 ~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
|||+++|+|.+++ |+|+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999998776 669999999999999999999999999999999865422
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccccccCc-------------------
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAEDLLSY------------------- 529 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~l~~~------------------- 529 (601)
.....++..|+|||++.++.++.++||||||+++|||+| |+.|+......+..+.+..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 223467889999999999999999999999999999998 6777766544333222211
Q ss_pred ----cCCCCCCCHHHHHHHHhc
Q 007490 530 ----EDPADRPSMATIVLALNS 547 (601)
Q Consensus 530 ----~dP~~RPt~~evl~~L~~ 547 (601)
.||.+|||+.||+++|+.
T Consensus 235 ~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHHHHH
Confidence 799999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=342.22 Aligned_cols=218 Identities=28% Similarity=0.431 Sum_probs=168.9
Q ss_pred cchhhhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccce
Q 007490 330 FDFKTIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRL 401 (601)
Q Consensus 330 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l 401 (601)
++..++++..++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|..++.++ +|+||+++
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 455677788889999999999999999999843 24689999997543 34456778888888887 68999999
Q ss_pred EEEEEeC-CeeEEEEeccCCCCccccc---------------------------------------ccccceeecccccc
Q 007490 402 LGFCLEG-DEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKA 441 (601)
Q Consensus 402 ~~~~~~~-~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp 441 (601)
++++... +..++||||+++|+|..++ |+|+++|+||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 9998765 4689999999999987653 56999999999999
Q ss_pred CcEEEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCC-CCCCCCCC
Q 007490 442 SNILLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK-KNSSFYQT 520 (601)
Q Consensus 442 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~p~~~~~~ 520 (601)
+||||++++++||+|||+++...............||+.|||||++.+..++.++|||||||++|||++|. +||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765544444455568999999999999999999999999999999999975 56654332
Q ss_pred Ccc-c--------------------ccc---CccCCCCCCCHHHHHHHHhc
Q 007490 521 DGA-E--------------------DLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 521 ~~~-~--------------------~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
... . +++ ...||.+|||+.||+++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 0 011 11799999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=344.66 Aligned_cols=215 Identities=29% Similarity=0.453 Sum_probs=179.7
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecC------CCceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLP------HGQEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 406 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 406 (601)
++++..++|++.++||+|+||+||+|++. +++.||||+++.. .......+.+|++++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 46677789999999999999999999863 3578999999754 3344567899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCccccc---------------------------------ccccceeeccccccCcEEEccCCCcE
Q 007490 407 EGDEKILVYEFVPNKSLDYFL---------------------------------YDSQLRIIHRDLKASNILLDVQMNPK 453 (601)
Q Consensus 407 ~~~~~~lv~E~~~~gsL~~~l---------------------------------~~h~~~iiHrdlkp~NIll~~~~~~k 453 (601)
.++..++||||+++|+|..++ |+|+++|+||||||+|||+++++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 999999999999999987654 56999999999999999999999999
Q ss_pred EeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCC-CCCCCCCCCcccccc-----
Q 007490 454 ISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGK-KNSSFYQTDGAEDLL----- 527 (601)
Q Consensus 454 L~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~p~~~~~~~~~~~l~----- 527 (601)
|+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+||. .|+...........+
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999998775544444445557899999999999999999999999999999999985 666543322111111
Q ss_pred ------------------CccCCCCCCCHHHHHHHHhcC
Q 007490 528 ------------------SYEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 528 ------------------~~~dP~~RPt~~evl~~L~~~ 548 (601)
...||.+|||+.+|+++|+..
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 117999999999999999775
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=340.27 Aligned_cols=215 Identities=28% Similarity=0.419 Sum_probs=175.0
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeecCC--------CceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVLPH--------GQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLG 403 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 403 (601)
++++..++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||++++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 356677889999999999999999998422 3479999997654 34457788999999888 8999999999
Q ss_pred EEEeCCeeEEEEeccCCCCccccc---------------------------------------ccccceeeccccccCcE
Q 007490 404 FCLEGDEKILVYEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 404 ~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
++.+++..++||||+++|+|.+++ |+|+.+|+||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 999999999999999999987765 56999999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
|++.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |++||........
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999999998765555445556788999999999999999999999999999999998 6888765443222
Q ss_pred ccccC-----------------------ccCCCCCCCHHHHHHHHhcC
Q 007490 524 EDLLS-----------------------YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 ~~l~~-----------------------~~dP~~RPt~~evl~~L~~~ 548 (601)
...+. ..||.+|||+.||+++|++.
T Consensus 247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11111 17999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-41 Score=334.70 Aligned_cols=209 Identities=27% Similarity=0.377 Sum_probs=165.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC---hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC----e
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS---GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----E 410 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~ 410 (601)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 57899999999999999999995 469999999997543 334567899999999999999999999998654 3
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.||||||+++++|..++ ++|++||+||||||+|||++.++..+|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 78999999999987655 6799999999999999999999999999999997654332
Q ss_pred Cc-cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------
Q 007490 468 TQ-GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA----------------------- 523 (601)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~----------------------- 523 (601)
.. .......||+.|||||++.+..++.++|||||||++|||++|+.||........
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 245 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 21 223456799999999999999999999999999999999999999975432110
Q ss_pred cccc---CccCCCCCC-CHHHHHHHHhc
Q 007490 524 EDLL---SYEDPADRP-SMATIVLALNS 547 (601)
Q Consensus 524 ~~l~---~~~dP~~RP-t~~evl~~L~~ 547 (601)
.+++ ...||.+|| |++++++.|..
T Consensus 246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0111 117999999 89999888754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-41 Score=344.78 Aligned_cols=175 Identities=27% Similarity=0.343 Sum_probs=156.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 415 (601)
++|++++.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999995 46999999998653 2234567899999999999999999999999999999999
Q ss_pred eccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 416 EFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 416 E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
||+.+|+|..++ |+|+++||||||||+|||++.++++||+|||+++.+... .
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----T 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----B
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----c
Confidence 999999987665 679999999999999999999999999999999876422 2
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
....||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 34689999999999999999999999999999999999999996543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=335.75 Aligned_cols=208 Identities=32% Similarity=0.419 Sum_probs=160.6
Q ss_pred cCCCCcCCcccccCcceEEeeecC--CC--ceeeEEEeccC---ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP--HG--QEIAVKRLSRS---SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
.++|++.+.||+|+||.||+|++. ++ .+||||++.+. .....++|.+|+++|++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 466899999999999999999853 22 37899998654 33445789999999999999999999999975 467
Q ss_pred EEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 412 ILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
++||||+++++|.+++ |+|+++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 8999999999987654 6799999999999999999999999999999999875443
Q ss_pred Cccc-cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCccc---------------------
Q 007490 468 TQGN-TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGAE--------------------- 524 (601)
Q Consensus 468 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~--------------------- 524 (601)
.... .....++..|+|||++.+..++.++|||||||++|||+| |+.||.........
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 3222 233467889999999999999999999999999999998 89998654322111
Q ss_pred ccc---CccCCCCCCCHHHHHHHHhc
Q 007490 525 DLL---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 525 ~l~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+++ ...||.+|||+.||++.|+.
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 11799999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-40 Score=342.75 Aligned_cols=201 Identities=28% Similarity=0.377 Sum_probs=164.2
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHH---HHHHHHHcCCCCccceEEEEEeCCee
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKN---EVVLVAKLQHRNLVRLLGFCLEGDEK 411 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~hpnIv~l~~~~~~~~~~ 411 (601)
-++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999954 68999999986432 122233344 46667777899999999999999999
Q ss_pred EEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 412 ILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
|+||||+++|+|..++ |+|+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 9999999999998766 6799999999999999999999999999999998765332
Q ss_pred ccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccccc--------------------
Q 007490 469 QGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDLL-------------------- 527 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l~-------------------- 527 (601)
.....||+.|||||++.. ..++.++|||||||++|||++|+.||..........+.
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 334589999999999875 56899999999999999999999999764433221111
Q ss_pred -----CccCCCCCCC-----HHHHHH
Q 007490 528 -----SYEDPADRPS-----MATIVL 543 (601)
Q Consensus 528 -----~~~dP~~RPt-----~~evl~ 543 (601)
...||.+||| +.|+++
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1179999999 688764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-41 Score=339.47 Aligned_cols=215 Identities=30% Similarity=0.441 Sum_probs=178.2
Q ss_pred hhhhhcCCCCcCCcccccCcceEEeeec------CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHc-CCCCccceEEEE
Q 007490 334 TIEVATNKFSSDNKLGRGGFGEVYKGVL------PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKL-QHRNLVRLLGFC 405 (601)
Q Consensus 334 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 405 (601)
.++...++|++.++||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4667778999999999999999999974 246789999997643 34556789999999999 699999999999
Q ss_pred EeCCeeEEEEeccCCCCccccc-----------------------------------------ccccceeeccccccCcE
Q 007490 406 LEGDEKILVYEFVPNKSLDYFL-----------------------------------------YDSQLRIIHRDLKASNI 444 (601)
Q Consensus 406 ~~~~~~~lv~E~~~~gsL~~~l-----------------------------------------~~h~~~iiHrdlkp~NI 444 (601)
.+.+..++||||+++|+|..++ |+|+++|+||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 9999999999999999886654 56999999999999999
Q ss_pred EEccCCCcEEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCCCcc
Q 007490 445 LLDVQMNPKISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETIT-GKKNSSFYQTDGA 523 (601)
Q Consensus 445 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 523 (601)
|++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+|+........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999998765444444455688999999999999999999999999999999999 4555544332211
Q ss_pred -ccccC-----------------------ccCCCCCCCHHHHHHHHhcC
Q 007490 524 -EDLLS-----------------------YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 524 -~~l~~-----------------------~~dP~~RPt~~evl~~L~~~ 548 (601)
..++. ..||.+|||+.||+++|++.
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11110 17999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=335.40 Aligned_cols=172 Identities=28% Similarity=0.375 Sum_probs=143.8
Q ss_pred cCCcccccCcceEEeeecC-CCceeeEEEeccCChh-----hHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 344 SDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQ-----GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 344 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.+++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 5899999998654322 134688999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
++++++..+. |+|++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc--cccc
Confidence 9987665433 67999999999999999999999999999999987643322 2334
Q ss_pred ccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 475 IVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
.+||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 5799999999998754 579999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-40 Score=329.07 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=167.5
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh---------hhHHHHHHHHHHHHHcC-CCCccceEEEEEeC
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG---------QGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG 408 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 408 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999995 4689999999875431 12346889999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 409 DEKILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 409 ~~~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
+..||||||+++|+|.+++ |+|+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 9999999999999998776 67999999999999999999999999999999998754
Q ss_pred CCCccccccccccccccCccccc------CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc-------------
Q 007490 466 DQTQGNTSRIVGTYGYMSPEYAM------HGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL------------- 526 (601)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l------------- 526 (601)
.. ......||+.|+|||.+. ...++.++||||+||++|||++|+.||...........
T Consensus 163 ~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 163 GE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp TC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 32 233467999999999985 34578899999999999999999999976542211110
Q ss_pred -------------cCccCCCCCCCHHHHHH
Q 007490 527 -------------LSYEDPADRPSMATIVL 543 (601)
Q Consensus 527 -------------~~~~dP~~RPt~~evl~ 543 (601)
+...||.+|||+.||++
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01178999999998864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=336.12 Aligned_cols=201 Identities=21% Similarity=0.307 Sum_probs=169.9
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999964 688999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCccccc------------------------ccccceeeccccccCcEEEccC--CCcEEeecccceecCCCCCccc
Q 007490 418 VPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQ--MNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 418 ~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~--~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
+++++|.+++ |+|+.||+||||||+|||++.+ ..+||+|||+++...... .
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---N 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---E
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC---c
Confidence 9999987665 6799999999999999999854 479999999998764322 2
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcc-----------------------cccc-
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGA-----------------------EDLL- 527 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-----------------------~~l~- 527 (601)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+++
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence 3345789999999999999999999999999999999999999976442111 1111
Q ss_pred --CccCCCCCCCHHHHHH
Q 007490 528 --SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 --~~~dP~~RPt~~evl~ 543 (601)
...||.+|||+.|+++
T Consensus 240 ~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCSSGGGSCCHHHHHH
T ss_pred HHccCChhHCcCHHHHhc
Confidence 1279999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=337.41 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=167.6
Q ss_pred CCCCcCCcccccCcceEEeeecC-CCceeeEEEeccCC---hhhHHHHHHHHHHHH-HcCCCCccceEEEEEeCCeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSS---GQGAQEFKNEVVLVA-KLQHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv 414 (601)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999954 68999999996532 233456667777665 68999999999999999999999
Q ss_pred EeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccc
Q 007490 415 YEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGN 471 (601)
Q Consensus 415 ~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 471 (601)
|||+++|+|..++ |+|+++|+||||||+|||+++++++||+|||+++...... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--cc
Confidence 9999999998776 6799999999999999999999999999999998654332 23
Q ss_pred cccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCcccc-------------------c---cCc
Q 007490 472 TSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAED-------------------L---LSY 529 (601)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~-------------------l---~~~ 529 (601)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... + +..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence 344689999999999999999999999999999999999999997544221111 1 112
Q ss_pred cCCCCCCCHH-HHHH
Q 007490 530 EDPADRPSMA-TIVL 543 (601)
Q Consensus 530 ~dP~~RPt~~-evl~ 543 (601)
.||.+||++. |+++
T Consensus 240 ~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSGGGSBTTBSCGGG
T ss_pred cCCCCCcCHHHHHHh
Confidence 7999999995 6753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-40 Score=330.58 Aligned_cols=175 Identities=27% Similarity=0.366 Sum_probs=140.4
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC----eeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----EKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~ 415 (601)
.+|.+.++||+|+||.||+|++ +|+.||||++..... .....+.|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577788999999999999997 789999999864432 2222344566667889999999999998654 579999
Q ss_pred eccCCCCccccc----------------------ccc--------cceeeccccccCcEEEccCCCcEEeecccceecCC
Q 007490 416 EFVPNKSLDYFL----------------------YDS--------QLRIIHRDLKASNILLDVQMNPKISDFGLARIFGV 465 (601)
Q Consensus 416 E~~~~gsL~~~l----------------------~~h--------~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~ 465 (601)
||+++|+|..++ ++| +++|+||||||+||||+.++++||+|||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999998776 334 57999999999999999999999999999987754
Q ss_pred CCCc--cccccccccccccCcccccCC------CCCchhhHHhHHHHHHHHHhCCCCCC
Q 007490 466 DQTQ--GNTSRIVGTYGYMSPEYAMHG------QFSVKSDVYSFGVLALETITGKKNSS 516 (601)
Q Consensus 466 ~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~~ 516 (601)
.... .......||+.|||||++.+. .++.++|||||||+||||+||..|+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 3322 123346799999999998754 36789999999999999999987763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=332.80 Aligned_cols=198 Identities=21% Similarity=0.269 Sum_probs=161.6
Q ss_pred cCCCCcCC-cccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHc-CCCCccceEEEEEe----CCee
Q 007490 339 TNKFSSDN-KLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLE----GDEK 411 (601)
Q Consensus 339 ~~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~ 411 (601)
.++|++.+ .||+|+||.||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 45788765 599999999999995 56899999998542 4567899987665 89999999999875 4568
Q ss_pred EEEEeccCCCCccccc-------------------------ccccceeeccccccCcEEEcc---CCCcEEeecccceec
Q 007490 412 ILVYEFVPNKSLDYFL-------------------------YDSQLRIIHRDLKASNILLDV---QMNPKISDFGLARIF 463 (601)
Q Consensus 412 ~lv~E~~~~gsL~~~l-------------------------~~h~~~iiHrdlkp~NIll~~---~~~~kL~Dfg~a~~~ 463 (601)
||||||+++|+|.+++ |+|+.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999999997765 669999999999999999985 567999999999876
Q ss_pred CCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccc-------------------
Q 007490 464 GVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAE------------------- 524 (601)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~------------------- 524 (601)
.... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.........
T Consensus 165 ~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 165 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp CCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred cCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 5432 233468999999999999999999999999999999999999999543321110
Q ss_pred --------ccc---CccCCCCCCCHHHHHHH
Q 007490 525 --------DLL---SYEDPADRPSMATIVLA 544 (601)
Q Consensus 525 --------~l~---~~~dP~~RPt~~evl~~ 544 (601)
+++ ...||.+|||+.|+++.
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011 11799999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=335.35 Aligned_cols=206 Identities=33% Similarity=0.475 Sum_probs=165.1
Q ss_pred CCCCcCCcccccCcceEEeeecCC-Cc--eeeEEEeccC-ChhhHHHHHHHHHHHHHc-CCCCccceEEEEEeCCeeEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPH-GQ--EIAVKRLSRS-SGQGAQEFKNEVVLVAKL-QHRNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 414 (601)
++|++.++||+|+||+||+|++.+ |. .||||++... .....+.+.+|+++|+++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999654 43 5788887644 344556799999999999 799999999999999999999
Q ss_pred EeccCCCCccccc---------------------------------------ccccceeeccccccCcEEEccCCCcEEe
Q 007490 415 YEFVPNKSLDYFL---------------------------------------YDSQLRIIHRDLKASNILLDVQMNPKIS 455 (601)
Q Consensus 415 ~E~~~~gsL~~~l---------------------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~ 455 (601)
|||+++|+|.+++ |+|+++|+||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999997765 4588999999999999999999999999
Q ss_pred ecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCC-CCCCCCCCccccccC------
Q 007490 456 DFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKK-NSSFYQTDGAEDLLS------ 528 (601)
Q Consensus 456 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~~~l~~------ 528 (601)
|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.........+.+.
T Consensus 170 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 170 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp CTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred cccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999998654322 2234468999999999999999999999999999999999764 565433222111111
Q ss_pred -----------------ccCCCCCCCHHHHHHHHhcC
Q 007490 529 -----------------YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 529 -----------------~~dP~~RPt~~evl~~L~~~ 548 (601)
..||++|||+.||++.|+..
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 17999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-40 Score=330.21 Aligned_cols=176 Identities=30% Similarity=0.489 Sum_probs=149.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999995 568999999996543 2335788999999999999999999999999999999999
Q ss_pred ccCCCCcccc------------------------cccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccc
Q 007490 417 FVPNKSLDYF------------------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNT 472 (601)
Q Consensus 417 ~~~~gsL~~~------------------------l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 472 (601)
|+.++.+... .|+|+++||||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--ccc
Confidence 9987544322 17799999999999999999999999999999998764332 223
Q ss_pred ccccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 473 SRIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
....||+.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 4457999999999887765 57899999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=329.41 Aligned_cols=204 Identities=29% Similarity=0.456 Sum_probs=165.2
Q ss_pred CCcccccCcceEEeeecCCC----ceeeEEEeccC-ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe-CCeeEEEEecc
Q 007490 345 DNKLGRGGFGEVYKGVLPHG----QEIAVKRLSRS-SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GDEKILVYEFV 418 (601)
Q Consensus 345 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~ 418 (601)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999996432 25899999753 45556789999999999999999999999876 45789999999
Q ss_pred CCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcc--cc
Q 007490 419 PNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQG--NT 472 (601)
Q Consensus 419 ~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~ 472 (601)
++++|.+++ |+|+.+|+||||||+|||+++++.+||+|||+++......... ..
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999997755 6699999999999999999999999999999998765432221 22
Q ss_pred ccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCC-cccc--------------------cc---C
Q 007490 473 SRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTD-GAED--------------------LL---S 528 (601)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-~~~~--------------------l~---~ 528 (601)
....||+.|+|||.+..+.++.++||||||+++|||++|+.||...... +... ++ .
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl 271 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHc
Confidence 3356899999999999999999999999999999999987776542211 1111 11 1
Q ss_pred ccCCCCCCCHHHHHHHHhcC
Q 007490 529 YEDPADRPSMATIVLALNSH 548 (601)
Q Consensus 529 ~~dP~~RPt~~evl~~L~~~ 548 (601)
..||.+||++.||++.|++.
T Consensus 272 ~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 272 HPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHHHHH
Confidence 17999999999999999765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=324.59 Aligned_cols=201 Identities=26% Similarity=0.438 Sum_probs=161.9
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCCh------hhHHHHHHHHHHHHHcC--CCCccceEEEEEeCC
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSG------QGAQEFKNEVVLVAKLQ--HRNLVRLLGFCLEGD 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~ 409 (601)
.++|++.++||+|+||+||+|+. .+|+.||||++.+... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999995 4689999999865321 12234678999999996 899999999999999
Q ss_pred eeEEEEeccCC-CCccccc-----------------------ccccceeeccccccCcEEEccC-CCcEEeecccceecC
Q 007490 410 EKILVYEFVPN-KSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQ-MNPKISDFGLARIFG 464 (601)
Q Consensus 410 ~~~lv~E~~~~-gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~-~~~kL~Dfg~a~~~~ 464 (601)
..++||||+.+ +++..++ |+|+++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 4544333 6799999999999999999854 789999999998754
Q ss_pred CCCCccccccccccccccCcccccCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCC-------------Ccccccc---
Q 007490 465 VDQTQGNTSRIVGTYGYMSPEYAMHGQF-SVKSDVYSFGVLALETITGKKNSSFYQT-------------DGAEDLL--- 527 (601)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~-------------~~~~~l~--- 527 (601)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .+..+++
T Consensus 163 ~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~ 238 (273)
T d1xwsa_ 163 DT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 238 (273)
T ss_dssp SS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHH
T ss_pred cc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHH
Confidence 32 2334689999999999987765 5779999999999999999999865321 1111122
Q ss_pred CccCCCCCCCHHHHHH
Q 007490 528 SYEDPADRPSMATIVL 543 (601)
Q Consensus 528 ~~~dP~~RPt~~evl~ 543 (601)
...||.+|||+.|+++
T Consensus 239 L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 239 LALRPSDRPTFEEIQN 254 (273)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred ccCCHhHCcCHHHHhc
Confidence 2279999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-39 Score=323.11 Aligned_cols=176 Identities=28% Similarity=0.464 Sum_probs=149.7
Q ss_pred CCCCcCCcccccCcceEEeeecCCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.++||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998889999999996653 23357899999999999999999999999999999999999
Q ss_pred cCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCcccccc
Q 007490 418 VPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 418 ~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
+.++.+..+. |+|+.+|+||||||+|||++.++.+||+|||.+........ ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 159 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTH 159 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccce
Confidence 9887654433 67999999999999999999999999999999987653322 2334
Q ss_pred ccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 475 IVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..+++.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 5689999999998764 568999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=323.15 Aligned_cols=177 Identities=28% Similarity=0.461 Sum_probs=146.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CC-CceeeEEEeccCC--hhhHHHHHHHHHHHHHc---CCCCccceEEEEEe----
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PH-GQEIAVKRLSRSS--GQGAQEFKNEVVLVAKL---QHRNLVRLLGFCLE---- 407 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~---- 407 (601)
.++|+++++||+|+||+||+|++ .+ ++.||||++.... ......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999985 34 5679999986532 22233456788777766 79999999999863
Q ss_pred -CCeeEEEEeccCCCCccccc------------------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 408 -GDEKILVYEFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 408 -~~~~~lv~E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
....+++|||++++.+.... |+|+++|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 34679999999987654221 77999999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 463 FGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.... .......||+.|+|||++.+.+++.++||||+||++|||++|+.||...
T Consensus 166 ~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 166 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 5422 2334568999999999999999999999999999999999999998643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=318.02 Aligned_cols=179 Identities=27% Similarity=0.439 Sum_probs=146.5
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe--------
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-------- 407 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 407 (601)
-++|++.++||+|+||+||+|++ .+|+.||||++... .......+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999995 57999999998654 33345678899999999999999999999865
Q ss_pred CCeeEEEEeccCCCCcccc-----------------------cccccceeeccccccCcEEEccCCCcEEeecccceecC
Q 007490 408 GDEKILVYEFVPNKSLDYF-----------------------LYDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFG 464 (601)
Q Consensus 408 ~~~~~lv~E~~~~gsL~~~-----------------------l~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~ 464 (601)
.+..++||||++++.+..+ .|+|++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 3457999999987665332 27799999999999999999999999999999998765
Q ss_pred CCCCc--cccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 465 VDQTQ--GNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 465 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 33221 123335799999999998765 689999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=318.56 Aligned_cols=180 Identities=23% Similarity=0.389 Sum_probs=147.0
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC-hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC----eeE
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS-GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----EKI 412 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~ 412 (601)
..+|+++++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999984 579999999997543 344567899999999999999999999997654 234
Q ss_pred EEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc-
Q 007490 413 LVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ- 469 (601)
Q Consensus 413 lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 469 (601)
++++|+.+++|.+++ |+|++|||||||||+|||++.++.+||+|||+++........
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 555667788887765 679999999999999999999999999999999876543222
Q ss_pred cccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 22345679999999999854 56789999999999999999999998643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=319.34 Aligned_cols=175 Identities=30% Similarity=0.435 Sum_probs=142.7
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEeCC-----
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGD----- 409 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 409 (601)
..++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999995 46999999999754 3344567899999999999999999999998665
Q ss_pred -eeEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCC
Q 007490 410 -EKILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVD 466 (601)
Q Consensus 410 -~~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 466 (601)
..++||||+ +.+|..+. |+|++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 469999999 44443322 779999999999999999999999999999999876432
Q ss_pred CCccccccccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 175 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 175 -----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp -----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 2345789999999998764 5689999999999999999999998653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-37 Score=309.76 Aligned_cols=207 Identities=19% Similarity=0.291 Sum_probs=166.9
Q ss_pred hcCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCC-CCccceEEEEEeCCeeEEEE
Q 007490 338 ATNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGDEKILVY 415 (601)
Q Consensus 338 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~ 415 (601)
..++|++.++||+|+||+||+|++ .+|+.||||++..... ...+.+|++.++.|+| +||+.+++++..+...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357899999999999999999995 4689999998865432 2356789999999965 89999999999999999999
Q ss_pred eccCCCCccccc------------------------ccccceeeccccccCcEEEcc-----CCCcEEeecccceecCCC
Q 007490 416 EFVPNKSLDYFL------------------------YDSQLRIIHRDLKASNILLDV-----QMNPKISDFGLARIFGVD 466 (601)
Q Consensus 416 E~~~~gsL~~~l------------------------~~h~~~iiHrdlkp~NIll~~-----~~~~kL~Dfg~a~~~~~~ 466 (601)
||+ +++|..++ ++|++||+||||||+|||++. ++.+||+|||+++.+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 998 56765544 669999999999999999974 577999999999986543
Q ss_pred CCc-----cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc---------------
Q 007490 467 QTQ-----GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL--------------- 526 (601)
Q Consensus 467 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l--------------- 526 (601)
... .......||+.|||||++.+..++.++|||||||++|||++|+.||...........
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 221 123346799999999999999999999999999999999999999975433211110
Q ss_pred ------------c---CccCCCCCCCHHHHHHHHhc
Q 007490 527 ------------L---SYEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 ------------~---~~~dP~~RPt~~evl~~L~~ 547 (601)
+ ...+|.+||+.+.+.+.|+.
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 0 11689999998888777654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-37 Score=309.79 Aligned_cols=206 Identities=23% Similarity=0.306 Sum_probs=160.3
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCcc-ceEEEEEeCCeeEEEEec
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV-RLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~ 417 (601)
++|++.+.||+|+||.||+|++ .+|+.||||++..... ..++..|++++++++|+|++ .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999995 4689999998865432 24578899999999877655 555666778889999999
Q ss_pred cCCCCcccc-----------------------cccccceeeccccccCcEEEc---cCCCcEEeecccceecCCCCCc--
Q 007490 418 VPNKSLDYF-----------------------LYDSQLRIIHRDLKASNILLD---VQMNPKISDFGLARIFGVDQTQ-- 469 (601)
Q Consensus 418 ~~~gsL~~~-----------------------l~~h~~~iiHrdlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~~-- 469 (601)
+.++.+..+ .|+|+++|+||||||+|||++ .+..+||+|||+++.+......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 965432221 167999999999999999985 3567999999999987543322
Q ss_pred ---cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCCCccccc--------------------
Q 007490 470 ---GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSFYQTDGAEDL-------------------- 526 (601)
Q Consensus 470 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~l-------------------- 526 (601)
.......||+.|||||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTS
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCC
Confidence 123346799999999999999999999999999999999999999976443221111
Q ss_pred -------cC---ccCCCCCCCHHHHHHHHhc
Q 007490 527 -------LS---YEDPADRPSMATIVLALNS 547 (601)
Q Consensus 527 -------~~---~~dP~~RPt~~evl~~L~~ 547 (601)
+. ..||.+||++.++.+.|+.
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11 1799999999998887764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-37 Score=307.65 Aligned_cols=174 Identities=28% Similarity=0.457 Sum_probs=151.1
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeCCeeEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 416 (601)
++|++.++||+|+||+||+|++ .+++.||||+++... .....++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 468899999986543 3446788999999999999999999999999999999999
Q ss_pred ccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCccccc
Q 007490 417 FVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQGNTS 473 (601)
Q Consensus 417 ~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 473 (601)
++.+++|..++ |+|+++|+||||||+|||++.++.+||+|||.++....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cce
Confidence 99988776544 67999999999999999999999999999999987654332 233
Q ss_pred cccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCC
Q 007490 474 RIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNS 515 (601)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~ 515 (601)
...+++.|+|||.+.+.. ++.++|||||||++|||++|+.||
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 346788999999987665 689999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-37 Score=313.23 Aligned_cols=179 Identities=27% Similarity=0.390 Sum_probs=152.0
Q ss_pred CCCCcCCcccccCcceEEeeec----CCCceeeEEEeccCC----hhhHHHHHHHHHHHHHcCC-CCccceEEEEEeCCe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL----PHGQEIAVKRLSRSS----GQGAQEFKNEVVLVAKLQH-RNLVRLLGFCLEGDE 410 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~ 410 (601)
++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999974 247899999986532 2334667899999999977 899999999999999
Q ss_pred eEEEEeccCCCCccccc-----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCC
Q 007490 411 KILVYEFVPNKSLDYFL-----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQ 467 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l-----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 467 (601)
.+++|||+.+++|..++ |+|+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 99999999999997765 6699999999999999999999999999999998765432
Q ss_pred CccccccccccccccCcccccCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCC
Q 007490 468 TQGNTSRIVGTYGYMSPEYAMHG--QFSVKSDVYSFGVLALETITGKKNSSFYQ 519 (601)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~ 519 (601)
. .......|++.|++||.+.+. .++.++|||||||+||||++|+.||....
T Consensus 184 ~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 184 T-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp G-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred c-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 223446799999999998764 46789999999999999999999996544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-37 Score=316.28 Aligned_cols=171 Identities=27% Similarity=0.414 Sum_probs=141.9
Q ss_pred CCCcCCcccccCcceEEeeecC-CCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCccceEEEEEeC------CeeEE
Q 007490 341 KFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG------DEKIL 413 (601)
Q Consensus 341 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~l 413 (601)
+|+..++||+|+||+||+|++. +|+.||||++...... ..+|+++|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999964 6899999999764322 34799999999999999999998643 24789
Q ss_pred EEeccCCCCccccc--------------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCC
Q 007490 414 VYEFVPNKSLDYFL--------------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVD 466 (601)
Q Consensus 414 v~E~~~~gsL~~~l--------------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~ 466 (601)
||||++++.+..+. |+|++||+||||||+|||++.++ .+||+|||+++.+...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 99999876432221 77999999999999999999775 8999999999876543
Q ss_pred CCccccccccccccccCcccccC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Q 007490 467 QTQGNTSRIVGTYGYMSPEYAMH-GQFSVKSDVYSFGVLALETITGKKNSSFY 518 (601)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~ 518 (601)
.. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 177 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 177 EP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp SC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 22 334579999999998765 56899999999999999999999998643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-36 Score=309.67 Aligned_cols=172 Identities=24% Similarity=0.435 Sum_probs=147.9
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeC--CeeEEEE
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEG--DEKILVY 415 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~ 415 (601)
++|+++++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999995 468999999986543 457889999999995 99999999999844 4689999
Q ss_pred eccCCCCccccc--------------------ccccceeeccccccCcEEEccCC-CcEEeecccceecCCCCCcccccc
Q 007490 416 EFVPNKSLDYFL--------------------YDSQLRIIHRDLKASNILLDVQM-NPKISDFGLARIFGVDQTQGNTSR 474 (601)
Q Consensus 416 E~~~~gsL~~~l--------------------~~h~~~iiHrdlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 474 (601)
||+++++|..+. |+|++||+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~ 188 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNV 188 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCS
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc---ccc
Confidence 999999987654 77999999999999999999765 589999999987654322 334
Q ss_pred ccccccccCcccccCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 475 IVGTYGYMSPEYAMHG-QFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 475 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
..+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 5789999999998765 479999999999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=313.60 Aligned_cols=176 Identities=28% Similarity=0.348 Sum_probs=141.7
Q ss_pred cCCCCcCCcccccCcceEEeeecC-CCceeeEEEeccC--ChhhHHHHHHHHHHHHHcCCCCccceEEEEEe------CC
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLP-HGQEIAVKRLSRS--SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE------GD 409 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~ 409 (601)
.++|++.++||+|+||+||+|++. +|+.||||++... ......++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999954 6999999999754 33445678999999999999999999999964 36
Q ss_pred eeEEEEeccCCCCccccc--------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCCc
Q 007490 410 EKILVYEFVPNKSLDYFL--------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQTQ 469 (601)
Q Consensus 410 ~~~lv~E~~~~gsL~~~l--------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 469 (601)
..|+||||+.++.+..+. ++|++||+||||||+|||++.++.+|++|||+++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~-- 173 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc--
Confidence 789999999887654322 7799999999999999999999999999999988654322
Q ss_pred cccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 470 GNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......+|+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 174 -~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 23345789999999999999999999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-36 Score=309.46 Aligned_cols=174 Identities=28% Similarity=0.407 Sum_probs=144.6
Q ss_pred cCCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCC--hhhHHHHHHHHHHHHHcCCCCccceEEEEEeC-----Ce
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEG-----DE 410 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 410 (601)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999994 569999999997543 34456788999999999999999999998643 33
Q ss_pred eEEEEeccCCCCccccc----------------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 411 KILVYEFVPNKSLDYFL----------------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 411 ~~lv~E~~~~gsL~~~l----------------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
.++++||+.+++|.+++ |+|++||+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---
Confidence 46677788899987765 67999999999999999999999999999999976432
Q ss_pred ccccccccccccccCcccccCCC-CCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQ-FSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 233457899999999877654 68999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.9e-31 Score=273.12 Aligned_cols=172 Identities=23% Similarity=0.301 Sum_probs=137.3
Q ss_pred CCCCcCCcccccCcceEEeeec-CCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-----------CCCccceEEEEEe
Q 007490 340 NKFSSDNKLGRGGFGEVYKGVL-PHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-----------HRNLVRLLGFCLE 407 (601)
Q Consensus 340 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~~ 407 (601)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999995 569999999996543 33467788999988885 5789999998864
Q ss_pred C--CeeEEEEeccCCCCcc--------------------------ccccccc-ceeeccccccCcEEEccCCC------c
Q 007490 408 G--DEKILVYEFVPNKSLD--------------------------YFLYDSQ-LRIIHRDLKASNILLDVQMN------P 452 (601)
Q Consensus 408 ~--~~~~lv~E~~~~gsL~--------------------------~~l~~h~-~~iiHrdlkp~NIll~~~~~------~ 452 (601)
. ...++++++...+... .+.++|+ .||+||||||+|||++.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3 4556666665443211 1126686 89999999999999987654 8
Q ss_pred EEeecccceecCCCCCccccccccccccccCcccccCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Q 007490 453 KISDFGLARIFGVDQTQGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLALETITGKKNSSF 517 (601)
Q Consensus 453 kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 517 (601)
+|+|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||..
T Consensus 172 kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 172 KIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 9999999986532 22345799999999999999999999999999999999999999853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=5.1e-21 Score=178.60 Aligned_cols=153 Identities=18% Similarity=0.130 Sum_probs=107.3
Q ss_pred CcCCcccccCcceEEeeecCCCceeeEEEeccCCh------------------hhHHHHHHHHHHHHHcCCCCccceEEE
Q 007490 343 SSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSG------------------QGAQEFKNEVVLVAKLQHRNLVRLLGF 404 (601)
Q Consensus 343 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~l~~~ 404 (601)
.+.++||+|+||+||+|+..+|++||||++..... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988899999998753210 012334578899999999999998866
Q ss_pred EEeCCeeEEEEeccCCCCccccc----------------ccccceeeccccccCcEEEccCCCcEEeecccceecCCCCC
Q 007490 405 CLEGDEKILVYEFVPNKSLDYFL----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARIFGVDQT 468 (601)
Q Consensus 405 ~~~~~~~~lv~E~~~~gsL~~~l----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 468 (601)
. ..+++|||+++..+..+. ++|+.||+||||||+|||+++++ ++|+|||.+........
T Consensus 83 ~----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp E----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTH
T ss_pred c----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCc
Confidence 3 237999999987654322 67999999999999999999655 89999999986542211
Q ss_pred ccccccccccccccCcccccCCCCCchhhHHhHHHHH
Q 007490 469 QGNTSRIVGTYGYMSPEYAMHGQFSVKSDVYSFGVLA 505 (601)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 505 (601)
.......+. .+ .| .....|+.++|+||..--+
T Consensus 158 ~~~l~rd~~---~~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 158 REILERDVR---NI-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HHHHHHHHH---HH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred HHHHHHHHH---HH-HH-HHcCCCCCcccHHHHHHHH
Confidence 100000000 00 01 1135678899999986444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=9.2e-07 Score=84.40 Aligned_cols=123 Identities=16% Similarity=0.101 Sum_probs=89.0
Q ss_pred cCCCCcCCcccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcC-CCCccceEEEEEeCCeeEEEEec
Q 007490 339 TNKFSSDNKLGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQ-HRNLVRLLGFCLEGDEKILVYEF 417 (601)
Q Consensus 339 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 417 (601)
-..|+..+..+.++.+.||+... +++.++||+...........+.+|...+..|. +--+.+++.+...++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34556556555556678998875 66778889886654444456788999988884 33367888888888899999999
Q ss_pred cCCCCccccc--------------------c-------------------------------------------------
Q 007490 418 VPNKSLDYFL--------------------Y------------------------------------------------- 428 (601)
Q Consensus 418 ~~~gsL~~~l--------------------~------------------------------------------------- 428 (601)
++|.++.... +
T Consensus 92 l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 92 ADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp CSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred cccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 9886542211 0
Q ss_pred --------cccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 429 --------DSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 429 --------~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
.....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0123489999999999999876677999988864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=3.1e-05 Score=72.96 Aligned_cols=112 Identities=18% Similarity=0.121 Sum_probs=81.3
Q ss_pred ccccC-cceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCC--CccceEEEEEeCCeeEEEEeccCCCCcc
Q 007490 348 LGRGG-FGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHR--NLVRLLGFCLEGDEKILVYEFVPNKSLD 424 (601)
Q Consensus 348 lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 424 (601)
+..|. .+.||+...+++..+++|....... ..+..|...++.|... .+.+++.+..+++..++|||+++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 3679999887788888997654432 3467788888887433 3567888888888899999999986653
Q ss_pred ccc---------------cc----------------------------------------------------------cc
Q 007490 425 YFL---------------YD----------------------------------------------------------SQ 431 (601)
Q Consensus 425 ~~l---------------~~----------------------------------------------------------h~ 431 (601)
... .+ ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 211 00 12
Q ss_pred ceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 432 LRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 432 ~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3489999999999999876678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.17 E-value=0.00044 Score=69.48 Aligned_cols=74 Identities=12% Similarity=0.130 Sum_probs=48.5
Q ss_pred CcccccCcceEEeeecCC-CceeeEEEeccC-------ChhhHHHHHHHHHHHHHcC-C--CCccceEEEEEeCCeeEEE
Q 007490 346 NKLGRGGFGEVYKGVLPH-GQEIAVKRLSRS-------SGQGAQEFKNEVVLVAKLQ-H--RNLVRLLGFCLEGDEKILV 414 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~~~~~lv 414 (601)
+.||.|....||+....+ ++.|+||.-... .+...++...|.+.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999965321 1123345567888887773 3 345556554 45567899
Q ss_pred EeccCCC
Q 007490 415 YEFVPNK 421 (601)
Q Consensus 415 ~E~~~~g 421 (601)
||++++.
T Consensus 110 mE~L~~~ 116 (392)
T d2pula1 110 MEDLSHL 116 (392)
T ss_dssp ECCCTTS
T ss_pred EeccCCc
Confidence 9999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.00066 Score=66.26 Aligned_cols=69 Identities=13% Similarity=0.074 Sum_probs=47.1
Q ss_pred ceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCcc--ceE-----EEEEeCCeeEEEEeccCCCCc
Q 007490 354 GEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNLV--RLL-----GFCLEGDEKILVYEFVPNKSL 423 (601)
Q Consensus 354 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv--~l~-----~~~~~~~~~~lv~E~~~~gsL 423 (601)
-.||+.+.++|+.+++|+.... ....+++..|...+..|....|. ..+ ......+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4799999989999999987543 22456788899999888533221 111 122345667889999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.26 E-value=0.011 Score=56.75 Aligned_cols=127 Identities=13% Similarity=0.074 Sum_probs=74.5
Q ss_pred hhhhhhcCCCCcCCc-----ccccCcceEEeeecCCCceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc--cceEE--
Q 007490 333 KTIEVATNKFSSDNK-----LGRGGFGEVYKGVLPHGQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL--VRLLG-- 403 (601)
Q Consensus 333 ~~~~~~~~~f~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~~-- 403 (601)
++++....+|.+.+. |..|---+.|+....+| .+++|+..... ..+++..|++++..|.+.++ ...+.
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceec
Confidence 344444556655443 44565577899887554 58999885432 23455667777877743322 11110
Q ss_pred ----EEEeCCeeEEEEeccCCCCccccc----------------------------------------------------
Q 007490 404 ----FCLEGDEKILVYEFVPNKSLDYFL---------------------------------------------------- 427 (601)
Q Consensus 404 ----~~~~~~~~~lv~E~~~~gsL~~~l---------------------------------------------------- 427 (601)
+.........++.++.+.......
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 122234456667766654322110
Q ss_pred ----------------ccccceeeccccccCcEEEccCCCcEEeeccccee
Q 007490 428 ----------------YDSQLRIIHRDLKASNILLDVQMNPKISDFGLARI 462 (601)
Q Consensus 428 ----------------~~h~~~iiHrdlkp~NIll~~~~~~kL~Dfg~a~~ 462 (601)
..-..|+||+|+.++||+++.+...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 00245799999999999999887778999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.38 E-value=0.018 Score=57.10 Aligned_cols=72 Identities=17% Similarity=0.293 Sum_probs=47.8
Q ss_pred CcccccCcceEEeeecCC--------CceeeEEEeccCChhhHHHHHHHHHHHHHcCCCCc-cceEEEEEeCCeeEEEEe
Q 007490 346 NKLGRGGFGEVYKGVLPH--------GQEIAVKRLSRSSGQGAQEFKNEVVLVAKLQHRNL-VRLLGFCLEGDEKILVYE 416 (601)
Q Consensus 346 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E 416 (601)
+.|+.|-.-.+|+...++ .+.|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 567778888899987543 245666665422 223455789999998853344 477777643 68999
Q ss_pred ccCCCCc
Q 007490 417 FVPNKSL 423 (601)
Q Consensus 417 ~~~~gsL 423 (601)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|